08.11.2014 Views

Here - American Geriatrics Society

Here - American Geriatrics Society

Here - American Geriatrics Society

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Dear Annual Meeting Attendee:<br />

The <strong>American</strong> <strong>Geriatrics</strong> <strong>Society</strong> Annual Scientific Meeting is the premier educational event in geriatrics, providing the latest<br />

information on clinical geriatrics, research on aging, and innovative models of care delivery. The 2012 Annual Meeting<br />

will address the professional and educational needs of geriatrics professionals from all disciplines through state-of-the-art<br />

educational sessions and research presentations.<br />

This supplement of the Journal of the <strong>American</strong> <strong>Geriatrics</strong> <strong>Society</strong> is devoted to abstracts of the scientific presentations<br />

that are scheduled for the 2012 AGS Annual Scientific Meeting. We are hopeful that this supplement will be helpful to<br />

those of you who are planning to attend the meeting so as to maximize your attendance at educational, research, and clinical<br />

presentations of interest to you.<br />

We are also pleased to provide these abstracts to subscribers of the Journal. We believe that they are an important way of<br />

keeping JAGS readers up-to-date on the latest advances in the field.<br />

Sincerely,<br />

Belinda Vicioso, MD<br />

Barbara Resnick, PhD, CRNP<br />

2012 AGS Annual Meeting Program Chair AGS President


P APER<br />

A BSTRACTS<br />

Paper Session<br />

Clinical Decision-Making<br />

Thursday, May 3<br />

7:30 am – 9:00 am<br />

P1<br />

Lagtime to Benefit for Colorectal Cancer Screening: A Survival<br />

Meta-Analysis.<br />

S. J. Lee, 1 W. J. Boscardin, 1,2 I. Stijacic-Cenzer, 1,2 J. Conell-Price, 1<br />

S. O’Brien, 1 L. C. Walter. 1,2 1. Division of <strong>Geriatrics</strong>, SFVAMC, UCSF,<br />

San Francisco, CA; 2. Department of Epidemiology and Biostatistics,<br />

University of California, San Francisco, San Francisco, CA.<br />

Supported By: Dr. Sei Lee was supported by Hartford <strong>Geriatrics</strong><br />

Health Outcomes Research Scholars Award, the Hellman Family<br />

Award for Early Career Faculty at UCSF and the KL2RR024130<br />

from the National Center for Research Resources, a component of<br />

the NIH.<br />

Dr. Louise Walter was supported by R01CA134425 from the<br />

National Cancer Institute, which was administered by the Northern<br />

California Institute for Research and Education.<br />

This work was supported with resources of the Veterans Affairs<br />

Medical Center, San Francisco, California.<br />

Background: Guidelines recommend targeting colorectal cancer<br />

(CRC) screening to healthy patients whose life expectancy exceeds<br />

the cancer screening’s lagtime to benefit (i.e. time between screening<br />

and when the benefits of screening are seen). However, the lagtime of<br />

CRC screening is uncertain. Our goal was to determine a pooled,<br />

quantitative estimate of the lagtime to benefit for CRC screening<br />

from randomized controlled trial (RCT) data.<br />

Methods: We conducted a survival meta-analysis of CRC<br />

screening RCTs focusing on older patients (age greater than 50) identified<br />

by Cochrane and USPSTF reviews as high quality. Four population-based<br />

RCTs of fecal occult blood testing from Denmark, England,<br />

Sweden, and the United States (n=327,043) were included in<br />

our meta-analysis.<br />

Results: 4.9 years (95%CI: 2.1 to 9.5) passed before one CRC<br />

death was prevented for 5000 persons screened (absolute risk reduction<br />

or ARR=0.0002). It took 10.4 years (95%CI: 6.1 to 16.6) before<br />

one CRC death was prevented for 1000 persons screened<br />

(ARR=0.001) and 14.6 years (95%CI: 9.7 to 21.2) for 2 CRC deaths<br />

to be prevented for 1000 persons screened (ARR=0.002).<br />

Conclusions:The lagtime to prevent one CRC death per 1000 persons<br />

screened is 10.4 years suggesting that CRC screening should be<br />

targeted toward patients with a life expectancy greater than ten years.<br />

P2<br />

Preferences for Deactivation of Implantable Cardioverter<br />

Defibrillators in the Setting of Advanced Illness.<br />

J. A. Dodson, 1 T. Fried, 1 P. H. Van Ness, 1 N. Goldstein, 2 R. Lampert. 1<br />

1. Yale University School of Medicine, New Haven, CT; 2. Mount Sinai<br />

School of Medicine, New York, NY.<br />

Background: Some implantable cardioverter defibrillator (ICD)<br />

recipients with advanced illness receive painful shocks at the end of<br />

life. The purpose of our study was to explore preferences for ICD deactivation<br />

in the setting of hypothetical advanced illness.<br />

Methods: We conducted a cross-sectional telephone survey of<br />

patients age ≥50 with ICDs followed in a single electrophysiology<br />

practice in New Haven, CT. Sociodemographic and clinical characteristics,<br />

as well as self-reported functional status, were obtained. Patients<br />

were then asked whether they would opt for ICD deactivation<br />

in five distinct scenarios: (1) permanently unable to get out of bed, (2)<br />

permanent memory problems, (3) burden to family members, (4) on<br />

breathing machine >1 month, (5) advanced incurable disease. Patients<br />

who answered “possibly yes” or “definitely yes” to any scenario<br />

were categorized as considering deactivation.<br />

Results: Surveys were completed in 100 patients. Mean age was 71<br />

years, 28% were female, and 18% were nonwhite.Among respondents,<br />

71 patients (71%) would consider ICD deactivation in one or more<br />

scenarios. Responses varied considerably by scenario. Patients considered<br />

deactivation most often in the setting of advanced incurable disease<br />

(61%), and least often if permanently unable to get out of bed<br />

(25%) (Figure). Patients were more likely to consider deactivation if<br />

they were white, had not received a prior ICD shock, or were disabled.<br />

Conclusions: The majority of patients with ICDs would consider<br />

deactivation in at least one scenario reflecting advanced illness.This preference<br />

was most common in the setting of incurable disease, but also not<br />

uncommon in the setting of cognitive impairment or burden to family.<br />

P3 Encore Presentation<br />

Self-rated Health and Walking Ability Predict 10-year Mortality in<br />

Older Women with Breast Cancer.<br />

J. A. Eng, 1,2 K. M. Clough-Gorr, 3,4 R. A. Silliman. 1,2 1. Medicine-<br />

<strong>Geriatrics</strong>, Boston University School of Medicine, Boston, MA; 2.<br />

Boston University School of Public Health, Boston, MA; 3. Institute<br />

of Social and Preventive Medicine, University of Bern, Bern,<br />

Switzerland; 4. National Institute for Cancer Epidemiology and<br />

Registration, Institute of Social and Preventive Medicine, University of<br />

Zurich, Zurich, Switzerland.<br />

Supported By: John A. Hartford Foundation, Health Resources and<br />

Services Administration (D01HP08796-05-00), National Institutes of<br />

Health (K05 CA92395), National Cancer Institute (R01 CA106979,<br />

R01 CA/AG 70818, R01 CA84506)<br />

Background: Self-rated health (SRH) and mobility predict mortality<br />

in general populations but have not been well-studied in older<br />

women with breast cancer. Methods: Women aged ≥65 years with primary<br />

stage I-IIIA breast cancer were enrolled at 4 sites. Data were<br />

collected over 10 years from medical records, annual interviews, and<br />

AGS 2012 ANNUAL MEETING<br />

S1


P APER<br />

A BSTRACTS<br />

the National Death Index. We created a 4-level variable combining<br />

baseline SRH and ability to walk several blocks (SRHWALK). Cox<br />

proportional hazards models were used to examine the impact of<br />

SRHWALK on 10-year all-cause mortality. Analyses were adjusted<br />

for age, socio-demographic and tumor characteristics, initial therapies,<br />

BMI, comorbidity, emotional health, social support, and upper<br />

body function. Results: 660 women with breast cancer were studied<br />

(18% age 80+, 48% stage II-III, 59% with ≥1 comorbidity). At 10<br />

years, 80% of women with low SRH and walking limitations had died<br />

vs. 50% of those with high SRH and no walking limitations (Figure 1,<br />

p0.85 (p=0.02). OS<br />

was associated with ECOG PS (HR 1.8, p=0.05), Activities of Daily<br />

Living (ADL) impairment (HR 5.6, p=0.005), and Vulnerable Elders<br />

Survey (VES-13, HR 5.3, p=0.002), but only VES-13 (HR 15.61,<br />

p=0.016) was significant in a backward stepwise multivariate regression<br />

model. Age was not associated with either RDI or OS.<br />

Conclusions: ECOG PS was associated with completing<br />

RDI>85%, a commonly used and validated cut-off for chemotherapy<br />

efficacy. SPPB may help further risk-stratify. VES-13, a validated 13-<br />

item questionnaire which is easily administered in clinic, was the<br />

strongest correlate of OS, stronger than age or ECOG PS. Age was<br />

not correlated with completion of full dose chemotherapy or OS in<br />

this older cohort. Geriatric screening measures including SPPB and<br />

VES-13 should be used in addition to ECOG PS to risk-stratify older<br />

patients with CRC.<br />

P5 Encore Presentation<br />

Preparing for Decision Making Beyond Advance Directives:<br />

Perspectives from Patients and Surrogates.<br />

R. McMahan, 1,2 S. J. Knight, 2,1 M. Fuez, 2 R. L. Sudore. 2,1 1. <strong>Geriatrics</strong>,<br />

UCSF, San Francisco, CA; 2. San Francisco VA, San Francisco, CA.<br />

Supported By: Veterans Affairs<br />

Background: Traditional advance care planning (ACP) has focused<br />

on documenting life-sustaining treatment preferences in advance<br />

directives (ADs). This focus fails to provide direction for or decrease<br />

the stress of making many, complex decisions over the course<br />

of serious illness. To identify steps beyond ADs to better prepare patients<br />

and their families, we sought to understand diverse, older patients’<br />

and surrogates’ experiences with decision making for serious<br />

illness.<br />

Methods: We conducted 13 English and Spanish-speaking focus<br />

groups with participants from San Francisco VA and county hospitals.<br />

Seven groups included patients (n=38), aged ≥65 years, who reported<br />

making serious medical decisions. Six groups included surrogate<br />

decision makers (n=31), aged ≥18 years. Semi-structured<br />

interviews asked about decision making experiences and what best<br />

prepared participants. Two reviewers performed qualitative, thematic<br />

content analysis.<br />

Results: Mean patient age was 78±8 years and 61% were nonwhite.<br />

Mean surrogate age was 57±10 years and 91% were nonwhite.<br />

Analysis revealed 5 themes to best prepare for decision making.<br />

(1) Identify and ask a surrogate to make decisions – “My wife<br />

wouldn’t be objective. My daughter would make good judgments,<br />

but she didn’t know I wanted her to. You have to ask.” (2) Discuss<br />

leeway in surrogate decision making – “As a child, I would feel better<br />

knowing he would want me to evaluate and change decisions<br />

based upon things which have occurred since he put that in writing.”<br />

(3) Reflect on past experiences to define values for care – “My father<br />

had cancer of the bile duct – he died a miserable death. I don’t<br />

want to put myself or my family through it. I know this.” (4) Tell<br />

others about one’s wishes – “We have three boys and a girl, and we<br />

selected the daughter. When the brothers got the directives they<br />

said, ‘Hey, dad, what’s going on?’ and so we had to talk about it.” (5)<br />

Ask clinicians about the outcomes of treatment – “I would ask<br />

about the side effects. You have to know how your life is going to<br />

be. Will it be good?”<br />

Conclusions: 5 additional ACP steps, beyond ADs, may better<br />

prepare patients and surrogates for complex medical decisions. To be<br />

effective, ACP needs to expand beyond asking patients to make decisions<br />

about life-sustaining treatment and must also focus on preparation<br />

for medical decision making.<br />

S2<br />

AGS 2012 ANNUAL MEETING


P APER<br />

A BSTRACTS<br />

P6<br />

CRASH: A Brief Screening Tool to Identify High-Risk Older<br />

Drivers.<br />

M. E. Betz, 1 R. Schwartz, 2 J. Haukoos, 1,3 C. DiGuiseppi, 4 M. Valley, 1<br />

R. Johnson, 1 S. Lowenstein. 1 1. Emergency Medicine, University of<br />

Colorado School of Medicine, Aurora, CO; 2. Division of <strong>Geriatrics</strong>,<br />

University of Colorado School of Medicine, Aurora, CO; 3.<br />

Emergency Medicine, Denver Health Medical Center, Denver, CO; 4.<br />

Epidemiology, Colorado School of Public Health, Aurora, CO.<br />

Supported By: Funding: Emergency Medicine Foundation and John<br />

A Hartford University of Colorado Denver Center of Excellence.<br />

This study was also supported in part by Grant Number<br />

R49/CCR811509 from the Centers for Disease Control and<br />

Prevention. Its contents are solely the responsibility of the authors<br />

and do not necessarily represent the official views of the CDC.<br />

Background: Current older driver screening tools are impractical<br />

for use in busy clinical settings. We sought to develop and internally<br />

validate a brief questionnaire to identify drivers needing further<br />

evaluation.<br />

Methods: Cross-sectional study of patients aged 65+ years at a<br />

geriatric clinic or emergency department (ED) who drove at least occasionally,<br />

spoke English and had no significant cognitive impairment.<br />

Study staff administered a confidential survey to 246 participants,<br />

enrolled equally from the clinic and ED (participation rate:<br />

43%). Logistic regression was used to identify characteristics associated<br />

with an adverse driving event (ADE), defined as 1+ reported<br />

crash or police stop while driving within the preceding 12 months.<br />

Results: Median participant age was 76 years; half were women.<br />

Most participants (82%, 95%CI 77-86%) reported daily or near-daily<br />

driving; 15% (95%CI 11-19%) reported an ADE. Age and gender<br />

were not associated with ADEs. The final model included five variables<br />

associated with an ADE, to which the CRASH tool assigns one<br />

point each (table): “C” ever feels confused or disoriented while driving;<br />

“R” regular (daily or near-daily) driver; “A” avoids driving alone;<br />

“S” has difficulty seeing the license plate in front while stopped; and<br />

“H” reports that someone has recommended handing over the keys<br />

in the past year. In internal validation, the CRASH tool maintained<br />

its goodness-of-fit (average p=0.70) and had an averaged area under<br />

the ROC curve of 0.72. A score of two or higher was 64% (95%CI 46-<br />

79) sensitive and 70% (95%CI 64-77) specific for an ADE.<br />

Conclusions: The simple, history-based CRASH screening tool<br />

may be useful to identify older drivers who need additional evaluation.<br />

Prospective testing is needed to validate the tool and determine<br />

optimal cut-points for clinical use.<br />

Paper Session<br />

Plenary<br />

Thursday, May 3<br />

11:00 am – 12:00 pm<br />

P7<br />

Out of Pocket Spending in the Last 5 Years of Life.<br />

A. S. Kelley, 1 K. McGarry, 2 J. S. Skinner. 3 1. <strong>Geriatrics</strong> and Palliative<br />

Medicine, Mount Sinai School of Medicine, New York, NY; 2.<br />

Department of Economics, University of California, Los Angeles, Los<br />

Angeles, CA; 3. Department of Economics, Dartmouth College,<br />

Hanover, NH.<br />

Background: A key objective of the Medicare program was to<br />

reduce the risk of financial catastrophe arising from out-of-pocket<br />

(OOP) health-related expenditures among older adults. Yet little is<br />

known about the financial risks faced by Medicare beneficiaries related<br />

to the death of a household head or spouse. We aimed to measure<br />

risks to financial security arising from OOP health-related expenditures<br />

among a nationally representative cohort of adults over<br />

age 65.<br />

Methods: We included participants from the Health and Retirement<br />

Study (HRS) aged 65 years or older, who died between 2003 -<br />

2008 (N = 3,809). We used detailed HRS survey data for each subject<br />

and spouse, when applicable, to examine total OOP health-related<br />

expenditures in the 5 years preceding the subject’s death. We also<br />

measured OOP spending by category of spending (e.g. nursing home,<br />

insurance, and others) and examined OOP spending stratified by<br />

cause of death and quartile of household wealth.<br />

Results: Average OOP expenditures in the five years prior to<br />

death were $34,497.99 (median, $20,876; 90th percentile, $77,910) for<br />

individuals and $46,767 (median $36,874; 90th percentile, $87,081) for<br />

married couples in which one spouse dies. Median expenditures were<br />

84% of median net financial wealth. By cause of death, individuals’<br />

average total spending ranged from $33,699 for those with infectious<br />

disease to $59,314 for those with Alzheimer’s disease. Spending on<br />

long-term care needs was substantial. For the entire sample, 24% of<br />

spending was for nursing home care and 9% for helpers and other expenses<br />

to retain independence at home. Spending differed sharply by<br />

wealth; ranging from $20,241 in the lowest wealth quartile to $49,477<br />

in the highest.<br />

Conclusion: Despite nearly universal insurance coverage under<br />

the Medicare program, older adults face considerable financial risk<br />

from out-of-pocket medical expenses in the last 5 years of life. Longterm<br />

care expenses appear large yet insurance coverage for these expenses<br />

is limited.Wealth-related differences in the components of care<br />

could exacerbate existing inequalities in well-being at the end of life.<br />

P8 Encore Presentation<br />

Geriatric versus General Medical Conditions have Opposite Effects<br />

on Overall Quality of Ambulatory Care.<br />

L. Min, 1,2 E. Kerr, 1,2 C. Blaum, 1,2 C. Cigolle, 1,2 D. Reuben, 4<br />

N. Wenger. 4,3 1. Medicine, University of Michigan, Ann Arbor, MI; 2.<br />

GRECC and Center for Clinical Management Research, VA<br />

Healthcare Systems, Ann Arbor, MI; 3. RAND, Santa Monica, CA; 4.<br />

UCLA, Los Angeles, CA.<br />

Supported By: Agency for Healthcare Quality and Research (Min<br />

and Blaum), VA Healthcare System Health Services Research<br />

(Kerr) and the Geriatric Research Clinical Care Center (GRECC,<br />

Min, Cigolle, and Blaum), Hartford Foundation (Min), RAND<br />

(Wenger, Min), NIA-Pepper Center (Min), NIH-LRP (Min), NIH-<br />

K08 (Cigolle).<br />

Background: Contrary to expectations, patients with greater comorbidity<br />

receive better - rather than worse - quality of care. We evaluated<br />

whether time-consuming geriatric conditions differ from general<br />

medical conditions in their effect on quality.<br />

Sample: 644 older (age >=75) ambulatory care patients in the<br />

Assessing the Care of Vulnerable Elders-2 (ACOVE-2) study.<br />

Methods: Predictors: Condition counts, defined as general medical<br />

(atrial fibrillation, coronary artery disease, heart failure, cerebrovascular<br />

disease, diabetes, hypertension) vs geriatric (falls, dementia,<br />

hearing impairment, incontinence, malnutrition, and<br />

osteoporosis). Outcome: Overall quality of care (QOC) using 65<br />

process-of-care quality indicators, calculated as a mean score across<br />

preventive and eligible general medical, and geriatric-specific care<br />

over 13 months. We used multivariable regression to test for relationships<br />

between overall quality and both geriatric and general medical<br />

condition counts, controlling for age, gender, functional status, and<br />

number of primary care visits.<br />

Results: General medical condition counts (mean 1.9, range 0-6)<br />

were comparable to geriatric conditions (mean 1.6, range 0-4) but the<br />

AGS 2012 ANNUAL MEETING<br />

S3


P APER<br />

A BSTRACTS<br />

two counts were uncorrelated (r=.04, p=.3). Nearly all had at least<br />

one condition in each category, and more than half (52%) had at least<br />

2 conditions in each category. Each additional general medical condition<br />

was associated with a 5% point increment in QOC, while each<br />

additional geriatric condition was associated with a 3.2% point decrement,<br />

independent of each other and the multivariable controls<br />

(p


P APER<br />

A BSTRACTS<br />

growth in NP care of Medicare patients from 1997-2008 and its relationship<br />

with state regulations and also with the availability of primary<br />

care physicians.<br />

Methods: Medicare beneficiaries aged 65 or above with Parts A<br />

and B coverage who were not enrolled in a health maintenance organization<br />

for the entire 12 months of each year during 1996-2008<br />

were selected. We assessed the percentage of community-dwelling<br />

and long term nursing home residents billed by an NP or who received<br />

the majority of their primary care from NPs.<br />

Results: The percentage of community-dwelling Medicare beneficiaries<br />

billed for outpatient NP services rose from 0.3% in 1997 to<br />

7.9% in 2008, while for nursing home patients the increase was from<br />

3.0% to 24.7%. By 2008, 2.2% of community-dwelling and 15.5% of<br />

nursing home residents received the majority of their primary care<br />

from NPs. The percent of community dwelling residents receiving the<br />

majority of their primary care from NPs in 2008 ranged from 0.7% in<br />

Hawaii to 10.8% in Alaska, while for nursing home patients it ranged<br />

from 0% in Wyoming to 44.3% in Tennessee. Compared with states<br />

with the most restrictive regulations, the odds of receiving the majority<br />

of primary care from NPs was 2.5 fold higher for communitydwelling<br />

patients in states with the most liberal regulations. Similar<br />

associations with state laws were found when we measured the number<br />

of NPs practicing per 100,000 adults in the state, using data from<br />

state licensing boards. The availability of primary care physicians<br />

modestly affected NP activity in community-dwelling patients. Neither<br />

availability of primary care physicians nor state regulations were<br />

associated with odds of receiving care from NPs for long term nursing<br />

home residents. In five states that modified their regulations during<br />

1997-2007, the percentage of patients with an NP as PCP increased<br />

significantly (P


P APER<br />

A BSTRACTS<br />

management in collaboration with primary care (PCP) improved care<br />

quality and reduced acute care utilization for seniors at high risk of<br />

hospitalization.<br />

Objective: To assess the impact of GRACE Team Care on hospital<br />

readmissions in older veterans at a Veterans Affairs Medical Center<br />

(VAMC).<br />

Methods: Veterans 65 or older with PCPs from 4 of 5 VAMC<br />

clinics were enrolled following discharge home from an acute hospitalization<br />

on the medicine service from April 2010 to June 2011. After<br />

an initial home-based transition visit, a nurse practitioner and social<br />

worker (GRACE Team) returned to conduct a geriatric assessment<br />

visit. Guided by 12 geriatric protocols and input from the GRACE<br />

geriatrician, pharmacist, and psychologist, the GRACE Team developed<br />

a veteran-centric care plan and collaborated with the PCP to<br />

implement that plan. Hospitalized veterans with PCPs from the fifth<br />

VAMC clinic that did not get GRACE but who otherwise met enrollment<br />

criteria served as a comparison group. Data on demographics,<br />

comorbidity, hospital utilization, and mortality were drawn from VA<br />

databases.<br />

Results: 174 veterans (mean age 78 years, range 65-97; 97%<br />

male) were enrolled in GRACE and followed for an average of 8.5<br />

months (range 0.4-15.5), and 77 veterans (mean age 77 years, range<br />

65-93; 94% male) in the comparison group were followed for an average<br />

of 8.6 months (range 0.4-16.0). Charlson Comorbidity Index<br />

scores were similar between groups: GRACE mean 2.40 (range 0-13)<br />

vs. comparison mean 2.17 (range 0-10). GRACE veterans vs. comparison<br />

had lower readmission rates at 7 days (2/174 [1.1%] vs. 5/77<br />

[6.5%], p=0.03); 14 days (8/174 [4.6%] vs. 7/77 [9.1%], p=0.25); 30<br />

days (17/174 [9.8%] vs. 13/77 [16.9%], p=0.11); and 60 days (26/164<br />

[15.9%] vs. 17/73 [23.3%], p=0.17). Over the follow-up period,<br />

GRACE veterans had a lower mortality rate than the comparison<br />

group (17/174 [10%] vs. 13/77 [17%], p=0.11).<br />

Conclusion: GRACE Team Care, which provided in-home, veteran-centric,<br />

geriatric care management while supporting VA primary<br />

care, had a positive impact on reducing hospital readmissions.<br />

GRACE may offer an opportunity for better care at lower costs in<br />

high risk older veterans.<br />

P15<br />

The Falls and Fractures Clinic: Testing an Integrated Model of<br />

Secondary Prevention in a High-Risk Older Population.<br />

G. Duque, 1,2 P. Suriyaarachchi, 1,2 D. Boersma, 1,2 O. Demontiero, 1,2<br />

G. Loza-Diaz, 1 A. Sharma. 2 1. Ageing Bone Research Program, The<br />

University of Sydney, Penrith, NSW, Australia; 2. Geriatric Medicine,<br />

Nepean Hospital, Penrith, NSW, Australia.<br />

Supported By: Nepean Medical Research Foundation<br />

INTRODUCTION: Although falls and fractures are highly<br />

prevalent in older persons, there is still a fragmentation in terms of<br />

falls being assessed by geriatricians and fractures remaining within<br />

the scope of other specialties. Therefore, an integrated model of secondary<br />

prevention for falls and fractures run by geriatricians is highly<br />

needed.<br />

OBJECTIVE: To evaluate the effectiveness of a multidisciplinary<br />

Falls and Fractures Clinic as an optimal integrated model to assess<br />

risk and to prevent new events in a high-risk older population.<br />

METHODS: Four hundred and thirty subjects (mean age=82,<br />

65% female) were assessed between January 2009-June 2011 at the<br />

Falls and Fractures Clinic, Nepean Hospital (Penrith, NSW, Australia).<br />

Assessment included fear of falling (SAFFE), risk factors for<br />

falls and fractures, physical examination, nutrition, depression, grip<br />

strength (dynamometer), densitometry, posturography (Medicaa,<br />

Uruguay), gait parameters (GaitRITE®), and blood tests for secondary<br />

causes of osteoporosis including vitamin D and parathyroid hormone<br />

(PTH). An integrated plan was then designed according to the<br />

subject’s risk factors. Subjects were surveyed by phone (month 3) and<br />

fully re-assessed at the clinic nine months later.<br />

RESULTS: 77% had suffered a fall and 38% had suffered a fracture<br />

before the assessment. An average of 6.5+/-2.8 falls and 3.5+/-1.8<br />

fracture risk factors were identified per subject. At the time of the<br />

second assessment, the incidence of falls was reduced in -<br />

65%(p


P APER<br />

A BSTRACTS<br />

ent. We hypothesize that resveratrol may be acting through SIRT-1,<br />

which in turn inhibits p53-regulated senescence. Because colon cancer<br />

is a disease whose incidence rises with age, the ability of resveratrol<br />

to inhibit senescence and the aging process in colonic mucosa will<br />

potentially have profound applicability to colon cancer prevention.<br />

P17<br />

The Role of SIRT3-dependent Autophagy in Age-Related<br />

Hearing Loss.<br />

I. Pena , F. A. Pereira. Huffington Center on Aging, Departments of<br />

Otolaryngology-HNS and Molecular & Cellular Biology, Baylor<br />

College of Medicine, Houston, TX.<br />

Supported By: <strong>American</strong> Federation for Aging Research / Medical<br />

Student Training in Aging Research Program, The Oticon<br />

Foundation / The <strong>American</strong> Academy of Otolaryngology–Head &<br />

Neck Surgery Foundation, Huffington Center on Aging–Baylor<br />

College of Medicine.<br />

Background: In 2005, the WHO estimated that 278 million people<br />

suffered moderate-to-profound hearing impairments. This number is<br />

expected to reach 900 million people by 2050, creating immense socioeconomic<br />

burdens worldwide. Age-related hearing loss (AHL), a<br />

disorder associated with accumulated cellular oxidative damage, affects<br />

more than 40% of <strong>American</strong>s over age 65. The mitochondrial<br />

deacetylase SIRT3 improves antioxidant defenses by activating isocitrate<br />

dehydrogenase 2, thereby increasing the reduced-to-oxidized glutathione<br />

ratio. Oxidative stress induces autophagy, a process by which<br />

cells degrade and recycle their contents to preserve cellular health.The<br />

precise molecular mechanisms by which cells respond to oxidative<br />

stress and induce autophagy via SIRT3 have not yet been elucidated.<br />

Methods: We investigated the role of SIRT3 in regulating autophagy<br />

in model systems. We used inner ears, brain, heart, and fibroblasts<br />

from wild type (WT), SIRT3-overexpressing, and Little<br />

mice (have 40% longer lifespan and reduced oxidative stress). Experiments<br />

included activation and inhibition of autophagy and expression<br />

of SIRT3 to determine its potential role in SIRT3-dependent<br />

protective mechanisms against cellular damage and AHL.<br />

Results: The average SIRT3 levels were increased 18% in 24-<br />

month-old WT mice and increased 628% in 24—month-old Little mice,<br />

compared to their 4-month-old littermate controls.When SIRT3 levels<br />

were depleted in WT fibroblasts using siRNA, autophagy was activated<br />

as measured by LC3-II/LC3-I ratio. After an 18- or 24-hour treatment<br />

with 100nM rapamycin, autophagy levels also increased 1.8-fold while<br />

SIRT3 levels decreased 1.37-fold.Activating autophagy by 2 or 4 hours<br />

of starvation increased activation 8.35-fold and SIRT3 levels decreased<br />

3.9-fold. Inhibiting autophagy with 50uM Wortmannin for 2 or 4 hours<br />

decreased autophagy 2.78-fold and increased SIRT3 levels 1.35-fold.<br />

Conclusion: These preliminary results suggest autophagy is<br />

linked to SIRT3: increased SIRT3 is associated with improved oxidative<br />

protection and decreased autophagy and vice versa. These findings<br />

may provide therapeutic insight into rational drug design of new<br />

medications that activate SIRT3 or autophagy for the prevention of<br />

age-related hearing loss and to improve health span.<br />

P18 Encore Presentation<br />

Lipid-depleted apolipoproteins and amyloid peptides are influenced<br />

by APOE genotype and cognitive diagnosis.<br />

A. J. Hanson, 1,2 J. L. Bayer-Carter, 1,2 P. S. Green, 1,2 T. J. Montine, 1,2<br />

L. D. Baker, 1,2 G. S. Watson, 1,2 L. M. Bonner, 2 M. Callaghan, 2<br />

J. B. Leverenz, 1,2 B. K. Walter, 2 E. C. Tsai, 1,2 C. W. Wilkinson, 1,2<br />

J. Zhang, 1 S. Craft. 1,2 1. University of Washington Medical Center,<br />

Seattle, WA; 2. GRECC, VA Puget Sound Health Care System,<br />

Seattle, WA.<br />

Supported By: T32 AG-000258-13 to Dr. Hanson, R37 AG-10880<br />

from NIA to Dr Craft, P50 AG-05136 to Dr. Montine.<br />

BACKGROUND: Sporadic Alzheimer’s disease (AD) is caused<br />

in part by decreased clearance of the Aβ amyloid breakdown products.<br />

Apolipoproteins play an important yet unclear role in Aβ peptide<br />

clearance, particularly ApoE since its E4 variant is a risk factor<br />

for AD. Work in cell culture and animal models have shown that<br />

lipid-depleted apolipoproteins are less effective at binding Aβ, and<br />

that lipoprotein-depleted (LD) fractions of Aβ peptides are more<br />

toxic to neurons. However, not much is known about the lipid states<br />

of these proteins in human CSF.<br />

METHODS: Cerebrospinal fluid (CSF) was obtained from 20<br />

participants with normal cognition (mean age 69 ± 7) and 27 with<br />

amnestic mild cognitive impairment (MCI) (mean age 67 ± 6). We determined<br />

the APOE genotype status of each participant. Lipid-depleted<br />

ApoE and ApoJ and lipoprotein-depleted Aβ peptides were<br />

separated by density gradient ultracentrifugation and levels were<br />

then measured by ELISA. Groups were compared using analysis of<br />

covariance.<br />

RESULTS: Subjects with an APOE ε4 allele (E4+) had higher<br />

lipid-depleted ApoE levels, for both normal and MCI groups<br />

(p


P APER<br />

A BSTRACTS<br />

control collagen had greater expression of alpha 2 integrin, which mediates<br />

cell-extracellular matrix interactions (Hynes, 1987). In conclusion,<br />

collagen from aged mice that have received short-term caloricrestriction<br />

or rapamycin display impaired capacity to polymerize into<br />

a 3D matrix. Fibroblasts placed in these gels display lower cell count<br />

and increased expression of SPARC, but decreased alpha 2 integrin.<br />

These data show that short-term caloric-restriction and rapamycin interventions<br />

alter collagen’s structural properties and influence fibroblast<br />

behavior in ways that might impair wound healing.<br />

P20<br />

Platelet and Monocyte Responses are Impaired in Elderly Septic<br />

Patients.<br />

M. Rondina, 1 C. K. Grissom, 2 E. S. Harris, 1 S. Kalva, 1 S. Men, 1<br />

G. A. Zimmerman, 1 A. S. Weyrich. 1 1. Internal Medicine, Univ. of<br />

Utah, SLC, UT; 2. Critical Care, IMC, SLC, UT.<br />

Supported By: Supported by grants from the NIH (HL091754,<br />

HL066277, K23HL092161, ULI-RRO25764).<br />

The ligand P-selectin (P-SEL) on the platelet surface allows for<br />

heterotypic formation of platelet-monocyte aggregates (PMAs) that<br />

augment innate immune responses. Impaired PMA formation in elderly<br />

patients may contribute to their higher risk of sepsis and subsequent<br />

adverse events but remains unexplored. We prospectively compared<br />

P-SEL expression and PMA levels in elderly (age≥65, n=29)<br />

and young (age


P APER<br />

A BSTRACTS<br />

centration ≤ 37.5 ng/ml. Sixty-four patients received either weekly vitamin<br />

D3(n=31) or placebo (n=33) for 6 months; both groups received<br />

800 mg calcium citrate daily. Baseline and 6 month measures<br />

included peak VO2, 6 minute walk distance (6MW) and Get Up and<br />

Go. Isokinetic muscle strength was measured at 60 and 120 degrees<br />

using knee extensors and flexors. Health status was measured with<br />

the Kansas City Cardiomyopathy Questionnaire (KCCQ). Between<br />

group comparisons were made using ANCOVA models that adjust<br />

for baseline measures.<br />

Results: Subjects in the vitamin D group were 65.8 ± 10.6 years<br />

old, 52% women, and 61% African <strong>American</strong>. Subjects in the placebo<br />

group were 66.0 ± 10.4 years old, 46% women and 67% African<br />

<strong>American</strong>. At baseline the vitamin D group mean serum 25OHD was<br />

19.1 ± 9.3ng/ml and increased by 42.3 ± 16.4 ng/ml at 6 months. Baseline<br />

mean serum vitamin D in the placebo group was 17.8 ± 9.0 ng/ml,<br />

and decreased by 0.2 ± 6.6 ng/ml at 6 months (between groups<br />

p0.15). Adjustment for baseline characteristics sex,<br />

race, and ejection fraction did not change results.<br />

Conclusions: There is no evidence to suggest that high dose vitamin<br />

D3 improves physical performance or health status for older<br />

adults with HF. Vitamin D repletion in patients with HF should conform<br />

to standard vitamin D guidelines for older adults.<br />

P23<br />

Improving 25-hydroxyvitamin D Status in Home-bound Elders and<br />

its Effect on Falls.<br />

D. K. Houston, 1 J. A. Tooze, 1 J. L. Demons, 1 B. Davis, 1 R. Shertzer-<br />

Skinner, 1 L. Kearsley, 2 R. Gottlieb, 2 J. D. Williamson. 1 1. Sticht Center<br />

on Aging, Wake Forest School of Medicine, Winston Salem, NC; 2.<br />

Senior Services, Inc., Winston Salem, NC.<br />

Supported By: Supported by the Wake Forest Translational<br />

Science Institute, Center for Integrative Medicine and Pepper<br />

Center (P30-AG21332).<br />

Background: Home-bound older adults are a particularly vulnerable<br />

subgroup of older adults for poor dietary intake and nutritional<br />

health, nutrition-related health conditions, and functional decline.<br />

Although vitamin D supplementation has been shown to be<br />

effective in preventing falls in controlled clinical trials, whether these<br />

findings can be successfully translated to community-based programs<br />

has not yet been determined. We conducted a 5-month randomized,<br />

placebo-controlled pilot study to assess the feasibility of delivering vitamin<br />

D supplements to home-bound older adults receiving Meals on<br />

Wheels (MOW) and the effectiveness of the vitamin D supplements<br />

to improve 25-hydroxyvitamin D (25(OH)D) levels and reduce falls.<br />

Methods: Sixty-eight MOW clients in Forsyth Co, NC, who were<br />

not currently taking prescription vitamin D 2<br />

or >1000 IU/day of vitamin<br />

D 3<br />

were enrolled from December 2010 through March 2011<br />

(mean age, 77.8 yrs; 72% women; 75% black). Serum 25(OH)D was<br />

measured at baseline and 5-month follow-up and falls assessed by<br />

monthly fall calendars and phone calls. Participants were randomized<br />

by MOW route to receive 100,000 IU vitamin D 3<br />

(n=38) or an active<br />

placebo control (n=30) once a month along with their MOW meal.<br />

Results: Serum 25(OH)D levels (mean±SD) at baseline were<br />

22.5±12.2 and 18.9±10.6 ng/mL in the intervention and control group,<br />

respectively (p=0.22). Ninety percent of participants received 4 or<br />

more of the 5 vitamin D/placebo monthly doses. Serum 25(OH)D<br />

levels improved significantly in the intervention group compared to<br />

the control group (LS means±SE: +20.4±1.8 vs. -2.2±2.1 ng/mL adjusted<br />

for age, gender, race, randomization group and baseline<br />

25(OH)D, p1.0 m/s and impaired<br />

motor skill (by Figure of 8 walk time, F8WT > 8 secs).<br />

Methods: Forty older adults were randomized to MS or SE<br />

treatment arms. Both arms were 1 hour, twice weekly, PT-supervised<br />

interventions for 12 weeks. Pre and post intervention assessments<br />

performed by masked assessors included gait efficiency or energy<br />

cost of walking (mean rate of O2 consumption for 3 minutes of preferred<br />

speed treadmill walking divided by speed, ml/kg-m), gait<br />

speed, obstacle walk, F8WT and the Late Life Function and Disability<br />

Index disability subscale (LLFDI). Outcomes between arms were<br />

compared with ANCOVA, adjusted for the pre-intervention value.<br />

Results: Of 40 randomized subjects; 38 completed the trial (MS,<br />

n=18; SE, n=20; mean age 77.1±6.0 years). Gait efficiency improved<br />

(energy cost decreased) marginally more in MS than SE (- 0.04 vs. -<br />

0.02 ml/kg-m, adjusted difference, AD=0.03, p=0.13). MS improved<br />

more than SE in gait speed (0.13 vs. 0.05 m/s; AD=0.11, p=0.008); obstacle<br />

walk time (-0.89 vs. -0 .42 secs; AD=0.60, p=0.01), and F8WT (-<br />

0. 22 vs. -0.89 seconds; AD=1.39, p


P APER<br />

A BSTRACTS<br />

creating a barrier to treatment. A simple 3-item measure (the 3IQ)<br />

was developed to facilitate diagnosis, but the efficacy and safety of<br />

using the 3IQ to initiate treatment are unknown.<br />

Methods: In this double-blinded trial, 645 ambulatory women<br />

diagnosed with urgency incontinence using the 3IQ rather than an extended<br />

evaluation were randomized to 12 weeks of pharmacologic<br />

therapy with fesoterodine (4-8 mg daily) (N=322) or placebo<br />

(N=323). Change in urgency incontinence over 12 weeks was assessed<br />

by voiding diaries. Safety was assessed through adverse event monitoring<br />

and measurement of post-treatment postvoid residual volume<br />

(PVR), with specialist referral for PVR ≥ 250 mL or safety concern.<br />

Results: Mean (SD) baseline urgency incontinence frequency<br />

was 3.9(3.0) episodes/day. After 12 weeks, women in the fesoterodine<br />

group reported an average of 0.9 fewer urgency incontinence, 1.0<br />

fewer total incontinence, and 0.9 fewer urgency-associated voids per<br />

day, compared to placebo (P 65 should receive 1-1.5<br />

mg/kg. We determined whether older patients were less likely than<br />

younger patients to be given propofol for induction; whether propofol<br />

dose decreased with increasing age, per published guidelines; and<br />

whether, for patients > 65 years, increasing doses of propofol were associated<br />

with post-induction hypotension.<br />

Methods: We conducted a retrospective multivariate analysis of<br />

data from the Anesthesia Information Management System at Mount<br />

Sinai Hospital with IRB approval. We obtained data for 41,156 cases<br />

age 18-90, undergoing GA between 2006 and 2010, after excluding<br />

cardiac and obstetric cases. Post-induction hypotension was defined<br />

by meeting either of 2 criteria: (1) mean arterial pressure (MAP) decrease<br />

> 40% and MAP < 70 mmHg, or (2) MAP < 60 mmHg.<br />

Results: In the population studied, 31,827 patients (77%) received<br />

propofol. The cohort receiving propofol was younger (53 years<br />

vs. 60 years), non-emergent (88% vs. 75%), and had lower ASA physical<br />

status (51% ASA I-II vs. 23%) (p < 0.001 for each). Propofol dose<br />

decreased with increasing age (Pearson correlation = -0.35). The median<br />

dose for patients 65 population,<br />

47% received > 1.5 mg/kg. A larger dose of propofol was associated<br />

with an increased likelihood of hypotension in the post-induction period,<br />

and this effect was age-dependent. For the same increase in<br />

propofol dose (0.5 mg/kg), a 65 year old was less likely to experience<br />

hypotension than an 80 year old (OR=1.09 vs. 1.15, respectively).<br />

Conclusions: A large cohort of patients > 65 were given higherthan-recommended<br />

doses of propofol for induction of GA. Higher<br />

doses were associated with increased incidence of significant hypotension<br />

in the post-induction period. This is clinically important because<br />

significant post-induction hypotension has been associated<br />

with increased incidence of post-operative adverse events.<br />

Paper Session<br />

Epidemiology<br />

Saturday, May 5<br />

10:45 am – 12:15 pm<br />

P28<br />

Risk Factors for Restricting Back Pain in Community-Living Older<br />

Persons.<br />

U. E. Makris, 1,2 L. Han, 3 L. Leo-Summers, 3 L. Fraenkel, 3,4 T. M. Gill. 3<br />

1. Internal Medicine, UT Southwestern Medical Center, Dallas, TX; 2.<br />

Medicine, Veterans Affairs, Dallas, TX; 3. Internal Medicine, Yale<br />

School of Medicine, New Haven, CT; 4. Medicine, Veterans Affairs,<br />

West Haven, CT.<br />

Supported By: T32 AG019134 Yale <strong>Geriatrics</strong> Training Program in<br />

Aging Related Research and Clinical Epidemiology; ACR<br />

REF/ASP Junior Career Development Award in Geriatric<br />

Medicine; RO3 AG040653 NIA GEMSSTAR.<br />

Background: Back pain is a common and costly condition<br />

among older persons. Few prospective studies have evaluated the risk<br />

factors for back pain in older persons.<br />

Methods: We evaluated the 731 participants (mean age 78.8<br />

years, 65% women) of the Precipitating Events Project, a prospective<br />

study of community-living persons, aged 70+ years, who completed<br />

monthly interviews of restricting back pain, defined as staying in bed<br />

for at least 1/2 day and/or cutting down on one’s usual activities due<br />

to back pain, for up to 126 months. Candidate risk factors were measured<br />

from five domains (demographic, cognitive-psychosocial, health<br />

related, habitual, physical capacity) during comprehensive homebased<br />

assessments that were completed every 18 months for up to 108<br />

months. Among participants without restricting back pain, two distinct<br />

outcomes were determined during each 18-month interval: (1)<br />

short-term (1 episode lasting 1 month) and (2) persistent (1 episode<br />

lasting >= 2 months) or recurrent (>= 2 episodes of any duration) restricting<br />

back pain. The cumulative incidence of the outcomes were<br />

estimated during the total follow-up period using a GEE binomial<br />

model. A multivariable Cox model was used to evaluate the adjusted<br />

associations between each candidate risk factor and the two outcomes<br />

of interest.<br />

Results: The cumulative incidence was 17.8% (95% CI: 16.5,<br />

19.3) for the short-term outcome and 17.9% (16.1, 19.9) for the persistent/recurrent<br />

outcome. Factors independently associated with a<br />

higher risk of developing short-term restricting back pain included female<br />

sex (HR 1.30, P=0.01), hip weakness (HR 1.19, P=.001) and poor<br />

grip strength (HR 1.24, P=.04); and for the persistent/ recurrent outcome<br />

included female sex (HR 1.48, P=0.01), depressive symptoms<br />

(HR 1.57, P=


P APER<br />

A BSTRACTS<br />

be amenable to interventions designed to prevent the occurrence,<br />

persistence, or recurrence of this common disorder in older persons.<br />

P29<br />

Falls and Orthostatic Hypotension: Re-examining Limits.<br />

A. Cleinman, 1 M. E. Griswold, 2 E. Simonsick, 3 W. M. Meeks, 1<br />

K. Gregg, 1 L. Ferrucci, 3 B. G. Windham. 1 1. Department of Medicine,<br />

Division of <strong>Geriatrics</strong>, University of Mississippi Medical Center,<br />

Jackson, MS; 2. Center of Biostatistics and Bioinformatics, University<br />

of Mississippi Medical Center, Jackson, MS; 3. Clinical Research<br />

Branch, NIH - National Institute on Aging, Baltimore, MD.<br />

Supported By: National Institutes of Health, National Institute<br />

on Aging<br />

Background: Guidelines recommend treating orthostatic hypotension<br />

(OH) to reduce risk of falls in older adults. We hypothesized<br />

that low systolic blood pressure (SBP) upon standing and/or decreases<br />

from usual SBP, even without meeting OH criteria, would also<br />

be related to falls risk.<br />

Methods: Baltimore Longitudinal Study of Aging participants (<br />

>65y) with a first visit that evaluated OH and self-report of falls in the<br />

previous 12 months were examined. Participants with >10 visits were<br />

excluded to minimize extended cohort participation bias. OH was defined<br />

using the classical definition of SBP decrease >20mmHg or diastolic<br />

BP decrease > 10mmHg, 3 minutes after standing from a<br />

supine, resting position. Logistic regression was used to examine associations<br />

between falls and BP measures, adjusting for age, sex, race,<br />

education, stroke, diabetes, hypertension, and vision.<br />

Results: Among 412 participants, (aged 65-97, 45% female, 64%<br />

white), 115 (28%) reported falling: 77 had one fall and 38 reported >2<br />

falls. Only 19 participants (4.6%) had formally defined OH. Falls<br />

were more common in those with OH (53% vs 27%, p=0.033). In adjusted<br />

models, falls were significantly associated with OH, OR=3.05<br />

(95% CI: 1.06, 8.78) p=0.038, but not with final standing SBP,<br />

OR=1.01 (0.99, 1.02) p=0.358. Furthermore, each 1mmHg decrease in<br />

SBP upon standing was associated with an additional 6% increase in<br />

risk, OR=1.06 (1.01, 1.10) p=0.008. This is equivalent to 31%, 73%,<br />

and 198% increases in risk for 5, 10, and 20mmHg drops in SBP. The<br />

risk associated with decreases in SBP upon standing did not depend<br />

on the final standing SBP (p=0.74 for interaction).<br />

Conclusions: The risk of falls in this sample depended on decreases<br />

in SBP upon standing rather than the final standing SBP. Although<br />

classically defined OH was associated with falls, increased<br />

risks were seen for any decrease in SBP upon standing, even those<br />

not meeting OH criteria. This suggests that a continuous spectrum of<br />

SBP drops upon standing conveys important information about risk.<br />

Any SBP drop may warrant consideration in falls risk assessments.<br />

P30<br />

Sensory and motor nerve function differentially relate to gait<br />

parameters: the Health ABC Study.<br />

E. S. Hile, 1 J. S. Brach, 1 M. Yang, 1 S. A. Studenski, 1 R. M. Boudreau, 1<br />

P. Caserotti, 2,3 S. Satterfield, 5 A. V. Schwartz, 4 E. Simonsick, 2<br />

L. Ferrucci, 2 T. B. Harris, 2 A. B. Newman, 1 E. S. Strotmeyer. 1 1.<br />

University of Pittsburgh, Pittsburgh, PA; 2. National Institute on<br />

Aging, Baltimore, Bethesda, MD; 3. University of Southern Denmark,<br />

Odense, Denmark; 4. University of California, San Francisco, CA; 5.<br />

University of Tennessee, Memphis, TN.<br />

Supported By: National Institute on Aging (NIA) Contracts N01-<br />

AG-6-2101; N01-AG-6-2103; N01-AG-6-2106; NIA grant R01-<br />

AG028050, and NINR grant R01-NR012459.<br />

Pittsburgh Claude D. Pepper Older <strong>American</strong>s Independence<br />

Center (P30 AG024827)<br />

BACKGROUND: Many older adults have subclinical or undiagnosed<br />

peripheral nerve decline. Sensory decline is associated with<br />

gait deviations [reduced speed; increased double support time (DST)<br />

and base of support (BOS)] in diabetic or neuropathic cohorts, but<br />

less is known about age-related decline. Poor sensory and motor<br />

nerve function associate with slower speed in the Health ABC cohort,<br />

but how biomechanical gait parameters explain this is unknown.<br />

We investigated relationships between nerve function and spatial or<br />

temporal gait parameters. METHODS: Of 3075 baseline Health<br />

ABC participants, we included 544 (83.4±2.7 yrs, 52.9% women,<br />

35.5% black) with Year 11 gait parameters [4-m usual walk speed,<br />

BOS, step length, step time, DST, stance and swing time] and nerve<br />

function [sensory:1.4 and 10g monofilament (MF) detection, vibration<br />

threshold (VT); motor: peroneal nerve conduction velocity<br />

(NCV) and amplitude (CMAP)]. Gait parameters were outcomes<br />

modeled with each nerve predictor by multivariate regression adjusted<br />

for age, sex, race, BMI, diabetes, PVD, stroke, physical activity,<br />

smoking and vision. Most gait parameters vary with speed, so final<br />

models were adjusted for speed to assess independence. RESULTS:<br />

Worse sensory and motor nerve function by VT or CMAP (but not<br />

MF or NCV) related to slower speed. Worse VT associated with<br />

longer stance and step times (p


P APER<br />

A BSTRACTS<br />

Conclusion: This study provides evidence that use of medications<br />

with strong or moderate AC effects in older women is associated<br />

with increased risk of falls, clinical vertebral fracture, and total<br />

fractures, but is not associated with hip fracture or lower arm/wrist<br />

fracture.<br />

P32<br />

Falls among Adult Patients Hospitalized in the United States:<br />

Prevalence and Trends.<br />

E. L. Bouldin, 1,2 E. M.Andresen, 2,3 N. E. Dunton, 4 M. Simon, 5<br />

T. M.Waters, 8 M. Liu, 2 M. J. Daniels, 2 L. C. Mion, 6 R. I. Shorr. 7,2 1.VA<br />

Puget Sound HSR&D, Seattle,WA; 2. University of Florida,<br />

Gainesville, FL; 3. Instistute on Disability and Development, Oregon<br />

Health & Science University, Portland, OR; 4. Health Policy and<br />

Management, University of Kansas Medical Center, Kansas City, KS; 5.<br />

Health Sciences, University of Southampton, Southampton, United<br />

Kingdom; 6. School of Nursing,Vanderbilt University, Nashville,TN; 7.<br />

Geriatric Research Education & Clinical Center, Malcolm Randall VA<br />

Medical Center, Gainesville, FL; 8. Department of Preventive Medicine,<br />

University of Tennessee Health Science Center, Memphis,TN.<br />

Supported By: NIH/NIA R01-AG025285, NIH/NIA R01-AG033005<br />

Background:The purpose of this study was to provide normative<br />

data on fall prevalence in US hospitals and to determine 27-month<br />

secular trend in falls prior to the implementation of the Centers for<br />

Medicare and Medicaid Service (CMS) rule which does not reimburse<br />

hospitals for care related to injury resulting from hospital falls.<br />

Methods: We used data from the National Database of Nursing<br />

Quality Indicators (NDNQI) collected between July 1, 2006 and September<br />

30, 2008 to estimate prevalence and secular trends of falls occurring<br />

in adult medical, medical-surgical and surgical nursing units.<br />

More than 88 million patient days (pd) of observation were contributed<br />

from 6,100 medical, surgical, and medical-surgical nursing<br />

units in 1,263 hospitals across the United States.<br />

Results: A total of 315,817 falls occurred (rate=3.56 falls/1,000<br />

pd) during the study period, of which 82,332 (26.1%) resulted in an<br />

injury (rate=0.93/1,000 pd). Both total fall and injurious fall rates<br />

were highest in medical units (fall rate=4.03/1,000 pd; injurious fall<br />

rate=1.08/1,000 pd) and lowest in surgery units (fall rate=2.76/1,000<br />

pd; injurious fall rate=0.67/1,000 pd). Falls (0.4% decrease/quarter,<br />

p


P APER<br />

A BSTRACTS<br />

age increased, the overall rate of catheterization for all older inpatients<br />

declined from 19.9% to 11.9%, a 40% reduction. The greatest<br />

improvement was seen on the ACE Unit, where the rate of catheterization<br />

declined from 20.4% to 9.7%, a 53% reduction. The catheter<br />

utilization ratio decreased from 68% to 20%, while the average<br />

catheter days per patient declined from 11.7 to 2.8 days per patient<br />

across all inpatient units. Conclusions: This study demonstrates the<br />

dramatic and sustained improvements in catheter utilization that can<br />

be achieved with the support of a multi-modal educational intervention<br />

in improving patient safety and quality care efforts around the<br />

appropriate use of urinary catheters in a variety of inpatient settings.<br />

P35<br />

A <strong>Geriatrics</strong> rotation as a Medicine elective: A smart option for<br />

medical students?<br />

A. Nguyen , 1 E. Duthie, 1 E. Duthie, 2 K. Denson, 2 J. Franco. 2 1.<br />

Institute for Health and <strong>Society</strong>, Medical College of Wisconsin,<br />

Milwaukee, WI; 2. Internal Medicine, Medical College of Wisconsin,<br />

Milwaukee, WI.<br />

Background: Medical schools must look at innovative ways to<br />

ensure that graduates achieve basic competencies in geriatrics and<br />

encourage new physicians to consider the subspecialty. Our objectives<br />

are to: 1) assess the impact of a month-long geriatrics rotation,<br />

as part of the internal medicine clerkship, on M3 students’ knowledge,<br />

skills, and attitudes toward geriatric practice and career choice;<br />

and 2) assess knowledge outcomes by comparing mean NBME internal<br />

medicine shelf exam scores between students who completed the<br />

geriatrics rotation and students who completed the internal medicine<br />

ward rotations.<br />

Methods: This study was conducted at a medical school where a<br />

month-long geriatrics evaluation and management (GEM) rotation<br />

fulfills a graduation requirement in internal medicine. One-hour<br />

focus groups were conducted with two cohorts: 1) students who rotated<br />

through GEM and 2) students who did not. Thematic analyses<br />

using the principles of grounded theory were performed to compare<br />

group responses between the two cohorts. One focus group of 4-6<br />

participants was conducted for each cohort. Independent t-test was<br />

performed to compare mean NBME internal medicine shelf exam<br />

scores between all GEM (n=124) and non-GEM (n=1318) students<br />

who matriculated between 2005 and 2011. ANOVA was used to compare<br />

the means after controlling for Step 1 exam scores.<br />

Results: Focus groups revealed differences in reported comfort<br />

and attitudes toward geriatric care with the GEM cohort reporting<br />

higher levels of confidence with geriatric assessment skills. Mean<br />

NBME internal medicine shelf exam scores between GEM students<br />

[mean (SD)=73.66 (±7.2)] and non-GEM students [mean (SD)=73.60<br />

(±7.4)] were not statistically significant (p=0.938). Controlling for<br />

Step 1 scores did not produce statistically significant differences<br />

(p=0.371).<br />

Conclusion: Completing an internal medicine ward rotation requirement<br />

using a geriatrics rotation is an innovation that medical<br />

schools should consider. Comparisons of NBME scores show that<br />

GEM students perform just as well on the internal medicine board<br />

exam as their non-GEM colleagues but were more comfortable<br />

with elder care. Evaluating geriatrics curricula will add to understanding<br />

of student perspectives about geriatrics as a career field<br />

and allow curriculum developers to identify areas of strength and<br />

areas for improvement.<br />

P36<br />

Case Presentation as a Direct Observation Method to Evaluate<br />

Internal Medicine Residents’ Systems-Based Practice Competency.<br />

K. Ouchida, S. Ramsaroop, S. Mehta, L. Logio, R. Adelman,<br />

E. Siegler. Medicine, Weill Cornell Medical Center New York<br />

Presbyterian Hospital, New York, NY.<br />

PURPOSE: Of the 6 core competencies the Accreditation<br />

Council of Graduate Medical Education requires, systems-based<br />

practice (SBP) often poses the greatest challenge for curriculum development<br />

and evaluation. A redesigned geriatrics rotation for internal<br />

medicine (IM) residents incorporates a SBP module with direct<br />

exposure to health care sites and services utilized by older adults. This<br />

study describes the use of a case presentation to evaluate IM residents’<br />

knowledge of the health care system and ability to navigate it.<br />

METHODS: Starting June 2011, all PGY-2 IM residents (N=48)<br />

complete a 1-week SBP module as part of the required 4-week geriatrics<br />

rotation. The module combines structured exposures to community-based<br />

programs, supervised patient care on house calls and in<br />

a transitional care clinic, and self-directed learning. Residents present<br />

an older continuity patient to the geriatrics interdisciplinary team,<br />

which then models a collaborative problem-solving approach. One<br />

faculty member takes notes and emails residents a summary of the<br />

identified problems and the team’s “action plan.” The problems and<br />

recommendations were analyzed to generate a list of themes for coding.<br />

Discrepancies in coding were resolved by discussion until consensus<br />

was reached.<br />

RESULTS: To date 21 (44%) IM residents have presented cases.<br />

Presentations generated 19 types of biopsychosocial issues (mean 3.8<br />

per patient) and 12 types of recommendations (mean 5.4). Lack of social<br />

support (15.1%), care coordination challenges (13.9%), and negative<br />

illness behaviors such as refusal of care (10.1%) represent the<br />

most frequently identified problems. The interdisciplinary team’s recommendations<br />

most often focused on care coordination strategies<br />

(15%), community resources (14.2%), medical treatment or workup<br />

(14.2%) and goals of care (13.3%). The case presentation received<br />

one of the highest ratings from residents on the module evaluation<br />

(4.75 out of 5).<br />

CONCLUSIONS: A case presentation represents an effective<br />

strategy for directly observing and evaluating IM residents’ systemsbased<br />

practice competency. Presentations reveal residents’ struggles<br />

with the health care system and comprehension of their older patients’<br />

needs, and offer exposure to geriatric approaches through<br />

practical advice. This evaluation method is feasibly implemented and<br />

well-received by residents.<br />

P37<br />

Replicating a Chief Resident Immersion Training in <strong>Geriatrics</strong><br />

(CRIT).<br />

S. Levine, 1 L. Caruso, 1 B. Brett, 2 H. Auerbach, 1 A. Jackson, 1<br />

A. Burrows, 1 S. Chao. 1 1. Boston Univerisity Medical Center<br />

(BUMC), Boston, MA; 2. Brett Consulting Group, Boston, MA.<br />

Supported By: John A. Hartford Foundation, Association of<br />

Directors of Geriatric Academic Programs (ADGAP)<br />

Background: Chief residents (CRs) play crucial roles in resident<br />

and student training and in quality patient care. They typically receive<br />

minimal formal education in geriatrics, teaching skills and leadership.<br />

With support from the John A. Hartford Foundation and ADGAP,<br />

BUMC disseminated its successful 2-day offsite CRIT program, addressing<br />

these deficiencies, to demonstrate national replicability.<br />

Methods: Through a competitive RFP, 12 institutions in 3 cohorts<br />

were selected to implement CRIT across specialties for 2 years<br />

each. The modular curriculum included an unfolding case discussed in<br />

small groups, evidence-based mini-lectures on geriatrics topics, and<br />

interactive seminars on teaching and leadership skills. 1-to-1 consults<br />

helped CRs develop an action project. Social opportunities were provided<br />

to develop relationships. Faculty mentors were invited to increase<br />

institutional “buy-in.” BUMC’s support to each institution included<br />

attending BUMC’s CRIT. National evaluation of CRIT<br />

included a self-report pre-survey, a 12-item pre- and immediate post-<br />

CRIT knowledge test, and a 6-month follow-up survey, administered<br />

by each institution. Results across institutions and cohorts were<br />

merged for analysis.<br />

Results: Over 3 years in 12 institutions, 301 CRs and 86 faculty<br />

mentors participated in CRIT, representing 29 specialties. Response<br />

AGS 2012 ANNUAL MEETING<br />

S13


P APER<br />

A BSTRACTS<br />

rates for CRs were 99% (n=299) for the pre-survey, 97% (n=293) for<br />

the pre-post test, and 78% (n=234) for matching pre to 6-month followup.<br />

CRs showed significant gains in knowledge (p


P APER<br />

A BSTRACTS<br />

Methods: Data for acute hospital admissions were obtained<br />

from 61 PACE programs across the US(over 25,000 enrollees), for the<br />

time period 6/1/2008-5/31/2010. Program enrollment data for this<br />

time period were also used together with diagnostic data on program<br />

participants. For each program, exposure-adjusted hospitalization, 30-<br />

day all-cause readmission, and PAH rates were calculated. Multivariate<br />

analyses, with program fixed-effects, were used to assess the impact<br />

of individual-level risk factors on hospitalization rates.<br />

Results: The average hospitalization rate in PACE (547/1000<br />

participants) was 43% lower than for non-PACE dually eligible recipients<br />

of home and community-based services (HCBS) (962/1000).<br />

PACE 30-day average readmission rate (19.1%) was 17% lower compared<br />

to non-PACE dually eligible beneficiaries, age 65+ (22.9%).<br />

The average PAH rate in PACE (175/1000) was 30% lower than<br />

among duals in HCBS programs (250/1000). There were significant<br />

variations across PACE sites in all hospital measures, which remained<br />

after risk-adjustment.<br />

Conclusions: Although PACE participants are among the<br />

frailest of Medicare and Medicaid beneficiaries, their risk of hospital<br />

use is significantly reduced in an integrated clinical care model that is<br />

reinforced by integrated financing. Variations in hospital rates across<br />

PACE indicate continued opportunities for further improvement<br />

with regard to hospital use.<br />

P41<br />

Evaluation of a National Care Transition Program.<br />

S. Wee, 1 P. Wang, 1 E. Koh, 1,2 A. Gan, 2 G. Ganesan. 2 1. Research,<br />

Health Information Management and Evaluation, Agency for<br />

Integrated Care, Singapore, Singapore; 2. Health Services Research<br />

and Evaluation, Ministry of Health, Singapore, Singapore.<br />

Background: Transitional care interventions for carefully selected<br />

patients from hospital to other settings had shown promise in<br />

reducing rates of subsequent hospitalizations. We evaluated the effectiveness<br />

of a state funded national care transition care program involving<br />

our five largest public hospitals to reduce acute care utilization.<br />

The program was adapted from Coleman’s Care Transition<br />

Program®.<br />

Objectives: To compare the risk of hospital re-admission and<br />

emergency department (ED) attendance of acutely ill patients on the<br />

program to other patients admitted during a similar time frame,<br />

matched for age, gender and hospital subsidy status.<br />

Methods: Retrospective cohort study of 4132 patients discharged<br />

from the five acute hospitals from Feb 2009 to Jul 2010 on<br />

care transition program and 4132 control patients chosen from the<br />

State Hospital Claim System. Propensity (conditional probability of<br />

enrolment into program) scores were derived by multiple logistic regression<br />

with the covariates age, gender, length of initial hospital stay,<br />

Charlson index, past 180 days hospital admission, past 180 days ED<br />

attendance. A logistic regression model was fitted to the data. Re-admission<br />

and ED attendance were compared after covariate adjustment<br />

and weighting by propensity scores.<br />

Results: The baseline characteristics of patients in the two<br />

groups were similar after weighting by propensity. Baseline characteristics<br />

for the program patients were: age (SD) 79.2 (7.7) y, 44%<br />

male, mean length of hospital stay (SD) 11.6 (13.1) days, mean Charlson<br />

index (SD) 1.6 (1.8), mean no. of hospitalization and ED attendance<br />

180 days prior to index admission were 0.79 and 1.9 respectively.<br />

Subjects enrolled on the program were less likely to be readmitted<br />

and visit the ED. The adjusted odds ratio (95% CI) comparing rehospitalisation<br />

and ED re-attendance of program subjects with that<br />

of controls at 30 days, were 0.68 (0.61, 0.76) and 0.79 ( 0.71, 0.89) respectively;<br />

and at 180 days, were 0.79 (0.72, 0.87) and 0.88 (0.80, 0.97)<br />

respectively.<br />

Conclusion: Supporting patients and caregivers to take a more<br />

active role during care transition through a care transition program is<br />

effective in reducing subsequent re-hospitalization and ED attendance<br />

in acutely ill patients at risk for transitions.<br />

P42<br />

The Epidemiology of Physically and Verbally Aggressive Behaviors<br />

of Nursing Home Residents Directed at Staff.<br />

M. Lachs, 1 A. Rosen, 2 K. Pillemer, 3 J. Teresi. 4 1. Medicine, <strong>Geriatrics</strong>,<br />

Weill Cornell Medical College, New York, NY; 2. Emergency Medicine<br />

Residency, New York Presbyterian Hospital, New York, NY; 3. Human<br />

Development, Cornell University, Ithaca, NY; 4. Research Division,<br />

Hebrew Home at Riverdale, Riverdale, NY.<br />

Supported By: National Institute on Aging<br />

National Institute of Justice<br />

New York State Department of Health<br />

Background: While considerable media attention has focused on<br />

abuse of nursing home residents by staff, little research focus has<br />

been directed towards examining the opposite phenomenon: physical<br />

and verbal aggression directed at staff by nursing home residents. We<br />

hypothesized that resident-to-staff aggression (RSA) is a potentially<br />

common phenomenon, as dementia-related behavioral problems are<br />

frequent in nursing home residents and often an impetus for nursing<br />

home placement.<br />

Objective: To perform the first methodologically rigorous study<br />

on the prevalence of RSA in nursing homes.<br />

Methods: We conducted this study as part of a large, multisite<br />

NIA-funded study attempting to estimate the prevalence of residentto-resident<br />

elder mistreatment in long term care facilities. For this<br />

project, the behavior of 1,550 residents of 5 nursing homes was evaluated.<br />

Certified nursing assistants primarily responsible for the care of<br />

residents under study in the parent project were asked whether any<br />

physical, verbal, or sexual behaviors were directed at them by the resident<br />

in the previous two weeks using an instrument validated for this<br />

purpose.<br />

Results: Staff reported that 15.7% of residents directed abuse<br />

towards them within the past two weeks. The most commonly reported<br />

types of verbally abusive behavior reported were screaming<br />

(9.0% of residents) and using bad words (7.2%). The most commonly<br />

reported types of physically abusive behavior reported were hitting<br />

(3.9% of residents) and kicking (2.6%). Aggressive behaviors reportedly<br />

occurred most commonly in the patient room (84.8%) and in the<br />

morning (84.3%).<br />

Conclusion: RSA in nursing homes is highly prevalent. This phenomenon<br />

may negatively affect quality of care, resident and staff<br />

safety, and job satisfaction and staff turnover. Further studies are<br />

needed to understand how and why it occurs, and to develop interventions<br />

to mitigate its potential impact.<br />

P43<br />

Defining medically complex patients using chronic conditions,<br />

healthcare utilization and functional status.<br />

W. W. Hung, 1,2 A. S. Kelley, 1 E. Livote, 2 J. Penrod, 1,2 A. Federman, 1<br />

A. L. Siu. 1,2 1. Mt Sinai School of Medicine, NY, NY; 2. JJP VAMC,<br />

Bronx, NY.<br />

Supported By: VA HSRD<br />

Background:<br />

The majority of healthcare costs are concentrated among a<br />

small proportion of medically complex older adults. While complexity<br />

is often defined by multiple chronic conditions, not all patients with<br />

chronic conditions are complex and patients with a single serious illness<br />

can have complex and costly medical needs. Our objective is to<br />

evaluate 3 different definitions of complexity based on chronic conditions,<br />

healthcare utilization, and functional measures by examining<br />

AGS 2012 ANNUAL MEETING<br />

S15


P APER<br />

A BSTRACTS<br />

each definition’s predictive value for healthcare costs and survival.<br />

We hypothesized that complexity should be predictive of healthcare<br />

costs and survival.<br />

Methods:<br />

We used Medicare Current Beneficiary Survey data from 2000<br />

(year 1) & 2001 (year 2). We excluded those under age 65, managed<br />

care participants, & decedents in 2000. Using year 1 data, we developed<br />

3 definitions of complexity from candidate variables including:<br />

chronic conditions from claims; healthcare utilization patterns associated<br />

with high costs in year 1; and self-reported functional status (i.e.<br />

performance of activities of daily living). For each definition, we<br />

measured prevalence, year 1 & 2 costs, and mortality in year 2 compared<br />

to the full sample.<br />

Results:<br />

Older adults with 4 or more chronic conditions accounted for<br />

24% of the population but accounted for 36% of health care costs in<br />

year 2. Those who had a major chronic condition (i.e. high cost conditions<br />

such as diabetes, dementia) and either 2 or more acute hospitalizations<br />

or 3 or more other conditions accounted for 14% of the sample<br />

but accounted for 29% of year 2 costs and had a year 2 mortality<br />

rate of 20% vs. 5%. Adding the functional limitation in bathing identified<br />

23% of the sample which accounted for 48% of costs in year 2<br />

and had a year 2 mortality rate of 20% vs. 3%.<br />

Conclusion:<br />

Using chronic conditions alone identifies a population that has a<br />

moderate concentration in future costs. Identification of medically<br />

complex adults is improved when prior hospitalizations and functional<br />

status are also considered. These measures can be used to identify<br />

patients as appropriate targets for interventions to improve care<br />

and reduce the costs of serious illness.<br />

P44<br />

Risk Factors for Early Hospital Readmission among Low Income<br />

Seniors.<br />

T. C. Iloabuchi, 1 W. Tu, 1,2 D. Mi, 2 S. R. Counsell. 1,2 1. Indiana<br />

University School of Medicine, Indianapolis, IN; 2. Indiana University<br />

Center for Aging Research, Indianapolis, IN.<br />

Background: Early hospital readmission among older persons<br />

often represents suboptimal care transitions and may result in adverse<br />

health outcomes and avoidable costs.<br />

Purpose: To identify risk factors available on admission that<br />

could be used in identifying hospitalized low-income seniors at increased<br />

likelihood for experiencing early readmission.<br />

Methods: Prospective cohort study using data from the Geriatric<br />

Resources for Assessment and Care of Elders (GRACE) randomized<br />

controlled trial (RCT), which enrolled and followed over two years<br />

951 adults ≥ 65 years with annual income


P OSTER<br />

A BSTRACTS<br />

Poster Session A<br />

Thursday, May 3<br />

12:00 pm – 1:30 pm<br />

A1<br />

FROZEN WITH PAIN.<br />

A. Bhagavan, 1 A. Talsania, 1 S. Bellantonio. 2 1. Internal medicine,<br />

Baystate Medical Center, Springfield, MA; 2. Geriatric medicine,<br />

Baystate Medical Center, Springfield, MA.<br />

Introduction:<br />

Sternoclavicular joint (SCJ) septic arthritis, first described in<br />

1896, constitutes


P OSTER<br />

A BSTRACTS<br />

been ruled out. It is then recommended that in patients who present<br />

with delirium, ammonia level should be considered as part of the<br />

workup especially if they have accompanying constipation.<br />

A4 Encore Presentation<br />

Delirious Because of Treatment: An Adverse Effect of Imipenem.<br />

B. L. Africa, 1,2 D. Carthen, 1,2 H. Arabelo. 1,2 1. <strong>Geriatrics</strong>, St. Luke’s<br />

Roosevelt Hospital Center, New York, NY; 2. Columbia University<br />

College of Physicians and Surgeons, New York, NY.<br />

The mainstay treatment of delirium is the reversal of the underlying<br />

cause. In the elderly population, this is often caused by an infection,<br />

for which antibiotics are initiated. However in this case, it was<br />

the antibiotic that led to the delirium.<br />

This is a case of a 91 year old woman with a history of chronic osteomyelitis<br />

from an infected hip implant, who was admitted due to<br />

weakness and lethargy. She was found to have a sinus tract in the left<br />

hip with draining fluid and a urinary tract infection. She was started<br />

on cefepime and vancomycin. On the subsequent day, her mental status<br />

and leukocytosis has improved. Fluid cultures taken from her hip<br />

grew Pseudomonas resistant to cefepime and thus imipenem was<br />

started. Two days later she was found to be lethargic. She was diagnosed<br />

that time with hypoactive delirium from the<br />

osteomyelitis/hardware infection. Orthopedic surgery was consulted<br />

for removal of her hip hardware; however she was deemed not a candidate<br />

for surgery. Her symptoms progressed and she became comatose.<br />

The family was informed regarding her poor prognosis. Subsequently,<br />

her antibiotics were stopped due to futility. Two days after<br />

stopping imipenem, she was awake and asking for food. Her condition<br />

continued to improve and she was then eventually discharged home.<br />

This case shows the clinical implication of an adverse effect of a<br />

medication. Hypoactive delirium although not a known side effect of<br />

imipenem, was observed in this particular case. This indicates the investigation<br />

of other underlying causes of delirium, in which antibiotics<br />

maybe one of them. There have been no known published articles<br />

relating hypoactive delirium due to imipenem. It may be<br />

worthwhile to investigate on this matter.<br />

A5<br />

Title: Multiple myeloma with spontaneous tumor lysis syndrome in<br />

an elderly patient; a rare entity.<br />

H. Chataut, M. Bednarczyk, M. Gorbien, M. Leiding, J. Olson.<br />

Division of <strong>Geriatrics</strong> Medicine and Palliative Medicine, RUSH<br />

University Medical Center, Chicago, IL.<br />

Purpose: To recognize complications especially tumor lysis<br />

which can be associated with multiple myeloma ( MM) in an elderly<br />

patient.<br />

Case Report: An 83 year old woman with history of coronary artery<br />

disease presented with fatigue, weakness and unintentional 15<br />

lbs weight loss over 3 months. She denied fever/chills, night sweats,<br />

bladder/bowel complaints, bleeding from any site. Physical exam revealed<br />

normal vital signs and unremarkable systemic exam. Laboratory<br />

analysis revealed Hb 6 g/dL with normal MCV, Platelet count<br />

48,000/dL creatinine 3.7 mg/dL, total protein 12.1g/dL with albumin<br />

2.4 g/dL, Calcium 10.6 mg/dL, LDH 346 U/dL. Serum protein electrophoresis<br />

showed monoclonal band. She was hydrated and transfused<br />

packed RBCs and a bone marrow biopsy showed sheets of<br />

plasma cells consisting of 70% of marrow cellularity. Bone survey revealed<br />

multiple lytic lesions in skull, humerus, mandible. Chemotherapy<br />

was being planned but in the interim the symptoms worsened and<br />

laboratory analysis showed worsening creatinine 4.8 mg/dL, uric acid<br />

13.9 meq/dL, phosphorus 6 meq/dL and potassium 5.3 meq/dL. She<br />

was started on aggressive hydration and rasburicase for presumed<br />

tumor lysis syndrome, which resulted in improvement in symptoms<br />

and laboratory parameters. Dexamethasone was added for MM. Further<br />

therapy is being planned as outpatient with bortezomib with<br />

very close follow-up.<br />

Discussion: The incidence of MM increases considerably with<br />

age. The number of geriatric patients with MM is expected to increase<br />

over time as a consequence of the increased life expectancy of the<br />

normal population, and management of these patients is likely to become<br />

particularly pertinent in coming years. MM in the elderly can be<br />

a therapeutic challenge. Acute tumor lysis syndrome is rarely observed<br />

in MM. The incidence is probably less than 1% of patients who<br />

are treated with intermediate or high-dose chemotherapy. It is only<br />

occasionally observed with dexamethasone or prednisone treatment.<br />

Few case reports exist of the same. Spontaneous tumor lysis syndrome,<br />

on the other hand, has not been reported in untreated<br />

myeloma. Our case is unique with spontaneous tumor lysis in a very<br />

elderly patient with new diagnosis of MM, rapidly declining performance<br />

status with co-morbidities, presenting a therapeutic challenge.<br />

A6<br />

A case of atypical Gastro-intestinal bleeding (GIB) in an elderly; not<br />

just diverticulosis.<br />

H. Chataut, 1 M. Bednarczyk, 1 M. Gorbien, 1 M. Leiding, 1 J. Olson, 1<br />

C. Teodoro, 1 R. Arora. 2 1. Department of Geriatric Medicine, RUSH<br />

university medical center, Chicago, IL; 2. Gastroenterology, Rush<br />

University Medical Center, Chicago, IL.<br />

Purpose: GIB may present with vague symptoms and can be fatal.<br />

Background: GIB that required multiple procedures along with<br />

octreotide.<br />

Method: Case report<br />

Case report: A 85 year old man with receiving aspirin and<br />

coumadin presented with confusion, hypotension, tachycardia, guaiac<br />

positive and Hgb 5 gm/dl, INR 2.2. After resuscitation emergent<br />

colonoscopy revealed diverticulosis, non bleeding angiodysplasia<br />

(AVMs) and colon full of blood up to cecum with no blood in the terminal<br />

ileum, suggesting colonic source for bleeding. EGD up to duodenum<br />

showed no evidence of recent or active bleeding. Patient’s<br />

Hgb continues to drop requiring 17 units of Packed RBC transfusion<br />

in 2 days. Technetium labeled RBC scan localized the bleeding to<br />

duodenum and jejunum. Enterescopy showed bleeding site in the<br />

duodenum at junction of bulb and second portion of duodenum along<br />

with non bleeding AVMs in small bowel. Bleeding site was treated<br />

with epinephrine and cauterization. This temporarily stopped the<br />

bleeding; however bleeding recurred in the following day. Then patient<br />

underwent visceral arteriogram and empiric embolization of<br />

gastroduodenal artery (GDA), superior rectal artery of inferior<br />

mesenteric artery (IMA). In the setting worsening GIB, patient had a<br />

trial of octreotide infusion along with pantoprazole intravenously.<br />

Octreotide inhibits gastric acid secretion and decreases splanchnic<br />

blood flow due to its vasoconstrictive effect. Thereafter, hemoglobin<br />

stabilized and patient recovered.<br />

Discussion: This is a complex case of GIB from multiple angiodysplasia<br />

concurrent with diverticulosis. Patient presented with<br />

hypovolemic shock from GI bleed, requiring multiple blood transfusions.<br />

Thus we can initially assume that GIB from a large and readily<br />

visible source. However, this was not the case. This presented a diagnostic<br />

dilemma, which necessitated multiple procedures. To conclude,<br />

a trial of octreotide was given in the context of worsening GIB. In this<br />

case, looking and targeting a specific lesion may not be the best therapeutic<br />

option. Thus we step back and treat the GI system with a<br />

medication that affects it at all levels. This clinical scenario is not uncommon<br />

since both occur in elderly patients. Octreotide has been<br />

shown to halt bleeding in cases of angiodysplasia and was successful<br />

in our patient.<br />

A7<br />

The four-year mystery diagnosis.<br />

M. Walker, D. A. Pasquale. UPMC, Pittsburgh, PA.<br />

Background:<br />

S18<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

Achalasia is a rare, elusive, and progressive disease that is usually<br />

diagnosed only once it has reached advance stages. Described is a<br />

case of an older adult who after four years of extensive testing received<br />

therapeutic treatment for symptoms of episodic hypersalivation,<br />

vomiting, and weight loss.<br />

Case description:<br />

A 79 yo female with a history of Alzheimer’s Disease, atrial fibrillation,<br />

and osteoporosis was first seen in the office in 2006 with the<br />

complaint of episodic hypersalivation, vomiting, and weight loss. Initial<br />

EGD was significant for H.pylori, pre-pyloric edema and ulcer,<br />

gastric antrum thickening, and antral erosion. Laboratory tests, CT of<br />

the abdomen, and ultrasound of the abdomen were negative. Her<br />

symptoms persisted, however, after eradication of the H. pylori and<br />

PPI therapy. Further investigations in 2009 involved obtaining a<br />

colonoscopy and a non-air contrast barium enema; both revealed diverticulosis.<br />

Transglutaminase and small bowel biopsy were subsequently<br />

negative for celiac disease. In April 2010 she was diagnosed<br />

with lymphoma and was started on Rituxan therapy; she completed 4<br />

treatments. She then underwent psychiatric evaluation and was<br />

treated for apparent paranoia.<br />

In 2010 she again presented to the office with similar complaints.<br />

She now stated that she regurgitated what she ate after approximately<br />

15 minutes. She was given a trial of applesauce to verify<br />

her statement and after 10 minutes she regurgitated the applesauce.<br />

She was immediately admitted to the hospital for a barium swallow<br />

study that resulted in retained barium confirming the diagnosis of<br />

achalasia. The diagnosis of achalasia came with great relief to the patient.<br />

Today, her symptoms have resolved with the use of botulinum<br />

toxin injections.<br />

diagnosis which often times diverts clinicians from less common and<br />

treatable causes. This is a case of failure to thrive with chronic abdominal<br />

pain suggestive of an underlying malignancy but found to<br />

have a benign cause.<br />

The patient is a 78 year old female, cognitively intact with no<br />

past medical or surgical history, from Senegal, presented with a progressive<br />

2- year history of intermittent, mild, lower abdominal pain<br />

with normal soft bowel movements and 30-lb weight loss. Symptoms<br />

worsened for the past 2 months. She reports bright red blood per rectum<br />

but denies diarrhea, constipation, hematemesis,vaginal bleeding<br />

or fever.<br />

On physical examination, her abdomen was soft, non-distended<br />

with mild bilateral lower quadrant tenderness, without guarding or<br />

rebound. Rectal exam showed no hemorrhoids or masses with brown,<br />

Guiac positive stools. CT scan of the abdomen revealed significant<br />

circumferential thickening at the lower anus and rectum suspicious<br />

for malignancy.<br />

Colonoscopy failed to show any discrete mass but found irregularity<br />

and bogginess of anal mucosa along with severe diverticulosis<br />

of entire colonic mucosa. Biopsies were sent and were negative for<br />

malignancy. Ova and parasite screen revealed Ascaris lumbricoides.<br />

Patient was started on mebendazole. A three-week follow-up<br />

was significant for improved appetite with relief of abdominal pain<br />

and diarrhea.<br />

Discussion:<br />

Dealing with immigrants, parasitic causes of failure to thrive<br />

should be considered. Most of the literature describes Ascariasis in<br />

tropical and subtropical areas affecting mostly children without mentioning<br />

any case in the Geriatric population. Adults with ascariasis<br />

are more likely to present with biliary complications. However, significant<br />

nutritional deficiencies can be seen due to malabsorption, as in<br />

this case. Hence in an immigrant with failure to thrive, parasitic<br />

causes should be entertained.<br />

Barium Swallow<br />

A8 Encore Presentation<br />

Worming Through a Case of Failure to Thrive.<br />

M. A. Rashad, 1 J. Angeles, 1 H. Arabelo, 1 B. Matti-Orozco. 1,2 1.<br />

Geriatric medicine, St Lukes Roosevelt Hospital, New York, NY; 2.<br />

Medicine, Columbia Univeristy College of Physicians and Surgeon,<br />

New york, NY.<br />

Failure to thrive is a common diagnosis in the elderly consisting<br />

of physical frailty, cognitive impairment and functional disability.<br />

Weight loss more than 5% within 1 year is considered as the key component<br />

and usually attributed to poor oral intake, medications, depression,<br />

stroke and dementia. Malignancy is also a major differential<br />

A9<br />

Arteriovenous malformations in End Stage Renal disease.<br />

N. Maheshwari, 1 R. Varma, 1 S. Kulkarni, 1 D. Kumari, 2 E. Ong, 1<br />

E. Roffe, 2 S. Chaudhari. 2 1. Internal Medicine, New York Medical<br />

College Metropolitan Hospital Centre, Manhattan, New York, NY; 2.<br />

<strong>Geriatrics</strong>, New York Medical College Metropolitan Hospital Center,<br />

New York, NY.<br />

Introduction: Angiodysplasias can cause upper and lower gastrointestinal<br />

(GI) bleeding in small percentage of patients with an increased<br />

prevalence in patients like ESRD. We present a case of a<br />

ESRD patient with recurrent GI bleeding secondary to AVM that ultimately<br />

required a life saving surgical intervention.<br />

Case presentation: A 68 year old African <strong>American</strong> male patient<br />

with ESRD on maintenance hemodialysis was referred from Dialysis<br />

Center for evaluation of severe anemia with hemoglobin (Hb) of<br />

5.1gm/dl. He was managed in the medical intensive care unit and stabilized<br />

with multiple blood transfusions. EGD, colonoscopy and capsule<br />

endoscopy were inconclusive except an AVM in the proximal jejunum<br />

which was photocoagulated. Patient was discharged but<br />

presented again after a repeat fall in Hb from 8.7 to 4.3 gm/dl and was<br />

readmitted to MICU. A small bowel endoscopy did not demonstrate<br />

any lesion this time, tagged RBC scan showed abnormal activity from<br />

hepatic flexure till the sigmoid colon. Colonoscopy showed multiple<br />

erythematous mucosal lesions in the cecum, ascending colon and a<br />

solitary lesion in the left colon resembling AVM which was photocoagulated.<br />

Patient continued to drop his Hb despite repeated blood<br />

transfusion. A repeat colonoscopy showed fresh red blood throughout<br />

the colon up till the cecum and no clear bleeding site identified.<br />

Angiography of the celiac axis and superior mesenteric artery failed<br />

to identify clear focus of bleeding. Finally patient underwent Right<br />

hemicolectomy and distal ileal resection as a life saving procedure.<br />

Patient remained stable postoperatively and made an uneventful recovery.<br />

AGS 2012 ANNUAL MEETING<br />

S19


P OSTER<br />

A BSTRACTS<br />

Discussion: Angiodysplasia are cause of recurrent and chronic<br />

GI bleeding with marked acute bleeding in a small minority of patients.<br />

The reason for increased prevalence among patients with<br />

ESRD is unknown. Angiodysplasia are usually diagnosed by endoscopy.Angiography<br />

is gold standard for the diagnosis but it has low<br />

sensitivity. Radionulide scanning is more sensitive than angiography<br />

but lacks specificity. Bleeding angiodysplasia is commonly treated endoscopically.<br />

Surgery and angiography are alternatives for patients in<br />

whom endoscopic therapy has failed. Physician should aware of angiodysplaisa<br />

as cause of GI bleeding in old age patient, especially<br />

with ESRD.<br />

A10<br />

Old habits die hard.<br />

Q. Syed. <strong>Geriatrics</strong>, Cleveland Clinic, Cleveland, OH.<br />

Supported By: no financial disclosures<br />

86 year old female is brought to the ER after being found by<br />

daughter unresponsive in her house, with a needle in her arm. Patient<br />

was not arousable by narcan IV 2mg administered by EMT. Past history<br />

significant for hypertension, hepatitis B and hepatitis C. Social<br />

history is significant for IV heroin abuse since age 25, along with inconsistent<br />

use of marijuana and cocaine. She was enrolled in opioid<br />

detoxification programs multiple times with no benefit. She received<br />

detoxification therapy with methadone in 2002 and 2006, and with<br />

buprenorphine and naloxone in 2009. She initially did well on<br />

buprenorphine and naloxone but had a relapse during the time period<br />

when close friends passed away. On arrival in ED, vital signs indicated<br />

bp=186/102,p=81, T=98.6, =20, spo2=99% RA. On exam pt<br />

was noted to be nonverbal, opening her eyes on painful stimulus only.<br />

Pupils were reactive to light bilaterally, corneal reflex intact. Patient<br />

was able to move all extremities in response to painful stimuli. CT<br />

showed new acute subdural hematoma over the left cerebral hemisphere<br />

measuring up to 1.4 cm at the level of the left frontal lobe with<br />

1 cm midline shift. Patient underwent urgent craniectomy for evacuation<br />

of left acute subdural hematoma. Urine toxicology screen was<br />

positive for opiates. Patient was transferred to ICU and received mechanical<br />

ventilation for supportive care. Neurological status improved<br />

gradually within 1 week, patient became awake and alert, was<br />

able to follow commands and verbally communicate. Muscular<br />

strength was noted to be 3/5 bilat extremities. She was extubated day<br />

10th. She was cleared by speech therapist for oral pureed diet. Rehab<br />

team evaluated her and she was noted to require complete assistance<br />

in moving from one side to another, and transfer. She was discharged<br />

to skilled rehab 2 weeks after admission.<br />

Heroin is the second most frequently cited primary substance of<br />

abuse, after alcohol, for all admissions to substance abuse treatment<br />

by adults over the age of 50. Analyses of the Treatment Episodes<br />

Data Set (TEDS) identified that in 2005, 1 in 5.3 substance abuse admissions<br />

of 50–54 year old were for heroin abuse. Review of literature<br />

supports the need for practitioners within substance abuse settings to<br />

be sensitive to the physical limitations of older adult clients. Reduced<br />

mobility and stamina along with cognitive impairments associated<br />

with aging and decades of substance abuse will require adaptations<br />

within the treatment setting.<br />

A11 Encore Presentation<br />

Case Report: Immune Thrombocytopenic Purpura (ITP) Triggered<br />

by Allopurinol Refractory to Steroids and Intravenous<br />

Immunoglobulin (IVIG) Responded to Rituximab.<br />

R. Kothari. Internal Medicine, Coney Island Hospital, Brooklyn, NY.<br />

Background: ITP is an autoimmune disease that involves peripheral<br />

and central opsonization of platelets by auto-antibodies directed<br />

against different surface glycoproteins, leading to their premature<br />

destruction by the reticulo-endothelial system. Allopurinol is a<br />

xanthine oxidase inhibitor commonly used for the prevention of<br />

gouty arthritis. Less than 1% of patients develop significant adverse<br />

reaction including thrombocytopenia and vasculitis.<br />

Case: An 89 year old lady with hypertension, chronic systolic<br />

heart failure, stage 2 chronic kidney disease, gouty arthritis and peptic<br />

ulcer disease was admitted with generalized petechial rash all over<br />

her body after taking allopurinol for one week. On admission,<br />

platelet counts were 127,000. She received intravenous steroids, Benadryl<br />

and was discharged with a tapering dose of oral steroids. Her<br />

platelet count was 73,000 upon discharge.<br />

She was readmitted after 2 days due to development of oral ulcers<br />

and odynophagia; platelet count was noted to be 52,000. Abdominal<br />

sonogram did not show splenomegaly. She received high dose intravenous<br />

steroids. Oral ulcers resolved, but there was no significant<br />

improvement in rash and platelet counts. Platelet counts decreased to<br />

14,000 after a total of 21 days of intravenous plus oral steroids, then<br />

she received IVIG. She completed 5 days of IVIG but platelet count<br />

decreased further to 7,000. Direct anticoagulation test was positive<br />

and due to refractory thrombocytopenia she was given Rituximab.<br />

After two doses of Rituximab, platelet counts increased to<br />

25,000 and she was discharged home with oral steroids. On subsequent<br />

clinic follow up visits, platelet counts improved to 100,000. She<br />

completed tapered steroid treatment and after 7 days the platelet<br />

count was within normal range. She was followed up in the clinic for<br />

next 2 months and there was no thrombocytopenia noted.<br />

Discussion: The principal therapeutic options for elderly patients<br />

are similar to that of young adults. Age influences the response<br />

and adverse effect of conventional ITP therapies. The duration of disease<br />

before treatment with Rituximab did not affect responsiveness<br />

to therapy.<br />

A12<br />

Case of nephrogenic diabetes inspidus due to chronic Lithium use.<br />

R. Otsuka, S. Rahgoshay, T. V. Caprio. the University of Rochester<br />

Medical Center, Rochester, NY.<br />

Background: Lithium continues to be the mainstay for treatment<br />

in many older adult patients with chronic psychiatric illness.<br />

Lithium also has the potential for toxicity, drug-drug interactions and<br />

life threatening side effects. Nephrogenic diabetes inspidus is one of<br />

major concerns, causing hypernatremia and dehydration which may<br />

be amplified in at-risk older adults. We present a case of acute lithium<br />

induced nephrogenic diabetes.<br />

Case Presentation: A 66 year old male with schizoaffective disorder<br />

and intellectual disability was prescribed lithium for many<br />

years and he presented to the hospital with lethargy for a few days.<br />

He had been noted to be drinking several times from the faucet and<br />

had increased nocturia prior to presentation. However due to his intellectual<br />

disability, he was not able to communicate effectively to<br />

make his needs known. Initial blood work revealed a serum sodium<br />

of 154 meq/L. His renal function and other electrolytes were normal.<br />

Lithium level was within a therapeutic range. He underwent desmopressin<br />

stimulation test and was diagnosed with nephrogenic diabetes<br />

inspidus. His Lithium was discontinued.<br />

Discussion: This case highlights several challenges with the use<br />

of lithium in older adults with chronic illness, impaired cognition, and<br />

limitations in communicative abilities. Chronic lithium use is associated<br />

with nephrogenic diabetic inspidus (resistance to ADH), resulting<br />

in polyuria and polydipsia in up to 20 to 40 percent of patients receiving<br />

therapy. Acute onset of nocturia is an important clue to<br />

diagnose this condition, however nocturia can be a common symptom<br />

in older adults which makes recognition challenging. Furthermore,<br />

older adults are more susceptible to salt and water imbalance, including<br />

dehydration and hypernatremia which can be life-threatening. In<br />

addition, impaired sensation of thirst occurs with aging and may exacerbate<br />

this condition. Another important consideration in this case is<br />

that people with intellectual disabilities or chronic psychiatric illness<br />

may have difficulty expressing their needs and obtaining access to hy-<br />

S20<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

dration. Therefore, careful clinical monitoring by facility staff or families<br />

and laboratory assessments are essential for patients receiving<br />

lithium. Finally, there should be a consideration of changing therapy<br />

to other medications if appropriate, especially for those at highest<br />

risk for lithium-induced complications.<br />

A13<br />

Clinical Challenge of diagnosing Amyotrophic Lateral Sclerosis<br />

(ALS) in Elderly Patients.<br />

S. Rana, 1,2 N. Manov, 2 S. S. Rana. 3 1. <strong>Geriatrics</strong>, University of<br />

Pittsburgh School of Medicine, Pittsburgh, PA; 2. <strong>Geriatrics</strong>, UPMC-<br />

St Margaret Hospital, Pittsburgh, PA; 3. Neurology, Allegheny<br />

General Hospital, Pittsburgh, PA.<br />

Amyotrophic Lateral Sclerosis (ALS) occurs in 2 to 3 per 100<br />

thousand population and predominantly affects elderly.Diagnosis is<br />

made on clinical examination and ruling out other possible disorders.<br />

Since the elderly patients commonly have other confounding comorbidities,<br />

ALS is often misdiagnosed. We present two cases of ALS that<br />

underwent spine surgery with misdiagnosis of weakness secondary to<br />

degenerative spine disease.<br />

Methods: Chart review of two patients<br />

Case studies<br />

Case 1: 78 year male with history of prostate and lung cancers<br />

treated with chemotherapy in 2008, developed footdrop in fall of<br />

2009. Initial EMG studies showed denervating process involving legs<br />

which were felt to be secondary to peripheral neuropathy.Based on<br />

imaging studies he underwent decompressive surgery at L4-5 level<br />

with presumed diagnosis of radiculopathy. Patient continued to<br />

worsen and developed diffuse weakness, progressive weight loss, and<br />

respiratory failure for which he required tracheostomy and ventilator<br />

support. Follow up EMG studies revealed widespread denervating<br />

process, consistent with ALS.<br />

Case 2: 71 year female with history of hypertension, coronary artery<br />

disease, presented with weakness in legs, recurrent falls and “sciatic<br />

pain”. She underwent imaging studies of spine and was diagnosed<br />

with scoliosis. She underwent surgery at the thoracic level. She continued<br />

to get weaker in her extremities and then developed<br />

dysarthria. EMG studies showed widespread denervating process and<br />

she was diagnosed with ALS.<br />

Conclusion: Early ALS can be difficult to diagnose as there is no<br />

diagnostic test available. In elderly patients, initial presentation of<br />

ALS is commonly attributed to radiculopathies secondary to degenerative<br />

spine disease. Better diagnostic tools are needed to help diagnose<br />

patients with ALS. In the interim, patients with painless onset of<br />

weakness, absence of sensory symptoms and presence of fasciculations,<br />

should raise suspicion for ALS. In these patients, judicious approach<br />

ie EMG studies by experienced electromyographers, and<br />

carefully correlating the results to imaging studies are warranted. Increased<br />

awareness, and multidisciplinary approach can prevent unnecessary<br />

spine surgeries in these patients.<br />

A14<br />

A Stuttering Discovery of Lithium Toxicity.<br />

S. Sabillo, 1 R. V. Samala, 2 J. O. Ciocon. 1 1. <strong>Geriatrics</strong>, Cleveland Clinic<br />

Florida, Weston, OH; 2. The Harry R. Horvitz Center for Palliative<br />

Medicine, Cleveland Clinic, Cleveland, OH.<br />

Objectives<br />

1. Describe a case of lithium toxicity presenting as stuttering<br />

2. Enumerate the medications that may cause stuttering<br />

3. Discuss the mechanisms and management of drug-induced<br />

stuttering<br />

Case<br />

An 86-year-old female nursing home resident was typically described<br />

by the care staff as alert, pleasant, and conversant, though disoriented<br />

to time and place at times. She was frequently seen in the<br />

hallways, interacting with personnel and patients, and often breaking<br />

into song with her melodious voice. Her past medical history was significant<br />

for dementia, epilepsy, and bipolar disorder. Chronic medications<br />

included donepezil, risperidone, primidone, and lithium carbonate.<br />

One day, she complained to her nurse that she had been<br />

stuttering, finding it difficult to complete a sentence, as well as sing.<br />

She grew increasingly bothered by her faltering speech as the days<br />

wore on, and also pointed out that her grip on objects was becoming<br />

weak. Her attending physician was subsequently informed of these<br />

new symptoms. Physical and neurological examinations were unremarkable<br />

aside from her obvious stutter. She was able to talk straight<br />

for a few words, and then would begin to repeat syllables and words<br />

until she became obviously frustrated and abruptly terminate her<br />

sentence. A CT scan of her head was done which was similarly unremarkable.<br />

Her stuttering persisted for 3 more months until a lithium<br />

level was checked, and came back elevated at 2.0 mmol/L (0.6 to 1.2<br />

mmol/L). Lithium carbonate was promptly stopped and after about 2<br />

weeks, her level was back to normal, and her stuttering had completely<br />

resolved.<br />

Discussion<br />

A broad array of drugs has been shown to cause stuttering. Included<br />

in the list are phenothiazines, tricyclic antidepressants, benzodiazepines,<br />

selective serotonin reuptake inhibitors, theophylline,<br />

phenytoin, carbamazepine, and clozapine. Proposed mechanisms involve<br />

different drug-receptor systems: cholinergic, dopaminergic, noradrenergic,<br />

and serotonergic. In all previously reported cases, stuttering<br />

stopped when the offending agent was discontinued. We find<br />

great interest in this case since there has been a scarcity of literature<br />

implicating lithium. Clinicians should, therefore, be aware of stuttering<br />

as a potential sign of drug toxicity.<br />

A15<br />

Elderly Female with Hypercalcemia: Hodgkin Lymphoma<br />

Masquerading as Relapsed Breast Cancer.<br />

S. Lee, Y. Ang, S. Bellantonio. Internal Medicine, Baystate Medical<br />

Center, Springfield, MA.<br />

INTRO<br />

Malignancy-associated hypercalcemia is common in metastatic<br />

breast and prostate cancers as well as multiple myeloma. Hodgkin<br />

Lymphoma(HL) infrequently causes hypercalcemia. In the elderly, it<br />

can present as delirium and fatigue. We report a septuagenarian female<br />

breast cancer survivor with hypercalcemia who was found to<br />

have stage IVA HL.<br />

CASE<br />

A 76-year-old lady with history of right breast cancer status post<br />

mastectomy and type 2 diabetes presented to her PCP with a 5 day<br />

history of generalized malaise, intermittent confusion, nausea, vomiting,<br />

diarrhea, and epigastric pain. An enlarged right supraclavicular<br />

lymph node was found. Due to concern for cancer relapse, she was<br />

sent to the hospital for evaluation. She was found to be hypercalcemic(iCa<br />

1.6mmol/L) with normal phosphorous(3.4mg/dL),<br />

PTH(52pg/ml), and PTHrP(0.74pmol/L) levels. Renal function was<br />

good, and she had not been on vitamin D supplementation. CT scans<br />

show multiple splenic masses, a liver lesion, and an enlarged right<br />

subclavicular lymph node. Bone scan revealed no osseous involvement.<br />

She was treated with IV fluids, zoledronic acid, and glucocorticoids<br />

with normalization of serum calcium and resolved symptoms.<br />

Eventually, a supraclavicular lymph node biopsy confirmed HL,<br />

nodular sclerosing type. She was discharged with prednisone and<br />

plans for outpatient chemotherapy.<br />

DISCUSSION<br />

Malignancy-associated hypercalcemia affects 20% of cancer patients.<br />

This is most often PTHrP mediated. Also common is osteolytic<br />

hypercalcemia due to cancer metastasis to bone. Overproduction of<br />

calcitriol is a rare cause of hypercalcemia in malignancy(1% of cases).<br />

Incidence of this complication in HL is about 5%[1]. HL can produce<br />

AGS 2012 ANNUAL MEETING<br />

S21


P OSTER<br />

A BSTRACTS<br />

calcitriol via 1alpha-hydroxylase activity. This syndrome is characterized<br />

by normal phosphate levels, normal or suppressed PTH and<br />

PTHrP concentrations, and no osseous involvement. As with our patient,<br />

glucocorticoids can reduce extrarenal calcitriol production and<br />

inhibit osteoclastic bone resorption.<br />

CONCLUSION<br />

Advanced age is a cancer risk factor. The elderly account for<br />

60% of newly diagnosed malignancies. Hypercalcemia is a common<br />

cancer complication that can present in the frail elder with subtle<br />

symptoms and oftentimes, delirium. This, in setting of a possible neoplasia,<br />

should be entertained.<br />

REFERENCE<br />

1.Seymour JF, Gagel RF.Calcitriol:the major humoral mediator<br />

of hypercalcemia in Hodgkin disease and nonHodgkin<br />

lymphoma.Blood 1993;82:1383–94<br />

A16<br />

Describing an atypical variant of Guillain-Barré syndrome.<br />

S. Gulati, S. Gupta, G. Gulati. Internal Medicine, The Reading<br />

Hospital and Medical Center, West Reading, PA.<br />

CASE:62-year-old Asian male, presented to the hospital with bilateral<br />

extremity weakness after a trip to India 3 weeks ago, at which<br />

time he had developed severe gastroenteritis. Weakness had started<br />

in his upper extremities, followed by the lower. During hospitalization<br />

he experienced wide fluctuations in his blood pressure and heart<br />

rate (systolic blood pressure of 100-190 mm of Hg and heart rate<br />

ranging from 60-130 bpm). On neurologic, he had 3/5 motor strength<br />

of bilateral upper extremities, 4/5 of lower extremities, areflexia in<br />

upper with normal reflexes in the lower extremities. Gait was normal,<br />

so was the sensory and cranial nerve exam. Routine laboratory studies<br />

including a CBC, basic metabolic panel, thyroid panel, vitamin<br />

B12, folate levels and autoimmune markers were normal. ESR was<br />

elevated at 48 mm/hour (normal: 0-15mm/hour). CSF analysis revealed<br />

an elevated protein of 86 mg/dL (normal: 20-45mg/dL), with<br />

normal glucose level and zero WBC’s. This suggested albuminocytologic<br />

dissociation. Nerve conduction studies showed evidence of demyelination.<br />

Despite his atypical presentation, he was diagnosed with<br />

Guillain-Barré syndrome(GBS) and started on IVIGg for five days.<br />

His respiratory status remained stable with an improved neurologic<br />

exam. The patient was discharged on prednisone to an acute rehabilitation<br />

facility.<br />

DISCUSSION: GBS, a post infectious immune mediated disease,<br />

manifests as an acute inflammatory ascending polyradiculoneuropathy<br />

(with weakness and diminished reflexes). It has an annual incidence<br />

in US of 1.2-3 per 100,000, making it the most common cause<br />

of acute flaccid paralysis. The disease has a bimodal distribution, with<br />

peaks in age 15-35 years and a second, higher peak in elderly patients<br />

aged 50-75 years. There is a history of an antecedent illness (GI or<br />

upper respiratory), 1-3 weeks prior to the onset.<br />

Many clinical variants have been well documented. These include<br />

acute inflammatory demyelinating polyneuropathy (AIDP),<br />

acute motor axonal neuropathy (AMAN), acute motor-sensory axonal<br />

neuropathy (AMSAN), Miller-Fisher syndrome, a pure sensory<br />

variant of GBS.<br />

CONCLUSION: A disease not fitting the typical definition of<br />

GBS should not dissuade physicians from complete work up and<br />

treatment. This becomes especially important in the elderly population,<br />

because there is a 6-fold increase in the rate of death in patients<br />

aged 60 years or older compared to persons aged 40-59 years.<br />

A17<br />

Recognize the likely association between herpes encephalitis and<br />

cardiac arrhythmias.<br />

S. Gulati, G. Gulati, R. Alweis. Internal Medicine, The Reading<br />

Hospital and Medical Center, West Reading, PA.<br />

CASE: A 73 year old male with past medical history of hypertension<br />

and coronary artery disease on beta blocker therapy presented<br />

to the hospital with an acute change in mental status following<br />

an episode of witnessed tonic-clonic seizure-like activity. The patient<br />

had recently flown and had developed low grade intermittent fever<br />

since. Examination revealed obtundation with an otherwise non-focal<br />

neurological exam. He was intubated for airway protection and transferred<br />

to the ICU. Laboratory evaluation revealed only mild leukocytosis<br />

with a normal differential. Blood chemistries were normal with<br />

negative toxicology screening. Lumbar puncture revealed clear appearance<br />

of the CSF, normal glucose of 76 mg/dl, elevated protein of<br />

64 mg/dl (nl 20-45 mg/dl), elevated white cell count of 304 cmm (nl 0-<br />

5 cmm), with 80% lymphocytes (nl 0-50%) and 1% neutrophils. Herpes<br />

Simplex type 1 DNA was detected by PCR. A diagnosis of herpes<br />

encephalitis was made and the patient was started on intravenous<br />

acyclovir. After transfer out of the unit, he was noted to have sinus<br />

bradycardia with heart rate ranging from 40-60 beats per minute. Review<br />

of his rhythm revealed a first degree heart block. The patient<br />

was evaluated and, for unclear reasons, restarted on his home dose of<br />

metoprolol. This was followed by development of complete heart<br />

block which necessitated implantation of a dual-chamber pacemaker.<br />

DISCUSSION: Herpes simplex virus is the most common cause<br />

of acute, sporadic viral encephalitis, accounts for 10% to 20% of all<br />

cases. Of these more than 95% are caused by subtype I virus. The clinical<br />

hallmark of HSV encephalitis is acute onset of fever accompanied<br />

by focal neurologic signs (most commonly involving the temporal<br />

lobes). There have been isolated case reports in literature<br />

connecting cases of herpes encephalitis with development of cardiac<br />

arrhythmias. Hence patients with encephalitis need close cardiac<br />

monitoring. Literature search reveals that these patients spontaneously<br />

recover with treatment of the underlying infection and have<br />

not needed pacemakers.<br />

Physicians taking care of patients need to recognize the association<br />

of cardiac arrhythmias with non-cardiac causes like viral infection.<br />

This can help avoid catastrophic sequelae.<br />

A18<br />

An unusual presentation of deep vein thrombosis due to May-<br />

Thurner syndrome in an elderly man.<br />

S. Nakagawa, 1 A. Fischman, 2 J. Farber, 1 F. Ko. 1 1. Department of<br />

<strong>Geriatrics</strong> and Palliative Medicine, Mount Sinai School of Medicine,<br />

New York, NY; 2. Departments of Radiology and Surgery, Mount<br />

Sinai School of Medicine, New York, NY.<br />

Case<br />

A 79 year-old man presented with 2 weeks of progressive left<br />

lower extremity (LLE) swelling with pain precluding ambulation. He<br />

had significant unilateral non-pitting edema with skin discoloration<br />

in the entire LLE and a positive Homans’ sign. A Doppler ultrasound<br />

showed acute deep vein thrombosis (DVT). Despite starting anticoagulation,<br />

swelling and pain worsened. A subsequent CT venogram<br />

showed an extensive occlusive DVT from the left common iliac vein<br />

to the popliteal vein. Endovascular Catheter Directed Thrombolysis<br />

(CDT) and pharmacomechanical thrombectomy was performed with<br />

successful clot removal. An intravascular ultrasound (IVUS) showed<br />

focal narrowing of the left common iliac vein due to a crossing right<br />

common iliac artery consistent with May-Thurner syndrome (MTS).<br />

A self-expanding iliac stent restored iliofemoral venous system patency<br />

and resolved LLE swelling. A small post-procedure hematoma<br />

was seen which subsequently resolved. The patient remained stable<br />

on enoxaparin with a patent stent 5 weeks after treatment.<br />

Discussion<br />

MTS typically occurs in women of childbearing age. The right<br />

common iliac artery causes chronic external compression of the left<br />

common iliac vein and predisposes patients to LLE proximal DVT.<br />

Iliac vein compression needs aggressive management because it results<br />

in recurrent thrombosis and post-thrombotic syndrome (PTS)<br />

on anticoagulation therapy alone. Venography with IVUS is a superior<br />

modality for diagnosis. CDT and stent placement followed by anticoagulation<br />

is the most effective treatment. Due to its rarity in eld-<br />

S22<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

erly men, index of suspicion for MTS was low in our patient. His striking<br />

initial presentation and worsening symptoms after anticoagulation<br />

prompted further evaluation, leading to the diagnosis of MTS.<br />

Although CDT is associated with a higher risk of bleeding compared<br />

to anticoagulation alone, its benefits outweigh risks in highly active<br />

patients.<br />

Conclusion<br />

In acute proximal lower extremity DVT with severe symptoms,<br />

diagnostic work-up with CT venogram and aggressive catheter-based<br />

intervention should be pursued if indicated. Although DVT due to<br />

MTS is very rare in older adults, failure to recognize can result in serious<br />

vascular sequelae, particularly PTS, and thus appropriate clinical<br />

suspicion should be maintained.<br />

A19<br />

The Importance of Goals of Care in Elders with Mild Dementia.<br />

S. Arora, S. Khosla, M. J. Brennan. Internal Medicine, Baystate<br />

Medical Center/Tufts Univ. School of Medicine, Springfield, MA.<br />

Background:<br />

Existing literature regarding goals of care for dementia patients<br />

focuses on those with advanced disease facing end of life decisions<br />

due to aspiration, infections and debility. Little attention has been<br />

paid to those with early impairment. The authors present a case of an<br />

elderly man with mild dementia for whom a lack of clarity around<br />

goals prevented optimal care.<br />

Case Report:<br />

Mr. S. was an 88 year old with DM and CKD. A geriatrician diagnosed<br />

a mild dementia while he was admitted for an RCA STEMI<br />

with shock requiring vasopressors and intubation. Six weeks later he<br />

was readmitted with syncope and bradycardia secondary to hypovolemia.<br />

An echo documented an EF of 30-35%. AICD or pacer placement<br />

for sinus node dysfunction was discussed; an EP consultant<br />

opted for conservative treatment noting that Mr. S. had dementia.<br />

There was no discussion with the patient or family about possible device<br />

therapies. Within a week, Mr. S. returned to the ER unresponsive,<br />

hyperkalemic and bradycardic with a heart rate in the 20s. He improved<br />

with atropine but bradycardia recurred and attempts to place<br />

a pacer failed. Mr. S. required prolonged CPR for PEA, asystole and<br />

VT but was resuscitated and reintubated. At that point, his family<br />

chose a DNR order. After a lengthy CCU stay and placement of a<br />

dual chamber pacemaker, he was discharged for rehabilitation with<br />

cognitive abilities near his baseline.<br />

Discussion and Conclusions:<br />

Would earlier pacemaker placement have saved Mr. S. suffering<br />

and a long hospital stay? Was the decision not to place a pacemaker<br />

influenced by his diagnosis of dementia? Potentially life-sustaining<br />

therapies should not be foregone due to mild, cognitive deficits especially<br />

if prognosis and goals of care have not been discussed. To avoid<br />

unconscious paternalism, providers must not make judgments about<br />

a patient’s quality of life without input from the patient and family. It<br />

is best to clarify understanding and goals in the outpatient setting<br />

when families are not overwhelmed and patients can participate. This<br />

case was medically complex; elders like Mr. S. have largely been excluded<br />

from the clinical trials of post MI devices. Improved communication<br />

among primary care MDs, geriatricians, cardiologists and patients/families<br />

is essential. Research on communication strategies to<br />

enhance advanced care planning and to clarify clinical outcomes for<br />

vulnerable geriatric cardiology patients are both sorely needed.<br />

A20<br />

Femoral Spontaneous fracture Associated with Bisphosphonate<br />

Therapy.<br />

S. Rahgoshay, S. M. Friedman, S. V. Bukata, T. V. Caprio. Division of<br />

<strong>Geriatrics</strong> and Aging, University of Rochester, Rochester, NY.<br />

BACKGROUND: Hip fractures are important because they are<br />

associated with an increased rate of morbidity, substantial costs, and<br />

overwhelming effects on quality of life. Bisphosphonates(BPPs) are<br />

widely used for treatment of postmenopausal osteoporosis. BPPs<br />

have proven efficacy in reducing the incidence of vertebral and nonvertebral<br />

fractures. Although short term efficacy, safety and tolerability<br />

of these drugs have been documented, an increasing number of recent<br />

case reports suggest that some subtrochanteric hip fractures<br />

might occur in patients who have been treated on a long-term with<br />

BPPs due to suppressed bone turn over.<br />

CASE SUMMARY: A 58 year old female with known osteoporosis<br />

presented to the hospital after hearing an “audible creak”<br />

while going up stairs, followed by a spontaneous right-sided subtrochanteric<br />

hip fracture. Two weeks before the fracture she had prodromal<br />

pain in the right thigh with walking difficulty and came to the<br />

emergency department. Xrays of the right leg and hip did not show<br />

any sign of fracture at that time and she was therefore treated with<br />

analgesics. Five years previously, the patient had started taking alendronate<br />

and after 2 years was switched to zoledronic acid with calcium<br />

and vitamin D. At presentation again to the emergency department<br />

she had severe pain, acute tenderness in the right thigh, and her<br />

lower extremity was shortened with external rotation. The subthrochanteric<br />

fracture was treated with an intramedullary gamma<br />

nail and the patient recovered from surgery successfully. Routine<br />

blood tests; including bone profile, viamin D, thyroid function tests<br />

were normal. She was taken off her BPPs, and was discharged on calcium,<br />

and vitamin D. Outpatient arrangements were made to repeat<br />

her DEXA and to consider an alternative like teraparatide treatment<br />

for osteoporosis.<br />

CONCLUSION:<br />

Bisphosphonates have proven efficacy in reducing the incidence<br />

of vertebral and non-vertebral fractures. The literature suggests the<br />

existence of BPP-related atypical fractures, with unique clinical and<br />

radiographic features in patients on long-term BPP therapy as observed<br />

in this case study. Continued use of BPPs beyond a treatment<br />

period of 3 to 5 years should be reevaluated annually.<br />

A21<br />

A Doggone Cough-an unusual complication of pet ownership-a case<br />

report. Nathan S, Gorbien M, Olson J, Leiding M, Bednarzcyk M.<br />

S. N. Nathan. Department of Geriatric Medicine, Rush University<br />

Medical Center, Chicago, IL.<br />

Purpose: Discuss an unusual health consequence of pet ownership.<br />

Background: Kennel Cough is an infectious tracheobronchitis. It<br />

is a canine respiratory syndrome, often contagious in high density<br />

areas-pet shops, kennels, etc. The most frequent bacterial isolate is<br />

Bordetella bronchiseptica (B.b.)[i]. B.b. is a recognized respiratory<br />

tract pathogen of mammals since 1910. Evidence suggests that it colonizes<br />

human respiratory tract and causes infection in compromised<br />

hosts[ii]. Old age is an immunocompromised state[iii]. Snakes are<br />

also prone to pneumonia, which is contagious between species.This is<br />

an 82 year old woman with Herpes Zoster, URI & systemic symptoms<br />

after her dog was diagnosed with Kennel Cough, after exposure to<br />

the neighbor’s dog. The neighbors illegally bred dogs, snakes & mice.<br />

Method: Case report.<br />

Case Report: Ms. C is an 82 year old woman with Herpes Zoster<br />

seen in clinic for 2-3 days of URI & systemic complaints. The whole<br />

family had been ill for weeks, they think from their dog. The dog was<br />

diagnosed with Kennel Cough. The neighbor would sneak over & try<br />

to get the family’s dog to impregnate his dog. The neighbor had 2 pitbulls<br />

who died 4 weeks prior, whose bodies were dumped in the family’s<br />

garbage. The neighbors also had an illegal snake farm, with 200 of<br />

the snakes dying shortly before this visit.<br />

Discussion: There is benefit to pet ownership in the elderly<br />

[iv][v]. However, pets can transmit illness. This case shows an unusual<br />

situation that put the patient, family & dog at risk for an unexpected<br />

illness.<br />

i J Vet Med Sci Vol 70: 563-569.(2008). “Etiologic Study of<br />

Upper Respiratory Infections of Household Dogs”. Mochizuki M,<br />

Yachi A, Ohshima T, Ohuchi A, Ishida T.<br />

AGS 2012 ANNUAL MEETING<br />

S23


P OSTER<br />

A BSTRACTS<br />

ii J Clin Micrbiol. 1995 Aug; 33(8):2002-6. Human Bordetella<br />

bronchiseptica infection related to contact with infected animals: persistence<br />

of bacteria in host. Gueirard P, Weber C, Le Coustumier A,<br />

Guiso N.<br />

iii Trnspl Int. 2009 Nov;22(11):1041-50. Epub 2009 Jul 16. The<br />

aging of the immune system. Weiskopf D, Weinberger B, Grubeck-<br />

Loebenstein B.<br />

iv J Am Geriatr Soc. 1999 Mar;47(3):323-9. Influence of companion<br />

animals on the physical and psychological health of older people:<br />

an analysis of a one-year longitudinal study. Raina P, Waltner-<br />

Toews D, Bonnett B, Woodward C, Abernathy T.<br />

v J Nutr Elder. 1996;15(3):15-31. Pet ownership may be a factor<br />

in improved health of the elderly. Dembicki D, Anderson J.<br />

A22<br />

Aphasia vs. Dementia: A Case of Primary Progressive Aphasia.<br />

S. S. Naqvi, C. D. Furman. Family & Geriatric Medicine, University of<br />

Louisville, Louisville, KY.<br />

Introduction: Primary Progressive Aphasia (PPA) presents with<br />

dysnomia and impaired speech. Language dysfunction remains the<br />

most salient feature and deteriorates most rapidly during the illness.<br />

Impairments in other cognitive functions, including dementia, may<br />

also emerge.<br />

Case Report: A 70 y/o white male with h/o bipolar disorder, hallucinations,<br />

hyperlipidemia, and PPA presented with his wife and son<br />

to determine if he had dementia. Patient also had a h/o stuttering as a<br />

child and alcoholism. Patient had memory problems the past 2 years<br />

with a rapid decline over past 2-3 weeks. Patient did not recognize his<br />

own home or wife and often wore wife’s clothes. He had difficulty<br />

swallowing and eating. He developed poor coordination skills and<br />

found it hard to place food into his mouth. In 2003, he retired as an attorney.<br />

His symptoms began in 1999 with speech problems. He had<br />

difficulty with expression of language, incomplete sentences, spelling<br />

errors and word loss without compensation. In 2003, he was diagnosed<br />

with PPA and was seen by multiple local and national neurologists<br />

and neuropsychologists who unanimously agreed on a diagnosis<br />

of PPA. Brain PET scans, done in 2006 and 2010, showed hypometabolism<br />

in the left temporoparietal region, compatible with a neurodegenerative<br />

disorder, most likely Alzheimer’s type. The patient was on<br />

donepezil and memantine with no improvement and received speech<br />

therapy with some improvement. At the current presentation, dementia<br />

was diagnosed based on his memory loss and functional decline.<br />

He was admitted to hospice because of dysphagia and his overall<br />

decline.<br />

Discussion:This case exemplifies affluent type PPA,a rare neurodegenerative<br />

disorder in which symptoms start with language difficulty. Patients<br />

with PPA can become mute and may eventually lose the ability to<br />

understand written or spoken language. PPA is considered a form of dementia<br />

because it causes a gradual cognitive decline to the point where<br />

activities of daily living become compromised. Approximately 30% of<br />

patients have shown the microscopic pathology of Alzheimer’s disease,<br />

presumably with an atypical distribution of lesions. 70% of PPA is known<br />

to be a type of frontotemporal lobar degeneration. Currently, there is no<br />

effective pharmacologic treatment. However, evaluation by a speech<br />

therapist is useful. When PPA is diagnosed, the patient and family should<br />

be informed that PPA is a type of progressive dementia.<br />

A23<br />

Aspergilloma: association with chronic bronchiectasis and IgG2<br />

deficiency.<br />

T. T. Suh, 1,2 T. Efeovbokhan, 1,2 M. R. Hosler. 3 1. Family &<br />

Community Medicine, UT Health Science Center in San Antonio, San<br />

Antonio, TX; 2. ACE Unit, Christus Santa Rosa Hospital-City Centre,<br />

San Antonio, TX; 3. Allergy, Asthma & Immunology Associates of<br />

South Texas, San Antonio, TX.<br />

BACKGROUND: Aspergilloma is fungal lung infection that<br />

often causes cavitary lung lesions and the characteristic “fungus ball”<br />

or mycetoma on CT scan. Up to 10% of patients with bronchiectasis<br />

eventually become infected with aspergillus. It is thought that high<br />

levels of complement found in patients with bronchiectasis prevent<br />

the killing of aspergillus, allowing this fungal infection to occur. Up to<br />

half of patients with idiopathic bronchiectasis have deficiency of either<br />

IgA or IgG2 antibodies. Aspergilloma can also be a very rare<br />

complication of etanercept for rheumatologic conditions like<br />

rheumatoid arthritis, affecting about 0.01% of patients reporting side<br />

effects with this drug.<br />

CASE: A 75 year old Caucasian woman with multiple drug allergies,<br />

BMI of 19.5, chronic bronchiectasis, rheumatoid arthritis<br />

(being treated with etanercept and prednisone 5mg daily), an IgG2<br />

subclass deficiency (being treated with monthly IVIg) and a functional<br />

humoral immunodeficiency (with poor response to Pneumovax)<br />

presented to her allergist with hemoptysis for one week. A<br />

contrast-enhanced CT scan of the chest revealed a cavitary right<br />

upper lobe lung lesion. The patient was hospitalized, and bronchoscopy<br />

was performed. Tuberculosis and cancer were ruled out<br />

from bronchial washings and biopsies, but results were suggestive for<br />

aspergilloma. Because the patient was not thought to be a good surgical<br />

candidate, she was placed on IV voriconazole for 4 weeks. After<br />

completing this course of antifungal therapy, her hemoptysis resolved<br />

and overall respiratory status improved.<br />

DISCUSSION: Aspergilloma is a generally rare fungal infection<br />

that can be seen in patients who are immunosuppressed. It is important<br />

for geriatricians to be aware that aspergilloma is associated with<br />

chronic bronchiectasis. In turn, chronic bronchiectasis is associated<br />

with IgG2 deficiency that can be treated with IVIg. In particular,<br />

geriatricians should also note that non-CF-related bronchiectasis is<br />

more common and more severe in underweight Caucasian women<br />

over the age of 60 years.<br />

A24<br />

CADASIL Disease: a case report of a rare, genetic early onset<br />

dementia.<br />

T. Leucker, 1 B. Setters. 2 1. Internal Medicine, University of Louisville,<br />

Louisville, KY; 2. Family & Geriatric Medicine, University of<br />

Louisville, Louisville, KY.<br />

INTRODUCTION: Cerebral autosomal dominant arteriopathy<br />

with subcortical infarcts and leukoencephalopathy (CADASIL), a<br />

genetically determined arteriopathy involving the NOTCH 3 gene on<br />

chromosome 19, is a rare cause of vascular dementia affecting only a<br />

few hundred families worldwide. Clinical progression involves the sequential<br />

development of migraine with aura at age 30, followed by ischemic<br />

strokes, mood disorders then dementia at 50 yo and gait difficulty<br />

at 60.<br />

CASE REPORT: A 60 y/o AAF with a 40 year history of recurrent<br />

headaches with nausea/vomiting, light sensitivity, worsening<br />

memory loss and depression presented to the hospital 2 years ago<br />

with a blurry vision, a lazy eye and left sided weakness. Exam on admission<br />

did not reveal any neurological deficits, but given her extensive<br />

family history of stroke and personal history of persistent symptoms<br />

over the past few months, a full evaluation was completed. A<br />

head CT demonstrated subtle areas of abnormal attenuation. Follow<br />

up MRI identified diffuse hyper-intensities, heaviest in the temporal<br />

lobes in a subcortical location involving white matter, which was very<br />

concerning for a possible diagnosis of CADASIL disease given the<br />

patient’s history. The remaining clinical workup, including lumbar<br />

puncture was negative. The patient was offered genetic testing for<br />

CADASIL disease, but due to lack of insurance no further testing was<br />

done. Since this initial evaluation the patient had two more admission<br />

for stroke like symptoms. She has shown progressive decline in cognitive<br />

function including memory loss, aphasia, apraxia and a disturbance<br />

in executive functioning resulting in a loss of her job and dependence<br />

on her family for care with her daily activities.<br />

CONCLUSION: CADASIL disease is a rare genetic cause of<br />

dementia that can affect people of all ages and as such is not part of<br />

S24<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

most physicians’ differential diagnosis when working up cognitive<br />

disorders even in younger patients. Given that the presenting symptoms<br />

may be vague and individually common with a routine evaluation<br />

that is usually non-diagnostic, the clinical and family history can<br />

be crucial in making the diagnosis. To establish the diagnosis a<br />

NOTCH3 mutation by genetic analysis or a skin biopsy showing ultra<br />

structural deposits within small blood vessels is needed.<br />

A25<br />

Space Occupying Lesions of the Brain Presenting with<br />

Neuropsychiatric Symptoms.<br />

T. Beben, M. F. Assal, D. D. Sewell, J. Reichstadt, J. W. Daly. UC San<br />

Diego, San Diego, CA.<br />

Supported By: No funders provided support for this research.<br />

Introduction: Cognitive and behavioral problems are often attributable<br />

to underlying degenerative or psychiatric processes. <strong>Here</strong><br />

we present two atypical cases.<br />

Case 1: An 86-year-old man with a history of CAD and TIAs developed<br />

memory and executive function deficits three years prior to<br />

his presentation at our institution. Brain imaging and labs were normal<br />

and he was eventually diagnosed with frontotemporal dementia.<br />

Five months prior, his decline accelerated prompting placement in a<br />

residential care facility. He was noted to have acutely worsening behavioral<br />

symptoms, including wandering, disorganization, agitation,<br />

and impulsivity leading to falls, which led to his admission to our behavioral<br />

unit. Basic labs were normal. A head CT, ordered due to a recent<br />

fall, unexpectedly demonstrated a large mass. Subsequent MRI<br />

delineated a 7x4cm right temporal lobe mass with ring enhancement<br />

and central necrosis, most consistent with glioblastoma multiforme,<br />

which was felt to account for his accelerated decline. The patient was<br />

treated symptomatically with divalproex, olanzapine, and dexamethasone.<br />

After a family meeting, he was referred to hospice.<br />

Case 2: A 60-year-old woman with a history of hypertension and<br />

depression was brought to our geriatric assessment clinic by her<br />

daughter to investigate the cause of her personality changes and decline<br />

in executive function. She had worked as a lab technician until<br />

six years prior, when she became unable to perform work on time or<br />

learn new tasks. She had since been unemployed and could not manage<br />

her finances. At times, she was withdrawn in her cluttered apartment<br />

and neglected her personal hygiene. She also showed poor impulse<br />

control and judgment through inappropriate actions with<br />

strangers and debt accrual. Our initial evaluation revealed a score of<br />

28/30 on the MoCA, but difficulty with attention. A routine brain<br />

MRI was obtained, revealing a 7.2 cm extraaxial right frontal lobe<br />

mass. She was admitted to neurosurgery. Upon successful resection of<br />

the mass, a diagnosis of meningioma was confirmed. After a post-operative<br />

course that was complicated by hydrocephalus requiring a VP<br />

shut, her former personality began to re-emerge.<br />

Conclusions: Brain masses should not be overlooked as a potential<br />

cause of neuropsychiatric symptoms. An accurate diagnosis can<br />

help define prognosis and may guide treatment options.<br />

A26<br />

Clinical significance of measuring Blood Pressures in bilateral arms<br />

in patients with dizziness.<br />

T. Gyurmey, P. Coll, K. Singh. <strong>Geriatrics</strong>, University of Connecticut<br />

Health Center, Farmington, CT.<br />

82 y/o lady with DM type 2, CAD, HTN, TIA, lumbar stenosis,<br />

anemia of chronic disease, depression, GERD and PVD presents<br />

with left arm easy fatigability and episodic dizziness for 1 year. She<br />

was evaluated for dizziness and medications were reviewed with discontinuation<br />

of betablockers and the left arm fatigue was presumed<br />

by the patient to be as a result of the left shoulder replacement.She<br />

was symptom free for a few months until they returned. Past surgical<br />

history is significant for left shoulder joint replacement and left<br />

carotid artery stenting. Medications include morphine, bupropion,<br />

pravastatin, amlodipine, alendronate, epoetin alfa injections and lorazepam<br />

prn.She is afebrile, BP Rt arm 142/48, BP Lt arm 102/40, PR<br />

88 regular with diminished left radial artery pulsations, RR 12, orhtostatics<br />

negative. EOMI, exams of the HEENT, lungs, heart, abdomen<br />

and CNS were unremarkable. No peripheral edema. B/L Lower limb<br />

pulses are equal and symmetric. Based on the difference in systolic<br />

blood pressures and the symptoms, a presumptive diagnosis of Subclavian<br />

artery stenosis with steal syndrome was made.<br />

Management included prompt percutaneous transluminal angiography<br />

followed by angioplasty involving tandem stents being<br />

placed at two proximal left subclavian stenosed sites before the origin<br />

of the vertebral artery without any complications. She was on clopidogrel<br />

for a month and currently takes aspirin 325 mg daily and is<br />

symptom free.<br />

Discussion: Dizziness is a very common symptom in the elderly<br />

and can lead to decreased quality of life and predispose to falls and<br />

subsequent morbidity and mortality.Blood pressures, pulse rates and<br />

orthostatics are routinely measured but not often in both arms which<br />

could lead to missing the diagnosis of subclavian stenosis and steal<br />

syndrome that this patient presented with. On the other hand a<br />

falsely normal blood pressure reading in the arm affected by a stenosis<br />

could delay a diagnosis of Hypertension and subsequently lead to<br />

avoidable and sometimes devastating short term complications and<br />

long term end organ damages. Measuring blood pressure and pulses<br />

in both arms is a very simple but invaluable step that should be done<br />

routinely.<br />

A27<br />

Closed head injury with multisensory loss in a 74 year old athlete<br />

while playing senior league basketball.<br />

U. Kakwan, 1 N. Miller, 3 U. Braun. 2,1 1. <strong>Geriatrics</strong>, Baylor College of<br />

Medicine, Houston,TX; 2. <strong>Geriatrics</strong>, Michael E. DeBakey VAMC,<br />

Houston,TX; 3. Brazos-Valley Community Agency Action, Bryan,TX.<br />

Supported By: Nothing to disclose.<br />

INTRODUCTION<br />

Seniors are becoming more involved in competitive sports, and<br />

injuries in this age group are not well described. We report a patient<br />

who suffered traumatic brain injury with multisensory loss.<br />

CASE PRESENTATION<br />

A 74 year old Caucasian clinic nurse presented to the ER after<br />

she was bumped into, fell backwards, and struck her head on the hard<br />

court while playing basketball. She had brief LOC, bled from her<br />

right ear canal, and reported hearing loss and severe dizziness.<br />

Past medical history was significant for breast cancer in remission,<br />

treated with an aromatase inhibitor, and severe osteoporosis,<br />

treated with Calcium, Vitamin D, and alendronate. Head CT showed<br />

bilateral temporal bone fractures, bleeding in both mastoids, contracoup<br />

injury to the left frontal lobe, and subdural hematoma/subarachnoid<br />

hemorrhage.<br />

She was treated nonsurgically and discharged after 72 hours.<br />

Dizziness was severe but responded to Eppley’s maneuver, followed<br />

by vestibular home exercises. She had moderate symmetrical bilateral<br />

sensorineural hearing loss of 40-50 dbl with minimal improvement<br />

over 6 months.<br />

She also suffers from complete anosmia and dysgeusia. The patient<br />

returned to work after 8 weeks but struggled with patients’<br />

names and short-term memory. Electronic records and her high preinjury<br />

skills and medical knowledge acquired over many years compensated<br />

for her losses.<br />

This patient quit all her athletic activities except walking and expressed<br />

that her losses are worse than when she faced cancer.<br />

DISCUSSION<br />

With the baby-boomers now turning 60, a more active generation<br />

of elderly who may still actively participate in competitive sports<br />

AGS 2012 ANNUAL MEETING<br />

S25


P OSTER<br />

A BSTRACTS<br />

is on the rise. Thus, more severe and complicated sports-related injuries<br />

are likely to be encountered by emergency room physicians in<br />

the near future.<br />

These “fit” elderly are often still employed and despite being<br />

high-performing, sports injuries sustained in this older group may be<br />

more devastating and potentially disabling.<br />

A28<br />

Hands Tell All.<br />

V. Nurpeisov, 1 A. Akintan, 1 N. Holland. 2 1. geriatric medicine, VA<br />

Medical Center, Decatur, GA; 2. Geriatric medicine, Emory University<br />

School of Medicine, Atlanta, GA.<br />

An 85 year old gentleman with a history of hypertension, hyperlipidemia,<br />

and tobacco use presented to the geriatric clinic with a history<br />

of craving ice chips for several months and a twenty pound<br />

weight loss over the previous six months. He denied any noticeable<br />

change in stool habits, hematemesis, abdominal pain, or vomiting. He<br />

did not use alcohol and had smoked cigarettes for the past 60 years.<br />

His medications were: Lisinopril 5 mg daily, Aspirin 81mg daily, and<br />

Hydrochlorothiazide 12.5 mg daily.<br />

On exam he was a thin and cachectic. His vitals were stable.<br />

There was no noticeable jaundice. His lungs were clear and heart<br />

exam was unremarkable. His abdominal exam didn’t reveal any palpable<br />

masses but revealed an enlarged liver.<br />

His nails revealed spooning, evidence of nicotine staining and<br />

changes consisitent with Terry’s nails. His labs showed normal<br />

chemistries and urinalysis. TSH and vitamin B12 levels were normal.<br />

He had a microcytic anemia, hemoglobin of 9 g/dl.<br />

This patient was admitted and by CT colonoscopy, diagnosed<br />

with colon cancer with metastasis to the liver. He and his family<br />

elected for him to receive hospice care.<br />

His Terry’s nail changes were consistent with hepatic disease.<br />

These are usually seen with cirrhosis but in this case we felt these<br />

changes were the result of hepatic metastasis. His nails also revealed<br />

spooning consistent with an iron deficiency anemia as well as nicotine<br />

staining on the second and third finger nails.<br />

Based only on this gentelman’s history and nail changes as described,<br />

colon cancer with liver metastasis was a leading diagnosis before<br />

getting any diagnostic studies. Subsequent CT colonoscopy confirmed<br />

this diagnosis. To our knowledge, this is the first case of<br />

association of Terry’s nails with hepatic metastasis without hepatic<br />

cirrhosis.<br />

In this age of growing technology getting back to the bedside<br />

and taking the time to listen, as well as look for subtle but important<br />

physical exam findings still remains an important art and skill which<br />

should not be overlooked.<br />

Nail changes are easy to observe and often are associated with<br />

important clues to underlying systemic illness in older patients.<br />

This case report emphasizes Sir William Osler’s quote that “<br />

every patient you see is a lesson in much more than the malady from<br />

which he suffers.”<br />

This poster will show pictures of this gentelman’s hands and nail<br />

findings as well as other diagnostic nail changes in systemic disease.<br />

A29 Encore Presentation<br />

Metformin-associated severe hypomagnesemia; A Case report.<br />

V. Kaushik. <strong>Geriatrics</strong>, UTMB, Galveston, Galveston, TX.<br />

Supported By: UTMB<br />

Introduction<br />

Metformin is a oral hypoglycemic agent which decreases hepatic<br />

glucose production, decreases intestinal absorption of glucose, and<br />

improves insulin sensitivity by increasing peripheral glucose uptake<br />

and utilization. The main use for metformin is in the treatment of diabetes<br />

mellitus type 2, especially in overweight patients. Metformin reduces<br />

diabetes complications and overall mortality. Hypomagnesemia<br />

is not referred to as a side effect in the drug’s summary of product<br />

characteristics information, but diarrhea is an important side effect<br />

of metformin and various degree of hypomagnesemia and other<br />

electrolyte imbalance from diarrhea have been reported in the literature.<br />

One report describes a patient on metformin who developed diarrhea<br />

and symptomatic hypomagnesemia (1).<br />

Case presentation<br />

Patient is an 78 year old Caucasian female with h/o diabetes<br />

type II for more than 15 years, hypertension, hyperlipidemia and osteoarthritis.<br />

Her diabetes was fairly controlled by glipizide and metformin.<br />

Metformin was added to her medications three years ago for<br />

better control of her diabetes. Her other medications include<br />

enalapril, Felodipine, Clopidogrel (Plavix), Rosuvastatin (Crestor),<br />

Hydrocodone-acetaminophen and Temazepam (Restoril). Patient<br />

had normal serum magnesium levels prior to adding metformin. Two<br />

months after adding metformin, her routine evaluation showed an<br />

unexplained hypomagnesemia (1.0 mg/dl). Serum calcium, phosphorus,<br />

potassium and renal function were normal. She did not report any<br />

diarrhea. She continued to have chronic moderate to severe hypomagnesemia,<br />

mostly in 0.9 -1.4 mg/dl range. Oral magnesium supplementation<br />

was not very helpful . Her Metformin was discontinued six<br />

months ago and since then her serum magnesium level is improving<br />

slowly, now mostly in 1.5 -1.8 mg/dl range.<br />

Conclusion<br />

The lab findings in this case suggest severe hypomagnesemia,<br />

without any evidence of diarrhea. Hypomagnesemia resolved with<br />

discontinuation of metformin. Based on this association with metformin<br />

and the lack of other clear precipitating causes, the most probable<br />

cause of hypomagnesemia in this patient appears to be metformin.<br />

Clinician should consider the possibility of<br />

metformin-associated hypomagnesemia in patients with otherwise<br />

unexplained hypomagnesemia.<br />

References:<br />

(1) A patient presenting with symptomatic hypomagnesemia<br />

caused by metformin-induced diarrhea: a case report. Svare A. Cases<br />

J. 2009 Oct 16;2:156.<br />

A30<br />

Birds Don’t Make the Best Companions: Hypersensitivity<br />

Pneumonitis In The Elderly.<br />

W. Ooi, S. Dahiya. Internal Medicine, Baystate Medical Center, West<br />

Springfield, MA.<br />

Hypersensitivity pneumonitis, also known as extrinsic allergic<br />

alveolitis, represents a spectrum of immunologic-driven response to a<br />

variety of inhaled allergens. The diagnosis requires a known exposure<br />

to the offending agent along with compatible clinical, radiological<br />

and laboratory studies.<br />

A 67 year old lady with a history of bilateral pulmonary embolisms<br />

presented with progressive dyspnea associated with productive<br />

cough over one month. Patient denied fever, chills or night<br />

sweats. No hemoptysis or lower extremity swelling. Past medical history<br />

includes schizoaffective disorder, morbid obesity and osteoarthritis.<br />

Physical exam was significant for hypoxia requiring 5L of<br />

oxygen supplementation by nasal cannula. Lung and cardiac exam<br />

were otherwise unrevealing. Laboratory studies were significant for<br />

chronic anemia with hemoglobin of 9.8 gm/dL and elevated N-terminal<br />

pro-brain natriuretic peptide of 826 pg/mL. Patient underwent a<br />

computed tomography (CT) angiogram of the chest which revealed<br />

mosaic pattern of lung attenuation bilaterally and mediastinal lymphadenopathy.<br />

She was started on ceftriaxone and azithromycin for<br />

treatment of atypical community-acquired pneumonia. Collateral history<br />

from patient’s family later during her hospitalization revealed<br />

that patient keeps 17 birds; parrots and macaws for the past 15 years.<br />

Her house was revealed to be in an unhygienic condition with animal<br />

excreta and clutter in her bedroom. Pulmonary recommended a<br />

serum precipitin panel which revealed a positive qualitative titer of<br />

S26<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

pigeon serum antibody. Inpatient pulmonary function test showed a<br />

restrictive pattern with significant reduction in her lung diffusing capacity.<br />

Patient was initiated on intravenous methylprednisolone for<br />

five days. Repeat CT scan of her chest 6 days from admission showed<br />

a significant improvement of her lung parenchymal disease and lymphadenopathy.<br />

There are limitations to several proposed diagnostic criteria especially<br />

in the setting of sub-acute or chronic disease. Misdiagnosis<br />

and delays occur in the absence of a comprehensive review of environmental<br />

exposure. This provides a diagnostic challenge in the elderly<br />

and psychiatric population. Serum precipitins have poor sensitivity<br />

and specificity. The risks of invasive diagnostic workup including<br />

bronchoscopic lavage and lung biopsy may outweigh its benefits in<br />

advanced disease. The treatment involves removal of the offending<br />

agent and glucocorticoids.<br />

A31<br />

Lipedema, a frequently misdiagnosed problem in elderly patient.<br />

Y. Ye, U. T. Efeovbokhan, R. W. Parker. UTHSCSA, San Antonio, TX.<br />

Background: Lipedema was first described in 1940 as a bilateral,<br />

gradual accumulation of fatty deposition in the lower extremities and<br />

buttocks. The feet are usually spared which is difference from lymphedema.<br />

This condition is found exclusively in females. It develops<br />

insidiously after puberty and progresses gradually. This condition is<br />

frequently misdiagnosed as lymphedema which is due to accumulation<br />

of protein-rich interstitial fluid with the skin and subcutaneous<br />

tissue caused by lymphatic dysfunction. We describe an elderly patient<br />

with gradually enlargement of bilateral lower extremities for<br />

five years complicated with recurrent skin infection and ulcers.<br />

Methods: This case report describes the presentation of lipedema<br />

in a 68 yr old female patient in which the lipedema is complicated<br />

with lymphedema and skin infection.<br />

Results: Case Presentation: A 68 yr old Caucasian female was<br />

admitted for pain and smelling in bilateral lower extremities. The patient<br />

noticed her both legs gradually becoming swelling for five years.<br />

The swelling becomes worse when sitting for a long time and alleviated<br />

when both legs are elevated. This condition made her confined<br />

to wheelchair. One month ago, patient felt the swelling was getting<br />

worse and she has severe pain in both calves. One course of clindamycin<br />

did not improve the symptom. Physical examination revealed<br />

massive bilateral lower extremity non-pitting edema. There<br />

were firm subcutaneous, cobblestone like nodules and papules with<br />

hyperpigmentation on both legs, especially in the lower one third of<br />

the legs. There was noticeable bilateral erythema up to knees. The<br />

skin was warm to touch. There is a 5x3cm open, foul smelling ulcer on<br />

the left lower extremity. Bilateral ankles and feet were spared. Stemmer’s<br />

sign was negative. Skin biopsy revealed benign polypoid skin<br />

with dermal myxedematous-like change.<br />

Conclusion: Although lipedema is not a rare condition, it is frequently<br />

missed because clinicians lack familiarity with lipedema. Patient’s<br />

history and physical examination are usually sufficient to differentiate<br />

lipedema from lymphedema. However, patient with long<br />

–standing lipedema may eventually develop mechanical insufficiency<br />

of the lymphatic system, producing “lipolymphedema”. The discoloration<br />

and epidermal change of the legs, as well as the skin infection<br />

in this patient is probably due to the dysfunction of lymphatic system.<br />

A32<br />

“We need an interpreter!”<br />

Y. Ang, S. Lee, M. Brennan. Internal Medicine, Baystate Medical<br />

Center/ Tufts University School of Medicine, Springfield, MA.<br />

Intro:<br />

A growing number of immigrant elders in the US are at risk of<br />

poorer health due to cultural and language barriers that limit access<br />

to care.<br />

Case:<br />

A 65 year old Somali man (Mr. K) with dementia presented for<br />

geriatric evaluation after years of cognitive decline. He was disoriented,<br />

disinhibited, impulsive and had decreased speech and repetitive<br />

vocalization. He responded “ I don’t know” to most queries. History<br />

was difficult as the Somali interpreter did not arrive and family<br />

members’ English was limited. Mr. K. was diagnosed with frontotemporal<br />

dementia. Organizing medical care was complex. The language<br />

barrier, poor health literacy and cultural beliefs (e.g. a reluctance to<br />

allow “outsiders” into the home, views about the appropriate role of<br />

women in the family and fears of “official paperwork”) presented<br />

challenges. Medication adherence was frequently problematic as<br />

even simple instructions were “lost in translation”. Appropriate documentation<br />

for exemption from a citizenship interview exam required<br />

significant time and a multidisciplinary effort.<br />

Discussion:<br />

37 million foreign-born immigrants lived in the US in 2006; 12-<br />

15% were aged 65 or older. By 2050, elders will be 61% non-Hispanic<br />

whites, 18% Hispanic, 12% black, 8% Asian, and 2.7%<br />

“other”(1). Geriatric immigrants receive much less health care than<br />

native-born seniors and are far more likely to be uninsured (33.2%<br />

vs 12.7% in 2007)(2). Reasons include a dearth of culturally competent<br />

services along with geographic and economic factors. However,<br />

low English proficiency remains the major risk for poor access to<br />

care. Communication is critical for effective and equitable health<br />

care for ethnic elders.<br />

Conclusion:<br />

Care of older immigrants is challenging given current limitations<br />

in culturally and linguistically sensitive services. Physicians must<br />

consider potential obstacles to care for older immigrants and pay attention<br />

to communication barriers and cultural values as well as clinical<br />

symptoms. It is crucial for institutions to develop system wide<br />

policies and practices that welcoming the diversity of our patient<br />

populations.<br />

References:<br />

1. McBride M. (2010). Ethnogeriatrics and Cultural Competence<br />

for Nursing Practice. Hartford Instutute for Geriatric Nursing<br />

2010. Retrieved Nov 25, 2011, from http://consultgerirn.org.<br />

2. Steven A. (2009, Aug). Facts on Immigration and Health Insurance.<br />

Center for Immigration Studies. Retrieved Nov 25, 2011,<br />

from http://www.cis.org/HealthCare-Immigration<br />

A33<br />

Heart failure in hospitalized elderly subjects in geriatric department:<br />

poor and unusual clinical signs.<br />

Y. Wolmark, 1 M. Gaubert-Dahan, 1 F. Tubach, 2,3 T. Zerah. 1 1. Hôpital<br />

Bretonneau, Paris, France; 2. Hôpital Bichat, Paris, France; 3.<br />

Université Paris Diderot, Paris, France.<br />

Background: Heart failure is a frequent and serious disease in<br />

the elderly. The purpose of the present study was to analyse the characteristics<br />

of the patients with acute heart failure and to compare the<br />

frequency of these characteristics between systolic heart failure (left<br />

ventricular ejection fraction ≤ 50%) and diastolic heart failure. Methods:<br />

The present study was an observational and prospective study<br />

about the clinical features and the radiology, biology and echocardiography<br />

results of 53 patients (mean age 87.8 years) hospitalized in<br />

geriatric care units at Bretonneau hospital in Paris. The Fisher’s exact<br />

test was used to compare 2 nominal variables and the Mann-Whitney<br />

test to compare 2 ordinal variables. Results: The majority of the patients<br />

had hypertension (83%), malnutrition (81%) and anaemia<br />

(62%). Thirty eight percents experienced a first episode of heart failure.<br />

Before the current episode of acute heart failure, 55% of patients<br />

were treated with diuretic agents, 55 % with angiotensin-converting<br />

enzyme inhibitors or angiotensin receptor blockers and 51% with<br />

beta-blockers. The patients had 3 clinical signs or symptoms of heart<br />

failure on average. The most frequent were: pulmonary rales (68%),<br />

dyspnea (60%), crepitant rales (55%), weight gain (64%), peripheral<br />

AGS 2012 ANNUAL MEETING<br />

S27


P OSTER<br />

A BSTRACTS<br />

edema (60%), and weakness (32%). Thirty six percents of the patients<br />

reported a fall in the few days before the current episode of<br />

heart failure. Fifteen percents of the patients had a delirium. The patients<br />

with systolic heart failure had more cardiovascular diseases<br />

(atrial fibrillation (28% versus 19%, p=0.028), angina (21% versus<br />

4%, p=0.001), diabetes (9% versus 2%, p=0.074), and hypercholesterolemia<br />

(15% versus 6%, p=0.041)) than the patients with diastolic<br />

heart failure. Conclusions: Whether the heart failure is systolic or diastolic,<br />

the clinical profile of old patients is poor and unusual, the<br />

prevalence of malnutrition and anaemia is high and their treatment is<br />

inadequate. Cardiovascular diseases are more frequent in patients<br />

with systolic heart failure. Echocardiography enables the comprehensive<br />

diagnosis of heart failure.<br />

A34 Encore Presentation<br />

Age Analysis of Long-Term Safety of Diclofenac Sodium 1% Gel<br />

for Patients With Osteoarthritis of the Knee.<br />

J. H. Peniston, 1 M. S. Gold, 2 M. S. Wieman, 3 L. K. Alwine. 4 1.<br />

Feasterville Family Health Care Center, Feasterville, PA; 2. Novartis<br />

Consumer Health, Inc., Parsippany, NJ; 3. Endo Pharmaceuticals<br />

Inc., Chadds Ford, PA; 4. Downingtown Family Medicine,<br />

Downingtown, PA.<br />

Supported By: Novartis Consumer Health, Parsippany, NJ, and<br />

Endo Pharmaceuticals, Inc., Chadds Ford, PA.<br />

Background: Oral nonsteroidal anti-inflammatory drugs should<br />

be used with caution in the elderly. This study evaluated the safety of<br />

topical diclofenac sodium 1% gel (DSG) in an open-label extension<br />

of 2 double-blind, randomized, 3-month trials of DSG in patients ≥35<br />

years with a ≥6-month history of symptomatic Kellgren-Lawrence<br />

grade 1–3 knee OA.<br />

Methods: Patients applied 4 g DSG to 1 or both knees 4 times<br />

daily for 9 (continuing patients) or 12 (new patients) months; use of<br />

rescue acetaminophen (≤4 g/d) was allowed. AEs were monitored<br />

throughout the study and the Western Ontario and McMaster Universities<br />

Osteoarthritis Index (WOMAC) pain, stiffness, and physical<br />

function subscales were assessed at baseline and 3, 6, 9, and 12<br />

months.<br />

Results: The safety population (947 patients; 575


P OSTER<br />

A BSTRACTS<br />

increased LOS. There were no gender differences, but <strong>American</strong> Indians<br />

had shorter LOS than Whites or African <strong>American</strong>s. History of<br />

cigarette smoking, advanced age, and unclear diagnosis were also associated<br />

with longer LOS.<br />

Conclusion: The severity of the stroke, co-morbidities, and prestroke<br />

status of a stroke survivor may contribute to the LOS of stroke<br />

patients and affect their overall post-stroke outcome. Although biological<br />

factors are most influential, social and psychological factors<br />

also played a role.<br />

A37<br />

Correlation of health professional (KPS) and patient-rated (pKPS)<br />

Karnofsky Performance Status and associations with measures of<br />

geriatric assessment (GA) domains.<br />

T. Jolly, 1 A. Deal, 1 G. Williams, 1 S. Alston, 1 B. Gordon, 1 J. Pan, 1<br />

S. Moore, 2 W. Taylor, 3 H. Muss. 1 1. University of North Carolina,<br />

Chapel Hill, NC; 2. Rex Hematology Oncology Associates, Raleigh,<br />

NC; 3. New Bern Cancer Care, New Bern, NC.<br />

Supported By: Supported in part by the University Cancer Research<br />

Fund, Lineberger Comprehensive Cancer Center, Chapel Hill, NC<br />

BACKGROUND: KPS is frequently used to assess function in<br />

older patients; however, it is prone to observer bias and has limited<br />

ability to detect abnormalities in other GA domains. This study explores<br />

the relationship between KPS and pKPS and their association<br />

with measures of GA domains.<br />

METHODS: Data from the Carolina Senior registry which includes<br />

the North Carolina Cancer Hospital and community affiliates<br />

for patients ≥65 years were analyzed using Fisher’s Exact and<br />

weighted kappa (κ) statistics. Patients completed a predominantly<br />

self administered GA (Hurria et al, Cancer 2005) which included rating<br />

scales for both KPS and pKPS.<br />

RESULTS: The 386 evaluable enrollees had median age: 73<br />

(range 65-97); and were 81% female; 89% white; 55% married; 83%<br />

retired; 72% at least some college education; 97% a cancer diagnoses.<br />

There was fair agreement [κ=0.26 (95% CI 0.18-0.33)] between<br />

KPS and pKPS for patients with scores ≥ 40% (Fig. 1). There<br />

were statistically significant associations between KPS and pKPS<br />

scores


P OSTER<br />

A BSTRACTS<br />

categories based on Mini-Mental State Examination (MMSE) scores:<br />

>23 and those < 23.<br />

Results: The following differences were found between dementia(D)<br />

and non-dementia(ND) patients: Proportion with of twice<br />

daily brushings or more: Annual dental visits: 36% (D) vs. 54% (ND);<br />

flosses teeth: 11% (D) vs. 25% (ND); 51% (D) vs. 54% (ND); problems<br />

with teeth:16%(D) vs. 26%(ND); complaining of dental pain:<br />

20% (D) vs.21% (ND); wear dentures: 57% (D) vs. 58% (ND); problems<br />

with dentures: 25% (D) vs. 30% (ND); Two of the comparisons<br />

attained statistical significance(p< .05): annual dental visits(r=.18)<br />

and flossing teeth (r=.18). There were no significant correlations between<br />

the dichotomized MMSE score and the dental variables. In the<br />

dementia group, having at least an annual visit to dentist was significantly<br />

associated with stage of dementia; 71% and 22% had annual<br />

visits among person with mild and moderate or severe stages, respectively<br />

(χ2 = 6.62, df=1, p=.01). However, no other sociodemographic,<br />

cognitive, or neuropsychiatric variables were associated with annual<br />

dental visits.<br />

Conclusion: Although both groups showed substandard levels of<br />

care, persons with dementia had significantly lower levels of dental<br />

care, and this worsened with the stage of the dementia. The study confirms<br />

that need for education of caregivers and increased accessibility<br />

to oral health care in older adults with dementia.<br />

Key Words:<br />

Dental care; <strong>Geriatrics</strong>; Dementia<br />

A40<br />

Counting Pop-Drops: Emergency Department Re-Visits by Persons<br />

with Dementia.<br />

C. Clevenger, 1,2 D. Khalili, 2 Z. Yang. 3 1. Birmingham/Atlanta<br />

GRECC, Department of Veterans’ Affairs Medical Center, Grayson,<br />

GA; 2. Nell Hodgson Woodruff School of Nursing, Emory University,<br />

Atlanta, GA; 3. Rollins School of Public Health, Emory University,<br />

Atlanta, GA.<br />

BACKGROUND: Twenty-six to forty percent of older emergency<br />

department (ED) patients are estimated to have dementia. We<br />

conducted a pilot study in which persons with dementia (PwD) had<br />

twice the number of ED visits over a one-year period compared to<br />

those without dementia. The purpose of this study is to compare the<br />

pattern of ED use, discharges, and hospital admissions between older<br />

ED re-visitors with and without dementia.<br />

METHODS: The study employed retrospective chart review of<br />

persons over the age of 70 who accessed the ED of an urban academic<br />

medical center ≥ 2 times in 2009 with chief complaints of moderate<br />

severity. We reviewed clinical notes from the ED visit as well as<br />

inpatient and outpatient records for documentation of dementia.<br />

Dates and outcomes of ED visits (admission to hospital or discharge<br />

from ED) were used to calculate interval between visits and variables<br />

of events occurring within 7, 30, 60 and 90 days. We asked the following<br />

research questions: What is the mean number of days between<br />

ED visits for PwD? How likely are PwD to re-visit the ED within 30<br />

days compared to those without dementia? Is there a delay in hospital<br />

admission for PwD as shown by multiple ED discharges prior to<br />

hospital admission?<br />

RESULTS: The study sampled 540 ED visits made by 154 persons;<br />

54 were PwD (35.1%). The mean number of days between ED<br />

visits was 41.5 for those without dementia and 33.7 for PwD<br />

(p=0.160). Persons with dementia made 207 of the 540 total ED visits<br />

(38.3%); 154 of the 386 re-visits (39.9%); and 95 of the 219 30-day revisits<br />

(43.4%). The likelihood ratio of an ED re-visit in = 65 years with at least 1 ED visit<br />

between 1/1/00 and 9/30/07 (N = 4,964). Latent class analysis models<br />

were estimated to identify groups (or classes) with similar numbers of<br />

(1) primary care (PC) visits; (2) outpatient ED visits (i.e. treated and<br />

released); and (3) hospital days within 12 months preceding the index<br />

S30<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

ED visit. A multinomial logistic regression model was used to compare<br />

health care utilization measures in each class to the overall sample<br />

mean.<br />

Results: 5 groups with distinct patterns of health service use in<br />

the year preceding an index ED visit emerged. Two groups, dubbed<br />

“Wellderly,” had fewer chronic conditions than the population mean.<br />

The 1st group [“Wellderly with PC”, 39%] used less ED and hospital<br />

care, but had higher PC visits compared to the overall mean (6.2 vs 4).<br />

Members of this group were more likely to be female, live alone and<br />

have higher income (P


P OSTER<br />

A BSTRACTS<br />

Methods: A longitudinal, retrospective database analysis included<br />

outpatient data from the Veterans Health Administration<br />

(VHA). The study sample included veterans age 65 years or older<br />

with at least one outpatient primary care visit or one inpatient visit<br />

between fiscal year 2003 to 2005. We identified veterans with an ICD-<br />

9 diagnosis of insomnia, anxiety, PTSD, depression or chronic pain<br />

and potentially inappropriate prescriptions of antihistamines, psychotropics,<br />

musculoskeletal relaxants and opioids. We examined demographic<br />

data, Selim index comorbidities, total number of medications<br />

prescribed, and utilization of geriatric primary care. All analysis<br />

was conducted using SPSS-14. We obtained IRB approval.<br />

Results: Of the 41, 432 veterans identified, 21.8% (9,086) received<br />

a HRME. Only 7.9% of veterans older than 85 years of age received<br />

a HRME. More minorities received a HRME than whites<br />

(10.7% vs. 74.8%).Veterans exempted from a medication co-payment<br />

received more HRME than those not exempt (76% vs. 23.5%). Of<br />

those veterans with a HRME, 44.6% received 12 or more medications.<br />

Utilizing geriatric care in 2005 resulted in fewer HRME prescriptions<br />

(3.5% vs. 4.8) whereas more than 33% of veterans with 5 or more primary<br />

care visits received a HRME. Veterans with 0 to 1 physical conditions,<br />

but >2 mental health conditions received fewer HRME.<br />

Conclusion: HRME are common in the older adult veteran population.<br />

Geriatric primary care and older veterans age are protective<br />

characteristics, which are similar to other studies. Future studies<br />

should focus on interventions to reduce the number of HRME older<br />

adults receive.<br />

References: 1. Zhan C, Sangl J, Bierman AS et al. Potentially inappropriate<br />

medication use in the community-dwelling elderly: findings<br />

from the 1996 Medical Expenditure Panel Survey. JAMA<br />

2001;286:2823-2829.<br />

A46<br />

Differences in Vitamin D Deficiency by Ethnic/Racial Background<br />

in a Geriatric Clinic, Houston, TX.<br />

N. Rianon, 3 K. Murphy, 1 C. Dyer, 2 B. Selwyn. 4 1. Family and<br />

Community Medicine, University of Texas Medical School at<br />

Houston, Houston, TX; 2. Integrative Nursing Care, University of<br />

Texas Houston Health Science Center- School of Nursing, Houston,<br />

TX; 3. Internal Medicine, University of Texas Medical School at<br />

Houston, Houston, TX; 4. Epidemiology, University of Texas Houston<br />

Health Science Center- School of Public Health, Houston, TX.<br />

Supported By: The project was supported by funding from the<br />

Herzstein Foundation<br />

Background: Vitamin D deficiency documented in a national<br />

study (NHANES 2001-2004) in more than 70% of older patients at<br />

risk of age related bone loss or osteoporosis occurred in a higher percentage<br />

of African <strong>American</strong>s (AA) (97%) and Hispanics (90%)<br />

than in Caucasians (72%). Under- recognition of vitamin D deficiency<br />

led to under-treatment in patients needing prevention of, and<br />

treatment for osteoporosis. This cross sectional pilot study describes<br />

variations in Vitamin D testing and deficiency by ethnic/racial background<br />

among at risk patients in Houston, Texas.<br />

Methods:<br />

Electronic chart review recorded the ethnic/racial background<br />

for 72 patients receiving treatment for menopausal symptoms, osteoporosis<br />

and related fractures in a geriatric clinic in Houston, Texas<br />

from January 2009 to December 2010. Orders for serum 25 hydroxy<br />

vitamin D indicated vitamin D testing, and serum vitamin D levels<br />

recorded as less than 30 ng/ml indicated deficiency in this study.<br />

Results:<br />

The patient group was mostly women (93%) and had a mean<br />

age of 79±9 years (range 57 – 97 years). Most of the patients were<br />

Caucasians (64%), while 25% were AA and 11% were of “Other”<br />

ethnicities (7 Hispanics, 1 Asian). About half (49%) were not tested<br />

for Vitamin D levels. Of those tested (N=37), 68% were Caucasians,<br />

24% were AA and 8% were of “Other” ethnicities. About 46% of<br />

those tested had Vitamin D deficiency. Vitamin D deficient patients<br />

(N=17) were 65% Caucasians, 23% AA and 12% were of “Other”<br />

ethnicities.<br />

Conclusions:<br />

We report a lower prevalence of vitamin D deficiency among<br />

African <strong>American</strong> and Hispanic patients in Houston, Texas compared<br />

to the NHANES data. Our results may be reflective of the dietary<br />

and environmental differences in the population served in this region.<br />

Further studies that outline vitamin D deficiency in diverse ethnic<br />

and racial groups will help to improve osteoporosis management<br />

in older patients.<br />

A47<br />

Impact of race on cognitive assessment among hospitalized elders.<br />

B. Benizry, 1 N. Campbell, 2,3 S. L. Hui, 1,3 T. Perkins, 3 B. A. Khan, 1,3<br />

M. O. Farber, 1 W. Ely, 4,5 M. A. Boustani. 1,3 1. School of Medicine,<br />

Indiana University, Indianapolis, IN; 2. Pharmacy Practice, Purdue<br />

University, Indianapolis, IN; 3. Regenstrief Institute, Inc., Indianapolis,<br />

IN; 4. School of Medicine, Vanderbilt University, Nashville, TN; 5.<br />

Geriatric Research Education Clinical Center (GRECC), VA<br />

Tennessee Valley, Nashville, TN.<br />

Supported By: This work was supported by grants K23AG26770-01<br />

and R01AG034205-01A1 from the National Institute on Aging<br />

(NIA); the Hartford Foundation; the Atlantic Philanthropy; and the<br />

<strong>American</strong> Federation for Aging Research (AFAR). Additionally,<br />

Braca Benizry was supported by a Medical Student Training in<br />

Aging Research (MSTAR) award administered by the AFAR and<br />

the NIA. The sponsor had no role in the study design, evaluation, or<br />

manuscript development.<br />

Background: Racial disparities in health care quality and outcomes<br />

have been studied and well characterized for various medical<br />

conditions. African <strong>American</strong>s have been suggested to have a higher<br />

likelihood of developing chronic forms of cognitive impairment such<br />

as dementia, however little information exists regarding racial disparities<br />

in acute cognitive impairment or delirium. Our objective was to<br />

evaluate the association between Race and diagnosis and recognition<br />

of cognitive impairment and delirium.<br />

Methods: This study was an observational cohort study taking<br />

place at Wishard Hospital, an urban public hospital in Indianapolis.<br />

Participants included 991 patients aged 65 years and older admitted<br />

to general inpatient medical services between July 2006 and March<br />

2008. Cognitive impairment was identified using the Short Portable<br />

Mental Status Questionnaire and delirium was identified using the<br />

Confusion Assessment Method. Recognition of cognitive impairment<br />

and delirium was determined by examining ICD-9 codes in the Regenstrief<br />

Medical Record System (RMRS) within one year prior to<br />

hospitalization through discharge or hospital admission through discharge,<br />

respectively.<br />

Results: 424 patients (43%) screened positive for cognitive<br />

impairment and 173 patients (17%) screened positive for delirium.<br />

Sixty-seven percent of those with recognized cognitive impairment<br />

and 68% of those with recognized delirium were African<br />

<strong>American</strong>. After adjusting for potential confounders, the odds<br />

ratio for the relationship between race and recognition of cognitive<br />

impairment was 1.61 (95% confidence interval = 0.98, 2.64)<br />

and recognition of delirium was 1.51 (95% confidence interval =<br />

0.64-3.57).<br />

Conclusion: Among hospitalized older adults, neither the diagnosis<br />

nor recognition of cognitive impairment and delirium differed<br />

between races; however, a trend towards better recognition<br />

of cognitive impairment and delirium among African <strong>American</strong>s<br />

may exist.<br />

S32<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

A48<br />

Ninety-Day Mortality Among Older Adults Following Hospital<br />

Admission for Pneumonia.<br />

O. E. Abreu Lanfranco, 1,2 H. Rahbar, 1,2 C. Biedron, 1,2 A. Singh, 2<br />

M. Tims, 2 B. Ramasamy, 2 T. Chopra, 1,2 K. S. Kaye. 2,1 1. Infectious<br />

Disease, Wayne State University, Detroit, MI; 2. Infectious Disease,<br />

Detriot Medical Center, Detroit, MI.<br />

Background: Pneumonia is one of the leading causes for acute<br />

hospitalization in the US. In older adults, pneumonia is associated<br />

with increased morbidity, functional status deterioration, resources<br />

and mortality. We aimed to identify factors associated with an increased<br />

risk for 90-day mortality after hospitalization for pneumonia<br />

in older adults and to define the impact of hospital readmission on<br />

mortality.<br />

Methods: Study conducted at the Detroit Medical Center. Retrospective<br />

chart review in patients over 65 years of age who had a primary<br />

diagnosis of pneumonia from January to March 2011. Data abstracted<br />

from medical records. Cases were defined as patients who<br />

died within 90 days following hospital discharge and controls were<br />

patients who did not die during the 90-day period following hospital<br />

discharge. Controls were matched by hospital and calendar time of<br />

admission.<br />

Results: A total of 160 patients were studied with a mean age of<br />

77.7 years +/-8.2, 54% were men. Thirty-four patients (21%) died<br />

within 90 days after the initial discharge (21%). Cases were more<br />

likely to be readmitted within 30 days of the index hospitalization<br />

(85.3% and 40.9%; OR 8.33, 95% CI 3.3-25), need assistance with 3 or<br />

more ADLs (64.7% and 38.9%, OR 2.88(95% CI 1.3-6.3), have a<br />

Braden score < 16 (55.9% and 29.4%; OR 3.1, 95% CI 1.4-6.6), have a<br />

pleural effusion on radiography (50% and 25.3%; OR 2.9, 95% CI<br />

1.3-6.4), be treated for healthcare-associated pneumonia(58.8% and<br />

30.2%; OR 3.3, 95% CI 1.5-7.2), more likely to have a higher Charlson’s<br />

Score (OR 3.05, 95% CI 1.28-7.25) and Pneumonia Severity<br />

Index(OR 0.14, 95% CI 0.24-0.78). In multivariate analysis, independent<br />

predictors of 90-day mortality included readmission within<br />

30 days (OR 6.8, 95% CI 2.4-19.6), Pneumonia Severity Index > 4<br />

(OR 3.29, 95% CI 1.32-8.19), and having been treated for HCAP (OR<br />

2.32, 95% CI 1.01-5.35).<br />

Conclusions: Among older adults discharged from the hospital<br />

with pneumonia, mortality rates exceeded 20%. Readmission within 30<br />

days was associated with a greater than 7-fold increase in 90-day mortality,<br />

patients treated for HCAP during their initial pneumonia admission<br />

had a greater than 2.5-fold increased risk for 90-day mortality.<br />

A49<br />

DRIVING CESSATION: NOT A ONE WAY DECISION.<br />

R. A. Marottoli, 1,2 K. Araujo, 1 P. Peduzzi. 1 1. Yale University School<br />

of Medicine, New Haven, CT; 2. VA CT, West Haven, CT.<br />

Background: While it is often assumed that driving cessation is a<br />

final decision, it is likely that many individuals return to driving after<br />

temporarily stopping. The purpose of this study was to determine the<br />

frequency of occurrence and factors associated with the resumption<br />

of driving after initial cessation.<br />

Methods: Participants were community-living active drivers age<br />

70 years and older recruited from general medical clinics and community<br />

sources. Participants were assessed in-person at baseline and<br />

followed prospectively for two years with phone contacts every six<br />

months that included questions on driving status.<br />

Results: 615 drivers had a mean age of 78.8 (+/-4.9) years, 12%<br />

were women, mean MMSE score was 27.4 (± 2.1) points, average<br />

mileage was 129 (± 109) miles per week, and 72% drove daily. 68 drivers<br />

(11%) stopped driving at some point during two years of followup.<br />

Of these, 25 (37%) had resumed driving by the end of two years of<br />

follow up. Compared to drivers who stopped permanently, those who<br />

returned to driving had higher weekly mileage (153 v. 90, p=.01),<br />

fewer chronic conditions (64 v. 84% w/≥3, p=.06), higher self-rated<br />

health (80 v. 58% excellent/good, p=.07), higher MMSE scores (64%<br />

v. 40% scored ≥ 28, p=.05), drove more often (92 v. 53% daily, p=.001),<br />

and faster gait speed (75 v. 47% ≤ 7 sec, p=.02).<br />

Conclusion: The decision to stop driving is not always final. In<br />

this cohort a substantial proportion of older people returned to driving<br />

after temporarily stopping. Identifying these individuals and the<br />

factors contributing to their decisions to both stop and return to driving<br />

may help clinicians counsel other drivers and families facing this<br />

transition.<br />

A50<br />

Differential impact of hypertension and diabetes on cognitive tests<br />

over 4 years.<br />

R. M. Allman, 1,2 P. Sawyer, 2 M. Crowe, 3 R. E. Kennedy, 4 R. V. Sims. 1<br />

1. Birmingham/Atlanta VA GRECC, Birmingham, AL; 2.<br />

Gerontology, <strong>Geriatrics</strong>, and Palliative Care, University of Alabama at<br />

Birmingham, Birmingham, AL; 3. Psychology, University of Alabama<br />

at Birmingham, Birmingham, AL; 4. Biostatistics,<br />

Birmingham/Atlanta VA GRECC, Birmingham, AL.<br />

Supported By: National Institute on Aging<br />

Purpose: To understand predictors of changes in cognitive<br />

screening tests over four years in community-dwelling older adults.<br />

Methods: This is a prospective, observational study of community-dwelling<br />

Medicare beneficiaries aged 65 years and older that<br />

completed a comprehensive baseline in-home assessment (1999-<br />

2001) and a repeat in-home assessment in 2004. Data included sociodemographics,<br />

medical conditions diagnosed by a physician and<br />

health behaviors. Cognitive tests included drawing a clock (CLOXI),<br />

copying a clock (CLOX2), and a 30-point multi-item cognitive assessment<br />

(MICA). Multivariable linear regression models controlling for<br />

age, race, sex, education, and income were used to test the independence<br />

and significance of associations between baseline diabetes, hypertension,<br />

arrhythmia, coronary artery disease, geriatric depression<br />

score (GDS), smoking pack years, BMI>30, unintentional weight loss,<br />

vision, leisure time physical activity, and incident stroke or dementia<br />

diagnoses on changes in the three cognitive tests over 4 years.<br />

Results: Mean age of the sample (N=580) at baseline was 73.6<br />

(53% female; 46% African <strong>American</strong>). Mean (SD) baseline cognitive<br />

scores were 10.9 (2.8) for CLOX1, 12.9 (1.9) for CLOX2, and 26.5<br />

(3.5) for MICA. Mean declines (SD) in the cognitive test scores were<br />

0.6 (3.4), 0.5 (2.3), and 0.9 (3.0), respectively (p


P OSTER<br />

A BSTRACTS<br />

Design. CaMos is an ongoing 10 year prospective cohort study.<br />

Population. Age and sex matched Canadian population who are<br />

non-institutionalized individuals and reside in nine CaMos study<br />

centers.<br />

Methods. Data from 2819 men and 6444 women were classified<br />

as current GC users and non-users. New fractures based on self-reports<br />

from an annually completed questionnaire included vertebral,<br />

hip, other (excluding hip, vertebral, toes, fingers, skull fractures) and<br />

any fracture (excluding toes, fingers, skull fractures). Multivariable<br />

survival analyses were conducted to examine the association between<br />

the time to new fracture and GC use. Hazard ratios and 95% confidence<br />

intervals (CI) were calculated.<br />

Results. The mean age, femoral neck T-score (standard deviation)<br />

and GC use at baseline of the cohort was 62.0 (13.3), -1.07<br />

(1.03) and 128 (1. 4%), respectively. During the 10 year period, 130<br />

(1.4%), 157 (1.7%), 869 (9.7%) and 1102 (11.9%) individuals developed<br />

a new osteoporotic vertebral, hip, other and any fracture. Ever<br />

taking GC for a minimum of one month in both men and women had<br />

a hazard ratio of 1.4 (95% CI: 1.0 -1.8), 1.9 (95% CI: 1.0-3.6), 0.97<br />

(95% CI: 0.4-2.2),1.2 (95% CI: 0.9-1.6) for developing a new nonspine,<br />

hip, spine and any fracture as compared to those who never<br />

took GC, respectively.<br />

Conclusions. CaMos is the first prospective long-term study with<br />

data over 10 years showing that GC use is associated with higher incident<br />

fragility fractures.<br />

Key Words: glucocorticoids, fractures, bone mineral density<br />

A52<br />

Unsteadiness in Post-acute Care (PAC): Prevalence and Associated<br />

Characteristics.<br />

S. Bangalore, S. E. Hardy. Medicine/<strong>Geriatrics</strong>, University of<br />

Pittsburgh, Pittsburgh, PA.<br />

Supported By: NIA, Hartford Foundation<br />

Background-Unsteadiness is a subjective sense of loss of equilibrium<br />

or balance in regard to the environment. Patients in PAC frequently<br />

complain of unsteadiness, requiring a detailed evaluation.<br />

The purpose of this study is to describe the prevalence of unsteadiness<br />

and the characteristics associated with it.<br />

Methods-We performed cross-sectional analysis of baseline data<br />

on previously community-dwelling older adults admitted to skilled<br />

nursing facilities for PAC (age 81±8, 85% white, 71% female) obtained<br />

by in-person assessment and review of hospital records. Of the<br />

125 participants, 35 (28%) had no unsteadiness, 18 (14.4%) had mild,<br />

50 (40%) had moderate, and 22 (17.6%) had severe unsteadiness. The<br />

characteristics of participants with and without unsteadiness were<br />

compared using Chi-Square, Fisher’s exact, and t-tests.<br />

Results-Characteristics significantly associated with any unsteadiness<br />

are presented in the table (values represent % or<br />

mean±SD). Age, sex, race, pain, systolic BP


P OSTER<br />

A BSTRACTS<br />

351,874 visits to the ED, out of which 63,278 (18%) were of adults<br />

aged 60 and over (A60), while 17,593 (5%) were aged 80 years or<br />

older (A80). There was an increase in 83.2% of elderly visits throughout<br />

the years. It was additionally verified that of the total number of<br />

A60 and A80, respectively 46.1% and 51% were female; 24.5% and<br />

31.9% were admitted to hospital wards (versus 5.4% among patients<br />

aged from 18 to 59 years); and 1.4% and 2.8% died still at the ED or<br />

subsequently during hospital stay (versus 0.4%). The median length<br />

of stay for A60 was 3.1 days at the ED, and 5 days at the hospital<br />

wards (versus 2.5 and 3 days). Injuries and their consequences<br />

(17.8%), symptoms and signs involving the digestive system and abdomen<br />

such as abdominal pain, nausea and vomiting (8.4%), general<br />

symptoms and signs such as fever, syncope and collapse, malaise and<br />

fatigue (5.5%), specific medical procedures and health care actions<br />

(4.7%), acute upper respiratory infections (4.4%) and dorsopathies<br />

(3.5%) were the most common diagnoses, as defined using the ICD-<br />

10 blocks of codes. Conclusion: Older adults are increasingly seeking<br />

care in the ED. They are more frequently hospitalized and have<br />

higher mortality than younger patients who seek care in the same setting.<br />

Injuries and digestive system complaints are the most frequent<br />

motivations for their visits. The high frequency of non-specific symptoms<br />

like malaise, fatigue and fever indicate the need of an expert<br />

team to make the correct diagnoses in this setting.<br />

A55<br />

Nonagenarians: an increasing reality in the emergency room.<br />

T. J. Avelino-Silva, L. A. Gil, A. L. Bierrenbach, C. Toscano, W. Jacob-<br />

Filho, F. Ganem. Hospital Sirio-Libanes, Sao Paulo, SP, Brazil.<br />

Supported By: None of the authors reported a potential, real, or<br />

perceived conflict of interest or financial disclosure. No sponsors<br />

participated in or funded this research.<br />

Background: In Brazil, as in more developed countries, the<br />

strongest growth of the older population shall be in the age bracket<br />

above 80. How does one guarantee an efficient health system and<br />

quality of life for this new mass of older citizens? It was our objective<br />

to better understand the characteristics of the patients over 90 years<br />

of age who seek care in the emergency room. Methods: We retrospectively<br />

reviewed a database containing information of all the patients<br />

who visited the emergency department (ED) of a 350-bed private tertiary<br />

care general hospital in São Paulo, Brazil, from January 2003 to<br />

December 2010. Data pertaining to the patients who were 90 years of<br />

age or older were searched for the following: age; gender; principal<br />

diagnosis (ICD-10 codes); hospital admission; length of stay; and outcome.<br />

Results: Over the 8-year study period, there were 351,874 visits<br />

to the ED, out of which 63,278 (18%) were of adults aged 60 and over<br />

(A60), while 4,099 (1.1%) were aged 90 or older (A90). There was an<br />

expressive growth of the number of older adult visits to the ED<br />

throughout the years (83.2%), but it was the age group over 90 that<br />

showed the most remarkable expansion (95.6%). Of the total number<br />

of A90, 58.1% were female, while only 46.1% were so if one considered<br />

A60. A90 were admitted to hospital wards in 35.1% of the cases<br />

(versus 24.5% for A60), and 4.1% died at the ED or subsequently<br />

during their hospital stay (versus 1.4%). The median length of stay<br />

was 3.1 days at the ED, and 5 days at the hospital wards, which was<br />

similar to younger geriatric patients. Injuries and consequences accounted<br />

for 17.9% of A90 visits. Other important reason for their visits<br />

were specific medical procedures and health care actions (7%).<br />

These were mostly related to surgical and orthopedic follow-up care,<br />

attention to artificial openings, like colonostomy and others and issue<br />

of repeat prescriptions. General symptoms and signs such as fever,<br />

syncope and collapse, malaise and fatigue (6.9%), symptoms and<br />

signs involving the digestive system and abdomen (6.9%), influenza<br />

and pneumonia (6%), and heart diseases (5.4%) followed in frequency.<br />

Conclusion: ED visits by patients over 90 had the greatest increase<br />

among older adults. The primary motivations for their visits<br />

were injuries, specific medical procedures and health care actions.<br />

Further discussion of adequate settings to provide care for these patients<br />

is needed.<br />

A56<br />

Cause of Death among Older Adults with Cognitive Impairment<br />

with and without Dementia: The Aging, Demographics, and<br />

Memory Study.<br />

T. Okura, 1 K. M. Langa. 2 1. Bajikoen Clinic, Tokyo, Japan; 2.<br />

University of Michigan, Ann Arbor, MI.<br />

(Background) Hypothesizing that older individuals with dementia<br />

die from different causes compared to those with the milder levels<br />

of cognitive impairment, we compared the cause of death for those<br />

with dementia to those with normal cognition or cognitive impairment<br />

without dementia (CIND) using longitudinal data from a nationally<br />

representative sample of older adults in the United States.<br />

(Methods) We used data from the Aging, Demographics, and<br />

Memory Study (ADAMS), a sub-study of the Health and Retirement<br />

Study (HRS) focused on cognitive impairment and dementia. We<br />

identified individuals aged 71 or older diagnosed as normal, CIND, or<br />

demented by the ADAMS consensus diagnosis panel. Date and cause<br />

of death during the 9-year study period were obtained from the HRS.<br />

(Results) 91.3% of those with dementia died during the followup<br />

period compared to 67.5% and 28.1% of those with CIND and<br />

normal cognition, respectively. Heart disease was the most common<br />

cause of death across all cognitive categories, accounting for about<br />

25% of deaths in each group. Those with dementia were more likely<br />

to die from stroke (13.5% vs. 4.3% for CIND, 4.6% for normal cognition,<br />

p


P OSTER<br />

A BSTRACTS<br />

incidents (64%) regardless of age or the presence of alcohol.The odds<br />

of an injury being due to a fall or motor vehicle accident in BAL+ patients<br />

compared to BAL- patients can be seen the table below.<br />

When controlling for the selected demographic factors and the<br />

presence of alcohol, the odds of an injury being the result of a fall increased<br />

significantly as patient age increased. Conversely, the odds of<br />

an injury being from a motor vehicle accident decreased significantly<br />

as the patient age increased.<br />

Conclusions: Age as well as alcohol does influence the odds of<br />

an injury being due to a fall or a motor vehicle accident in older<br />

adults. Our findings suggest that alcohol related injury prevention<br />

programs should be tailored to the age group targeted.<br />

Unadjusted odds of injury being due to falls or motor vehicle accident<br />

by age group<br />

A58<br />

Long term treatment with metformin in patients with type 2 diabetes<br />

and risk of vitamin B-12 deficiency.<br />

V. Nurpeisov. Emory, Dunwoody, GA.<br />

Background: Identification of risk factors for metformin-related<br />

vitamin B12 deficiency has major potential implications regarding the<br />

management of DM.<br />

Methods: A case-control study was conducted from a database<br />

in which the source population consisted of subjects who had levels of<br />

both serum vitamin B12 and hemoglobin A1C checked in a laboratory.<br />

63 cases of diabetes mellitus (HbA1C>7) and vitamin B12 deficiency<br />

secondary to metformin treatment were identified. 73 controls<br />

which were identified as HbA1C>7 with normal vitamin B12 greater<br />

than 200pmol/L served as the comparison group.<br />

Results: After adjusting for confounders, we found a clinically<br />

important and statistically significant association of vitamin B12 deficiency<br />

with duration of metformin use. After adjusting for confounders,<br />

we found a clinically important and statistically significant<br />

association of vitamin B12 deficiency with duration of metformin use.<br />

Among those using metformin for 1 year or more compared with<br />

those receiving metformin for less than 1 year, the adjusted odds ratio<br />

was 8.91 with a CI(4.1; 19.4),(P


P OSTER<br />

A BSTRACTS<br />

cancer (84%), liver cirrhosis (2%), end stage renal disease (2%),<br />

and AIDS (2%). Overall, 38% of the patients seen by palliative<br />

care died at home, 24% in the hospital, 5% in a nursing home, and<br />

4% at an inpatient hospice. Sixty percent of patients who received a<br />

palliative care consult went on to choose hospice for EOL care. In<br />

multivariable analyses, patients with cancer (AOR: 2.23, 95% CI:<br />

1.88, 2.65), those who had a social work assessment (1.39, 1.20,<br />

1.62), and those with an advance directive (1.72, 1.41, 2.08) or DNR<br />

order (2.11, 1.59, 2.80) were more likely to use hospice. Race and<br />

ethnicity were not statistically significant predictors of hospice use<br />

in this cohort.<br />

Conclusion: In this cohort, once patients received a palliative<br />

care consult, there were no racial and ethnic disparities in hospice<br />

use. This suggests that despite being historically underutilized, palliative<br />

care and hospice services are viable EOL care options for<br />

URMs and persons of low SES. Though cancer sufferers often receive<br />

palliative care consultation, continued efforts should be<br />

made to encourage consultation for patients with other life-limiting<br />

illnesses.<br />

A61<br />

Physical Restraints of Home-dwelling Elders: Perception by Home<br />

Care Providers.<br />

S. Kurata. Gerontological Nursing, Hamamatsu University School of<br />

Medicine, Hamamatsu, Japan.<br />

Supported By: Grant-in-Aid for Research Activity Start-up from<br />

the Ministry of Education, Culture, Sports, Science and Technology<br />

of Japan<br />

Background: Family caregivers may unconsciously use physical<br />

restraints on home-dwelling elders, which could include or lead to<br />

abuse. Home care providers need to grasp the conditions and specificities<br />

of physical restraints in home care and to support family caregivers.<br />

I investigated how the home care providers perceive physical<br />

restraints.<br />

Methods: A self-administered questionnaire survey was conducted<br />

for home care providers (home helpers, visiting nurses, visiting<br />

physicians, and care managers) of home-dwelling elders: the Japanese<br />

version of the perceptions of Physical Restraint Use Questionnaire;<br />

whether or how they recognize 12 physical restraints prohibited in institutions<br />

and 10 harmful effects of physical restraints; and whether<br />

they have taken courses of physical restraints.<br />

Results: Total 568 home care providers responded: 201 home<br />

helpers, 78 visiting nurses, 131 visiting physicians, and 158 care managers.<br />

The number of physical restraints recognized as prohibited was<br />

significantly different among visiting physicians (5.2±2.9), visiting<br />

nurses (5.9±3.2), home helpers (6.3±3.3), and care managers (8.4±2.6;<br />

p


P OSTER<br />

A BSTRACTS<br />

TNF-R1 levels were compared across tertiles of IL-6 levels using a<br />

Hodges-Lehmann non-parametric K-sample median test.<br />

Results: The analytic sample included 1429 participants with<br />

available data for both inflammatory markers and all adjusted covariates,<br />

among whom 408 were HIV-infected and 1021 were HIV-uninfected.<br />

In an adjusted model, a one log increase in ln(IL-6) was associated<br />

with a 0.123 (95% confidence interval [CI] =0.102-0.145, p <<br />

.001) log increase in ln(TNF-R1). This association was further<br />

demonstrated by a 0.115 log increase in ln(TNF-R1) for every one<br />

standard deviation change in ln(IL-6) (95% CI =0.095-0.135, p <<br />

.001). Moreover, higher median TNF-R1 levels were observed in the<br />

top tertile of IL-6 levels (1753 versus 1404 pg/ml, p < .001), regardless<br />

of HIV status and changes in CRP.<br />

Conclusions: IL-6 and TNF-R1 levels were positively associated<br />

in the ALIVE study. These findings provide initial insight into the relationship<br />

between IL-6 and TNF-R1 in this unique population and<br />

suggest further investigations into potential mechanisms leading to<br />

generalized inflammation and immune activation in HIV infection<br />

and aging.<br />

A64<br />

Care of the Vulnerable Elder Practice Improvement Module: Chart<br />

Review Alone as a Valuable Educational Experience.<br />

E. Oleson, S. McGee, M. Zanetti, S. Barrett, M. Pugnaire,<br />

J. Gurwitz, C. DuBeau. University of Massachusetts Medical School,<br />

Worcester, MA.<br />

Supported By: Supported by the Donald W. Reynolds Foundation<br />

Background: The Care of the Vulnerable Elder Practice Improvement<br />

Module (COVE-PIM) was developed by the <strong>American</strong><br />

Board of Internal Medicine for maintenance of board certification<br />

and has been adapted for residency programs. The COVE-PIM includes<br />

chart review of geriatric care to identify any gap in care, evaluation<br />

of the care system, and a quality improvement (QI) project to<br />

address the gap. We included COVE-PIM into a new required Ambulatory<br />

Care Block rotation for Medicine residents at UMass Memorial<br />

Medical Center as part of the geriatric medicine curriculum. Care<br />

system review and QI projects were not feasible in our setting, therefore,<br />

we adapted COVE-PIM as a formative exercise with chart review<br />

and a reflective evaluation on changes the residents would make<br />

make in the care of their older patients as a result of the exercise.<br />

Methods: Residents were asked to complete chart reviews on<br />

five patients > 60 years in their continuity clinic using the standard<br />

COVE-PIM review of documented chronic medical conditions,<br />

health habits, screening measures, physical exam, and advanced directive<br />

discussions. The reflective evaluation consisted of the resident’s<br />

anticipated changes in care of the elderly in screening for geriatric<br />

syndromes, such as cognitive impairment and falls, and documenting<br />

surrogate decision makers and advanced directives by completing the<br />

COVE-PIM chart review.<br />

Results: A total of 31 PG1 and PG2 Medicine residents completed<br />

112 chart reviews across 9 different clinical sites. Ninety percent<br />

of residents reported that the formative experience was useful<br />

and 100% of the residents felt the exercise increased the likelihood<br />

they would screen for common geriatric conditions. In the chart review,<br />

34% of residents reported documentation of wishes for life-sustaining<br />

care and 39% had recorded surrogate decision makers. In the<br />

reflective evaluation, 90% of residents felt that the exercise would<br />

improve their likelihood of documenting surrogate decision makers<br />

and discussions regarding end-of-life care.<br />

Conclusions: COVE-PIM chart review alone with added reflective<br />

evaluation helped residents identify gaps of care among their<br />

older patients and was considered a valuable educational experience<br />

that residents anticipated would impact future care. This modification<br />

may be more suitable for shorter ambulatory rotations.<br />

A65<br />

Integration of Geriatric Medicine into a Multi-Year Ambulatory<br />

Care Block Curriculum.<br />

E. Oleson, S. McGee, E. Murphy, G. Manchester, C. DuBeau.<br />

University of Massachusetts Medical School, Worcester, MA.<br />

Supported By: Supported by the Donald W. Reynolds Foundation<br />

Background: We describe the successful transition of a PGY1<br />

geriatric medicine block rotation for Medicine residents into an integrated,<br />

multi-year PGY1-3 Ambulatory Care Block (ACB) curriculum.<br />

The ACB was developed as a yearly, one-month required rotation<br />

incorporating elements of geriatric medicine, gender medicine, a<br />

primary care core curriculum and intensive continuity clinic experience,<br />

with a 3-year cyclical curriculum.<br />

Methods: A review of literature, online geriatric modules, and<br />

previous geriatric medicine curriculum was done to expand the ACB<br />

geriatric medicine educational content. Required GeriaSims modules,<br />

didactics, and an Evidence-Based Medicine (EBM) exercise<br />

were adapted from the previous PGY1 experience. We designed a<br />

progressive curriculum with PGY-specific objectives in the context of<br />

a specific theme (Curriculum Year 1 - geriatric assessment; Year 2 -<br />

transitions in care). Geriatric clinical experiences were PGY-specific<br />

(e.g., PGY1 - skilled nursing facility, PGY2 - geriatric clinic, PGY3 -<br />

home visit and Elder Services). A PGY4 chief resident designed a<br />

geriatric morning report as his CRIT project. Residents also completed<br />

a formative COVE-PIM chart review of their continuity clinic<br />

patients. These were added to primary care didactics, quality improvement<br />

project, and continuity and subspecialty clinics. An online<br />

Wiki was created as a resource for schedules, lectures, and independent<br />

assignments.<br />

Results: The ACB pilot year included 28 PGY1 and 29 PGY2<br />

residents. Feedback from residents and faculty was quite positive and<br />

90.5% of the residents agreed or strongly agreed that the integrated<br />

ACB was a better learning experience than the previous separate<br />

components. Feedback led to changes in clinical site scheduling, required<br />

online modules, and structure of the EBM session in the second<br />

year of this rotation.<br />

Conclusions: A geriatric medicine curriculum was successfully<br />

integrated into an ambulatory block rotation for Medicine residents.<br />

Now in its second year the block has been expanded to include PGY3<br />

residents and a new set of didactic sessions and home care clinical experiences<br />

for what will eventually be a three year rotating curriculum.<br />

Overall, we found a valuable geriatric medicine experience may be<br />

incorporated into the ambulatory curriculum for Medicine residents.<br />

A66<br />

Development and Validation of a Novel Geriatric Skills Assessment<br />

Tool (GSAT) to Identify Training Needs of Internal Medicine<br />

Residents and Faculty.<br />

N. Jamshed, 1 P. Zeballos, 1 S. Sinha. 2 1. Internal Medicine,<br />

WHC/Georgetown University School of Medicine, Washington, DC; 2.<br />

University of Toronto, toronto, ON, Canada.<br />

Purpose: This study reports the pilot data and preliminary validation<br />

of a novel, learner-focused, Geriactic Skills Assessment Tool<br />

(GSAT), in assessing training needs in geriatrics at a large academic<br />

community hospital. Methods: A voluntary survey was conducted<br />

amongst the IM faculty and residents using the GSAT. GSAT was developed<br />

based on 15 basic competencies identified by the <strong>American</strong><br />

Board of Internal Medicine (ABIM) for IM trainees. Faculty and residents<br />

were each asked to rate their confidence in performing, confidence<br />

in teaching and interest in further training, in each skill set. We<br />

assessed the cronback alpha coefficient for reliability of the GSAT.<br />

Fisher’s exact test was used to evaluate the participant confidence in<br />

performing and teaching particular skills, as well as their interest in<br />

pursuing further training around them. Results: 27 faculty and 27 residents<br />

completed the survey. The cronback alpha coefficient for the<br />

S38<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

reliability of the GSAT was 0.96. 70% participants identified high<br />

need for training in medication management and in differentiating<br />

delirium, dementia and depression (p〈0.05). Residents were significantly<br />

more likely to report interest in training in differentiating<br />

delirium, dementia and depression (p〈0.05) when compared to faculty.62%<br />

of all participants reported low confidence in performing<br />

fall risk assessment with no statistically significant difference between<br />

the groups (p〈0.05). Lowest confidence in teaching was in modifying<br />

management, assessing fall risk, and use of antipsychotics (p〈<br />

0.05). There was no statistically significant difference between the<br />

groups. Residents with high interest of training in medication management,<br />

fall assessment, differentiating delirium, dementia and depression,<br />

and end of life care discussions also had high confidence in<br />

teaching and performing these skills (p〈0.05). It appears that residents’<br />

further interest in training was independent of their confidence.<br />

IM Faculty had no statistically significant interest in further<br />

training in any geriatric skill set.Conclusion: GSAT is reliable at identifying<br />

training needs in geriatric competencies. In this cohort the<br />

need was greater amongst the residents than the faculty. This pilot<br />

data supports the reliability and validity of this tool for curriculum<br />

development in geriatrics.<br />

A67<br />

An Alternative to the Geriatric Physical Diagnosis Lab for Second<br />

Year Medical Students.<br />

N. A. Kayani, S. Hazelett. Summa Health System, Akron, OH.<br />

Background: Previous physical diagnosis labs (PDL) in our institution<br />

involved mock physical exams of community-dwelling elderly<br />

volunteers and were not found to be valuable teaching tools for<br />

second year medical students. Building on an idea from an AGS education<br />

swap in 2009, we developed a new format to teach the important<br />

aspects of basic geriatric care within a limited 2 hour timeframe.<br />

Purpose: To describe a novel interdisciplinary curriculum for<br />

second year medical students that allow students to practice, visualize<br />

and experience for themselves some of the material they have<br />

learned in the classroom setting prior to exposure to real patients.<br />

Methods: During the PDL, the students rotate through a series<br />

of 5 stations each of which is precepted by one of the following Geriatric<br />

Medicine specialists: a physician, a pharmacist, a Fellow in training,<br />

a Clinical Nurse Specialist, Social Worker and an Occupational<br />

Therapist. Six students attend 20 minute sessions at each of the following<br />

stations:<br />

1) Cognitive assessment tools<br />

2) Pharmacology of aging<br />

3) Role of PT and OT<br />

4) Problems with transitions of care using an investigator generated<br />

“price is right” (sources of payment) interactive game<br />

5) Sensory changes with aging<br />

A survey was administered at the end of the PDL where students<br />

were asked to rate from 1-5 the value of the information<br />

gained.<br />

Results: The PDLs have been offered for the last 3 years, with<br />

120 students participating per year. When asked to rank how well<br />

each session helped them become more prepared for assessments or<br />

gain insights into geriatric issues on a scale of 1-5 with 5 being the<br />

best, the average for the cognitive assessments for years 1, 2 and 3<br />

were 4.4, 4.4 and 4.3, respectively. For pharmacology of aging/sources<br />

of payment averages were 4.1, 4.5 and 4.4. For the role of PT and OT<br />

averages were 4.4, 4.5 and 4.4. For transitions of care averages were<br />

4.5 and 4.3, measured in years 2 and 3 only. For sensory changes the<br />

average score was 4.4, measured in year 3 only. Overall value of the<br />

PDL as a learning experience averaged 4.5 each year.<br />

Conclusion: We have combined some standard PDL sessions<br />

with some sessions unique to our program (e.g., the “price is right”<br />

game for the transitions session) which has resulted in a highly valuable<br />

learning experience as reported by students.<br />

A68<br />

Image Atlas of Aging: Highlighting Normal Age-Related Gross and<br />

Histologic Changes.<br />

P. J. Bonavitacola, G. P. Blanchard, S. McGee, K. Johansen,<br />

V. Vanguri, K. Cornejo, A. Khan, C. Burnham, J. Gurwitz,<br />

M. Pugnaire. Division of Geriatric Medicine, University of<br />

Massachusetts Medical School, Worcester, MA.<br />

OBJECTIVE: The Image Atlas of Aging is an original UMMS<br />

educational product developed to highlight normal age-related<br />

anatomic and histologic changes within the renal system. Our goal<br />

was to integrate the Image Atlas into the existing MS1 “Disease,<br />

Structure, and Function” (DSF) curriculum, emphasizing: 1) Normal<br />

anatomic, physiologic, and histologic differences between the young<br />

and aged kidney; 2) The principle of homeostenosis, illustrating how<br />

the renal system becomes more susceptible to acute injury with the<br />

loss of age-related functional reserve (but that disease is not inevitable<br />

with normal aging).<br />

BACKGROUND: There is a dearth of existing educational resources<br />

that pictorially contrast normal age-related anatomic and histologic<br />

organ system changes. Most available resources demonstrate<br />

normal versus pathologic.<br />

METHODS: Pivotal to Image Atlas completion was developing<br />

partnerships with the UMMS Pathology Department and UMMS Division<br />

of Anatomy and Cell Biology. UMMS’ Advancing <strong>Geriatrics</strong><br />

Education (AGE)/Reynolds summer student forged new working relationships<br />

with two pathology chief residents and the co-DSF course<br />

director.<br />

Drawing from existing histological and anatomic images generated<br />

by the UMMS Department of Pathology (histologic slides,<br />

culled from recent autopsies and a legacy slide collection) and the<br />

UMMS Division of Anatomy and Cell Biology (dissection images),<br />

and online textbooks, a MS2 student compiled, annotated, and produced<br />

an online module to be used by anatomy students/faculty and<br />

geriatricians.<br />

After discussions with UMMS’ AGE team, the DSF course directors<br />

agreed to integrate the Image Atlas into the DSF curriculum.<br />

The Atlas served as the student prep material both for two UMMS<br />

geriatrician visits to the anatomy lab during abdominal cavity dissections<br />

and an introductory lecture given by an academic geriatrician.<br />

EVALUATION: All MS1s (n=125) will complete an end-ofcourse<br />

evaluation for DSF that will encompass the Image Atlas<br />

module.<br />

CONCLUSIONS: The Image Atlas was successfully incorporated<br />

into the existing DSF curriculum, introducing the concepts of<br />

normal aging and homeostenosis to first year medical students. Our<br />

goal is to have the Image Atlas serve as a prototype to illustrate normal<br />

aging in other organ systems that will also be integrated within<br />

the DSF curriculum.<br />

A69<br />

The Effects of a Pre-Clinical <strong>Geriatrics</strong> Curriculum on Attitudes<br />

Towards and Interest in Geriatric Medicine.<br />

P. Borker, A. Talati, E. O’Toole, P. DeGolia. Case Western Reserve<br />

University School of Medicine, Cleveland, OH.<br />

Supported By: MacGregor Foundation and the Health Resources<br />

Services Administration, Bureau of Health Professions Geriatric<br />

Education Centers Program<br />

BACKGROUND: It is projected that by 2030, 20% of the U.S.<br />

population will be over age 65. Since 1978, the IOM has called for improvements<br />

in geriatric education for health care providers, most recently<br />

re-addressing this issue in 2008. In this study, we assessed the<br />

effects of a multi-year, pre-clinical geriatrics curriculum on student’s<br />

interest in and knowledge of care for geriatric patients.<br />

METHODS: Cohort study of fourteen volunteering medical<br />

students during their second years immersed in a six-week geriatrics<br />

AGS 2012 ANNUAL MEETING<br />

S39


P OSTER<br />

A BSTRACTS<br />

curriculum between 2010–11 and 2011–12. Students met twice per<br />

week for the following activities: (1) focus group sessions discussing<br />

clinical and personal experiences with older adults; (2) interactive<br />

group sessions with geriatric specialists; and (3) shadowing activities<br />

with volunteering physicians and geriatric patients. Students participating<br />

in 2011 – 2012 also participated in a first year introductory<br />

course to geriatric patients and self-selected to participate during the<br />

second year curriculum. Students are surveyed regarding interest in<br />

geriatrics and examined using a geriatrics knowledge test pre and<br />

post intervention. Weekly focus group sessions are recorded and analyzed<br />

using grounded theory methodology.<br />

RESULTS: Pre-intervention geriatric interest survey for<br />

2011–12 show that 60% of students ‘strongly agree’ with the statement<br />

“I understand the unique issues involved in care for the elderly,<br />

compared to 22% of students from 2010–11. Furthermore, 20% of<br />

participating students reported that they are interested in pursuing a<br />

career in geriatrics during the 2011–12 curriculum; by contrast only<br />

11% of students reported interest in geriatrics from 2010–11. Pre-Intervention<br />

use of the <strong>Geriatrics</strong> Knowledge Test showed mean score<br />

of 50% (sd = 11%) during 2011–12; no significant change from<br />

2010–11 in which mean score was 48% (sd= 9%).<br />

CONCLUSION: Current data suggests longer exposure<br />

through a focused curriculum may improve interest and comfort with<br />

older adults, both within geriatrics or other medical fields, although<br />

study lacks power to comment on significance. Data collection, including<br />

career interest surveys for the class of 2010-11 and post intervention<br />

surveys for 2011–12, is in progress. Further investigation, including<br />

use of a 2:1 matched comparison control group is also<br />

pending, but may help eliminate selection bias and further validate<br />

study results.<br />

A70<br />

Fulfilling an ACGME Competency: Impact of a Novel<br />

Communication Skills Curriculum.<br />

R. Ramaswamy, 1,2 A. Williams, 1,2 A. S. Kelley, 1 E. M. Clark. 2,1 1.<br />

Brookdale Department of <strong>Geriatrics</strong> and Palliative Medicine, Mount<br />

Sinai School of Medicine, New York, NY; 2. GRECC, James J. Peters<br />

VA Medical Center, Bronx, NY.<br />

Introduction: Effective communication is essential to health<br />

care delivery, especially in care of the elderly, and is associated with<br />

increased adherence to treatment and patient satisfaction. The<br />

ACGME has designated communication skills as a core competency.<br />

Following a needs assessment, we developed an evidence-based communication<br />

skills curriculum with the objective to increase confidence<br />

and expertise among Internal Medicine interns in communicating<br />

with older patients.<br />

Methods: The communication skills curriculum was integrated<br />

in the 4-week <strong>Geriatrics</strong> block in the first year of Internal Medicine<br />

residency training at the Bronx VA. Developed and facilitated by 2<br />

geriatrics fellows, the curriculum consists of 2 small group sessions,<br />

1.5 hours each, involving 2 interns at a time. The sessions include didactic<br />

learning, discussion, role-play and self-study. Skills taught include<br />

Active Listening, Ask-Tell-Ask and SPIKES [1]. Participants<br />

complete questionnaires at baseline, after the course and at 3 months.<br />

Baseline data include demographics, past training in communication<br />

and self-identified communication challenges. Self-reported confidence<br />

with specific communication tasks is also measured on a 4-<br />

point Likert scale (1= minimal confidence, 4= high confidence).<br />

Results: To date, 9 interns have completed the curriculum. Five<br />

were ≥ 30 years old and 5 had medical school training in English.<br />

Only 3 reported any prior training in communication skills. Respondents<br />

found developing rapport and building trust with older patients<br />

most challenging. Compared to baseline, the interns’ average overall<br />

confidence in communicating with older patients increased by 25%<br />

(from 3.0 to 3.75); comfort level in delivering bad news to an older patient<br />

increased by 50% (from 2.0 to 3.0); comfort level in discussing<br />

advance care planning with an older patient and in conducting a family<br />

meeting both increased by 48% (from 2.11 to 3.13). SPIKES was<br />

felt to be the most useful skill and 71% respondents preferred the<br />

small group format as a safe way to learn and practice the skills.<br />

Conclusion: Implementation of a structured, standardized communication<br />

skills curriculum in Internal Medicine internship has<br />

been effective in improving confidence and comfort in communicating<br />

with older adults.<br />

[1] Baile WF, et al., Oncologist 2000; 5:302–311.<br />

A71<br />

An Intervention to Improve Medical Students’ Interprofessional<br />

Acumen.<br />

R. M. Wright, 1 J. H. Lingler, 2 J. P. Pschirer, 3 J. F. Mahoney, 4<br />

D. A. Nace. 1 1. Medicine/Division of <strong>Geriatrics</strong>, University of<br />

Pittsburgh, Pittsburgh, PA; 2. School of Nursing, University of<br />

Pittsburgh, Pittsburgh, PA; 3. School of Pharmacy, University of<br />

Pittsburgh, Pittsburgh, PA; 4. School of Medicine, University of<br />

Pittsburgh, Pittsburgh, PA.<br />

Supported By: Josiah P. Macy Foundation<br />

Health Resources and Services Administration (GACA)<br />

Background: Teamwork and interdisciplinary collaboration are<br />

essential to providing the best geriatric care but are challenging to<br />

teach medical students. We compared pre- and post-course knowledge,<br />

skills, and attitudes toward interprofessional (IP) teamwork<br />

among medical students who underwent a multimodal, IP team education<br />

intervention and among students who did not.<br />

Methods: 197 3rd-year medical students, nurse practitioner<br />

(NP)students, and pharmacy students, were divided into 6 IP teams<br />

(intervention group) and 10 non-IP, medical student-only teams (controls).<br />

Each IP team consisted of 4 or 5 self-selected medical students,<br />

4 or 5 NP and 1 or 2 pharmacy students. All teams received a lecture<br />

on transitions of care (TOC) and participated in a geriatric case TOC<br />

simulation and debriefing session. IP team instruction included a lecture<br />

on effective teamwork and IP competencies, a video demonstration<br />

of ineffective IP teamwork, and self-assessment of videorecorded<br />

teamwork. Before-and-after team performance surveys<br />

assessed students on perceived IP teamwork knowledge, skills, and<br />

attitudes. Paired t-test analyses assessed within-group pre- and posttest<br />

differences.<br />

Results: 18 (67%) IP and 83 (61%) non-IP medical students returned<br />

both 28-item surveys. Both groups demonstrated significant<br />

improvement on multiple items. Knowledge items that improved only<br />

within the IP group were “teams are more responsive to the complex<br />

needs of geriatric patients;” “team approach makes the delivery of<br />

care more efficient;” and “I see caring for older patients as a unique<br />

challenge.” Despite having lower pre-test ratings on 9 teamwork<br />

skills items, IP students rated post-test skills on average as “very<br />

good” or better for 10 of 11 skill items while non-IP students rated<br />

their post-test skills as “very good” or better on only 4 out of 11 items.<br />

Conclusion: Medical students generally considered themselves<br />

knowledgeable but not skillful at working in teams. A multimodal, experiential<br />

IP curriculum effectively improved knowledge, skills and<br />

attitudes toward IP teamwork. Additional analyses from this rich<br />

dataset will be presented. Future directions include testing for retention<br />

and transfer of IP team concepts.<br />

A72<br />

Teaching Fall Risk Assessment to Medical Students Using Meals on<br />

Wheels.<br />

S. Chenna, K. M. Sink, K. Callahan, J. Demons, H. Atkinson.<br />

<strong>Geriatrics</strong>, Wake Forest University, Winston Salem, NC.<br />

BACKGROUND: The AAMC and John A. Hartford Foundation<br />

have recommended a set of minimum geriatric competencies for<br />

S40<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

medical students, which include fall risk assessment. We describe an<br />

innovative method of teaching fall risk assessment using the Meals on<br />

Wheels (MOW) community program.<br />

METHODS: During an intense one week geriatric rotation, 3rd<br />

year students perform a fall risk assessment on a MOW client in their<br />

home. The evaluation includes: history of falls, fear of falling, medication<br />

review, visual acuity, Get-up and Go test, Mini-Cog, and brief<br />

home safety evaluation. ADLs and IADLs are also obtained. 4 of the<br />

8 recommended competency domains are covered in this experience.<br />

A <strong>Geriatrics</strong> attending reviews the assessment and provides relevant<br />

teaching. Students provided anonymous feedback on the MOW fall<br />

risk assessment on a scale of 1-10 (10=best). Using a retrospective prepost<br />

survey we assessed the self-reported change in the students’ confidence<br />

and perceived competence in elements of fall risk assessment.<br />

RESULTS: In the class of 2012, 110/124 completed the in-home<br />

fall risk assessment. 14 students did not complete it due to logistical<br />

problems. Students rated the MOW fall risk assessment highly (mean<br />

of 7.26 (of 10)). Students commented that it was a unique, “eye opening<br />

experience” to see the depth of need and the services available<br />

and enjoyed the novel opportunity for learning outside of the typical<br />

hospital setting. 60/110 (54%) completed the retrospective survey.<br />

Results on confidence in performing individual tasks are presented in<br />

the Table. 51% of students also report having assessed fall history<br />

since this rotation.<br />

CONCLUSION: The innovative MOW fall risk assessment experience<br />

efficiently teaches 4 of 8 competency domains with minimal<br />

faculty effort, was well received by medical students, and resulted in<br />

much improved confidence in elements of fall risk assessment. Our<br />

MOW falls risk assessment could easily be adopted by most medical<br />

schools.<br />

Percentage of students who reported moderate to very high confidence/competence<br />

BEFORE and AFTER the MOW fall risk<br />

assessment<br />

A73<br />

Evaluation of Medical Student Training and Attitudes towards<br />

<strong>Geriatrics</strong> at Wuhan Medical School.<br />

S. M. Shi, R. Sherer, I. Morgan, H. Dong, B. Cooper. University of<br />

Chicago - Pritzker School of Medicine, Chicago, IL.<br />

Supported By: Pritzker School of Medicine via Summer Research<br />

Program<br />

<strong>Geriatrics</strong> is an emerging field in China, with no national certification<br />

or formal specialty training presently. In the past decade,<br />

China has prioritized shifting the delivery of primary care for urban<br />

populations to community health centers (CHCs) rather than larger<br />

public hospitals. The ease of access, closer proximity, and lower outof-pocket<br />

costs make CHC care a more favorable alternative over<br />

sub-specialty care in tertiary hospitals for many elderly. Thus geriatrics<br />

training has become an increasing imperative to effective delivery<br />

of primary care in CHCs. We evaluated faculty and student attitudes<br />

towards geriatrics, and investigated whether a new CHC<br />

Clerkship experience at Wuhan University affected student opinions.<br />

We also explored the delivery of health care in local community settings,<br />

particularly to the elderly.<br />

Students at Wuhan University Medical School were surveyed, as<br />

well as elder care givers at the QingShan Community Health Center.<br />

A total of 18 pilot CHC clerkship students (‘Pilot’) were surveyed,<br />

with questions regarding their perceptions of geriatrics as well as<br />

judgment on current exposure to geriatrics during clinical and preclinical<br />

training. Parallel surveys were administered to 41 fourth year<br />

medical students who did not participate in the pilot (Control). ‘Elderly<br />

patients’ were defined as age over 60 years.<br />

In general, more CHC students reported that their medical<br />

school training, both courses and clinical, prepared them for work<br />

with the elderly. None of these differences were statistically significant<br />

(Mann-Whitney test, no P values


P OSTER<br />

A BSTRACTS<br />

A75<br />

<strong>Geriatrics</strong> and Aging through Transitional Environments (GATE):<br />

A Longitudinal, Competency-Based Medical Student Curriculum.<br />

S. Limaye, S. Williams, S. G. Smith, A. Baron. Medicine, University of<br />

Chicago, Chicago, IL.<br />

Supported By: Pritzker School of Medicine Dean’s Award,<br />

University of Chicago<br />

Background:<br />

The AAMC requires medical schools to address 26 minimum<br />

geriatric competencies. GATE targets 17 of these in a 4 year, systemsbased<br />

curriculum focused on geriatric assessment and transitions of<br />

care. Goals of the GATE curriculum are to improve medical students’<br />

geriatric assessment skills, develop competency-based evaluation<br />

tools, and integrate nationally recognized geriatrics curricula into<br />

existing ones.<br />

Methods:<br />

In a 2 year pilot integrated longitudinally into existing medical<br />

school courses from MS1-4, the GATE curriculum teaches geriatric<br />

assessment skills pertinent to different care settings: in-home geriatric<br />

functional history and home safety assessments; outpatient geriatric<br />

assessments (e.g. MMSE) and clinical skills (e.g. advance directives);<br />

hazards of hospitalization and transitions of care; and nursing<br />

home assessment and interdisciplinary care planning.<br />

Teaching methods include: lectures, in-home interviews with<br />

trained patients; reflective essays; skills-based practice workshop;<br />

simulated patient experiences; pocket cards; inpatient teaching<br />

rounds; podcast, and; geriatrician-led nursing home rounds.<br />

GATE evaluation is curriculum year specific and longitudinal,<br />

with periodic assessments of students’ knowledge of ADLs/IADLs,<br />

attitudes towards older adults, and confidence in skills in select competency<br />

domains.<br />

Results:<br />

Students’ knowledge of ADLs/IADLs improved after GATE<br />

intervention. Pre GATE-1 mean score = 5.58 (14 possible correct).<br />

Post GATE-2 mean score =11.70; t(121) =-6.9, p


P OSTER<br />

A BSTRACTS<br />

RESULTS:To date 20 IM residents have completed the rotation<br />

and 85% have completed an evaluation. The average overall<br />

score was 4.6/5. The case presentation and transitional care clinic received<br />

the highest scores of 4.75. Resident feedback has been positive<br />

and constructive, and the module has been modified in response.<br />

Example comments include, “more experiences like this<br />

week would be helpful,” and “great experience and rotation definitely<br />

helps me understand what to focus on and recognize in the<br />

care of elderly patients.”<br />

CONCLUSION:Medical residents express a strong need to<br />

learn about systems-based practice. A geriatrics rotation designed to<br />

underscore competency in systems-based practice has been well received<br />

and helped to address attitudes and gaps in knowledge about<br />

the care of older adults.<br />

A78<br />

Health professional students’ perceived need for interprofessional<br />

geriatric education.<br />

S. B. Bhattacharya, 1 M. Rosso, 1 V. Villareal, 1 C. Obering, 2 M. Eng, 3<br />

M. Peterson, 1 D. Ebbert, 1 R. Bhattacharya. 4 1. Family Medicine,<br />

Division of Geriatric Medicine, Univ of Kansas Medical Ctr, Kansas<br />

City, KS; 2. Pharmacy Practice, Univ of Missouri Kansas City, Kansas<br />

City, MO; 3. Pharmacy Practice, Univ of Kansas Medical Ctr, Kansas<br />

City, KS; 4. Internal Medicine, Univ of Kansas Medical Ctr, Kansas<br />

City, KS.<br />

Background<br />

An Institute of Medicine core competency for all healthcare<br />

professions is the ability “to work in interdisciplinary teams”. In addition,<br />

the Cochrane Library asserts that delivery of care will require<br />

the involvement of multiple health professions due to an aging<br />

population and a shift from acute to chronic care. Consequently,<br />

good interprofessional collaboration to coordinate patient care is<br />

critical.<br />

The <strong>Geriatrics</strong> Champions Program began in the Fall of 2011 at<br />

the University of Kansas Medical Center to build interprofessional<br />

collaboration in geriatric care utilizing a Team-Based Learning<br />

(TBL) format. This 8 session program was based on the “Minimum<br />

<strong>Geriatrics</strong> Competencies for IM-FM Residents” (released 6/09). Targeted<br />

audiences were family medicine residents and nurse practitioner,<br />

pharmacy and social work students. Prior to Session 1, we assessed<br />

their perception of the need for interprofessional education<br />

(IPE) in geriatric care and their familiarity with TBL. <strong>Here</strong>, we present<br />

our results.<br />

Methods<br />

Prior to Session 1, learners completed 2 voluntary and confidential<br />

electronic surveys. The 1st 6 item survey asked about their school<br />

and source of program knowledge. The 2nd 11 item Likert scale survey<br />

asked about their interest and expectations in learning geriatrics<br />

in an IPE and TBL format, as well as their prior experience and perceived<br />

benefit of IPE and TBL.<br />

Results<br />

Eighty-seven of 133 completed the survey including 47 Nursing<br />

(54% of total), 30 Pharmacy (34%), 9 Resident (10%), and 1 Social<br />

Work (1%) student. Most (72%) heard about this program from faculty<br />

and 91% were glad to participate in the program. Despite 53%<br />

and 68% knowing about IPE and TBL, this was the first IPE opportunity<br />

for 87%. Eighty-five (97%) anticipated learning something<br />

new. Most (95%) felt that IPE, and 78% and 76% felt that TBL, was<br />

useful and necessary, respectively.<br />

Discussion<br />

The majority were new to the IPE format, yet anticipated a good<br />

experience. Most felt that IPE was useful, but were less optimistic about<br />

TBL.This data shows learner willingness to engage in IPE and TBL for<br />

geriatric education, in concert with national recommendations.<br />

A79<br />

<strong>Geriatrics</strong> and Aging through Transitional Environments (GATE)<br />

MS2 Curriculum: Introduction to Geriatric Assessments.<br />

S. Williams, S. Limaye, S. G. Smith, A. Baron. Medicine, University of<br />

Chicago, Chicago, IL.<br />

Supported By: Pritzker School of Medicine Dean’s Award,<br />

University of Chicago<br />

Background:<br />

The GATE curriculum is a 4 year, systems-based curriculum<br />

teaching geriatrics across the spectrum of care settings to medical students.<br />

GATE-2 focuses on outpatient geriatric assessment and communication<br />

skills. Goals are to enhance skills in targeted AAMC<br />

competency domains (falls/balance/gait, health care planning and<br />

promotion, and cognitive and behavioral), and to develop competency-based<br />

evaluation tools and methods.<br />

Methods:<br />

GATE-2 includes a lecture on geriatric assessments and strategies<br />

for: communicating with patients with dementia and caregivers;<br />

conducting advance directive discussions; addressing health literacy,<br />

and; administering geriatric screening tests for depression, physical<br />

function, and cognition. A two hour skills based workshop facilitated<br />

by inter-disciplinary faculty allows role play and skills assessment.<br />

Geriatric SP encounters present challenges assessing patient’s cognition,<br />

depression, and physical function, addressing advance directives<br />

and health literacy, and jointly interviewing patients with dementia<br />

and collateral historian. Encounters are videotaped. Student’s performance<br />

is evaluated verbally by preceptor and SP. Student, SP and<br />

preceptor complete a written, competency-based evaluation of student’s<br />

clinical and interviewing skills.<br />

Results:<br />

Eighty-seven Pritzker MS2 participated in geriatric SP encounters.<br />

In a 360 degree evaluation of geriatric interviewing skills across<br />

cases, there was no difference in self, preceptor and SP evaluations for<br />

Depression, Health literacy and Dementia cases. SP scores were<br />

lower than both preceptor and student self-evaluations for MMSE<br />

and Physical Function cases. Student self-evaluation was lower than<br />

SP evaluation for Advance Directives case. In evaluation of case specific<br />

clinical skills, there was no difference in self, preceptor and SP<br />

evaluations for Depression, Health literacy, Dementia and Advance<br />

Directives cases. For Physical Function and MMSE cases, SP evaluation<br />

was lower than both preceptor and student self-evaluation.<br />

Conclusions:<br />

A 360 degree criterion-based assessment tool provides variable<br />

perspectives of student competencies in discrete assessment and communication<br />

skills. Future work will focus on inter-rater reliability in<br />

assessments via training students, preceptors and simulated patients<br />

on use of instrument.<br />

A80<br />

Increasing Residency Training of Goal-oriented Treatment Options<br />

in Patients with Life-Limiting Illnesses.<br />

T. Lee, 1 Q. Cao, 1 S. Hayes, 2 P. Austin, 1 M. Zafar, 1 R. Newman. 1 1.<br />

Family Medicine, East Carolina University, Greenville, NC; 2. Family<br />

Medicine, Naval Hospital, Jacksonville, FL.<br />

Supported By: HRSA:K01 HP20471, Geriatric Academic Career<br />

Award<br />

Objectives: For many patients with life-limiting illnesses, defining<br />

and discussing goals of future medical care (advance care planning)<br />

are very important. This study measures the effects of education<br />

to the in-training residents of family medicine (FM) and internal<br />

medicine (IM) residency programs at East Carolina University<br />

(ECU).<br />

AGS 2012 ANNUAL MEETING<br />

S43


P OSTER<br />

A BSTRACTS<br />

Design: Based on the results of the informal assessment of need<br />

from the residents and faculty, educational materials were developed.<br />

These included discussion of advance care planning, MOST (POLST)<br />

form, FIVE WISHES, healthcare power of attorney, and living will. A<br />

2-hour education and discussion session was given to all in-training<br />

FM and IM residents at ECU. Pre- and post-tests were administered<br />

to measure their medical knowledge as well as attitudes toward advance<br />

care planning.<br />

Results: A total of 70 pre-test and 53 post-test scores were analyzed.<br />

Overall knowledge improved with the educational sessions<br />

(74.9% vs 90.5% correctly answered pre- and post-test, respectively).<br />

Also, the residents’ own attitude toward advance care planning<br />

changed favoring less aggressive care at the end-of-life (EOL).<br />

Conclusions: Educational sessions significantly impacted residents’<br />

knowledge and attitude about advance care planning and<br />

EOL care.<br />

Knowledge and attitude scores<br />

EOL = end of life<br />

A81<br />

Implementing the Objective Structured Clinical Examination<br />

(OSCE) in a <strong>Geriatrics</strong> Fellowship Program – a three-year<br />

experience.<br />

T. J. Avelino-Silva, L. A. Gil, S. M. Lin, L. L. Farias, E. L. Kikuchi,<br />

C. K. Suemoto, W. Jacob-Filho. <strong>Geriatrics</strong> Division, Department of<br />

Internal Medicine, University of Sao Paulo Medical School, São<br />

Paulo, SP, Brazil.<br />

Supported By: None of the authors reported a potential, real, or<br />

perceived conflict of interest or financial disclosure. No sponsors<br />

participated in or funded this research.<br />

Background: The Objective Structured Clinical Examination<br />

(OSCE) appears to be an effective alternative for assessing not only<br />

medical knowledge, but also clinical skills, including effective communication<br />

and physical examination skills. Our purpose was to implement<br />

an OSCE model in a <strong>Geriatrics</strong> fellowship program and to compare<br />

the instrument with traditional essay examination.<br />

Methods: Seventy first- and second-year geriatric fellows were<br />

initially submitted to a traditional essay examination and scored from<br />

0 to 10 by a faculty member. Subsequently, the same fellows underwent<br />

an OSCE with eight ten-minute stations, covering a wide range<br />

of essential aspects of geriatric knowledge. Each OSCE station had<br />

an examiner responsible for its evaluation according to a predefined<br />

checklist. Checklist items were classified for analysis purposes as clinical<br />

knowledge items (CKI) and communication skills items (CSI);<br />

student responses were scored 0-10.<br />

Results: While essay exams took from 30 to 45 minutes to complete,<br />

180 to 200 minutes were required to evaluate students using the<br />

proposed OSCE method. Students scored an average of 6.2±1.2 on<br />

the traditional essay examination versus 6.6±1.0 on the OSCE<br />

(p


P OSTER<br />

A BSTRACTS<br />

A83<br />

Preparing to Care for an Aging Population: Medical Student<br />

Reflections on their Clinical Mentors within a New <strong>Geriatrics</strong><br />

Curriculum.<br />

T. W. Farrell, 1 R. R. Shield, 3 A. Nanda, 2 S. Campbell, 3 T. Wetle. 4 1.<br />

Division of <strong>Geriatrics</strong>, University of Utah School of Medicine, Salt<br />

Lake City, UT; 2. Division of <strong>Geriatrics</strong>, Warren Alpert Medical<br />

School of Brown University, Providence, RI; 3. Center for<br />

Gerontology and Healthcare Research, Warren Alpert Medical School<br />

of Brown University, Providence, RI; 4. Public Health Program,<br />

Warren Alpert Medical School of Brown University, Providence, RI.<br />

Supported By: This work was supported by a grant from the Donald<br />

W. Reynolds Foundation.<br />

Background:<br />

Mentoring relationships between faculty and medical students<br />

are increasingly recognized as key contributors to medical students’<br />

developing clinical expertise and approaches to specific patient populations.<br />

Reflective writing techniques such as journaling help provide<br />

insights into the process by which medical students are mentored in<br />

clinical settings and develop into practicing physicians. However,<br />

medical students’ reflections about their experiences with physician<br />

mentors have rarely been studied.<br />

Methods:<br />

From 2007 to 2010, we collected and analyzed 405 medical student<br />

journal entries regarding students’ experiences with a new geriatrics<br />

curriculum at the Warren Alpert Medical School of Brown University,<br />

including both formal and informal mentored experiences in<br />

community and hospital settings. Thirty preclinical and clinical volunteer<br />

medical student journalers from all class years participated in<br />

this journaling project. We employed qualitative analytic techniques<br />

in which rigor and saturation of categories were achieved. Using an iterative<br />

interdisciplinary team process, key themes were identified relating<br />

to students’ experiences with their clinical mentors.<br />

Results:<br />

Three major themes regarding mentoring emerged from the<br />

journals: (1) Exposure to clinical mentors challenged students’ preconceptions<br />

regarding older adults and geriatric medicine; (2) Students<br />

learned new subject matter and techniques from observing<br />

their mentors; and (3) Students provided both positive and negative<br />

assessments of their mentors.<br />

Conclusions:<br />

Opportunities exist to improve current approaches to clinical<br />

mentoring of medical students learning to care for older adults. Such<br />

mentorship may be particularly relevant to promoting medical students’<br />

interest in older persons and geriatrics. Reflective journaling<br />

provides important insights into the process by which medical students<br />

draw upon mentored clinical experiences during their training.<br />

A84<br />

A New Strategy for Teaching Residents Roles of<br />

Interprofessional Teams.<br />

T. C. James, 1 G. R. Westmoreland, 1 C. Arenson, 2 S. R. Counsell. 1 1.<br />

Section of <strong>Geriatrics</strong>, Indiana University School of Medicine,<br />

Indianapolis, IN; 2. Family and Community Medicine, Thomas<br />

Jefferson University, Philadelphia, PA.<br />

Supported By: HRSA GACA<br />

Background: New models of interprofessional care have been<br />

shown to improve outcomes for seniors at high risk for functional decline.<br />

However, Internal Medicine (IM) residents have few opportunities<br />

to learn the roles of interprofessional teams (IPTs). The Minnesota<br />

Complexity Assessment Method (MCAM) tool evaluates<br />

person-specific factors that interfere with usual decision-making and<br />

can highlight roles for IPTs.<br />

Methods: For this mini-course, IM residents completed an online<br />

audio PowerPoint lecture describing the MCAM tool and roles of<br />

the IPT. IM residents met with the geriatrician faculty member who<br />

demonstrated how to use the MCAM tool. Residents practiced using<br />

the MCAM tool on a case scenario then were given a real patient to<br />

assess using the MCAM tool. During the IPT conference the MCAM<br />

tool was applied to a patient the resident had researched in preparation<br />

for the meeting. Evaluation included pre- and post-tests assessing<br />

attitudes about IPTs and qualitative responses to questions pertaining<br />

to usefulness of the mini-course.<br />

Results: Twenty IM residents completed the mini-course. Results<br />

comparing pre- and post-tests demonstrate movement towards<br />

greater understanding of IPT care. There were higher average agreement<br />

ratings in the post-test compared to the pre-test for: “interdisciplinary<br />

health professionals know each other’s roles,” “I know when<br />

my patient needs an interdisciplinary team” and “interdisciplinary information<br />

tells us about disease progression;” and lower average<br />

agreement for items “working with colleagues in my own profession<br />

is more efficient” and “the goal of interdisciplinary teams is to support<br />

physician care plans.” Residents agreed that the mini-course was<br />

useful to their practice (40% agreed and 60% strongly agreed) and<br />

that MCAM was a useful tool (70% agreed, 25% strongly agreed and<br />

5% undecided). Residents stated they will look for opportunities to<br />

collaborate with IPTs.<br />

Conclusions: For IM residents, using the MCAM tool for evaluation<br />

of patient complexity in an IPT setting appears to be a successful<br />

strategy to highlight the roles of IPT care. Response to this minicourse<br />

suggests that residents may be receptive to additional<br />

opportunities for learning about, from, and with other health professionals<br />

to improve outcomes for at risk seniors.<br />

A85<br />

Quality Improvement Curriculum for <strong>Geriatrics</strong> Fellows Using Lean<br />

Methodology.<br />

G. Gupte, 1 J. A. Eng, 2,1 M. Young, 2 R. M. Zitnay, 2 K. James, 2<br />

M. Sissoko, 2 W. Suen. 2 1. Boston University School of Public Health,<br />

Boston, MA; 2. Section of <strong>Geriatrics</strong>, Boston University Medical<br />

Center , Boston, MA.<br />

Supported By: HRSA: Geriatric Academic Career Award<br />

John A. Hartford Foundation<br />

BACKGROUND: Practice-based learning and improvement<br />

(PBLI) and systems-based practice (SBP) are two out of the six competencies<br />

required by the Accreditation Council for Graduate Medical<br />

Education. However, few curricula exist as examples of how to<br />

teach and evaluate PBLI and SBP. “Lean” is a quality improvement<br />

philosophy replicated in many industries that focuses on maximizing<br />

customer value while minimizing waste throughout a system, using<br />

tools such as process mapping and identification of waste. The authors<br />

describe a curriculum that uses Lean techniques as a framework<br />

to teach and evaluate fellows in PBLI and SBP.<br />

METHODS. Five Geriatric medicine fellows chose to participate<br />

in a project aimed at improving the routine laboratory ordering<br />

process in their home care practice. The fellows met monthly with the<br />

QI mentors to discuss the ongoing project. The interactive sessions included<br />

introducing and applying the Lean tools of process mapping<br />

and identification of waste, identifying stakeholders, designing a pilot<br />

data collection process, brainstorming solutions, and pilot-testing the<br />

solution. Post-curriculum survey and reflection pieces were administered<br />

and analyzed.<br />

RESULTS. All five fellows worked together to complete a QI<br />

project. The fellows enjoyed the interactive curriculum, gained experience<br />

in systematically performing a QI project, identified challenges<br />

involved in the process, and had an increased understanding of the<br />

stakeholders and the system in which they work. The project was<br />

completed within the year-long geriatric fellowship curriculum.<br />

CONCLUSIONS.The year-long QI project using Lean management<br />

principles and tools allowed for a hands-on, interactive QI experience<br />

that fulfilled the PBLI and SBP competencies for Geriatric<br />

AGS 2012 ANNUAL MEETING<br />

S45


P OSTER<br />

A BSTRACTS<br />

medicine fellows. Future plans include expanding the project to increase<br />

the Geriatric section’s interdisciplinary staff involvement in QI<br />

endeavors and sharing the curriculum with other training programs.<br />

A86<br />

Incremental Value of Cardiovascular Assessment in Patients with<br />

Unexplained Non-Accidental Falls: The Faint and Fall Clinic<br />

Experience.<br />

N. Sanders, 1 T. Jetter, 2 S. L. Wasmund, 2 C. F. Pacchia, 2 M. Brignole, 2<br />

M. Hamdan. 3 1. <strong>Geriatrics</strong> Division, University of Utah, Salt Lake<br />

City, UT; 2. Cardiology Division, University of Utah, Salt Lake City,<br />

UT; 3. Ospedali del Tigullio, Lavagna, Italy.<br />

Background: Falls cause significant morbidity and mortality.<br />

Due to amnesia and lack of witnesses, some falls may be due to syncope.<br />

We sought to identify the incremental value of cardiovascular<br />

assessment in patients with unexplained non-accidental (NA) falls.<br />

Methods: Patients with NA-falls and no history of syncope underwent<br />

a standardized fall assessment (SA) by a geriatrician. Tilt<br />

Table Testing (TTT) and/or carotid sinus massage (CSM) were recommended<br />

in patients with unexplained falls after the initial evaluation.<br />

If a cause was still not found, insertion of an implantable loop<br />

recorder (ILR) was recommended. The rate of diagnosis was assessed<br />

as a percent of explained NA-falls following each step of the<br />

evaluation.<br />

Results: 51 patients were included in the analysis. Mean age was<br />

73. The number of NA-falls explained after initial SA was 27 (53%).<br />

The use of TTT and CSM identified the cause of falls in 10 more patients<br />

(n=37; 73%). 5 patients consented to insertion of an ILR. After<br />

an 11-month follow up period (mean 5.3 ± 4.8), the diagnosis was<br />

made in 1 additional patient (n=38; 75%)(Figure).<br />

Conclusion: The addition of CSM and/or TTT followed by the<br />

insertion of an ILR to a SA of patients with NA-falls leads to a sequential<br />

increase in the percent of explained falls. These tests should<br />

be considered in the evaluation of patients with unexplained falls.<br />

A87<br />

Matrix Metalloproteinase-9 and the Geriatric Syndrome of Frailty.<br />

N. Guo, D. Halade, M. L. Lindsey, S. Espinoza. Barshop Institute for<br />

Longevity and Aging Studies, UT Health Science Center, San<br />

Antonio, TX.<br />

Supported By: NIA, AFAR, UT Health Science Center at San<br />

Antonio<br />

Background: Aging of the US population comes with an increase<br />

in the incidence of frailty, a geriatric syndrome associated with<br />

adverse health outcomes that can be regarded as an exacerbation of<br />

the normal aging process. Frailty status shows a strong association<br />

with a number of inflammatory molecules, including interleukin-6, C-<br />

reactive protein, and D-dimer. Interestingly, these inflammatory components<br />

of frailty also serve as biomarkers for cardiovascular disease<br />

(CVD), suggesting a correlation between frailty and CVD. Matrix<br />

Metalloproteinase-9 (MMP-9) is secreted by inflammatory cells and<br />

is a known biomarker of CVD. Due to the knowledge of existing<br />

shared inflammatory biomarkers between frailty and CVD, we studied<br />

MMP-9 as a possible frailty biomarker and hypothesized that increased<br />

plasma MMP-9 concentration would be associated with<br />

frailty.<br />

Methods: Subjects were 65 community-dwelling older adults in<br />

San Antonio, TX (mean age= 81 years; range=66-93 years). Frailty<br />

was determined by standardized criteria. Chronic diseases were ascertained<br />

by self-report of physician-diagnosed disease. MMP-9<br />

serum concentrations for each sample were determined by ELISA.<br />

Characteristics by frailty status were analyzed using ANOVA for continuous<br />

measures and chi-squared test for categorical measures<br />

(STATA).<br />

Results: Mean age of the patients was 80.6 ±6.4 years. Of these,<br />

33.8% were non-frail, 47.7% were pre-frail, and 18.5% were frail.<br />

MMP-9 concentrations (ng/mL) were 27.2±8.6, 28.7±11.5, and<br />

33.8±10.2 in non-frail, pre-frail, and frail, respectively (p=.202).<br />

Discussion: Matrix Metalloproteinase-9 (MMP-9), an inflammatory<br />

protein and CVD biomarker, may be increased in frailty; however,<br />

perhaps due to small sample size, the trend of increasing MMP-<br />

9 by increasing frailty status did not reach significance in this study.<br />

Prior studies have shown an association between CVD and frailty;<br />

however, future longitudinal studies will be useful to examine the role<br />

that CVD may play in the development of frailty in older adults.<br />

A88<br />

Interventions and barriers to medication adherence in cognitively<br />

impaired older adults: a systematic review.<br />

N. Campbell, 1,2 M. A. Boustani, 2,3 E. Skopeljia, 3 S. Gao, 2,3<br />

F. Unverzagt, 2,3 M. D. Murray. 1,2 1. Pharmacy Practice, Purdue<br />

University, Indianapolis, IN; 2. Regenstrief Institute, Inc., Indianapolis,<br />

IN, IN; 3. School of Medicine, Indiana University, Indianapolis, IN.<br />

Background: The existence of known cognitive impairment<br />

challenges the ability to adhere to the complex medication regimens<br />

often required to treat the multitude of diagnoses common to older<br />

adults. This report describes a systematic evidence-based review to<br />

accomplish two objectives: 1) identify barriers to medication adherence<br />

in cognitively impaired adults, and 2) identify interventions<br />

aimed at improving medication adherence in adults with cognitive<br />

impairment.<br />

Methods: We searched PubMed, Medline, PsycINFO, Google-<br />

Docs and CINAHL between 1966 and November 1, 2010. Target participants<br />

for both study objectives included adults ≥ 45 years of age<br />

with a diagnosis of cognitive impairment of any degree (mild cognitive<br />

impairment or dementia of any type). Inclusion criteria for the<br />

first objective consisted of any observational study describing risk<br />

factors or barriers to medication non-adherence. Inclusion criteria for<br />

the second objective consisted of any clinical trial with an intervention<br />

targeting medication adherence in cognitively impaired adults.<br />

Studies were excluded if they were not specific to a cognitively impaired<br />

population, lacked a measure of medication adherence, or described<br />

case reports, reviews, or psychiatric or infectious disease populations.<br />

Results: A total of 584 articles were retrieved through the initial<br />

search. Eight studies met inclusion criteria for objective one and<br />

three studies met inclusion criteria for objective two. Two studies<br />

evaluated reminder systems and did not show a benefit in a small<br />

group of participants with cognitive impairment. One study improved<br />

adherence through telephone and televideo reminders at each dosing<br />

S46<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

interval. Results are limited to published articles and articles with at<br />

least an abstract published in English.<br />

Conclusions: This review identified that few barriers to medication<br />

adherence have been addressed in the cognitively impaired population.<br />

Future interventions should better address reported barriers<br />

to medication adherence, as well as evaluate the impact on disease<br />

markers and cognitive function as clinical endpoints.<br />

A89 Encore Presentation<br />

Atypical presentation is common in Late Onset Rheumatoid<br />

Arthritis.<br />

P. Chatterjee, A. B. Dey. <strong>Geriatrics</strong>, AIIMS, New delhi, India.<br />

Background-Presentation of rheumatoid arthritis (onset after<br />

60 years of age) is varied and atypical, posing diagnostic uncertainties.<br />

Objective- To examine the mode of presentation of late onset<br />

rheumatoid arthritis (LORA) and to identify baseline clinical and<br />

laboratory features that would contribute to diagnosis and prognostication.<br />

Methodology- 31 cases of inflammatory arthritis were diagnosed<br />

as RA among the patients attending Geriatric OPD of AIIMS,<br />

using revised <strong>American</strong> Rheumatology Association criteria for RA<br />

or with clinical (atypical presentation), laboratory and radiologic evidence<br />

of RA. Patients were followed 2 weeks, 3 months then 6<br />

months to see the response to DMARDs by Disease activity score<br />

and development of disability using Stanford Health Assessment<br />

Questionnaire disability index (HAQ DI).<br />

Result- Mean age of presentation 66.32 ± 4.24 years, mean duration<br />

of presentation 20.74 ±30.23 months. Female to male ratio was<br />

1.8. 51.61% had both large and small joint involvement, 29.35% had<br />

exclusive small joint involvement, 19.35% had exclusive large joint<br />

disease, 58.6% had peri-arthritis of shoulder joint and 51.6% had<br />

polymyalgic symptoms on presentation. 67.7% has bilaterally symmetrical<br />

presentation. 74.2% had RA factor positivity; 41.9% had x-<br />

ray features suggestive of RA; 25.8% had anti-CCP antibody positivity;<br />

and 61.3% had ADL impairment on diagnosis. 61.3% of the<br />

LORA patients had more than 3 co-morbidities. 80.6% patient responded<br />

to methotrexate and 19.4% developed deformity during follow-up.<br />

ADL impairment was significantly (p=0.001) associated with<br />

large joint involvement and RA factor positive group had significant<br />

XRAY changes (p=0.02) and ADL impairement(p=0.03)<br />

Conclusion- LORA is associated with female predominance as<br />

in young age. But due to late and atypical presentations, ADL impairment<br />

is common. Response to DMARD is satisfactory. Multiple comorbidities<br />

and early disability compromises the quality of life.<br />

Larger scale prospective studies are required to provide better diagnostic<br />

criteria and treatment recommendations.<br />

A90 Encore Presentation<br />

Factors Associated with Geriatric Syndromes in Older Homeless<br />

Adults.<br />

R. T. Brown, 1,2 D. K. Kiely, 3 M. Bharel, 4 S. L. Mitchell. 3,5 1. Division<br />

of <strong>Geriatrics</strong>, University of California, San Francisco, San Francisco,<br />

CA; 2. San Francisco Veterans Affairs Medical Center, San Francisco,<br />

CA; 3. Hebrew SeniorLife Institute for Aging Research, Boston, MA;<br />

4. Boston Healthcare for the Homeless Program, Boston, MA; 5.<br />

Division of Gerontology, Beth Israel Deaconess Medical Center,<br />

Boston, MA.<br />

Supported By: 1. NIH-NIA T32 AG000212<br />

2. NIH-NIA K24 AG033640<br />

Background: Although older homeless adults have high rates of<br />

geriatric syndromes, little is known about the risk factors for these<br />

syndromes. We sought to identify factors associated with geriatric<br />

syndromes in 250 homeless adults ≥50 years old recruited from eight<br />

homeless shelters in Boston, Massachusetts.<br />

Methods: Multivariate regression models were used to estimate<br />

the association of subject characteristics with the following outcomes:<br />

1) total number of geriatric syndromes; 2) cognitive impairment<br />

(Mini-Mental State Examination (MMSE) score and Trail Making<br />

Test Part B (TMT-B) duration); 3) fall in the past year; 4) frailty; and<br />

5) major depression.<br />

Results: Total number of geriatric syndromes was associated<br />

with < high school education, diabetes, binge-drinking, drug use problem,<br />

and impairment in Activities of Daily Living (ADL). Lower<br />

MMSE score (worse cognition) was associated with older age, < high<br />

school education, non-English primary language, binge-drinking, and<br />

longer duration of homelessness. Longer TMT-B duration (worse executive<br />

function) was associated with older age, non-White race, <<br />

high school education, non-English primary language and stroke.<br />

Falling was associated with arthritis, binge-drinking, ADL impairment<br />

and depression. Frailty was associated with diabetes and depression.<br />

Finally, depression was associated with younger age, < high<br />

school education, drug use problem, traumatic brain injury, and ADL<br />

impairment.<br />

Conclusions: This study identifies modifiable factors associated<br />

with geriatric syndromes in older homeless adults. This knowledge<br />

can help health care providers identify and assess homeless patients<br />

who may have geriatric syndromes, and may provide targets for interventions<br />

to improve the health of older homeless adults.<br />

A91<br />

A Mystery of Vision & Thrombosis.<br />

S. Hodroge, R. Lands, B. Pearman. Internal Medicine, University of<br />

Tennessee Medical Center, Knoxville, TN.<br />

Introduction:<br />

Unilateral orbital pain, swelling, limitations in ocular motion<br />

and diplopia, are concerning in any patient. This usually signals the<br />

presence of pathology within the orbit or paranasal sinuses. We present<br />

a patient with these symptoms who was found to have a right<br />

spontaneous superior ophthalmic vein thrombosis (SOVT) and a<br />

lupus anticoagulant.<br />

Case Report:<br />

A 56-year-old white female presented to University of Tennessee<br />

Medical Center with a 2-month history of progressive right<br />

sided periorbital redness, swelling, pain and finally opthalmoplegia.<br />

CT scanning revealed periorbital cellulitis. She was treated with several<br />

rounds of antibiotics, steroids, and NSAIDs without improvement.<br />

Upon presentation to our hospital, she had noted worsening of<br />

right-sided headache, photophobia, and vision deterioration with decreased<br />

red color discrimination. She reported no purulent nasal discharge<br />

or fever. She fell three months prior to admission, but denied<br />

loss of consciousness or neurologic symptoms. Risk factors for thrombosis<br />

included the use of estradiol. She had no family history of<br />

thrombophilia. Physical exam revealed right periorbital swelling with<br />

erythema, proptosis, ptosis and a lateral rectus palsy of the right eye.<br />

Dilated fundoscopic exam showed 1+ disc edema as well as abnormally<br />

engorged retinal veins. Pupils were reactive to light but the<br />

right pupil was smaller than the left. Right intraocular pressure was<br />

mildly elevated at 25mm Hg. Lab findings included a normal white<br />

blood cell count and ESR. Magnetic resonance angiography demonstrated<br />

a right superior ophthalmic vein thrombosis. The patient was<br />

anticoagulated with heparin and treated with IV antibiotics pending<br />

return of negative blood cultures. After ruling out carotid cavernous<br />

fistula, arteriovenous malformation, and intracranial aneurysm, she<br />

had a cerebrovascular angiogram that was normal. The patient’s<br />

symptoms improved after the angiogram. Evaluation for acquired hypercoagulable<br />

states demonstrated the presence of a lupus anticoagulant,<br />

which was still present three months later. She remains on Warfarin<br />

and will require anticoagulation indefinitely.<br />

Discussion:<br />

SOVT is a rare condition usually related to inflammation of the<br />

orbit or paranasal sinuses, clinically similar to periorbital cellulitis.<br />

AGS 2012 ANNUAL MEETING<br />

S47


P OSTER<br />

A BSTRACTS<br />

While we were not able to find another reported case of SOVT associated<br />

with the presence of a lupus anticoagulant, evaluation for hypercoagulation<br />

syndromes is probably warranted.<br />

A92<br />

Spontaneous Retroperitoneal Bleed Presenting as Right leg pain:<br />

Psoas sign.<br />

T. Hashim, A. H. Chaudhry. Hospitalist, Highline Medical Center,<br />

Burien, WA.<br />

We report case of 88year old man with past medical history of<br />

atrial fibrillation on anti- coagulation with Coumadin for chronic<br />

atrial fibrillation. Patient presented to our emergency room with 1<br />

day history of right leg pain and inability to walk secondary to severe<br />

pain and leg weakness. Patient denied any trauma. The pain was in<br />

right groin which was made worse with extension of the hip and was<br />

relieved with hip flexion. All other review of systems were negative.<br />

His medical problems included diabetes, hypertension and history of<br />

CHF.His home medications included Coumadin, Lisinopril, simvastatin<br />

and Carvidelol.<br />

On physical examination, his blood pressure was 122/65 heart<br />

rate 110/min irregular, respiratory rate 22 /min and temperature of<br />

98.7F. His cardio-pulmonary exam was unremarkable. Abdominal<br />

exam was benign. Patient however was constantly keeping his right<br />

thigh flexed. When patient was turned on his left side and an attempt<br />

was made to extend his right leg at the thigh; it resulted in severe pain<br />

(positive psoas sign). He also had sensory loss on the anterior upper<br />

thigh and also has significant weakness of the right Quadriceps<br />

Femoris Muscle.<br />

Laboratory data showed hematocrit of 28 which was a drop<br />

from his baseline hematocrit of 35. The INR was 4.6 and rest of the<br />

chemistry panel was with in normal limits.<br />

A CT scan of the abdomen and pelvis without contrast showed<br />

huge 13cmx5cmx6.5cm complex fluid collection close to the right iliacus<br />

muscle consistent with retroperitoneal bleed. Patient was admitted<br />

to ICU for close monitoring. He was transfused 4 units of Fresh<br />

frozen plasma along with 2 units of PRBCS and 10mg of IV vitamin<br />

K. Surgery recommended conservative management and complete<br />

reversal of anticoagulation and frequent hemoglobin checks.<br />

Over the next couple of days the patient’s condition improved<br />

and his hematocrit stabilized.<br />

On the 5th day of hospitalization, patient was discharged home<br />

with home health for physical therapy.<br />

Conclusion:<br />

Retroperitoneal bleed is a Known complication of anticoagulation<br />

which usually presents with abdominal pain and back pain. However,<br />

sometimes it presents as isolated Psoas sign. Clinicians taking<br />

care of patients on anti- coagulation should have low threshold for<br />

imaging the abdomen (CT or MRI) for patient who present with<br />

groin pain or leg pain.<br />

A93<br />

The Functional Performance Predictors of Adverse Health Outcomes<br />

in Community-Dwelling Older Adults: A preliminary study.<br />

T. J. Tseng, 1 P. S. Lin, 1 H. S. Cheng, 2 B. H. Gi. 1 1. Department of<br />

Physical Therapy, Graduate Institute of Rehabilitation Science, Chang<br />

Gung University, Taoyuan, Taiwan; 2. Internal Medicine, Chang Gung<br />

Memorial Hospital, LinKou Branch, Taoyuan, Taiwan.<br />

Background and Purpose: The number of older adults keeps increasing<br />

in Taiwan. “Frailty” is a newly defined syndrome, the declined<br />

physiologic reserve capacities will make older people highly<br />

vulnerable to adverse health outcomes, such as hospitalization and<br />

mortality. Finding predictors is one of the solutions to prevent or<br />

defer those adverse health outcomes. There are two purposes of this<br />

study: (1) To examine the differences of the occurrence of the adverse<br />

health outcomes in different levels of frailty for 2-year period. (2) To<br />

examine the functional performance predictors of older adults’ adverse<br />

health outcomes after 2-year period. Method: A convenient<br />

sample of 337 older adults, aged 65 years and older, living in the community<br />

participated in this study. The baseline evaluation included<br />

demographic and health status, functional tests, mental and depressive<br />

status. The subjects will be followed up annually and finally, medical<br />

record confirms of the occurrence of adverse health outcomes, including<br />

hospitalization, emergency visit, and fall. Results: Among the<br />

337 enrolled, 96 of whom were “non-frail”, 191 were “pre-frail”, and<br />

50 were “frail”. Results of preliminary analyses showed, at baseline,<br />

the three groups were significantly different in height, weight, comorbidity,<br />

GDS, MMSE and all functional tests. The frail older adults<br />

have significantly higher percentage of falls (X2= 13.305, p=0.01). The<br />

5-meter gait speed test, functional reach (FR) and 6-min walking test<br />

(6 MWT) were the tests that could significantly predict older adults’<br />

hospitalization, emergency visit and falls 2 years later, respectively.<br />

Conclusion: The 5-meter gait speed test, FR and 6 MWT were recommended<br />

for use to identify community-dwelling older adults who are<br />

at risk of future adverse health outcomes.<br />

A94<br />

Older Minority Persons Living with HIV/AIDS (PLWHA) The<br />

Influence of Social Support on Willingness to Participate in HIV<br />

Clinical Trials.<br />

R. Arakawa, 1,2 G. Corbie-Smith. 2,3 1. University of Hawaii John A<br />

Burns School of Medicine, Honolulu, HI; 2. The Program on Health<br />

Disparities Cecil G. Sheps Center for Health Services Research, The<br />

University of North Carolina Chapel Hill, Chapel Hill, NC; 3. School<br />

of Medicine, The University of North Carolina Chapel Hill, Chapel<br />

Hill, NC.<br />

Background: Racial and ethnic minorities are disproportionately<br />

affected by the AIDS epidemic, yet have been underrepresented<br />

in HIV research, including clinical trials. Older adults are increasingly<br />

infected, and the population over 50 years old living with<br />

AIDS is expected to grow. The unique experience of being an older<br />

minority person living with HIV/AIDS (PLWHA), in the context of<br />

clinical trial participation, is poorly understood. This study looked for<br />

age-related differences in willingness to participate in a clinical trial<br />

and specific facilitators of participation.<br />

Methods: A cross-sectional, stratified analysis of baseline survey<br />

data was conducted as an aspect of Project EAST (Education and<br />

Access to Services and Testing), a community-based research project<br />

devoted to increasing rural minority participation in research in<br />

North Carolina. Textual data from interviews with PLWHA was<br />

queried for qualitative support of the findings.<br />

Results: Age was not associated with willingness to participate<br />

(WTP), and study participants demonstrated a high level of baseline<br />

willingness. Older age was associated with high levels of perceived social<br />

support from church & religious faith, but lower levels of perceived<br />

support from friends. Older participants had lower perceived<br />

pressure from their doctors to participate, but most believed their<br />

doctor would support their decision to enroll. Both age groups received<br />

a higher frequency of support from other resources, including<br />

their spouse/partner and other family.<br />

Discussion: This study provides no empiric basis for excluding<br />

older minority PLWHA from clinical trials research. The high baseline<br />

willingness demonstrated by the survey participants is encouraging,<br />

but social desirability should be examined as a possible con-<br />

S48<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

founder. Future efforts to maintain participation should include engagement<br />

of faith leaders and doctors to lead discussions about HIV.<br />

Additionally, peer-lead interventions to increase knowledge amongst<br />

friends may increase subsistence-type support associated with better<br />

engagement in care.<br />

A95 Encore Presentation<br />

Hypertension Control in all Age Groups – a VA 10 Year Multicenter<br />

Analysis.<br />

R. Fletcher, 1,3 V. Papademetriou, 1 R. Kheirbek, 1,2 R. Amdur, 1,2<br />

C. Faselis, 1,2 R. Jones. 1 1. Veterans Affairs Medical Center, Washington<br />

DC, DC; 2. George Washington University Medical Center,<br />

Washington DC, DC; 3. Georgetown University Medical Center,<br />

Washington DC, DC.<br />

Introduction: While the benefits of blood pressure (BP) control<br />

are well known, BP control is rarely studied in large populations.<br />

Elderly patients have been considered difficult to control. We reviewed<br />

blood pressure control in a large cohort of VA patients.<br />

Methods: From September 2000 to August 2010, we assessed<br />

BP control in 582,851 hypertensive patients from 15 VA hospitals<br />

in various geographic locations around the United States. Patients<br />

were divided in 4 groups based on age: G1:


P OSTER<br />

A BSTRACTS<br />

and knowledge promoted advance care planning. Illness awareness,<br />

perceived barriers about advanced care planning, knowledge, access<br />

to medical care (esp palliative) influenced decisions about EOL and<br />

hospice, not one’s ethnicity. Patient & family education by health professionals<br />

led to increased awareness of disease and better EOL decision<br />

making. The international studies revealed the following: In a<br />

Korea study most subjects viewed advance directives positively which<br />

was not influenced by information disclosure, ICU experience, prognosis<br />

or gender. In a Taiwan study, knowledge of palliative care &<br />

hospice increased willingness to execute advance directives & many<br />

elderly cancer patients preferred to die at home with hospice care in<br />

their last year. In a China study, less awareness of prognosis increased<br />

anxiety and communication difficulties with family members.A survey<br />

of Chinese medical interns felt they had received insufficient palliative<br />

care education in medical school. Both individualistic and family<br />

autonomy models were observed in the US and International<br />

studies.<br />

Conclusion: Ethnicity or geography did not influence decisions<br />

regarding EOL, hospice, palliative care and advance directives.<br />

Rather, education and awareness improved outcomes. Asian populations<br />

both in the US and internationally could benefit by having active<br />

dialogue among health care professionals, patients and families.<br />

Clinicians should be more culturally sensitive in accepting a familycentered<br />

decision making process along with the autonomy model<br />

A98<br />

Neighborhood Socioeconomic Disadvantage and Walking: the<br />

Cardiovascular Health Study.<br />

T. Yan, 1 M. Cheung, 2 L. Liang, 3 S. D. Vassar, 1 W. T. Longstreth, 4<br />

S. S. Merkin, 5 J. J. Escarce, 3 A. F. Brown. 3 1. Department of<br />

Neurology, University of California, Los Angeles, Los Angeles, CA; 2.<br />

John A Burns School of Medicine, Honolulu, HI; 3. Division of GIM<br />

& HSR, University of California, Los Angeles, Los Angeles, CA; 4.<br />

Departments of Neurology and Epidemiology, University of<br />

Washington, Seattle, WA; 5. David Geffen School of Medicine,<br />

University of California, Los Angeles, Los Angeles, CA.<br />

Background: We examined the association between neighborhood<br />

socioeconomic status (NSES) and walking in older adults and<br />

assessed variation in the relationship by race and gender.<br />

Methods: We used data from the Cardiovascular Health Study, a<br />

multicenter study of cardiovascular disease in older adults 65 years<br />

and older, to examine the association between NSES (the summed z-<br />

scores of census variables representing income, wealth, education and<br />

employment) and self-reported blocks walked in the prior week. We<br />

constructed race- and gender-stratified multilevel binomial models<br />

adjusted for clustering by NSES quartile, sociodemographic, behavioral,<br />

and clinical characteristics.<br />

Results: The sample included 4005 whites (57% female) and 844<br />

African <strong>American</strong>s (62% women). Overall, adjusted mean blocks<br />

walked was higher among whites than African <strong>American</strong>s and among<br />

men than women (p


P OSTER<br />

A BSTRACTS<br />

patients (age ≥65) in outpatient settings in the USA using the<br />

NAMCS data from 2000 to 2007.<br />

Methods: Patients 65 years or older who visited outpatient clinics<br />

for non-malignant pain management were identified by one of the<br />

following methods: i) documented either by patients’ self-report of<br />

reason for visit; or ii) ICD-9 code for assessments recorded by physician<br />

for that visit or iii) prescription received for pain management<br />

during that visit.<br />

Results: A total of 206,879,848 weighted (5968 un-weighted)<br />

outpatient visits for older patients with non-malignant pain from<br />

2000-2007 were analyzed. About 89% of these visits recorded<br />

NSAIDs prescriptions. The mean age for the NSAIDs prescription<br />

receivers was 75.4 years and majority of these patients were women<br />

(68%) and Whites (87.6%). Half (50.6%) of the NSAIDs prescriptions<br />

were given by primary care providers. A large percentage of the<br />

NSAIDs users had Medicare (75%) while 15% had private insurance.<br />

Most patients (68.8%) received a total of 4 prescriptions during the<br />

outpatient visit and only 0.9% of the NSAIDs users had a diagnosis<br />

of kidney disease.<br />

Conclusions: A large percentage of older adults were prescribed<br />

NSAIDs for non-malignant pain management in outpatient<br />

settings. While pain severity and length of treatment are not reported<br />

in NAMCS to fully determine appropriate use of NSAIDS in older<br />

adults, it is imperative to further explore if appropriate guidelines<br />

are used for pain management in these patients who are at higher<br />

risk of ADRs.<br />

A101<br />

Effect of “as needed” dosing of antipsychotics and benzodiazepines<br />

for delirium on hospital length of stay and readmissions N.<br />

Rodgers,1 K.Young 1, V. Argento, Department of Medicine<br />

Bridgeport Hospital, Bridgeport, CT.<br />

N. Rodgers, K.Young,V.Argento. Bridgeport Hospital, Bridgeport, CT.<br />

Background: Despite the initial 2005 FDA advisory against antipsychotics,<br />

conventional and atypical antipsychotics as well as benzodiazepines<br />

continue to be used for the treatment of acute agitation/delirium<br />

in demented seniors. Few studies have explored the<br />

effect of cumulative as needed dosing of these medications on patient<br />

outcomes. This study seeks to determine if PRN dosing of antipsychotics<br />

and benzodiazepines is associated with increased hospital<br />

length of stay and more frequent 30 day hospital readmissions.<br />

Methods:<br />

Retrospective database review was performed on seniors (n=<br />

245, average age: 85) with baseline dementia who were admitted to<br />

the Bridgeport Hospital Inpatient Medical Units between 2006-2010<br />

with a diagnosis of delirium. Controls were matched for age, gender,<br />

and co-morbidities stratified using the Charleson index. Subjects<br />

were grouped into 5 categories based on prn medication given: typical<br />

antipsychotics, atypical antipsychotics, benzodiazepines, combinations<br />

of typical and atypical antipsychotics, any combination of the<br />

above, and no prn doses. Length of hospital stay and 30 day re-admission<br />

rates were compared.<br />

Results:<br />

The average length of hospitalization in patients with no prn<br />

medications was 14.1 days. Those receiving prn atypical antipsychotics<br />

had an average stay of 24.7 days (CI 4.0-17.3 p=0.0018). Dual<br />

antipsychotic administration had a stay of 24.0 days (CI 2.8-17.1<br />

p=0.0068). Mean hospital stay was longest for patients receiving combinations<br />

of benzodiazepines and antipsychotics with a mean stay of<br />

28.2 days (CI: 7.9-20.3 p= 0.0001). Comparison of 30 day readmission<br />

rates did not meet statistical significance, except for the prn benzodiazepines<br />

group having an 11 fold greater readmission rate (OR=<br />

11.3; CI: 1.6-64.8). Cumulative data for all prn medications showed a<br />

non-significant trend toward increased re-admissions (OR=2.1; CI:<br />

0.8-5.5).<br />

Conclusion:<br />

Hospital length of stay and readmissions may be adversely impacted<br />

by cumulative prn dosing of: atypical antipsychotics, dual antipsychotics,<br />

and triple combinations of antipsychotics with benzodiazepines.<br />

In addition to non-pharmacological management of<br />

agitation whenever possible; this study reinforces the need for more<br />

standardized prn administration practices among geriatricians and<br />

nurses.<br />

A102<br />

A Retrospective Study of Basal Insulin Analogs in Elderly Nursing<br />

Home Residents with Type-2 Diabetes.<br />

K. L. Davis, 1 W. Wei, 2 J. Meyers, 1 B. S. Kilpatrick, 3 N. Pandya. 4 1. RTI<br />

Health Solutions, Triangle Research Park, NC; 2. sanofi-aventis U.S.,<br />

Bridgewater, NJ; 3. AnalytiCare, San Francisco, FL; 4. Nova<br />

Southeastern University, Davie, FL.<br />

Supported By: This study was funded by sanofi-aventis U.S.<br />

Background: Guidelines recommend long acting basal insulin<br />

use when oral agents fail to control type 2 diabetes (T2DM) in elderly<br />

patients.<br />

Methods: This retrospective, cross-sectional study examined the<br />

use of basal insulin analogs in long term care (LTC) facilities and the<br />

associated outcomes. Data were extracted from medical charts and<br />

the Minimum Data Set (MDS). Treatment regimens of patients receiving<br />

insulin glargine (IGlar) or detemir (IDet) were investigated<br />

and indices of glycemic control and other outcomes compared descriptively<br />

between groups. Patients with T2DM were included if they<br />

were resident in LTC for ≥3 months, had ≥1 full MDS assessment and<br />

≥2 records of insulin dispensing. Patients using insulin pumps, receiving<br />

hospice care, or in a comatose state were excluded.<br />

Results: 2,096 patients were identified from 117 facilities, >50%<br />

received basal insulin (N=1142, mean [SD] age 73.5 [11.9], female<br />

60%). The majority (82.5%, N=942) were treated with IGlar. Baseline<br />

characteristics were generally similar between groups. Co-administration<br />

of sliding scale insulin (SSI) was common (IGlar: 53.3%; IDet:<br />

54.5%), either with basal alone (IGlar: 45.3%; IDet: 49.5%) or with<br />

basal-bolus regimens. Treatment with basal-only (23.1%), basal-bolus<br />

(10.6%) and multiple insulin regimens also occurred. Twice daily injections<br />

(BID) were less common in the IGlar group (5.5% vs 22.0%,<br />

P


P OSTER<br />

A BSTRACTS<br />

made more eye contact during anxiety-provoking visits, patients<br />

made more eye contact during routine visits. Given the rising prevalence<br />

of prostate cancer (PCa) in the aging population, the likelihood<br />

of PCa communication being anxiety-provoking, and the role of anxiety<br />

in decision-making about PCa, we compared eye contact during<br />

PCa communication with other clinical interactions.<br />

Methods: We analyzed NIA videotapes of older men and male<br />

physician interactions (n=26) during three different types of clinical<br />

visits involving: 1) PCa (n=9), 2) other anxiety-provoking situations<br />

(depression/suicidal ideation, behavioral issues, and acute medical issues;<br />

n=9), and routine situations (n=8). Using NVivo 9 Qualitative<br />

Software, history-taking segments were time-stamped and transcribed<br />

for each tape, enabling simultaneous independent assessment<br />

of eye contact—in terms of length, frequency and quality—and<br />

speech of both physicians and patients.<br />

Results: Compared to other situations, the length and frequency<br />

of physician eye contact was lowest during PCa interactions. The<br />

quality of eye-contact during PCa communication was characterized<br />

by the lowest number of sustained eye contact episodes per visit (1.5),<br />

followed by slightly higher number in routine visits (2), and the highest<br />

during anxiety-provoking visits (3). In contrast, patients made the<br />

most eye contact in PCa and routine visits, and least in other anxietyprovoking<br />

visits. The amount of verbal communication between<br />

physicians and patients was similar. The frequency of eye contact of<br />

physicians and patients was about twice that of verbal speech.<br />

Conclusions: Physicians and patients display different eye contact<br />

patterns during discussions of PCa when compared with other<br />

anxiety-provoking and routine care discussions. While the frequency<br />

of verbal utterances was similar, physicians display least eye contact<br />

while patients display most eye contact during PCa discussions. Understanding<br />

nonverbal communication patterns and designing interventions<br />

to improve eye contact can help enhance patient-centered<br />

communication for this preference-sensitive disease.<br />

A104<br />

QI Reducing 25 OH Vitamin D Ordering.<br />

R. Aminbakhsh, 1 Z. Aung, 1 G. Guo, 1 D. Chau, 1 S. Leong. 2 1. Internal<br />

Medicine, University of Nevada School of Medicine, Reno, NV; 2. Lab<br />

and Pathology, Veteran Affairs, Reno, Reno, NV.<br />

There has been an increase in the 25 OH Vitamin D lab orders<br />

to our VA healthcare system without any clear evidence based data to<br />

document appropriateness, need for general testing, and guidance.<br />

Recently, The IOM [Institute of Medicine]concluded that there’s evidence<br />

of vitamin D benefits for bone, but there is not enough on nonbone<br />

outcomes. Target blood level of 25OH vitamin D- 20 ng/mL<br />

cover the needs of at least 97.5% of the population. Labs for vit. D<br />

have variable ranges & these ranges can mislabel patients. At our Veteran<br />

Affairs approx. 1500 tests are sent per month at a cost of $18 per<br />

test. PARTICIPANTS of the QI project consisted of all ambulatory<br />

and hospital care providers who ordered 25 OH Vitamin D from August<br />

to November of 2011. # 25OHD Labs ordered by provider was<br />

reviewed (2011):August 982;September 1531;October 1078. INTER-<br />

VENTION: The QI team sent an educational letter September 2011<br />

based upon the IOM report, possible unneccessary testing to the VA<br />

primary care providers. This letter provided providers with the education,<br />

guidance, and recs on appropriate 25 OH Vitamin D lab testing.<br />

Following the letter, the team reviewed the lab orders for vitamin D<br />

and provided 1:1 education based on IOM directed towards PCPs<br />

who ordered high #s of tests. 2/10 PCPs ordered 20% of vit.D lab,5x<br />

more # of tests than by endocrinologist. In addition to education, a<br />

new in house lab for vitamin D testing was implemented standardizing<br />

D ranges of lab reported. MEASUREMENTS: We reviewed the<br />

lab orders for vitamin D prior to the quality improvement education<br />

process, the cost of the lab testing pre and post education. RESULTS:<br />

Of the 3591 tests ordered of 25 OHD from August - October only 8%<br />

had abnormal 25 OH vitamin D values, including deficient and insufficient<br />

vitamin D status. After the preliminary intervention, the 25 vitamin<br />

D lab test ordered was reduced from 1531 in the month of September<br />

to 1078 in the month of October a drop of 29.59%.CONCLU-<br />

SION: A QI project using educational email plus 1:1 education to<br />

outlying providers, and internally standardizing 25 OH lab reports<br />

lowered the number of vitamin D testing and abnormal reporting. We<br />

have also proposed to provide more education for primary care<br />

physicians through additional 1:1 and team education.<br />

A105<br />

Does Low Social Support Predict Hospitalization and Outcomes<br />

among Aging Veterans with and without HIV?<br />

R. Greysen, 1 L. I. Horwitz, 2 K. E. Covinksy, 1 R. Desai, 2 M. E. Ohl, 3<br />

M. Duggal, 2 A. C. Justice. 2 1. Dept of Medicine, University of<br />

California, San Francisco, CA; 2. Dept of Medicine,Yale University,<br />

New Haven, CT; 3. Dept of Medicine, University of Iowa, Iowa City, IA.<br />

BACKGROUND: Social isolation is common among aging Veterans,<br />

especially those infected with HIV, and may affect healthcare<br />

utilization and outcomes of care. Our objectives were to compare levels<br />

of social support in aging Veterans with and without HIV and determine<br />

associations between social support and hospital admission,<br />

length of stay, and disposition.<br />

METHODS: Using the Veterans Aging Cohort Study we created a<br />

10-point scale for social support using survey responses about: marital<br />

status, housing status, food security, number of friends/family and frequency<br />

of visits,and involvement in volunteer work,religious or self-help<br />

groups, or other community activities. We stratified data by HIV status<br />

and used multivariable regression to assess effects of social support on<br />

admission, length of stay, and skilled nursing facility (SNF) placement.<br />

RESULTS: Data were available for 1,836 Veterans: age 55-91<br />

(mean=61), 98% male, 68% non-white, 76% annual income


P OSTER<br />

A BSTRACTS<br />

be more reluctant to do so. However, they do value incorporation of<br />

their concerns and wishes into clinical decisions. Therefore, we developed<br />

a method for discussing goals with frail older people. <strong>Here</strong>, we<br />

describe primary care professionals’ first experiences with this<br />

method.<br />

Methods: We developed a two-step method for discussing goals<br />

with community-dwelling frail older people. It consists of an openended<br />

question: If there is one thing we can do for you to improve<br />

your situation, what would you like?; followed by an agenda-setting<br />

chart. Primary care nurses and gerontological social workers then<br />

used this method to discuss goals with community-dwelling frail older<br />

people of ≥ 70 years. The research team reviewed the goals elaborated<br />

and studied professionals’ experiences with the method using a<br />

survey. This included questions concerning time spent on discussing<br />

goals; reasons for not formulating goals; and perceived value of the<br />

method.<br />

Results: 140 frail older people described a total of 175 goals.<br />

These most frequently concerned mobility (n=43; 24.6%), well-being<br />

(n=52; 29.7%), and social context (n=58; 33.1%). Professionals (n=18)<br />

were positive about the method, which took about 16 minutes for<br />

each step. 17 (94.4%) agreed with the statement that it had helped<br />

them determine what the frail older person valued and 15 (83.3%)<br />

agreed that it had helped them to put the wishes of frail older persons<br />

first. Goals were not always formulated, frequently mentioned reasons<br />

for this were the frail older person being comfortable with the<br />

current situation; not being accustomed to discussing goals; or not<br />

being able to formulate goals due to cognitive problems.<br />

Conclusions: The first experiences with this brief two-step goalsetting<br />

method have shown that discussing goals with frail older people<br />

helps professionals to gain insight into what a frail older person<br />

values. This can assist professionals, and possibly frail older people, in<br />

choosing the most appropriate treatment or care option, thus increasing<br />

frail older people’s involvement in decision making.<br />

A107<br />

The Relationships between the Type of Long-Term Care Benefits<br />

and Cognitive Function among Long-Term Care Insurance<br />

Beneficiaries with Dementia in Korea, 2008-2010.<br />

T. Lee, 1 J. Chung, 2 E. Cho. 1 1. Dept. of Nursing Environments &<br />

Systems, Yonsei University College of Nursing, Seoul, Republic of<br />

Korea; 2. Dept. of Biobehavioral Nursing & Health Systems,<br />

University of Washington School of Nursing, Seattle, WA.<br />

Supported By: Korean National Health Insurance Corporation<br />

Background: In Korea, the population over age 65 is expected to<br />

double by 2020, and the prevalence of dementia among those will rise<br />

up to about 10%. The Act on Long-term Care Insurance for Senior<br />

Citizens (LTCI) was enacted in 2008 in an effort to fulfill the care<br />

needs of the elderly with chronic diseases, and the number of beneficiaries<br />

with dementia has reached approximately 80,000. In this<br />

paper, we aimed to examine the relationships between the type of<br />

LTC benefits and the level of cognitive function among LTCI beneficiaries<br />

with dementia.<br />

Methods: We assembled a national sample of all LTCI beneficiaries<br />

with dementia aged ≥ 65 years (N=80,293), examined for LTC<br />

rating in 2008 and followed through 2010. A standardized 10-item<br />

scale was used to assess cognitive function, with higher scores indicating<br />

lower cognitive function. Linear mixed models were used to investigate<br />

whether the LTC benefit type (fixed effects) was a significant<br />

predictor for cognitive function improvement over time<br />

(random effects).<br />

Results: There are three benefit types: in-home services (HS, a<br />

physician/nurse visits the homes of beneficiaries and provides services),<br />

aged care facility services (FS, the LTC facility provides services),<br />

and a combined type of in-home services and aged-care facility<br />

services (CS). From 2008 to 2010, there was a decrease in the mean<br />

cognitive function scores (CFS) for HS beneficiaries from 6.25 to 6.20<br />

(p < .001) and for FS beneficiaries from 7.19 to 6.86 (p < .001). However,<br />

the mean CFS of CS beneficiaries increased from 6.25 to 6.58<br />

during the same period (p < .001) (Table).<br />

Conclusion: Older adults with dementia showed an improvement<br />

in their cognitive function after receiving LTC services delivered<br />

at their home or aged care facilities.<br />

Mean Cognitive Function Scores of Long-Term Care Beneficiaries<br />

with Dementia by Benefit Type and Year<br />

A108<br />

Lower Cost of Care for Serious Chronic Disease by Increasing<br />

Services Not Restrictions.<br />

T. Edes, 1 S. Shreve, 2 L. Klepac, 1 B. Kinosian. 3 1. Dept Veterans Affairs,<br />

Washington, DC; 2. Dept of Veterans Affairs, Lebanon, PA; 3. Dept of<br />

Veterans Affairs and Univ of PA, Philadelphia, PA.<br />

Supported By: No research funding support.<br />

Purpose: To demonstrate that systems can increase access, improve<br />

quality and lower total cost of care by adding services rather<br />

than restricting services.<br />

Background: Congressional Budget Office report (2007) noted<br />

the cost per patient per year in the 7 years from 1998 to 2005 rose<br />

29% in Medicare, while costs rose only 1.7% in Department of Veterans<br />

Affairs (VA). The highest cost patients were those with multiple<br />

serious chronic diseases, many of whom were homebound. One factor<br />

attributed for VA’s cost containment was that VA has programs in<br />

place specifically for persons with serious chronic disease. VA has<br />

continued to expand programs specifically for Veterans with serious<br />

advanced chronic disease to receive patient-centered care in the least<br />

restrictive setting. We report an economic impact analysis of two such<br />

VA programs: Hospice & Palliative Care (HPC), and Home Based<br />

Primary Care (HBPC).<br />

Methods: VA databases were used to determine Veterans’ use of<br />

HBPC, use of HPC in all settings, and location of death. Utilization<br />

and costs of care were determined for 2003 and 2010.<br />

Results: Between 2003 and 2010, while the number of VA enrollee<br />

deaths decreased 11% and the number ofVA inpatient deaths decreased<br />

15%,the number of deaths inVA acute medical hospital decreased 36%,<br />

the number in VA inpatient hospice beds increased 179% and the number<br />

of Veterans in VA-paid home hospice increased 592%. 4582 fewer<br />

deaths occurred in acute medical plus ICU, and 5731 more Veterans received<br />

VA-paid home hospice per day. With the cost difference, the net<br />

cost reduction was over $8 million for each day 4500 Veterans received<br />

care in home hospice rather than VA acute medical inpatient care. The<br />

number of Veterans receiving HBPC increased 190%. Total net cost<br />

avoidance for 24,957 HBPC patients was over $70 million, at $2900 per<br />

patient per year largely by reducing avoidable inpatient days.<br />

Conclusion: Increasing access to inpatient hospice care, to VA-paid<br />

home hospice care and toVA-provided HBPC resulted in net reductions<br />

in total VA costs of care, without imposing any restrictions of services.<br />

A109 Encore Presentation<br />

Geriatric Surgery: The Association between Adherence to Processbased<br />

Quality Indicators and Postoperative Complications.<br />

V. Martelli, 3 S. A. Fraser, 1 V. Isabelle, 3 M. Deban, 3 C. Holcroft, 3<br />

M. Monette, 3 J. Monette, 2 S. Bergman. 1 1. Surgery, Jewish General<br />

Hospital, Montreal, QC, Canada; 2. Geriatric Medicine, Jewish<br />

General Hospital, Montreal, QC, Canada; 3. Lady Davis Institute for<br />

Medical Research, Jewish General Hospital, Montreal, QC, Canada.<br />

Supported By: Canadian Institutes of Health Research<br />

Background:<br />

AGS 2012 ANNUAL MEETING<br />

S53


P OSTER<br />

A BSTRACTS<br />

This study’s purpose was to understand the association between<br />

process- and outcome-based quality of care measurement in elderly<br />

surgical patients. Process measures describe the care that patients receive.<br />

Outcome measures are the result of care.<br />

Methods:<br />

This was a retrospective review of 143 patients over the age of<br />

65, who underwent elective general surgery between November 2009<br />

and July 2010. Adherence to 9 surgical Quality Indicators (QIs) (antibiotic<br />

and anti-thrombotic prophylaxis, euglycemia, early withdrawal<br />

of urinary catheter, central line inspection, early mobilization,<br />

malnutrition screening, medication list, surgical safety checklist) and<br />

6 geriatric QIs (delirium screening, standard delirium work-up, cognitive<br />

assessment, complete discharge planning, level of care documentation,<br />

pressure ulcer prevention) was abstracted from medical<br />

records. Surgical and Geriatric Quality Scores were calculated for<br />

each patient (#QIs passed / #QIs eligible x100). The primary outcome<br />

was 1 or more postoperative complications, recorded by NSQIP. The<br />

association between the Quality Score and complications was determined<br />

using logistic regression analysis.<br />

Results:<br />

The median Surgical Quality Score was 66.7%; the median Geriatric<br />

Quality Score was 20.0%. Descriptive statistics of the Low and<br />

High Quality Groups, stratified by the median Quality Score, are<br />

summarized in Table 1. Multivariate logistic regression analysis, adjusting<br />

for age, gender, comorbidities and functional status, revealed a<br />

higher risk of complications in the High Geriatric Quality Group,<br />

compared to the Low Geriatric Quality Group (OR=2.99,<br />

95%CI=1.21-7.33, p=0.017).<br />

Conclusions:<br />

We have assessed quality of surgical care in elderly patients<br />

using a novel, process-based approach. Better geriatric care was associated<br />

with a higher likelihood of developing complications, although<br />

the latter probably drives the former.<br />

Comparison of Patient Characteristics and Outcome in High and<br />

Low Quality Groups<br />

A110<br />

Depressive symptoms and high levels of stress significantly lower<br />

PSA screening rates in men with long life-expectancies in a<br />

nationally-representative sample.<br />

A. A. Kotwal, 1 S. G. Mohile, 2 W. Dale. 1 1. Department of Medicine,<br />

Section of <strong>Geriatrics</strong> & Palliative Medicine, University of Chicago,<br />

Chicago, IL; 2. Department of Medicine, James Wilmot Cancer Center,<br />

University of Rochester, Rochester, NY.<br />

Supported By: The National Social Life, Health, and Aging Project<br />

(NSHAP) is supported by grants from the National Institutes of<br />

Health, including the National Institute on Aging, the Office of<br />

Research on Women’s Health, the Office of AIDS Research, and the<br />

Office of Behavioral and Social Sciences Research (5R01 AG021487),<br />

and by NORC, which was responsible for the data collection.<br />

Background: Guidelines recommend informed decision-making<br />

regarding prostate specific antigen (PSA) screening for men having<br />

10 years of remaining life expectancy (RLE), but there remains a high<br />

rate of non-RLE-based PSA screening. Few studies have specifically<br />

examined the relationship of psychological health to cancer screening<br />

behaviors in men. We therefore assessed whether RLE-based screening<br />

is related to men’s psychological health.<br />

Methods: A nationally-representative sample of men over 57<br />

without prostate cancer (N=1,032) was selected from the National<br />

Social life, Health and Aging Project (NSHAP) and stratified into<br />

two RLE categories: 0-9 years (inappropriate to screen) and 10+<br />

years (appropriate to screen). The relationship of PSA screening<br />

rates within these RLE categories with psychological health variables<br />

anxiety, depression, and stress was assessed using multivariable logistic<br />

regression analyses to control for various potential confounders.<br />

Results: Men with 10+ year RLE with moderate/severe depressive<br />

symptoms had a significantly decreased odds of having PSA<br />

screening (OR=0.55 p=0.02). Men with 10+ year RLE with high stress<br />

levels also had decreased odds of receiving PSA screening (OR=0.37<br />

p=0.02). There was no significant difference in PSA screening rates by<br />

psychological variables in the 0-9 year RLE.<br />

Conclusions: Depression and stress significantly lower PSA<br />

screening rates in men with long life-expectancies for whom an informed<br />

decision on screening would be appropriate. Psychological<br />

morbidity may therefore be a barrier to appropriate informed decision<br />

making on PSA screening in healthy men with long life expectancies.<br />

A111<br />

Elder Self-Neglect and Hospitalization: Findings from the Chicago<br />

Health and Aging Project.<br />

X. Dong. Rush University, Chicago, IL.<br />

Supported By: NIH<br />

Objective: The objective of this study is to quantify the relation<br />

between reported elder self-neglect and rate of hospitalization in a<br />

community population of older adults.<br />

Design: Prospective population-based study<br />

Setting: Geographically-defined community in Chicago.<br />

Participants: Community-dwelling older adults who participated<br />

in the Chicago Health and Aging Project. Of the 6,864 participants<br />

in the Chicago Health and Aging Project, a subset of 1,165 participants<br />

was reported to social services agency for suspected elder<br />

self-neglect.<br />

Measurements: The primary predictor was elder self-neglect reported<br />

to social services agency. Outcome of interest was the annual<br />

rate of hospitalization obtained from the Center for Medicare and<br />

Medicaid System. Poisson regression models were used to assess<br />

these longitudinal relationships.<br />

Results: The average annual rate of hospitalization for those<br />

without elder self-neglect was 0.6 (1.3) and for those with reported<br />

elder self-neglect was 1.8 (3.2). After adjusting for sociodemographic,<br />

socioeconomic, medical commorbidities, cognitive function and physical<br />

function, elders who self-neglect had significantly higher rate of<br />

hospital utilization (RR, 1.47, 95% CI, 1.39-1.55). Greater self-neglect<br />

severity (Mild: PE=0.24, SE=0.05, p


P OSTER<br />

A BSTRACTS<br />

charge summaries at the time of transfer and high readmission rates<br />

for older patients within 30 days of discharge. Methods: Facility leadership<br />

chartered a multidisciplinary “Transition Redesign Team”<br />

(TRT) to examine factors contributing to patient and provider dissatisfaction<br />

after handovers from hospital to the subacute rehabilitation<br />

unit (rehab) at one VA Medical Center. Patients and families cited<br />

lack of advance information about the transfer. Rehab providers reported<br />

discharge summaries were often lacking at the time of transfer<br />

and also cited late times of transfer. Results: The TRT determined<br />

that despite the existence of adequate policies, hospital and rehab<br />

providers frequently lacked important information about factors pertaining<br />

to transfer specifics (e.g. patient information and ideal timing.)<br />

After discussion with the TRT, the rehab charge nurse joined the<br />

hospital team each morning for their “discharge huddle”. Information<br />

was exchanged about bed availability, prospective patient transfers,<br />

and feedback on past transfers. TRT realized that until the attending<br />

physician co-signed the discharge summaries, they were not<br />

visible in the EMR. The hospital team increased their verbal communication<br />

around transition planning, including negotiating time of<br />

transfer directly with the rehab charge nurse, reminding attending<br />

physicians to co-sign discharge summaries promptly, and talking with<br />

patients and families about possible transfer plans in advance. A dramatic<br />

improvement in provider satisfaction with the transition<br />

process occurred over the subsequent 9 months. Upon EMR review<br />

100% (76/76) of discharge summaries and 99% of patient discharge<br />

instructions were complete on the day of transfer to rehab. Patients<br />

and families reported moderately increased satisfaction with timeliness<br />

of information about transfer, and the TRT continues to work<br />

with hospital case managers to improve this communication process.<br />

Conclusion: Direct communication in the form of a discharge huddle<br />

appears to be important in improving provider and patient satisfaction<br />

with handovers from hospital to rehab.<br />

A113<br />

<strong>Geriatrics</strong> in Primary Care: Integrating Comprehensive Geriatric<br />

Care into the Medical Home.<br />

P. A. Engel, 1,3 A. Morgan, 1 J. Spencer. 2,3 1. Geriatric Research,<br />

Education and Clinical Center, VA Boston Healthcare System,<br />

Boston, MA; 2. Medicine, VA Boston Healthcare System, Boston, MA;<br />

3. Medicine, Harvard Medical School, Boston, MA.<br />

Supported By: This project is funded by the Department of Veterans<br />

Affairs<br />

Background: Most elderly patients are cared for by primary care<br />

physicians rather than geriatricians. In New England 48% of Veterans<br />

are aged ≥65 including 69,000 ≥85, a group in which cognitive and<br />

functional disabilities are endemic. The current healthcare system is<br />

not specifically designed to care for this vulnerable group. As a result<br />

frail aged Veterans may experience care that is fragmented, inefficient,<br />

costly and potentially harmful.<br />

Methods: <strong>Geriatrics</strong> in Primary Care (GPC), a clinical demonstration<br />

project addresses this problem by integrating geriatric clinicians<br />

and services directly into two large VA primary care practices<br />

that serve nearly 1,800 Veterans aged ≥85.At the heart of the program<br />

is the on-site presence of a consulting geriatrician and geriatric nurse<br />

care manager who combine forces with existing interdisciplinary<br />

teams to offer comprehensive geriatric care within the evolving VA<br />

medical home model known as PACT (Patient Aligned Care Team).<br />

The program promotes recognition of patients at risk, enhanced patient<br />

access, targeted care management, efficient resource use and a<br />

shift in care focus from multiple subspecialty sites to the PACT.<br />

Results: 175 patients have been evaluated and care managed<br />

since project initiation, August, 2010. 37 referrals to GPC versus 15 to<br />

a traditional stand alone interdisciplinary geriatric clinic (August-October<br />

2011) reflects a shift in geriatric consultation site to GPC. Complex,<br />

fragmented care seen in the first 50 patients (aged 82±7) referred<br />

to GPC indicates a need for this service. In the year prior to<br />

referral these patients made 15±14 total clinic visits with 34% attending<br />

≥5 subspecialty clinics. 74% were cognitively impaired, 18%<br />

lacked family caregivers and 40% received care in ≥2 health systems.<br />

Prorated 12 month follow-up of this original sample indicates a shift<br />

in locus of care with reduced total and mean subspecialty visits, (372<br />

to 269, 7.4±8.0 to 5.4±5.0, NS), significantly increased PACT visits<br />

(3.1±1.5 to 3.7±1.6, p=0.038) and use of phone contact by GPC<br />

(2.3±2.0) for follow-up care.<br />

Conclusion: Preliminary data suggests that GPC improves access<br />

to comprehensive geriatric care, reduces subspecialty service use<br />

and embraces clinical efficiencies by effectively creating interdisciplinary<br />

geriatric teams within PACT.<br />

A114<br />

Subset analysis of antidepressant medication utilization among<br />

geriatric patients with depression: Comparison between usual care<br />

and collaborative care using care managers.<br />

R. DeJesus. Mayo Clinic, Rochester, MN.<br />

Supported By: Nothing to disclose<br />

Depression poses significant economic and health burden yet<br />

remained under-diagnosed and inadequately treated. This is particularly<br />

true among geriatric patients. The STAR*D trial under the National<br />

Institute of Mental Health showed that more than one antidepressant<br />

medication is often necessary to achieve disease remission<br />

among patients seen in both psychiatric and primary care settings.<br />

The collaborative care model (CCM), using care managers, has been<br />

showed in numerous studies to be effective in achieving sustained<br />

outcomes in depression management compared to usual care. In<br />

March 2008, this model was implemented at Mayo Family Clinics<br />

Northwest in Rochester, Minnesota and was subsequently rolled out<br />

to other primary care sites. We hypothesized that utilization of antidepressant<br />

medications among patients with depression managed<br />

under the collaborative care management (CCM) model would be<br />

different from usual care even among geriatric patients.<br />

Records of patients who have been enrolled in CCM from<br />

March 2008 until March 2009 were reviewed and compared to those<br />

under usual care. Pattern of antidepressant medications utilization<br />

were compared between patients with depression enrolled in the<br />

CCM model and those under usual care. Sub-analysis was done on<br />

geriatric patients defined as those aged 65 and older.<br />

Those who were followed under CCM had significantly greater<br />

number of antidepressant medication utilization when compared to<br />

those under usual care. After 6 months, mean PHQ-9 score of patients<br />

under CCM was statistically lower than those in usual care.Subset<br />

analysis of patients aged 65 years and older (N=35) showed no statistically<br />

significant difference in mean PHQ-9 score at 6 months (p<br />

value: 0.59) and anti-depressant medications utilization (p value:<br />

0.29) between the two groups. This observation may reflect correlation<br />

between medication utilization and treatment response; however,<br />

sample number is small to account for any statistical difference.<br />

The collaborative care model for depression management is associated<br />

with greater anti-depression medication utilization with increased<br />

response rate compared to usual care. Future similar analysis<br />

on a larger sample of geriatric patients is needed to evaluate the true<br />

impact of CCM on antidepressant medication utilization and response<br />

rate.<br />

A115<br />

Incorporating INTERACT II Tools In Daily NH Practice,<br />

Recognizing Areas of Improvement.<br />

R. Madan, 1,2 F. Washington, 2 Y. Ye, 1 S. Oakes. 1,2 1. <strong>Geriatrics</strong>, UTH-<br />

SCSA, San Antonio, TX; 2. Buena Vida Nursing Home, San<br />

Antonio, TX.<br />

Background: Hospitalizations of frail nursing home residents<br />

can result in higher costs, complications and death. Research suggests<br />

AGS 2012 ANNUAL MEETING<br />

S55


P OSTER<br />

A BSTRACTS<br />

that a substantial proportion of these hospitalizations may be avoidable.<br />

INTERACT II(Interventions to Reduce Acute Care Transfers)<br />

has shown to address these issues from the nursing home perspective.<br />

Objective: Decrease the number of inappropriate transfers by<br />

using INTERACT II tools. Recognize areas for future improvement<br />

and cultural change.<br />

Design and Intervention: Quality improvement. IDT was<br />

formed and monthly sessions done by all lead members “on line”<br />

using INTERACT II modules. Cases following care pathways implemented<br />

for staff education. Physicians trained by attending medical<br />

executive committee. Using tools given through INTERACT II, all<br />

transfers that took place from May to September were evaluated.<br />

One preventable and one non-preventable transfer from each month<br />

evaluated in detail. In September there were no preventable transfers<br />

so 2 non preventable transfers evaluated in detail.<br />

Results: 31 transfers took place from May to September. 4<br />

deemed to be preventable and 27 non-preventable. 100% of patients<br />

transferred to the ED were admitted to the hospital. 70% of the patients<br />

transfer came from the hospital in the prior admission. None of<br />

the preventable and 33% non-preventable transfers had end of life<br />

planning. In the preventable transfers 75% used the “stop and watch”<br />

tool, 75% used the “SBAR” tool, 25% followed the “care pathways”<br />

and 75% used the “change in condition cards”. In the non-preventable<br />

transfers 83% used the “stop and watch” tool, 83% used the<br />

“SBAR” tool, 67% followed the “care pathways” and 100% used the<br />

“change in condition cards”.<br />

Discussion: Comprehensive advance care planning will likely<br />

improve number of transfers. Following the INTREACT II tools requires<br />

ongoing commitment and training in all levels of care.<br />

Lessons learned: 1.Ongoing education is needed for physician<br />

and non-physician staff due to turnover and cross coverage issues.<br />

Reinforcing standardized tools and approaches such as care pathways<br />

is needed. 2. Quality improvement projects need to work in<br />

identifying residents that are at increased risk for transfers. 3. Increased<br />

awareness to complete comprehensive end of life planning<br />

(POLST) should be undertaken in all residents, and especially those<br />

who are at increased risk of transfers.<br />

A116<br />

Geriatric Medicine Transfer-of-Care for Older Surgical Inpatients:<br />

Our Experience and Current Trends (2006-2009).<br />

R. Gonzales, A. Khoo, D. Basic. Geriatric Medicine, Liverpool<br />

Hospital, Liverpool, NSW, Australia.<br />

Supported By: No outside funding was used for this project.<br />

OBJECTIVE: To examine statistical trends regarding transferof-care<br />

to Geriatric Medicine for older patients admitted under surgical<br />

teams.<br />

BACKGROUND: Liverpool Hospital, Australia is a 700-bed<br />

teaching hospital in southwest Sydney and is the major surgical and<br />

trauma centre for the region. With older surgical patients having a<br />

longer length of stay and worse overall prognosis than younger patients,<br />

there has been an increasing need for geriatrician involvement<br />

in their care. In reviewing models of care, the literature suggests a<br />

transfer-of-care model improves functional capacity and decreases<br />

likelihood of placement compared with usual consultative care.<br />

METHODS: The Department of Geriatric Medicine, Liverpool<br />

Hospital has been maintaining a comprehensive database of consultation<br />

requests and outcomes since 2001. Statistical tests of trends in<br />

proportions were applied to transfer-of -care cases.<br />

RESULTS: A review of surgical consultations (n=741) to Geriatric<br />

Medicine (2006-2009) showed the majority were from neurosurgery<br />

(25.1% of surgical team consults) followed by orthopaedics<br />

(21.9%). The majority of the consultations were for medical assessment<br />

(39.2%), followed by high-level residential facility placement<br />

(30.1%). Geriatrician response times to surgical consultation remained<br />

similar over the four-year period. The proportion of surgical<br />

consultations leading to transfer-of-care ranged from 13.2-31.7%<br />

over 2006-2009, with neurosurgical patients highest among transfers<br />

(25.2% of all transfers). However, the proportion of all (medical and<br />

surgical) consultation patients whose care was transferred decreased<br />

significantly by year (2006-2009, Mantel-Haenszel trend test,<br />

p


P OSTER<br />

A BSTRACTS<br />

ratory failure become chronically critically ill, requiring prolonged<br />

mechanical ventilation (PMV). Older adults who are ventilator dependent<br />

and admitted to long-term care hospitals (LTCH) have a<br />

~50% mortality rate at 1 year, are at high risk for hospital and ICU<br />

readmission. But there is scant data about older adults who receive<br />

care at long-term care skilled nursing facilities (LTC-SNF). This study<br />

examines outcomes of adults on PMV, who were not able to be<br />

weaned, 1 year after their admission to a LTC-SNF.<br />

Methods: A retrospective chart review of mechanically ventilated<br />

adults, admitted to a 60-bed ventilator unit at Silvercrest Center<br />

for Nursing and Rehabilitation (SCNR) from 1/1/2009 to 12/31/2009<br />

and their outcomes at 1 year follow up. Demographic and clinical<br />

data were collected at the time of admission. At 1 year follow up, possible<br />

outcomes included: 1) Alive, 2) Dead, and 3) Lost to follow up.<br />

Also examined was number of readmissions.<br />

Results: During the 1 year time frame, there were a total of 167<br />

subjects on PMV. Of these, 98 were excluded (38 were ventilator liberated<br />

and 60 were admitted prior to 1/1/2009); 69 were admitted for<br />

the first time in 2009 and were included in this study. For these 69 subjects,<br />

the average age was 75 (19-104), with 39 female and 30 male.<br />

The ethnic composition was 37.7% White, 23.2% Black, 24.6% Hispanic,<br />

10% Asian and 4% other. The primary reasons for respiratory<br />

failure were: pneumonia (23.2%), CVA (20.3%), sepsis (15.9%),<br />

COPD (14.5%), anoxic brain injury (10%) and other (16%). At 1<br />

year follow up, 40 (58%) subjects died on the ventilator; 16 (23%)<br />

were alive with 15 in SNF and 1 in the hospital; and 13 (19%) were<br />

lost to follow up due to readmission. On average, subjects experienced<br />

3.3 readmissions (range 0-11). For subjects who were alive at 1<br />

year, readmission rate was 4.7 (range 1-8).<br />

Conclusions: Older adults who require prolonged mechanical<br />

ventilation have a high risk of mortality at 1 year and experience multiple<br />

transitions of care, with many resulting in loss to follow up. Subjects<br />

who survive at 1 year follow up have a higher readmission rate<br />

and none were able to go home.<br />

A119<br />

Improving Transitions to Home in Older Veterans after<br />

Hospitalization.<br />

M. Mather, 1,2 T. Patel, 1,2 S. Espinoza. 1,2 1. GRECC, South Texas<br />

Veterans Healthcare System, San Antonio, TX; 2. UT Health Science<br />

Center, San Antonio, TX.<br />

Supported By: GRECC, Veterans Administration<br />

Background: Approximately 20% of Medicare beneficiaries experience<br />

readmission after hospital discharge (DC). Follow-up (FU)<br />

is usually scheduled 7-10 days after DC, although the high risk time<br />

for post-DC complications, such as falls, is 24-72 hrs after DC. The<br />

goal of this quality improvement project was to improve transitions<br />

to home by contacting patients during this time window in order to<br />

increase safety awareness, improve medication compliance, and prevent<br />

readmission.<br />

Methods: Patients were outpatients enrolled in the Geriatric<br />

Evaluation and Management (GEM) clinic at Audie Murphy VA<br />

Hospital. Scripted follow up calls were made 24-72 hrs post-DC over<br />

a 15-month period by a clinical nurse leader (CNL), who asked about<br />

new disability, new medications, social work (SW) concerns, capacity<br />

for self-care, and whether FU was scheduled. All actions resulting<br />

from the call made by the GEM interdisciplinary team (CNL, MD,<br />

SW, clinical pharmacist) were documented. A standardized retrospective<br />

chart review was performed for data collection, and the information<br />

was summarized using descriptive statistics.<br />

Results: 96 patients were called: mean age was 77.3 ±11.5 yrs,<br />

93.8% were male, 53.1% were Non-Hispanic White, and 30.2% were<br />

Hispanic. Medical comorbidity was common: 65.4% had 2 or more of<br />

diabetes, congestive heart failure, chronic obstructive pulmonary disease,<br />

and hypertension. 73.9% had received new medications upon<br />

DC, and 16.7% had a new disability. While most (88.1%) were taking<br />

medications appropriately, 4.8% were taking the wrong medication<br />

or dose, and required medication reconciliation. 12.1% of calls lead to<br />

intervention by the MD, and readmission was prompted by the call in<br />

15.3% of patients. 4.8% experienced a fall after DC and 15.3% were<br />

readmitted within 30 days. Neither falls nor readmission were associated<br />

with any specific chronic disease.<br />

Conclusion: The GEM team identified the need for post DC FU<br />

calls to improve communication with patients and address unmet<br />

needs. Anecdotally, patients reported increased satisfaction and reduced<br />

anxiety transitioning to home post DC as a result of this intervention,<br />

although this was not formally evaluated. Patients and their<br />

families should receive disease and safety education, particularly with<br />

regard to falls, at every encounter.<br />

A120<br />

Improving Care of the Geriatric Trauma Patient.<br />

S. Hobgood, L. Scheider, P. Boling. <strong>Geriatrics</strong>/Internal Medicine,<br />

Virginia Commonwealth University, Richmond, VA.<br />

Background: Trauma from falls, motor vehicle crashes, and other<br />

mechanisms causes much morbidity, hospital use and mortality. Patients<br />

over age 65 now account for 12% of trauma admissions, rising<br />

to 40% by 2050. While studies have shown benefit from linking <strong>Geriatrics</strong><br />

and Orthopedic Surgery services, little evidence exists regarding<br />

outcome impacts by <strong>Geriatrics</strong> in other surgical areas. VCU Medical<br />

Center admits hundreds of trauma patients aged 65 and older<br />

each year. Every weekday, the Geriatric Consult Service (GCS) sees<br />

and follows Trauma patients on request. We assert that the VCU GCS<br />

intervention benefits trauma patients.<br />

Methods: We conducted a detailed structured electronic record<br />

review of all patients age 65 or older, seen by the GCS at VCU Medical<br />

Center in 2010, including 73 of 251 (29%) geriatric Trauma Surgery<br />

admissions. We studied patient characteristics, financial data, disposition,<br />

and mortality.<br />

Results: The table shows the main results. There were no differences<br />

in sex, race, zip code, or other demographic characteristics.<br />

Conclusions: Trauma patients seen by GCS were older, and were<br />

sicker than other elderly trauma patients based on a significant difference<br />

in DRG weights, and ICU days. GCS patients more often<br />

went to nursing homes which may reflect acuity or GCS intervention<br />

effects, and though the sicker GCS patients stayed longer and cost<br />

more, they had a better financial outcome for the hospital. Despite<br />

the acuity, in-hospital mortality was lower although not statistically<br />

significant in this small sample, an encouraging finding that we continue<br />

to study.<br />

Geriatric trauma patients seen by GCS versus those not seen by GCS<br />

A121<br />

Transition Coaching to Reduce Hospitalization and Emergency<br />

Department Use.<br />

S. Pandey, 1,2 D. Ifon, 2 L. Williams, 2 K. Blackstone, 1,2 E. L. Cobbs. 1,2 1.<br />

Medicine, George Washington University, Washington, DC; 2.<br />

<strong>Geriatrics</strong>, Extended Care and Palliative Care, Washington DC VA<br />

Medical Center, Washington DC, DC.<br />

Background: Transition Coaching (TC) is a short term program<br />

to help patients with functional decline. TC provides short term case<br />

management using home visits and person- and family-centered care.<br />

TC comprehensively assesses the patient and caregiver situation, provides<br />

meaningful education, improves medication management, and<br />

identifies needed resources. Goals are to achieve a comprehensive assessment,<br />

improve patient and family understanding of the disease,<br />

AGS 2012 ANNUAL MEETING<br />

S57


P OSTER<br />

A BSTRACTS<br />

articulate goals of care, reduce inefficiencies of care, and reduce caregiver<br />

burden.<br />

Methods: The TC program started in 10/10 and was fully operational<br />

in 2/11. Two nurse practitioners (NP) deliver short term transition<br />

coaching in response to consultation requests. Outcome measures<br />

include patient and family satisfaction, referring provider<br />

satisfaction, hospital and emergency department utilization, advance<br />

care planning documentation (ACP) and additional resources accessed.<br />

Initial funding was obtained with grant support for two NP<br />

salaries. NPs were embedded into an existing geriatric clinic team.<br />

Revenues from the home visits will sustain the TC program.<br />

Results: 63 patients were served by the TC program from 10/10<br />

to 10/11. 52 completed the program. The most common reasons for<br />

TC consult were medication use, averting functional decline, and alleviating<br />

caregiver burden. The mean age was 83, and all were men.<br />

Most were living with a caregiver. The two most common diagnoses<br />

were heart failure and dementia. 100% underwent comprehensive<br />

assessment, 96% had patient-centered medication management, and<br />

83% had ACP documentation. 37% were linked to new resources,<br />

38% received social worker consultation, 75% received durable<br />

medical equipment, 15% enrolled in home hospice, and 13% enrolled<br />

in home-based primary care. To date, hospital and emergency<br />

department use have been reduced by half, when compared with the<br />

year prior to TC. Patient, family and provider satisfaction has been<br />

excellent.<br />

Conclusion: TC appears to add an important piece to the array<br />

of interventions to help patients remain at home. TC helps optimize<br />

medical management, document ACP, and access resources to decrease<br />

hospital and emergency department use.<br />

A122<br />

Use of the Frailty Index to evaluate the risk of death in older<br />

patients presenting to hospital.<br />

S. Evans, 1 A. Mitnitski, 2 K. Rockwood. 2 1. Medicine, Mercy Hospital<br />

of Buffalo, Buffalo, NY; 2. Medicine, Dalhousie University, Halifax,<br />

NS, Canada.<br />

Supported By: Mercy Hospital of Buffalo, NY<br />

Community Health Foundation of Western and Central New York<br />

Dalhousie Medical Research Foundation<br />

QEII Fountain Innovation Fund<br />

Background: The frailty index can identify groups at increased<br />

risk of deathy in older adults, as reported by ours and other groups. In<br />

hospitals, a Frailty Index (FI) based on a Comprehsnive Geriatric assessment<br />

(CGA) can be built from routinely collected data. The objectives<br />

of our study were: 1. To test the predictive validity of the FI-<br />

CGA in relation to length of stay (LOS) and mortality. 2. To compare<br />

the impact of change in health status over a two week period on outcomes.<br />

Methods: This is a prospective cohort study of 754 patients age ≥<br />

75 admitted to a medical unit at Mercy Hospital, Buffalo NY.. Main<br />

outcome measures were mortality and hospital LOS. Kaplan-Meier<br />

survival analysis was performed separately in men and women.The logrank<br />

test was used to assess differences between survival curves. Cox<br />

proportional hazard regression model was applied to analyse the association<br />

of the FI-CGA with mortality, adjusted for age and sex. Multivariate<br />

logistic regression was used to analyse the association of the FI-<br />

CGA with 30-day and 90-day mortality.A generalized linear model was<br />

usedtoanalyseLOSinrelationtotheFI-CGAandotherfactors.<br />

Results: 754 older adults were enrolled, of whom complete data<br />

are available on 751. These patients were older (mean age 84.0<br />

(SD=5.5) and most (480; 60.7%) were women. Their mean length of<br />

stay in hospital was 5.2 (SD=5.1) days. 30-day mortality rate was<br />

11.5% (91/751) which increased to 16.4% (130/751) by 90 days. On<br />

average, patients were moderately frail at baseline (median FI-<br />

CGA=0.35), but their health status had worsened significantly in the<br />

two weeks prior to admission, at which time their median FI-CGA<br />

was 0.46. In Cox regression analysis, age, sex and the FI-CGA score<br />

were significantly associated with mortality (e.g., for the FI-CGA, the<br />

HR=1.04 (95%CI=1.03, 1.05) for each 1% FI-CGA increment. Multivariate<br />

logistic regression also showed the age and sex adjusted risk<br />

of death was highly associated with the FI-CGA (OR=1.06 (1.04,<br />

1.08) for 30-day mortality and OR=1.05 (1.03, 1.07) for 90-day mortality..<br />

Likewise, a higher FI-CGA was significantly associated with<br />

LOS (R2=0.3).<br />

Conclusion: <strong>Here</strong>, the FI-CGA stratified the risk of death and<br />

long LOS in older adults admitted to hospital.<br />

A123<br />

GHEST-3D: Greenwich Hospital Executive Screening Tool for<br />

Delirium, Depression and Executive Dysfunction. Report on an<br />

observational quality improvement study.<br />

S. Buslovich, 1 G. J. Kennedy. 2 1. Internal Medicine, Greenwich<br />

Hospital-Yale New Haven Health, Greenwich, CT; 2. Geriatric<br />

Psychiatry, Einstein-Montefiore Medical Center, Bronx, NY.<br />

Supported By: Greenwich Hospital funded the part time salary of a<br />

geriatric screening nurse to administer the survey instruments.<br />

Cognitive decline is omnipresent in the geriatric patient population.<br />

The risk of cognitive impairment increases with age and is further<br />

enhanced after hospitalization as supported in the literature.<br />

Screening patients for cognitive impairment during hospital admission<br />

could be the first step in early identification of cognitive impairment,<br />

allowing for implementation of appropriate interventions. Several<br />

conditions that significantly impact functionality and<br />

independence may be subtle and undiagnosed.<br />

We evaluated patients considered to be at high-risk for hospital<br />

re-admissions, such as patients admitted with CHF exacerbations,<br />

acute myocardial infarctions, pneumonia and COPD exacerbations<br />

for delirium, depression and executive dysfunction. A screening tool<br />

was designed utilizing evidence based tools, such as, the Confusion<br />

Assessment Method (CAM), Patient Health Questionnaire (PHQ-9),<br />

Controlled Oral Word Association Test (COWAT), and Oral Trail<br />

Making Test (OTMT) to conduct an oral interview and identify patients<br />

with delirium, depression and executive dysfunction.<br />

The original sample size consisted of 43 case patients and 27 control<br />

patients. Control patients were age, and sex matched surgical floor<br />

patients without history of the high-risk diagnoses. 91.3% (21) of the<br />

23 readmitted (within one year) case patients tested positive for executive<br />

dysfunction; 50% (3/6) original study subjects that tested positive<br />

for depression were readmitted with one year; 75% (3/4) original study<br />

subjects tested positive for delirium were readmitted in the same time<br />

period. The subject pool was inadequate to identify a reliable time to<br />

readmission for each specific diagnosis in this observational study.<br />

This study illustrates the potential value of systemic screening for<br />

cognitive impairment in acute stay hospitalized elderly patients and possible<br />

implications of all-cause readmission rates. Further cohort studies<br />

are needed to evaluate whether recognition and targeted interventions<br />

could contribute to positive outcomes, specifically, follow through with<br />

the discharge plan of care, medication regimen adherence, reduction in<br />

nursing home admissions, depressive symptom remission, hospital readmissions,<br />

mortality and improvements in the patients’ quality of life.<br />

A124<br />

Safety in Transitions of Care; Identifying Needs Among Key<br />

Providers in an Urban Academic Hospital.<br />

U. K. Ohuabunwa, 1,2 S. Shah, 1 Q. Jordan, 2 K. Johnson, 1 C.Tai, 1<br />

J. Flacker. 1 1. Division of <strong>Geriatrics</strong>, Dept of Medicine, Emory<br />

University,Atlanta, GA; 2. Senior Services, Grady Hospital,Atlanta, GA.<br />

Supported By: HRSA - Geriatric Academic Career Award<br />

Hartford Center of Excellence Clinician Educator Award<br />

Background: Medication errors, poor communication, and poor<br />

coordination between providers are major contributory factors to<br />

failure in transitions of care.<br />

S58<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

Objectives: 1. To determine the knowledge, attitude and care<br />

transitions practices of key inter professional providers involved in<br />

the discharge process.<br />

2. To determine their perceived patient, provider and system related<br />

factors contributing to failure in transitions of care<br />

Design: Mixed methods approach using surveys and focus group<br />

sessions<br />

Setting: A 953 bed academically affiliated inner city hospital<br />

Participants: Key providers involved in the discharge process including<br />

physicians, nurses, social workers and case managers.<br />

Procedure: We administered questionnaires to these key<br />

providers exploring their knowledge of care transitions best practices,<br />

attitudes and practices. Focus group sessions were held to further explore<br />

their perceived patient needs; and patient, provider and system<br />

related barriers to safe transitions of care.<br />

Results: 108 participants including 74 medical residents, 12 medical<br />

students, 7 social workers, 5 nurse case managers and 6 inpatient<br />

unit nursing directors /charge nurses completed the questionnaires.<br />

21% of the participants had received no formal training on care transitions<br />

best practices at anytime. Up to 61% reported no training on<br />

effective communication and patient education strategies. The areas<br />

of least training were on determination of patient - appropriate settings<br />

of care (27%) and communication and coordination of care with<br />

outside care facilities (18%). Medication reconciliation and scheduling<br />

of appointments were the most common provider practices reported.<br />

The following themes emerged during the focus group sessions<br />

as provider related factors contributing to failure in care<br />

transitions: 1) Poor communication between members of the healthcare<br />

team.2)Poor understanding of roles of members of the healthcare<br />

team.3) Poor patient education by providers and poor knowledge<br />

as to patient education best practices.4) Poor understanding of<br />

the care transitions process and recommended best practices. Conclusion:<br />

Determination of provider related deficiencies in the knowledge<br />

and practice of care transitions will form a basis for educational interventions<br />

to reduce provider related errors.<br />

A125<br />

Understanding the Southern Arizona Dual-Eligible Special Needs<br />

Patient (SNP) population.<br />

V. Nagaraja, 1 H. Goel, 1 A. Gilligan, 2 J. Mohler, 1 T. Ball, 3 I. Abraham, 2<br />

M. Fain. 1 1. Arizona Center on Aging, University of Arizona, Tucson,<br />

AZ; 2. HOPE Center, University of Arizona, Tucson, AZ; 3. University<br />

of Arizona Health Network, Tucson, AZ.<br />

Background: The dual-eligible population (Medicare and Medicaid<br />

eligible) represents a group of patients with disproportionally<br />

large healthcare expenditures and multiple chronic conditions. They<br />

are likely to have multiple inpatient stays and emergency room visits.<br />

New innovative chronic care models are needed for this population.<br />

The primary objective of this study was to characterize and analyze<br />

the most costly dual-eligible enrollees in a Special Needs Program<br />

(SNP) within a southern Arizona academic medical center and understand<br />

patterns of suboptimal utilization and barriers to coordination.<br />

Methods: This study was retrospective, with data consisting of<br />

patient chart reviews and administrative cost data. Information regarding<br />

socio-demographics, general health status health resource<br />

utilization (HRU), and total cost of care (TCoC) of the top 10%<br />

(n=30) of the most costly dual eligible enrollees assigned to providers<br />

within the hospital’s outpatient programs were collected.<br />

Results: Sixty percent of the sample was female (n = 18). Mean<br />

age was 60 years (SD=13). Mean body mass index (BMI) was 31.9<br />

(SD=9.2), and 14 patients (46.7%) were clinically obese (BMI >30).<br />

Nearly 50% were diabetic. Seventy-five percent had four or more<br />

chronic conditions, with 75% having one or more concomitant psychiatric<br />

illness. The average number of PCP visits was 7.7 per six<br />

months (SD=5.9; 95%CI: 0-23). Average number of hospitalizations<br />

per six months was 1.4 (SD=1.5; 95%CI: 0-6). Thirty-day re-admission<br />

rates averaged 27% (SD=0.45). TCoC averaged $15,955/six months<br />

(SD=$10,890; 95%CI: $6,570-$59,068). Hospital admissions were a<br />

statistically significant contributor to TCoC (p = 0.001). The top 5%<br />

of this population accounted for nearly 50% of total spending.<br />

Conclusion: Finding effective, efficient and high quality means<br />

for coordinating the care of the dual-eligibles could help to assure the<br />

fiscal sustainability of the Medicare and Medicaid programs in the future.<br />

Findings will be used to create inter-professional chronic care<br />

models in collaboration with patients and their families, which address<br />

suboptimal utilization and barriers to coordination and incorporate<br />

value-based, high-touch, high-tech care.<br />

A126 Encore Presentation<br />

Improving quality of care for older veterans through a RHIOenhanced<br />

Care Transitions Intervention (CTI).<br />

W. W. Hung, 1,2 C. M. Dunn, 1 N. E. Moodhe, 1 E. M. Gottesman, 1<br />

B. Morano, 1,2 K. S. Boockvar. 1,2 1. GRECC, James J Peters VA<br />

Medical Center, Bronx, NY; 2. <strong>Geriatrics</strong>, Mount Sinai School of<br />

Medicine, New York, NY.<br />

Supported By: VA GEC T21 grant<br />

Background: Older veterans who transition from acute care to<br />

home are at risk for adverse outcomes such as readmissions and medication<br />

errors. This is especially true for veterans who use both VA<br />

and non-VA services, which is common in the Medicare-eligible population.<br />

The Bronx Regional Health Information Organization<br />

(RHIO), a regional electronic health information network, provides<br />

an opportunity to improve care coordination between VA and non-<br />

VA systems by providing a platform for sharing clinical data. The objective<br />

of this project was to implement a CTI that used real time<br />

RHIO notification of hospitalization events.<br />

Methods: Our CTI was based on the Coleman model, which had<br />

components of patient education, medication management, tools for<br />

self-management, and patient and caregiver empowerment. Referrals<br />

and case finding were used to identify appropriate older adults aged<br />

60+ discharged from our VAMC. For veterans who agreed to be monitored<br />

through the Bronx RHIO, the CTI team received electronic<br />

notifications from the Bronx RHIO informing them of hospitalization<br />

events at non-VA hospitals in the Bronx. The care transitions coordinator<br />

delivered the intervention with a visit in the hospital, with a<br />

home visit 2 days after discharge, and with 3 follow-up phone calls.<br />

Results: We modified the CTI to adjust education material for<br />

health literacy level and to make additional calls or visits as needed.<br />

Also, for some with poor health literacy, our coordinator needed to<br />

follow up clinical issues with providers. The CTI was associated with a<br />

lower 30-day rehospitalization rate of 17.8% among those served by<br />

the CTI as compared with 24.4% among those referred but not<br />

served. 91% of veterans served had a follow up visit within 30 days at<br />

the VA Medical Center and on average 1.1 unmet needs (such as<br />

medication discrepancy or mishaps) addressed. Projected cost reduction<br />

was $103000 annually which can be used to support the salary of<br />

the coordinator.<br />

Conclusion: Quality of care for veterans across health systems<br />

can be improved through care transitions activities enhanced by the<br />

use of a RHIO, with the potential for cost neutrality or cost savings.<br />

A127<br />

Access to Primary Care Using a Care Transitions Program: a<br />

Cohort Study.<br />

Y. Chen, 1 H. Syed, 1 J. M. Naessens, 2 N. D. Shah, 2 A. S. Rahman, 2<br />

K. M. Swanson, 2 P. Y. Takahashi. 1 1. Internal Medicine, Mayo<br />

Clinic, Rochester, MN; 2. Health Science Research, Mayo Clinic,<br />

Rochester, MN.<br />

Background: Care transitions involve a smooth handoff from<br />

the hospital to the home environment. One important aspect of care<br />

AGS 2012 ANNUAL MEETING<br />

S59


P OSTER<br />

A BSTRACTS<br />

transitions involves access to primary care which may provide better<br />

care coordination. Our clinical practice has initiated a care transitions<br />

program (CTP) with nurse practitioners after hospital stay in<br />

high risk elders. The aim of this study is to evaluate the number of<br />

primary care visits 60 days prior to enrollment and 60 days after enrollment<br />

in CTP.<br />

Methods: This was a retrospective cohort study of older adults<br />

enrolled in CTP from March 2011 till September 2011. CTP was initiated<br />

after hospital dismissal in high-risk adults over 60. Data was<br />

collected using administrative billing data on primary care (PC) visits<br />

prior to enrollment and after enrollment. Primary outcomes included<br />

the percentage of people with at least one visit to the PC<br />

team and average number of PC visits. Secondary outcomes included<br />

visits to specialists. Analysis used McNemar test and paired t-<br />

test respectively.<br />

Results: 95 patients were identified who had enrolled in CTP in<br />

mid 2011. Subjects visited their PC team 84.2% of the time before enrollment<br />

compared to 94.74% after enrollment (p-value


P OSTER<br />

A BSTRACTS<br />

A130<br />

The effect of Thai traditional music on cognitive function,<br />

psychological health and quality of sleep among older Thai<br />

individuals with dementia.<br />

P. Sithinamsuwan, 1 S. Saengwanitch, 1 A. Pinidbunjerdkool, 1<br />

S. Ukritchon, 2 M. Mungthin. 3 1. Division of Neurology, Department<br />

of Medicine, Phramongkutklao Hospital, Bangkok, Thailand; 2.<br />

Office of Research Development, Phramongkutklao College of<br />

Medicine, Bangkok, Thailand; 3. Department of Parasitology,<br />

Phramongkutklao College of Medicine, Bangkok, Thailand.<br />

Supported By: 1.Phramongkutklao College of Medicine<br />

2.Department of Medicine, Phramongkutklao Hospital<br />

Background: This study was designed to investigate the effects<br />

of Thai traditional music on cognitive function, activities of daily living,<br />

mood, behavior and sleep quality in demented Thai elderly.<br />

Methods: An 8-week, interventional, controlled, cross-over<br />

study was undertaken in 67 patients with dementia. We randomly allocated<br />

patients into 2 groups; group-1 [intervention (4-week) followed<br />

by control (4-week)], group-2 [control followed by intervention].<br />

During the interventional period, care givers played the music<br />

CD for each patient for at least 30minutes daily. Cognitive function<br />

[Mini-Mental State examination (MMSE)], activities of daily living,<br />

mood, behavior [Behavioral Pathology in Alzheimer’s Disease Rating<br />

Scale (BEHAVE-AD)] and sleep quality [Pittsburgh Sleep Quality<br />

Index (PSQI)], were assessed at 1stvisit (baseline), 2nd and 3rdvisit.<br />

Results: The mean age was 77.6 years and mean initial MMSE<br />

17.5. Average daily listening time was 51.2 minutes. Music significantly<br />

improved scores in MMSE (p = 0.009), 2-domain of BEHAVE-<br />

AD [Diurnal rhythm disturbance (p = 0.021) and Anxiety/phobia (p =<br />

0.025)] as well as the summation of behavioral symptomatology (p =<br />

0.008) and one sleep index [Daytime dysfunction (p = 0.005)]. Also,<br />

there was a trend to improvement in 2 more domains of BEHAVE-<br />

AD [Paranoid/delusion and Aggressiveness], ADL and global sleep<br />

quality index. Median visual analog scale of satisfaction this intervention<br />

was 80. The optimal duration of music exposure to improve cognitive<br />

and neuropsychiatric functions was 15minutes/day.<br />

Conclusions: Thai traditional music is an effective tool for addressing<br />

neuro-psychological symptoms, especially in cognitive function,<br />

behavioral and sleep problems, in elderly Thai with dementia.<br />

This study suggests that regularly scheduled listening to music more<br />

than 15 minute/day promotes a positive short-term effect on emotional<br />

memory.<br />

A131 Encore Presentation<br />

Systemic inflammation inhibits low-density lipoprotein receptorrelated<br />

protein-1 mediated clearance of amyloid-β from blood:<br />

implications for Alzheimer’s disease.<br />

P. E. Hartvigson, 1,2 M. A. Erickson, 2,3 W. A. Banks. 1,2 1. University of<br />

Washington School of Medicine, Seattle, WA; 2. GRECC-VA Puget<br />

Sound Health Care System, Seattle, WA; 3. Saint Louis University,<br />

Saint Louis, MO.<br />

Supported By: Medical Student Training in Aging Research<br />

Program; National Institute on Aging (T35AG026736); National<br />

Institute on Aging (R01AG029839); John A. Hartford Foundation<br />

MetLife Foundation; Lillian R. Gleitsman Foundation; VA Merit<br />

Review (WAB)<br />

Background: Alzheimer’s disease (AD) is a neurodegenerative<br />

disease characterized by the formation of amyloid plaques containing<br />

amyloid-β (Aβ) in brain parenchyma. Neurons produce Aβ constitutively.<br />

In normal physiology low density lipoprotein receptor-related<br />

protein-1 (LRP-1) transports Aβ from brain across the blood-brain<br />

barrier (BBB) into blood (efflux). Aβ is then taken up by peripheral<br />

organs (primarily liver) for degradation. LRP-1 mediates liver uptake<br />

of Aβ from blood. It has been proposed that Aβ in blood may also<br />

contribute to Aβ accumulation in brain, thus liver uptake may play a<br />

significant role in maintaining brain Aβ homeostasis. Lipopolysaccharide<br />

(LPS) -induced inflammation recapitulates many components of<br />

this aspect of the AD phenotype, and evidence suggests oxidative<br />

modification (adding 3-nitrotyrosine (3-NT) and 4-hydroxy-2-nonenal<br />

(4-HNE)) inhibits BBB LRP-1. We tested whether systemic inflammation<br />

inhibits liver LRP-1 and peripheral Aβ uptake by the<br />

same proposed mechanism.<br />

Methods: We injected young CD-1 mice with intraperitoneal<br />

LPS (control: saline) to induce inflammation, and then injected radiolabeled<br />

albumin and Aβ intravenously. Blood, liver and kidney were<br />

collected at various time points. Aβ/albumin uptake and serum clearance<br />

were assessed by gamma counting. Exposure time was calculated<br />

with multiple-time regression analysis. Liver LRP-1 expression<br />

and liver protein carbonyl were determined by dot blot. 3-NT and 4-<br />

HNE modifications on liver LRP-1 were assayed with Western blot.<br />

Results: LPS treatment significantly increased liver protein carbonyl,<br />

liver LRP-1 expression and 4-HNE modification on liver LRP-<br />

1. 3-NT modification on liver LRP-1 increased 38.8%. LPS significantly<br />

inhibited serum Aβ clearance as well as the rate of liver and<br />

kidney Aβ uptake.<br />

Conclusions: These findings support the hypothesis that oxidative<br />

modification on LRP-1 in liver increases circulating Aβ, which<br />

has been shown to increase brain Aβ concentration and contribute to<br />

amyloid plaque formation, hallmarks of AD pathology.<br />

A132<br />

Age, gender and blood pressure predict cerebral cortical thickness in<br />

normotensive and prehypertensive middle-aged adults.<br />

S. Wo,A. Heim, L.Yadlosky, J. Owens, J. R. Jennings. Department of<br />

Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA.<br />

Supported By: National Heart, Lung, and Blood Institute<br />

Thickness of the human cerebral cortex decreases with normal<br />

aging, and accelerated cortical thinning has been demonstrated in<br />

several pathologies, including Alzheimer’s disease. Previous studies<br />

have shown that subclinical levels of cerebrovascular risk factors such<br />

as high blood pressure are associated with decreased regional cortical<br />

thickness in community-dwelling elderly adults. In this study, we examine<br />

the relationship between cortical thickness and blood pressure<br />

in normo- and prehypertensive middle-aged adults. Our sample consists<br />

of 89 adults aged 35-60 years without neurological, cerebrovascular<br />

or cardiovascular histories whose blood pressures were normal<br />

to prehypertensive (systolic BP


P OSTER<br />

A BSTRACTS<br />

findings suggest that early control of elevated blood pressure may<br />

promote successful brain aging.<br />

A133 Encore Presentation<br />

A Driving Assessment Clinic: Structure and Statistics.<br />

S. Suraj, G. Madero, M. Shawn, N. Shirley. <strong>Geriatrics</strong> Department,<br />

Marshall University, Huntington, WV.<br />

OBJECTIVE: The decision whether a patient of advanced age<br />

or with a diagnosis of dementia should stop driving is a complex one,<br />

as there are no firm guidelines. Clinicians do not generally provide<br />

uniform assessments; indeed they rarely do any formal assessment to<br />

decide the answer for each patient. At the Hanshaw Geriatric Center<br />

we reviewed records of the patients from our Driving Assessment<br />

clinic to find whether any general recommendations can be made for<br />

Primary Care Physicians to assist them in planning for driving assessments<br />

for their patients.<br />

PATIENTS AND METHODS: Records where reviewed from<br />

all patients evaluated at our Driving Assessment Clinic at the Hanshaw<br />

Geriatric Center from August 2007 to mid 2010. We first assessed<br />

patterns of appointments themselves (kept/cancelled/“noshowed”),<br />

and subsequently reviewed actual assessment results.<br />

RESULTS: Out of 144 appointment slots available, 109 (76%)<br />

were filled. 26 (24%) of 109 appointments were Cancelled out of<br />

which 16 (62%) rescheduled and were evaluated. 14 (13%) of 109<br />

were “No Shows” out of which 1 (7%) rescheduled and was evaluated.<br />

A total of 49 patients (29 men and 19 women) where evaluated,<br />

3 of whom underwent the testing twice, for a total of 52 evaluations.<br />

Mean age was 75.4. The prevalence of CNS disorders was high<br />

among those tested. In 27 evaluations (52%), the patient had the diagnosis<br />

of dementia at the time of the assessment. Eleven (21%) had<br />

suffered head trauma, four of whom also had a dementia diagnosis.<br />

Nine (17%) had strokes. In two cases, all three diagnoses coexisted,<br />

yet the patients were still driving.<br />

CONCLUSIONS: In spite of the value of having objective data<br />

about our patients’ driving skills, in is difficult to obtain such data.<br />

Formal driving assessment is labor intensive and cancellation and noshow<br />

rates are quite high. We conclude that this is not a process which<br />

can be accomplished in the primary care office, nor even in many<br />

larger institutions. Regional assessment clinics are a possible approach,<br />

but would likely have to be supported by funds other than<br />

fee-for-service.<br />

A134<br />

Identifying the malady of synaptic plasticity-related genes in human<br />

Alzheimer’s Disease.<br />

S. M. Harvey, J. Knebl, J. Simpkins, S. Sarkar. University of North<br />

Texas Health Science Center, Fort Worth, TX.<br />

Early Alzheimer’s disease (AD) pathophysiology is characterized<br />

by synaptic changes induced by degradation products of amyloid<br />

precursor protein (APP). Although there is evidence for synaptic dysfunction<br />

induced by soluble oligomeric Aβ, the pre- or postsynaptic<br />

sites of action and the specific mechanisms responsible for such dysfunction<br />

have not been established. We reasoned that by measuring<br />

pre-and postsynaptic plasticity related gene expression in different<br />

brain regions from age matched control (AMC) and AD patients,<br />

candidate defective gene(s) by the criteria of severe loss of expression<br />

in AD could be identified. Preliminary results from western blot<br />

analysis show region specific severe loss of expression of pre-synaptic<br />

proteins AP-180, synaptogamin and dynamin in AD compared to<br />

AMC. These losses were most profound in the occipital and temporal<br />

cortices, but not significant in the cerebellum. The loss of expression<br />

of pre-synaptic protein molecule could lead to defects in synaptic<br />

function and ultimately to synapse loss that underlies the memory impairment<br />

evident in the early phase of AD.<br />

A135<br />

Defining Dementia Multimorbidity in a National Sample.<br />

T. Sadak, J. Katon, S. Borson. University of Washington, Seattle, WA.<br />

Supported By: JAHF Atlantic Philanthropies Claire Fagin<br />

Fellowship<br />

National Alzheimer’s Diseases Coordinating Center<br />

Background: Clinicians cite clinical complexity as a major challenge<br />

in caring for dementia patients, and no general model of care<br />

has found wide acceptance. Quantifying clinical complexity is a first<br />

step toward developing the necessary infrastructure for populationbased<br />

dementia care. Our goal was to describe dementia multimorbidity,<br />

using prevalence estimates for single and complex dementia<br />

etiologies, neuropsychiatric symptoms (NPS), and co-morbid chronic<br />

psychiatric and medical conditions in a large, systematically diagnosed<br />

national sample.<br />

Methods: Baseline visit data in the National Alzheimer’s Coordinating<br />

Center repository [U01 AG016976] were analyzed for 3851<br />

persons enrolled in an Alzheimer’s Disease Research Center<br />

(ADRC) and diagnosed with one of the four most common primary<br />

dementias (Alzheimer’s (AD), Lewy Body (DLB), behavioral variant<br />

Frontotemporal (BvFTD), and Vascular (VaD)). ‘Complex dementia’<br />

was defined as >1 concurrent etiologic diagnoses; severity<br />

was indexed by the clinical dementia rating (CDR). Co-morbid conditions<br />

(present or absent) included cardiovascular disease (CVD),<br />

cerebrovascular disease (CVAD), diabetes, hypertension (HTN), hypercholesterolemia<br />

(HCL), and primary psychiatric disorders. NPS<br />

were rated using the total NPI-Q score (prevalence X severity<br />

summed across 12 symptoms). Results: The sample prevalence of primary<br />

dementia diagnoses was 3338 for AD, 241 for DLB, 189 for<br />

bvFTD, and 83 for VaD. Overall, 202 persons (5%) had >1 etiology.<br />

Dementia was mild (CDR 1) in 64% of the sample. Almost all patients<br />

(93%) had at least one additional clinical problem; 89% had a<br />

comorbid chronic medical condition and 27% had ≥3. 41% had a psychiatric<br />

diagnosis (nearly all depression), and 88% had at least one<br />

current NPS, with total NPIQ scores varying by dementia etiology<br />

(AD 5.4, DLB 8.7, bvFTD 9.3, VaD 7.0). Severe dementia (CDR 3+)<br />

was more prevalent among persons with complex etiologies (17%)<br />

compared to those with a single etiology (11%, p < 0.05) and mean<br />

NPIQ scores were higher (7.5 vs. 5.8, p < 0.05).<br />

Conclusions: Multimorbidity is part of the reality of dementia,<br />

even among participants in ADRC’s, where the prevalence of ‘pure’<br />

AD is higher and overall clinical complexity is expected to be lower<br />

than in an unselected population. This study points to the need for<br />

conceptual and pragmatic approaches to care that incorporate complexity<br />

and its impact on clinical outcomes.<br />

A136<br />

Reliability of the Rey Complex Figure Test for Identifying Mild<br />

Cognitive Impairment.<br />

T. V. De Beritto, 1 K. D. Tingus, 2 P. H. Lu, 2 E. Teng. 2,3 1. University of<br />

Utah School of Medicine, Salt Lake City, UT; 2. Neurology, UCLA,<br />

Los Angeles, CA; 3. VA Healthcare System, Los Angeles, CA.<br />

Supported By: MSTAR (Medical Student Training in Aging<br />

Research Grant)<br />

Background: Individuals meeting criteria for mild cognitive impairment<br />

(MCI) progress to dementia at higher rates than agematched<br />

controls. However, the optimal operationalization of the<br />

MCI criteria remains uncertain. The Rey Complex Figure Test<br />

(RCFT) is widely used to assess memory and visuospatial functioning.<br />

Previous work indicates that the RCFT has good sensitivity for<br />

identifying cognitive impairment, but RCFT deficits are unstable.<br />

This study explores potential factors limiting the utility of the RCFT<br />

for identifying MCI.<br />

Methods: We identified 182 participants who met criteria for<br />

MCI (n=106) or normal cognition (NC; n=76) and had been assessed<br />

S62<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

with the copy and 3 minute delayed recall portions of the RCFT using<br />

the Meyers & Meyers (1995) scoring criteria and normative data (impairment<br />

defined as performance ≤-1.5 SD below normative means).<br />

We evaluated the effects of different scoring criteria and normative<br />

data on diagnostic classification. A rater blinded to prior diagnoses<br />

rescored RCFT figures using Taylor (1969) criteria, and participants<br />

were reclassified as impaired or unimpaired using Boone et al. (1993)<br />

and Van Gorp et al. (1990) norms. Concordances between different<br />

diagnostic classifications were calculated using Cohen’s κ.<br />

Results: The proportion of participants defined as having impaired<br />

RCFT performance was dependent on which scoring criteria<br />

and normative data were used. RCFT analyses using Taylor criteria<br />

yielded higher rates of impairment with the Boone norms (copy:<br />

31.8%; recall: 27.4%) than with the Van Gorp norms (copy: 17.0%; recall:<br />

8.2%). Concordance between norms was moderate for RCFTcopy<br />

(κ=0.47) and fair for RCFT-recall (κ=0.38). Use of the Meyers &<br />

Meyers criteria and norms yielded intermediate rates of impairment<br />

on the RCFT-copy (25.8%) and recall (21.9%) subtests.<br />

Conclusions: Although the RCFT may be sensitive to cognitive<br />

impairment, the use of different normative means yielded different<br />

proportions of impaired participants. Differences seen with different<br />

normative data sets were greater than differences seen with different<br />

scoring criteria and may reflect subjective differences in scoring between<br />

studies. Investigations of inter-rater reliability with this data set<br />

are ongoing. These findings suggest that the RCFT may have limited<br />

reliability when used in isolation to identify MCI.<br />

A137<br />

Normal aging, neuroinflammation, and the brain-a sheep in wolf’s<br />

clothing?<br />

T. Harris. University of Nebraska Medical Center, Omaha, NE.<br />

Neuroinflammation is known to occur in clinically significant<br />

neurodegenerative processes including Parkinson’s and Alzheimer’s<br />

disease. Moreover, prior studies of aging and CNS transcriptome expression<br />

have implicated neuroinflammation as a potential process<br />

observed in normal CNS aging. Our earlier work has shown that<br />

overexpression of immunne/defense-related gene transcripts may be<br />

associated with age-related loss of important functional behaviors.<br />

Since many of the gene trascripts showing age-related changes in expression<br />

are well-known molecules used by the immune system (e.g.<br />

complement, class I histocompatibility molecules, cytokines,<br />

chemokines), this process has been assumed to be neuroinflammatory<br />

as well. However, no studies have been performed to specifically<br />

localize these molecules in the microglia-the resident immune cell-of<br />

the aging brain. In the current study, I extracted and purified microglia<br />

from the hypothalamus and cerebellum of C57BL/6 and<br />

BALB/cBy mice in a minimally stressful manner. Using RT-qPCR, I<br />

measured and analyzed the expression of several inflammatory genes<br />

in microglia. I found that the expression of these genes remained similar<br />

between young, middle-aged, and aged mice, with a few genes<br />

even decreasing in expression. This finding suggests that even though<br />

CNS aging is characterized by increased expression of multiple immune<br />

transcripts, neuroinflammation is not the underlying etiology.<br />

A138<br />

Effects of Multimedia Fall Prevention Training in Persons with<br />

Dementia.<br />

V. Panzer, 1,2 J. Burleson, 1 F. Into, 2 H. Waite, 2 P. Atwood. 3 1.<br />

Community Medicine & Health Care, University of Connecticut<br />

Health Center, Farmington, CT; 2. Brookside Research &<br />

Development, North Salem, NY; 3. Dementia Care, Hebrew Health<br />

Care, West Hartford, CT.<br />

Supported By: University of Connecticut TRIPP Center<br />

Background: Persons with dementia (PwD) in long-term care<br />

(LTC) experience 4.05 falls/year compared to 2.33 for those without<br />

dementia. Falls are attributed to the lack of safety awareness and patient<br />

education is the most common intervention attempted by LTC<br />

nursing staff. We examined the influence of multimedia fall prevention<br />

(MFP) training on safety awareness in PwD as demonstrated by<br />

recognition of circumstances that could result in falls.<br />

Methods: Ten LTC residents (age 77-95,mean(M)=88;MMSE<br />

10-20,M=15; Katz ADL 1-4,M=2) with a history of falls were asked to<br />

identify ‘Fall Threats’ that could make someone fall in 5 video clips.<br />

Participants received 3-4 once-weekly 15 minute standardized MFP<br />

training sessions, incorporating a total of 3-5 multimedia vignettes<br />

which concerned daily activities and included common Fall Threats.<br />

In post-tests 3-5 weeks AFTER the last training session, participants<br />

were asked to identify Fall Threats in 5 novel video clips that did<br />

NOT include circumstances featured in pre-test clips OR in the training<br />

vignettes. Usual care nurses who were not involved in study procedures<br />

recorded falls per state regulations. Repeated-measures<br />

ANOVA was used to compare pre and post-test results and assess<br />

awareness. Fall records were examined for 2 month periods prior to,<br />

during (including the 3-5 week period before post-testing) and after<br />

the study.<br />

Results: Participants recognition of Fall Threats in 5 novel video<br />

clips improved dramatically, (p


P OSTER<br />

A BSTRACTS<br />

and its sum of boxes. DLB patients without Capgras were able to tolerate<br />

and continue taking cholinesterase inhibitors (p=0.03) without<br />

other significant differences in medication management.<br />

Conclusions<br />

We found that DLB-C patients had more visual hallucinations,<br />

and that caregivers of DLB-C patients endorse greater caregiver burden.<br />

We were unable to discern specific patient characteristics or psychometric<br />

performance data to help us predict who may be at greater<br />

risk of developing Capgras syndrome. Future research is needed to<br />

evaluate management and treatment options for the clinically challenging<br />

behavioral sequelae of DLB and Capgras syndrome.<br />

A140<br />

Computational Modeling of Aging in Cardiac Myocytes.<br />

P. Dalal, E. Sobie. Pharmacology and Systems Therapeutics, Mt. Sinai<br />

School of Medicine, New York, NY.<br />

Supported By: This research is supported by the Medical Student<br />

Training in Aging Research (MSTAR) at Mount Sinai School of<br />

Medicine.<br />

BACKGROUND: The risk of susceptibility to more serious<br />

forms of cardiac arrhythmia rises significantly with normal aging.<br />

These forms of arrhythmia can manifest as palpitations, fibrillation,<br />

and even sudden death. One indicator of arrhythmia risk is action potential<br />

duration in cardiac myocytes. Specifically, the prolongation of<br />

action potential leads to a larger vulnerability period towards after<br />

depolarization. Such rogue depolarization can result in dangerous,<br />

self-sustaining circular currents. Animal studies in the past have<br />

shown that age associated molecular changes in cardiac myocytes include:<br />

a 40% reduction in SERCA pump protein, a 20% reduction in<br />

the transient outward current, a 59% increase in the peak L-Type calcium<br />

channel current, and a 142% increase in the inactivation time<br />

constant of the L-Type calcium channel. Additionally, the action potential<br />

is prolonged by 92% in older rats when compared with<br />

younger rats and the calcium transient decay is slower in aged rats<br />

while its amplitude remains the same.<br />

HYPOTHESIS: Implementing the molecular changes in rat myocytes<br />

into the computational models of Hund (2004), et al and Ten<br />

Tusscher (2004), et al will prolong the action potentials and slow the<br />

calcium transient decay of these models, creating a computational<br />

tool to study age associated arrhythmia risk.<br />

RESULTS: After implementing the four major molecular<br />

changes associated with cardiac aging, the action potential was prolonged<br />

by 4% in the Hund (2004) model and by 77% in the Ten Tusscher<br />

(2004) model. The calcium transient decay was slower in both<br />

models while the calcium transient amplitude was only unchanged in<br />

the Ten Tusscher (2004) model. In the Hund (2004) model, the amplitude<br />

was increased.<br />

CONCLUSIONS: It is possible to generate a computational<br />

model that replicates the age associated changes seen in cardiac myocytes.<br />

The Ten Tusscher (2004) model more accurately replicates<br />

these changes than the Hund (2004) model.<br />

A141<br />

Isolated CNS Post-transplant Lymphoproliferative Disorder in a<br />

Kidney Transplant Recipient.<br />

S. Dahiya, W. Ooi, A. Asik. Internal Medicine/Division of Hematology<br />

and Oncology, Baystate Medical Center, Springfield, MA.<br />

Introduction<br />

Post-transplantation lymphoproliferative disorder(PTLD)is a<br />

very well recognized complication of solid organ transplantation. Its<br />

incidence varies, depending on the graft recipient’s age,the type and<br />

intensity of immunosuppression, and the organ type transplanted.<br />

Extranodal involvement is common in PTLD, although the central<br />

nervous system (CNS) is an uncommon site of disease, especially in<br />

isolation. Literature review suggests less than handful of cases in geriatric<br />

population.<br />

Case<br />

65 year old female presented with complaints of intermittent expressive<br />

aphasia. Her medical history was remarkable for polycystic<br />

kidney disease leading to kidney failure and thus requiring transplant.<br />

Her transplant history includes, failed first transplant in 1995<br />

from a deceased donor and subsequent living-related donor transplant<br />

in 2005 from her son with unrelated blood type requiring heavy<br />

immunosuppresion. She was on mycophenolate, tacrolimus and prednisone<br />

for immunosuppressive regimen. Her neurological exam was<br />

significant for word finding difficulty and left eye ptosis. Rest of the<br />

physical exam was within normal limits. A spinal tap showed slight elevation<br />

of proteins to 149mg/dl and decreased glucose to 36mg/dl,<br />

raising a question of ongoing infectious process. An urgent MRI was<br />

obtained which showed multiple discrete enhancing lesions throughout<br />

the supratentorial and infratentorial white matter with leptomeningeal<br />

involvement. An extensive infectious workup looking<br />

for various causes of enhancing lesion in this severely immunosuppressed<br />

patient was negative. A brain biopsy was eventually performed,<br />

which showed monomorphic PTLD, categorized as EBV-associated<br />

diffuse large B-cell lymphoma. Given her kidney disease, she<br />

was started on a rather unconventional regimen with weekly rituximab<br />

for 8 weeks and 4 cycles of monthly intrathecal cytarabine. Her<br />

immunosuppresive regimen was changed to sirolimus only. She has<br />

been in remission since last 1 year, but unfortunately developed allograft<br />

rejection because of reduction in immunosuppressive regimen.<br />

Discussion<br />

Isolated CNS-PTLD following kidney transplant is exceedingly<br />

rare. However, it must be considered as a differential in transplant patients<br />

with CNS symptoms to avoid delay in diagnosis. Advanced age<br />

is considered as a poor prognostic factor, but this elderly patient did<br />

rather well with the unconventional regimen as outlined above.<br />

A142<br />

Deep Vein Thrombosis and Pulmonary Embolism (DVT/PE) with<br />

JAK2 positive Polycythemia Vera (PCV) and mild hematologic<br />

findings.<br />

R. Lands, S. Kelley. Department of Medicine, University of Tennessee,<br />

Knoxville, TN.<br />

An 81-year-old man came to the emergency room after becoming<br />

suddenly short of breath while taking a shower. Any exertion<br />

after that exacerbated his dyspnea but was relieved by lying down. He<br />

did not have chest pain, pleuritic or otherwise. He had no preceding<br />

illness, immobilization or prolonged travel. He was previously<br />

healthy with a history of hypertension and gout, but he was on no<br />

meds at the time of admission. Physical examination showed him to<br />

be in no distress at rest while wearing oxygen. Lungs were without<br />

rales or rhonci and his respiratory effort was normal. There was no<br />

edema of either lower extremity. High sensitivity D-Dimer was<br />

greater than 5000 ng/ml. EKG demonstrated right heart strain. Chest<br />

x-ray demonstrated elevation of the hemidiaphragm. Creatinine was<br />

1.9 mg/dl. Ventilation perfusion scan of the lungs was interpreted as<br />

high probability for left and right lower lobe pulmonary emboli.<br />

Doppler venous studies demonstrated bilateral deep vein thromboses<br />

of the lower extremities.<br />

Hgb was 17 g/dl and Hct 53%. WBC was 32,000 without basophilia<br />

or eosinophilia. Cells containing JAK-2 V617F mutation<br />

were present. BCR/ABL was absent. Erythropoietin was 1 mIU/ml.<br />

No further imaging was performed given his marginal renal function.<br />

Review of his old records demonstrated a very mild leukocytosis and<br />

upper normal hemoglobin levels for several years prior to this admission.<br />

One month after discharge, he followed up in the hematology<br />

clinic where his WBC was 15x103 and his hemoglobin 15.8mg/dL.<br />

Discussion: JAK2 is a gain of function mutation with tyrosine kinase<br />

activity that is present in 90% of patients with PCV. While it is<br />

primarily a diagnostic marker now, there is evidence that it might<br />

S64<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

have inherent procoagulant effect by itself. Prior to this admission,<br />

our patient’s blood findings were only mildly abnormal. When he was<br />

stable and on treatment for the DVT/PE, his blood findings reverted<br />

to their previous levels. We believe this case demonstrates that even<br />

mild elevations of blood elements should be investigated to rule out a<br />

myeloproliferative syndrome in the context of thrombosis, and further<br />

molecular testing might be warranted in some patients whose<br />

blood counts are mildly, but consistently abnormal. Myeloproliferative<br />

disorders, especially those that are JAK2 positive, should be considered<br />

in the differential diagnosis of acquired hypercoagulation<br />

syndromes.<br />

A143<br />

JAK2 positive Polycythemia Vera in a patient with sleep apnea.<br />

Competing causes for erythrocytosis.<br />

R. Lands, S. Y. Bae. Department of Medicine, University of Tennessee,<br />

Knoxville, TN.<br />

In the course of having blood work in her health maintenance, a<br />

75-year-old woman was found to have an elevated hemoglobin. She<br />

was not hypertensive, but had been treated for hyperlipidemia for<br />

several years. She had a left body stroke about a year prior to the<br />

clinic visit from which there was no residual and for which she was<br />

taking aspirin. She had never smoked cigarettes. She complained of<br />

fatigue and daytime sleepiness. Her husband noted that she snored,<br />

but he had not observed apnea. She did not complain of restless legs.<br />

Oxygen saturation was 98% on room air. The tongue was of normal<br />

size. There was no abdominal organomegaly.<br />

CBC demonstrated a hemoglobin of 17mg/dL and hematocrit of<br />

50%. The white blood cell count and platelet counts were normal although<br />

the platelets were quite large. The bone marrow demonstrated<br />

panhyperplasia. Megakaryocytes were increased with prominent<br />

pleomorphism. There was no increase in reticulin. JAK-2 V617F<br />

was found to be present in a population of cells tested. BCR/ABL<br />

was absent. Erythropoietin was 31mIU/ML (4.2-27.8), and the CT abdomen<br />

demonstrated an enlarged spleen. She was placed on hydroxyurea<br />

and one phlebotomy was performed.<br />

In the interim, she reluctantly accepted a referral to a sleep specialist.<br />

Sleep studies demonstrated mild to moderate sleep apnea. She<br />

was prescribed C-PAP and quickly noted a remarkable improvement<br />

in her fatigue and in her daytime somnolence. Furthermore, her hemoglobin<br />

dropped into the low normal range, more than expected<br />

from just one phlebotomy. The hydroxyurea and the phlebotomies<br />

were discontinued. She has been compliant with her C-PAP has not<br />

required resumption of hydroxyurea or phlebotomy in one year.<br />

Discussion: With a hemoglobin greater than 16.5mg/dL and the<br />

presence of JAK2, the patient met WHO diagnostic criteria for Polycythemia<br />

Vera. The history of cerebrovascular accident and<br />

splenomegaly further support a diagnosis of the myeloproliferative<br />

syndrome. The inappropriately high normal erythropoietin level together<br />

with the rapid improvement in her hemoglobin after treatment<br />

for sleep apnea suggest that the predominate cause of her erythrocytosis<br />

at the time of diagnosis was due to her sleep apnea. Myeloproliferative<br />

syndromes may be quite subtle in their presentation and may<br />

accompany other diseases that mask and delay their diagnosis.<br />

A144<br />

Calcium Supplement May be Associated with Optimal Responses to<br />

Vitamin D Supplementation in Adults.<br />

V. Heh, 1 C. Forman, 2 J. Gau. 2 1. Office of Research and Grants, Ohio<br />

University Heritage College of Osteopathic Medicine, Athens, OH; 2.<br />

Geriatric Medicine, OU-HCOM, Athens, OH.<br />

Background: Deficiency of vitamin D is a common problem in<br />

adult patients. There are efforts in aggressively treating these patients<br />

as benefits have been shown in reducing the risk of falls and fractures.<br />

Clinical observation suggests that some patients receiving a high-dose<br />

supplement may not have achieved an optimal serum 25-hydroxy<br />

(OH) vitamin D levels with months of therapy. The objective of this<br />

study is to characterize factors that may be associated with patients’<br />

responses to vitamin D supplementation. This characterization is<br />

based on the existence of possible unobserved groups, also called latent<br />

classes.<br />

Methods: Medical records of a geriatric clinic population who<br />

had baseline and follow-up serum 25(OH)D levels during the period<br />

of January 2007 and June 2011 were reviewed. All patients received<br />

vitamin D supplements to achieve levels above 30 ng/mL. Forty-one<br />

adults receiving an average daily dose more than 3,300 IU per day.<br />

These patients were sub-divided into two groups reflecting ideal (i.e.,<br />

> 40 ng/mL; N=24) and suboptimal levels (N=17) of serum 25(OH)D<br />

on the follow-up measurements.A cut-off value of 40 ng/mL was used.<br />

Results: The two groups, ideal respondents and suboptimal respondents<br />

to high dose regimens, were similar in age, gender, weight,<br />

BMI measures, baseline 25(OH)D and serum calcium levels, average<br />

daily dose (5,500 [1,800] vs. 5,100 [1,200] IU; p=0.44), and duration of<br />

therapy (11.9 [7.3] vs. 8.6 [5.3] months; p=0.11). However, those patients<br />

who had ideal levels of follow-up 25(OH)D had significantly<br />

higher baseline serum albumin levels (mean =4.1 gm/dL, SD=0.4 vs.<br />

mean =3.7 gm/dL, SD=0.4, p=0.026); were about 6 times more likely<br />

to be on calcium supplements (12 [50%] vs. 2 [12%], p=0.018, Fisher’s<br />

exact test). The suboptimal respondents were about 3 times more<br />

likely to use oral laxatives; 9(64%) vs. 5(21%), p=0.048. After adjusting<br />

for height, weight, and use of oral laxatives, calcium supplement<br />

was associated with a better response to high dose supplementation.<br />

Limitations of this study: small sample size, unknown compliance<br />

with supplements, and not a controlled clinical trial study.<br />

CONCLUSIONS: Calcium supplement may be associated with<br />

patients’ responses to vitamin D regimens. Nutrition status and better<br />

study design will need to be included in the future study.<br />

A145 Encore Presentation<br />

Nontuberculous mycobacterial infections in elderly patients with<br />

rheumatological diseases.<br />

V. Nagaraja, 1 J. Terriquez, 2 J. Lisse, 3 S. Hoover. 2 1. Arizona Center on<br />

Aging, University of Arizona, Tucson, AZ; 2. Infectious Diseases,<br />

University of Arizona, Tucson, AZ; 3. Rheumatology, University of<br />

Arizona, Tucson, AZ.<br />

Background: Non-tuberculous mycobacterial (NTM) infections<br />

are frequently identified in elderly patients with rheumatologic disease.<br />

Management of these infections can be challenging. The aim of<br />

this study was to describe the management and outcomes of cases of<br />

NTM infections in patients with any form of rheumatologic disease.<br />

Methods: A retrospective chart review of inpatient and outpatient<br />

records was performed at two health-care facilities. ICD-9 diagnostic<br />

codes were used to identify patients with NTM infection. Patients<br />

with any pre-existent rheumatologic disease were included in<br />

the study. The review focused on rheumatologic disease, its treatment,<br />

other co-morbidities, the NTM infection and its treatment, and impact<br />

of the infection on the rheumatologic disease management.<br />

Results: Of 339 patients with NTM infection, 11 with rheumatologic<br />

disease were identified. Ten were females. The median age at the<br />

time of diagnosis of the infection was 67 years. Eight cases were pulmonary<br />

and 3 were extrapulmonary. 5/11 patients had radiologically<br />

pre-existent bronchiectasis. There were patients with rheumatoid<br />

arthritis(5), systemic lupus erythematosus(2), polymyalgia rheumatic(1),<br />

scleroderma(1), polymyositis(1) and sarcoidosis(1). Patients<br />

were on one of the following medications for a significant period of<br />

time: prednisone, methotrexate, and anti-tumor necrosis factor (TNF)<br />

agents. In 4/9 cases who were on immunosuppressive therapy, the implicated<br />

medication was discontinued. In 3/9 it was continued, and in<br />

2/9 it was restarted after a brief discontinuation. Mycobacterium<br />

avium complex was the commonest species isolated. Treatment for<br />

AGS 2012 ANNUAL MEETING<br />

S65


P OSTER<br />

A BSTRACTS<br />

NTM infection was started in 8/11 patients. 2/8 patients had recurrence<br />

of the infection. 3/11 patients died, with no death directly related<br />

to NTM infection.<br />

Conclusions: This is the first study to describe the natural history<br />

of NTM infections in an older rheumatologic disease patient cohort.<br />

As in the general population with NTM infection, patients tended to<br />

be female with pre-existing bronchiectasis. The infection could often<br />

be successfully treated, but there appeared to be some risk of recurrence<br />

in patients who are continued on immunosuppressive therapy.<br />

Such cases will likely continue to be identified and more studies on<br />

the optimal management is needed.<br />

A146<br />

Lack of Effort Towards Removal of Foley Catheters Before<br />

Transferring Patients For Rehabilitation (Rehab).<br />

M. S. Ashraf, 1 N. Sheikh, 1 V. Kinzie, 2 K. Cochran, 2 C. Faulk, 1<br />

K. Ramsey. 1,2 1. East Carolina University, Greenville, NC; 2. Pitt<br />

County Memorial Hospital, Greenville, NC.<br />

Supported By: Study was supported in part by Centers for Disease<br />

Control and Prevention<br />

Background: Geriatricians commonly admit patients who are<br />

discharged with indwelling foley catheters from the hospitals to subacute<br />

care settings, and often these foleys are no longer indicated. We<br />

designed a study to review the effort of various health care providers<br />

towards removing foleys before discharging patients for rehab.<br />

Methods: A retrospective chart review of hospital and rehab admissions<br />

was performed on all adult patients admitted with an indwelling<br />

foley to a 75 bed rehab facility over a period of 1 year (9/09 to<br />

10/10). Data analysis was primarily descriptive to obtain the frequency<br />

of appropriate documentation for presence of the foley, plan for its<br />

discontinuation, timing of its removal and demographic information.<br />

Results: Total of 114 patients (Median age 65 year, 51% Male)<br />

were admitted in the facility with indwelling foleys and 103 hospital<br />

charts were available for review. A majority (n=61) of them were discharged<br />

by surgical teams as opposed to medical teams (n=42) and all<br />

were evaluated by the rehab service. Rehab providers mentioned<br />

presence of foley in their exams only 30% of the time. Similarly surgery<br />

and medical teams recognized the presence of foleys in less than<br />

half of the cases within 2 days before the discharge (38% & 31% respectively).<br />

In many cases (n=64, 62%) rehab service did not make<br />

recommendation to remove foley during hospitalization. Interestingly,<br />

a third of these patients (n=24, 37.5%) had their foley removed<br />

within 2 days of rehab admission. Even though the rehab providers<br />

recommended removing foleys in 39 (38%) cases, the primary team<br />

did not respond. Eventually 60% (n=23) of these foleys were also removed<br />

within 2 days of rehab admission. Surgical and Medical teams<br />

provided reasons for continuing foley in their final notes in only a<br />

third of cases (34% & 33% respectively).<br />

Conclusions: 1) We have identified that health care providers<br />

frequently under-recognize the presence of foleys in patients who are<br />

being transferred for rehab. 2) When they do identify, efforts are lacking<br />

to remove it in a timely fashion. 3) There is a need for improved<br />

communication among consulting rehab service, primary inpatient<br />

teams and physicians at accepting facilities to promote timely removal<br />

of foleys which should reduce the incidence of subsequent<br />

catheter associated urinary tract infections in this patient population.<br />

A147<br />

Hyponatremia and falls in the elderly in hospital setting Neychelle<br />

Fernandes MD,Mary Musuku MD, Arnold Eiser Md,FACP.<br />

N. Fernandes. Internal Medicine, Mercy Catholic Medical<br />

Center,Drexel university, Darby, PA.<br />

Background:Falls are the most frequently reported adverse<br />

events in inpatient settings.Mild chronic hyponatremia may appear to<br />

be asymptomatic and remain unnoticed by both physician and patient<br />

but has been associated with gait unsteadiness and attention deficits<br />

in the elderly<br />

Methods: The study objective was to determine the incidence of<br />

hyponatremia in patients above 65 years who experienced a fall and<br />

associated risk factors for falls<br />

During a twelve month period from Sept 2009- Sept2010 serum<br />

sodium levels were evaluated in 60 cases of falls in patients aged<br />

65years and older and in 60 randomly selected non fall patients aged<br />

65years and older seen in acute inpatient setting. The following data<br />

were extracted for all patients: age, gender, medical morbidities, and<br />

number of medications, details of medications, serum sodium level<br />

and length of hospital stay. Initial blood chemistry on day of fall was<br />

used for evaluation of hyponatremia. Non-fall group blood chemistry<br />

on day of admission was used. Hyponatremia was classified as Serum<br />

Na level less then 136mmol/l. Fall/nonfall groups who had a glucose<br />

level on chemistry above 200 mg/dl were excluded from study. Use of<br />

medication including drugs potentially associated with hyponatremia<br />

- SSRI, diuretics, antihypertensive, benzodiazepines,psycholeptics<br />

was also analyzed in both groups.<br />

Results:Majority of fallers were female (75%) and mean age of<br />

fall and non-fall groups were 78±8 and 79±7 respectively. Hyponatremia<br />

was detected in 18 (30%) of fall group, compared to 5(18%) in<br />

nonfall group (P value 0.0004). Mean sodium level was 131±3meq/l<br />

and lowest level of serum sodium was 124meql/l in fall group. In fall<br />

group when controlling for other independent risk factors hyponatremic<br />

patients were four times more likely to fall (Pvalue0.004). .<br />

Those in the fall group had a longer length of stay and were more<br />

likely to be nursing home residents. A greater proportion of fallers<br />

had multiple medical co-morbidities (HTN, CHF, AF) and were on<br />

more likely to be on four or more medications at presentation than<br />

non-fallers.<br />

Conclusion:Hyponatremia is an independent risk factor for falls<br />

in elderly acute inpatient setting and should be added to the list of<br />

common conditions causing falls. Screening for low serum sodium<br />

level,finding the etiology and treating it when present may be a step<br />

forward to prevent falls and related injuries.<br />

A148<br />

Osteoporosis awareness in men at risk for fragility fracture and<br />

osteoporosis.<br />

S. Kashan, N. Lecea, G. Bachuwa. Hurley Medical Center, Flint, MI.<br />

Supported By: No author received funding related to this research<br />

project.<br />

Background: Osteoporosis is a major public health problem. Its<br />

hallmark is fragility fractures and increased risk of morbidity and<br />

mortality which are known to be higher in men than in women. In<br />

2001, the direct cost of osteoporosis was $17 billion for <strong>American</strong>s<br />

and $3.4 billion of which was related to the care for men. The number<br />

of men age 50 and older with osteoporosis (and osteopenia) in the US<br />

was predicted to increase from greater than 14 million in 2002, to over<br />

17 million in 2010, and to well over 20 million in 2020.<br />

Aim: Evaluate the awareness and knowledge of osteoporosis in<br />

men. Estimate the proportion of men at risk for osteoporosis who received<br />

appropriate screening. Estimate the proportion of men at high<br />

risk for osteoporosis who received appropriate Calcium and Vitamin<br />

D supplements.<br />

Method: Our participants in this study were recruited by consecutive<br />

sampling from the Hurley Medical Center Senior Ambulatory<br />

Clinic. We included only Males who are greater than or equal to 54<br />

years old. Participants were asked to fill a self-administered survey.<br />

The questionnaire included questions about demographic data, Osteoporosis<br />

awareness, diagnosis and treatment, Co-morbid medical<br />

conditions and medications list including OTC and supplements. This<br />

study was approved by the Hurley Medical Center Institutional Review<br />

Board.<br />

S66<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

Results: We distributed 250 questionnaires and 105 were returned.<br />

Ninety-seven questionnaires were included based on our inclusion<br />

criteria. On a 13-question examination, subjects with risk factors<br />

correctly answered 5.3 (40.7%) questions correctly, compared to<br />

4.1 (31.5%) by subjects without risk factors. Of subjects with risk factors,<br />

only 15% believed that they were at risk for osteoporosis. Only<br />

6% of subjects with risk factors had a Dexa scan done. Among patients<br />

with a risk factor for osteoporosis, only 27% reported taking a<br />

vitamin D or calcium supplement.<br />

Conclusion: A good proportion of participants were aware of<br />

the term osteoporosis, however many were not knowledgeable of the<br />

disease itself. Having a risk factor for osteoporosis did not increase<br />

the awareness of condition by itself. Only one fourth of patients with<br />

risk factors have been taking Vitamin D or Calcium. A very small<br />

number of patients, regardless of risk factors, had Dexa scan done.<br />

Health care provides must do more to increase awareness of this<br />

common and costly health problem.<br />

A149<br />

The Effects of Aerobic Exercise and Stretching on Self-Reported<br />

Sleep Quality in Community Dwelling Older Adults with Cognitive<br />

Complaints: A Randomized, Controlled Trial.<br />

W. Goodson, 1,2 A. Bloch, 3 W. Santos-Modesitt, 1,2 K. Yaffe, 1,2<br />

A. C. King, 4 D. E. Barnes. 1,2 1. University of California, San Francisco,<br />

San Francisco, CA; 2. San Francisco Veterans Affairs Medical Center,<br />

San Francisco, CA; 3. Alliant University, San Francisco, CA; 4.<br />

Stanford University, Palo Alto, CA.<br />

Supported By: This work was supported by the Alzheimer’s<br />

Association (IIRG-06-27306), the National Institutes of Health<br />

(K01-AG024069, KL2 RR024130), and an AFAR MSTAR Summer<br />

Research Stipend.<br />

Background: Sleeping difficulties are common in older adults<br />

and are linked to poor health outcomes. Sedative use in older adults is<br />

problematic because sedatives have been linked to an increase in<br />

falls. There is an imperative for identifying effective, non-pharmacological<br />

strategies for improving sleep in older adults. Exercise is an<br />

appealing intervention because it is relatively low cost, does not require<br />

a health professional and has potential health benefits beyond<br />

sleep improvement. Few studies have directly compared aerobic exercise<br />

and stretching effects on self-reported sleep quality in older<br />

adults with cognitive complaints.<br />

Methods: Participants were randomized into aerobic exercise<br />

(n=63) and stretching groups (n=63) and completed 12-week interventions.<br />

The primary outcome was a total sleep quality score derived<br />

from 7 questions on the Sleep Disorders Questionnaire of the 2005-<br />

2006 NHANES (Range: 0-28 with higher scores reflecting worse<br />

sleep quality). Baseline characteristics of study participants were assessed<br />

using analysis of variance, chi-square analysis, and Fisher<br />

Exact Tests. Analyses of sleep quality change within groups and between<br />

groups were conducted intent-to-treat and per protocol analyses,<br />

which yielded similar results. Nearly half of participants did not<br />

report any sleep problems at baseline and, therefore, could not improve.<br />

As such, all analyses were repeated in the subgroup that reported<br />

at least some sleep difficulties at baseline.<br />

Results: Sleep quality did not change significantly within or between<br />

the groups when the entire participant population was considered<br />

(n=126). In the subgroup of participants who reported sleep<br />

problems at baseline (n=72), there was a significant different between<br />

the groups (p=.02) in which sleep quality improved within the stretching<br />

group (12.0 to 8.8, p


P OSTER<br />

A BSTRACTS<br />

death because “nobody told me”. Retrospectively, some families suspected<br />

that the healthcare providers knew death was approaching because<br />

the older adult was moved to the comfort care hospital room or<br />

the palliative care team was brought in, but the rationale for the action<br />

was never disclosed or conferred to the family up front. In some<br />

cases, family members knew death was approaching without being<br />

told and sought out healthcare providers to arrange end-of-life care.<br />

Providers who may or may not be perceptive to approaching death<br />

either disagreed with the family and resisted, or agreed and facilitated<br />

arrangements. In addition, there were inconsistent messages regarding<br />

the end-of-life stage of life by providers.<br />

Conclusions: From family’s perspective, healthcare providers do<br />

not openly communicate about approaching death, do not provide<br />

enough explanation how current condition may lead to death, and<br />

there are variations in healthcare providers’ readiness to communicate<br />

about end of life with patient and families.<br />

A152<br />

Adjustment to Aging: A Validation for Adjustment to Aging<br />

Schedule (ATAS-33).<br />

S. von Humboldt, I. Leal. Research Unit in Psychology and Health,<br />

Instituto Superior Psicologia Aplicada, Lisbon, Lisbon, Portugal.<br />

Supported By: This work was supported by a grant of the<br />

Portuguese Science and Technology Foundation (FCT) [grant number<br />

SFRH/BD/44544/2008].<br />

Background: There has been little attention in the research literature<br />

on adjustment to aging. This research aims at examining the relationships<br />

between older adults’ adjustment and aging.<br />

Methods: The measures used to in the study were selected to assess<br />

the reliability and validity of one new instrument, Adjustment to<br />

Aging Schedule (ATAS-33). Measures were completed using a variety<br />

of culturally appropriate methods, including mail-outs, self-administration<br />

and interviews. For the purposes of this study, the Health<br />

Survey Questionnaire (SF-6D), one measure of cognitive functioning<br />

- the Mini-Mental State Examination (MMSE) and demographics,<br />

were included. All variables had fewer than 1% missing values and<br />

there complete data were available for 709 older adults (mean age<br />

82.4, SD = 6.45, (range 74-102)) from eight different nationalities. Exploratory<br />

factor analyses were run for data reduction and for exploring<br />

theoretical structure. Controlling for age, gender and country of<br />

origin, we assessed the level of adjustment of elderly people, and its<br />

effect on aging.<br />

Results: The sampling adequacy was confirmed by the Kaiser-<br />

Meyer-Olkin test (KMO=0.775) and the total variance explained by<br />

this eight-factor structure is 75.09%. Adjustment to aging appears to<br />

be a catalyst to attitudinal markers of maturity and internal development<br />

which in turn impact quality of life and aging, across cultures.<br />

All estimates were statistically significant (p


P OSTER<br />

A BSTRACTS<br />

A155<br />

Intensity and Impact of Pain in Military Veterans Following Cancer<br />

Treatment.<br />

W. L. Mills, 1,2 A. June, 3 J. Moye, 3 B. Mulligan, 3 A. Jahn, 3 K. King, 3<br />

J. Gosian, 3 L. Herman, 1,2 A. Walder, 1 A. D. Naik. 1,2 1. Health Services<br />

Research & Development Center of Excellence, Michael E. DeBakey<br />

VA Medical Center, Houston, TX; 2. Baylor College of Medicine,<br />

Houston, TX; 3. VA Boston Healthcare System, Brockton, MA.<br />

Supported By: Veterans Administration, Rehabilitation Research<br />

and Development IIR Grant VA I01 RX000104<br />

Background: According to the National Cancer Institute, more<br />

than 60% of individuals with a cancer diagnosis will survive beyond 5<br />

years, extending the time survivors must contend with cancer-related<br />

complications and treatment, including pain. Poorly controlled pain<br />

can negatively impact quality of life, increasing depression, anxiety,<br />

and sleep disturbance. The purpose of this study was to improve care<br />

provided to cancer survivors through increasing knowledge of the intensity<br />

and impact of pain experienced in the post-treatment period.<br />

Methods: Participants for this study were 120 adults (M age =<br />

65) included in the Veterans Cancer Rehabilitation Study, which assesses<br />

psychological and rehabilitation needs 6 and 12 months after<br />

diagnosis of oral-digestive cancers. The participants, mostly white<br />

(81%) and male (100%), were treated for head and neck cancers<br />

(44%), esophageal (11%), stomach (3%), and colorectal (42%) cancers.<br />

From the larger battery, the current study examines outcomes<br />

from the Patient Reported outcomes Measurement Information System-29,<br />

a self-report measure of quality of life and pain intensity.<br />

Results: At 6 months, 22% of participants reported no pain, 39%<br />

reported mild pain, 31% reported moderate pain, and 8% reported<br />

severe pain. Survivors of stomach cancer reported higher levels of<br />

pain (M=6.0) compared to head and neck (M=3.9), esophageal<br />

(M=4.0), and colorectal (M=3.0) cancers, with differences approaching<br />

statistical significance (p=.07). Participants endorsed interference<br />

from pain, including daily activities (56%), work around the home<br />

(52%), enjoyment of life (51%), and social activities (46%). Intensity<br />

of pain was related to (all p values


P OSTER<br />

A BSTRACTS<br />

A158<br />

Curved Path Walking Predicts 12-Month Physical Function in Older<br />

Adults without Mobility Limited Physical Function.<br />

R. M. Hibbs, 1 J. M. VanSwearingen, 1 S. A. Studenski, 2 J. S. Brach. 1 1.<br />

Physical Therapy, University of Pittsburgh, Pittsburgh, PA; 2.<br />

Geriatric Medicine, University of Pittsburgh, Pittsburgh, PA.<br />

Supported By: Research/Grant Support: Pittsburgh Older<br />

<strong>American</strong>’s Independence Center, 1 P30 AG024827; Pitt Clinical<br />

Research Training- <strong>Geriatrics</strong>/Gerontology T32 AG021885; K23<br />

AG026766<br />

Background: Daily activities involve walking curves to navigate<br />

and participate in the environment, particularly among older adults<br />

who function within their home and community. We examined the<br />

usefulness of measures of curved path and straight path walking to<br />

predict future physical function in community-dwelling older adults<br />

without mobility limited physical function.<br />

Methods: Older adults (n=73, mean age, 77.1±6.0 years) independent<br />

in ambulation and without mobility limited physical function<br />

(Late Life Function and Disability Instrument, LLFDI, function ><br />

mobility limited mean, 48.2) performed curved path walking (Figure<br />

of 8 Walk test, time) and straight path walking (gait speed) at baseline.<br />

Self-reported physical function, (LLFDI function, 0-100) was<br />

recorded at baseline and 12 months. Receiver Operator Characteristic<br />

curves were used to determine a cutoff value that optimized sensitivity,<br />

specificity, and area under the curve (AUC) of the Figure of 8<br />

Walk test time and gait speed for good physical function (LLFDI<br />

function > non-mobility limited mean, 59.8) one year later.<br />

Results: Curved path and straight path walking predicted physical<br />

function at 12 months. Figure of 8 Walk time at an optimal cutoff<br />

of 8.72s, sensitivity, 65.8%, specificity, 65.2%, and AUC=.704, p=.008<br />

predicted LLFDI functioning. Gait speed at an optimal cutoff of<br />

1.12m/s, sensitivity, 65.8%, specificity, 56.5%, and AUC=.667, p=.030<br />

predicted LLFDI functioning.<br />

Conclusion: Curved path walking was a little better than gait<br />

speed in identifying individuals who did not have good physical function<br />

one year later among older adults without mobility limited physical<br />

function. Curved compared to straight path walking may better<br />

represent the complexity of walking in daily life characteristic of activities<br />

of well functioning, community-dwelling older adults.<br />

A159<br />

Dementia, Delirium, and Capacity to Consent to Research among<br />

Older Post-acute Care Recipients.<br />

S. E. Hardy, S. A. Studenski. Medicine/<strong>Geriatrics</strong>, University of<br />

Pittsburgh, Pittsburgh, PA.<br />

Supported By: NIA, Hartford Foundation<br />

Background: Dementia and delirium present particular challenges<br />

for research in post-acute care (PAC). We examine the relationship<br />

between cognitive function, delirium, and the capacity to<br />

consent to participation in an observational study of older adults<br />

newly admitted to skilled nursing facilities for PAC.<br />

Methods: We assessed capacity to consent with a 5-item instrument<br />

measuring understanding of the study procedures, risks, and<br />

benefits; cognitive function with the Montreal Cognitive Assessment<br />

(MoCA), delirium with the CAM. Among those with significant cognitive<br />

impairment, we assessed pre-hospital cognition via proxy using<br />

the IQCODE. ADL function was assessed on a scale of 0-14 with<br />

higher scores representing greater impairment and depressive symptoms<br />

were assessed with the PHQ-9.<br />

Results: Of the 179 participants assessed for capacity, 138 (77%)<br />

were deemed able to provide consent to participate. Of those able to<br />

consent, 1 declined to consent, 8 were ineligible to participate (for<br />

reasons unrelated to cognition), and 8 withdrew prior to the baseline<br />

assessment. Of the 41 without capacity, 8 were excluded because no<br />

surrogate was available and 2 because the surrogate declined to consent,<br />

2 were ineligible, and 1 withdrew prior to baseline assessment.<br />

The characteristics of the remaining 149 participants by capacity to<br />

consent are presented in the table. Regardless of capacity to consent,<br />

the 51 participants with significant cognitive impairment (MoCA


P OSTER<br />

A BSTRACTS<br />

A161<br />

Discharge to subacute rehabilitation as a predictor of 30 day<br />

readmission in elderly patients with acute decompensated heart<br />

failure.<br />

W. Qureshi, 1 F. Khalid, 1 Z. Alirhayim, 1 M. Al-Mallah. 2,3 1. Internal<br />

Medicine, Henry Ford Health Systems, Detroit, MI; 2. Department of<br />

Cardiology, King Abdul-Aziz Hospital, Riyadh, Saudi Arabia; 3.<br />

Wayne State University, Detroit, MI.<br />

Background: Acute decompensated heart failure is the admission<br />

diagnosis in 1/10th of all the hospitalization in US. Many of these<br />

patients may be discharged to rehabilitation centers or home with<br />

physical therapy. It is not known if the patient’s discharge disposition<br />

is a predictor for 30 - day readmission. The aim of the study was to determine<br />

if there was a difference in readmissions in patients discharged<br />

to home with physical therapy compared to subacute rehabilitation<br />

center.<br />

Methods: This is a single-center retrospective parallel group cohort<br />

study. Chart reviews of all the patients from 2009 - 2010 with primary<br />

DRG of acute decompensated heart failure was carried out.<br />

Primary outcome was 30-day all cause readmission. Secondary outcome<br />

was 1-year mortality. The baseline characteristic differences<br />

were evaluated by chi-square test and t-test. Logistic regression was<br />

used to adjust for baseline variables hypertension, diabetes, dysplipidemia,<br />

presence of coronary artery disease, age, gender to predict the<br />

binary outcome as readmission versus no readmission based on the<br />

discharge disposition.<br />

Results<br />

Out of 1543 total admissions, 542 were discharged to either<br />

home with home physical therapy or subacute rehabilitation center.<br />

The mean age was 75.3 +/- 7.0 years and females were 61%. Out of<br />

these, 324 (59.8%) were discharged to subacute rehabilitation center<br />

and ischemic cardiomyopathy was present in 335 (61.8%) of the patients.<br />

There were 256 (47%) 30 day readmissions to the hospital.<br />

About 66 (12.2%) of the patients died within 1 - year. Discharge to<br />

subacute rehabilitation was associated with higher readmission rates<br />

(adjusted OR 1.84; 95% CI, 1.19 – 2.83) p = 0.005 while, there was no<br />

difference in the secondary outcomes. There was no significant difference<br />

in the all-cause mortality (adjusted OR 1.56; 95% CI, 0.84 – 2.9)<br />

p = 0.16.<br />

Conclusion<br />

This study shows that even after adjustment for baseline characteristics,<br />

discharge to subacute rehabilitation was a weak but independent<br />

predictor of 30 – day readmission. This might be because of<br />

early detection of an exacerbation of acute decompensated heart failure<br />

at subacute rehabilitation center as compared to at home; however<br />

there was no significant association of mortality with the discharge<br />

disposition.<br />

A162 Encore Presentation<br />

Fighting the weekend trend: increased mortality in older adult TBI<br />

patients admitted on weekends.<br />

S. A. Hirani, 1,2 E. B. Schneider, 2 H. L. Hambridge, 2 E. R. Haut, 2<br />

A. R. Carlini, 2 R. C. Castillo, 2 D. T. Efron, 2 A. H. Haider. 2 1.<br />

University of Texas Southwestern Medical School, Dallas, TX; 2.<br />

Surgery, Johns Hopkins School of Medicine, Baltimore, MD.<br />

Background: Weekend admission is associated with mortality in<br />

cardiovascular emergencies and stroke. We sought to determine<br />

whether weekend vs. weekday differences exist for older adults with<br />

substantial head trauma.<br />

Methods: Data from the 2006-2008 Nationwide Inpatient Sample<br />

were combined and head trauma admissions were isolated. Abbreviated<br />

Injury Scale (AIS) scores were calculated for using ID-<br />

CMAP. Individuals aged 65 to 89 years with head AIS = 3 or 4 and no<br />

other region score > 3 were included. Individuals with missing mortality,<br />

gender or insurance data were excluded. Wilcoxon rank sum<br />

and Student t-tests compared LOS, demographic, and total charge<br />

data. Chi-square tests compared gender and head injury severity. Logistic<br />

regression modeled mortality adjusting for age, gender, injury<br />

severity, comorbidity and insurance status.<br />

Results: Of the 39,728 patients meeting criteria, 10,189 (25.6%)<br />

were admitted on weekends. Mean age was similar but more weekend<br />

admissions were female (51.5% vs. 50.0%, p = 0.011). Weekend<br />

patients demonstrated slightly lower comorbidity (mean Charlson =<br />

1.09 vs. 1.15, p < 0.001) and head injury severity (58.5% vs. 60.9%<br />

AIS=4, p < 0.001). Median weekend LOS was shorter (4 vs. 5 days, p <<br />

0.001), but total charges did not differ. Proportional mortality was<br />

higher among weekend patients (9.4% vs. 8.4%, p = 0.001). After adjustment,<br />

weekend patients demonstrated 17% increased odds of<br />

mortality (O.R. 1.17, 95% CI: 1.08-1.26).<br />

Conclusions: Older adults with traumatic brain injury admitted<br />

on weekends are less severely injured, carry less comorbidity and<br />

generate similar total charges compared to those admitted weekdays.<br />

However, weekend patients demonstrated 17% greater odds of<br />

mortality.<br />

A163<br />

Postoperative Cognitive Complications in the Elderly: Risks and<br />

Outcomes.<br />

S. J. Agarwal, M. G. Erslon, S. D. Kelley. Covidien, Mansfield, MA.<br />

Supported By: Covidien<br />

Background: Cognitive complications occur in elderly patients<br />

following surgery. The burden of postoperative cognitive complications<br />

(POCC) is difficult to assess due to differences in determining<br />

and documenting POCC. We utilized a large administrative database<br />

to assess the incidence, risk factors and patient outcomes associated<br />

with POCC in elderly patients across the top 5 major diagnostic categories<br />

(MDC).<br />

Methods: Inpatient surgical discharges in the top five MDCs for<br />

patients older than 50 years from the Premier Perspective® Database<br />

(Premier, Inc.) for CY2010 were selected. POCC was identified by<br />

ICD9 codes 780.09 and 293.0. We determined incidence and used<br />

multivariate logistic regression to estimate the adjusted risk of POCC<br />

based on age (reference: 50-64 years old), admitting status, general<br />

anesthesia (GA), ICU stay, comorbidity and MDC type (reference:<br />

circulatory system surgeries). We compared mortality, length of stay<br />

(LOS), costs and discharge disposition between patients with and<br />

without POCC.<br />

Results: 576821 discharges were selected, and 6553 (1.1%) were<br />

coded for POCC. The risk of POCC increased with age (85+ years:<br />

311% increased risk), ICU stay (183% increased risk), non-elective<br />

admission (94%), and GA (19%). Compared to circulatory system<br />

surgeries, other surgeries increased risk of POCC: musculoskeletal<br />

(158% increase), digestive system (86%), nervous system (48%) and<br />

hepatobiliary/pancreatic (46%). Patients with POCC had increased<br />

inpatient resource utilization and compromised outcomes (Table 1).<br />

Conclusion: Although the incidence of POCC based upon ICD9<br />

coding was limited, the reported cases were associated with significantly<br />

increased inpatient mortality, facility discharge, LOS and costs<br />

AGS 2012 ANNUAL MEETING<br />

S71


P OSTER<br />

A BSTRACTS<br />

compared to patients without POCC. Age, emergency admissions,<br />

ICU stay and GA independently increased risk for POCC. Large administrative<br />

databases and coded definitions of POCC should facilitate<br />

studies to determine whether preventing or managing POCC in<br />

elderly surgical patients improves outcomes.<br />

Table1: Outcomes for patients with and without POCC<br />

All comparisons are significant at p < 0.001<br />

A164<br />

Can a simple frailty score predict outcomes in elderly patients<br />

undergoing cardiac surgery?<br />

S. Kim, 1 J. Chikwe, 2 L. Croft. 1 1. Cardiology, Mount Sinai School of<br />

Medicine, New York, NY; 2. Cardiothoracic surgery, Mount Sinai<br />

School of Medicine, New York, NY.<br />

Supported By: MSTAR<br />

Elderly patients tend to have more postoperative complications<br />

and longer lengths of stay following cardiac surgery.They also display<br />

a range of biological statuses that varies from robust to frail, which<br />

makes predicting their surgical outcomes difficult. Frailty is an emerging<br />

concept in geriatrics that can account for a patient’s physiological<br />

reserve, and therefore useful in predicting outcome following cardiac<br />

surgery. As such, the two objectives that were investigated include:<br />

1. Are there easily assessable preoperative variables that can<br />

measure frailty in elderly patients undergoing cardiac surgery?<br />

2. Can such variables be used to predict clinical outcomes in elderly<br />

patients following cardiac surgery?<br />

Data was collected from the New York State Cardiac Surgery<br />

Database and EPIC/EDR for patients ≥ 70 years. Categories of preoperative<br />

variables collected to determine frailty included nutritional<br />

status, functional status, mental status, and social support status. An<br />

unweighted frailty score was calculated with these variables, and patients<br />

with a score ≥ 3 determined as frail. Univariate and multivariate<br />

logistic regression models were used to determine independent<br />

predictors of the major outcomes (Early postoperative mortality &<br />

morbidity; Prolonged length of stay; Discharge to institution). Statistical<br />

analysis was performed using IBM SPSS Statistics for Mac 19.0.<br />

The frailty score was significantly related to whether or not patients<br />

were institutionalized following cardiac surgery (P=.003). Although<br />

the frailty score did not predict any major outcomes, individual<br />

variables used to calculate frailty did predict them. Impaired<br />

mental status significantly predicted early postoperative morbidity &<br />

mortality (OR=8.5, 95% CI: 1.2-58.2), while being dependent in activities<br />

of daily living significantly predicted receiving institutionalized<br />

care (OR=3.2; 95% CI: 1.3-8.1).<br />

The unweighted frailty score by itself does not predict any major<br />

outcomes, but individual variables like impaired pre-operative mental<br />

state and lower Katz index do predict them. These can be used to<br />

identify at risk frail patients early, for whom providers of surgical care<br />

may intervene more aggressively to prevent poor clinical outcomes.<br />

A165<br />

Functional capacity as possible predictor of outcome in older<br />

patients who are undergoing surgery for urological malignancies.<br />

S. Sun, 1,2 V. Shklar, 1 H. Yulico, 1 B. Korc-Grodzicki . 1,2 1. Medicine,<br />

MSKCC, New York, NY; 2. Medicine, Weill Cornell Medical College,<br />

New York, NY.<br />

Background<br />

Urological cancers are disease of the older persons and many<br />

geriatric patients undergo major urological surgeries to achieve curative<br />

treatment. In order to understand their unique physiologic vulnerabilities,<br />

it has become very important to recognize the factors<br />

which lead to poor outcomes in these geriatric patients. Previously,<br />

pre-existing cognitive dysfunction has been shown to predict delirium<br />

and markers of frailty have been shown to predict 6 month mortality.<br />

Method:<br />

This is a retrospective review of patients who are 75 years of age<br />

or older in whom geriatric specific assessment has been performed<br />

prior to major urological cancer surgery in a tertiary cancer center.<br />

Geriatric preoperative assessments were performed by 4 geriatricians<br />

over the course of one year (January 1, 2010 to Decmber 31, 2010).<br />

The evaluation included, independence in basic activities of daily living(ADLs)<br />

and instrumental ADLs(iADLs), Charlson comorbidity<br />

index, albumin, Mini-Cog test, Hb, and falls within last 6 months. Outcome<br />

measures included presence of postoperative delirium, 30 day<br />

and 90 day postoperative mortality.<br />

Results:<br />

Forty seven patients(age 78.3±3.4) underwent geriatric preoperative<br />

assessment prior to major urological surgeries. Fourteen patients(30%)<br />

were female and 41 patients(87%) identified themselves<br />

as caucasians. Twenty six patients (55%) were identified as having<br />

bladder cancer or urothelial carcinoma. Thirty day mortality was 0%<br />

and 6 month mortality was 4.3% (2/47). Fifteen percent(7/47) of the<br />

patients developed delirium postoperatively. Of those seven, 1 patient<br />

died within 90 days of the surgery and both of the 6 month mortality<br />

cases had delirium postoperatively. Three out of 7 patients who<br />

developed delirium were dependent on ADLs or iADLs. More than<br />

91% of the patients who did not develop delirium were independent<br />

of ADLs and iADLs. There were no difference in Hemoglobin level,<br />

albumin level, and Charlson comorbidity index score between the<br />

two groups of patients who developed delirium and who did not. History<br />

of falls and Mini-cog test did not seem to be associated with postoperative<br />

delirium.<br />

Conclusions:<br />

Dependency in basic and/or instrumental activities of daily living<br />

seems to be a candidate for predictor of postoperative delirium.<br />

Patients who developed delirium had greater risk of dying within 6<br />

months of surgery.<br />

A166<br />

Relationship between age and incidence of chronic pain developing<br />

after cardiothoracic surgery.<br />

A. Raju, 1 M. Eckmann, 1,2 M. B. Little. 1,2 1. The University of Texas<br />

Health Science Center San Antonio, San Antonio, TX; 2. University<br />

Health System, San Antonio, TX.<br />

Supported By: AFAR- MSTAR Program<br />

Background:<br />

The effect of age on the development of chronic pain has been<br />

considered, but these studies have been on a limited population. In<br />

addition, studies have indicated that the occurrence of other outcomes<br />

such as depression/anxiety, neurological/cognitive problems,<br />

and sleep disturbances increase post-CT surgery, but these outcomes<br />

have not been quantified, nor have they been analyzed by age. Most<br />

of the existing studies have been in the form of patient questionnaires.<br />

Objective:<br />

To determine if age affects the incidence of post-surgery outcomes<br />

such as chronic pain, depression/anxiety, neurological problems,<br />

and sleep disturbances.<br />

Methods:<br />

A retrospective medical record review at University Health System,<br />

San Antonio was performed for CT surgery patients between<br />

5/15/2006 to 5/15/2009 (n= 412). Post surgery medical records were<br />

analyzed to determine if the patient developed any outcomes of interest<br />

and the date of onset. A Fisher test with a 2x2 contingency table<br />

using p < 0.05 as significant was used to analyze results.<br />

Results:<br />

S72<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

The incidence of the high occurrence outcomes were chronic<br />

pain (22.3%), neurological problems (20.4%), and depression/anxiety<br />

(14.1%). Patients above 60 years of age had significantly lower incidence<br />

of chronic pain (p = 0.0129), depression/anxiety (p = 0.0017),<br />

and neurological problems (p = 0.015).<br />

Conclusions:<br />

Patients above 60 years of age had lower incidences of all outcomes,<br />

possibly because of their retired lifestyle being less stressful<br />

and less physically demanding. Another contributing factor is older<br />

patients having more severe health problems such that these outcomes<br />

go unrecognized. In addition, cultural differences between<br />

generations may mean that the older generation is more tolerant of<br />

pain and less likely to seek care for these symptoms.<br />

Presidential Poster Session B<br />

Thursday, May 3<br />

4:30 pm – 6:00 pm<br />

B1<br />

Are osteosarcopenia, sarcopenia and osteoporosis different<br />

syndromes? Results from the Women’s Health and Aging Study<br />

(WHAS) II.<br />

A. Frisoli, 1,2 A. Diniz, 1 J. Diniz, 1 S. Inghan, 1 P. Chaves. 2 1. Cardiology<br />

Division, Federal University of São Paulo, Sao Paulo, Brazil; 2. Center<br />

on Aging and Health, Johns Hopkins University, Baltimore, MD.<br />

Substantial heterogeneity is observed among sarcopenic and osteoporotic<br />

patients, however, the concomitant occurrence of these<br />

two syndromes has not been evaluated. The goal of this study was to<br />

examine the body composition and muscle strength profile among osteoporosis,<br />

sarcopenia and osteosarcopenia in community-dwelling<br />

older women.<br />

Methods: Cross-sectional analysis of data from WHAS 2, an observational<br />

study of the epidemiology of disability onset in community-dwelling<br />

older women, Baltimore, USA. The analytic sample for<br />

this study included all women who underwent DEXA evaluation and<br />

had available data on fat, muscle and bone mass (n=248). Osteoporosis<br />

was defined as a bone mineral density (BMD) t-score


P OSTER<br />

A BSTRACTS<br />

Methods: We are conducting a 6-week, randomized, 3-arm clinical<br />

trial to compare the efficacy of 2 tailored, multi-component exercise<br />

programs for improving physical performance of older PCa patients<br />

on ADT. Men, aged 70 and older, were randomly assigned to<br />

either an established progressive resistance and walking program<br />

(EXCAP), a similar home-based computer-generated exercise program<br />

utilizing Nintendo’s Wii-Fit technology (Wii), or a usual care<br />

arm (UC). Assessments were completed at baseline and post-intervention.<br />

Primary outcome was a comparison of change scores on the<br />

Short Physical Performance Battery (SPPB) (0-12). Secondary outcomes<br />

were comparisons of changes in lean muscle mass (DEXA),<br />

chest press repetition maximum (CPRM), handgrip strength (HG),<br />

and total body weigh (TBW). T-tests were used to compare change<br />

scores between arms.<br />

Results: Sixteen (of 30 projected) men have completed post-intervention<br />

assessments (7 in Wii, 4 in EXCAP, and 5 in UC). The<br />

mean age of participants at enrollment was 76.9 years (70-87) and<br />

mean SPPB score was 7.6 (4-11). Mean duration of ADT was 57<br />

months. Mean SPPB scores improved by 1.25 in Wii vs UC (p=0.054),<br />

while mean scores improved by 1.33 in Wii vs EXCAP (p=0.061).<br />

There was no significant difference in change of scores between<br />

EXCAP and UC (p=0.903). Mean total body weight decreased by 4<br />

kg in Wii vs UC (p=0.092) and mean handgrip strength increased by<br />

4.37 kg in Wii vs UC (p=0.0274), and mean CPRM increased by 12.9<br />

reps in Wii vs UC (p=0.092). Lean muscle mass improved by 820<br />

grams in Wii compared to UC, although this was not statistically significant<br />

(p=0.42).<br />

Conclusions: Change scores were improved in all measures for<br />

Wii arm, while there were no changes in UC arm. This pilot study<br />

demonstrates the potential of Wii Fit technology to improve physical<br />

performance in older men on ADT over 6 weeks.<br />

B4<br />

REDD in the elderly.<br />

A. Chakka, A. Garrido, T. Iloabuchi, F. Perez. <strong>Geriatrics</strong>, Indiana<br />

University, Indianapolis, IN.<br />

81 y/o AAF with h/o Dementia, HTN, Gout, Hypothyroidism,<br />

DVT s/p IVC filter and GI bleed was admitted for decreased PO intake<br />

and weakness. She had B/L leg pain and progressive edema. Patient<br />

was only on Levothyroxine as all her medications were stopped<br />

for drug induced hepatitis. On exam- lethargy; Tmax-39.4’ C, BP-<br />

76/40, HR-94. Oral mucous membrane hyperemia; RS- clear; CVS-<br />

RRR; ABD- soft, BS+; CNS- confusion; BLE- 2+ edema; Skin- diffuse<br />

macular erythema. Labs: Wbc- 11.5, Eos- 15, Pl.let- 29, BUN/Cr-<br />

25/1.39 (baseline cr- 0.49), UC+ staph.aureus, BC+ MSSA. TEE, CT<br />

chest/abdomen, and vasculitis work up were negative. Patient was admitted<br />

to ICU with sepsis and treated with cephazolin for 3 weeks.<br />

Patient was stable in a week, erythema resolved but a week later developed<br />

generalized desquamation involving palms and soles with<br />

itching, which resolved in 2 weeks. Ten days later she was re-admitted<br />

for abdominal pain, hypotension and hypothermia. She had a similar<br />

clinical picture associated with myositis and the same diffuse erythema<br />

followed by diffuse desquamation, which continued over 4<br />

weeks till she was discharged.<br />

DISCUSSION:<br />

The Differential Diagnosis consisted of Staphylococcal Toxic<br />

shock syndrome (TSS), Stevens - Johnson syndrome, Toxic Epidermal<br />

Necrolysis, Kawasaki disease, Mercury Poisoning and Syphilis. Patient<br />

was diagnosed with a TSS variant, recalcitrant erythematous<br />

desquamating disorder (REDD)[1]. It is a toxin-mediated illness[2],<br />

usually precipitated by infection with Staphylococcus aureus. REDD<br />

is a presumed variant of TSS and is distinguished from classic TSS by<br />

its subacute presentation and recalcitrant course. Although the majority<br />

of patients described to date have had acquired immunodeficiency<br />

syndrome (AIDS), some cases without AIDS have been reported.<br />

Our patient did not have any risk factors for HIV. The<br />

diagnostic criteria met by our case are: Temp > 38.9 ‘C, SBP < 90<br />

mmHg, Diffuse macular erythema with subsequent desquamation involving<br />

palms and soles and multiorgan involvement. To our knowledge<br />

this is the first case report of REDD in an elderly patient.<br />

REFERENCES:<br />

1. Verbon, A. and C.J. Fisher, Jr., Severe recalcitrant erythematous<br />

desquamating disorder associated with fatal recurrent toxic<br />

shock syndrome in a patient without AIDS. Clin Infect Dis, 1997.<br />

24(6): p. 1274-5.<br />

2. Manders, S.M.,Toxin-mediated streptococcal and staphylococcal<br />

disease. J Am Acad Dermatol, 1998. 39(3): p. 383-98; quiz 399-400.<br />

B5<br />

Fever of Unknown Origin in women with osteoporosis.<br />

B. Peddagovindu, E. Oleson, C. DuBeau. <strong>Geriatrics</strong>, UMass Med<br />

School, Worcester, MA.<br />

Introduction:<br />

Recognition of atypical presentation of disease and prescribing<br />

cascades from adverse drug effects (ADEs) are tenets of geriatric<br />

care. We present 2 cases of an ADE and the costly investigative cascade<br />

that followed it due to non-recognition of the uncommon pattern<br />

of the ADE.<br />

Case 1:<br />

A 63yo woman with osteoporosis, hypertension, diabetes,<br />

COPD, pneumonitis and anxiety who was a poor historian was hospitalized<br />

due to fever 101.3, malaise, myalgia, nausea/vomiting, cough<br />

and dyspnea of one-day duration. Initial work up for infectious<br />

causes was negative. She received zoledronic acid (ZA) for treatment<br />

of osteoporosis 2 days prior, but it was not on her medication list and<br />

not discovered until 5 days into her stay. She continued to have fevers<br />

spikes to 101F and dyspnea. Empiric antibiotics for pneumonia were<br />

given for 5 days and repeat fever work up was negative. She was discharged<br />

after 1 week with diagnosis of fever from ZA ADE upon exclusion<br />

of other causes.<br />

Case 2:<br />

A 71yo woman with history of non-hodgkin’s lymphoma, cirrhosis,<br />

anxiety, osteoporosis, and nephrolithiasis was hospitalized due to<br />

fever 101F, and nausea/vomiting 1 day after ZA infusion and discharged<br />

in 24h after symptom control and negative infectious work<br />

up. She then developed a rash on her neck thought to be shingles and<br />

was given valcyclovir. She was seen by ID and given doxycycline for<br />

suspected tick borne illness. Due to daily fevers to 101F and worsening<br />

cough she was readmitted 12 days after original d/c. Per ID and<br />

oncology, pertussis titers, serology for tick-borne illnesses and CT<br />

chest/abdomen/pelvis for possible lymphoma recurrence done were<br />

negative. After 20 days, diagnosis of exclusion of fever from ZA was<br />

made. Total duration of fever was more than 20 days.<br />

Discussion:<br />

Fever is the most common ADE of ZA, likely from an increase<br />

in TNF-a and IL-6. In cases presented, patients had extended hospital<br />

stays and costly work ups because 1) ZA use was initially missed, and<br />

2) duration of fever > 72 hrs (usual for this ADE), “atypical presentation”<br />

of ZA ADEs, was not recognized. ZA fever may last 14+ days<br />

with rash and cough. These cases demonstrate the need to keep ZA<br />

on active med lists, understanding and informing patients about ZA<br />

ADEs, and using careful follow-up rather than costly evaluations for<br />

even prolonged fever after ZA. Prevention with acetaminophen or<br />

ibuprofen following ZA infusion can decrease this common ADE.<br />

B6<br />

81 year old man hospitalized with hypercalcemia - of course its<br />

cancer!<br />

C. Hathaway, D. Bynum. Division of Geriatric Medicine and Center<br />

for Aging and Health, University of North Carolina, Chapel Hill, NC.<br />

Supported By: University of North Carolina Division of Geriatric<br />

Medicine and Center for Aging and Health<br />

Introduction: It is very unusual for patients in the geriatric population<br />

to present with sarcoidosis as a new diagnosis, and thus there<br />

S74<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

is a paucity of literature about this unique subgroup of patients. Sarcoidosis<br />

is a systemic illness that typically presents in younger populations;<br />

peak incidence is between the ages of 20-40. Typical symptoms<br />

on presentation are systemic malaise, fever, and pulmonary<br />

complaints. There is a gender predilection with women being affected<br />

more often than men, and a racial predilection with African <strong>American</strong>s<br />

affected more so than Caucasian populations.<br />

Case: An 81 year old Caucasian man with a medical history of<br />

coronary artery disease, chronic obstructive pulmonary disease, and<br />

laryngeal cancer status post resection presented with a three week<br />

history of decline characterized by weakness, confusion, and frequent<br />

falls. Upon admission the patient was found to have an elevated calcium<br />

level of 13.5 mg/dL. Chest roentogram was unremarkable, but<br />

computed tomography of the chest with contrast revealed mediastinal<br />

lymphadenopathy. Lab results demonstrated parathyroid hormone<br />

(PTH) 20. The captopril challenge test confirmed<br />

the results in 2 patients, while Case 2 had an elevated ratio twice. CT<br />

scans of the abdomen were performed in 2 cases, revealing normal adrenal<br />

glands. All 3 patients were diagnosed with primary aldosteronism<br />

(PA) and were treated medically with spironolactone. In Case 1<br />

and 2, all BP medications were discontinued with the exception of<br />

spironolactone (50 mg daily in Case 1 and 125 mg daily in Case 2). In<br />

Case 3, BP improved with the addition of spironolactone 125 mg daily.<br />

Discussion: Idiopathic PA peaks in the sixth decade of life. PA<br />

has a prevalence of 5-15%. These 3 cases were found within a small<br />

primary care clinic panel of 215 patients. PA can commonly be found<br />

in a community-based primary care geriatric clinic setting (not just in<br />

specialized HTN referral centers). These cases had been treated as essential<br />

HTN for 1-2 years before diagnosis. The diagnosis may frequently<br />

be missed if not considered, including in HTN patients without<br />

hypokalemia. The Endocrine <strong>Society</strong> recommends that patients<br />

who have BP>160/100, or drug-resistant HTN, or HTN with spontaneous<br />

or drug-induced hypokalemia be screened for PA. In Case 1<br />

and 2, polypharmacy was markedly reduced. In Case 3, although BP<br />

improved, polypharmacy was not reduced, perhaps suggesting PA<br />

plus essential HTN. Even if the diagnosis of PA was a false positive,<br />

spironolactone is an effective BP medication to be considered in<br />

drug-resistant HTN. More importantly, there is now evidence to suggest<br />

that aldosterone excess in PA leads to adverse cardiovascular<br />

and renal outcomes independent of its effects on BP. Treatment<br />

specifically directed against aldosterone excess protects against the<br />

development of these complications more effectively than non specific<br />

BP medications, further emphasizing the importance of not missing<br />

the diagnosis of PA.<br />

B9 Encore Presentation<br />

Bilateral popliteal vein aneurysms: a rare cause of leg pain.<br />

F. Cardona, 1 T. T. Suh, 1 M. Sideman. 2 1. Division of Community<br />

<strong>Geriatrics</strong>, Department of Family and Community Medicine, UTH-<br />

SCSA, San Antonio, TX; 2. Division of Vascular & Endovascular<br />

Surgery,Department of Surgery, UTHSCSA, San Antonio, TX.<br />

BACKGROUND: Although popliteal vein aneurysms (PVAs)<br />

are the most common reported venous aneurysms, they are still rare<br />

AGS 2012 ANNUAL MEETING<br />

S75


P OSTER<br />

A BSTRACTS<br />

with only about 125 cases published in the literature. When encountered,<br />

PVAs are usually unilateral, with only 7 reported cases of bilateral<br />

PVAs. The causes of PVA are unclear, but are thought to result<br />

from congenital vascular malformation, inflammation, trauma or degenerative<br />

changes. Age at presentation is variable, ranging from 27<br />

to 79 years. We describe the oldest case of PVAs to date.<br />

CASE: An 81 year old retired mail carrier presented with burning<br />

sensation in his lower extremities and discomfort after prolonged<br />

standing, which began to limit his activities. Physical examination revealed<br />

bilateral lower extremity varicose veins along the greater<br />

saphenous vein and pain on palpation of the right leg. Duplex ultrasonography<br />

showed bilateral PVAs without any evidence of thrombosis.<br />

Three months later, his leg pain became more persistent, with<br />

worsening pain at night. Serial resections of the PVAs were performed,<br />

leading to complete resolution of the leg pain and return to<br />

his previous activity level and independent functional status.<br />

DISCUSSION: First described by Sir William Osler in 1915,<br />

PVAs are uncommon and the exact incidence is unknown. The clinical<br />

presentation of PVAs is widely variable; however, over 50% of the<br />

reported cases present as thromboembolic disease, with pulmonary<br />

embolism being the most common presentation (47% of cases vs. 7%<br />

for deep venous thrombosis). Diagnosisof PVAs because of leg pain<br />

has been reported in only 12% of cases, while 20% have been associated<br />

with the presence of varicose veins. Since only 5% of reported<br />

cases have been bilateral, this case represents an unusual presentation<br />

of PVAs. Duplex ultrasonography remains the diagnostic test of<br />

choice, although newer techniques have emerged such as CT angiography<br />

and MRI. Surgery is indicated whenever thromboembolic disease<br />

is present regardless of PVA size or if the PVA size is greater<br />

than 20mm. Anticoagulation for six months is generally recommended<br />

during the post-operative period. Geriatricians need to be<br />

aware of this condition since it can present in older adults.<br />

B10<br />

Challenges in diagnosing Creutzfeldt - Jakob disease.<br />

G. K. Penmetsa, 1 E. Zamrini. 2 1. <strong>Geriatrics</strong>, University of Utah hospital,<br />

Salt lake city, UT; 2. Center for Alzheimer’s Care, Imaging and<br />

Research, University of Utah, Salt Lake City, UT.<br />

Background:The rate of progression of cognitive impairment<br />

provides important insight into the differential diagnosis of dementia.<br />

Creutzfeldt-Jakob disease (CJD) is a rare neuro-degenerative disorder<br />

characterised by very rapid decline in cognitive and motor function.<br />

Diagnosis can be challenging<br />

Case history: A 65 year old previously healthy and fully functional<br />

man with no significant past medical problems was admitted to<br />

an outside hospital for sub-acute change in alertness and cognitive<br />

function over a period of 2 weeks. He could no longer engage in any<br />

family activities, communicate fluently or name family members, and<br />

required moderate assistance with all activities of daily living<br />

(ADLs). Extensive inpatient work-up included blood work, CSF<br />

studies and brain MRI, but the patient remained without a specific diagnosis<br />

at discharge on a tapering burst of prednisone. When referred<br />

to the University of Utah neuro-cognitive disorders clinic four weeks<br />

later, he was doubly incontinent and fully dependent in all ADLs. He<br />

also had personality changes, myoclonic jerks, ataxia and falls. CJD<br />

was suspected by the consultant and review of the outside hospital<br />

MRI with adjustment of the contrast windows revealed cortical ribbons<br />

and increased signal in the basal ganglia on diffusion weighed<br />

images (DWI) and FLAIR. The family was counselled. The patient<br />

was placed in hospice and died shortly afterwards.<br />

Discussion: CJD is a fatally progressive prion disease characterized<br />

by rapidly deteriorating dementia. The diagnosis of CJD may be<br />

made by performing an EEG, brain MRI or CSF studies for 14.3.3<br />

protein. MRI findings of cortical ribbons on DWI windows have<br />

higher sensitivity and specificity for CJD. The brain MRI was initially<br />

reported as inconclusive,but further review of the same images by the<br />

cognitive neurologist and a neuro-radiologist demonstrated cortical<br />

ribbons. This case highlights the need to consider CJD in patients<br />

with rapidly progressing dementia. It also offers insight towards the<br />

utility of expediting clinical consultation and expert review of imaging<br />

studies in diagnosing CJD.<br />

B11<br />

Encephalopathy Responsive to Zolpidem.<br />

M. Howard, 1 D. Rye, 2 J. Greene, 2 A. I. Levey. 2 1. <strong>Geriatrics</strong>, Emory<br />

University, Atlanta, GA; 2. Neurology, Emory University, Atlanta, GA.<br />

Encephalopathy has a wide variety of etiologies and presentations<br />

as in this case of sub acute persistent altered mental status.<br />

Zolpidem is FDA approved for treatment of primary insomnia. A<br />

newer active area of research is exploring its activity in patients with<br />

altered levels of consciousness.<br />

A 64 year old Caucasian woman was referred to a university<br />

neurology memory clinic with sub acute onset of altered mental status<br />

over the preceding 3 months. Shortly following a European vacation,<br />

the previously healthy woman became progressively more paranoid,<br />

anxious, confused, insomnic, and dependent in activities of daily<br />

living. Previous evaluation included brain imaging and lumbar puncture<br />

without definitive diagnosis. She was given empiric treatments<br />

including benzodiazepines, antipsychotics, and antidepressants which<br />

had no effect except for zolpidem which her husband noticed caused<br />

normalization of her behaviors and functional and cognitive abilities<br />

for a few hours following the dose. In clinic, exam showed marked<br />

anxiety with prominent deficits in attention and concentration as well<br />

as problems with memory and language (particularly fluency), increased<br />

rigidity, and frontal release signs.<br />

Upon hospital admission, workup included neurologic examination<br />

on and off of zolpidem, placebo, lorazepam and flumazenil. Objective<br />

improvement in neuropsychological function was noted only<br />

with zolpidem and worsening with flumazenil. Continuous EEG<br />

monitoring was normal. On functional MRI she was unable to do<br />

tasks before medication but after 24 hours on zolpidem she was able<br />

to do tasks and had normal activation of expected areas. FDG-PET<br />

imaging showed improvement in hypometabolism of multiple brain<br />

regions on zolpidem. Whole body imaging, cerebrospinal fluid, and<br />

serum studies were negative for infection, occult malignancy and<br />

paraneoplastic antibodies. Lumbar puncture before and after continuous<br />

zolpidem administration showed a small decrease in protein<br />

level from 60 to 46 mg/dL, and was otherwise unremarkable. She was<br />

discharged on zolpidem CR 12.5 mg three times a day with some improvement<br />

maintained at follow up several weeks later.<br />

The activating effects of zolpidem in the setting of altered levels<br />

of consciousness have been described in a few studies, mainly in the<br />

setting of persistent vegetative and minimally conscious states. This<br />

case appears to represent a case of encephalopathy of unknown etiology<br />

that responds to zolpidem.<br />

B12<br />

ATRIAL TACHYARRHYTHMIA PRESENTING AS<br />

POLYURIA.<br />

N. Maheshwari, 1 S. Anand, 1 D. Kumari, 2 J. Hanoi, 1 E. Ong, 1 E. Roffe, 2<br />

S. Mushiyev, 3 S. Chaudhari. 2 1. Internal Medicine, New York Medical<br />

College Metropolitan Hospital Centre, Manhattan, New York, NY; 2.<br />

<strong>Geriatrics</strong>, New York Medical College Metropolitan Hospital Center,<br />

New York, NY; 3. Cardiology, New York Medical College<br />

Metropolitan Hospital Center, New York, NY.<br />

INTRODUCTION: Polyuria is associated with atrial flutter and<br />

atrial fibrillation and excessive urine formation associated with any<br />

abnormal atrial rhythm or activity has been seen in few case reports.<br />

We report an unusual case of atrial tachyarrhythmia presenting as<br />

polyuria.<br />

CASE REPORT: 87 years-old female with history of blindness<br />

in left eye presented to the emergency department with complains of<br />

S76<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

urinary frequency of more than 10 episodes daily for last 10 days; review<br />

of systems was negative except for polyuria, On physical examination<br />

(PE) revealed tachycardia of 200 beats/min, Cardiovascular<br />

examination revealed tachycardia with irregular pulse, left eye blindness,<br />

rest of PE including genitourinary examination was normal.<br />

Electrocardiogram (EKG) showed atrial flutter and repeat EKG<br />

showed atrial fibrillation (AF), Troponin of 0.17ng/mL, normal renal<br />

bladder ultrasound. She was started on diltiazem drip and subsequently<br />

switched to oral long acting beta blocker (BB) and her urinary<br />

frequency and tachycardia resolved, started on Coumadin for<br />

AF. Echocardiogram showed ejection fraction of less than 25%. Next<br />

day patient again have tachycardia and urinary frequency and BB<br />

dose was increased and she improved. During the hospital stay patient<br />

developed multiple episodes of tachycardia and urinary frequency<br />

until BB dose titrated to achieve a controlled heart rate with<br />

normal sinus rhythm and urinary frequency resolved.<br />

DISCUSSION: Polyuria associated with abnormal atrial activity<br />

like atrial flutter or atrial fibrillation has been reported in few<br />

cases in past, but no exact mechanism is known. Wood suggested that<br />

polyuria is secondary to anti diuretic hormone inhibition; later<br />

Michael J et al speculate that human atrial hyperactivity from an<br />

atrial arrhythmia represents a natural experiment in man simulating<br />

volume expansion, and signaling the kidney to decrease renal tubular<br />

sodium and water reabsorption. The diuresis begins at once and becomes<br />

manifest in few minutes, stops immediately when the attack<br />

ends, as seen in our case. Physicians should keep polyuria as one of the<br />

rare presentation or differential diagnosis of atrial tachyarrhythmia.<br />

B13<br />

Diffuse Lewy Body Dementia (DLBD): Missed diagnosis can be life<br />

threatening.<br />

N. Bansal, D. Manocha, S. Brangman. SUNY Upstate Medical<br />

University, Syracuse, NY.<br />

Background: DLBD accounts for around 20% cases of adults<br />

with dementia. Clinical features include cognitive impairment with<br />

fluctuating course, neuropsychiatric manifestations, motor and autonomic<br />

dysfunction. Heightened sensitivity to neuroleptics is a grievous<br />

complication.<br />

Case Report: We present a unique learning case of a 65 year old<br />

lady with past medical history of remitting relapsing multiple sclerosis(MS)<br />

on betasetron prophylaxis. She had two recent hospitalizations<br />

for worsening agitation and hallucinations at an outside facility<br />

which were interpreted as manifestations of MS flare. Escalating<br />

doses of antipsychotics (19 mg of haloperidol intravenously over 24<br />

hours) were administered besides the therapy for MS. Subsequently,<br />

she was transferred to our institution for need of neuro ICU management<br />

of MS. She was dehydrated, febrile(102 F), had rigidity and myoclonus<br />

on initial evaluation. Her metabolic profile revealed elevated<br />

creatine kinase levels(9812 IU/ L) and acute kidney injury. A diagnosis<br />

of neuroleptic malignant syndrome was made. She responded well<br />

to medical management. After resolution of acute complications, patient<br />

started re experiencing visual hallucinations, depressive symptoms<br />

and memory lapses to create a diagnostic and management<br />

dilemma for the primary team. A detailed geriatric assessment was<br />

then performed. It revealed history of worsening short term memory<br />

loss with fluctuations over the past 1year, complicated by bradykinesia<br />

and depression for 7 months and visual hallucinations for 4<br />

months. The mental status testing revealed impaired visuospatial orientation,<br />

recall and execution. Work up for reversible causes (including<br />

Vitamin B12/ TSH/RPR-VDRL) and brain imaging were noncontributory.<br />

Thus a diagnosis of Diffuse Lewy Body Dementia with<br />

sensitivity to neuroleptics with neuroleptic malignant syndrome was<br />

made. The patient was started on donapezil for cognition, citalopram<br />

for depression and valproic acid for other secondary behavior problems<br />

with partial stabilization of her symptoms. Discussion: Use of<br />

neuroleptics has been associated significant adverse reactions in 54-<br />

81% patients with DLBD. Studies have shown increased mortality<br />

and shortened survival times in affected patients. Compromised nigrostriatal<br />

dopaminergic transmission predisposes to neuroleptic sensitivity<br />

even at modest doses.Co-existing medical conditions may<br />

delay the diagnosis and appropriate management as was the case in<br />

our patient.<br />

B14 Encore Presentation<br />

Getting the Patient Out of the Woods - Near Death from Babesiosis<br />

in an Elder.<br />

R. Jaber, M. Brennan. Internal Medicine, Baystate Medical Center,<br />

Springfield, MA.<br />

Supported By: Baystate Medical Center/Tufts Univ. School of<br />

Medicine<br />

Introduction<br />

Babesiosis is a tick-borne disease common in the Northeast and<br />

Midwest. The parasite, Babesia microti, infects red blood cells and can<br />

cause serious illness. The authors report a case of life threatening infection<br />

in an elder who recovered after prompt diagnosis and aggressive<br />

treatment.<br />

Case summary<br />

An 85-year-old man had 5 days of malaise, lethargy, and fever.<br />

PMH included ischemic stroke, hyperlipidemia and possible<br />

myelodysplastia. He lived in Monson, Massachusetts and had recently<br />

been gardening in a wooded area.<br />

On physical examination he appeared ill, was diaphoretic,<br />

slightly confused and febrile (101.7 F). He had a regular tachycardia<br />

(115 bpm). His bp was 137/75, RR was 20 and his O2 saturation was<br />

93% on 3 ls; there was no rash or lymphadenopathy. He had a few<br />

coarse crackles at the left base but his exam was otherwise normal.<br />

His wbc count was 3.9 K and left shifted with 13% bands. His hemoglobin<br />

was 9.7 gm/dl and the platelet count was 40 K. Most notably,<br />

he had an RBC parasitemia of 10 % classic for Babesiosis.<br />

Chest X-ray revealed left lower lobe atelectasis. Azithromycin and<br />

atovaquone were begun and he was tested for anaplasmosis (Human<br />

Monocytic Ehrlichiosis) since patients often have concomitant infections<br />

and this requires adjusting antibiotics. This was positive, so<br />

doxycycline was added. On hospital day 4, he developed severe hemolysis;<br />

his hemoglobin dropped to 6 and his parasitemia rose to 19<br />

%. Red blood cell exchange was performed; antibiotics were switched<br />

to clindamycin and quinine. The patient improved; at discharge the<br />

parasitemia was under 1 %.<br />

Discussion:<br />

Life-threatening Babesiosis occurs most often in elders (age> 75<br />

yrs) and those who are immunosuppressed or asplenic. Most deaths<br />

are due to hemolysis, thrombocytopenia, DIC, or multi-organ failure.<br />

Early recognition is critical. This patient’s life likely was saved by<br />

prompt diagnosis in a community hospital. This resulted in rapid<br />

transfer to tertiary care thereby facilitating immediate response to<br />

subsequent massive hemolysis. The case also highlights the importance<br />

of assessing for co-infection with Ehrlichia. Failing to identify<br />

all major infections would probably have proved fatal. Geriatricians<br />

often care for immunocompromised, frail elders. To prevent unnecessary<br />

deaths they must be aware of the presentation, natural history,<br />

treatments and complications of Babesiosis and screen promptly for<br />

co-infections.<br />

B15<br />

An Unusual Case of a Prosthetic Joint Infection with Lactobacillus.<br />

R. Zitnay, S. Chao. Section of <strong>Geriatrics</strong>, Boston University Medical<br />

Center, Boston, MA.<br />

Background: Lactobacillus is a Gram positive organism found<br />

as normal flora in the oral cavity, genital, and gastrointestinal tract. It<br />

is classically a nonpathogenic organism, found in fermented food<br />

products and probiotic supplements. Serious infections are very rare,<br />

AGS 2012 ANNUAL MEETING<br />

S77


P OSTER<br />

A BSTRACTS<br />

with typical risk factors being an immunocompromised state, malignancy,<br />

or translocation after invasive gastrointestinal procedures. We<br />

describe a patient with a subacute presentation of prosthetic joint infection<br />

with Lactobacillus as the culprit organism. Case: A 95 year old<br />

female with a history of dementia, a left hip fracture with hemiarthroplasty<br />

one year prior, and a clostridium difficile infection now on probiotic<br />

supplementation, developed a new complaint of left leg pain.<br />

The pain was worse with weight bearing, but did not compromise her<br />

walking. Physical examination was remarkable only for superficial<br />

tenderness to palpation of the distal anterio-lateral quadriceps muscle.<br />

Left hip and femur Xrays were normal with her prosthesis in<br />

anatomic alignment. Six months later she developed new difficulty in<br />

transferring from bed to stand, requiring one person assist and skin<br />

breakdown over the left lateral hip. A CT scan showed femoral diaphyseal<br />

cortical defects and subcutaneous and intramuscular enhancing<br />

collections concerning for infected hip prosthesis with sinus tract.<br />

Intra-operative cultures revealed lactobacillus casei/paracasei. Multiple<br />

peripheral blood cultures were negative. She completed a fourweek<br />

course of intravenous penicillin and then was placed on oral dicloxacillin<br />

for long term suppressive therapy. Discussion: This case<br />

demonstrates the subtle history and physical examination findings<br />

that can accompany subacute prosthetic hip infections in advanced<br />

age. The index of suspicion should remain high despite the reassuring<br />

lack of classic local or systemic infectious signs or symptoms. In the<br />

face of suspicion, the history should consider a broad range of potential<br />

pathogens. Current research argues against a link between systemic<br />

disease and probiotic therapy, but this case suggests such a link.<br />

B16<br />

POEMS Syndrome: A Rare Cause of Gait Imbalance.<br />

S. Arshad, J. Angeles, H. A. Arabelo. <strong>Geriatrics</strong>, St. Luke’s-Roosevelt<br />

Hospital, Academic Affiliate of Columbia University College of<br />

Physicians & Surgeons, New York, NY.<br />

Gait imbalance is very common in the elderly and could result<br />

from multiple causes, some of which are treatable. Loss of balance<br />

can be very debilitating.<br />

An 87 year old patient presented with bilateral leg weakness<br />

and imbalance. He reported trouble walking for the past year accompanied<br />

with ankle edema. Upon admission he was found on the floor<br />

and unable to ambulate. He complained of tingling in his feet &<br />

hands bilaterally. On physical exam he had no fasciculations, normal<br />

muscle tone, mild finger abductor weakness & 1+ bicep reflexes. He<br />

had weakness in both legs, markedly diminished pinprick in the legs<br />

to the mid thigh bilaterally, absent vibratory sensation in his feet, absent<br />

position sense in the toes, absent Achilles reflexes, and cautious<br />

gait with increased base. MRI of the spine showed DJD and mild<br />

compression fracture of T12 with no nerve impingement or cord lesions.<br />

TSH, B12 levels, and the Lyme Antibody were unremarkable.<br />

An EMG showed moderate to severe peripheral neuropathy with significant<br />

slowing in the right tibial and peroneal nerves, consistent<br />

with acquired demyelination. An IgG lambda spike on protein and<br />

immune fixation electrophoresis was noted. The skeletal survey was<br />

without lytic or blastic lesions. The patient had gait ataxia from severe<br />

peripheral neuropathy with monoclonal gammopathy as the etiology.<br />

Our patient has features of POEMS with sensory motor<br />

polyneuropathy, endocrinopathy with recent diabetes mellitus, edema<br />

and IgG lambda protein monoclonal gammopathy. He will follow up<br />

with his Hematologist & Neurologist for treatment and also have<br />

physical therapy.<br />

POEMS is a multisystemic syndrome that occurs in the setting<br />

of plasma cell dyscrasia. It is rare and can be underdiagnosed leading<br />

to recurrent falls. POEMS syndrome occurs because of the growth of<br />

certain clonal plasma cells that produce an abnormal amount of<br />

blood proteins, which damage body organs & result in this acronym<br />

for the syndrome’s most common features consisting of polyneuropathy,<br />

organomegaly, endocrinopathy or edema, monoclonal protein<br />

and skin changes. Not all features of the disease are required to make<br />

the diagnosis. POEMS syndrome begins around age fifty and affects<br />

twice as many men as women. If untreated it is progressive and often<br />

fatal. Only 60% survive five years after onset. However, the symptoms<br />

can improve if the blood disorder is diagnosed and treated.<br />

B17 Encore Presentation<br />

A Rare Etiology of Acute Cardiomyopathy and Respiratory Failure.<br />

S. Lee, S. Bellantonio, D. Joseph. Internal Medicine, Baystate Medical<br />

Center, Springfield, MA.<br />

INTRO<br />

Adult-onset Still’s Disease(AOSD) is a rare systemic inflammatory<br />

disorder of unknown etiology, commonly presenting with fever,<br />

rash, and arthritis/arthralgias. It more commonly affects women; median<br />

age of onset is 25. We report an atypical presentation of an<br />

AOSD flare with possible Macrophage Activation Syndrome(MAS)<br />

associated with extreme hyperferritinemia in a 60 year old male.<br />

CASE<br />

A 60-year-old high-functioning male with history of AOSD presented<br />

with subacute fever, rigors, and diarrhea. His exam was unremarkable,<br />

with no evidence of rash, synovitis or lymphadenopathy.<br />

Labs revealed mild leukocytosis and creatinine of 3.2mg/dL. He was<br />

admitted for acute renal failure and treated supportively with IV fluids.<br />

The next day, he developed acute, progressively worsening respiratory<br />

distress. CXR showed multifocal atelectasis without pulmonary<br />

congestion. There were no ischemic EKG changes, but<br />

troponinT was elevated(0.37). Echocardiogram revealed new diffuse<br />

hypokinesis with depressed systolic function(EF 30%). Serum ferritin<br />

was markedly elevated(103,670). He was transferred to the ICU and<br />

put on noninvasive ventilation. High dose IV steroids were initiated<br />

with impressive improvement in respiratory status. He was transitioned<br />

to PO steroids, and a week later initiated on an IL1 antagonist(anakinra)<br />

and discharged with normal renal function. Hypoxemia<br />

and dyspnea resolved over the ensuing weeks with ferritin<br />

returning to normal. Repeat echo showed normal cardiac function.<br />

Steroids were eventually tapered and anakinra continued.<br />

DISCUSSION<br />

Besides AOSD and MAS, there are few, if any conditions presenting<br />

with this extraordinary degree of hyperferritinemia. MAS,<br />

commonly associated with rheumatologic conditions, is caused by<br />

overwhelming macrophage activation resulting in phagocytosis of<br />

erythrocytic precursors in bone marrow. Both AOSD flare and MAS<br />

can be triggered by infection, and similarly managed with immunosuppression,<br />

as in our patient. The absence of cytopenias and hypofibrinogenemia<br />

militate against MAS. MAS is only confirmed with bone<br />

marrow biopsy, but with high false negative rates.<br />

CONCLUSION<br />

AOSD flare and MAS are rapidly fatal conditions that can<br />

occur in older adults. Both mimic sepsis with multiorgan dysfunction,<br />

and diagnosis is often delayed. Quick recognition and treatment is<br />

vital for favorable outcome.<br />

B18<br />

Dysphagia with a Large Goiter: What You See Is Not Necessarily<br />

What You Get.<br />

S. McCullough, 1 J. Reckrey, 1,2 B. Shah. 1,2 1. Mount Sinai School of<br />

Medicine, New York, NY; 2. Department of <strong>Geriatrics</strong>, Mount Sinai<br />

Hospital, New York, NY.<br />

Dysphagia commonly accompanies acute presentations of the<br />

elderly. This case illuminates the importance of maintaining a broad<br />

differential for dysphagia and highlights the phenomenon of<br />

pseudoachalasia.<br />

A 90 year old woman with a history of GERD, dysphagia, hyperthyroidism<br />

with a 7-cm multinodular goiter and atrial fibrillation<br />

with rapid ventricular response was transferred from her nursing<br />

S78<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

home for altered mental status and percutaneuous endoscopy gastrostomy<br />

(PEG) placement. The patient had dysphagia presumed to<br />

be caused by compression from her goiter. In the month prior to admission<br />

her daughter reported worsening dysphagia with the patient<br />

now unable to tolerate medications. Due to the dysphagia, the patient<br />

planned for ambulatory PEG placement; however, the patient became<br />

delirious and was transferred. Initial evaluation revealed a right<br />

lower lobe pneumonia and an E coli UTI which were treated with antibiotics.<br />

A goals of care (GOC) discussion with family confirmed the<br />

decision for PEG placement. A neck CT done to evaluate for airway<br />

compression showed no change in goiter size. Esophagogastroduodenoscopy<br />

(EGD) revealed stricturing and a fungating mass at the<br />

gastric cardia, identified pathologically as an invasive poorly differentiated<br />

adenocarcinoma. After the procedure the patient remained<br />

somnolent and GOC were readdressed. In accordance with the family’s<br />

wishes, the patient was transferred to the palliative care unit<br />

where she passed away with her family at bedside. In evaluating this<br />

patient’s dysphagia, our premature diagnostic closure attributed her<br />

dysphagia to external compression and failed to consider gastric cancer<br />

with resulting pseduoachalsia. Older age, sudden onset, and<br />

weight loss are clues to differentiating pseudoachalasia from achalasia.<br />

Pseudoachalsia is most commonly due to adenocarcinoma of the<br />

gastric cardia and can result from mechanical compression of the<br />

lower esophageal sphincter or myenteric plexus infiltration. The case<br />

makes clear that the less common causes of dysphagia such as<br />

pseudoachalasia should be considered when evaluating an elderly patient.<br />

The patient’s prior treatment decisions along with GOC discussions<br />

helped the daughter make end of life decisions. This case highlights<br />

a common problem in the elderly and reminds clinicans to<br />

maintain a broad differential, be knowledgable about the causes of<br />

dysphagia, and discuss GOC frequently.<br />

B19<br />

Transitioning into the Weekend, Staffing Constraints and Delayed Care.<br />

W. Colon Cartagena, M. Brennan. Internal Medicine, Baystate<br />

Medical Center/Tufts Univ. School of Medicine, Springfield, MA.<br />

Background<br />

Hospital staffing and specialty care is often reduced on weekends;<br />

studies suggest that certain types of patients have excess mortality<br />

if they are hospitalized on a weekend as compared to a weekday<br />

(1). However, little is known about the impact of delayed<br />

assessments for frail elders in acute care settings. The authors report a<br />

case of one man who was subjected to a lengthy hospitalization and<br />

much suffering due to delays in care over a weekend.<br />

Case<br />

Mr. R. was a 94 year old man with sub-acute, progressing leg<br />

pain and weakness. He arrived on a Friday evening for evaluation<br />

after an MRI showed a mass at L5. He was alert and oriented to person,<br />

place and time and had no motor or sensory deficits. His major<br />

complaint was pain. A CT showed bilateral pulmonary masses and<br />

suspicious lesions in his pelvis; cancer was high in the differential. A<br />

PSA and CEA were unremarkable. A CT-guided mass biopsy was ordered<br />

to identify the pathology and clarify the suitability of palliative<br />

radiation. The procedure was scheduled for Monday due to a lack of<br />

interventional radiology personnel over the weekend. However, Mr.<br />

R. became delirious on Sunday night and was discharged to a nursing<br />

home with ongoing delirium about a week later. His agitation resulted<br />

in an 11 day delay in obtaining the biopsy which eventually revealed<br />

multiple myeloma.<br />

Discussion<br />

Much attention has been paid to transitions of care between different<br />

institutions but the transition through a hospital’s weekly<br />

staffing cycle creates similar challenges. In this case, timely intervention<br />

would have identified multiple myeloma earlier allowing targeted<br />

treatment to improve pain and stabilize function. Hospitalizations<br />

have a disproportionately detrimental effect on older adults,<br />

leading to complications such as delirium and functional decline.<br />

These prolong hospital stay, increase costs and decrease patients’<br />

quality of life. However, it is unclear if these adverse outcomes are<br />

more common for elders admitted during a weekend. This is an important<br />

question for future research by geriatricians, hospitalists, and<br />

health care quality experts.<br />

Bibliography<br />

1. The association between night or weekend admission and hospitalization-relevant<br />

patient outcomes. Khana, R, et al., et al. Jan<br />

2011, Journal of Hospital Medicine, pp. 6(1):10-4.<br />

B20<br />

Understanding Surrogate Decision-makers’ Perceptions of Feeding<br />

Options for Patients with Dementia.<br />

E. A. Snyder, 1 R. Gilliam, 3 A. Caprio, 2 L. . Hanson. 2 1. School of<br />

Medicine, University of North Carolina, Chapel Hill, NC; 2. Division<br />

of Geriatric Medicine, University of North Carolina, Chapel Hill, NC;<br />

3. Cecil G. Sheps Center for Health Services Research, University of<br />

North Carolina, Chapel Hill, NC.<br />

Supported By: Funder: NIH-NINR 1R01 NR009826<br />

Background: Feeding problems are common in advanced dementia<br />

patients, requiring surrogates to make decisions about feeding<br />

options. Little is known about surrogates’ understanding of tube<br />

feeding and assisted oral feeding. Our study explores surrogate perception<br />

of these feeding options and assesses the impact of a decision<br />

aid on their perspectives, knowledge and decisional certainty.<br />

Methods: The study was conducted in 24 skilled nursing facilities<br />

in North Carolina as a part of a larger, randomized controlled trial.<br />

Study population included surrogate decision-makers for nursing<br />

home residents with advanced dementia and feeding problems<br />

(n=255). The intervention group viewed a decision aid about tube<br />

feeding and assisted oral feeding. Baseline interviews included items<br />

measuring knowledge, expectation of benefit from tube feeding and<br />

open-ended questions about the advantages and disadvantages of<br />

feeding options. Answers were compared before and after viewing<br />

the interventional decision aid.<br />

Results: Surrogates varied in their understanding of feeding options,<br />

yet commonly cited maintaining enjoyment, independence and<br />

dignity as major areas of importance. Surrogates provided conflicting<br />

responses regarding the effect of tube feeding vs. oral feeding on prolonging<br />

life and were uncertain of the effects on nutrition. Exposure<br />

to a structured decision aid modified surrogate understanding of<br />

feeding options. Surrogates were more likely to provide responses<br />

consistent with those presented in the decision aid. Detailed interviews<br />

with surrogates following exposure to the decision aid revealed<br />

increased knowledge (15.5 vs. 16.8; p


P OSTER<br />

A BSTRACTS<br />

The aim of this study was to determine if osteoarthritis (OA)-related<br />

biomarker levels were associated with hand symptoms severity<br />

and functional disability as reported by the Australian/Canadian<br />

Hand Osteoarthritis Index (AUSCAN) among middle- and olderaged<br />

adults.<br />

Methods<br />

AUSCAN total scores and biomarker measurements were<br />

available for 661 participants from the Johnston County Osteoarthritis<br />

Project. AUSCAN is a 15-item self-report measure of hand pain,<br />

stiffness, and function that has been previously validated among individuals<br />

with hand OA. Higher AUSCAN scores indicate worse pain<br />

or function in the hand. Commercially-available kits were used to<br />

measure levels of: serum hyaluronic acid (HA), serum carboxy-terminal<br />

propeptide of type II collagen (sCPII), serum type II collagen<br />

degradation product (C2C), urinary C-terminal crosslinked telopeptide<br />

of type II collagen (CTX-II) , and urinary N-terminal crosslinked<br />

telopeptide (NTX); serum cartilage oligomeric matrix protein<br />

(sCOMP) was measured with an in-house sandwich enzyme linked<br />

immunosorbent assay. The ratio of sC2C:sCPII was calculated. Spearman<br />

correlation coefficients were computed between AUSCAN and<br />

each biomarker. Linear regression models were used to estimate associations<br />

between AUSCAN total score and a biomarker, adjusting<br />

for age, race, current smoking status (yes/no), BMI, current alcohol<br />

usage, and radiographic hip, knee, and hand OA, each defined by<br />

Kellgren-Lawrence grade 2-4 in at least one joint in that joint group.<br />

Results<br />

After adjusting for possible confounders, AUSCAN total score<br />

was positively associated with uNTX-1, sCOMP, and negatively associated<br />

with C2C, CPII, and their ratio. The adjusted associations between<br />

AUSCAN scores and uCTX-II and HA were not statistically<br />

significant.<br />

Conclusion<br />

Even after adjusting for other factors and concomitant radiographic<br />

hip, knee, and hand OA, the AUSCAN index for hand symptoms<br />

and function was independently associated with biomarkers related<br />

to type 1 collagen resorption, non-collagenous matrix protein<br />

degradation, and decreased type II collagen synthesis. These findings<br />

suggest that biological processes related to these biomarkers are important<br />

in hand OA and its symptomatic consequences.<br />

B22<br />

Does antipsychotic dose reduction result in worsening behavior<br />

among nursing home residents with dementia: a systematic review of<br />

the literature.<br />

J. Tjia, A. Kanaan, J. Donovan. <strong>Geriatrics</strong>, University of Massachusetts<br />

Medical School, Worcester, MA.<br />

Supported By: This study was supported by a grant from the Agency<br />

for Healthcare Quality and Research.<br />

Background: While federal regulations require gradual dose reduction<br />

trials of antipsychotics prescribed for behavior management<br />

in nursing home (NH) residents with dementia, widespread concern<br />

about precipitating behavioral disturbances limits implementation.<br />

We conducted a systematic review of the literature to identify clinical<br />

trials of antipsychotic dose reductions. The study aim was to describe<br />

dose reduction practices and evidence for risk of behavior escalation.<br />

Methods: A comprehensive literature search was conducted in<br />

MEDLINE, EMBASE, and International Pharmaceutical Abstracts<br />

between January 1970 and October 2011 using the terms “antipsychotic<br />

agent or neuroleptic agent,” “dementia,” “nursing homes,” and<br />

“withdrawal.” One investigator reviewed abstracts for inclusion<br />

based on: English-language, human subjects, clinical trial, nursing<br />

home site, and reported reduction in antipsychotic medications. We<br />

excluded review articles, commentaries and secondary analysis of<br />

main trial results. The remaining articles were reviewed by 2 investigators<br />

for final inclusion, resulting in 9 articles.<br />

Results: The nine articles meeting inclusion criteria included<br />

randomized controlled trials of both typical and atypical antipsychotics.<br />

Study populations ranged in size from 55 to 183 NH residents<br />

with dementia and dose reductions typically targeted patients who<br />

were not psychotic and did not have a history of violent behavior.<br />

Gradual dose reduction protocols typically followed a strategy of<br />

50% dose reduction per week for 2-3 sequential weeks. Outcomes<br />

measured included behavioral problems, cognitive function, and resumption<br />

of antipsychotic medications. All 9 studies reported that the<br />

majority of residents randomized to gradual dose reductions of antipsychotics<br />

had no overall detrimental effect on functional and cognitive<br />

status, or exacerbation of behavioral symptoms.<br />

Conclusions: Clinical trials evaluating the withdrawal of antipsychotic<br />

medications from NH residents with dementia do not<br />

show evidence of rebound behavioral escalation after gradual dose<br />

reductions.<br />

B23<br />

Is Fracture Risk Assessment Index (HFRAI), an Electronic Medical<br />

Database Derived Tool, comparable to Femur neck Bone Mineral<br />

Density (FNBMD)?<br />

M. Albaba, S. S. Cha, P. Y. Takahashi. Mayo Clinic, Rochester, MN.<br />

BACKGROUND<br />

Femur neck bone mineral density (FNBMD) is the cornerstone of<br />

hip fracture risk stratification in current clinical practice. Other risk stratification<br />

tools use FNBMD with other selected risk factors. We have derived<br />

and validated the Hip Fracture Risk Assessment Index (HFRAI)<br />

(score range 0, 32) that uses electronic medical records data to predict<br />

risk for hip fracture in community-dwelling older adults. Using appropriate<br />

computer program,HFRAI is computed automatically to provide the<br />

clinician with a readily available score that assesses patient’s risk for sustaining<br />

hip fracture, without the need to manually calculate a score, perform<br />

a physical examination or obtain a radiology test.It is unknown how<br />

HFRAI compares to FNBMD and to other FNBMD based risk stratification<br />

tools.The goal of this study was to compare HFRAI to FNBMD.<br />

METHODS<br />

This was a retrospective cohort study. All community-dwelling<br />

subjects over 60 years of age in a primary care panel in Olmsted<br />

County, MN on January 1st, 2005 were enrolled.<br />

Since HFRAI uses electronic medical records data of the previous<br />

two years, we excluded all subjects that did not have a FNBMD<br />

tested during the two-year time frame (01/01/2003, 01/01/2005).<br />

We created two receiver-operating curves (ROC), one ROC<br />

using the HFRAI scores as of 01/01/2005, and the other using the lowest<br />

recent FNBMD T-score. The primary outcome was incident hip<br />

fracture in the subsequent four years (2005, 2008). We computed the<br />

area under the curve (AUC) for each ROC. We used Z statistics to<br />

compare AUC between the two ROCs. We evaluated each of<br />

FNBMD and HFRAI for sensitivity and specificity.<br />

RESULTS<br />

On 01/01/2005 13,457 subjects over 60 years were empanelled in<br />

the practice. 12,650 subjects (94%) consented to the study, among<br />

which 1953 subjects had FNBMD-DXA (dual-energy X-ray absorptiometry)<br />

scan within the previous two years. 83 subjects (4.3%) sustained<br />

a hip fracture between 01/01/2005 and 12/31/2008. AUC for<br />

HFRAI was 0.79, slightly larger than AUC for FNBMD of 0.74<br />

(Z=1.82, p=0.09). The best combined sensitivity and specificity for<br />

HFRAI tool was at a score of >12 (84% sensitive and 55% specific),<br />

and for FNBMD tool was at a T-score of


P OSTER<br />

A BSTRACTS<br />

Femur neck bone mineral density (FNBMD) is the cornerstone<br />

of hip fracture risk stratification in current clinical practice. Other<br />

risk stratification tools use FNBMD with other selected risk factors.<br />

It is unknown whether electronically derived available patient information<br />

is useful in predicting hip fracture. The goal of this study was<br />

to demonstrate the use of electronic medical records to create an<br />

index which is able to risk-stratify heterogeneous older population.<br />

METHODS<br />

This was a retrospective cohort study. All community-dwelling<br />

patients over 60 years in a primary care panel in Olmsted County,<br />

MN on January 1st, 2005 were enrolled (N=12,650).<br />

Subjects were randomly assigned to two groups, a development<br />

cohort (N=8,387) and a validation cohort (N=4,263).<br />

Using the development cohort’s electronic medical records<br />

(EMR), risk factors over the previous two years including demographic<br />

characteristics and comorbidities were evaluated for significance<br />

in univariate and multivariate logistic regression. The primary<br />

outcome was incident hip fracture in the subsequent four years. Risk<br />

factors were assigned a score based on their regression coefficient estimate<br />

and a total risk score was created. We used EMR of the validation<br />

cohort to evaluate the total risk score for sensitivity and specificity<br />

and create a receiver-operating curve.<br />

RESULTS<br />

288 (3.43%) subjects in the development cohort sustained a new<br />

hip fracture. The final model included age ≥75 (odds ratio (OR) 10,<br />

95% CI 4.4, 23), age 70-74 (OR 7.7, 95% CI 3.3, 18.1), age 65-70 (OR<br />

3.8, 95% CI 1.6, 9.4), white race (OR 2.5, 95% CI 1.2, 5.5), female gender<br />

(OR 1.5, 95% CI 1.1, 1.9), prior hip fracture (OR 5.3, 95% CI 3.8,<br />

7.4), liver cirrhosis (OR 2.7, 95% CI 1, 7.6), malnutrition (OR 2.6,<br />

95% CI 1.6, 4.5), peripheral arterial disease (OR 1.7, 95% CI 1.2, 2.3),<br />

Parkinson’s disease (OR 1.6, 95% CI 1.2, 2.1), prior nursing home<br />

stay (OR 1.7, 95% CI 1.2, 2.3), and prior hospitalization (OR 1.4, 95%<br />

CI 1.1, 1.8). Area under receiver-operating curve (AUC) was 0.818,<br />

SE 0.017. Subjects with the highest 10% of the total risk score had<br />

(OR 9.1, 95% CI 6.5,12.6); thus a 9 fold increased risk for acquired<br />

hip fracture versus the rest of the cohort.<br />

CONCLUSION<br />

Electronically obtained, readily available patient information<br />

can be utilized for hip fracture risk stratification, without the need for<br />

further patient evaluation or FNBMD testing.<br />

B25<br />

Comparative impact of continence promotion interventions<br />

targeting older women reluctant to seek care for urinary<br />

incontinence.<br />

R. Agnew, 1,2 E. van den Heuvel, 2 C. Tannenbaum. 1 1. Université de<br />

Montreal, Montreal, QC, Canada; 2. Brunel University, Uxbridge,<br />

United Kingdom.<br />

Supported By: This work was funded by a partnership grant between<br />

the Canadian Institutes of Health Research and the United<br />

Kingdom New Dynamics on Aging Program.<br />

Surveys suggest that only 13% to 50% of older women with urinary<br />

incontinence (UI) talk to a health care practitioner about their<br />

condition or implement evidence-based treatment. Continence<br />

awareness programs exist, but their effectiveness remains unknown.<br />

We sought to determine the comparative impact of a constructivist<br />

learning workshop on UI, an evidence-based self-management tool<br />

for UI, or both, compared to the effects of a sham workshop, on incontinent<br />

women’s perceived improvement in their UI condition.<br />

Methods: a 2x2 factorial open-label cluster randomized controlled<br />

trial testing is currently being conducted in the United Kingdom.<br />

The cluster (unit of randomization) is at the level of each local<br />

community senior’s group, from whence participants are recruited for<br />

the workshops. One of four interventions (3 experimental and 1 sham<br />

intervention) is randomly assigned to each community group, with<br />

randomization achieved by computer-generated random digits, balanced<br />

in block groups of four. Eligible participants are communitydwelling<br />

women 60 years of age or older, who have not sought medical<br />

advice for incontinence symptoms in the last 5 years, and who experience<br />

urinary incontinence with a frequency no less than twice<br />

weekly. One outcome for the trial is an improvement in UI at three<br />

months post-intervention, measured by a rating of improvement on<br />

the Patient’s Global Impression of Improvement questionnaire.<br />

Results: Five-hundred and twenty-four women attended the<br />

workshops and 200 (mean age 70 + 7 years) met eligibility criteria<br />

and were recruited to the trial. At 3-month follow-up, 47% of women<br />

in the combined group reported that their UI condition was very<br />

much or much better, compared to 35% of the constructivist workshop<br />

group alone, 28% of the self-management group, and 14% of<br />

the sham control group (p=0.013). Less than 5% of participants were<br />

lost to follow-up.<br />

Conclusion: Results of this interim analysis suggest that a continence<br />

promotion intervention combining constructivist learning theory<br />

debunking myths about UI being a normal part of aging and use<br />

of a self-management tool has the greatest impact on improvements<br />

in UI in older women with incontinence.<br />

B26<br />

The effects of life review writing on depressive symptoms: A<br />

randomized control trial.<br />

T. Chippendale. Occupational Therapy, Tufts University,<br />

Somerville, MA.<br />

Supported By: <strong>American</strong> Occupational Therapy Foundation<br />

Background:The purpose of this RCT was to evaluate the effectiveness<br />

of life review through writing with respect to decreasing depressive<br />

symptoms in older adults residing in senior residences. Life<br />

review is an important developmental task and therapeutic intervention.<br />

When executed through writing, the benefits may be multiplied.<br />

This study sought to provide support for this psychosocial intervention<br />

for older adults. Although meta-analysis reveals a number of<br />

studies that have examined the effectiveness of life review as an intervention<br />

for decreasing depressive symptoms (1), some have called for<br />

a refinement and validation of intervention protocols. The intervention<br />

used in this study, the “Share you Life Story” Workshop (2), includes<br />

the added therapeutic benefits of writing. Life review through<br />

writing, as opposed to life review through the oral method, has not<br />

been well studied (3) and may be a more beneficial approach (4).<br />

Methods: Participants: 45 older adults 65 years and older, who<br />

spoke English and who had a negative screen for probable dementia<br />

on the Mini-Cog.Setting:4 senior residences in NYC. Design: A randomized<br />

control trial with participants assigned to the treatment or<br />

wait list control group. Randomized was within each site using randomization<br />

with forced equal sample size. Data was analyzed using<br />

an RMANOVA and SPSS version 17 with a .05 significance level. The<br />

Geriatric Depression Scale was the primary outcome measure. Results:<br />

A statistically significant decrease in depressive symptoms was<br />

found for the treatment group as compared to the control group<br />

(N=45, p=.03, effect size d=.7). Conclusions: The results support the<br />

“Share your life story” writing workshop as an effective intervention<br />

for addressing depressive symptoms in older adults.<br />

(1)Bohlmeijer, E., Smit, F. & Cuijpers, P. (2003). Effects of life review<br />

on late life depression: A meta-analysis. International Journal of<br />

Geriatric Psychiatry, 18(12), 1088-1094.<br />

(2)Sierpina, M. (2002). Share your life story workshops. Galveston:<br />

University of Texas Medical Branch.<br />

(3)Richeson, N. & Thorson, J. A. (2002). The effect of autobiographical<br />

writing on the subjective well-being of older adults. North<br />

<strong>American</strong> Journal of Psychology, 4, 395-404.<br />

(4)Sherman, E. (1995). Differential effects of oral and written<br />

reminiscence in the elderly. In B. H. Haight, & Webster, J. D. (Eds.),<br />

The art and science of reminiscing (pp. 255-264). Washington: Taylor<br />

& Francis.<br />

AGS 2012 ANNUAL MEETING<br />

S81


P OSTER<br />

A BSTRACTS<br />

B27<br />

Shared Decision Making in the Selection of Outpatient Analgesics<br />

for Older Emergency Department Patients.<br />

C. G. Isaacs, C. E. Kistler, K. Hunold, G. Pereira, M. Buchbinder,<br />

S. A. McLean, T. F. Platts-Mills. University of North Carolina at<br />

Chapel Hill, Chapel Hill, NC.<br />

Supported By: This study was supported by a Medical Student<br />

Training in Aging Research grant (Isaacs), a National Center for<br />

Research Resources grant KL2 RR025746 (Platts-Mills), an Agency<br />

for Healthcare Research and Quality K12 HS19468-01 (Kistler), and<br />

institutional resources.<br />

Background: Shared decision making has been shown to improve<br />

patient satisfaction and clinical outcomes for chronic disease<br />

management. Given the presence of individual variations in the effectiveness<br />

and side effects of commonly used analgesics in older adults,<br />

shared decision making might also improve clinical outcomes in this<br />

setting. We sought to characterize shared decision making regarding<br />

the selection of an outpatient analgesic for older ED patients with<br />

acute musculoskeletal pain and to examine associations with outcomes.<br />

Methods: We conducted a prospective observational study with<br />

consecutive enrollment of patients age 65 or older discharged from<br />

the ED following evaluation for moderate or severe musculoskeletal<br />

pain. Two essential components of shared decision making, 1) information<br />

provided to the patient and 2) patient participation in the decision,<br />

were assessed via patient interview at one week using fourlevel<br />

Likert scales.<br />

Results: Of 233 eligible patients, 110 were reached by phone and<br />

87 completed the survey. Only 25% (21/87) of patients reported receiving<br />

‘a lot’ of information about pain medications, and only 21%<br />

(18/87) reported participating ‘a lot’ in the selection of the analgesic.<br />

There were trends towards white patients (p=.06) and patients with<br />

higher educational attainment (p=.07) reporting more participation<br />

in the decision. After adjusting for gender, race, and initial pain severity,<br />

patients who reported receiving ‘a lot’ of information were more<br />

likely to report optimal satisfaction with the analgesic than those receiving<br />

less information (78% vs. 47%, p


P OSTER<br />

A BSTRACTS<br />

the use of instruments validated for this particular environment is not<br />

yet widespread. The ideal timing of or interval during which a delirium<br />

screening process should take place has yet to be determined. Future<br />

research in the ED will be needed to both validate delirium<br />

screening instruments that are currently used for investigation and<br />

clinical care as well as to define the ideal timing and form of the delirium<br />

assessment process for older adults.<br />

B30<br />

Pain Care in the Emergency Department: Is it Satisfactory?<br />

M. Barlow, U. Hwang. Department of Emergency Medicine;<br />

Department of <strong>Geriatrics</strong> and Palliative Medicine, Mount Sinai<br />

School of Medicine, New York, NY.<br />

Supported By: Michelle Barlow was funded by an AFAR grant<br />

through the 2011 MSTAR program.<br />

Ula Hwang is supported by a K23 award from the NIA.<br />

BACKGROUND: Pain is a common reason for emergency department<br />

(ED) visits by older adults. There is evidence that older<br />

adults receive poorer ED pain care than younger patients, but many<br />

of these studies used retrospective data and were unable to assess patient<br />

satisfaction. The objective of this study is to compare the quality<br />

of ED pain care received with patient satisfaction.<br />

METHODS: This is a prospective observational study at an academic,<br />

tertiary care medical center that has been ongoing since July<br />

2011. Adult patients (≥ 20 years), who present to the ED with severe<br />

abdominal pain (pain score 10 out of 10) are surveyed at the end of<br />

their ED visit regarding their pain, care received, and satisfaction levels.<br />

Quality metrics of pain care received as well as covariates (age,<br />

gender, ethnicity, Charlson comorbidity score, etc.) are abstracted<br />

from the medical record.<br />

RESULTS: Between July 7 and November 14, 2011, 90 subjects<br />

meeting inclusion criteria were surveyed. There were no significant<br />

differences between older adults (65+ years, 16%) and younger<br />

adults (20-64 years, 84%) in their surveyed pain scores, time to first<br />

analgesic administration, nor overall receipt of analgesics. There was<br />

also no difference in pain care satisfaction. When comparing the 69%<br />

of patients satisfied with pain care versus the 31% who were unsatisfied,<br />

those who were satisfied had lower surveyed pain scores (5.64 vs.<br />

8.88, p < 0.0001) and were less likely to want more analgesics (37% vs.<br />

86%, p < 0.0001). Unsatisfied patients waited longer for administration<br />

of first analgesic (trend, p = 0.09). There was, however, no significant<br />

difference in analgesic administration (86% of unsatisfied received<br />

analgesics vs. 85% of satisfied).<br />

CONCLUSIONS: Pain care satisfaction is associated with lower<br />

pain scores and decreased desire for additional analgesics. Contrary<br />

to growing evidence of poorer ED pain care for older adults, subjects<br />

in this cohort appear to receive equivalent care to their younger<br />

counterparts. Older and younger adults received and had analgesics<br />

administered in similar time frames; they also had similar pain scores<br />

and levels of satisfaction. This is the opposite of recent studies and<br />

may indicate that both the type (abdominal versus other pain) and<br />

severity of pain described as well as the quality indicators used to define<br />

appropriate care may impact the level of discrepancy observed.<br />

B31<br />

Functional Impairment and Disability during the Last Two Years<br />

of Life.<br />

A. K. Smith,Y. Miao,W. Boscardin, K. Covinsky. Medicine, Division of<br />

<strong>Geriatrics</strong>, University of California, San Francisco, San Francisco, CA.<br />

Supported By: NIA, NCRR.<br />

Background: We know little about the national prevalence of<br />

disability at varying points across the last years of life.<br />

Methods: Data are from participants ages 50+ who died in the<br />

Health and Retirement Study (HRS) between the years 1995 and<br />

2008. Each participant was interviewed once in the last 24 months of<br />

life. We used the HRS interview closest to death to reconstruct national<br />

estimates of the monthly prevalence of functional impairment<br />

and disability in the two years prior to death. Measures of functional<br />

impairment and disability included: IADL difficulty (Difficulty with<br />

cooking, shopping, using telephone, taking medications, managing<br />

money); ADL dependence (requires assistance with dressing,<br />

bathing, eating, transferring, walking across the room, and toileting).<br />

We estimated the predicted probability of functional impairment or<br />

disability by age at death and gender, adjusting for race or ethnicity,<br />

educational level, net worth, and proxy status.<br />

Results: There were 7624 decedents (mean age at death 80,<br />

52%% women, 84% White, 10% African-<strong>American</strong>, 4% Latino, 27%<br />

proxy interview). The unadjusted prevalence of all forms of functional<br />

impairment rose linearly over the last two years of life (Table).<br />

The predicted prevalence of disability prior to death rose with advancing<br />

age. After adjustment for gender, race/ethnicity, educational<br />

level, net worth, and proxy status, the predicted prevalence of any<br />

ADL dependency for elders ages 50-69 12 months prior to death was<br />

24% (95% CI 18-29), compared to 29% (24-34) for ages 70 to 79, 37%<br />

(31-44) for ages 80 to 89, and 47% (41-54) for ages 90 and older (p for<br />

trend


P OSTER<br />

A BSTRACTS<br />

SES, adiposity and memory and executive function factor scores were<br />

assessed with multiple regression analyses (with age, sex, and race as<br />

covariates).<br />

Results: Higher levels of education and income were associated<br />

with higher memory (high vs. low education B = .41*** and income B<br />

= .28***) and executive function scores (high vs. low education B =<br />

.82*** and income B = .51***), and lower levels of adiposity. Small, but<br />

significant negative associations were found between adiposity indicators<br />

and cognitive function scores. However, coefficients for SES predictors<br />

remained relatively unchanged with the inclusion of adiposity<br />

indicators into analytic models, suggesting that adiposity indicators did<br />

not mediate observed SES variations in levels of cognitive functioning.<br />

Conclusion: Both lower SES and greater adiposity are associated<br />

with lower levels of cognitive functioning. Those of lower SES<br />

also have significantly greater levels of adiposity. However, results do<br />

not support adiposity as a mediator of SES variations in cognitive<br />

function. An important objective for future research is the identification<br />

of other biomedical and behavioral variables that may underlie<br />

SES disparities in cognitive function.<br />

B33<br />

Prediction of 5-Year Risk of Becoming Dependent in Activities of<br />

Daily Living in Community-Dwelling Older Adults.<br />

D. H. Kim, 1,3 E. Newton, 2 L. A. Lipsitz. 1,2 1. Gerontology, Beth Israel<br />

Deaconess Medical Center, Boston, MA; 2. Institute for Aging<br />

Research, Hebrew SeniorLife, Boston, MA; 3. Epidemiology, Harvard<br />

School of Public Health, Boston, MA.<br />

Supported By: Dr. Kim is supported by John A. Hartford Center of<br />

Excellence Award.<br />

Background: Several risk factors have been identified for activity<br />

of daily living (ADL) dependence, but it remains unclear how to<br />

optimally combine them into a simple clinical prediction model.<br />

Methods: Using data from the Established Populations for Epidemiologic<br />

Studies of the Elderly, a prospective cohort of community-dwelling<br />

older adults, we developed and validated a prediction<br />

model of ADL dependence, based on self-reported information and<br />

brief examination. In the derivation set (n=7,982), we used Cox proportional<br />

hazards regression to develop a risk score that predicted<br />

the 5-year risk of becoming dependent in 3 or more ADLs for at least<br />

2 consecutive years, or at 1 year followed by death in the subsequent<br />

year. We tested the score in the validation set (n=3,993), and examined<br />

its relations to hospitalizations and mortality within 5 years.<br />

Results: During 5 years, the incidence rate of ADL dependence<br />

was 2% in both derivation set (663/34,382 person-years) and validation<br />

set (359/17,128 person-years). A risk score calculated using age,<br />

income, visual impairment, self-rated health, diabetes mellitus, stroke,<br />

cognitive function, and self-reported upper and lower extremity function,<br />

showed good agreement between expected and observed absolute<br />

risks and excellent discrimination (C statistic, 0.80 in the derivation<br />

set and 0.77 in the validation set). The score predicted<br />

mortality as well as recurrent hospitalizations for myocardial infarction,<br />

stroke, cancer, and fracture within 5 years.<br />

Conclusions: A simple risk score based on self-reported information<br />

and brief cognitive assessment can accurately predict a persistent,<br />

severe form of disability within 5 years.<br />

B34<br />

The Utilization of HEDIS High-Risk Medications in Veteran’s<br />

Administration Nursing Homes.<br />

D. M. Dosa, 2,1 O. Intrator, 2,1 S. Hyde. 2 1. Research Enhancement<br />

Award Program, Providence VA Medical Center, Providence, RI; 2.<br />

Medicine, Brown University, Providence, RI.<br />

Supported By: Veteran’s Administration-(Dosa-Career<br />

Development Award)<br />

Background: Nursing homes (or Community Living Centers as<br />

they are referred to within the Veteran’s Administration) have been<br />

identified by the Institute of Medicine (2000) as the most common<br />

site for Adverse Drug Events (ADE) with over 800,000 estimated<br />

prescription related errors annually. Such errors in the long term care<br />

environment have been associated with a high degree of morbidity<br />

and mortality. A common error described in the literature is the utilization<br />

of high risk medications in the elderly—a population most<br />

likely to experience morbidity relative to ADEs. The purpose of this<br />

study was therefore to evaluate the use of prescriptions classified by<br />

the Healthcare Effectiveness Data Information Set (HEDIS) as high<br />

risk medications over time in VA Community Living Centers (CLCs)<br />

and assess variability by region and institution.<br />

Methods: Nursing home Minimum Data Set records from calendar<br />

year 2004-2009 were merged with VA Decision Support System<br />

Pharmacy Data to identify residents of Community Living Centers<br />

who received at least one medication on the HEDIS high risk list for<br />

the elderly.<br />

Results: Between 2004 and 2009, a total of 25,105 out of 186,986<br />

(Average=13.81%, SD=5.93%) veterans admitted to a CLC received<br />

at least one HEDIS high risk medication. Annual proportion of CLC<br />

veterans using HEDIS medications varied among CLCs from 3.6%<br />

to 44.2% and among VISNs from 7.2% (VISN22) to 22.6%<br />

(VISN10). Steady reduction in the use of high risk medications was<br />

noted, however, between 2004 and 2009. In 2004, the average proportion<br />

of veterans using HEDIS medications in any CLC was 15.0%<br />

(SD=7.2, Min= 2.9%, Max=47.1%); by 2009 the average rate was<br />

6.4% (SD=4.6; Min= 0.3%, Max=30.6%).<br />

Conclusions: The utilization of high risk medications at VA<br />

CLCs has improved over time but significant variation exists between<br />

homes. More work needs to be conducted to determine if patient specific<br />

and/or facility factors predict utilization of HEDIS medications<br />

amongst elderly nursing home veterans at high risk for ADEs.<br />

B35<br />

Risk Factors for Readmissions in Patients 65 or Older Admitted For<br />

Pneumonia.<br />

H. Rahbar, 1,2 O. Abreu-Lanfrranco, 1,2 A. Singh, 2,4 M. Tims, 2<br />

B. Ramasamy, 2 C. Biedron, 1,2 L. Mody, 3 K. S. Kaye. 1,2 1. Wayne State<br />

Medical School, Detroit, MI; 2. Detroit Medical Center, Detroit, MI; 3.<br />

University Of Michigan, Ann Arbor, MI; 4. Fuqua School of Business,<br />

Duke University, Durham, NC.<br />

Supported By: MSTAR Grant<br />

Background: Pneumonia is one of the most common infections<br />

leading to inpatient visits and is an important cause of morbidity and<br />

mortality, particularly in older adults. Recently Medicare began decreasing<br />

coverage for all-cause readmissions within the 30-day discharge<br />

period for patients who were admitted with a primary diagnosis<br />

of pneumonia. This study aimed to identify risk factors for hospital<br />

readmission within a 30-day period following hospitalization for<br />

pneumonia in adults > 65 years of age.<br />

Methods: This study was conducted at Detroit Medical Center,<br />

an 8-hosital tertiary care health system. Retrospective chart review<br />

was conducted for patients > 65 years old with primary diagnosis of<br />

pneumonia from January 2010 to March 2011, and data pertaining to<br />

demographics, comorbid conditions, functional status and medications<br />

were abstracted. “Cases” who experienced readmission within<br />

30 days of discharge for any reason were identified; and were compared<br />

to “controls” who were matched to cases by hospital and calendar<br />

time of initial admission.<br />

Results: Eighty cases who were readmitted within 30 days were<br />

compared to 80 controls that were readmitted after an initial pneumonia<br />

diagnosis, after matching a total of 160 patients were analyzed.<br />

Cases and controls had similar demographics (Mean Age of 77.7 +8.2,<br />

54.4% were female; and 55% were African <strong>American</strong>) and functional<br />

status. Cases were more likely to have diabetes than controls (50%<br />

and 30%, p=.015) and a were more likely to have a Braden Score < 16<br />

(36% and 20%, p=.013). Cases also had a greater severity of illness as<br />

S84<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

measured by CURB65, Pneumonia Severity Index [PSI] and Charlson’s<br />

Comorbid Index. Cases also had significantly more discharge<br />

medications than controls (median of 12.36 and 10.53, p=. 009) and<br />

were more likely to have received influenza vaccination in the year<br />

prior to initial hospital admission (59% and 41%, p=.009).<br />

Discussion: Among older adults, Braden Score was an objective,<br />

strong predictor of readmission following pneumonia hospitalization.<br />

The association between prior receipt of influenza vaccination and<br />

increased likelihood of readmission was unexpected and warrants<br />

further investigation.<br />

B36<br />

IS LENS TRANSPARENCY ASSOCIATED WITH<br />

CARDIOVASCULAR OR METABOLIC DISEASE OR<br />

COGNITIVE FUNCTION IN OLDER WOMEN? DEFINING A<br />

NEW BIOMARKER OF AGING.<br />

J. Sanders, A. Nau, Y. Conley, R. Boudreau, L. Niedernhofer,<br />

L. Kuller, A. Newman. University of Pittsburgh, Pittsburgh, PA.<br />

Background: Few primary markers of aging are validated in<br />

human population studies. The lens is of interest because transparency<br />

can be measured accurately, noninvasively, and repeatedly<br />

throughout life. To evaluate the lens as a biomarker of aging we<br />

tested the association of lens transparency and cataract surgery to<br />

markers of aging and disease including risk factors for coronary atherosclerosis,<br />

coronary artery calcium (CAC), fasting plasma glucose<br />

or insulin, cognitive function and ApoE genotype. Methods: We<br />

measured lens transparency with Scheimpflug photography (N=136)<br />

and cataract surgery with self-report (N=231) in participants of the<br />

Healthy Women Study (mean (SD) age 73.3 (1.7) years). Atherosclerosis<br />

risk factors (age, smoking, waist circumference, BMI, lipids,<br />

blood pressure, fasting glucose and insulin, medication use) were<br />

measured concurrently with lens transparency and 13 years previously.<br />

CAC was measured with electron beam tomography at the<br />

time of lens measurements and ~7, 10, and 13 years previously. Cognitive<br />

indicators included the Modified Mini Mental Status Exam and<br />

ApoE genotype. Results: Cross-sectionally, cataract surgery was associated<br />

with larger waist circumference and diabetes (P


P OSTER<br />

A BSTRACTS<br />

care (OR 1.93, 95% CI, 1.67-2.24 for high-risk antihistamines; OR<br />

5.97, 95% CI 0.76-47.03 for high-risk cardiac drugs; OR 1.99, 95% CI<br />

1.29-3.07 for psychotropics). Index exposure to high-risk cardiac<br />

drugs also significantly increased musculoskeletal adverse outcomes<br />

(OR 2.28, 95% CI 1.76-2.96) but incident exposure to psychotropics<br />

did not significantly increase gastrointestinal adverse outcomes (OR<br />

1.14, 95% CI 0.75-1.72). Conclusion: Incident exposure to HRME is<br />

associated with adverse outcomes within one year following index<br />

day in senior veterans with chronic pain. Further research is needed<br />

to develop intervention measures to limit such exposure.<br />

B39<br />

Novel predictors of new antibiotic resistant organism (ARO)<br />

colonization in nursing home (NH) residents.<br />

L. Min, 1,2 L. Mody. 1,2 1. Medicine, University of Michigan, Ann Arbor,<br />

MI; 2. GRECC, VA Health Care Systems, Ann Arbor, MI.<br />

Supported By: Agency for Healthcare Quality and Research (Min),<br />

VA Healthcare System Geriatric Research Clinical Care Center<br />

(GRECC, Min and Mody), Hartford Foundation (Min), NIA-<br />

Pepper Center (Min, Mody), NIH (K23AG028943 and<br />

R01AG032298 Mody), NIH-LRP (Min), T Franklin Williams<br />

(Mody).<br />

Objective: NH residents with functional disability are at risk for<br />

ARO colonization. We tested (1) whether function predicts AROs independent<br />

of clinical risk factors (co-morbidities, wounds, hospitalization)<br />

& (2) whether specific activities of daily living (ADLs) are<br />

associated with higher risk due to greater nursing contact time (e.g.<br />

feeding) or bodily exposure (e.g. toiling).<br />

Methods: Longitudinal surveillance of 178 NH residents, half<br />

with indwelling device, actively cultured at multiple anatomic sites at<br />

baseline and every 30 days until discharge or 1 yr.<br />

Outcomes: Time to new colonization for methicillin-resistant<br />

Staphylococcus aureus (MRSA), vancomycin-resistant enterococci<br />

(VRE), and resistant gram-negative bacteria (GNB-R). A new ARO<br />

was defined as a positive culture following a negative previous culture<br />

for that ARO. A patient could have multiple new colonizations if<br />

negative cultures were collected in between positive ARO cultures.<br />

Control variables (baseline): device, functional impairment (overall<br />

vs 6 ADLs [Table]), co-morbidity (Charlson index [CCI] vs conditions<br />

from CCI). Time-varying predictors: interval hospitalization or<br />

wound/pressure ulcer. We modeled time to new ARO using multiplefailure<br />

Cox proportional hazard models to allow for fluctuation in<br />

colonization status.<br />

Results: 111 had ≥2 visits (729 follow-up visits total). 76 had at<br />

least 1 new ARO colonization, with multiple new colonizations occurring<br />

in 51 residents.<br />

Conclusions: Besides known risk factors such as hospitalization,<br />

indwelling devices, and wounds, we identified contact-intense ADLs<br />

such as assistance in feeding and walking & chronic conditions such<br />

as heart failure and hemiparesis that predict new ARO colonization<br />

in NH residents.<br />

* p


P OSTER<br />

A BSTRACTS<br />

of all ACS hospitalized in 1 year in the Florence area, Italy, patients<br />

aged 75+ years with ST-segment or non-ST-segment elevation myocardial<br />

infarction (STEMI, NSTEMI) were selected. Background<br />

risk was assessed with the Silver Code (SC), a validated tool based on<br />

administrative data, which predicts mortality in subjects aged 75+<br />

hospitalized for medical reasons. Multivariable odds ratio with 95%<br />

confidence interval (CI) for PCI application, and hazard ratio (HR)<br />

for 1-year mortality by PCI utilization were calculated. RESULTS: In<br />

698 patients (358 women, mean age 83 years, STEMI=176), for each<br />

point increase in the SC score the odds for the use of PCI decreased<br />

by 11%, while the hazard of 1-year mortality increased by 10%, adjusting<br />

for comorbidity, STEMI vs. NSTEMI, Killip class, low<br />

glomerular filtration rate, anaemia, low platelets and peak troponin<br />

tertile. PCI reduced 1-year mortality progressively more with increasing<br />

SC score, with HR (95% CI) of 0.8 (0.19-1.21), 0.41 (0.18-0.45),<br />

0.41 (0.23-0.74), and 0.26 (0.14-0.48) for SC scores of 0-3, 4-6, 7-10,<br />

and 11+. CONCLUSIONS: Exclusion of older ACS patients from<br />

PCI increases with increasing background risk. This procedure, conversely,<br />

appears to be more effective in older patients with more severe<br />

background risk, as indicated by the SC score.<br />

B42<br />

A meta-analysis of mortality rates associated with comorbid<br />

depression among older adults with diabetes.<br />

M. Park, W. Katon. University of Washington, Seattle, WA.<br />

Supported By: NIMH 2 T32 MH 73553-6<br />

Background: Comorbid depression has shown a strong association<br />

with increased negative health outcomes among those with medical<br />

illness.<br />

Objectives: To examine mortality rates associated with comorbid<br />

depression among the older adults with diabetes.<br />

Methods: A systematic literature search, appraisal, and metaanalysis<br />

were conducted. Using various combinations of keywords<br />

(depression, diabetes, mortality), we searched five databases: Medline,<br />

CINAHL, Cochrane Library, Embase, and Science Direct. Selection<br />

criteria include English-language, peer-reviewed articles published<br />

between January 2000-June 2011, reporting hazard ratio for<br />

mortality from longitudinal and prospective epidemiological studies,<br />

and study of older adults.<br />

From 769 potentially relevant articles, we found four articles<br />

that met the selection criteria. The studies reported outcomes of<br />

29312 elderly persons.<br />

Findings: The weighted hazard ratios were 1.38 (95% CI: 1.24,<br />

1.52). The older adults with comorbid depression and diabetes experience<br />

approximately 38% elevated risk for death from all cause compared<br />

to those with only diabetes.<br />

Conclusion: Screening and treating depression among older<br />

adults with diabetes is important for better health outcomes in older<br />

adults populations<br />

Forest Plot<br />

B43<br />

Epidemiology of Restricting Fatigue in Older Adults.<br />

N. de Rekeneire, L. Leo-Summers, T. Gill. Yale University School of<br />

Medicine, New Haven, CT.<br />

Supported By: No Financial Disclosure<br />

Background: Fatigue is a frequent complaint among older adults<br />

and has been linked to functional decline and disability. Longitudinal<br />

data on fatigue leading to restricted activity are sparse. Our objectives<br />

were to estimate the rate of restricting fatigue among community-living<br />

older adults and to determine whether the rates differ according<br />

to age, sex, race and physical frailty.<br />

Methods: Participants were members of the Precipitation<br />

Events Project (PEP), a longitudinal study of 754 nondisabled community-living<br />

older adults aged 70+ years who were evaluated<br />

monthly for over 10 years. Restricting fatigue was defined as staying<br />

in bed for at least ½ a day and/or cutting down on one’s usual activities<br />

because of fatigue for 3+ consecutive months. Physical frailty was<br />

defined on the basis of slow gait speed.<br />

Results: The mean age of our study sample was 78.4 years; 64.6%<br />

were women, 90.5% were white and 42.7% had physical frailty. During a<br />

median follow-up of 111 months,66 (24.7%) of the men and 171 (35.1%)<br />

of the women developed an episode of restricting fatigue (p= 0.003).<br />

Among the 237 (31.4%) participants with restricting fatigue, the median<br />

(interquartile range) number of episodes was 1.0 (1.0-2.0).The mean duration<br />

of the 459 episodes of restricting fatigue was 3 months (3-4) and<br />

did not differ according to age, sex, race or physical frailty. The overall<br />

rate of restricting fatigue was 6.7 per 1000 person-months. As shown in<br />

the Table, rates were higher in women than men (p< 0.001), participants<br />

80+ yrs than those 70-79 yrs (p=0.045) and participants who were physically<br />

frail vs. not frail (p< 0.001), but did not differ according to race.<br />

Conclusions: Among community-living older adults, restricting<br />

fatigue is common. Women, the oldest old and those with physical<br />

frailty had higher rates of restricting fatigue. Additional research is<br />

warranted to better understand the characteristics associated with the<br />

development and recurrence of restricting fatigue in older persons.<br />

B44 Encore Presentation<br />

Trajectories of Positive Aging: Observations from the Women’s<br />

Health Initiative Study.<br />

O. Zaslavsky, 1 N. F. Woods, 1 B. Cochrane, 1,2 A. LaCroix . 1,2 1.<br />

University of Washington, Seattle, WA; 2. Fred Hutchinson Cancer<br />

Reserach Institute, Seattle, WA.<br />

Background: Our analyses of data from the Women’s Health<br />

Initiative (WHI) participants yielded a two-factor index of positive<br />

aging: physical-social functioning and emotional functioning. These<br />

two factors predicted years of healthy living, years of independent living<br />

and mortality. Based on these findings, we then described trajectories<br />

of positive aging indicators over time and identified those baseline<br />

characteristics that predict trajectory group membership.<br />

Methods: Women ages 65 years and older who enrolled in one<br />

or more WHI clinical trials and had data available on the positive<br />

aging indicators at baseline and years 1, 3, 6 and 9 were included in<br />

these analyses (N=2,281). We used Group-Based Trajectory Modeling<br />

to identify distinct subgroups of individuals, following a similar pattern<br />

of change over time on the two factors of positive aging. Then,<br />

multinomial logistic regression was conducted to identify baseline<br />

predictors of membership in these positive aging trajectories.<br />

Results: A 5-trajectory model was chosen to best represent the<br />

data. These trajectories included Low Maintainer (8.3%), Low Improver<br />

(11%) Moderate Decliner (12.5%), Moderate Maintainer<br />

(29.7%) and High Maintainer (38.6%) groups for Physical-Social<br />

Functioning and Low Maintainer (3.1%), High Improver (8.7%),<br />

Moderate Decliner (8.6%), Moderate Maintainer (29.7%), High<br />

Maintainer (55.8%) groups for Emotional Functioning. Using the<br />

Low Maintainer group as the reference category for Physical-Social<br />

Functioning, the High Maintainer group was younger, predominantly<br />

white, and more physically active. High Maintainers also had lower<br />

BMI, less pain and depression, fewer somatic symptoms, fewer chronic<br />

conditions, higher optimism, and either mild or moderate alcohol consumption.<br />

Similarly, odds ratios using the Low Maintainer group as the<br />

reference category for Emotional Functioning showed that High<br />

Maintainers had less pain and depression, fewer somatic symptoms,<br />

fewer negative life events, higher optimism, and greater social support.<br />

AGS 2012 ANNUAL MEETING<br />

S87


P OSTER<br />

A BSTRACTS<br />

Conclusion: Aging women are heterogeneous in terms of positive<br />

aging indicators over time. Somatic experiences (i.e., pain, symptoms)<br />

and number of chronic conditions were the strongest predictors<br />

of membership in non-robust trajectories for Physical-Social<br />

Functioning and depression was the strongest predictor of Emotional<br />

Functioning.<br />

B45<br />

Patterns of Comorbid Chronic Diseases and Geriatric Conditions<br />

Associated with Greater Severity of Chronic Obstructive Pulmonary<br />

Disease in Older Adults.<br />

S. S. Chang, T. M. Gill. <strong>Geriatrics</strong>/Internal Medicine, Yale School of<br />

Medicine, New Haven, CT.<br />

Supported By: This research was funded in part by the John A.<br />

Hartford Foundation for Excellence in Geriatric Medicine at Yale<br />

University (Grant 2007-0009), the Yale Claude D. Pepper Older<br />

<strong>American</strong>s Independence Center (National Institute on Aging P30<br />

AG021342), and Clinical Translational Science Award (Grant UL1<br />

RR024139/ KL2 RR024138) from the National Center for Research<br />

Resources (NCRR), a component of the National Institutes of<br />

Health (NIH), and NIH roadmap for Medical Research.<br />

Background:<br />

Chronic obstructive pulmonary disease (COPD) is the third<br />

leading cause of death in the U.S. and increases in prevalence with<br />

advancing age. Extrapulmonary diseases, which occur throughout all<br />

stages of COPD, can complicate its management and negatively impact<br />

long-term prognosis, especially as COPD worsens. Geriatric<br />

conditions, which confer high risk of adverse health outcomes, add to<br />

the complexity of effectively managing COPD in older adults. Identifying<br />

patterns of comorbid chronic diseases and geriatric conditions<br />

which are associated with greater COPD severity will provide<br />

insight into enhanced approaches to optimize outcomes in older<br />

adults with COPD.<br />

Methods:<br />

Data were drawn from the Cardiovascular Health Study, a<br />

prospective multi-center cohort of U.S. community-dwelling adults<br />

aged 65-80 who completed baseline spirometry (N=3583). COPD was<br />

established by spirometric criteria for airflow limitation, using the<br />

Lambda-Mu-Sigma (LMS) method, an approach which accounts for<br />

age-related changes in lung function. We performed ordinal logistic<br />

regression to evaluate the relationships between patterns of comorbidities<br />

and COPD severity, staged according to LMS-derived spirometric<br />

Z scores (mild, moderate, and severe) and the <strong>American</strong> Thoracic<br />

<strong>Society</strong> (ATS-DLD-78) dyspnea scale (grades 1-5). Models<br />

were adjusted for age, gender, education, and smoking.<br />

Results:<br />

Of the participants with COPD (13.8%), comorbid hypertension<br />

(HTN) and arthritis (28.0%), atherosclerotic vascular disease<br />

(AVD) and HTN (24.3%), and HTN and polypharmacy (11.1%)<br />

were among the most frequent comorbidity patterns. Individuals with<br />

COPD who had comorbid HTN and arthritis (adjusted OR=1.60,<br />

95%CI=1.08-2.38), AVD and HTN (1.55, 1.03-2.32), and HTN and<br />

polypharmacy (1.95, 1.09-3.46) were more likely than those without<br />

these respective comorbidities to have greater COPD severity, assessed<br />

by spirometry. Similarly, having comorbid HTN and arthritis<br />

(adjusted OR=1.63, 95%CI=1.11-2.39), AVD and HTN (1.65, 1.11-<br />

2.44), and HTN and polypharmacy (2.70, 1.57-4.63) was significantly<br />

associated with worsening dyspnea.<br />

Conclusions:<br />

Specific patterns of comorbid chronic diseases and geriatric conditions<br />

are associated with worsening COPD. These findings could inform<br />

the design of interventions to improve outcomes in older adults<br />

with COPD.<br />

B46<br />

Cognitive Status and Care-seeking Behavior in Elderly Patients with<br />

Acute Heart Failure.<br />

S. N. Levin, 1 A. Hajduk, 2 D. M. Lessard, 2 F. A. Spencer, 3<br />

J. H. Gurwitz, 1,2 R. J. Goldberg, 1 J. S. Saczynski. 1,2 1. Meyers Primary<br />

Care Institute and Division of Geriatric Medicine, UMASS Medical<br />

School, Worcester, MA; 2. Department of Quantitative Health<br />

Sciences, UMASS Medical School, Worcester, MA; 3. Department of<br />

Medicine, McMaster University, Hamilton, ON, Canada.<br />

Background: Heart failure (HF) is a chronic disease characterized<br />

by acute exacerbations and high rates of rehospitalization.<br />

In response to worsening symptoms, patients are advised to<br />

promptly seek medical care. Cognitive impairment (CI) is highly<br />

prevalent in patients with HF and may impact their decision or<br />

ability to seek treatment for an acute exacerbation. We examined<br />

the association of impairment in specific cognitive domains and<br />

time to emergency department (ED) presentation following acute<br />

HF symptom onset.<br />

Methods: The sample included 564 patients hospitalized with<br />

acute HF (mean age = 72 years, 45% female) between 2007 and 2010<br />

at several tertiary care and community medical centers. CI was assessed<br />

in 3 domains (memory, processing speed, executive function)<br />

using standardized measures. Time to ED presentation was collected<br />

from a structured interview during hospitalization. The time interval<br />

between the patient’s latest reported symptoms of HF and ED presentation<br />

was assessed.<br />

Results: More than three quarters (78.2%) of patients were impaired<br />

in at least one cognitive domain. The average pre-hospital<br />

delay for patients who experienced acute symptoms of decompensated<br />

HF was 4.2 days (100 ± 12 hr) while their median delay time<br />

was 14 hours. Over two fifths (43%) of all participants waited at<br />

least one day before presenting to the ED. Compared to patients<br />

with intact cognitive function, those with CI had a longer delay to<br />

ED presentation following symptom onset (median delays: 15.0 hr<br />

vs. 8.6 hr; p = 0.03). Pre-hospital delay times varied according to specific<br />

cognitive domains. Patients with deficits in memory or processing<br />

speed had longer median delay times than unimpaired patients<br />

(memory: 23.2 hr vs. 11.4 hr, p = 0.02; Speed: 19.4 hr vs. 11.3 hr, p =<br />

0.05). Executive function was not associated with duration of prehospital<br />

delay.<br />

Conclusion: Cognitive impairment is common among patients<br />

hospitalized for HF and is associated with delays in seeking emergency<br />

care. Interventions to enhance the care of patients with acute<br />

heart failure should take into consideration the important impact of<br />

cognitive status.<br />

S88<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

B47<br />

The Impact of Cognitive Impairment on Mortality in Older Adults<br />

with Heart Failure.<br />

T. Gure, 1 C. Blaum, 1,3 J. Ha, 1 S. Hummel, 4 L. Min, 1,3 C. Cigolle, 6,3<br />

A. Galecki, 1 K. Langa. 2,5 1. Geriatric & Palliative Medicine, University<br />

of Michigan, Ann Arbor, MI; 2. General Internal Medicine, University<br />

of Michigan, Ann Arbor, MI; 3. GRECC, VA Healthcare System, Ann<br />

Arbor, MI; 4. Cardiovascular Medicine, University of Michigan, Ann<br />

Arbor, MI; 5. VA Center for Practice Management & Outcomes<br />

Research, VA Healthcare System, Ann Arbor, MI; 6. Family Medicine,<br />

University of Michigan, Ann Arbor, MI.<br />

Supported By: The National Institute on Aging (NIA) provides<br />

funding for the Health and Retirement Study (U01 AG09740)<br />

which is performed at the Institute for Social Research, University<br />

of Michigan; NIA grants R01 AG027010 and R01 AG030155<br />

(Langa); Ann Arbor VA Geriatric Research, Clinical and Education<br />

Center (Blaum, Cigolle, and Min); NHLBI grant K23 HL109176<br />

(Hummel); AHRQ grants R21 HS017621 and R21 HS 019459<br />

(Min); NIA grant K08 AG031837 (Cigolle); NIA Diversity<br />

Supplement award R01 AG027010-02S1 (Gure); John A. Hartford<br />

Foundation Center of Excellence (Cigolle, Gure, and Min); the NIA<br />

Claude D. Pepper Center Research Career Development Core<br />

(Cigolle, Gure, and Min); National Center for Research Resources<br />

UL1 RR024986 (Gure).<br />

Background: Cognitive impairment (CI) is highly prevalent in<br />

older adults with heart failure (HF), yet our understanding of the impact<br />

of CI on mortality in this population is limited. We aimed to estimate<br />

the risk of death over 4 yrs of follow-up in older adults with<br />

HF, stratified by cognitive function. Methods: We used the 2004 wave<br />

of the Health and Retirement Study (HRS) linked to Medicare<br />

claims. A HF case-finding algorithm identified HRS respondents<br />

with highest likelihood of a HF diagnosis (“HF patients”). CI was assessed<br />

using previously published HRS population-based screening<br />

measures. Death was identified using the HRS data verified by National<br />

Death Index. We tested the relationship between cognitive<br />

function and mortality in HF patients using unweighted Kaplan-<br />

Meier survival curves and Cox proportional hazard models. Results:<br />

Of 707 HF patients identified, 286 (42%) died over the 4 yr-period.<br />

Survival of older HF patients was significantly influenced by their<br />

cognitive status (p


P OSTER<br />

A BSTRACTS<br />

B49<br />

Prevalence and Correlates of Self-Reported Medication Non-<br />

Adherence among Older Adults with Diabetes Mellitus, Coronary<br />

Heart Disease, and/or Hypertension.<br />

Z. A. Marcum, 1 Y. Zheng, 1 S. Perera, 1 E. Strotmeyer, 1 A. Newman, 1<br />

E. Simonsick, 2 R. Shorr, 3 D. C. Bauer, 4 J. M. Donohue, 1 J. T. Hanlon. 1<br />

1. University of Pittsburgh, Pittsburgh, PA; 2. NIA Intramural<br />

Research Program, Baltimore, MD; 3. VA GRECC, Gainesville, FL; 4.<br />

UCSF, San Francisco, CA.<br />

Supported By: Supported in part by National Institute on Aging<br />

grants and contracts (R56AG 0207017, P30AG024827, T32 AG021885,<br />

K07AG033174, R01AG034056, 3U01 AG012553, N01-AG-6-2101,<br />

N01-AG-6-2103, and N01-AG-6-2106), a National Institute of Mental<br />

Health grant (R34 MH082682), a National Institute of Nursing<br />

Research grant (R01 NR010135), Agency for Healthcare Research<br />

and Quality grants (R01 HS017695, K12 HS019461, R01HS018721),<br />

and a VA Health Services Research grant (IIR-06-062). This research<br />

was also supported in part by the Intramural Research program of the<br />

NIH, National Institute on Aging.<br />

Background: Medication non-adherence is common among<br />

older adults with chronic co-morbidity, but the underlying factors are<br />

largely unexplored. This study examines the prevalence and correlates<br />

of self-reported medication non-adherence among communitydwelling<br />

older adults with chronic cardiovascular conditions (i.e., diabetes<br />

mellitus [DM], coronary heart disease [CHD], and/or<br />

hypertension [HTN]).<br />

Methods: The study sample (mean [SD] age 82.1 [2.8], 52.5% female,<br />

37.0% black) included 897 members from the Health Aging<br />

and Body Composition cohort (n=3075) with any DM (n=338;<br />

37.7%), CHD (n=381; 42.5%), or HTN (684; 76.3%) at year 10. Selfreported<br />

medication non-adherence was measured by the 4-item<br />

Morisky Medication Adherence Scale (MMAS) and 2-item Cost-Related<br />

Non-Adherence scale (CRN) at year 11; these scales separately<br />

assess different reasons for medication non-adherence. We used multivariable<br />

logistic regression models with backward selection to identify<br />

correlates (i.e., demographic, health status, and access to care factors)<br />

of non-adherence for each measure.<br />

Results: Non-adherence by MMAS and CRN was reported by<br />

40.7% and 7.7%, respectively. Non-adherence by MMAS was associated<br />

with black race (adjusted odds ratio=AOR=1.85, 95% interval=1.25-2.74)<br />

and hospitalization in the previous 6 months<br />

(AOR=1.97, 95% interval=1.22-3.17). Non-adherence by CRN was<br />

associated with marital status (married vs. unmarried; AOR=0.47,<br />

95% interval=0.23-0.98) and money-related delay in medical care<br />

(AOR=6.94, 95% interval=2.41-19.97). Age, gender, and the total<br />

number of regularly scheduled medications were not associated with<br />

non-adherence by either MMAS or CRN.<br />

Conclusions: Self-reported medication non-adherence is common<br />

in older adults with chronic cardiovascular conditions, and nonadherence<br />

measured by CRN is less prevalent than MMAS. No correlates<br />

for non-adherence were detected consistently across both<br />

measures. Future studies should evaluate targeted interventions<br />

based on patient-specific modifiable barriers to improve medication<br />

adherence.<br />

B50<br />

Health Care Proxy Involvement and Satisfaction in Decision-<br />

Making for the Treatment of Infections in Nursing Home Residents<br />

with Advanced Dementia.<br />

C. K. Ankuda, 1 J. L. Givens, 2,3 S. L. Mitchell. 2,3 1. University of<br />

Vermont College of Medicine, Burlington, VT; 2. Division of<br />

Gerontology, Beth Israel Deaconess Medical Center, Boston, MA; 3.<br />

Hebrew SeniorLife Institute for Aging Research, Boston, MA.<br />

Supported By: National Institutes of Health (NIH)<br />

Background: Infections are common in advanced dementia, and<br />

health care proxies (HCPs) are often called upon to make treatment<br />

decisions. This study describes the awareness, involvement, and satisfaction<br />

of HCPs in decision making regarding infectious episodes for<br />

a cohort of nursing home (NH) residents with advanced dementia.<br />

Methods: From 2010-2011, data were prospectively collected<br />

from 135 NH residents with advanced dementia and their HCPs at 22<br />

Boston area facilities. For each infectious episode, information was<br />

obtained on whether the HCP: 1. could be contacted by study staff; 2.<br />

was aware of the infection; and 3. was involved in decision making.<br />

Multivariable logistic regression was used to determine resident,<br />

HCP and episode characteristics associated with HCP awareness of<br />

the infectious episode.<br />

Results: Residents experienced 287 infectious episodes (82 respiratory,<br />

114 urinary tract infection, 37 skin and 53 fever). HCPs were<br />

able to be contacted by study staff for 217/287 episodes. Once contacted,<br />

HCPs were aware of 94/217 (43%) of episodes, and of these,<br />

were involved in decision-making for 57/94 (61%). HCP awareness of<br />

the episode was associated with the HCP being the child of the resident<br />

(vs. other relationship) [adjusted odds ratio (AOR) 2.34, 95% CI<br />

1.19 – 4.59], female (AOR 2.79, 1.37-5.66), and the episode being<br />

treated with antibiotics (AOR 3.68, 1.56-8.66).<br />

Conclusions: The majority of infectious episodes in NH residents<br />

with advanced dementia do not involve HCPs in decision-making.<br />

Awareness of infections among HCPs is more likely for episodes<br />

treated with antibiotics, and when the HCP is the resident’s child and<br />

is female. These factors may help target infectious episodes that require<br />

greater attention with respect to better informing HCPs of their<br />

loved one’s health status.<br />

B51<br />

Can a patient navigator get older patients and their oncologists on<br />

the same page?<br />

E. Vig, 1,2 C. Clark, 2 R. Engelberg. 2 1. <strong>Geriatrics</strong>, VAPSHCS, Seattle,<br />

WA; 2. Medicine, University of Washington, Seattle, WA.<br />

Supported By: <strong>American</strong> Cancer <strong>Society</strong><br />

Background Older patients may approach cancer management<br />

decisions differently than younger patients. Although older patients<br />

may be more concerned about quality of life than cure, oncologists do<br />

not routinely elicit patients’ quality of life concerns. As a result, older<br />

patients and their oncologist may not be on the same page during office<br />

visits.<br />

We undertook a two phase pilot study to test whether a patient<br />

navigator intervention could facilitate shared decision-making between<br />

older patients with cancer and their oncologists.<br />

Methods In the study’s first phase, we interviewed oncologists,<br />

older cancer patients, and their family members about their decisionmaking,<br />

and whether/how a patient navigator might help. Interviews<br />

were recorded, transcribed, and analyzed using grounded theory<br />

methods.<br />

In the second phase, the patient navigator met with an older patient<br />

prior to an oncology appointment to identify his/her quality of<br />

life and other concerns. The navigator then accompanied the patient<br />

to the oncology appointment and debriefed afterwards. Several days<br />

later, an investigator debriefed separately with the oncologist and the<br />

patient/family. Content analysis and descriptive statistics were used to<br />

analyze study data.<br />

Results In the first phase, we recruited 9 oncologists from 2 clinics,<br />

12 of their patients, and 3 of their family members. Oncologists<br />

and patients thought navigators could be helpful by clarifying understanding,<br />

taking notes, and helping patients ask questions.<br />

In the second phase, the 9 oncologists identified 9 additional patients.<br />

Prior to the navigated visits, patients identified their main concerns<br />

(mean 3 concerns, range 1-5). During the visits, the navigator reminded<br />

the patient of concerns in 4 visits, facilitated discussion about<br />

referral to a pain specialist in 1 visit, clarified referral to a cardiologist<br />

in 1 visit, and clarified the follow up plan with the oncologist in 2 visits.<br />

Patients described the navigator as helpful, reported that all their<br />

S90<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

concerns had been addressed during the visit, and wished that navigator<br />

involvement could be ongoing. Oncologists described the presence<br />

of the navigator as helpful and not burdensome or intrusive.<br />

Conclusion A patient navigator who identifies older patients’<br />

concerns before an oncology visit, accompanies them to a visit, and<br />

debriefs with them afterwards can help to ensure that their concerns<br />

are elicited and addressed.<br />

B52<br />

Association of Experience with Illness and End-of-life Care with<br />

Advance Care Planning.<br />

H. Amjad, 1 V. Towle, 1 T. Fried. 1,2 1. Yale University School of<br />

Medicine, New Haven, CT; 2. VA Connecticut Healthcare System, West<br />

Haven, CT.<br />

Background: Advance care planning (ACP) remains an underused<br />

tool in medical care, and identifying factors associated with increased<br />

participation in ACP is important for the promotion of this<br />

health behavior. This study examines the relationship between previous<br />

experiences with illness and end-of-life care with the stages of<br />

change for six ACP behaviors.<br />

Methods: 304 individuals aged 65 and older were recruited from<br />

physician practices and a senior center. Participants were asked<br />

whether they had ever faced a life-threatening illness or surgery. They<br />

were also asked whether they had ever made a medical decision for<br />

someone who was dying, whether they knew someone who they believe<br />

had a bad death due to receiving too much or too little medical<br />

care, and whether they had experienced the death of a loved one who<br />

made his or her wishes about end-of-life known. Stages of change<br />

were assessed for six ACP behaviors: completion of a living will and<br />

healthcare proxy, communication with loved ones regarding use of<br />

life-sustaining treatments and quantity versus quality of life, and communication<br />

with physicians about these same topics. Mantel-Haenszel<br />

chi-square analysis was used to examine the association between<br />

each life experience and stages of change for each ACP behavior.<br />

Results: 84% of participants had experiences with their own illness<br />

or end-of-life care for a loved one. Personal experience with lifethreatening<br />

illness was not associated with increased readiness to participate<br />

in ACP behaviors except for discussing life-sustaining<br />

treatments with loved ones (p


P OSTER<br />

A BSTRACTS<br />

Conclusions: The study demonstrated that MED-SAIL is a valid<br />

brief screening tool to identify older adults with impaired capacity for<br />

remaining safe and independent in their current living environment.<br />

The tool will be useful for health and social service professionals<br />

working in the community.<br />

B55<br />

Differential regulation of mitochondrial biogenesis with Losartan in<br />

the heart and liver of young and aged mice.<br />

B. R. Manwani, H. Yang, C. Lin, J. Walston, P. Abadir. <strong>Geriatrics</strong>,<br />

Johns Hopkins University, Baltimore, MD.<br />

Supported By: National Institute of Aging<br />

Background<br />

The renin-angiotensin system (RAS) regulates multiple physiological<br />

functions through angiotensin (Ang) II type 1 (AT1R) and<br />

type 2 (AT2R) receptors. We recently identified a functional mitochondrial<br />

RAS, with AT2R located in inner mitochondrial membrane<br />

that decreases in number with age and increases with AT1R blocker<br />

losartan. Given the known relationship between aging and mitochondrial<br />

biogenesis, and the emerging understanding of local mitochondrial<br />

RAS system, we hypothesized that blocking AT1R with losartan<br />

in vivo would increase mitochondrial biogenesis and survival gene<br />

production.<br />

Methods<br />

10 young (20 wks) mice were equally divided into control group<br />

or treated with Losartan for 20 wks. 10 old (50 wks) mice were treated<br />

similarly. All mice were sacrificed at the same time and RNA isolated<br />

from liver and heart. For biogenesis, quantitative PCR was used to<br />

calculate CytB (mitochondrial gene)/GAPDH (nuclear gene) ratio<br />

and to measure mitochondrial survival genes Sirt1, Sirt3, Nampt, and<br />

PGC-1α. All data were analyzed using the Pfaffl method<br />

Results<br />

AT1R blockade increased the CytB/GAPDH ratio in the heart<br />

of treated young and old mice (3.84 fold and 4.37 fold increase respectively)<br />

but significant reduction in mitochondrial level was observed<br />

in the liver where the ratio in treated young and old mice was<br />

only 1.5% and 2.3% as much as their respective controls.<br />

Mitochondrial survival gene expression in the heart was not increased<br />

and PGC-1α, one of the main regulators that drive biogenesis,<br />

was in fact down-regulated by 50% and 55% in young and old<br />

treated mice respectively.<br />

Conclusion<br />

Older mice treated for 20 weeks with Losartan, irrespective of<br />

age, have increased mitochondrial biogenesis in the heart but not in<br />

the liver despite the fact that mitochondrial survival genes were not<br />

up-regulated in the heart. Mitochondrial survival genes and especially<br />

PGC-1α might have been up-regulated in the earlier phases of<br />

the treatment. The role of the RAS system in maintaining mitochondrial<br />

levels might therefore be a key mechanism in promoting<br />

healthy aging.<br />

Effects of AT1R blockade on mitochondrial biogenesis and survival<br />

genes expression in young and aged mice<br />

B56 Encore Presentation<br />

Cellular Senescence in Patients with Barrett’s Esophagus: A Pilot Study.<br />

E. Gorospe, J. Penfield, K. Wang. Department of Medicine, Mayo<br />

Clinic, Rochester, MN.<br />

BACKGROUND: Cellular senescence is an irreversible mechanism<br />

whereby cells enter a non-mitotic state as a response to oncogenic<br />

stress. Barrett’s esophagus (BE) is the leading risk factor for the<br />

development of esophageal adenocarcinoma, one of the fastest growing<br />

cancers in middle-aged and elderly Caucasian men.<br />

AIM: To assess if cellular senescence is present in BE as a tumor<br />

suppressing mechanism<br />

METHODS: We examined esophageal tissue from a series of 11<br />

patients (age 67.3 ± 7.9 y.o) who underwent clinically-indicated endoscopic<br />

mucosal resection (EMR) for BE. Cellular senescence was determined<br />

using the Senescent Cell Histochemistry Kit (Sigma<br />

CS0030, St. Louis, MO) that determines SA B-galactosidase activity,<br />

which is the gold standard for senescence. In addition, we assessed the<br />

expression of cyclins B1, B2, C, D1, D2, E1, F, G1, G2, H, T1 and T2;<br />

CDK 1A, 1B, 2A (p16), 2B (p15), 3, MCM2, MCM3, MCM4, RB1,<br />

RBBPB, RBL1, RBL2, RPA3 in biopsies taken from the Barrett’s<br />

esophagus segment. The biopsies were stored in RNAlater (Qiagen,<br />

Valencia, California) at -80 degrees Celsius until RNA purification.<br />

Tissue was then disrupted and homogenized in buffer solution. The<br />

lysate was then purified using an RNAeasy spin column (Qiagen, Valencia,<br />

California) and rinsed twice with 50 ul of RNAase free water.<br />

The RNA was then used to prepare cDNA using the RT First Strand<br />

Kit (Superarray, Frederick, MD) as per manufacturer’s instructions.<br />

The cDNA was placed with the RT qPCR mastermix with SYBR<br />

green and a reference dye, the mixture was then aliquoted across an<br />

expression array, thermal cycling was performed with real time amplification.<br />

Changes in gene expression were noted while internal array<br />

controls for genomic DNA contamination, efficiency of the RT, and<br />

the efficiency of the PCR were all found to be within specified norms.<br />

RESULTS: We detected senescent cells in 9 (81.85%) patients.<br />

The 2 patients who did not have senescence had non-dysplastic BE.<br />

The presence of senescence was further confirmed by the decreased<br />

expression of cell regulatory genes including a decrease in RB -197<br />

fold, p


P OSTER<br />

A BSTRACTS<br />

ferent than previously reported to be occurring in aging mice, highlighting<br />

the importance of confirming animal model data in people.<br />

B58<br />

An Isocaloric Low Protein Diet in Rodents: an Experimental Model<br />

of Frailty and/or Sarcopenia.<br />

P. Ammann, R. Rizzoli. Department of rehabilitation and geriatrics,<br />

Division of bone diseases, Geneva, Geneva, Switzerland.<br />

Frailty and sarcopenia are very frequent in the oldest old. Even<br />

if clinical diagnosis criteria are becoming recognized for both conditions,<br />

these disorders are still missing an operational definition and<br />

their pathophysiology remains still unclear. This is partially due to the<br />

lack of experimental models of acquired frailty and/or sarcopenia.<br />

To better understand the pathophysiology and potential therapeutic<br />

strategies of frailty and/or sarcopenia, we set up an experimental<br />

model in adult rats or mice. Animals were pair fed with an<br />

isocaloric low protein diet (50 % of the minimal amount necessary to<br />

maintain sex hormone status) and compared to animals with a normal<br />

protein diet. Both diets differed only by the casein content as the<br />

source of protein, the same amount of calories being provided by carbohydrate<br />

addition.<br />

This dietary modulation resulted in both sexes in a rapid reduction<br />

of GH and IGF-I production and in a resistance to IGF-I action<br />

(somatotrop axis), in a lower sex hormones concentration or function<br />

(gonadotrop axis) and decreased calcitriol levels and higher circulating<br />

PTH independently of the 25OH vitamin D status (vitamin<br />

D/PTH axis). These alterations were associated with a rapid decrease<br />

in bone mass, in alterations in bone microstructure and material level<br />

properties, a reduction in bone strength, and a marked decrease in<br />

muscle mass. A spontaneous reduction of the food intake was also observed.<br />

Under the isocaloric low protein diet, the response to exogenous<br />

IGF-I, growth hormone or PTH was blunted. All the bone, muscle<br />

and hormones abnormalities were corrected by essential amino<br />

acids supplements.<br />

These features in rodents fed an isocaloric low protein diet are<br />

quite reminiscent of the situation in the frail oldest old. This model<br />

should be of help to further study the pathophysiology of frailty<br />

and/or sarcopenia, and to explore preventive or curative measures.<br />

B59<br />

Osteopontin, a marker of sleep disordered breathing in older<br />

individuals.<br />

S. Shah, N. Punjabi, A. Jain, N. Fedarko. Johns Hopkins University<br />

School of Medicine, Baltimore, MD.<br />

Background: Sleep-disordered breathing (SDB), characterized<br />

by recurrent arousals from sleep and intermittent hypoxemia, is common<br />

among older adults. Studies have linked SDB to hypertension,<br />

cardiovascular, cerebrovascular disease, and dementia. Osteopontin<br />

(OPN) is a secreted glycophosphoprotein that plays a role in a diverse<br />

set of processes involved in stress response and/or chronic immune<br />

activation. The levels of circulating OPN have not been studied<br />

in the context of aging or SDB. We hypothesize that OPN levels correlate<br />

with measures of SDB. Additionally we sought to determine<br />

the influences of the covariates of age, gender, race, and BMI on OPN<br />

values.<br />

Methods: The group under study comprised of 205 healthy individuals<br />

ranging from 20 to 82 years. Subjects free of medical comorbidity<br />

had fasting morning serum tested for OPN levels by competitive<br />

ELISA. Full night polysomnography was conducted and the<br />

apnea-hypopnea index (AHI) was calculated. Differences between<br />

groups were assessed by Mann-Whitney t-tests and associations between<br />

OPN and individual covariates by Spearman rank correlation.<br />

Additionally, OPN levels were modeled by multiple linear regression<br />

with covariates including age, BMI, gender, race, and AHI.<br />

Results: The median level of OPN in the total study population<br />

was 56.4 ng/ml with a range of 5.4 to 426.5 ng/ml. OPN levels were<br />

found to differ by race and gender significantly (p 5, Spearman<br />

r = 0.7, p < 0.0001. Multiple regression of OPN values as a function<br />

of age, race, gender, BMI and AHI values revealed that the association<br />

of OPN with AHI remained significant even after correcting<br />

for these covariates.<br />

Conclusions: The observed differences in circulating OPN<br />

levels may be reflecting underlying differences by race and gender<br />

in allostatic load. Because effective treatments for SDB exist,<br />

early identification and treatment in the elderly may represent a<br />

novel management strategy for reducing the morbidity and mortality<br />

burden associated with SDB and its associated comorbid<br />

diseases.<br />

B60<br />

A calcium channel blocker characteristically prevents endothelial<br />

senescence: Possible implication for atherosclerosis.<br />

T. Hayashi, K. Ina, T. Yamaguchi. <strong>Geriatrics</strong>, Nagoya University<br />

Graduate School of Medicine, Nagoya, Japan.<br />

Supported By: No funders support for this research.<br />

Background: Aging is one of strongest risk factor of atherosclerosis,<br />

and endothelial senescence has been reported to precede atherosclerosis<br />

in vivo. We have reported the important role of glucose and<br />

NO on the endothelial senescence (PNAS 2006, JPET2011). Although<br />

HMG-CoA reductase inhibitor is shown to prevent endothelial<br />

senescence, the effect of anti-hypertensive agents on senescence<br />

was not known enoughly.<br />

Methods: We measured senescence-associated-β-galactosidase<br />

activity, telomerase activity, and telomere length after the exposure of<br />

human endothelial cells(HUVECs) to glucose, oxidized LDL or angiotensin<br />

II for 2days. Anti-hypertensive agents (calcium channel<br />

blocker:CCB, angiotensin converting enzyme inhibitor:ACEI and β<br />

blocker:βB) were pre- or co-incubated with the stimulus as above<br />

(such as high glucose). The experiment using small-interfering-RNA<br />

targeting endothelial-NO-synthase (eNOSsiRNA) was done to investigate<br />

the mechanisms. Finally, streptozotocin-induced diabetes<br />

showed more senescent cells in aortic endothelium of aged rats and<br />

the effect of anti-hypertension agents was investigated.<br />

Results: After the exposure of HUVECs to glucose (22 mM),<br />

oxidized LDL or angiotensin II for 2 days, senescence-associated-βgalactosidase<br />

activity was increased and decreased telomerase activity,<br />

and the effect of glucose is strongest.<br />

Among various anti-hypertensive agents which pre- or co-incubated<br />

with the stimulus as above (such as high glucose), only CCB,<br />

but not ACEI or betaB, preserved telomere<br />

length and delayed endothelial senescence, which was associated<br />

with reduced reactive oxygen species and increased nitric oxide<br />

(NO). The experiment using eNOSsiRNA suggested the role of NO<br />

in the anti-senescence effects of physiological concentration of CCB.<br />

High glucose and oxidized LDL worked additively. Finally, streptozotocin-<br />

induced diabetes showed more senescent cells in aortic endothelium<br />

of aged rats and the effect of CCB was investigated.<br />

Nifedipine is used in this experiment.<br />

Conclusion: The regulatory effects of CCB on endothelial senescence<br />

is observed in high glucose, oxidized LDL or angiotensin II induced<br />

senescence. These interactions may help explain the pivotal<br />

roleof CCB in atherosclerosis in elderly.<br />

AGS 2012 ANNUAL MEETING<br />

S93


P OSTER<br />

A BSTRACTS<br />

B61<br />

Losartan increases mitochondrial biogenesis in human fibroblast cells.<br />

V. Cheng, 2,1 B. Manwani, 1 J. Walston, 1 P. Abadir. 1 1. Johns Hopkins<br />

University, Baltimore, MD; 2. University of Kansas Medical Center,<br />

Kansas City, KS.<br />

Supported By: <strong>American</strong> Federation for Aging Research<br />

Mitochondrial function declines with age and is thought to influence<br />

chronic disease and frailty. The renin-angiotensin system (RAS)<br />

acts through angiotensin (Ang) II type 1 (AT 1<br />

R) and type 2 (AT 2<br />

R)<br />

receptors. We recently found a mitochondrial RAS, with AT 2<br />

R located<br />

in inner mitochondrial membranes that decrease with age and<br />

increase with AT 1<br />

R blocker losartan. Given these results, we hypothesized<br />

that the RAS plays a key role in mitochondrial biogenesis.<br />

Human fetal lung fibroblast cells (MRC-5) were grown in culture<br />

and separated into a control and treatment groups with serially<br />

increasing concentrations of losartan and Ang II. Cells given 100nM<br />

Ang II were subjected to losartan (0.01nM to 100nM). After 48 hrs,<br />

we measured mitochondrial gene ND6 and nuclear gene TK2 with<br />

qPCR. A ratio to compare gene expression based on treatment was<br />

generated.<br />

Mitochondrial biogenesis increased with higher doses of losartan.<br />

Cells given Ang II showed an increased ratio with Ang II up to<br />

1nM and decreased fold change above 1nM. Cells with Ang II and<br />

losartan displayed a reversal of AT 1<br />

R effects and increased mitochondrial<br />

biogenesis with losartan up to 10nM.<br />

These results illustrate a potentially important role of the RAS<br />

on mitochondrial biogenesis. While higher concentrations of losartan<br />

increase fold change, our results suggest a level of losartan that maximizes<br />

AT 1<br />

R blocking efficacy. Optimizing mitochondrial biogenesis<br />

via losartan is a novel approach that warrants further study in frail,<br />

older adults.<br />

ND6/TK2 ratio<br />

Cells with higher doses of losartan showed a higher ratio. Cells<br />

given Ang II show an increased ratio up to 1nM. Cells with 100nM<br />

Ang II and losartan showed an initial increase in ratio.<br />

B62<br />

The Hospital to Home Program: A Window into Healthcare<br />

Transitions for Older Adults.<br />

A. Cornell, J. Speice, T. Caprio, R. McCann. University of Rochester,<br />

Rochester, NY.<br />

Supported By: Reynolds Foundation<br />

HRSA GTPD Grant# HP08792<br />

BACKGROUND: Hospital readmission rates and levels of patient<br />

satisfaction have increasingly become a focus of attention as<br />

federal reimbursement policies change. Although a few programs<br />

have increased the efficiency of the discharge process, most hospitals<br />

lack sufficient resources to support a comprehensive discharge planning<br />

program outside the hospital. Data accumulated from the University<br />

of Rochester’s medical resident education program provides<br />

insight into the older adult patient’s perception of the discharge<br />

process.<br />

METHODS: A retrospective analysis from data collected from<br />

20 patients, age >60 years old, who participated in Highland Hospital’s<br />

“Hospital to Home Program” between September 2009 and September<br />

2011. This program focuses on training medical residents to<br />

identify discharge concerns during an inpatient bedside interview<br />

which is videotaped. Residents follow up with the patient one week<br />

after discharge in another videotaped encounter to gather information<br />

about the patient’s discharge experience. Video footage was reviewed<br />

by a clinical psychologist and the medical resident to identify<br />

common themes that contributed to negative discharge experiences.<br />

Learning points are highlighted in a video compilation that is presented<br />

to a group of medical residents during a teaching noon conference<br />

at the hospital to create a shared learning experience.<br />

RESULTS: Five main themes were identified from the patient<br />

feedback obtained during the program: difficulty accessing pain medicine<br />

or medical equipment, unclear discharge instructions, failure to<br />

have barriers to a safe return to home identified, inadequate follow<br />

up from home health nursing services, and difficulty obtaining answers<br />

to medical questions after discharge. One unique theme that<br />

was also identified was an expressed wish by some patients for more<br />

time to recover in the hospital due to preexisting caregiver responsibilities<br />

at home.<br />

CONCLUSION: The Hospital to Home program provides valuable<br />

insight into the problems that older adult patients experience<br />

after discharge from the hospital. Besides the educational value of this<br />

program, the identified themes provide distinct areas of focus for institutions<br />

striving to prevent unnecessary readmissions to the hospital.<br />

B63<br />

Enhancing Access to Palliative Care: An Initiative to Improve<br />

Advance Care Planning Documentation.<br />

A. Beyea, 1 H. Laura, 1,2 A. Caprio, 1,2 G. Winzelberg, 1,2 K. Wessell, 3<br />

C. Rowe. 4 1. Division of Geriatric Medicine and Center for Aging and<br />

Health, University of North Carolina, Chapel Hill, NC; 2. Palliative<br />

Care Program, The University of North Carolina, Chapel Hill, NC; 3.<br />

Cecil G. Sheps Center for Health Services Research, The University of<br />

North Carolina, Chapel Hill, NC; 4. Division of Hematology and<br />

Oncology, The University of North Carolina, Chapel Hill, NC.<br />

Purpose: This prospective study focused on improving documentation<br />

of advance care planning discussions for patients aged 65<br />

and older admitted to an Acute Care for the Elderly (ACE) unit at a<br />

university hospital. The primary aim was to increase utilization of an<br />

Advance Care Planning (ACP) note, a hospital-specific documentation<br />

tool in the electronic medical record (EMR).<br />

Methods: A case-based education session was repeated nine<br />

times from August 2010 to June 2011 to reach all physicians and medical<br />

students providing care to patients admitted to an ACE unit. Education<br />

covered communication and documentation about decisionmaking<br />

and preferences for life-sustaining treatments (LST).<br />

Following education sessions, participants received group performance<br />

data feedback. A gift card incentive was also used to encourage<br />

ACP discussions and documentation. Weekly chart review of patients<br />

discharged was used to collect data on outcomes: frequency of documented<br />

discussions about patient preferences for LST, and frequency<br />

of documentation with the ACP note tool.<br />

Results: Baseline chart review (N=88) showed 27% of patients<br />

had documentation of LST preferences, while only 4% were documented<br />

in the ACP note. Of the 204 charts reviewed during the intervention<br />

phase, 49% had documentation of LST preferences and 14%<br />

had an ACP note. For patients with dementia (N=64), 53% had documented<br />

discussion of LST preferences in the EMR; 41% in an ACP<br />

note. Among patients confused, sedated, or nonverbal (N=95), 56%<br />

had documented LST preferences in the EMR; 32% in an ACP note.<br />

Discussion: ACP note utilization facilitates effective communication<br />

about changes in health status and patient preferences for LST<br />

across a continuum of care. This quality improvement intervention<br />

was associated with an overall increase in frequency of ACP note utilization.<br />

Documentation practices among patients with dementia and<br />

confusion suggest that providers engage in discussions about LST<br />

preferences at least 50% of the time with patients at risk for progressive<br />

decline, adverse outcomes, and death.<br />

S94<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

B64<br />

Residency Training in Optimizing Hospital to Nursing Home<br />

Transitions.<br />

A. Nazir, A. K. Chakka, M. Tegeler, A. D. Graves,<br />

G. R. Westmoreland. Medicine, Indiana University, Indianapolis, IN.<br />

Supported By: 1. Dr. Arif Nazir was funded by the Geriatric<br />

Academic Career Award sponsoerd by Health Resources and<br />

Services Adminsitration.<br />

Background: Selecting an appropriate Post-Acute Care (PAC)<br />

venue and ensuring a seamless transition are critical for the recovery<br />

of older hospitalized patients. We implemented a course for Internal<br />

Medicine and Medicine/Pediatrics residents on selection of PAC venues,<br />

best practices in transitional care, and PAC insurance coverage.<br />

Methods: A formal needs assessment helped structure the aims<br />

that included teaching: 1) various PAC options and Medicare and<br />

Medicaid coverage, 2) strategies to help patients and families select<br />

the most appropriate skilled nursing facility (SNF), and 3) best practices<br />

in transitional care. Course pre-work included an online self-efficacy<br />

survey, a pretest and assigned readings. Sessions 1 and 2 of the<br />

course were conducted by geriatricians in 2 local SNFs. Session 1 included<br />

case-based discussions and role-play in a mock family meeting<br />

focusing on description and insurance coverage of various PAC options,<br />

and the physician’s role in helping families select the most appropriate<br />

SNF. In session 2 residents used a formal tool to assess the<br />

quality of patient transitions and patient awareness of their diseases<br />

and PAC goals. The course concluded with residents repeating the online<br />

self-efficacy survey, a posttest and course evaluation.<br />

Results: Twelve residents have taken the course. Preliminary<br />

survey results show that after taking the course the residents who<br />

were ‘aware OR very much aware’ of ‘available PAC options’ increased<br />

from 3 to 12; those who were ‘knowledgeable OR very<br />

knowledgeable’ about PAC insurance coverage increased from 0 to 7;<br />

and those who were ‘familiar OR very familiar’ with ‘transitional care<br />

issues in elders increased from 2 to 11. Similarly, more residents felt<br />

‘confident OR very confident’ to ‘carry out a family meeting regarding<br />

appropriate PAC venue’, ‘facilitate successful transition for an<br />

older patient’, and ‘help a family to select the best SNF’. There was a<br />

16% mean gain in posttest vs. pretest scores and 85% would recommend<br />

this course to others. Most felt the course will impact their practice.<br />

One learner said, “I will check discharge summaries, look up<br />

(star) rating information on facilities and have early discussions<br />

about goals of care.”<br />

Conclusion: Early findings show that a structured course may<br />

improve residents’ knowledge, skills and attitudes about their role in<br />

patient selection of appropriate PAC options and transitional care.<br />

B65<br />

Inadequate Understanding of Code Status Improved by Case-Based<br />

Learning.<br />

A. Sangarlangkarn, M. Drickamer. <strong>Geriatrics</strong>, Yale School of<br />

Medicine, New Haven, CT.<br />

Multiple studies show continued deficiencies in education on<br />

end-of-life care. However, there is limited literature on whether<br />

providers have an adequate understanding of DNR/DNI, which is essential<br />

in end-of-life care. Our study evaluates the understanding of<br />

DNR/DNI among physicians in training and the efficacy of casebased<br />

learning in code status education.<br />

In Fall 2011, we surveyed medical students and residents at Yale<br />

School of Medicine before and after a course on challenging end-oflife<br />

cases. Constructed using the same standards as the nationally utilized<br />

Yale Office-Based Medicine Curriculum, the course focused on<br />

DNI/not DNR patients, reversibility of code status, and futility of<br />

care. Mcnemar test was used to evaluate changes in responses.<br />

Results from 44 surveys are shown in attached image. After the<br />

course, participants were 9 times more likely to correctly forego<br />

amiodarone in coding DNR patients (p=0.02), and 11 times more<br />

likely to correctly offer ambu-bag in DNI patients (p=0.01). When<br />

asked if participants possess adequate understanding of DNR/DNI<br />

on a scale of 1 (disagree) to 5 (agree), there was a 0.93 point increase<br />

after the course (before=3.26, after=4.19, p=0.00). Ninety-three percent<br />

would recommend the course to others.<br />

Surveys showed that many participants would provide contraindicated<br />

interventions to DNR patients while failing to offer appropriate<br />

interventions to DNI patients. After the course, more participants reported<br />

having an adequate understanding of DNR/DNI. A significant<br />

number appropriately offered manual lung inflation to DNI patients<br />

and correctly withheld antiarrhythmics in coding DNR patients. Our<br />

study showed that physicians in training may benefit from code status<br />

education, particularly case-based learning which may improve their<br />

understanding of DNR/DNI and the quality of end-of-life care.<br />

B66<br />

Development of an Ambulatory <strong>Geriatrics</strong> Exam for Internal<br />

Medicine Residents.<br />

J. L. Kalender-Rich, 1,2 J. D. Mahnken, 4 I. Dong, 4 A. M. Paolo, 3<br />

S. K. Rigler. 1,2 1. Internal Medicine, University of Kansas School of<br />

Medicine, Overland Park, KS; 2. Landon Center on Aging, University<br />

of Kansas School of Medicine, Overland Park, KS; 3. Office of<br />

Medical Education, University of Kansas School of Medicine,<br />

Overland Park, KS; 4. Department of Biostatistics, University of<br />

Kansas School of Medicine, Overland Park, KS.<br />

Background<br />

Internal Medicine residents must complete geriatric-specific<br />

training. Ambulatory care is now increasingly emphasized in Internal<br />

Medicine residency which has traditionally focused on inpatient care.<br />

Two widely used geriatrics knowledge exams focus mainly on nonambulatory<br />

topics. Our goal was to create a valid ambulatory-focused<br />

geriatrics knowledge exam for residents.<br />

Methods<br />

We created exam questions that cover common clinical topics<br />

likely to be tested on in-training and board exams. Questions were reviewed<br />

by experts in Internal Medicine, Geriatric Medicine, and<br />

Medical Education for content and structure. The exam was administered<br />

to 55 interns and residents after which item analysis was performed<br />

to assess discrimination and level of difficulty; five questions<br />

were discarded based on poor item performance, creating a final 25<br />

question exam. It was also completed by 20 fourth year medical students,<br />

11 general medicine faculty, and 10 geriatrics fellowshiptrained<br />

faculty. We compared the mean correct score for each group<br />

with one-way ANOVA, and also treated group as ordinal and tested<br />

for a trend using simple linear regression.<br />

Results<br />

The mean correct scores for the four groups were 65%, 59%,<br />

60%, 70% and 80% for students, interns, residents, general medicine<br />

faculty and geriatric medicine faculty, respectively. The test of equal<br />

mean scores across groups was rejected (p


P OSTER<br />

A BSTRACTS<br />

Conclusions<br />

Our overall results demonstrated a gradient of increasing scores<br />

from learners to generalist faculty to geriatrics faculty. Interns and<br />

residents did not score as well as the fourth year medical students;<br />

however, all fourth year medical students at our institution have completed<br />

a required third year geriatrics rotation. In contrast, interns<br />

and residents have a wide variety of backgrounds and many had not<br />

had previous dedicated geriatric exposure. We conclude that this new<br />

exam is an appropriate tool to assess knowledge gained by learners in<br />

an ambulatory geriatric rotation.<br />

B67<br />

A Comprehensive Curriculum to Train Internal Medicine Residents<br />

on Care Transitions.<br />

M. Eskildsen, C. Payne, J. Bonsall, A. Miller, E. Rimler,<br />

U. Ohuabunwa, M. Khosravanipour, A. M. Galvez, J. Stein.<br />

Department of Medicine, Emory University School of Medicine,<br />

Atlanta, GA.<br />

Supported By: John A. Hartford Foundation<br />

Background: Medically complex patients are at risk for complications<br />

during care transitions among providers and hospital units, as<br />

well as in the period after hospital discharge. To address this problem,<br />

Emory’s internal medicine residency program started a new care<br />

transitions curriculum.<br />

Methods: The curriculum, which was developed for medical interns,<br />

addressed patient handovers between providers during a hospital<br />

stay, as well as discharge practices. Components included a two-hour<br />

workshop during intern orientation, two plenary presentations, and a<br />

pocket card outlining preferred practices. A pilot initiative at one participating<br />

hospital also incorporated direct feedback of residents’ discharge<br />

summaries. 71 of 89 interns participated in the curriculum during<br />

the 2010-2011 academic year.We administered pre- and post-course<br />

surveys which addressed confidence in performing care transitions, and<br />

their fund of knowledge on the topic. In addition, the post-course survey<br />

asked about the role the course played in their ability to perform<br />

care transitions. The evaluation also included surveys assessing intern<br />

satisfaction with a pilot discharge summary training program.<br />

Results: Pre- and post-course surveys were completed by 71 and<br />

43 interns, respectively. 16 interns took part in the discharge summary<br />

training pilot and completed a separate questionnaire. Interns’ confidence<br />

in their ability to perform care transitions tasks improved from<br />

19.8 to 25.7 on a 30-point scale (p


P OSTER<br />

A BSTRACTS<br />

Using this scale, the average score improved from -6.25 pre-curriculum<br />

to -4.95 post-curriculum, p=.000.<br />

Conclusion: We have designed an effective curriculum that improves<br />

both knowledge and self efficacy for residents and medical<br />

students to learn and practice the principles of appropriate prescribing<br />

for older adults that is coordinated and patient-centered.<br />

B70<br />

Identifying the Training Needs of Internal Medicine Faculty in<br />

<strong>Geriatrics</strong> utilizing the <strong>Geriatrics</strong> Skills Assessment Tool (GSAT).<br />

P. Yin, 1 N. Jamshed, 2 H. Hu, 1 S. K. Sinha. 1 1. Faculty of Medicine,<br />

University of Toronto, Toronto, ON, Canada; 2. Faculty of Medicine,<br />

Georgetown University, Washington, DC.<br />

Supported By: Mount Sinai Hospital Department of Medicine<br />

Research Fund<br />

Background: As many internists have had no formal training in<br />

geriatrics, improving their geriatrics skills is becoming especially important<br />

given our ageing population. This study assessed the training<br />

needs in geriatrics of faculty across one of North America’s largest<br />

academic Departments of Medicine. Methods: The <strong>Geriatrics</strong> Skills<br />

Assessment Tool (GSAT) was developed around the 15 core geriatric<br />

skills competencies defined by the <strong>American</strong> Board of Internal Medicine<br />

(ABIM) for Internal Medicine (IM) residents. A GSAT Survey<br />

was distributed to all active IM faculty at the University of Toronto,<br />

asking each participant to rate each skill in regards to their confidence<br />

in performing, teaching and interest around acquiring further<br />

training in it while also providing some basic demographic information<br />

on training background, sub-specialty etc. Chi-squared, Kendall<br />

Tau-b, and ANOVA tests were used to evaluate associations between<br />

the responses and the demographic profiles of the respondents. Results:<br />

369/491 (75%) faculty members representing 12 sub-specialties<br />

completed the survey, with a minimum response rate of 60%<br />

achieved per specialty. Compared to all other subspecialists, Geriatricians<br />

consistently expressed the highest levels of confidence in performing<br />

and teaching all skills except for those related to end-of-life<br />

care (p


P OSTER<br />

A BSTRACTS<br />

Significant increases in the mean and variability of reaction time<br />

on the SART were significantly associated with both falls (p < 0.01)<br />

and reduced falls efficacy (p < 0.05) in older adults. An increase in<br />

omission errors was also associated with falls (p < 0.01) and reduced<br />

falls efficacy (p < 0.05). Upon controlling for age and gender affects,<br />

logistic regression modelling revealed that increasing variability reflective<br />

of the vigilance (top-down) aspect of sustained attention was<br />

a retrospective predictor of falling in the previous year (p < 0.01, OR<br />

= 1.14, 95% CI: 1.03 – 1.26) and was weakly correlated with reduced<br />

falls efficacy in non-fallers (p = 0.07).<br />

Conclusions<br />

Greater variability in sustained attention is strongly associated<br />

with retrospective falls and to a lesser degree with reduced falls efficacy.<br />

This cognitive measure may provide a novel and valuable biomarker<br />

for falls in older adults, potentially allowing for early detection<br />

and the implementation of preventative intervention strategies.<br />

B73<br />

Under-recognition of Weight Loss in Community-Dwelling Elders.<br />

A. Dobracki, 1,2 W. Zirker. 2 1. <strong>Geriatrics</strong>, Temple University,<br />

Philadelphia, PA; 2. <strong>Geriatrics</strong>, Crozer Chester Medical Center,<br />

Upland, PA.<br />

Background: Intentional and unintentional weight loss has been<br />

shown to produce negative outcomes in morbidity and mortality in<br />

older populations, even in the overweight. It has been associated with<br />

a decline in bone mineral density and an increase in fractures. Weight<br />

loss may herald impending Alzheimer’s dementia and earlier institutionalization.<br />

Because weight loss may portend adverse outcomes,<br />

recognition is clinically relevant. This study sought to identify the<br />

scope of under-recognition of weight loss using electronically generated<br />

patient records.<br />

Methods: The electronic database of a community-based health<br />

network was used to retrospectively identify patients age 70 and<br />

older who sustained a 5% weight loss during any 12-month time span<br />

occurring between May 2006 and September 2011. Data included age,<br />

gender, height and weights, documentation by the physician of weight<br />

loss and the number of missed opportunities to document weight loss.<br />

A missed opportunity was defined as an office visit in which weight<br />

loss went unrecognized. Patients were excluded if cancer was an active<br />

problem or if weights were not measured at least twice in a year.<br />

Descriptive statistics were used to analyze the results.<br />

Results: A total of 2387 charts were reviewed, 439 were excluded,<br />

and 1948 charts met inclusion criteria. These included charts<br />

from 143 different physicians. Weight loss occurred in 643 patients<br />

(33%), 237 (37%) were recognized, but 406 (63%) were not. Of those<br />

who lost weight, 133 (21%) were recognized at the first visit by 46 different<br />

physicians, and 95 (71%) of these were recognized by the same<br />

18 providers. If weight loss was initially unnoticed, there was an average<br />

of 2.3 missed opportunities and 4.7 months that elapsed before its<br />

recognition.<br />

Conclusions: In this sample, weight loss in elderly outpatients<br />

was unrecognized in the majority of cases. Only a small number of<br />

providers identified the majority of weight loss cases. Even with the<br />

use of an electronic medical record, most providers did not document<br />

the acknowledgement of weight loss. Given the problems associated<br />

with weight loss, its under-recognition could potentially have serious<br />

consequences in the elderly.<br />

B74<br />

Facilitating frailty identification in clinical practice: Comparison of<br />

two methods among community-dwelling older adults.<br />

A. Islam, 1,2 S. Muir, 2 M. Montero Odasso. 2,3 1. School of Kinesiology,<br />

University of Western Ontario, London, ON, Canada; 2. Geriatric<br />

Medicine, Parkwood Hospital, London, ON, Canada; 3. Lawson<br />

Health Research Institute, London, ON, Canada.<br />

Frailty is characterised by an increased vulnerability for adverse<br />

events such as falls, fractures, nursing home admission, and death.<br />

Several models for the identification of frailty have been developed,<br />

including Fried’s widely accepted Frailty Phenotype Index (FPI). Alternatively,<br />

the 9-category Clinical Frailty Scale (CFS) has been proposed<br />

based on its simplicity for retrieving information from clinical<br />

history and physical exams. The CFS evaluates energy level, mobility<br />

capabilities, comorbidities, self-reported physical activity and functionality.<br />

The CFS scores range from 1 (‘very fit’), to 9 (‘severely<br />

frail’). Each increment in the CFS score increases the risk of death or<br />

institutionalization by approximately 20% (within a six year time<br />

frame). To date, the CFS has not been validated against the FPI. Our<br />

aim was to test the agreement between the FPI and the CFS to identify<br />

community older adults with frailty. Methods: One hundred nine<br />

community-dwelling older adults, aged ≥75, were included in the<br />

study. Participants were first classified as robust, pre-frail or frail<br />

using the FPI. Subsequently, two clinicians blinded from the first assessment,<br />

determined frailty status by applying the CFS to our sample.<br />

Differences amongst assessments were resolved by consensus.<br />

Inter-rater reliability agreement was assessed using kappa statistics.<br />

Frailty status in the same individual by CFS was compared to the<br />

number of FPI components present using Pearson Correlation coefficients.<br />

Results: Analysis of kappa statistics showed a substantial<br />

agreement among raters in applying the CFS to the sample (κ= 0.76,<br />

95% CI (0.68, 0.84)). The CFS was also found to be positively correlated<br />

with an increasing number of frailty components of the FPI<br />

(r=0.69, p


P OSTER<br />

A BSTRACTS<br />

thus, 90% were considered non-adherent with at least one medication.<br />

The mean number of medications that individuals were non-adherent<br />

to was 3.4. None of the cognitive or physical function measures<br />

appeared to be associated with medication non-adherence in this<br />

study.<br />

Medication non-adherence is a very prevalent problem among<br />

elders who self-neglect. Physicians who find high rates of medication<br />

non-adherence should consider the possibility of elder self-neglect in<br />

their patents. Future efforts should focus on studying the underlying<br />

reasons for medication non-adherence in larger samples of elder selfneglecters.<br />

This would facilitate the development of interventions to<br />

reduce medication non-adherence in this population.<br />

B76<br />

Nocturia and overnight polysomnography outcomes among adults<br />

with Parkinson disease.<br />

C. P. Vaughan, 1,2 J. L. Juncos, 3 L. M. Trotti, 3 T. M. Johnson, II, 1,2<br />

D. L. Bliwise. 3 1. Birmingham/Atlanta VA GRECC, Decatur, GA; 2.<br />

Geriatric Medicine & Gerontology, Emory University, Atlanta, GA; 3.<br />

Neurology, Emory University, Atlanta, GA.<br />

Supported By: Supported by NINDS RO1 NS-050595 and PHS<br />

Grant UL1 RR025008 and KL2 RR025009 (Dr. Trotti) from the<br />

Clinical and Translational Science Award program, National<br />

Institutes of Health, National Center for Research Resources. Dr.<br />

Vaughan is supported by a VA Rehabilitation R&D career development<br />

award.<br />

Background: Epidemiologic studies have shown nocturia to be a<br />

frequent and bothersome complaint for patients with Parkinson disease<br />

(PD). Detailed clinical and sleep data have not been available<br />

for this population and may provide insight into the pathophysiology<br />

and bother related to nocturia in the setting of PD.<br />

Methods: PD patients were recruited from university-based<br />

movement disorders clinics for two consecutive nights of in-laboratory<br />

polysomnography regardless of any sleep or voiding complaints.<br />

Nocturia frequency and overall satisfaction related to urinary symptoms<br />

were assessed using the <strong>American</strong> Urological Association<br />

Symptom Index. Measured sleep characteristics included total sleep<br />

time (minutes) and sleep efficiency (percent). Differences between<br />

those with at least two episodes of nocturia and those with fewer<br />

were determined using chi-square, t-tests, or Wilcoxon signed rank<br />

tests. Linear and logistic regression techniques were used to assess<br />

factors associated with nocturia frequency.<br />

Results: Sixty-three adults (65% male, mean age 63, (range 32-<br />

83)) with PD completed the study. Fifty-nine (93%) participants had<br />

1 or more and 37 (61%) reported 2 or more nocturia episodes nightly.<br />

Unified Parkinson Disease Rating Scale motor score was a predictor<br />

of nocturia occurring at least twice nightly (p=0.02). This association<br />

persisted when controlling for age and gender (p=0.03). MMSE score<br />

did not predict nocturia frequency. Compared to participants with 2-3<br />

episodes of nocturia who were mostly satisfied with their urinary<br />

symptoms (n=13), participants with 2-3 episodes who reported being<br />

dissatisfied with their urinary symptoms (n=12) demonstrated significantly<br />

less total sleep time (372.5 ± 58.7 min vs. 280.5 ± 116.1 min,<br />

p=0.03) and worse sleep efficiency (75.9% ± 11.2 min vs. 59.2% ±<br />

22.7, p=0.04).<br />

Conclusions: Nocturia at least twice per night in adults with PD<br />

is predicted by motor symptom severity, but not cognitive impairment.<br />

PD patients with 2-3 episodes of nocturia and dissatisfaction<br />

related to urinary symptoms have significantly worse sleep compared<br />

to those reporting 2-3 episodes and no dissatisfaction with urinary<br />

symptoms. Improving sleep as part of a multicomponent treatment<br />

strategy for nocturia in PD patients might be an independent target<br />

for therapy.<br />

B77<br />

Consumer-Targeted Drug Information to Reduce Inappropriate<br />

Prescriptions: Feedback from Older Adults and Preliminary<br />

Effectiveness.<br />

C. Tannenbaum, 1 R. Tamblyn, 2 S. Ahmed. 2 1. Université de Montreal,<br />

Montreal, QC, Canada; 2. McGill University, Montreal, QC, Canada.<br />

Supported By: This research was supported by a grant from the<br />

Canadian Institutes of Health Research. There are no financial disclosures<br />

to report in relation to this work.<br />

Previous interventions have targeted physicians and pharmacists<br />

to reduce inappropriate prescriptions. We sought to ascertain<br />

older adults’ response to directly receiving a knowledge transfer intervention<br />

aimed at empowering them to discuss benzodiazepine discontinuation<br />

with their pharmacist and/or physician.<br />

Methods: A written knowledge transfer tool was validated by a<br />

panel of geriatric pharmacists and pilot tested with focus groups of<br />

adults aged 60+. The tool includes a self-assessment component, presentation<br />

of evidence-based risks associated with benzodiazepine use,<br />

knowledge statements designed to create cognitive dissonance about<br />

the safety of benzodiazepine use, education about drug interactions,<br />

peer-champion stories intended to augment self-efficacy, suggestions<br />

for equally or more effective therapeutic substitutes for insomnia and<br />

anxiety, and simple tapering recommendations. The tool was distributed<br />

to eligible participants recruited and randomized to the intervention<br />

group of an open-label cluster randomized controlled trial on<br />

inappropriate prescribing being conducted in Quebec, Canada. Participants<br />

consuming any benzodiazepine > 3 months were contacted<br />

one week after receiving the intervention to ascertain their initial reaction,<br />

change in knowledge with respect to the risks associated with<br />

benzodiazepines and their anticipated course of action.<br />

Results: 50 participants (75% female, mean age 75 + 7 years,<br />

mean duration of benzodiazepine use 11 + 9 years) were contacted<br />

for their feedback. Prior to receipt of the tool, less than 27% correctly<br />

answered questions about the long-term safety of benzodiazepine<br />

use. After receipt of the tool, the proportion increased to 66%<br />

(p


P OSTER<br />

A BSTRACTS<br />

frailty have increased prevalence and incidence of cognitive impairment,<br />

that those with cognitive impairment have increased prevalence<br />

and incidence of frailty, and that those with both have increased<br />

mortality.<br />

We used data from the 2004, 2006, and 2008 waves of the Health<br />

and Retirement Study (HRS), a nationally-representative longitudinal<br />

health interview survey. The study sample included adults >=65<br />

years who completed physical performance measures in 2004<br />

(n=2,111, representing 35.5 million). We operationalized the frailty<br />

phenotype model and used a performance-based cognitive measure.<br />

We determined prevalence in 2004 and 2- and 4-year cumulative incidence<br />

(2006, 2008) of pre-frailty and frailty and of mild cognitive impairment<br />

(MCI) and dementia. We examined mortality using Kaplan-<br />

Meier survival curves and Cox proportional hazards models.<br />

Prevalences in 2004 were: frailty only, 9%; MCI/dementia only,<br />

20%; frailty and MCI/dementia, 9%. The 2-year cumulative incidence<br />

of MCI/dementia was 16.7% (p=.0009) for the pre-frail and was<br />

18.6% (p=.013) for the frail. Of those with MCI/dementia, the 2-year<br />

cumulative incidences of pre-frailty and of frailty were 54.4%<br />

(p=.002) and 11.0% (p=.002). Both conditions impacted 4-year survival<br />

(Table, p


P OSTER<br />

A BSTRACTS<br />

B81<br />

Antihypertensive Drug Class Use Associated with Urinary<br />

Incontinence in Community-Dwelling Elderly Women?<br />

E. P. Peron, 1 Y. Zheng, 1 S. Perera, 1 A. B. Newman, 1 N. M. Resnick, 1<br />

R. I. Shorr, 2 D. C. Bauer, 3 E. M. Simonsick, 4,5 S. L. Gray, 6<br />

J. T. Hanlon, 1 C. M. Ruby. 1 1. University of Pittsburgh, Pittsburgh, PA;<br />

2. Gainesville VA Geriatric Research, Education and Clinical Center,<br />

Gainesville, FL; 3. University of California, San Francisco, CA; 4.<br />

Johns Hopkins University, Baltimore, MD; 5. National Institute on<br />

Aging Intramural Research Program, Baltimore, MD; 6. University of<br />

Washington, Seattle, WA.<br />

Supported By: This study was primarily supported by National<br />

Institute on Aging grants and contracts (P30 AG024827, T32<br />

AG021885, K07 AG033174, R56 AG027017, R01 AG034056), a<br />

National Institute of Nursing Research grant (R01 NR010135), and<br />

Agency for Healthcare Research and Quality grants (R01<br />

HS017695, R01 HS018721, K12 HS019461).<br />

Background: Medication use is a potentially reversible cause of<br />

urinary incontinence (UI). This cohort study evaluated whether the<br />

use of specific antihypertensive classes is associated with self-reported<br />

incident UI in community-dwelling older women.<br />

Methods: The sample consisted of 959 black and white women<br />

aged 72 to 81 years without baseline (Year 1) UI from the Health,<br />

Aging and Body Composition study. Use of any antihypertensive<br />

from 10 drug classes (i.e., alpha blockers [central], alpha blockers [peripheral],<br />

angiotensin-converting enzyme inhibitors, angiotensin-II<br />

receptor blockers, beta blockers, calcium channel blockers, diuretics<br />

[loop], diuretics [potassium-sparing], diuretics [thiazide], or vasodilators)<br />

was determined during Year 3 in-person interviews. Self-reported<br />

UI, operationally defined as leaking urine at least weekly during<br />

the previous 12 months, was assessed at Year 4 visits.<br />

Results: Overall, 197 women (20.5%) reported incident UI. Use<br />

of specific antihypertensive drug classes ranged from a high of 32.4%<br />

for diuretics (specifically, 8.1% for loop, 9.8% for potassium-sparing,<br />

and 24.3% for thiazide) to a low of 5.6% for peripheral alpha blockers.<br />

Use of nine of the 10 antihypertensive classes was not associated<br />

with incident UI (all p>0.05). Only peripheral alpha blocker use (i.e.,<br />

prazosin, doxazosin, terazosin) increased the risk of UI (adjusted<br />

odds ratio [AOR] 4.47; 95% confidence interval [CI] 1.79-11.21).<br />

There was an even greater increased risk of UI with peripheral alpha<br />

blockers when taken in combination with loop diuretics (AOR 8.81;<br />

95% CI 1.78-43.53).<br />

Conclusions: In elderly community-dwelling women, peripheral<br />

alpha blocker use was associated with incident UI, and this risk nearly<br />

doubled when used in combination with loop diuretics.<br />

B82<br />

Increased Rhythmic Gait Variability May Contribute to Falls Risk in<br />

Older Knee Osteoarthritis Patients.<br />

J. E. DeCaria, 1 R. J. Petrella, 1,2 M. Montero-Odasso. 2,3 1. Aging,<br />

Rehabilitation & Geriatric Care, Lawson Health Research Institute,<br />

London, ON, Canada; 2. Schulich Faculty of Medicine and Dentistry,<br />

The University of Western Ontario, London, ON, Canada; 3. Gait and<br />

Brain Lab, Parkwood Hospital, London, ON, Canada.<br />

BACKGROUND: Reduced joint motion and flexibility in knee<br />

osteoarthritis (OA) patients may impair gait consistency. Increased<br />

gait variability is associated with instability, and is a valid and strong<br />

predictor of falls. However, the role of gait variability as a contributor<br />

to falls in knee OA is unknown. Our objective was to determine if<br />

rhythmic and postural gait variability is elevated in a sample of older<br />

knee OA patients compared to healthy older adults.<br />

METHODS: Community-dwelling older adults without cognitive<br />

or neurological impairment were included. The gait characteristics<br />

of 30 older knee OA patients (Kellgren-Lawrence II-III) were<br />

compared to those of 23 healthy older adults. Gait characteristics<br />

during self-selected gait velocity were determined with a 10 metre<br />

electronic walkway (GAITRite). Rhythmic and postural gait variability<br />

was calculated as the coefficient of variation (CoV) for stride<br />

time (StrTM) and double-support time (DSTM) respectively. Significant<br />

differences between groups (p


P OSTER<br />

A BSTRACTS<br />

Conclusion: In this analysis of palliative care inpatients, we<br />

found that escalating ARS increases the odds of delirium. In an effort<br />

to minimize delirium, anticholinergic medications should be added<br />

with caution in this vulnerable cohort. Further prospective studies are<br />

needed to establish a directly causal relationship.<br />

B84<br />

Screening for osteoporosis in elderly patients admitted to post-acute<br />

rehabilitation.<br />

K. Major, 1 S. Monod, 1 C. Bula, 1 S. Rochat, 1 O. Lamy, 2 D. Hans, 2<br />

A. Laszlo, 3 M. Krieg. 2 1. Service of <strong>Geriatrics</strong> medicine and geriatric<br />

rehabilitation, University of Lausanne Medical center, Lausanne,<br />

Switzerland; 2. Center of Bone Diseases, Lausanne University<br />

Hospital, Lausanne, Switzerland; 3. Service of Geriatric medicine,<br />

Hospital of Fribourg, Fribourg, Switzerland.<br />

Background: Screening for osteoporosis is important in older<br />

patients admitted to post-acute rehabilitation. However, DXA measurement<br />

is sometimes difficult to perform because of difficulties in<br />

positioning the patient and artefacts (osteoarthritis, prosthesis). The<br />

objectives were to determine the prevalence of unknown clinical osteoporosis<br />

in rehab patients and to determine new strategies for identifying<br />

clinical osteoporosis in this population.<br />

Method: Over a 9-months period, patients consecutively admitted<br />

to post-acute rehabilitation were included in th stdy. Patients with<br />

osteoporosis diagnosis, and those with terminal illness or severe physical<br />

limitations were excluded. Patients underwent Bone Mineral<br />

Density (BMD) by DXA and Vertebral Fracture Assessment (VFA).<br />

Clinical osteoporosis was defined as BMD ≤-2.5 SD at any site (lumbar<br />

spine, femoral neck, total hip or distal radius), ≥1 vertebral fracture,<br />

≥1 hip fracture, or another fragility fracture and BMD ≤-2 SD.<br />

Results: Overall, 102 (17.0%) of the 600 patients admitted to<br />

rehab refused to participate in the study or were unable to consent.<br />

Among the 498 remaining patients, 99 (19.9%) were excluded because<br />

of already known diagnosis of osteoporosis, 101 (20.3%) were<br />

excluded because of terminal illness, severe physical limitations, and<br />

45 (9.0%) because of inability to perform DXA during the stay<br />

(death, hospital transfer). Overall, 253 patients were assessed with<br />

DXA and VFA (166 women, mean age 83±7 years, mean BMI 27±6<br />

kg/m2, and 87 men, mean age 82±6 yrs, mean BMI 27±5 kg/m2). Of<br />

these, 70% had history of fall during the last 6 months and 9.1% had<br />

hip fracture history. Prevalence of osteoporotic vertebral fracture was<br />

36% in women and 32% in men. Overall, 152 (60.1%) patients had<br />

clinical osteoporosis (women: 67%; men: 46%) according to above<br />

criteria. Hip fracture history and vertebral fracture assessment identified<br />

correctly 105 (69.1%) of these 152 patients.<br />

Conclusion: A high prevalence of osteoporosis was observed in<br />

this population of rehab patients. Osteoporosis status should be systematically<br />

assessed in these patients at high fall risk, at least with<br />

careful history of hip fracture and an assessment for vertebral fractures<br />

with spine X-ray.<br />

B85<br />

Reasons for not prescribing guideline-recommended medications to<br />

veterans with heart failure.<br />

L. Dimaano, 1 C. Peterson, 2 M.A. Steinman. 2 1. University of California,<br />

San Francisco, CA; 2.VA Medical Center, San Francisco, CA.<br />

Supported By: MSTAR Program Grant 2 T35 AG026736-06<br />

Department of Veteran Affairs Grant 06-080-02<br />

Background:<br />

ACE inhibitors and beta blockers reduce mortality among patients<br />

with heart failure, yet some patients are not prescribed these<br />

medications. While general barriers to prescribing have been previously<br />

described, little is known about the reasons for foregoing treatment<br />

in individual patients, and whether this represents appropriate<br />

or inappropriate care. In this study, we described the distribution of<br />

reasons for not prescribing guideline-recommended drugs to older<br />

adults with heart failure.<br />

Methods:<br />

We conducted a chart review of patients from 4 VA health care<br />

systems who had systolic heart failure but were not prescribed ACE<br />

inhibitors (or ARBs) or beta blockers. For each patient, we used a<br />

standardized chart abstraction tool to identify the clinician’s reasons<br />

for not prescribing these drugs. Because chart review may not fully<br />

capture reasons for non-prescribing, we interviewed 61 clinicians who<br />

cared for patients in our cohort and compared the reasons they cited<br />

in the interview with reasons found in chart review.<br />

Results:<br />

Among 2846 patients screened, 301 were included in the study.<br />

Mean age of subjects was 75 +/- 10 years and 98% were male. 70%<br />

were not prescribed ACE inhibitors or ARBs, 18% were not prescribed<br />

beta blockers, and 11% were not prescribed both drugs. Using<br />

chart review, we identified reasons for non-prescribing in 65% of patients.<br />

The most common reason was clinical contraindications (58%).<br />

We identified at least one non-biomedical reason in 18% of patients,<br />

including patient attitude, adherence, and misuse of drugs (10%), and<br />

co-management with another clinician (6%). Interviews with clinicians<br />

yielded substantially more reasons than chart review (1.6 vs 0.9<br />

reasons per patient, P < .001). While clinical contraindications remained<br />

the most common reason for non-prescribing (70%), clinicians<br />

described other reasons in 66% of patients. These included patient attitude,<br />

adherence and misuse; co-management with other clinicians;<br />

and believing that the drug was not indicated (21-27% each).<br />

Conclusion:<br />

Clinical contraindications are the most common reason for not<br />

prescribing guideline-recommended drugs to heart failure patients.<br />

While chart review indicates that clinical contraindication eclipses all<br />

other reasons in importance, clinician interviews suggest that nonbiomedical<br />

factors figure equally in the decision not to prescribe<br />

these medicines.<br />

B86<br />

Tai Chi training increases the complexity of standing postural<br />

control in frail older adults.<br />

M. Lough, 1 B. Manor, 2 M. Gagnon, 1 I. Iloputaife, 1 P. Wayne, 3<br />

L. Lipsitz. 1,2 1. Institute for Aging Research, Boston, MA; 2. Beth<br />

Israel Deaconess Medical Center, Harvard Medical School, Boston,<br />

MA; 3. Osher Center for Integrative Medicine, Boston, MA.<br />

Background: The development of frailty in old age is accompanied<br />

by a loss in the dynamic “complexity” of standing postural control.<br />

In this case, complexity refers to the multi-scale structure contained<br />

within postural sway fluctuations, which is believed to arise<br />

from the numerous processes that regulate the body’s movements<br />

over time. Tai Chi is a mind-body exercise with goals of targeting multiple<br />

physiological processes and integrating their dynamics. We<br />

therefore hypothesized that Tai Chi training would increase postural<br />

sway complexity in frail older adults.<br />

Methods: Subjects were recruited from supportive housing facilities<br />

and randomized into a Tai Chi group (11 women and 3 men;<br />

age=83±6yrs) or educational control group (12 women and 3 men;<br />

age=84±8yrs). Tai Chi and education interventions consisted of two,<br />

60min instructor-led group sessions per week for 12 weeks. To assess<br />

postural sway, center-of-pressure dynamics were recorded during<br />

standing with eyes-open and eyes-closed. Postural sway complexity<br />

was estimated by multi-scale entropy analysis. Average sway speed<br />

and area were also computed. Cognition (i.e., Trail Making Test,<br />

TMT) and physical function (i.e., gait speed, timed up-and-go, TUG)<br />

were evaluated.<br />

S102<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

Results: Groups were similar in age, height, body mass, and<br />

baseline metrics of postural sway, cognition and physical function.<br />

Following the intervention, the Tai Chi group increased postural sway<br />

complexity when standing with eyes open (p = 0.001) and eyes closed<br />

(p = 0.05) as compared to controls. No changes were observed in the<br />

traditional metrics of sway speed or area. As compared to controls,<br />

the Tai Chi group also exhibited improved performance in the TMT<br />

(Part A, p = 0.04), 4-meter walk time (p = 0.04) and TUG (p = 0.04).<br />

The percent increase in eyes-open postural sway complexity after Tai<br />

Chi training related to percent increases in 4-meter walk (r 2 =0.34,<br />

p=0.02) and TUG (r 2 =0.29, p=0.05) performance.<br />

Conclusion: Tai Chi training effectively increased postural sway<br />

complexity in a cohort of older frail adults. As 1) no changes were observed<br />

in average sway speed or area, and 2) increased complexity<br />

was associated with improved physical function, we contend that Tai<br />

Chi may combat frailty by targeting the complex dynamics of the<br />

human postural control system.<br />

B87<br />

Polypharmacy and Prescribing Quality in Older HIV-Infected<br />

Adults.<br />

M. Greene, M. Steinman, K. Nicolas, V. Valcour. University of<br />

California San Francisco, San Francisco, CA.<br />

Supported By: NIH [K23-AG032872(VV), P50-AG023501(BM)],<br />

UL1 RR024131(UCSF GCRC), P30-AI027763(UCSF CFAR)] and<br />

the UCSF AIDS Research Institute<br />

Background: Advances in antiretroviral therapy have led to an<br />

aging HIV-infected population, with many individuals suffering from<br />

multiple chronic diseases. The burden of HIV and non-HIV disease<br />

puts patients at high risk for polypharmacy and medication-related<br />

complications, yet little is known about the characteristics and burden<br />

of prescribing problems in this population. Our aim was to describe<br />

the frequency of polypharmacy and prescribing quality issues in an<br />

older HIV-infected population.<br />

Methods: We performed a retrospective chart review of subjects<br />

enrolled in a cohort study of HIV infected adults age 60 and older in<br />

San Francisco. Total number of medications, frequencies of inappropriate<br />

medications as defined by the modified Beers criteria, anticholinergic<br />

drug burden as defined by the Anticholinergic Risk Scale,<br />

and potential drug-drug interactions were examined. The Lexicomp<br />

drug interactions database was used to analyze drug-drug interactions<br />

with a focus on severity scores D (consider therapy modification)<br />

and X (contraindicated). Findings were compared to age and<br />

gender matched HIV-negative controls.<br />

Results: 89 HIV-infected subjects’ medications were reviewed.<br />

Most subjects were Caucasian (91%) and male (94%) with a mean<br />

age of 64 (range 60-82). Common co-morbidities included hyperlipidemia,<br />

hypertension, peripheral neuropathy, and depression. A total<br />

of 1,198 medications were prescribed, with a mean of 13 medications<br />

per subject (range 2-38). At least one inappropriate medication was<br />

prescribed in 34 subjects (38%), most commonly zolpidem, alprazolam,<br />

and fluoxetine. A majority of subjects had at least one potential<br />

drug-drug interaction, with 65 (73%) having a category D interaction<br />

and 7 (8%) having a category X interaction. 15 subjects (17%) had an<br />

anticholinergic risk scale score of ≥3. In contrast, HIV-negative controls<br />

had a mean of 6 medications per subject, 18% had at least one<br />

inappropriate medication, and 4% had an anticholinergic risk scale<br />

score of 3 (p-value


P OSTER<br />

A BSTRACTS<br />

BMI=28.4, mean PSQI=8.7 and mean PHQ-9=4.6. Previously unrecognized<br />

SA was common, with a mean AHI=19.5; 49.3% of participants<br />

had AHI ≥15 (suggesting moderate-severe SA). 14.2% of all<br />

participants were prescribed BzRAs, and 11.5% reported using the<br />

BzRA during the study period. Among participants with moderatesevere<br />

SA, 9.6% were prescribed BzRAs and 8.2% actually used the<br />

medication. There were no significant differences between participants<br />

with or without moderate-severe SA in BzRA prescription<br />

(Chi-square=2.504, p=.157) or BzRA use (Chi-square=1.513, p=.303).<br />

CONCLUSIONS: We found that half of community-dwelling<br />

older Veterans meeting diagnostic criteria for insomnia had objective<br />

evidence of unrecognized moderate-severe SA. Nearly 10% of these<br />

individuals were prescribed BzRAs, some of which may worsen SA<br />

and increase risk for adverse health outcomes. Further research is<br />

needed to address the recognition and management of coexisting insomnia<br />

and SA in older adults.<br />

B90<br />

Pyridostigmine Improves Orthostatic Tolerance and Symptoms in<br />

Patients with Orthostatic Hypotension and Supine Hypertension:<br />

The Faint and Fall Clinic Experience.<br />

N. Sanders, 1 T. Jetter, 2 S. Wasmund, 2 C. Pacchia, 2 M. Hamdan. 2 1.<br />

<strong>Geriatrics</strong> Division, University of Utah, Salt Lake City, UT; 2.<br />

Cardiology Division, University of Utah, Salt Lake City, UT.<br />

Background: Orthostatic Hypotension (OH) is a common problem<br />

in the elderly. While midodrine helps OH, its use is often limited<br />

by the presence of supine hypertension (HTN). Pyridostigmine is an<br />

acetylcholinesterase inhibitor that increases sympathetic tone by improving<br />

cholinergic neurotransmission. Its efficacy in patients with<br />

OH remains uncertain.<br />

Methods: All patients with symptomatic OH and supine HTN<br />

were included. Supine, 1-min and 3-min orthostatic BP measurements<br />

were obtained at baseline and following 30 days of pyridostigmine at<br />

60 mg PO TID. The decreases in SBP and DBP at 1 and 3 minutes<br />

were assessed at baseline and compared to the 30-day follow-up values.<br />

Clinical symptoms were also assessed and categorized as worsening,<br />

no change or improving.<br />

Results: A total of 10 patients were enrolled with 2 patients not<br />

tolerating the drug (Mean age=75). At baseline, the supine BP and<br />

HR were 139/82 mmHg and 74 bpm. The mean decrease in SBP/DBP<br />

at 1 minute and 3 minutes were 28/12 mmHg and 31/10 mmHg respectively.<br />

After 30 days of drug therapy, the baseline supine BP and<br />

HR were 132/78 and 73 bpm. The mean decrease in SBP/DBP at 1<br />

minute and 3 minutes were 16/7 mmHg (p=0.055 for SBP; p=NS for<br />

DBP when compared to baseline) and 13/9 mmHg (p=0.05 for SBP;<br />

p=NS for DBP when compared to baseline) respectively (see Figure).<br />

All patients reported improvement in their symptoms.<br />

Conclusion: Pyridostigmine improves orthostatic tolerance and<br />

symptoms in patients with OH and supine HTN at 30 days. Its longterm<br />

efficacy awaits additional studies.<br />

B91<br />

Cancer, Functional Decline, and the Vulnerable Elders Survey<br />

(VES-13) in Older Medicare Beneficiaries.<br />

P. Wroe, 1 A. Naeim, 2 W. Dale, 1 L. Fan, 3 S. Mohile. 3 1. University of<br />

Chicago, Chicago, IL; 2. University of California, Los Angeles, Los<br />

Angeles, CA; 3. University of Rochester, Rochester, NY.<br />

Supported By: The Medical Student Training in Aging Research<br />

Program, the National Institute on Aging (T35AG026736), the John<br />

A. Hartford Foundation, the MetLife Foundation, and the Lillian R.<br />

Gleitsman Foundation.<br />

University of Rochester John Hartford Foundation Center of<br />

Excellence Grant (to Mohile).<br />

Background: The US population is aging rapidly, cancer is more<br />

prevalent among older adults, and older adults account for a large<br />

and growing percentage of cancer cases and deaths. The longitudinal<br />

association between a cancer history and functional decline has not<br />

been determined, nor has the use of the Vulnerable Elders Survey<br />

(VES-13) as a screening tool for predicting decline or death in older<br />

cancer survivors.<br />

Methods: Using data from the 2003 and 2004 Medicare Current<br />

Beneficiary Survey, we compared older adults with and without a cancer<br />

history on functional status (Activities and Instrumental Activities<br />

of Daily Living, I/ADLs), geriatric syndromes, and vulnerability<br />

(VES-13 score 3 or higher) with chi-squared tests of proportion. We<br />

used receiver operating characteristic (ROC) curves to assess the<br />

ability of the VES-13 survey instrument (VES-13 score 3 or higher) to<br />

predict functional decline or death one year after baseline.We defined<br />

functional decline as one of the following: a one-year increase of 2 or<br />

more functional deficits, one or more functional deficits after one year<br />

if zero functional deficits at baseline, or a nursing home admission.<br />

Results: Older Medicare beneficiaries with a cancer history<br />

(n=1,210) were significantly more likely than those without a cancer<br />

history (n=5,278) to have functional limitations (56.2% vs. 49.3%,<br />

p


P OSTER<br />

A BSTRACTS<br />

who reported an MD diagnosis of arthritis were asked to identify the<br />

location of their arthritis as well as the presence of pain and stiffness<br />

in their joints. Life-space (LS) was measured by distance, frequency<br />

and independence of movement within four weeks of the interview<br />

(range 0-120; higher scores represent greater mobility). Linear regression<br />

was used to examine the association of arthritis with LS adjusting<br />

for age, race, gender, rural residence, comorbidity, BMI, depression<br />

and cognitive impairment. LS among participants reporting<br />

a diagnosis of arthritis was examined using ANOVA according to location,<br />

number of joint types involved and the presence of joint pain<br />

and/or stiffness.<br />

Results: Of 1000 participants (50% male; 50% African <strong>American</strong>;<br />

51% rural; mean age (SD)=75.3 (6.7)), 662 reported an MD diagnosis<br />

of arthritis. Elders with arthritis had a significantly lower mean<br />

(SD) LS than those without arthritis (60.8±24.9 vs. 70.6±23.7 respectively;<br />

p


P OSTER<br />

A BSTRACTS<br />

Each subject’s score was calculated as a sum of the points for the diseases<br />

and conditions they had.<br />

RESULTS: The variables retained in the model were congestive<br />

heart failure (2 pts), peptic ulcer (1 pt), dementia (1 pt), cerebrovascular<br />

disease (1 pt) and history of tumor (1 pt). Using these, we created<br />

a score more parsimonious and more predictive than the Charlson<br />

score. Scores given by our tool and Charlson scores were used as<br />

predictors in a Cox model, revealing our score’s statistically significant<br />

predictive value (p


P OSTER<br />

A BSTRACTS<br />

sess caregiver burden, the surviving spouse reported whether assistance<br />

was provided with 6 ADLs and 4 IADLs in the last 3 months of<br />

life. To assess change in depressive symptoms and health, we compared<br />

CES-D (≥2 symptoms from the 8-item version) and self-rated<br />

health (good or better) reported by the surviving spouse in the interview<br />

waves before and after death.<br />

Results: A total of 555 caregivers were women (mean age=70.6;<br />

mean age of their deceased husbands=70.9) and 190 caregivers were<br />

men (mean age=73.1; mean age of their deceased wives =75.1). Overall<br />

the sample was 85% white, 12% African <strong>American</strong>, and 5% Hispanic.<br />

For decedents, cancer was the leading reported cause of death<br />

(41%). A majority (55%) of caregiver spouses provided help with<br />

bathing, 53% with dressing, 43% with transferring, 38% with walking<br />

37% with toileting, and 29% with eating. Assistance with IADLs was<br />

also common: 54% helped with medications; 39% helped with meals;<br />

29% helped with shopping; and 23% helped with phone calls. Men<br />

and women did not differ in terms of the ADL tasks they performed,<br />

but gender differences were observed with IADL assistance. Men<br />

provided more help with meals (57% vs. 33%, p


P OSTER<br />

A BSTRACTS<br />

There is growing evidence that the broader process of advance care<br />

planning (ACP) benefits patients at the end of life (EOL). Most clinicians<br />

receive little training in ACP and medical institutions often lack<br />

effective documentation tools.<br />

Purpose: 1) To assess whether an educational intervention for<br />

health care providers improves the quality of ACP discussion documentation;<br />

and 2) to describe the preferences for EOL care of older<br />

veterans.<br />

Methods: Interventions included 1) a new template for ACP discussion<br />

documentation introduced in electronic medical record in<br />

February 2009; 2), educational trainings by 2 staff geriatricians (lectures<br />

and small group discussions) emphasizing importance of ACP<br />

documentation. Continuous 100 ACP discussion notes were selected<br />

for review from pre-education period (PRE) and post-education period<br />

(POST) respectively. Designation of desired surrogate decision<br />

maker, use of quotes from patients or family, description of<br />

goal/value, limitation of medical care, and EOL setting were compared<br />

between PRE and POST.<br />

Results: PRE was 2/09-6/09 with 97 patients and POST was 4/11-<br />

8/11 with 93 patients. Patients in POST were younger (79.2 ± 9.5 vs<br />

75.1 ± 12.3, p=0.012), and more patients in POST have 1 or more comorbidities<br />

(66% vs 80%, p=0.036), and lacked decision-making capacity<br />

(9.3% vs 20.4%, p=0.040). Descriptions of desired medical care<br />

did not differ significantly (75% vs 80%, p=0.40), and among those<br />

notes with descriptions, 91% expressed desires for certain limitations.<br />

Among those who had decision-making capacity, there was no difference<br />

of designation of desired surrogate decision maker (92 % vs 87<br />

%, p=0.44). Description of goals/values (36% vs 52%, p=0.02) and<br />

EOL setting (8% vs 18%, p=0.04) increased significantly in POST.<br />

Among those notes without descriptions of desired medical care, specific<br />

reasons were documented in significantly more notes (36% vs<br />

70%, p=0.02).<br />

Conclusion: The vast majority of older veterans expressed desired<br />

limitations of medical care at EOL. Educational sessions to<br />

health care providers led to improved quality of ACP documentation.<br />

B102<br />

Rehospitalization of Older Adults Discharged to Hospice Care.<br />

A. M. Goldenheim, 1 D. Oates, 1 V. Parker, 2 M. Russell, 1 M. Winter, 2<br />

R. Silliman. 1,2 1. Boston University School of Medicine, Boston, MA;<br />

2. Boston University School of Public Health, Boston, MA.<br />

Supported By: <strong>American</strong> Federation for Aging Research<br />

T 35AG038027-01 (MSTAR)<br />

Background: Hospital readmission of older adults receiving hospice<br />

care can be traumatic, costly, and often preventable; acute care is<br />

generally not aligned with the goals of hospice. We identified factors<br />

associated with 30-day readmission of older adults newly discharged<br />

to hospice from Boston Medical Center.<br />

Methods: A structured medical record review of 59 patients, 19<br />

readmitted within 30 days and 40 randomly selected controls who<br />

were not readmitted, from 206 subjects newly discharged to hospice<br />

between February 1, 2005 and January 31, 2010. We collected information<br />

about disease characteristics, hospital course, end-of-life planning<br />

and decision-making, and post-hospitalization follow-up. We calculated<br />

bivariate associations and used a Cox Proportional Hazards<br />

model to examine the relation between index admission characteristics<br />

and readmission.<br />

Results: Subjects had a mean age of 79.7 ± 8.4; 74.6% were female.<br />

Among those readmitted, 25% received a palliative care consultation,<br />

compared to 47.1% of those not readmitted (p = 0.06). Patients<br />

who did not have a surrogate involved in their hospice decision<br />

had 3.5 times the risk of readmission with 30 days, compared to patients<br />

who had a surrogate involved in the hospice decision (HR 3.53,<br />

CI 0.97, 12.82). Patients who had one or more telephone contacts with<br />

their primary care physician (PCP) during the first week after discharge<br />

had 2.4 times the risk of readmission with 30 days, compared<br />

to patients who had no telephone contacts with PCPs during this period<br />

(HR 2.35, CI 0.9, 6.1).<br />

Conclusions: Readmission within 30 days of initial discharge to<br />

hospice appears to be associated with a lack of education and communication<br />

about the goals and course of hospice care. There is a<br />

need for greater support for the patient and family during the transition<br />

from hospital to hospice.<br />

B103<br />

Analysis of patient and clinician complaints related to care<br />

transitions in a large, urban teaching hospital.<br />

A. Levenson, 1 O. Hasan. 2 1. Mount Sinai School of Medicine, New<br />

York, NY; 2. Center for Clinical Excellence, Brigham and Women’s<br />

Hospital, Boston, MA.<br />

Supported By: This research is supported by the Medical Student<br />

Training in Aging Research program (MSTAR).<br />

Many patients experience problems during transitions from one<br />

care setting to another. Although patient concerns regarding care<br />

transitions have been investigated in small, focused studies, a systematic<br />

review of hospital-wide patient and clinician complaints has not<br />

been published to date. To fill this gap, we aggregated and analyzed<br />

all patient and clinician complaints related to care transitions filed at<br />

an 800-bed urban, teaching hospital from January through June 2011.<br />

We reviewed all relevant free-text complaints from three hospital reporting<br />

databases: clinician-filed Patient Safety Reports tagged “Coordination<br />

of Care” (n=208), Press-Ganey patient survey comments<br />

in the “Discharge” section of the survey (n=698), and Patient & Family<br />

Relations complaints tagged “Continuity of Care” and “Discharge”<br />

(n=138). Reports unrelated to transitions into or out of the<br />

hospital and complimentary comments were excluded from further<br />

analysis. Of 1044 reports initially reviewed, 468 were found to be relevant<br />

and were coded and examined in further detail. On the Press-<br />

Ganey patient survey (n=347), 92 (26.5%) of complaints were about<br />

delays in discharge, 46 (18.4%) were about unclear discharge instructions,<br />

and 49 (14.1%) were about patient unreadiness for discharge.<br />

Of the patient-generated Patient & Family Relations complaints<br />

(n=84), 24 (28.6%) concerned patient confusion or discomfort with<br />

the plan of care, 21 (25%) were about patient unreadiness for discharge,<br />

and 14 (16.7%) were about insufficient care coordination. Of<br />

the clinician-filed Patient Safety Reports (n=37), 18 (48.6%) were<br />

about poor communication between providers, 4 (10.8%) concerned<br />

unclear discharge instructions, and 3 (8.1%) were about insufficient<br />

care coordination. Gaps in communication emerged as a dominant<br />

theme in this analysis. Patients were most concerned about insufficient<br />

communication of the discharge plan, while both patients and<br />

clinicians felt that there was insufficient communication between clinicians<br />

during transitions in care.<br />

B104<br />

Improving Documentation of Advance Care Planning in an<br />

Electronic Medical Record.<br />

B. Chauhan, C. Chang, A. Kelley. Department of <strong>Geriatrics</strong> and<br />

Palliative Care, Mount Sinai School of Medicine, New York, NY.<br />

Background: Advance care planning (ACP) is important to promote<br />

patient dignity and autonomy in the setting of serious illness.<br />

Electronic medical records (EMR) may help improve communication<br />

among providers about ACP. Since 2005, the <strong>Geriatrics</strong> Practice<br />

at Mount Sinai Hospital, a patient centered medical home, has used<br />

an EMR for all aspects of patient care. While providers may discuss<br />

ACP regularly, monthly quality measures of ACP documentation are<br />

low (27%, July 2011). Thus, we aimed to understand how providers<br />

document and retrieve ACP discussions in the EMR.<br />

Methods: Using mixed methods, we first surveyed providers regarding<br />

their current pattern of documenting ACP and areas they felt<br />

S108<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

need improvement. We then conducted and audio-recorded semistructured<br />

interviews with providers to better understand practice<br />

patterns and challenges in documenting and retrieving ACP.<br />

Results: Of 42 providers, 33 (79%) responded to the survey. Despite<br />

low observed rates of ACP documentation (27%), 42.5% report<br />

discussing ACP with patients yearly and 30% state they have documented<br />

a Health Care Proxy for >50% of their patients. Yet 46% did<br />

not know how to document DNR orders; 79% had never received<br />

training on documenting ACP in the EMR; and 97% stated they<br />

would benefit from such training. Of 28 providers (14 fellows & 14 attendings)<br />

completing qualitative interviews, 24 (85%) said the primary<br />

place they document ACP discussions is the progress note for<br />

that visit, while 4 (14 %) primarily document the discussion in a permanent<br />

section of the chart (e.g., demographic notes). When asked<br />

about locating ACP information on another provider’s patient, interviewees<br />

commented, “People are having the conversations but documenting<br />

it all over the place”; “When you can’t find the discussions, it<br />

can significantly impact the trust of patients. It is a big problem.” On a<br />

likert scale of 1-5 (5= absolutely certain), providers averaged 1.8 on<br />

certainty of finding ACP documentation: “I do not know where to<br />

start”.<br />

Conclusions: Despite a well established EMR, ACP documentation<br />

varies widely among providers thus making this important information<br />

difficult to find. A standardized ACP template in a labeled<br />

section of the EMR and training providers to document ACP uniformly<br />

may enhance high-quality patient centered care.<br />

B105<br />

Self-rated Health and Memory Impairment. A Connection?<br />

D. Peng, 1 K. Connor, 1 S. Vassar, 1 M. Lee, 1 B. Vickrey, 1,2 J. Chodosh. 1,2<br />

1. VA GLAHS / UCLA, Los Angeles, CA; 2. RAND Health, Santa<br />

Monica, CA.<br />

Supported By: SCAN Health Plan<br />

Veterans Administration<br />

Background: Dementia has high personal and societal costs. Diagnoses<br />

are often substantially delayed, yet those with dementia are<br />

at greater risk for functional decline than non-demented patients.<br />

Cognitive screening applied to all older patients may be too stigmatizing<br />

and burdensome due to false positives. Thus, screening those atrisk<br />

for dementia through self-reported general health ratings - a<br />

known predictor of functional decline –may be desirable.<br />

Methods: Randomly selected seniors ≥ 75 years enrolled in a<br />

Southern California “Medicare Advantage” HMO and seen in a primary<br />

care practice between 2003 and 2006 to yield an analytic sample<br />

of ~300 was drawn from administrative data; those with an ICD code<br />

for dementia or prescription for anti-dementia medication were excluded.<br />

For consented subjects, cognitive impairment was assessed<br />

using the Memory Impairment Screen for Telephone (MIS-T), a 4-<br />

item cue-recall test. Self-reported health was measured using a 5-<br />

point scale (excellent, very good, good, fair, or poor). Cut-points predictive<br />

of dementia (MIS-T of ≤ 4) provided prevalence estimates<br />

and were used to assess specificity of self-rated health for memory<br />

impairment. Association between MIS-T scores and self-rated health<br />

were assessed using multivariable regression, controlling for age, gender,<br />

ethnicity, and education.<br />

Results: Of 458 potential subjects, 60% (N=275) were interviewed,<br />

of which 30% were male; mean age was 82.1 years; 83% were<br />

Caucasian; and 89% had at least a high school education. Fifteen percent<br />

(N=40) had MIS-T scores predictive of dementia. Overall, 29%<br />

(N=81) rated their health as “fair” (N=57) or “poor (N=24),” including<br />

55% (22 of 40) of those with memory impairment versus 25% (59<br />

of 235) of those without impairment (p-value75 years old, 658 (61%)<br />

failed a screen for > 1 condition (mean 1.6 conditions) and triggered a<br />

mean 7.1 QIs. Charts were reviewed for a randomly selected 485 of<br />

these. Approximately half (237 (49%) were seen by a NP for co-management.<br />

Overall 53% of QIs were passed. Quality scores for those<br />

seen by a NP were higher for all conditions except depression<br />

(Table).<br />

In multivariate analyses, adjusting for gender, age of patient,<br />

number of conditions, site, and a NP estimate of physician management<br />

style, team care remained significant (p


P OSTER<br />

A BSTRACTS<br />

variation in utilization of screening mammography in women with<br />

limited life expectancy at the level of the usual care provider (UCP)<br />

and associated physician characteristics.<br />

Methods: We used 100% Texas Medicare claims data to select a<br />

cohort of Texas female Medicare beneficiaries aged 67-90 years, with<br />

a life expectancy based on age and comorbidity of less than 7 years,<br />

and with an identifiable UCP. The sample contains 103,385 women<br />

and 11,554 UCPs. Data were linked to the <strong>American</strong> Medical Association<br />

masterfile to obtain UCP characteristics. Each woman was followed<br />

up for two years to measure her screening mammography utilization.<br />

Descriptive statistics and multilevel modeling were used for<br />

the analyses.<br />

Results: 28.4% of women with


P OSTER<br />

A BSTRACTS<br />

life care. Application of this benefit to NH residents has come under<br />

increasing scrutiny due to dramatic expansion in recent years and increasing<br />

costs. We used a unique merged dataset to describe trends<br />

over time in NH patients who used hospice.<br />

Methods:Between 1999-2009, data was collected on 33,387 people<br />

over age 65 who had contact with a large, urban public hospital<br />

which serves a population that is largely poor, about 60% women and<br />

35% black. Clinical data from the local comprehensive electronic<br />

medical record was merged with Medicare claims, Indiana Medicaid<br />

claims, Minimum Data Set, and Outcome and Assessment Information<br />

Set. Patients with a hospice claim and the sub-group of hospice<br />

patients in NHs were identified. We present trends over time with descriptive<br />

statistics.<br />

Results: 4361 patients used hospice in the 10 year period; about<br />

1/3 of overall decedents enrolled in hospice. About 1/3 of the overall<br />

cohort had a nursing home stay. There were 1260 patients who used<br />

hospice and lived in NHs. In this NH-hospice cohort 62% of patients<br />

were female; 61% were white and 38% were black. Average age at<br />

hospice enrollment was 81 years and did not change appreciably over<br />

time. A trend of increased enrollment over time was evident. The proportion<br />

of NH-hospice patients with non-cancer diagnoses increased<br />

over time from 35% in 1999 to 79% in 2009. In 1999, the median<br />

length of stay on hospice was 93 days (mean 195 days) and remained<br />

high throughout the study period. The overall median for the 10 year<br />

period was 85 days (mean 161). For hospice patients not in NHs, the<br />

median length of stay was 16 days (mean 58).<br />

Conclusions: Consistent with national data, the use of hospice<br />

by nursing home patients and proportion with non-cancer diagnoses<br />

has risen over time. A striking difference from other studies is the<br />

much longer length of stay of NH-hospice patients throughout the 10<br />

year study period. In contrast to our results, NH-hospice patients<br />

were found to have a median length of stay of 46 days in 1999 and a<br />

steady increase over time in a national sample. Additional analyses<br />

will use this rich dataset to probe factors affecting length of stay and<br />

use of hospice in this population of vulnerable older adults.<br />

B111<br />

Can primary care providers estimate remaining life expectancy in<br />

older adults with chronic kidney disease and other comorbidities?<br />

K. H. Campbell, 1 S. G. Smith, 2 C. Fox, 3 J. W. Mold, 4 J. W. Shega, 1<br />

W. Dale. 1 1. Section of <strong>Geriatrics</strong> and Palliative Medicine, University<br />

of Chicago, Chicago, IL; 2. Pritzker School of Medicine, University of<br />

Chicago, Chicago, IL; 3. UNYNET, University at Buffalo, Buffalo,<br />

NY; 4. OKPRN, University of Oklahoma, Oklahoma City, OK.<br />

Supported By: Supported by the John A. Hartford Foundation<br />

Center of Excellence in <strong>Geriatrics</strong> at the University of Chicago Pilot<br />

Research Award.<br />

Background: Estimating remaining life expectancy (RLE) is<br />

considered preferable to using age to guide medical decision-making<br />

for older adults. We evaluated whether primary care providers<br />

(PCPs) were able to estimate RLE in older patients with chronic kidney<br />

disease (CKD) and various comorbidities with known RLE associations.<br />

Methods: Using a cross-sectional survey of PCPs in 2 practicebased<br />

regional networks designed to evaluate referral decisions for<br />

older adults with chronic kidney disease, we developed clinical vignettes<br />

of older adults. Vignettes randomly varied 6 factors dichotomously<br />

(age, race, gender, presence of stage III congestive heart failure<br />

(CHF), ability to ambulate, and presence of moderate dementia)<br />

in a block factorial design. PCPs were asked to estimate RLE of vignette<br />

patients. We categorized vignettes as: 1) no comorbidities; 2)<br />

presence of CHF; 3) presence of dementia; and 4) presence of both<br />

CHF and dementia. Each category was assigned an “expected” RLE<br />

using life tables, placing each group into upper, middle, and lower<br />

quartiles by age and gender. We compared the mean RLE estimated<br />

by the PCPs with the expected RLE from life tables using t-test.<br />

Results: Eighty-two PCPs answered RLE questions about 8 randomly-assigned<br />

vignettes. Providers significantly underestimated<br />

RLE of patients assigned to the “no comorbidities”: women age 67<br />

RLE estimate 12.4 years versus life table expected RLE 21.3 years;<br />

p


P OSTER<br />

A BSTRACTS<br />

complex elders should consider extra clinic visits and resources (e.g.,<br />

pharmacy to review additional medication burden).<br />

B113<br />

Defining Fever in Nursing Home Patients.<br />

P. D. Sloane, 1,2 C. Kistler, 2 C. Mitchell, 1 A. S. Beeber, 4 R. Bertrand, 5<br />

S. Zimmerman. 1,3 1. Sheps Ctr for Health Services Research, Univ. of<br />

North Carolina at Chapel Hill, Chapel Hill, NC; 2. Department of<br />

Family Medicine, Univ. of North Carolina at Chapel Hill, Chapel Hill,<br />

NC; 3. School of Social Work, Univ. of North Carolina at Chapel Hill,<br />

Chapel Hill, NC; 4. School of Nursing, Univ. of North Carolina at<br />

Chapel Hill, Chapel Hill, NC; 5. Abt Associates, Inc., Cambridge, MA.<br />

Supported By: Agency for Healthcare Research and Quality<br />

Background: Existence of fever is often identified as a criterion<br />

for determining the “appropriate” use of systemic antibiotics; however,<br />

several different criteria exist for determining what temperature<br />

in a nursing home patient constitutes a fever.Among the more popular<br />

fever guidelines are those of Loeb et al., who defined fever as either<br />

37.9°C [100°F] or 1.5°C [2.4°F] above average routine temperature.<br />

Methods: To develop a more empirical basis for definition of<br />

fever, we evaluated 257 residents of six North Carolina nursing<br />

homes who had been treated with antibiotics for a presumed infection<br />

during a two month observation period. Data collected included<br />

the temperature recorded on the day the treatment was started, and<br />

three prior routine temperatures recorded when the residents were<br />

not ill. We then proposed to redefine fever based on the temperature<br />

distribution in the sample, and used that standard to evaluate<br />

whether or not fever was present at the time of a suspected infection<br />

for each of the 257 residents using both the standard Loeb fever criteria<br />

and this new definition.<br />

Results: The mean routine temperature was 97.8°F, with a standard<br />

deviation of 0.59°F. Based on these routine temperatures, we derived<br />

two empirical definitions of fever in nursing home patients: (1)<br />

a temperature of 99.0° F or higher (i.e., above the 95th percentile for<br />

the sample); or (2) 1.2° F (i.e., two standard deviations) above the average<br />

temperature for an individual patient. Applying these criteria<br />

to the 257 episodes of antibiotic prescribing, we found that 21% of<br />

urinary tract infections, 22% of respiratory infections, and 15% of<br />

skin infections treated with systemic antibiotics were accompanied by<br />

a fever. In contrast, 13% of urinary infections, 14% of respiratory infections,<br />

and 6% of skin infections met the Loeb fever criteria.<br />

Conclusions: The presence or absence of fever should be assessed<br />

using different criteria in nursing home patients from that used<br />

with the general adult populations. Whether, when, and how often a<br />

fever should be present for antibiotic prescribing to be considered<br />

“appropriate” remains debatable.<br />

B114<br />

Reducing Potentially Inappropriate Antibiotic Prescribing in<br />

Nursing Homes.<br />

S. Zimmerman, 2,4 P. D. Sloane, 1,2 A. S. Beeber, 3 C. Kistler, 1<br />

R. Bertrand, 5 L. Haddon, 5 C. Mitchell. 2 1. Dept. of Family Medicine,<br />

Univ. of North Carolina, Chapel Hill, NC; 2. Sheps Ctr for Health<br />

Services Research, Univ. of North Carolina, Chapel Hill, NC; 3.<br />

School of Nursing, Univ. of North Carolina, Chapel Hill, NC; 4.<br />

School of Social Work, Univ. of North Carolina, Chapel Hill, NC; 5.<br />

Abt Associates Inc., Cambridge, MA.<br />

Supported By: Agency for Healthcare Research and Quality<br />

Background: As concern regarding antibiotic-resistant organisms<br />

has reached global proportions, attention has become focused<br />

on populations in which prescribing is high and may be inappropriate.<br />

Nursing home residents are one such population.<br />

Methods: To examine the extent of potentially inappropriate antibiotic<br />

prescribing and the ability of educational efforts to reduce<br />

such prescribing, we conducted and evaluated a quality improvement<br />

program in six North Carolina nursing homes. The program had four<br />

components: 1) training physicians in antibiotic prescribing criteria,<br />

especially criteria prescribed by Loeb and colleagues; 2) training<br />

nursing home (NH) nurses in the use of a Medical Care Referral<br />

Form (MCRF) to report the signs and symptoms of the Loeb criteria<br />

to physicians; 3) providing information to residents, their family<br />

members, and other NH staff about antibiotic prescribing; and 4)<br />

maintaining contact with physicians and NH staff during a six-month<br />

quality improvement program, providing information about prescribing<br />

rates, concurrence with the Loeb criteria, and use of the MCRF.<br />

Results: At baseline, the number of monthly antibiotic prescriptions<br />

(unadjusted) ranged from 26-52 across the six NHs. Within three<br />

months of initiating the program, five of the six settings evidenced reduced<br />

prescribing ranging from 19-41%. Adherence to the Loeb criteria<br />

for prescribing increased for urinary tract infections (8% at<br />

baseline to 12% at follow-up), respiratory infections (2% at baseline<br />

to 8% at follow-up) and especially for skin infections (41% at baseline<br />

to 82% at follow-up). The MCRF was used to report information<br />

for only a minority of treated infections (from 0 to 17%).<br />

Conclusions: Antibiotic prescribing may be reduced in nursing<br />

homes through concerted efforts including prescriber training, more<br />

detailed and focused staff-prescriber communication, and patient and<br />

family education. While not all treated infections should meet published<br />

criteria for appropriateness, some further reduction in prescribing<br />

that does not meet criteria would likely constitute optimal care.<br />

The MCRF may be a mechanism to improve prescribing practices.<br />

B115<br />

Where Heroes Meet Angels:the Medical Foster Home.<br />

T. Edes, 3 C. Levy, 4 D. Goedken, 3 B. kinosian. 2,1 1. Univ of PA,<br />

Philadelphia, PA; 2. CHERP, Philadelphia VAMC, Philadelphia, PA;<br />

3. Dept. Veterans Affairs, Washington DC, DC; 4. Denver VAMC,<br />

Denver, CO.<br />

Background: Medical Foster Home (MFH) merges care in a personal<br />

home with an interdisciplinary home care team (IDT), such as<br />

VA Home Based Primary Care (HBPC). MFH is for veterans who<br />

cannot live independently because of complex chronic medical, psychological<br />

and functional impairments and lack of adequate family<br />

support. The Department of Veterans Affairs (VA) has rapidly expanded<br />

the availability of MFHs, growing from 3 programs in 2008 to<br />

over 56, with 358 foster homes caring for 484 veterans. Over 1,245 veterans<br />

have been served since program inception. All Veterans in<br />

MFH meet nursing home level of care. MFH is intended to be the Veteran’s<br />

home often until the end of life. HBPC provides comprehensive<br />

care in the home, as well as caregiver training and support.Veterans<br />

pay the MFH caregiver, approximately $1800 to $2500 per month.<br />

Methods: All 56 MFH programs for FY 2011 were analyzed in<br />

terms of their expenses (administration, coordination, HBPC-IDT<br />

management of complex care needs) and their revenue, creating an<br />

internal, virtual firm. We operationalized revenue as the lowest-cost<br />

nursing facility care VA could provide to veterans who were eligible<br />

to have VA covered nursing home care (veterans in Priority Group<br />

1A), crediting monthly NH payments each month a P1A veteran was<br />

in MFH. In FY2011, the community NH rate VA paid was<br />

$7076/month, while HBPC and MFH administration cost<br />

$1520/month. We also examined savings if VA were to cover the<br />

MFH housing cost of $2400/mo for P1A veterans.<br />

Results: During FY 2011, census grew from 297 total and80 P1A<br />

to 454 total and 132 P1As at year end. Discharges averaged<br />

6%/month (240 for FY2011), with 13% to an assisted living facility,<br />

9% to a nursing home, 18% to their own or family’s home, and 49%<br />

due to death. With a total of 4459 MFH months/1217 months for<br />

P1As, expenses would be $6.372M with revenues of $8.61 M, or a net<br />

margin of $2.24M (35% ROI). Serving 27% P1A veterans, the program<br />

would still be slightly in the black ($6.4M in net revenue, or a<br />

S112<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

net margin of $48,980), if it covered the housing payment now made<br />

by the veteran.<br />

Conclusion: Medical Foster Home is a cost-saving alternative to<br />

nursing home care. When organized as a virtual “firm”, a MFH program<br />

can generate savings for further non-institutional care investment,<br />

improving the re-balancing of long term living dollars.<br />

B116<br />

Improving Care for Frail Elders: A Home-Visiting Provider<br />

Program for Medicare Advantage Members.<br />

J. M. McBride, 1 R. D. Laird, 2 L. C. Hanson. 1 1. Division of Geriatric<br />

Medicine and Center for Aging and Health, University of North<br />

Carolina at Chapel Hill, Chapel Hill, NC; 2. Health First Aging<br />

Institute, Melbourne, FL.<br />

Supported By: Health First Health Plan, Melbourne, Florida;<br />

INSPIRIS, Inc., Brentwood, Tennessee;<br />

Center for Aging and Health, University of North Carolina at<br />

Chapel Hill<br />

Background: A Medicare Advantage plan in Florida desired to<br />

improve the hospital readmission rate of members with repeated hospitalizations<br />

and multiple medical co-morbidities, many of whom had<br />

barriers to access. The plan partnered with a physician house call<br />

company in 2004 to implement a home visit program, and evaluated<br />

its effect on hospitalization rates.<br />

Program Description: Patients were eligible for the program if<br />

they had > 1 hospitalization in the previous 12 months and multiple<br />

chronic illnesses; participation was voluntary with no additional cost<br />

to the patient. Home visits were provided by physicians and nurse<br />

practitioners who were employed full-time by the program; participants<br />

maintained relationships with their primary care physicians.<br />

Home visits were provided as needed, but no less than monthly. A<br />

provider was always on call, making home visits on nights and weekends<br />

as necessary. Telephonic nurse case managers were an integral<br />

component of the program, coordinating and facilitating care.<br />

Results: The program served 997 patients during 2010. 59%<br />

were female, the mean age was 80.4 years, and the mean number of<br />

major chronic disease diagnoses (included in the Medicare Hierarchical<br />

Condition Categories model) was 2.96 per patient. The hospitalization<br />

rate in 2010 for program participants was 1,047 per thousand<br />

person- years, compared to an expected hospitalization rate of 2,611<br />

using actuarially adjusted baseline data. For the entire 23,000 member<br />

plan, the 30-day hospital readmission rate in 2010 was 15.2%,<br />

compared to a baseline readmission rate of 18.2%. The decrease in<br />

the 30-day readmission rate for the plan closely corresponded to the<br />

decrease in hospitalizations among the program participants.<br />

Conclusions:Implementation of a physician and nurse practitioner<br />

home visit program is associated with a reduced hospitalization rate for<br />

high risk geriatric patients. Clarification of the role of the home-visiting<br />

provider as a“house call specialist”co-managing the member collaboratively<br />

with the primary care physician was important in gaining acceptance<br />

from members as well as community physicians.Community physicians<br />

now see the program as an important resource for their most<br />

vulnerable patients, and regular referrals to the program continue.<br />

B117<br />

Patients Surviving 6 Months in Hospice Care: Who are they?<br />

L. Rothenberg, 1,5 G. Cordts, 2 L. Simon, 3 J. Gryczynski, 4<br />

D. Doberman. 3 1. Stony Brook School of Medicine, Port Jefferson,<br />

NY; 2. Geriatric Medicine and Gerontology, Johns Hopkins Bayview<br />

Center, Baltimore, MD; 3. Gilchrist Hospice Care, Hunt Valley, MD; 4.<br />

Friends Research Institute, Baltimore, MD; 5. Medical Student<br />

Training in Aging Research (MSTAR) Program, Johns Hopkins<br />

School of Medicine, Baltimore, MD.<br />

BACKGROUND: In 2011, CMS regulation required U.S. hospices<br />

to conduct a “face-to-face” (F2F) assessment of ongoing hospice<br />

eligibility for all patients entering their 3rd certification period.<br />

Using a cohort of patients enrolled in hospice we sought to characterize<br />

those requiring F2F assessment.<br />

METHODS: Retrospective program records were obtained for<br />

hospice patients enrolled 6 months prior to January 1, 2011 (N=375).<br />

Patients who remained in hospice on January 1, 2011 and received a<br />

F2F (n=140) were compared to patients who were no longer in hospice<br />

(n=235) on demographics, terminal condition, presence of comorbidity,<br />

length of stay, and hospice outcome using bivariate statistics.<br />

Predictors of F2F assessment were examined using a multivariable logistic<br />

regression model controlling for demographics, setting of care<br />

prior to admission, comorbidity, and primary terminal diagnosis.<br />

RESULTS: Patients with a F2F were older (p64 years of age and reside within 35 miles<br />

of the Durham, NC VA. Comprehensive in-home needs assessments<br />

are performed by the COACH RN and social worker, with subsequent<br />

case review by the full COACH team (geriatrician, geriatric<br />

psychiatrist, geriatric pharmacist, RN, geriatric social worker) and<br />

recommendations are made to PCP. Individualized follow-up plans<br />

are developed and monitored.<br />

Data from the 92 p-cd enrolled during the first 12 months of the<br />

program’s existence were analyzed. Rates of NHP were tracked and<br />

compared with historical controls. Health delivery was evaluated using<br />

percentage of caregivers receiving education on available resources,<br />

identification of patients with behavioral disturbance, and number of<br />

geriatric psychiatry referrals. Caregiver burden was measured at baseline<br />

and over time with the Caregiver Strain Index (CSI). Quality of life<br />

was evaluated by caregiver satisfaction survey. Costs, cost avoidance<br />

and savings were estimated and compared with accepted averages for<br />

similar community populations to determine cost-effectiveness.<br />

RESULTS<br />

Three COACH patients were placed in nursing homes as compared<br />

with the estimated average annual risk of NHP for COACH<br />

patients of 13%, or 6 patients (50% reduction). Average CSI score<br />

was reduced by one point, from 7 to 6. 90% of caregivers reported<br />

AGS 2012 ANNUAL MEETING<br />

S113


P OSTER<br />

A BSTRACTS<br />

satisfaction with the program. COACH is estimated to have saved the<br />

health care system $223,000 in a year by delaying NHP.<br />

CONCLUSIONS<br />

The COACH program reduced NHP in its first year of existence,<br />

while also improving dementia care delivery, caregiver burden<br />

and quality of life. These outcomes were achieved cost-effectively.<br />

The COACH program represents an innovative collaborative care<br />

model for patients with dementia.<br />

B119<br />

Knowledge-To-Action for Delirium Prevention: Diffusion of the<br />

Hospital Elder Life Program (HELP).<br />

T. T. Hshieh, 1 P. Chen, 1 S. Dowal, 2 S. K. Inouye. 1,2 1. Internal<br />

Medicine, Beth Israel Deaconess Medical Center, Boston, MA; 2.<br />

Hebrew SeniorLife, Harvard Medical School, Boston, MA.<br />

Background: Delirium is a common, increasingly prevalent condition<br />

among older hospitalized patients with significant morbidity<br />

and mortality. HELP has been a successful evidence-based model of<br />

care to prevent delirium and functional decline in hospitalized elders,<br />

which has been disseminated widely. Knowledge translation and diffusion<br />

in healthcare is important but often challenging, and theoretical<br />

frameworks to do so effectively are underutilized.<br />

Aim: To evaluate the effectiveness and scope of the HELP diffusion<br />

process (2000-2011), we applied the Knowledge-To-Action<br />

framework (Straus 2009) to determine adherence of HELP diffusion<br />

to best practices in translation and diffusion.<br />

Methods: The Knowledge-To-Action framework consists of 10<br />

phases (3 knowledge creation, 7 action phases), incorporating knowledge<br />

translation into a collaborative, multi-level, systems-based approach.<br />

The 3 knowledge creation phases are: inquiry, synthesis, products/tools.<br />

The 7 action phases are: identify problem/knowledge,<br />

adapt to local context, assess barriers, implement intervention, monitor<br />

use, evaluate outcomes, sustain use.<br />

Results: HELP adheres to all 10 phases of the Knowledge-To-<br />

Action framework (See Table). Many HELP diffusion steps were assignable<br />

to more than one feature.<br />

Conclusions: The HELP diffusion process followed best practices<br />

in translation of knowledge. The steps to evaluate efficacy, costeffectiveness,<br />

adaptations, barriers, and ongoing outcomes may have<br />

helped contribute to its success. We hope this case example may assist<br />

others in developing their own effective knowledge translation programs<br />

for innovations in geriatrics.<br />

HELP Diffusion Adheres To Knowledge-To-Action Framework<br />

B120<br />

Factors associated with Survival after Stroke among Elderly Women<br />

in the WHI.<br />

C. L. Bell, 1 A. LaCroix, 2 S. Smoller, 3 K. Masaki, 1 J. Curb, 1<br />

E. M. Hade, 4 T. Manini, 5 W. Mysiw. 6 1. Geriatric Medicine, University<br />

of Hawaii John A Burns School of Medicine, Honolulu, HI; 2. Fred<br />

Hutchinson Cancer Research Center, Seattle, WA; 3. Epidemiology &<br />

Social Medicine, Albert Einstein College of Medicine, Bronx, NY; 4.<br />

Center for Biostatistics, Ohio State University, Columbus, OH; 5.<br />

Aging and Geriatric Research, University of Florida, Gainesville, FL;<br />

6. Physical Medicine & Rehabilitation, Ohio State University,<br />

Columbus, OH.<br />

Supported By: National Heart, Lung and Blood Institute<br />

Background: Data are limited on factors affecting long-term<br />

post-stroke survival in older women.<br />

Methods: Women’s Health Initiative (clinical trials and observational<br />

study) data on women aged 50-79 and stroke-free at baseline,<br />

with incident stroke prior to 2005, were analyzed for survival through<br />

2010. Prestroke physical function used Rand-36 subscale scores<br />

(range 0-100, higher=better).<br />

Results: Of 3,173 women, 2,062 (65%) survived through 2010;<br />

1,111 (35%) died. On multivariable Cox models, prestroke factors associated<br />

with post-stroke mortality included: older age at stroke<br />

(HR=1.07, 95%CI= 1.05-1.08, p


P OSTER<br />

A BSTRACTS<br />

trolling for resident demographics, acuity, and facility characteristics,<br />

there was a 2.8% (Standard Error 0.01; p=0.004) increase in death at<br />

30 days and a 3.9% (Standard Error 0.01; p=0.008) increase in death<br />

at 90 days for residents with severe dementia who evacuated for Hurricane<br />

Gustav.<br />

Conclusions: Nationwide, of the approximately 1.6 million<br />

adults who live in nursing homes, an estimated 50% to 70% carry a<br />

diagnosis of Alzheimer’s disease or a related dementia. This research<br />

reveals the deleterious effects of evacuation on residents<br />

with severe dementia. Interventions need to be developed and<br />

tested to determine the best methods for protecting this at-risk<br />

population when there are no other options than to evacuate the<br />

facility.<br />

B122<br />

Proteinuria in Mid-Life and Cognitive Function in Late-Life: The<br />

Honolulu-Asia Aging Study.<br />

M. Higuchi, 1 R. Chen, 2 C. Bell, 1 L. Wongvarcharoen, 1 W. Ross, 3,1<br />

H. Petrovitch, 1,2 L. Launer, 4 R. Abbott, 1 K. Masaki. 1,2 1. Geriatric<br />

Medicine, University of Hawaii, Honolulu, HI; 2. Kuakini Medical<br />

Center, Honolulu, HI; 3. VA Pacific Islands Healthcare System,<br />

Honolulu, HI; 4. National Institute on Aging, Bethesda, MD.<br />

Supported By: The National Heart, Lung, and Blood Institute; the<br />

National Institute on Aging; Veterans Affairs Pacific Islands<br />

Healthcare Systems; John A. Hartford Foundation Center of<br />

Excellence in <strong>Geriatrics</strong>, University of Hawaii.<br />

Background: Impairment of renal function has been linked to<br />

cognitive impairment. There are few longitudinal studies of proteinuria<br />

and cognitive function. We assessed mid-life proteinuria and<br />

cognitive decline or incident dementia in an elderly Asian male population.<br />

Methods: The Honolulu Heart Program (HHP) is a prospective<br />

study that began in 1965 with 8,006 Japanese-<strong>American</strong> men ages 45-<br />

68 years. Mid-life proteinuria was detected by urine dipstick at exam<br />

3 (1971-74). Subjects were classified into 3 groups: no proteinuria,<br />

trace, and positive. The Honolulu-Asia Aging Study of dementia<br />

began 20 years later with HHP exam 4 (1991-93) with 3,734 men ages<br />

71-93 years. Global cognitive function was assessed by the Cognitive<br />

Abilities Screening Instrument (CASI) (score range 0-100). Cognitive<br />

decline was defined as drop in CASI score of >=1 SD (>=10<br />

points at 3 years, >=14 at 6 years, >=14 at 8 years). Standard criteria<br />

were used to classify 8-year incident dementia (DSM-IIIR),<br />

Alzheimer’s Disease (NINDS-ADRDA), and Vascular Dementia<br />

(California ADDTC).<br />

Results: No proteinuria was found in 97.2% of subjects, trace in<br />

1.7% and positive proteinuria in 1.1%. Age-adjusted incident dementia<br />

rates increased significantly from 13.8, to 22.8, to 39.7 per 1,000<br />

person years follow-up, among those with no, trace and positive proteinuria<br />

respectively, p=0.004. Using multiple logistic regression adjusting<br />

for age, education, apoE4, prevalent stroke, hypertension, diabetes,<br />

and baseline CASI, those with positive proteinuria were more<br />

likely to have cognitive decline (3-year decline OR=2.89, 95%<br />

CI=1.28-6.55, p=0.011; 6-year decline OR=3.46, 95% CI=1.15-10.4,<br />

p=0.027; 8-year decline OR=3.74, 95% CI=1.15-12.1, p=0.028), using<br />

no proteinuria as reference. Multivariate Cox regression found a significant<br />

association between positive proteinuria and all-cause incident<br />

dementia (RR=2.71, 95% CI=1.20-6.09, p=0.016) and incident<br />

Vascular Dementia (RR= 6.38, 95%CI=1.98-20.5, p=0.002), using no<br />

proteinuria as reference.<br />

Conclusion: Proteinuria in mid-life was an independent predictor<br />

for late-life incident dementia and cognitive decline over 8<br />

years. This association needs to be confirmed in other ethnic groups<br />

and women.<br />

B123<br />

Effect of rapamycin in a mouse model of synucleinopathy.<br />

M. Hughes, 1 M. Wey, 2 X. Bai, 2 A. Martinez, 2 E. Fernandez, 2,3<br />

R. Strong. 2,3 1. School of Medicine, UTHSCSA, San Antonio, TX; 2.<br />

Pharmacology, Barshop Institute for Longevity and Aging Studies,<br />

San Antonio, TX; 3. Geriatric Research, Education and Clinical<br />

Center, South Texas Veterans Health Care Network, San Antonio, TX.<br />

Supported By: MH was supported by the MSTAR program, the<br />

<strong>American</strong> Federation for Aging Research and the NIA. Support for<br />

this project also included PHS grants AG022307, AG036613 and<br />

AG13319 and by a grant from the Department of Veterans Affairs<br />

Medical Research Program (RS).<br />

Background: Synucleinopathies, including Parkinson’s disease<br />

(PD), multiple system atrophy and the Lewy body variant of<br />

Alzheimer’s disease (AD), are age-related neurodegenerative disorders<br />

characterized by expression of pathological intracellular inclusions<br />

containing α-synuclein. Mice transgenic for α-synuclein containing<br />

the human A53T mutation, expressed specifically in neurons,<br />

exhibit severe motor symptoms. Rapamycin has been shown to be<br />

neuroprotective in mouse models of several neurodegenerative disorders,<br />

including AD, Huntington’s disease and PD. However, it was<br />

unknown whether rapamycin would be effective in an animal model<br />

of synucleinopathy. The aim of this study was to determine whether<br />

rapamycin reduces accumulation of α-synuclein and attenuates<br />

motor deficits in A53T transgenic mice.<br />

Methods: Mouse diet containing microencapsulated rapamycin<br />

(14 ppm in diet; 2.25 mg/kg body weight/day) was fed to age-matched<br />

wild type and A53T transgenic mice from 13 to 41 weeks of age. The<br />

control diet contained the microencapsulation material. The mice<br />

were assessed on several tests of motor performance including the<br />

pole test, forepaw stepping adjustment test, accelerating rotarod, grip<br />

strength test, gait performance and the challenging beam traversal<br />

test. Expression of α-synuclein in midbrain, striatum, cerebellum, and<br />

spinal cord was tested by Western analysis.<br />

Results: Rapamycin significantly improved performance on the<br />

forepaw stepping adjustment test, the rotarod and the pole test in<br />

both genders of transgenic mice. Rapamycin significantly reduced<br />

error steps on the challenging beam traversal test in male, but not female,<br />

transgenic mice. Feeding rapamycin had no effect on grip<br />

strength or stride length or any effect in wild-type mice. Rapamycin<br />

significantly reduced expression of human α-synuclein in midbrain<br />

and spinal cord, but not in striatum or cerebellum.<br />

Conclusions: Rapamycin significantly attenuated motor deficits<br />

in the A53T mice by reducing human α-synuclein expression in midbrain<br />

and spinal cord. Further experiments will determine whether<br />

the effect of rapamycin is through enhancement of autophagy and<br />

whether rapamycin prevents neurodegeneration.<br />

B124<br />

Does Slow Reaction Time Predict Incident Parkinson’s Disease?:<br />

The Honolulu-Asia Aging Study.<br />

M. Inaba, 1 M. Kamal, 1,2 R. D. Abbott, 1 K. Fong, 2 C. Bell, 1<br />

H. Petrovitch, 1,2 C. Tanner, 4 W. G. Ross. 3,1 1. Geriatric Medicine,<br />

University of Hawaii, Honolulu, HI; 2. Kuakini Medical Center,<br />

Honolulu, HI; 3. Veterans Affairs Pacific Islands Healthcare System,<br />

Honolulu, HI; 4. The Parkinson’s Institute, Sunnyvale, CA.<br />

Supported By: National Parkinson Foundation; the National<br />

Institute on Aging; Veterans Affairs Pacific Islands Healthcare<br />

Systems; John A. Hartford Foundation Center of Excellence in<br />

<strong>Geriatrics</strong>, University of Hawaii.<br />

Introduction: Many studies have shown a deficit in reaction time<br />

(RT) in Parkinson’s disease (PD) patients. To date, there have been<br />

no longitudinal population-based studies of RT and incident PD. We<br />

studied whether RT may identify individuals at risk for PD among<br />

elderly Japanese-<strong>American</strong> men.<br />

AGS 2012 ANNUAL MEETING<br />

S115


P OSTER<br />

A BSTRACTS<br />

Methods: The Honolulu-Asia Aging Study (HAAS) is a longitudinal<br />

cohort study of aging, cognition and movement disorders in<br />

Japanese-<strong>American</strong> men in Hawaii, which began in 1991 among survivors<br />

of the Honolulu Heart Program cohort, followed since 1965.<br />

The fifth examination cycle was held in 1994-96, when 2,705 men ages<br />

74 to 95 years were examined. Subjects were administered simple RT<br />

(SRT) and choice RT (CRT) tests performed with a laptop computer.<br />

Subjects were divided into quartiles based on reaction time. Diagnosis<br />

of PD was based on consensus from at least 2 neurologists according<br />

to published criteria. Incident PD data were available for 7 years<br />

of follow-up, and those with prevalent PD were excluded. Separate<br />

analyses were performed for SRT and CRT, using the lowest quartile<br />

of each as reference.<br />

Results: There were 25 cases of incident PD during follow-up,<br />

and incidence rates increased by quartiles of SRT, from 5.7, to 20.0, to<br />

19.1, to 25.0 per 10,000 person-years follow up, p for trend=0.03.<br />

Using multivariate Cox regression, adjusting for age, education, baseline<br />

cognitive test score, prevalent stroke, handedness, handgrip<br />

strength, percent SRT error rate and amount of caffeine intake, men<br />

in the highest (slowest) quartile of SRT were significantly more likely<br />

to develop incident PD (RR=5.32, 95% CI=1.05-26.9, p=0.04). Analyses<br />

were repeated on men who were cognitively intact at baseline and<br />

without prevalent stroke, and those in the highest quartile of SRT still<br />

had higher incidence of PD (RR=5.03, 95% CI=0.96-26.2, p=0.055).<br />

We found no significant associations between CRT and incident PD.<br />

Conclusions: Men in the slowest quartile of SRT were significantly<br />

more likely to develop incident PD compared to those in the fastest<br />

quartile. Measurement of RT is a low-cost method that may help to<br />

identify those at risk for PD who may benefit from early intervention.<br />

B125<br />

Neuropsychological and Functional Performance in Adult<br />

Protective Services Clients.<br />

M. T. Le, D. J. Goldstein, J. E. Schillerstrom. University of Texas<br />

Health Science Center at San Antonio, San Antonio, TX.<br />

Supported By: The research reported on this abstract was supported<br />

by Hartford/AFAR Medical Student Training in Aging Research<br />

(MSTAR) Program.<br />

Background: In fiscal year of 2010, Texas Adult Protective<br />

Services (APS) validated 56,053 cases of neglect, abuse, or exploitation.<br />

The UTHSCSA Department of Psychiatry performs decisionalcapacity<br />

assessments across Region 8 which encompasses 29 Texas<br />

counties. In Texas, the legal definition of decisional capacity is heavily<br />

dependent on the functional status of the client. The purpose of this<br />

study was to determine which cognitive domains contribute independent<br />

variance to instrumental activities of daily living (IADL) in<br />

elderly APS referrals. Methods: We performed a retrospective<br />

medical record review of referrals (n=157 of which n=75 subjects<br />

completed all measures), calculated Spearman correlation coefficients<br />

between cognitive and functional scores, and regressed neuropsychological<br />

measures onto IADL to search for independent contributions.<br />

Results: There was no correlation between IADL and<br />

the Geriatric Depression Scale. IADL correlated significantly with<br />

the Executive Interview (r=0.68, p


P OSTER<br />

A BSTRACTS<br />

RESULTS: Participants had a mean age of 77.6 (SD=5.8, range<br />

69-98), 42% were African <strong>American</strong>, 50% were female, and 29% and<br />

20% had eGFR levels 45-59 and


P OSTER<br />

A BSTRACTS<br />

B130<br />

Early Discontinuation of Adjuvant Chemotherapy among Veterans<br />

with Colon Cancer.<br />

H. Riggs, 1,4 K. Lane, 1 S. Rawl, 3,4 P. Loehrer, 1,4 S. Hui, 1 M. Weiner. 1,2 1.<br />

Indiana University School of Medicine, Indpls, IN; 2. Center of<br />

Excellence on Implementing Evidence-Based Practice, VHA HSR&D<br />

HFP 04-148 at Richard L. Roudebush VA Medical Center, Indpls, IN;<br />

3. Indiana University School of Nursing, Indpls, IN; 4. Indiana<br />

University Melvin and Bren Simon Cancer Center, Indpls, IN.<br />

Supported By: John A. Hartford Foundation<br />

BACKGROUND: Standard therapy for patients (pts) with<br />

colon cancer and high-risk features or lymph node involvement is 6<br />

months (mos) of adjuvant chemotherapy (C) after surgical resection.<br />

Receipt of 5 mos or less of C may be a marker for inferior outcomes.<br />

Whether advanced age, regimen-specific or other clinical and demographic<br />

factors are associated with delivery of C is uncertain. We evaluated<br />

the association of baseline characteristics and planned C regimen<br />

with C delivery in pts with resected colon cancer.<br />

METHODS: We identified stage II or III colon cancer pts from<br />

our local VA tumor registry and assembled a cohort who initiated C<br />

at our VA between 2004 and 2010. C delivery was measured as the<br />

percentage of planned cumulative dose (PCD) of C that was actually<br />

delivered. Baseline characteristics were pts’ demographics, disease<br />

stage, travel distance to the treatment site, Adult Comorbidity Evaluation-27<br />

score (ACE), and lab results. We classified C as oral<br />

capecitabine- or intravenous 5-fluorouracil-based and as oxaliplatinor<br />

non-oxaliplatin-containing. Linear regression tested each association<br />

with PCD. Toxicities, hospitalization, and other reasons for modifying<br />

or discontinuing C were recorded.<br />

RESULTS: Fifty pts (98% male) initiated C for stage II (n=6)<br />

and III (n=44) disease. Median age was 63 years (range 41-82); median<br />

baseline estimated glomerular filtration rate (GFR) was 83<br />

mL/min/1.76 m 2 (range 26-171); 76% were white; 28% were married;<br />

52% had moderate or severe comorbidity; 74% received oxaliplatin;<br />

and 24% received oral capecitabine. The median travel distance was<br />

40 miles. The median PCD was 75%; median treatment duration was<br />

5 mos. Lower PCD was associated with older age (P=0.05), lower<br />

GFR (P=0.05), higher travel distance (P=0.02), and receipt of<br />

capecitabine (P


P OSTER<br />

A BSTRACTS<br />

ther studies should target the evaluation of connective tissue markers<br />

and pathological mechanisms linking low BMD and pelvic floor<br />

symptoms.<br />

B133<br />

Biomarkers of Joint Metabolism and the Severity of Radiographic<br />

Hand Osteoarthritis.<br />

I. Perjar, 1 A. Shi, 1 Y. Golightly, 1 J. Renner, 1 A. Nelson, 1 V. Kraus, 2<br />

J. Jordan. 1 1. Thurston Arthritis Research Center, UNC School of<br />

Medicine, Chapel Hill, NC; 2. Duke University School of Medicine,<br />

Durham, NC.<br />

Supported By: <strong>American</strong> Federation for Aging Research, <strong>American</strong><br />

College of Rheumatology<br />

Background: Osteoarthritis (OA) is a joint disorder traditionally<br />

diagnosed using physical examination and radiographic imaging.<br />

Focus has turned to the possibility of using biomarkers of joint metabolism<br />

to assess the extent of joint damage and understand the biological<br />

processes involved in OA. Most studies to date have examined<br />

biomarkers in relation to knee OA, but few have investigated biomarker<br />

patterns in hand OA (hOA) in diverse populations. We examine<br />

the association of two biomarkers with hOA in a bi-racial population-based<br />

study.<br />

Methods: The sample consisted of 667 African <strong>American</strong> (AA)<br />

and Caucasian adults (37% AA, 49% men, mean age 64 years, mean<br />

BMI 30 kg/m 2 ) with available hOA and biomarker data from the<br />

Johnston County Osteoarthritis Project, a prospective cohort of OA<br />

in a rural county in North Carolina. Radiographs were obtained for<br />

the DIP (distal interphalangeal), PIP (proximal interphalangeal),<br />

MCP (metacarpophalangeal), and CMC (carpometacarpal) joints, as<br />

well as the knees and hips. Radiographic OA in a joint was defined as<br />

a Kellgren-Lawrence score of ≥2. We examined urine C-terminal<br />

crosslinked telopeptide of type II collagen (CTX-II), a marker of collagen<br />

breakdown, and serum hyaluronic acid (HA), a component of<br />

cartilage and synovium, in relation to hOA defined by hand joint<br />

group affected and total number of hand joints affected. Separate<br />

multiple regression models were used to estimate the association between<br />

each hOA outcome and biomarker, adjusting for race, gender,<br />

age, BMI, and knee and hip OA status.<br />

Results: The prevalence of radiographic OA in the sample was<br />

26% for hand, 27% for hip, and 36% for knee. Looking at individual<br />

joint groups, CTX-II was associated with OA at the DIPs (p


P OSTER<br />

A BSTRACTS<br />

IgE antibodies in serum. Additional work is needed to test large numbers<br />

of samples for clinical application.<br />

B136<br />

Does this Patient have Benign Prostatic Hypertrophy with Bladder<br />

Outlet Obstruction?<br />

K. A. D’Silva , 1 P. Dahm, 2 C. L. Wong. 1 1. Geriatric Medicine,<br />

University of Toronto, Toronto, ON, Canada; 2. Urology, University of<br />

Florida, Gainesville, FL.<br />

Background: Although benign prostatic hyperplasia (BPH) is<br />

very common in older men, not all men with histologic BPH will develop<br />

the non-specific symptoms known as lower urinary tract symptoms<br />

(LUTS). Likewise, not all men with LUTS have histologic BPH.<br />

Bladder outlet obstruction (BOO) refers to the pressure gradient at<br />

the bladder neck/prostatic urethra which can be measured by invasive<br />

urodynamics. Accurate diagnosis of BOO is important because it<br />

can cause not only immediate symptoms including severe pain and<br />

urinary retention but also lead to complications, e.g.incontinence and<br />

renal insufficiency.<br />

Objective: To systematically review the evidence on the diagnostic<br />

accuracy of office-based tests for BPH with BOO in males<br />

with LUTS.<br />

Methods: Search of MEDLINE and EMBASE (from 1950 to<br />

August 12, 2010), Cochrane Central Register of Controlled Trials via<br />

Ovid, and references of retrieved articles, to identify diagnostic studies<br />

of patients with LUTS due to BPH with BOO.<br />

Data selection: Prospective studies comparing at least one diagnostic<br />

test, feasible in a clinical setting and readily available to a nonspecialist<br />

clinician, to the gold standard reference test, invasive urodynamic<br />

studies. Studies were excluded if they used pediatric patients<br />

or if participants had confounding medical conditions.<br />

There were 6692 unique citations identified with 9 prospectively<br />

conducted studies (N=1217 patients) meeting inclusion criteria and<br />

describing use of 2 symptom questionnaires as well as individual<br />

symptom(s). All tests were administered and scored based on international<br />

guidelines. The best constellation of symptoms that suggested<br />

BPH with BOO was ‘poor stream and frequency and/or nocturia’<br />

(positive LR, 1.76; 95% CI, 1.17- 2.64). The most useful<br />

symptom in which the absence made a diagnosis of BPH with BOO<br />

less likely, was nocturia (negative LR, 0.19, 95% CI, CI 0.05-0.79). The<br />

best symptom questionnaire to support or rule out a diagnosis of<br />

BPH with BOO was the International Prostatic Symptom Score (I-<br />

PSS) at a cut-off of 8 (summary positive LR, 1.34; 95% CI, 1.06-1.70;<br />

summary negative LR, 0.28, 95% CI, CI 0.12-0.70).<br />

Conclusions: Although urodynamic investigations are the gold<br />

standard for diagnosis of BPH with BOO, symptoms obtained<br />

through history may be useful for diagnosis. The best evidence supports<br />

asking the patient about nocuturia, stream and frequency.<br />

B137<br />

Predicting Mortality Following Clostridium difficile Infection.<br />

L. Archbald-Pannone, 1,2 R. Pinkerton, 1,3 R. Guerrant. 1,3 1. Internal<br />

Medicine, University of Virginia, Charlottesville, VA; 2. Division of<br />

General Medicine, <strong>Geriatrics</strong>, and Palliative Care, University of<br />

Virginia, Charlottesville, VA; 3. Division of Infectious Diseases and<br />

International Health, University of Virginia, Charlottesville, VA.<br />

Supported By: NIH/ NIAID 5K23AI074681-04<br />

Background: With increasing incidence & severity of Clostridium<br />

difficile (C. difficile) infection (CDI), there are no objective factors<br />

at diagnosis that have been proven to predict poor outcome. We<br />

evaluated demographics, co-morbidities, medications, & laboratory<br />

tests in a cohort of hospitalized patients to determine factors that<br />

could predict death following CDI diagnosis. Methods: After obtaining<br />

consent, adult inpatients with CDI diagnosed in our hospital<br />

(September 2008-May 2010, UVA HSR-IRB 13630) were followed 12<br />

months after C. difficile diagnosis to determine short-term mortality<br />

(STM, 1 month) & long-term (LTM, 12 months). Age & Charlson comorbidities<br />

score were calculated on day of CDI diagnosis. White<br />

blood cell count (WBC) & renal function (BUN, GFR, & Creatinine)<br />

were recorded on day of diagnosis; serum albumin recorded within 7<br />

days of diagnosis (mean, if multiple); & medications prior to diagnosis<br />

were recorded. Binary logistic regression (SPSS 19) determined a<br />

model to best predict mortality, using univariate predictors of mortality<br />

(student’s t-tests, chi-squared) & backward regression to eliminate<br />

non-significant factors. Significance set p ≤ 0.05. Results: 85 subjects;<br />

age 63.4 years (sd 16.9); Charlson score 5.8 (sd 4.0); time to death 2.4<br />

months (sd 3.6); STM rate 32.9% (n=28); LTM rate 52.9% (n=45).<br />

Factors associated with STM & LTM, respectively: age (both<br />

p


P OSTER<br />

A BSTRACTS<br />

Table 1. Multivariable Odds Ratios (95% Confidence Intervals) for<br />

Malignancy by Serum Ferritin Level<br />

B139<br />

IL-6 inhibits erythroid maturation in human TF-1<br />

erythroleukemia cells.<br />

N. M. Cruz, 1 B. J. McCranor, 1 F. Peña-Cruz, 1 A. E. Berger, 2<br />

C. Cheadle, 2 C. I. Civin, 3 C. N. Roy. 1,4 1. Division of Geriatric<br />

Medicine, Johns Hopkins University School of Medicine, Baltimore,<br />

MD; 2. Lowe Family Genomics Core, Johns Hopkins University<br />

School of Medicine, Baltimore, MD; 3. Center for Stem Cell Biology<br />

& Regenerative Medicine and Departments of Pediatrics and<br />

Physiology, University of Maryland School of Medicine, Baltimore,<br />

MD; 4. Division of Hematology, Johns Hopkins University School of<br />

Medicine, Baltimore, MD.<br />

Supported By: MSTAR/AFAR 5T35AG026758-07; <strong>American</strong><br />

<strong>Society</strong> for Hematology Scholars Award (CNR); R01 DK082722<br />

Background: Approximately 10% percent of adults over 65<br />

years of age are anemic. One-third of cases can be attributed to anemia<br />

of inflammation (AI). Aging, even in the absence of disease, can<br />

be considered a chronic pro-inflammatory state. Interleukin-6 (IL-6)<br />

increases with age and is elevated in the serum of patients with AI.<br />

We tested the hypothesis that IL-6 inhibits erythroid precursor maturation.<br />

To provide rationale for future studies in human volunteers,<br />

we used TF-1 human erythroleukemia cells as an in vitro model of<br />

human erythroid maturation and AI.<br />

Methods: We incubated TF-1 cells overnight in basal medium,<br />

and then treated the cells for 3-4 days with erythropoietin (Epo) to<br />

induce erythroid maturation in the presence or absence of 100 ng/mL<br />

of human IL-6. Erythroid maturation was assessed by staining with<br />

CD44 and glycophorin A (GYPA) monoclonal antibodies and flow<br />

cytometry. We performed quantitative RT-PCR to measure fold<br />

changes in expression of aminolevulinic acid synthase 2 (ALAS2)<br />

and band 3 (SLC4A1), which are markers of heme biosynthesis and<br />

erythroid maturation.<br />

Results: We found that Epo-treated TF-1 cells became phenotypically<br />

more mature, as measured by CD44 and GYPA. The mature<br />

population was 45 ± 11% of total cells, but this population was<br />

reduced to 33 ± 9% of total cells with IL-6 treatment. ALAS2 expression<br />

increased in Epo-treated cells to 10 times that of untreated<br />

cells (p


P OSTER<br />

A BSTRACTS<br />

contribution by heightened immune activation to age-associated accelerated<br />

HIV disease progression has not been delineated.<br />

Methods: Prospective, age-differentiated, multicenter cohort<br />

study of older (≥45 years) and younger (18-30 years) subjects who received<br />

192 weeks of a uniform ART regimen. Age-group differences<br />

in the time course of a diverse array of immunologic indices were assessed<br />

with adjustment for other correlates of T cell restoration in<br />

mixed-effects models.<br />

Results: 90 subjects enrolled in this cohort, including 45 younger<br />

(median age 26, range 18-30 yrs) and 45 older (median age 50, range<br />

45-79 yrs) subjects. The increases of naive, memory and total CD4<br />

cells, and naïve CD8 cells per week with ART did not differ significantly<br />

between the age-groups, but older subjects maintained significantly<br />

fewer circulating naive ( P


P OSTER<br />

A BSTRACTS<br />

ing decisions when patients develop dementia. The purpose of this<br />

study was to describe the perspectives of family caregivers toward<br />

forgoing or continuing cancer screening.<br />

We audio-taped and transcribed focus group sessions with a<br />

convenience sample of caregivers of patients with dementia attending<br />

4 local Alzheimer’s Association support groups. Session topics included<br />

recent experiences with screening decisions and preferences<br />

for patient-clinician communication. The interviews were coded independently<br />

by all investigators to identify key themes using methods<br />

of grounded theory.<br />

We conducted 4 focus group sessions with 32 caregivers of patients<br />

with dementia. Mean age was 65.5 (range 49-85), 25 were<br />

women, 7 were African <strong>American</strong>, 24 white, and 1 African <strong>American</strong>/Indian.<br />

Caregivers were 14 daughters, 13 were spouse, and 5<br />

other. The most important factor in making decisions about screening<br />

tests preserving the patient’s Quality of Life. One said, “I was concerned<br />

about her quality of life and making sure that she was very,<br />

very comfortable, and I think that means more than putting people<br />

through a lot of unnecessary, uncomfortable…procedures.” The second<br />

theme involved the Increasing Burdens and Decreasing Benefits<br />

of continued screening as dementia worsened. Specifically, the inability<br />

to understand procedures and patient agitation increased the test<br />

burdens. Caregivers noted their own Pivotal Role in Decision Making,<br />

often stepping in to stop invasive tests and deciding when to take<br />

over decision making from the patient. Caregivers noted variable levels<br />

of Physician Knowledge/Expertise, with some having limited<br />

knowledge of the course or challenges of dementia.<br />

Caregivers of patients with dementia consider cancer screening<br />

tests in light of their impact on quality of life. Given their perceptions<br />

of the changing balance of burdens and benefits as dementia worsens,<br />

many caregivers choose to forgo screening. The perspective of caregivers<br />

contrasts with prior research on patient perspectives, which<br />

finds that many patients plan to continue screening for themselves<br />

despite possible future declines in health.<br />

B145<br />

Older Adult Opinions of “Advanced Driving Directives”<br />

M. E. Betz, 1 S. Lowenstein, 1 R. Schwartz. 2 1. Emergency Medicine,<br />

University of Colorado School of Medicine, Aurora, CO; 2. Division<br />

of <strong>Geriatrics</strong>, University of Colorado School of Medicine, Aurora, CO.<br />

Supported By: Emergency Medicine Foundation and John A<br />

Hartford University of Colorado Denver Center of Excellence.<br />

BACKGROUND: Discussions and decisions about driving retirement<br />

are difficult. “Advanced driving directives” [ADDs], similar<br />

to advanced directives for end-of-life care, would allow drivers to designate<br />

a person to help make decisions about driving cessation when<br />

their driving skills decline. It is not known if older drivers support the<br />

idea of ADDs; we sought to describe older adults’ experiences and<br />

opinions about driving discussions and ADDs”.<br />

METHODS: A convenience sample of English-speaking adults<br />

(55+ years) at two independent living facilities and two community<br />

centers were invited to complete an anonymous survey.<br />

RESULTS: Of the 168 participants, 133 (80%) were female and<br />

the median age was 76.5 (range: 56-93) years. Most reported driving a<br />

motor vehicle at least occasionally (96%; 95%CI:92-98) and only<br />

29% (95CI:22-37) found driving somewhat or very stressful. Seven<br />

percent (95CI:4-12) reported a crash in the past year. Most participants<br />

(73%; 95CI:66-80) supported mandatory age-based driver testing;<br />

of these, half (50%; 95CI:40-59) though testing should begin at<br />

age 80 or higher. More thought that the driver (71%; 95CI65-78),<br />

family (61%; 95CI:53-68) or physician (59%; 95CI:51-66) should determine<br />

license revocation for an unsafe driver rather than the department<br />

of motor vehicles (32%; 95CI:25-39). A minority had spoken<br />

with someone about driving safety (5%; 95CI:2-10) or wishes<br />

when driving skills decline (21%; 95CI:15-28); of these, 83%<br />

(95CI:67-94) had spoken with a family member but only 17%<br />

(95CI:6-33) with a healthcare provider. However, older adults were<br />

open to discussions (table) and 54% (95CI:46-62) said they would<br />

complete an ADD if recommended. Of these, 79% (95CI:69-87) said<br />

it was likely or very likely they would follow the ADD in the future.<br />

CONCLUSION: Older drivers are open to driving discussions<br />

with physicians, supporting the important physician role in counseling<br />

and coordinating conversations about driving. Advanced planning<br />

with ADDs may facilitate future decisions about driving retirement.<br />

B146<br />

Walking Ability is Associated with Pain, Depression, and<br />

Overweight among Community Dwelling Older Adults.<br />

N. Satchidanand , 1 C. Fox, 1 K. Brunton, 2 G. S. Cherr . 2 1. Family<br />

Medicine, State University of New York at Buffalo, Buffalo, NY; 2.<br />

Surgery, State University of New York at Buffalo, Buffalo, NY.<br />

Supported By: <strong>American</strong> <strong>Geriatrics</strong> <strong>Society</strong>: Dennis W. Jahnigen<br />

Career Development Scholars Awards Program.<br />

BACKGROUND: Maintenance of mobility is an important goal<br />

for the elderly. Impaired physical function limits the ability of older<br />

adults to live independently and is strongly associated with declining<br />

health. The association between physical comorbidities and disability<br />

is well studied. However, less is known about the influence of modifiable<br />

factors on physical function. The study purpose was to examine<br />

the influence that select treatable factors have on walking ability<br />

among older adults.<br />

METHODS: A total of 200 subjects, age ≥65 were included<br />

(62.5% female). Depressive symptoms, psycho-social stress and<br />

chronic pain were assessed using literature validated questionnaires.<br />

Body mass index (BMI) was calculated. Physical function was assessed<br />

using the Six Minute Walk Test. Pre-existing medical conditions<br />

which may impact walking ability (i.e. PAD, COPD, CHF) were<br />

also assessed. Path analysis was performed to characterize the contribution<br />

of each predictor variable (depression, stress, chronic pain,<br />

BMI) on distance walked and to derive path coefficients, R 2 -values<br />

and probability values.<br />

RESULTS: The predictor variables demonstrated low to moderate<br />

correlations with one another, (0.27 to 0.54). Depressive symptoms,<br />

pain and BMI (but not psychosocial stress) were significant predictors<br />

of distance walked.The overall causal model accounted for about 30%<br />

of the variance in distance walked among all patients. After adjusting<br />

for pre-existing medical conditions, the proposed model still accounted<br />

for about 30% of the variance in distance walked.The strongest association<br />

with distance walked was with chronic pain for both the overall<br />

model (β = -.296, p < .01) and adjusted model (β = -.250, p < .01).<br />

CONCLUSIONS: Among community dwelling older adults,<br />

three treatable factors were significantly associated with impaired<br />

walking ability. These associations remained after adjusting for medical<br />

conditions that are also associated with impaired physical function.<br />

Further research is needed to determine the most efficacious interventions<br />

to treat depression, ameliorate chronic pain, and prevent weight<br />

gain in aging in order to preserve physical function and quality of life.<br />

B147<br />

“SERIOUSLY ILL OCTOGENARIANS &<br />

NONAGENARIANS”– ROLE OF PALLIATIVE CARE<br />

CONSULTS IN INITIATING “DO NOT ESCALATE CARE”<br />

PATHWAY AND DISCHARGE TO HOSPICE IN SERIOUSLY<br />

ILL OLDEST OLD PATIENTS ADMITTED TO A TERTIARY<br />

ACADEMIC MEDICAL CENTER.<br />

F. Kawai, V. Periyakoil. Stanford University School of Medicine,<br />

Stanford, CA.<br />

Supported By: Stanford University School of Medicine<br />

Background:<br />

AGS 2012 ANNUAL MEETING<br />

S123


P OSTER<br />

A BSTRACTS<br />

The oldest old (age>85yo) are the fastest growing segment of<br />

the US population<br />

About 27% of Medicare’s annual $426 billion budget goes to<br />

care for patients in their final year of life, with acute hospitalizations<br />

being a major cost.<br />

Evidence supports improved clinical and utilization outcomes<br />

with palliative care consults for seriously ill patients and increased<br />

patient and family satisfaction.<br />

The goal of this study was to assess the role of palliative care<br />

consults(PCC)in preventing futile escalation of care in a cohort of seriously<br />

ill oldest old inpatients.<br />

Methods:<br />

A retrospective chart review of palliative care consults in a tertiary<br />

academic medical center between August 2008 and June 2011<br />

yielded 314 patients >85 yo. Charts were reviewed to extract patient<br />

demographics,admitting diagnosis, inpatient mortality and disposition<br />

post PCC including initiation of “Do Not Escalate Care” pathway<br />

and facilitation of Hospice discharge.<br />

Results:<br />

-Of the 314 patients identified, there were 148 males (47%) and<br />

166 females (53%).153 patients (49%) were nonagenarians.<br />

-Admission diagnosis included Cancer: 25% (77), Stroke:15%<br />

(48), Cardiac:15% (47), Dementia: 12% (36), Pulmonary: 6% (8), and<br />

Other (including infection, falls, failure to thrive, Hepatic & Renal<br />

disease): 27% (86)<br />

-36% (113 patients) died during the course of hospitalization.<br />

-PCC resulted in the initiation of the “Do Not Escalate Care”<br />

pathway in 73% (229 patients) during the hospitalization.<br />

-Of the 201 patients who did not die during the hospitalization,hospice<br />

was initiated in 60% (113 patients): 32% home hospice,<br />

22% long term care facility with hospice, 6% inpatient hospice. Non<br />

hospice discharges: 17% SNF and 18% home. No discharge data<br />

available: 5%.<br />

Conclusions:<br />

-Oldest old inpatients had a high (36%) in hospital mortality.<br />

Most deaths were expected and due to serious illnesses including<br />

Cancer, Stroke, end stage cardiac, lung and renal disease.<br />

-PCC resulted in initiation of the “Do Not Escalate Care” pathway<br />

in 73% of the patients, thereby preventing ineffective interventions<br />

(such as CPR, invasive procedures, ICU care) in this seriously ill<br />

population of older adults;<br />

-PCC facilitated discharge to hospice in 60% of the survivors,<br />

thereby promoting comfort and quality of life while avoiding prolonged<br />

hospitalizations.<br />

B148<br />

Predicting Mortality in End Stage Dementia: A Retrospective<br />

comparison of Medicare Guidelines and Mitchell Criteria for<br />

Hospice Referral.<br />

J. Almeida, M. C. Galicia-Castillo. Internal Medicine/<strong>Geriatrics</strong>,<br />

Eastern Virginia Medical School, Norfolk, VA.<br />

Background: Dementia is the sixth-leading cause of death posing<br />

a significant cost of $183 billion annually(1). The progression of<br />

the disease is variable, with the end stage lasting as long as three<br />

years(2). Current guidelines for predicting six-month mortality have<br />

been under scrutiny; they are not evidenced-based and were never<br />

studied prior to implementation as hospice criteria(3,4). Mitchell et al<br />

derived a mortality risk index for six-month mortality using items<br />

from the minimum data set. The objective of this study was to compare<br />

the Mitchell risk index to Medicare guidelines in predicting sixmonth<br />

mortality in end-stage dementia(3).<br />

Methods: A retrospective chart review of patients who died<br />

from dementia in a nursing home facility from January 2004 through<br />

December of 2009 was performed. Data points from three, six and<br />

twelve months prior to death were collected from the minimum data<br />

set. At each point subjects were coded as eligible or ineligible for hospice<br />

according to Mitchell risk index and Medicare guidelines.<br />

Results: At six months prior to death, out of 24 subjects, the<br />

Mitchell risk index score identified 13 (54%) as eligible for hospice<br />

and Medicare guidelines identified six(25%; p =0.16). Three months<br />

prior to death, out of 24 subjects Mitchell risk index identified 19<br />

(79%); using Medicare guidelines identified nine(37.5%, p=0.118)<br />

Conclusion: Current guidelines for predicting six-month mortality<br />

for appropriate hospice referral for end-stage dementia are inaccurate.<br />

The Mitchell risk index may be a better tool to help clinicians<br />

better prognosticate six-month mortality and employ hospice services<br />

earlier.<br />

References<br />

1 Herbert, LE; Scherr, PA; Bienias, JL; Bennet, DA. Alzheimer<br />

Disease in the U.S. Population: Prevalence Estimates Using the 2000<br />

Census. Archives of Neurology August 2003:60(8)1119-1122.<br />

2 Shuster, J. Palliative Care for Advanced Dementia. Clinics in<br />

Geriatric Medicine 2000: 16(2).<br />

3 Mitchell, SL; Kiely, DK; Hamel, MB; Park, PS; Morriss, JN;<br />

Fries, BE. Estimating Prognosis for Nursing Home Residents with<br />

Advanced Dementia. JAMA2004:291 (22) 2734-2740.<br />

4 Schonwetter RS, Han B, Small BJ, Martin B, Tope K, Haley<br />

WE. Predictors of six-month survival among patients with dementia.<br />

<strong>American</strong> Journal of Hospice and Palliative Care 2003:(20):105-113.<br />

B149 Encore Presentation<br />

Pain is good for you? Non-cancer pain predicts improved 5-year<br />

survival.<br />

J. Shega, 1 M. Andrew, 2 D. Lau, 3 K. Herr, 4 M. Ersek, 5 D. Weiner, 6<br />

W. Dale. 1 1. Medicine, University of Chicago, Chicago, IL; 2.<br />

Medicine, Dalhousie University, Halifax, NS, Canada; 3. Pharmacy,<br />

University of Illinois, Chicago, IL; 4. Nursing, University of Iowa, Des<br />

Moines, IA; 5. Nursing, University of Pennsylvania, Philidelphia, PA;<br />

6. Medicine, University of Pittsburgh, Pittsburgh, PA.<br />

Supported By: NIA<br />

Background: Non-cancer pain is known to result in significant<br />

morbidity, but little is known about its impact on mortality. We assessed<br />

the relationship of self-reported non-cancer pain at baseline<br />

and subsequent 5-year mortality among community-dwelling older<br />

adults.<br />

Methods: We analyzed data from a large prospective cohort<br />

study, the 1996 wave of the Canadian Study of Health and Aging.<br />

Non-cancer pain was assessed using the 5-point verbal descriptor<br />

scale, dichotomized into “no/very mild” versus “moderate” or greater<br />

pain. Frailty was measured as the sum of self-reported health (1<br />

item), social support (1 item), co-morbidity (17 items), and functional<br />

abilities (14 items) with each item scored from 0 to 1, ranging from 0-<br />

33, with higher scores indicating greater frailty. Cognitive status was<br />

measured using the Modified Mini-Mental Status Exam, ranging<br />

from 0-100, with a score 11<br />

indicating depression. Multivariable logistic regression was used to<br />

analyze the relationship between pain and mortality, controlling for<br />

other factors.<br />

Results: Of the 5,703 participants, 4,694 (82.3%) had complete<br />

data for analysis. Of these, 35.4% reported moderate or greater pain<br />

and 28.6% had died at 5-year follow-up. The 5-year mortality odds<br />

increased by 1.12 (CI: 1.10, 1.13); p


P OSTER<br />

A BSTRACTS<br />

older adults are needed to better understand its trajectory, associated<br />

factors, and outcomes.<br />

B150<br />

Factors associated with enrollment in a randomized controlled trial<br />

of oxycodone vs acetaminophen for moderate or greater noncancer<br />

pain.<br />

J. Shega, C. Ogbevire, W. Dale. Medicine, University of Chicago,<br />

Chicago, IL.<br />

Supported By: NIA<br />

Background: Studies document the under-identification and<br />

treatment of non-cancer pain among older persons. In addition optimal<br />

pharmacologic management remains unclear.<br />

An obstacle of analgesic use in this setting is lack of high-quality<br />

comparative effectiveness data comparing acetaminophen to opioids<br />

in community-based populations, particularly African <strong>American</strong>s<br />

(AA). We sought to identify factors associated with the likelihood of<br />

older adults enrolling in a randomized control trial (RCT) of these<br />

therapies.<br />

Methods: A face-to-face screening questionnaire was completed<br />

for all referred older adults who were eligible for an analgesic intervention<br />

conducted in a predominantly AA, community-based geriatrics<br />

clinic. Information elicited from the screening questionnaire included<br />

basic demographics, pain intensity (verbal descriptor scale: 0<br />

[no pain] to 5 [excruciating pain], frequency of pain in the past week,<br />

number of painful sites, mobility difficulty, and presence of adequate<br />

social support.<br />

Results: Among the first 50 participants (46/50, 96%, AA) referred,<br />

15 (30%) elected to enroll in the RCT. The most commonly<br />

cited reasons for not enrolling were: 1) infrequency of pain (6%) and<br />

2) fear of opioid-related side effects (8%). Age was not associated<br />

with likelihood of enrollment, 82.2 ( SD=6.78) years versus 82.0<br />

(SD=6.72) years, p=0.94. Gender (female) 31% vs 69%, p=0.55, pain<br />

severity 2.87 ( SD=1.1) versus 3.18 ( SD=1.2), p=0.40, number of<br />

painful sites 2.6 (SD=1.6) versus 2.1 (SD=1.4), p=.53, mobility difficulty<br />

60% versus 40%, p=0.31, and availability of social support 93%<br />

versus 97%, p=1.00 were also not associated with study enrollment.<br />

Those who reported pain everyday, compared with those reporting<br />

pain 1-3 times per week were more likely to enroll, 100% versus<br />

31%., p=0.065.<br />

Conclusion: In this preliminary analysis, the number of older,<br />

primarily AA adults in a community setting enrolled in a RCT that<br />

included an opioid mirrored the rates from cancer clinical trials.<br />

Common stated reasons for not enrolling were concern for side effects<br />

and pain considered insufficient for treatment. The experience<br />

of pain everyday was positively associated with enrollment, while age,<br />

gender, pain intensity, number of pain sites, mobility difficulty, and social<br />

support were not associated with study enrollment. This is unique<br />

information on AA enrollment in RCT for pain management.<br />

B151<br />

Experiences of informal caregivers of older adults discharged from<br />

nursing homes to the community through the Money Follows the<br />

Person Demonstration Program.<br />

L. Kristof, C. Butler, J. Robison, R. Fortinsky. Center on Aging,<br />

University of Connecticut, Farmington, CT.<br />

Background: The multi-state Money Follows the Person (MFP)<br />

Demonstration Program enables Medicaid recipients residing in<br />

nursing homes to move back to their communities. Little is known<br />

about how family and other informal caregivers are affected by older<br />

adults returning to the community after what was considered longterm<br />

nursing home residence. We examined caregiver burden and the<br />

positive aspects of caregiving in caregivers of older adults (age >65)<br />

enrolled in Connecticut’s MFP who were discharged to the community<br />

after a nursing home stay of more than 3 months. Secondary outcomes<br />

evaluated were depressive symptoms and anxiety in caregivers.<br />

Methods: In this cross-sectional study, caregivers completed a<br />

self-administered questionnaire 6 months after their family members<br />

returned to the community. We asked caregivers about stress levels<br />

compared to previous time points. Caregiver burden was measured<br />

using the Modified Zarit Burden Interview. Positive aspects of caregiving<br />

were evaluated using the COPE index. We evaluated for symptoms<br />

of depression using the 2 question PRIME-MD screen. Statistical<br />

analysis was done using SPSS.<br />

Results: Preliminary results from 21 caregivers were analyzed<br />

(M age = 57, range 30-77; 81% female; 48% live with the MFP participant;<br />

32% work full time, 53% do not work). The mean Burden<br />

Index score was 5.38 (M=5.38, Range 0-12); mean score for the<br />

COPE index was 8.85 (M=8.85, Range 0-10). Compared to the time<br />

when the older adults resided in nursing homes, 75% of caregivers<br />

felt less stressed, 10% felt the same stress, and 15 % felt more<br />

stressed. Compared to the period before nursing home admission,<br />

61.1% of the caregivers felt less stress, 27.8% felt the same stress, 11.1<br />

% felt more stressed. Burden scores and COPE index scores were not<br />

significantly different whether caregiver lived with the MPF participant<br />

or not (Burden M=4.2 vs. M=6.45, p=0.081; COPE M=9.6 vs. M=<br />

8.18, p=0.234).<br />

Conclusions: Preliminary results suggest a decrease in caregiver<br />

stress and, compared to other studies of community-based caregivers,<br />

lower levels of caregiver burden and higher levels of positive aspects<br />

of caregiving for caregivers of older MFP participants in CT.<br />

B152<br />

FUNCTIONAL OUTCOMES AND HEALTH RELATED<br />

QUALITY OF LIFE AFTER TRANSCATHETER AORTIC<br />

VALVE IMPLANTATION IN ELDERLY PATIENTS WITH<br />

SEVERE AORTIC STENOSIS.<br />

M. G. Mendieta F., 1 N. F. Pereyra, 1 E. Sánchez G., 1 E. Gutierrez, 2<br />

F. Fernández Aviles, 2 H. Bueno, 2 M. Vidán A.. 1 1. Geriatry, Gregorio<br />

Marañón Hospital, Madrid, Madrid, Spain; 2. Cardiology Service,<br />

Gregorio Marañon Hospital, Madrid, Madrid, Spain.<br />

Background: Transcatheter aortic valve implantation (TAVI)<br />

improves survival in patients with aortic stenosis unelegible for surgery.<br />

The changes in patients functional performance and quality of<br />

life (QoL) after TAVI are not well known.<br />

Methods: The change in health related quality of life (SF-12<br />

questionnaire), autonomy for activities of daily living (ADL), mobility<br />

and social help was prospectively evaluated in a cohort of consecutive<br />

patients one month after TAVI. Demographic and clinical characteristics,<br />

in-hospital complications and clinical evolution were also<br />

evaluated.<br />

Results: Between January 2009 and November 2011, 57 patients<br />

were enrolled in the Cardiology Department, with a mean age of 82.2<br />

± 5.7 years. Thirty-day mortality was 12,2%. Among survivors, 58%<br />

improved cardiac symptoms, 26% improved mobility, and 15% improved<br />

autonomy for ADL but 30% increased dependency for ADL.<br />

In addition, 41% needed new social or private help for daily living.<br />

Baseline SF-12 physical summary was 36.3± 10 and baseline mental<br />

summary was 43±9.2. Both scores showed modest improvements<br />

after one month: 2.9±9.6 (p=0.04) and 2.7±11.6 (p=0.02), for physical<br />

and mental scores, respectively. The proportion of patients with relevant<br />

improvement (>2points) in physical health was 47.7%, and<br />

59.1% in mental health. No significant association between cardiac<br />

symptoms improvement and changes in quality of life was found.<br />

Conclusions: Most inoperable patients with severe aortic stenosis<br />

show improvements in symptoms and quality of life one month<br />

after TAVI but the changes are modest in absolute terms and not always<br />

associated with functional improvement. Longer-term follow-up<br />

is ongoing.<br />

AGS 2012 ANNUAL MEETING<br />

S125


P OSTER<br />

A BSTRACTS<br />

B153 Encore Presentation<br />

Too Many Finger Sticks for Nothing? A Study of Sliding Scale<br />

Insulin Use Among Elderly Nursing Home Residents With Type 2<br />

Diabetes.<br />

N. Pandya, 1 W. Wei, 2 B. S. Kilpatrick, 3 J. L. Meyers, 4 K. L. Davis. 4 1.<br />

Nova Southeastern University, Ft. Lauderdale, FL; 2. sanofi-aventis,<br />

Bridgewater, NJ; 3. AnalytiCare, LLC, Glenview, IL; 4. RTI Health<br />

Solutions, Research Triangle Park, NC.<br />

Supported By: This study was funded by sanofi-aventis U.S. The authors<br />

received editorial support in the preparation of the abstract,<br />

funded by sanofi-aventis U.S.<br />

Background: Type 2 diabetes mellitus (T2DM) patients in longterm<br />

care (LTC) often receive sliding scale insulin (SSI) therapy;<br />

however, this provides suboptimal glycemic control.<br />

Methods: This retrospective study assessed the burden associated<br />

with SSI use in older T2DM patients treated with insulin at US<br />

nursing homes, using merged medical chart data and the Minimum<br />

Data Set (MDS). Patients who were not comatose or receiving hospice<br />

care, residing in LTC facilities for ≥3 months were included if<br />

they had ≥1 full MDS assessment and ≥2 records of insulin dispensing<br />

with no insulin pump use.<br />

Results: A total of 2,096 patients (mean [SD] age = 74 [12.1]<br />

years) were identified with a median of 56 days of medical administration<br />

record sheet data available (range 6-424 days). Among these<br />

patients, 35.1% had ≥1 glycated hemoglobin AIC (A1C) value<br />

recorded (mean [SD] A1C = 7.2% [1.3]); 51.1% had A1C ≤7.0% and<br />

mean (SD) fasting blood glucose was 146.4 (43.6) mg/dL. Seventyfour<br />

percent of patients (n=1,550) were on SSI (either alone or as<br />

supplemental therapy with another regimen) for the entire follow-up;<br />

30.9% (n=648) were exclusively on SSI throughout follow-up. On average,<br />

patients received 19.9 SSI-related finger sticks per week, with<br />

12.5 (62.8%) of these showing blood glucose levels that did not necessitate<br />

subsequent insulin administration.<br />

Conclusions: Despite older T2DM patients maintaining relatively<br />

good glycemic control, SSI use was widespread in the LTC facilities<br />

examined and was associated with a high finger-stick burden.<br />

These findings question the need of prolonged SSI therapy among<br />

older T2DM patients in LTC.<br />

B154<br />

Attitudes of medical providers regarding the withdrawal of life<br />

sustaining interventions during end-of-life care.<br />

A. J. Shipley, 2 Q. Cao, 1 D. Cummings. 1 1. Family Medicine, East<br />

Carolina University, Greenville, NC; 2. Brody Medical School, East<br />

Carolina University, Greenville, NC.<br />

Supported By: HRSA:K01 HP20471, Geriatric Academic Career<br />

Award<br />

Background: Taking care of patients near the end of life is a<br />

daunting and delicate task. Interventions like pacemakers, implantable<br />

cardioverter defibrillators (ICDs), hemodialysis, artificial<br />

hydration and nutrition, and ventilator support all can prolong life,<br />

often without improving quality of life. The distinction between terminating<br />

a life sustaining treatment and physician assisted suicide<br />

(PAS) has been questioned and the decisions about withdrawal are<br />

challenging.<br />

Objective: A statewide cross-sectional survey was developed to<br />

assess the attitudes among medical providers in North Carolina related<br />

to withdrawal of life sustaining interventions.<br />

Methods: The survey was conducted online in November 2011.<br />

Participants were asked if withdrawal of a specific intervention constituted<br />

PAS and whether they would feel comfortable with the withdrawal<br />

if patient preference was known. Demographic questions include<br />

age, gender, race, the medical school, and the year of<br />

graduation, the residency program, and the specialty/subspecialty.<br />

Survey responses were based on a Likert scale and T-tests compared<br />

differences between groups.<br />

Results: n=888 medical providers participated in the survey; the<br />

vast majority of respondents were white, with a mean age of 53 ± 14<br />

years. The sample was 65% Male; 35% female. 64% of respondents<br />

were specialists and 36% were primary care providers. Over 79% of<br />

participants either strongly disagreed or disagreed that withdrawal of<br />

a specific intervention constituted PAS and the majority of them felt<br />

comfortable with the withdrawal of life-sustaining interventions.<br />

There were small but statistically significant differences by age with<br />

younger providers (< 48 yrs) expressing stronger disagreement with<br />

intervention withdrawal being equated with PAS and more comfort<br />

in withdrawing interventions (p


P OSTER<br />

A BSTRACTS<br />

B156<br />

The Impact of Testing Protocol on Recorded Gait Speed.<br />

A. Sustakoski, J. M. VanSwearingen, S. Perera, S. A. Studenski,<br />

J. S. Brach. University of Pittsburgh, Pittsburgh, PA.<br />

Supported By: T32 AG021885, K23 AG026766, P30 AG024827<br />

Background: Gait speed predicts disability, cognitive decline,<br />

hospitalization, nursing home admission and mortality. Although gait<br />

speed is often measured in clinical practice and research, testing protocols<br />

vary widely and its impact on recorded gait speed has yet to be<br />

explored. Our purpose is to describe and compare gait speeds obtained<br />

from different testing protocols in the same individuals.<br />

Methods: Subjects were 104 community-dwelling older adults<br />

who could ambulate household distances independently (mean<br />

age=77.2±6.1). Gait speed was recorded over 4 meters using the protocols:<br />

1) standing start, usual pace over ground, 2) walking start,<br />

usual pace over ground, 3) walking start, usual pace on a computerized<br />

walkway, and 4) walking start, fast pace on a computerized walkway.<br />

Paired t-tests were performed to compare gait speeds within individuals<br />

across different protocols. Linear regression was used to<br />

derive an equation to convert standing start usual pace to walking<br />

start usual pace gait speed.<br />

Results: Mean±SD gait speed for each condition was: standing<br />

start, usual pace over ground 0.97±0.23 m/s; walking start, usual pace<br />

over ground 1.14±0.25 m/s; walking start, usual pace on walkway<br />

1.01±0.26 m/s; and walking start, fast pace on walkway 1.31±0.34 m/s.<br />

On average, the determined gait speed was 0.17 m/s faster during the<br />

walking compared to the standing start (p=1 transition/year<br />

(aHR=3.70, 95%CI=2.23-6.14, p


P OSTER<br />

A BSTRACTS<br />

B159<br />

Accuracy of Formulas to Predict Resting Metabolic Rate in Elderly<br />

Admitted to a Recuperative Care Unit.<br />

D. H. Sullivan, 1,2 K. P. Padala, 1,2 K. K. Garner, 1,2 R. A. Dennis, 1,2<br />

M. Bopp, 1,2 P. R. Padala. 1,2 1. Geriatric Research Education and<br />

Clinical Center, VISN16/CAVHS, North Little Rock, AR; 2. <strong>Geriatrics</strong>,<br />

University of Arkansas for Medical Sciences, Little Rock, AR.<br />

Supported By: VA Health Services and Clinical Science Research<br />

and Development programs (HSR&D IIR-04-298 and CSR&D)<br />

and a University of Arkansas for Medical Sciences Tobacco<br />

Settlement award<br />

Background: There is a lack of validation studies of formulas for<br />

estimating resting metabolic rate (RMR) in elderly patients in the recuperative<br />

phase of illness. Given the importance of such formulas<br />

for estimating the nutrient requirements of older medically complex<br />

patients, this study was undertaken to explore this issue.<br />

Methods: This prospective study included 156 males over 64<br />

years of age admitted to a recuperative care and rehabilitation unit<br />

located within a Veterans Affairs hospital Community Living Center.<br />

RMR was measured (mRMR) within seven days after admission by<br />

indirect calorimetry in the fasted state prior to the subjects’ arising in<br />

the morning. Height and weight were measured at the same time.<br />

Results: The subjects had a mean age of 79 + 8 years and 85%<br />

were white. Although free of metastatic cancer and other terminal<br />

conditions, all were deconditioned and most were undernourished<br />

and frail. For all 10 published formulas evaluated, estimated RMR<br />

(eRMR) was highly correlated with mRMR (r = 0.70 to 0.74,<br />

p


P OSTER<br />

A BSTRACTS<br />

a different strategy than young adults to deal with a walking challenge<br />

may potentially inform interventions to improve motor skill in<br />

walking.<br />

B162<br />

Dual-Stiffness Flooring: Does it Reduce Fracture Rates Among<br />

Older Fallers ?<br />

F. Knoefel, 1 L. Patrick, 1 J. Taylor, 1 R. Goubran. 2,1 1. EBRI Research<br />

Institute, Ottawa, ON, Canada; 2. Engineering and Design, Carleton<br />

University, Ottawa, ON, Canada.<br />

Supported By: Satech Inc., Chehalis, WA, USA<br />

BACKGROUND: Fractures in older adults are associated with<br />

significant morbidity and mortality. Falls in this population lead to<br />

fractures approximately once every 20 falls. A number of bio-mechanical<br />

studies suggest that dual-stiffness flooring (DSF) diminishes<br />

the impact of contact with a floor, potentially reducing injuries associated<br />

with falls. To our knowledge however, there has never been a<br />

controlled study comparing fracture rates on regular flooring to that<br />

on DSF. METHODS: Mountain View Manor is a Skilled Nursing Facility<br />

in Prescott, Arizona where two resident bedrooms have DSF<br />

flooring (SmartCells flooring). Falls and related injuries were tracked<br />

during the period of July 1, 2008 to December 31, 2010. Injury rate<br />

comparisons, based on Chi-Square analyses, and prediction of room<br />

type allocation based on the number of injuries sustained, using Logistic<br />

Regression, were conducted. RESULTS: A total of 167 falls<br />

were reviewed. Fifty-five percent (55%) of falls resulted in an injury<br />

and 26% in a significant injury, defined as abrasion, cut, fracture or<br />

two or more injuries. There were 82 falls on the DSF and 85 falls on<br />

the regular floor. Patients in the dual-stiffness flooring rooms were<br />

significantly younger and took significantly fewer medications; these<br />

factors were thus treated as covariates in the analyses. There was a<br />

marked tendency for residents falling on DSF to have less bruising<br />

and abrasions, while having more redness and cuts. There were two<br />

fractures on regular flooring (2.4% fracture rate) and none on the<br />

DSF flooring (0% fracture rate). DISCUSSION: A 2.4% fracture<br />

rate (as noted on the regular floor) is consistent with numerous incidence<br />

reports in the literature; whereas a 0% rate (as noted on Smart-<br />

Cells DSF floor) is a clinically significant improvement over prior reported<br />

results. Both clinical findings and preliminary statistical trends<br />

analysis suggest a positive effect of dual-stiffness flooring. This suggests<br />

that DSF may be a practical approach for institutions and consumers<br />

to reduce fall-related injuries. In contrast to other solutions,<br />

like hip protectors, DSF requires no active client participation. A<br />

large scale study to achieve sufficient statistical power to statistically<br />

confirm these preliminary findings is warranted.<br />

B163<br />

Subcortical Hyperintensities and Outcomes of Targeted Gait<br />

Interventions for Mobility Impairment.<br />

N. K. Nadkarni, S. Perera, J. Brach, H. Aizenstein, C. Rosano,<br />

S. A. Studenski, J. M. Van Swearingen. University of Pittsburgh,<br />

Pittsburgh, PA.<br />

Supported By: Source of funding: Pittsburgh Claude D. Pepper<br />

Older <strong>American</strong>’s Independence Center grant (P30 AG024827)<br />

Background: Gait interventions that incorporate motor-skill acquisition<br />

are superior to standard therapy in improving mobility impairment<br />

in elderly. Subcortical hyperintensities (SH), commonly<br />

seen on brain MRI of older adults, are associated with impairments in<br />

gait and executive function.<br />

Objective: We examined whether regional SH volumes influence<br />

gait outcomes from two types of gait interventions.<br />

Methods: We analyzed data from a 12 week randomized trial of<br />

community-dwelling older adults with mobility impairment receiving<br />

two interventions: progressive strength, balance and endurance training<br />

(I) vs goal-directed motor learning, adaptive stepping, pattern<br />

walking and dual-tasking (M). A linear model was used to study the<br />

relationship between pre- to post-intervention change in outcomes<br />

(gait speed, double-support time, step-time, stance time variability)<br />

with baseline SH in regions associated with executive function (anterior<br />

prefrontal cortex (APC), dorsolateral prefrontal cortex<br />

(DLPFC), ventrolateral prefrontal cortex (VLPFC), anterior cingulate<br />

(AC), basal ganglia and posterior parietal cortex).<br />

Results: Significant interactions emerged between right APC<br />

SH and intervention on changes in gait speed (p=0.04), step-time<br />

(p=0.001) and double-support time (p=0.01). With respect to steptime<br />

change, significant interactions emerged for SH in left APC<br />

(p=0.02), right and left DLPFC (p=0.03 and 0.02), right VLPFC<br />

(p=0.04) and right AC (p=0.02) with intervention. In the I-group,<br />

greater right APC and right AC SH were associated with poorer<br />

changes in gait speed (p=0.005 and 0.02), double support time<br />

(p=0.002 and 0.001), step-time (p=0.002 and 0.001) and variability in<br />

stance-time (p=0.004 and 0.01). In the M-group, there were no significant<br />

associations between changes in outcomes and SH in any of the<br />

above brain regions.<br />

Conclusion: Gait interventions that incorporate motor-skill acquisition<br />

and dual-tasking may benefit older adults irrespective of SH<br />

severity in brain regions linked to executive function while benefits<br />

from impairment-based interventions may depend on SH burden in<br />

these regions.<br />

B164<br />

Mood and Neurocognitive Measures to Predict Intake and Function<br />

in Elderly in a Recuperative Care Unit.<br />

P. R. Padala, 1,3 P. Dubbert, 1,3 K. P. Padala, 1,2 K. Garner, 1,2<br />

R. A. Dennis, 1,2 M. Bopp, 1,2 D. H. Sullivan. 1,2 1. Geriatric Research<br />

Education and Clinical Center, VISN16/CAVHS, North Little Rock,<br />

AR; 2. <strong>Geriatrics</strong>, University of Arkansas for Medical Sciences, Little<br />

Rock, AR; 3. Psychiatry, University of Arkansas for Medical Sciences,<br />

Little Rock, AR.<br />

Supported By: VA Health Services and Clinical Science Research<br />

and Development programs (HSR&D IIR-04-298 and CSR&D)<br />

and a University of Arkansas for Medical Sciences Tobacco<br />

Settlement award<br />

Background: Among older patients hospitalized for recuperative<br />

care and rehabilitation, persistent anorexia and poor functional<br />

rehabilitation are associated with high levels of inflammatory markers<br />

and other indicators of illness severity at admission. It is not<br />

known whether cognitive dysfunction or depression also contribute<br />

to the persistent anorexia and poor functional outcomes.<br />

Methods: This prospective study included patients over 64 years<br />

admitted to a recuperative care and rehabilitation unit in a VA hospital<br />

Community Living Center. Each subject’s daily total nutrient intake<br />

from all sources was measured using a standardized protocol.<br />

Depression was measured by the Geriatric Depression Scale-15 items<br />

(GDS), apathy was derived from 3 items on the GDS related to motivation<br />

(GDS-apathy), and executive function was measured by verbal<br />

fluency, digit span and Florida praxis battery. Correlation analyses<br />

were performed between the dependent variables of energy and protein<br />

intake with independent variables of mood and neurocognitive<br />

measures followed by regression analyses. T-tests were performed on<br />

the neurocognitive measures based on if the subjects were apathetic<br />

or not.<br />

Results: 416 veterans were enrolled. Mean scores at baseline<br />

were 3.7 (± 2.7) for GDS, 1.5 (±0.9) for GDS-apathy, 5.9 (±3.7) for<br />

Verbal Fluency-F, 7.4 (±2.5) for Digit Span Forward, 4.6 (±2.2) for<br />

Digit Span Backwards, 14.6 (±1.4) for Florida Praxis Battery, 83.8<br />

(±35.7) and 59.7 (±23.6)for Average Energy and Protein Intake respectively.<br />

Baseline measures of apathy, depression, executive function<br />

did not predict either energy or protein intake. However baseline<br />

AGS 2012 ANNUAL MEETING<br />

S129


P OSTER<br />

A BSTRACTS<br />

GDS and GDS apathy were negatively correlated to change in walking<br />

and walking endurance. The impact of depression and apathy on<br />

changes in walking endurance persisted even after controlling for<br />

change in inflammatory markers. Apathetic patients when compared<br />

to those without apathy had lower scores on verbal fluency (p=0.01-<br />

0.04), and increased intake (0.02).<br />

Conclusions: Depression and apathy scores but not neurocognitive<br />

scores were strong correlates of change in measures of physical<br />

function.<br />

B165<br />

Three, Five or Seven Days: How Much is Enough When Measuring<br />

Physical Activity with an ActiGraph Accelerometer in Older<br />

Adults?<br />

S. J. Francois, S. A. Studenski, J. S. Brach. University of Pittsburgh,<br />

Pittsburgh, PA.<br />

Supported By: Research/Grant Support: K23 AG026766, P30<br />

AG024827, T32 AG021885<br />

Background/Aims: Accelerometers provide valid and reliable<br />

measures of physical activity but have primarily been studied in<br />

healthy, young adults. Little is known about the reliability or wear<br />

time of accelerometers for measuring physical activity in older adults.<br />

Current protocols suggest 7 days to provide the best estimates of<br />

daily activity. Therefore, our goal is to assess the test-retest reliability<br />

of the ActiGraph accelerometer in community-dwelling older adults<br />

and determine if the number of days worn (3, 5, or 7) impact the testretest<br />

reliability of the measure.<br />

Methods: Participants included 32 community-dwelling older<br />

adults (mean age 78.0 ± 5.5 years) who ambulated independently<br />

(mean gait speed 0.96 ± 0.28 m/s). Physical activity was measured using<br />

an ActiGraph GT1M accelerometer (ActiGraph LLC, Pensacola, FL)<br />

worn on the waist during waking hours for 7 days. Subjects recorded<br />

wear times of the accelerometer in a daily journal. Subjects wore the<br />

accelerometers for another 7 days approximately 1 week later. Physical<br />

activity was summarized for each time period as the mean counts<br />

per minute per day (cpm) averaged over all 7 days, the first 5 days, and<br />

the first 3 days. Paired t-tests were used to compare physical activity<br />

measures from time 1 and time 2 and intraclass correlation coefficients<br />

(ICCs) were calculated to estimate the test-retest reliability.<br />

Results: The mean physical activity was similar for time 1 and<br />

time 2 for 7 days (135.4 and 135.3 cpm), 5 days (127.6 and 133.1 cpm)<br />

and 3 days (121.1 and 133.7 cpm); all p>0.15. The ICCs (95% CI) for<br />

7, 5, and 3 days of wear were 0.93 (0.86, 0.97), 0.92 (0.83, 0.96), and<br />

0.87 (0.73, 0.94), respectively.<br />

Conclusions: Compared to previous research in communitydwelling<br />

older adults (70+), the older adults in this sample demonstrated<br />

slightly lower levels of physical activity. Test-retest reliability<br />

for the ActiGraph accelerometer indicates moderate (3 days) to high<br />

(5 and 7 days) agreement in this older adult population. Taking into<br />

consideration accuracy of measurement and participant burden, our<br />

initial recommendation is at least 5 days of wear. The impact of weekend<br />

versus weekdays on physical activity measurement needs to be<br />

examined in future studies of older adults.<br />

B166<br />

How Do Falls, Fear and Cognition Influence the Association<br />

between Physical Performance and Self-Reported Function in Older<br />

Adults?<br />

V. A. Hornyak, 1 J. VanSwearingen, 1 D. Wert, 1 S. Studenski, 2 J. Brach. 1<br />

1. Physical Therapy, University of Pittsburgh, Pittsburgh, PA; 2.<br />

Geriatric Medicine, University of Pittsburgh, Pittsburgh, PA.<br />

Supported By: Support: Pittsburgh Older <strong>American</strong>’s Independence<br />

Center, 1 P30AG024827; Geriatric Academic Career Award<br />

K01HP20478; K23 AG026766.<br />

Background: Fall history, fear of falling (FOF) and cognitive<br />

function associate with reported physical functioning but how they<br />

influence the relation between physical performance and self-reported<br />

physical function is not known. We examined the relation of<br />

fall history, fear and cognition to reported physical functioning, controlling<br />

for performance in older adults.<br />

Methods: Older adults, independent in ambulation (n=70, mean<br />

age, 77± 5.3 years) completed physical performance and self-reported<br />

measures of function and cognition. The Late Life Function and Disability<br />

Instrument (LLFDI) overall functioning was used to determine<br />

physical function in daily life. Gait speed a performance measure<br />

of physical function was determined from self-paced walking over<br />

an instrumented walkway. Fall history and FOF were determined<br />

from the participant’s report. Cognitive function was determined<br />

using the Digit Symbol Substitution Test (DSST) and Trail-Making<br />

Test B (Trails B), measures of executive cognitive functioning. Pearson<br />

bivariate correlations were used to determine the relation between<br />

age, gait and cognitive functioning with physical functioning<br />

and define the related variables to include in the regression model. A<br />

linear regression model was used to determine the relative association<br />

of falls, fear and cognition to physical functioning, controlling for<br />

age, gender and gait speed.<br />

Results: Self-reported functioning (LLFDI) was related to gait<br />

speed (r=.56, p


P OSTER<br />

A BSTRACTS<br />

ent effect of cardiopulmonary comorbidities on VTE. Secondarily, we<br />

analyzed functional status expressed in a summary physical component<br />

score (PCS) in a subset of patients for whom it was available.<br />

Results: There were 24,051 THR and TKR surgeries performed<br />

at the VA during the study period. COPD predicted a 24% increase in<br />

VTE (OR=1.24, 95% CI 1.06-1.45). Low values of PCS, which was<br />

available for 3256 patients, demonstrated a trend of increased risk of<br />

VTE (lowest quartile OR =1.65, 95% CI 0.96-2.85 compared with<br />

highest quartile).<br />

Conclusions: COPD predicted a small increase in VTE whereas<br />

low functional status appeared to increase the odds of VTE substantially.<br />

Our findings suggest that cardiopulmonary comorbidities<br />

should not be factored into decisions about prophylaxis but that functional<br />

status probably should be assessed. More definitive conclusions<br />

about the role of these comorbidities and functional status are<br />

limited by typical constraints of administrative data analysis.<br />

B168<br />

Psychoactive Medications as Predictors of Post-operative Delirium<br />

in Hip Fracture Patients.<br />

A. L. Gruber-Baldini, 1 E. R. Marcantonio, 2 D. Orwig, 1 E. Barr, 1<br />

N. Ma, 1 M. Terrin, 1 J. Magaziner, 1 J. L. Carson. 3 1. Epidemiology &<br />

Public Health, University of Maryland School of Medicine, Baltimore,<br />

MD; 2. Division of General Medicine and Primary Care, Beth Israel<br />

Deaconess Medical Center, Boston, MA; 3. . Division of General<br />

Internal Medicine, UMDNJ-Robert Wood Johnson Medical School,<br />

New Brunswick, NJ.<br />

Supported By: Supported in part by grants from the National Heart,<br />

Lung, & Blood Institute: R01 HL085706, U01 HL073958 and U01<br />

HL074815, by a National Institute on Aging training grant: T32<br />

AG00262, and by funds from the Claude D. Pepper Older<br />

<strong>American</strong>s Independence Center, National Institute on Aging, P30<br />

AG028747.Dr. Marcantonio is a recipient of a Mid-Career<br />

Investigator Award in Patient-Oriented Research (K24 AG035075)<br />

from the National Institute on Aging.<br />

Delirium is common after hip fracture and is associated with<br />

poor short- and long-term outcomes. Previous research suggests that<br />

psychoactive medications may increase risk of delirium, and it is hypothesized<br />

that anticholinergic medications may also increase delirium.<br />

In this paper we examine the association of psychoactive medications<br />

on delirium severity in 131 patients from the Transfusion<br />

Trigger Trial for Functional Outcomes in Cardiovascular Patients Undergoing<br />

Surgical Hip Fracture Repair(FOCUS) Cognitive Ancillary<br />

Study, a randomized clinical trial examining the impact of blood<br />

transfusion strategy on delirium. Medication administration records<br />

24 hours before initial post-surgery assessment were coded by drug<br />

class, and also using 3 scales which summarize anticholinergic effects:<br />

Anticholinergic Drug Scale (ADS), Anticholinergic Risk Scale<br />

(ARS), and Anticholinergic Cognitive Burden Scale (ACBS). Delirium<br />

severity was measured 1-5 days post-surgery (Mean=1.8, SD=0.8)<br />

using the Memorial Delirium Assessment Scale (MDAS) and delirium<br />

presence using Confusion Assessment Method Diagnostic Algorithm<br />

(CAM). Average age was 81.8 (SD=9.0), 74.1% female, and<br />

90.8% white. The average number of psychoactive medications administered<br />

24-hours before initial post-operative assessment was 1.7<br />

(SD=1.8, range 0-8). Mean MDAS 7.1 (SD=5.3) and 29.8% CAM<br />

delirium. Percentage on medications by class: antipsychotics 2.3%,<br />

antidepressants 13.7%, opiates 0.8%, antihistamines 6.1%, analgesics<br />

62.6%, sedative-hypnotics 10.7%, anticholinergics 5.3%, ADS 57.3%,<br />

ARS 22.1%, ACBS 58.0%. The simple count of anticholinergic drugs<br />

was significantly associated with MDAS delirium severity (r=0.22,<br />

p=0.01), but none of the more complicated anticholinergic scales (all<br />

r0.10). Number of opiates, antihistamines, analgesics, antidepressants,<br />

and sedative-hypnotics was not associated with delirium<br />

severity or presence. Greater antipsychotic medication use was associated<br />

with worse MDAS delirium severity (r=0.18, p=0.03). Simple<br />

counts of antipsychotics and anticholinergics in prior 24 hours were<br />

associated with delirium after hip fracture surgery.<br />

B169<br />

Complications Following Cochlear Implantation in Older Adults.<br />

D. M. Clarrett, 1 L. Li, 2 F. R. Lin. 3 1. University of Cincinnati College<br />

of Medicine, Cincinnati, OH; 2. The Johns Hopkins Center on Aging<br />

and Health, Baltimore, MD; 3. Otolaryngology-Head and Neck<br />

Surgery, Johns Hopkins Hospital, Baltimore, MD.<br />

Supported By: Medical Student Training in Aging Research<br />

(MSTAR) program at Johns Hopkins University<br />

Background: Cochlear implantation (CI) is a hearing rehabilitative<br />

option for individuals with severe-to-profound sensorineural<br />

hearing loss. However, older adults with hearing loss are infrequently<br />

referred for CI, in part due to concerns about surgical risks and the<br />

potential for poor recovery among older adults. The objective of this<br />

study was to analyze the postoperative complications associated with<br />

CI surgery in a large, consecutive case series of older adults (≥60<br />

years) undergoing CI. Methods:The Johns Hopkins Listening Center,<br />

the largest provider of cochlear implants in North America, maintains<br />

a prospective database of all patients receiving cochlear implants at<br />

Johns Hopkins. We queried this database to ascertain all individuals<br />

≥60 years who underwent a first CI from 1999-2011. We then performed<br />

a retrospective chart review of the electronic patient record<br />

system at Johns Hopkins to abstract data on post-operative follow-up<br />

and complications. Abstracted data were coded and validated by randomly<br />

sampling 15% of the sample for repeat data abstraction. Statistical<br />

analyses comparing observed frequencies were performed<br />

using goodness-of-fit Fisher exact tests. Results: From 1999-2011, 445<br />

individuals ≥60 years received a first cochlear implant at Johns Hopkins.<br />

The mean age at implantation was 72.7 years (range 60-94.9<br />

years) and the median duration of follow-up was 4.8 years (range 0.1-<br />

12.5 years). There were a total of 42 minor complications (surgical<br />

site infection, balance problems, delayed transient facial weakness, facial<br />

nerve stimulation) in 41 patients (9.2%) and 36 major complications<br />

(device failure, skin flap dehiscence, surgical device removal) in<br />

21 patients (4.7%). There were no cases of meningitis or postoperative<br />

facial paralysis. Seventeen patients (3.8%) required surgical device<br />

removal. Complication rates did not differ between individuals<br />


P OSTER<br />

A BSTRACTS<br />

status, procedure complexity, and the presence or absence of major<br />

complications.<br />

Results: 100,831 patients were included for analysis. In general,<br />

advanced age was associated with increased preoperative comorbidities<br />

and postoperative complications. After adjustment for these associations,<br />

however, advanced patient remained an independent predictor<br />

of overall and diagnosis-specific mortality and for<br />

failure-to-rescue (mortality after the development of a major complication;<br />

see Table). Of the 32 variables included for risk adjustment,<br />

the strongest predictor of postoperative mortality for those patients<br />

aged ≥80 years was the development of a major postoperative complication<br />

(adjusted odds ratio 5.69, 95% CI 4.88-6.59).<br />

Conclusions: Advanced age is an indepedendent predictor of<br />

mortality after emergency general surgery, even after adjustment for<br />

other known perioperative predictors. Failure-to-rescue is identified<br />

as a primary reason for this increase in mortality. Efforts to improve<br />

the outcomes of elderly patients needing emergent surgery should<br />

focus on prevention of major postoperative morbidity.<br />

B171<br />

Age and Preoperative Geriatric Assessments in Predicting Surgical<br />

Outcomes in a Prospective Study of Patients Undergoing<br />

Pancreaticoduodenectomy.<br />

J. A. Hemmerich, 1 K. K. Roggin, 2 A. M. Kamm, 2 E. Melstrom, 1<br />

S. Wilson, 1 W. Dale. 1 1. Medicine, The University of Chicago, Chicago,<br />

IL; 2. Surgery, The University of Chicago, Chicago, IL.<br />

Supported By: The Michael Rolfe Foundation, Rita Meltzer, The<br />

John A. Hartford Foundation<br />

Drs. Hemmerich and Roggin are co-first authors.<br />

Objective: Older patients with pancreas cancer are often not<br />

considered for pancreaticoduodenectomy (PD) due to anticipated<br />

perioperative complications and prolonged recovery. Pre-operative<br />

geriatric assessment (GA) of vulnerability might better predict major<br />

complications, readmissions, discharge site, and hospital stays. We<br />

conducted a prospective study of GA in older patients who were undergoing<br />

PD.<br />

Methods: PD-eligible patients were enrolled into a single-site<br />

prospective observational study. Preoperative GA included components<br />

of Fried’s Model of Frailty (weight loss/weakness/self-reported<br />

exhaustion), the Vulnerable Elder Survey (VES-13), the short physical<br />

performance battery (SPPB). Socio-demographics, body mass<br />

index (BMI) clinical characteristics (including co-morbidities), and<br />

<strong>American</strong> <strong>Society</strong> of Anesthesiologist (ASA) scores were also collected<br />

at baseline. Outcomes included graded surgical complications<br />

(Clavien classification), length of hospital stay, discharge location<br />

(home vs rehab) and 30-day readmissions. Linear and logistic regressions<br />

were used to control for the influence of patient age, body mass<br />

BMI, preoperative ASA score, and co-morbid burden.<br />

Results: A total of n=76 had a PD (median age 68 years; range<br />

36-88). Significant preoperative vulnerability was identified in the<br />

sample: VES-13 >3 in 15.0%; SPPB


P OSTER<br />

A BSTRACTS<br />

80% show signs of this condition. The goals of treatment are pain reduction<br />

and preservation of functional status. Treatment is often multimodal<br />

including surgery and medications, such as NSAIDs and opioids.<br />

Many of these options pose a significant risk of adverse events.<br />

Therefore assessing the efficacy of noninvasive and “alternative”<br />

treatments, such as acupuncture, should be a primary focus of research.<br />

Acupuncture is a low risk and likely effective treatment for a<br />

number of chronic conditions. It is growing in popularity in the public<br />

consciousness. Ralph Gardner addressed this topic when writing in<br />

the Wall Street Journal (October 27, 2011) of his mother’s “willingness<br />

to undergo (this) treatment” for her neck pain. Given the suitability<br />

of the elderly as a target population for acupuncture, our objective<br />

was to determine if geriatric populations are represented in<br />

clinical studies on this subject.<br />

Methods: A PubMed search of the combined MESH terms<br />

“acupuncture and pain” and “acupuncture and osteoarthritis” for articles<br />

published between 1999 and 2011 found 4017 articles. Studies<br />

were excluded if they were not clinical trials or were in a language<br />

other than English. The final number of publications was 40, 37 of<br />

which were controlled trials. An analysis was carried out to determine<br />

how well the older population was represented.<br />

Results: Osteoarthritis was the primary indication for acupuncture<br />

treatment in 38% of all 40 trials, with the remainder of the studies<br />

evaluating other pain syndromes and insomnia. 78% of the studies<br />

identified fewer than 20% adverse events. Only 20% analyzed subjects<br />

who were 65 years of age or greater. No studies analyzed subjects<br />

of age greater than 85. 32% of the controlled studies reported an<br />

improvement in more than half the subjects<br />

Conclusions: The use of acupuncture has many advantages for<br />

the elderly because it is noninvasive, poses low risk of side effects, and<br />

frequently appears to be efficacious. In spite of these advantages,<br />

acupuncture is insufficiently studied in the elderly, the population for<br />

which it is likely most indicated.<br />

of paramount importance to consider CAA prior to thrombolysis for<br />

acute stroke in elderly.<br />

Multifocal hemorrhages<br />

C3<br />

Thrombolysis Related Intracerebral Hemorrhage due to Cerebral<br />

Amyloid Angiopathy.<br />

A. S. Danve, S. P. Kulkarni, M. Belal, S. Anand, S. Awasthi, E. Roffe.<br />

Internal Medicine, Metropolitan Hospital New York, New York, NY.<br />

INTRODUCTION-<br />

Intracerebral hemorrhage (ICH)is most feared complication of<br />

thrombolysis for acute stroke.Cerebral amyloid angiopathy (CAA) is<br />

a known risk factor for thrombolysis related ICH especially in elderly.<br />

CASE-<br />

A 90 year old woman developed acute onset right sided weakness<br />

45 minutes prior to arrival to ER. She had hypertension,<br />

Alzheimer’s dementia and mitral valve replacement. Her medications<br />

included Coumadin, Namenda and hydrochlorothiazide. On examination,<br />

patient had global aphasia and right hemiparesis. INR was<br />

1.12 with normal CBC and metabolic panel. CT Brain did not show<br />

any new infarct. Thrombolytic therapy was administered after neuro<br />

evaluation. One hour later, patient became unresponsive and developed<br />

decerebrate posturing. NIH score worsened from 13 to 36. Repeat<br />

CT Brain showed multifocal bilateral cerebral and cerebellar<br />

hemorrhages mainly at gray-white junction. Patient died 3 days after<br />

supportive care in ICU. Retrospectively, she was diagnosed to have<br />

underlying probable CAA (based on Boston Criteria) leading to<br />

thrombolysis related ICH.<br />

DISCUSSION-<br />

CAA is heterogeneous disorder characterized by deposition of<br />

Aβ fibrils in the walls of medium sized arteries in brain. Sporadic<br />

CAA is common in elderly, its incidence and severity increasing with<br />

age. It affects about 50 % of people above 80 years. In elderly, CAA is<br />

important risk factor for thrombolysis related ICH. It is typically multifocal,<br />

lobar, at corticosubcortical areas and associated with dementia.<br />

Currently, there is no specific therapy available for treatment. It is<br />

C4<br />

A Case Report Of Lung Cancer With Metastasis To Pancreas.<br />

A. Iraqi, T. Hughes. Syracuse VA medical center, Syracuse, NY.<br />

Introduction: Lung cancer is the leading cause of cancer deaths<br />

in the United States of America. It is broadly classified in two major<br />

histological entities, small cell lung (SCLC) and non-small cell lung<br />

cancer (NSCLC).SCLC is distinguished from NSCLC by its rapid<br />

doubling time and early development of widespread metastases with<br />

a propensity to spread to liver, adrenals, bone, bone marrow, and<br />

brain. However, it is rare for lung cancer including SCLC to metastasize<br />

to the pancreas. The usual histology of pancreatic cancer is adenocarcinoma<br />

and rare to have small cell.<br />

We describe a case of lung cancer which has metastasis to the<br />

pancreas.<br />

Case Description: A 77 year old male was hospitalized with<br />

painless jaundice. He had elevated bilirubin of 13.6 ( ref. 0.1 to<br />

1mg/dl ) with direct bilirubin of 10.4 ( ref. 0.0 to 0.5mg/dl) and alkaline<br />

phosphatase of 208 ( ref. 50-136 units/L ). His medical history included<br />

prior CVA, Atrial fibrillation, chronic kidney disease. Abdominal<br />

sonogram showed a 5.5cm mass in the region of pancreatic head<br />

with intra and extrahepatic biliary ductal dilation, no gall bladder<br />

wall thickening. Abdominal CT confirmed a 5 mm mass at pancreatic<br />

head with no evidence of masses outside the pancreatic head. He underwent<br />

ERCP with sphincterotomy, brushing with cytology and<br />

common bile duct (CBD) stenting. CBD and pancreatic duct brushings<br />

cytology were benign. Subsequently, he underwent endoscopic<br />

ultrasound with fine needle aspiration of the mass in the pancreatic<br />

head, and pathology showed small cell carcinoma, and special stains<br />

suggested against the diagnosis of lymphoma and melanoma. Following<br />

this, CT thorax showed a mediastinal mass, and CT brain negative<br />

for metastasis. Over time his condition declined and was complicated<br />

by pneumonia, GI bleed, infective endocarditis, worsening kidney<br />

function and intracranial bleed with metastasis to brain. With declining<br />

condition he opted for hospice care.<br />

AGS 2012 ANNUAL MEETING<br />

S133


P OSTER<br />

A BSTRACTS<br />

In this case it was thought that mediastinal mass is due to SCLC<br />

with metastasis to pancreas, and that he does not have a primary pancreatic<br />

cancer with metastasis to mediastinum or that he did not have<br />

two primary cancers.<br />

Conclusion: This case is un-usual as it is rare for lung cancer to<br />

have metastasis to pancreas and it is also rare for primary pancreatic<br />

cancer to be small cell.<br />

C5<br />

An Unusual Approach to Aggressive Behavior in Dementia<br />

Patients.<br />

A. I. Akintan, 1 V. Nurpeisov, 1 B. Patel, 2 N. Holland. 2 1. Geriatric medicine,<br />

Emory University, Atlanta, GA; 2. Geriatric medicine, VA<br />

Medical Center, Decatur, GA.<br />

We recently saw an 85 year old gentleman in the geriatric clinic<br />

with a past medical history of hypertension, osteoarthritis and dementia.<br />

He has had Alzheimer’s dementia for the past four years with<br />

increasing episodes of agitation. He was on the following medications;<br />

Aspirin, Metoprolol, Donepezil, Memantine, Allopurinol,<br />

Cyanocobalamin, Lisinopril, Furosemide and Acetaminophen.<br />

In an attempt to decrease his polypharmacy his Allopurinol was<br />

weaned off as he had no history of gout for the past five years. His aggressive<br />

behavior increased shortly after stopping the Allopurinol<br />

and this was subsequently restarted at the family’s request. His aggressive<br />

behavior stabilized after restarting Allopurinol.<br />

A review of the literature looking at Allopurinol in the treatment<br />

of aggression in dementia revealed two case reports.<br />

Allopurinol, a xanthine oxidase inhibitor decreases production<br />

of oxygen free radicals and promotes accumulation of purines and<br />

thus increases circulating pools of adenosine that may ultimately<br />

have antipsychotic and anxiolytics effects.<br />

We present this case as we feel that the possible association of<br />

using Allopurinol in treatment of aggressive behavior in patients with<br />

dementia is not well known.<br />

This may offer an alternative therapy for aggressive behavior in<br />

dementia patients who also have recurring gouty arthritis and may<br />

prove useful with more studies in other patients with dementia and<br />

aggressive behavior.<br />

C6<br />

Infection Associated Parasthesia: Case of “parasthesias gone wrong”<br />

A. Itticheria, B. Setters, R. Gopalraj. Family & Geriatric Medicine,<br />

University of Louisville, Louisville, KY.<br />

Introduction: Parasthesia is a main symptom of stroke, TIA’s,<br />

and other neurological conditions. Other underlying etiologies including<br />

the possibility of an infectious process should also be considered.<br />

Symptoms such as generalized or unilateral weakness, numbness<br />

and tingling of the extremities and sensory deficits have been<br />

seen in patients with acute infections.<br />

Case Report: A 64 yo female with history of a right middle cerebral<br />

artery stroke presented with acute left handed weakness that was<br />

gradually worsening. This was associated with asthenia and dysuria.<br />

Review of systems found stumbling and falls. Physical exam revealed<br />

mild left sided facial droop, decreased sensation of the left side, including<br />

face, arm and leg. Strengths were 5/5 and reflexes were 2+ bilaterally.<br />

She was dehydrated, with mild renal insufficiency and hypotension.<br />

A CT of the head was negative for any acute changes and<br />

brain MRI was unchanged showing a previous full occlusion of right<br />

cervical and intracranial internal carotid artery. EEG was also negative.<br />

A diagnosis of urosepsis was made and the patient was started on<br />

IV antibiotics and aggressive IVF hydration. With appropriate treatment<br />

in the next few days her symptoms fully resolved and the patient<br />

was discharged home.<br />

Three months later, she presented to the office with generalized<br />

weakness, tingling sensation in the fingertips of the right hand with<br />

numbness, blurred vision of the right eye, and sinusitis like symptoms.<br />

Again, her vital signs and exam were unremarkable, but given her history<br />

she was admitted to the hospital for further evaluation where<br />

MRI/A of the head showed no changes. She was diagnosed with acute<br />

sinusitis and treated with oral antibiotics. Her symptoms immediately<br />

improved and had resolved by the next day when she was discharged<br />

home at her baseline functional status. On both hospital visits the<br />

neurology consultant was not able to link any symptoms to a neurologic<br />

diagnosis.<br />

Conclusion: This case illustrates that paresthesias may not always<br />

be due to the typical neurological etiologies. As such other<br />

causes including infection must be considered and a comprehensive<br />

history and exam must be completed. Infectious processes may mimic<br />

such symptoms due to associated sepsis, fever, or dehydration.<br />

Recognition and treatment of potential infections might be the unusual<br />

but simple answer to a startling presentation of new onset<br />

paresthesias.<br />

C7<br />

Case Report of a Purple Rash and Gum Pain.<br />

A. Lum. Geriatric Medicine, University of Pittsburgh Medical Center,<br />

Pittsburgh, PA.<br />

Case Report<br />

Lum, Albert. University of Pittsburgh Medical Center Geriatric<br />

Fellow. Pittsburgh, PA<br />

A 68 years old Caucasian female with complaints of burning<br />

pain to her oral mucosa and gums off and on for 4 months seen at<br />

an outpatient clinic. She described the pain as burning type especially<br />

after eating hot spicy foods and worsened in the morning<br />

when she brushes her teeth. She also noticed purple pruritic rash to<br />

her hands started approximately same time as her gums. She had no<br />

previous history of similar symptoms. Her past medical history include<br />

GERD and borderline hypertension. She denies smoking, illicit<br />

drugs and alcohol use. She lives alone and is not sexually active.<br />

She is currently taking omeprazole 20mg daily for GERD and<br />

started on lisinopril 5mg daily approximately 5 months ago.On<br />

physical exam her vital signs were normal. Oral exam her buccal<br />

mucosa and gums had shallow, tender, erythematous small erosions<br />


P OSTER<br />

A BSTRACTS<br />

C8<br />

Blisters from my surgery: clinical history helped by internet pictures.<br />

A. I. Garrido, A. Chakka, T. Iloabuchi, F. Perez, A. Nazir.<br />

<strong>Geriatrics</strong>/Internal Medicine, Indiana University-<strong>Geriatrics</strong> fellowship,<br />

Indianapolis, IN.<br />

84 y/o WF admitted to a sub-acute rehab. to recover from complication<br />

from a total knee arthroplasty. PMHx. consists of DM, HTN,<br />

anemia, HLD, CAD, COPD, CKD, anxiety, and Hypothyroidism.<br />

After two weeks of successful rehabilitation, she developed blisters<br />

in her extremities and torso, with no other symptoms. When the<br />

blisters burst, they express a clear fluid, then crust and new blisters<br />

appear in other parts of her body.<br />

The patient was started on Prednisone while in the hospital but<br />

no documentation was found regarding the reason for it. With further<br />

interrogation, she stated that she had the blisters before and that<br />

steroids usually improved them. Until then, since no documentation<br />

found about her blisters, COPD exacerbations were the presumable<br />

cause for her steroid treatments.<br />

After reviewing and taking in consideration that the patient is a<br />

female older than 60, with previous episodes of non-complicated blistering,<br />

also that those blisters have responded to steroids treatment,<br />

and finally and foremost after comparing her lesions with the ones<br />

posted online in multiple sites Our patient was diagnosed with Bullous<br />

Pemphigoid and started on a long prednisone taper after which<br />

she improved and was successfully discharged home.<br />

Discussion:<br />

Bullous Pemphigoid is a fairly uncommon disease, but when<br />

present is usually in elderly females, it is one differential diagnosis we<br />

should think of when blisters are present in the elderly, followed by<br />

Pemphigus (similar but less common blistering disease). The difference<br />

between the two is auto antibodies to intradermal epitopes in<br />

the latter vs. sub dermal auto antibodies in the former. Both have<br />

been linked with higher risk of death, and this is why primary care<br />

geriatricians and anyone taking care of the elderly should be vigilant<br />

to diagnose and treat Bullous Pemphigoid, the treatment is mainly<br />

wound care (treat like a burn) and oral steroids. Recurrence is common<br />

and even longer steroid tapers might be required. Etiology is<br />

not well understood but an autoimmune response is known. The diagnosis<br />

is clinical. An association with some medications use is<br />

known (Furosemide, Penicillamine, and Captopril –among the most<br />

prominent-).<br />

References:<br />

1. Beth G Goldstein, MD, Bullous pemphigoid and other pemphigoid<br />

disorders. Topic review/Uptodate 2011<br />

2. González Ramírez A, Romero de Ávila AD, Mazoteras<br />

Muñoz V, Rev Esp Geriatr Gerontol. 2011 Nov 16.<br />

C9<br />

When Safe is Really Sad: Omeprazole Induced Depression with<br />

Psychotic Features.<br />

A. Tucker, B. Setters. Family and Geriatric Medicine, University of<br />

Louisville, Louisville, KY.<br />

Introduction: Omeprazole, a proton pump inhibitor, is used to<br />

reduce acid production and relieve symptoms associated with gastric<br />

reflux disease and is considered highly effective with relatively few<br />

side effects. As a result, it is considered a safe medication even for<br />

elderly patients and those sensitive to other medication classes.<br />

Case Report: A 70 yo female presented to the hospital with<br />

complaints of confusion. She had developed an acute change in her<br />

mentation with audio- visual hallucinations, delusions about her family<br />

and severe depression with vegetative type symptoms including<br />

anhedonia, anorexia and self-neglect which was very atypical for this<br />

active, fully independent woman. She had been recently diagnosed<br />

with Sjogren’s syndrome and had been referred for an endoscopy<br />

after persistent complaints of stomach discomfort. She was diagnosed<br />

with lower esophageal sphincter dysfunction and was started on<br />

omeprazole and fluconazole for oral thrush. Within the next two<br />

weeks, the patient’s mental status changed and she declined into a<br />

vegetative state. Examination found an unkempt, withdrawn, nonverbal<br />

woman fixated upon the death of her family and everyone around<br />

her. She was very bradykinesic and her mental status was equally<br />

slowed and impaired with a 20/30 MMSE score and a 2/4 clock drawing<br />

and she was hyponatremic (sodium 128). Her medications<br />

(omeprazole and losartan) save fluconazole were stopped for a medication<br />

washout. A complete work up ensured due to concern over<br />

acute mental changes; including CT and MRI of the head, EEG, lumbar<br />

puncture, cultures, toxicology and viral screens were all negative.<br />

Neuropsychological testing for dementia was also negative. As a result,<br />

she was started on olanzapine. Her symptoms persisted and she<br />

eventually required electroconvulsive therapy to restore her function<br />

and reverse her depression. She responded immediately to the ECT<br />

therapy and was able to return home to her active, independent,<br />

happy life.<br />

Conclusion: While cognitive changes and other psychological<br />

symptoms such as depression and hallucinations have been reported<br />

with proton pump inhibitors, they are very rare and often overlooked.<br />

This case illustrates the importance of considering unusual pharmacologic<br />

side effects as an underlying cause of acute psychotic and depressive<br />

symptoms, especially in the elderly patient. If overlooked,<br />

this patient may not have recovered.<br />

C10<br />

Follow the polypharmacy leader: medication induced heart block in<br />

a frail elderly female after failed cardio version.<br />

A. Burke, 1 B. Setters. 2 1. Internal Medicine, University of Louisville,<br />

Louisville, KY; 2. Family and Geriatric Medicine, University of<br />

Louisville, Louisville, KY.<br />

Introduction: Physicians continue to treat elderly patients with<br />

the same goals and protocols used for less complicated, younger patients.<br />

Slowed physiological responses, normal aging changes and<br />

often times frailty mean many elderly patients do not have the ability<br />

to appropriately respond to acute illness. Medical comorbidities and<br />

polypharmacy complicate this already convoluted treatment picture<br />

and lead to unexpected adverse events.<br />

Case Report: Mrs. M, a 71 year old female with a history of oxygen<br />

dependent COPD, diastolic dysfunction, paroxysmal atrial fibrillation<br />

(Afib) treated with cardioversion, obesity and diabetes, present<br />

to the emergency department with “trouble breathing” and palpations.<br />

EKG revealed Afib with a heart rate in the 120’s. She was admitted<br />

to the hospital for rate control, management of mild COPD<br />

exacerbation, and acute renal insufficiency (Cr 2.99; clearance 16<br />

ml/min). Mrs. M’s baseline rhythm on previous EKG was sinus bradycardia<br />

with a first degree AV block. Cardiology was consulted due to<br />

her complicated heart history and propafenone (225mg three times<br />

daily) and digoxin (0.125mg daily) were continued at home dosages<br />

with an increase dose of metoprolol (100mg twice daily from 75mg<br />

twice daily). Mrs. M then developed two episodes of unresponsiveness<br />

and subsequent code despite having a DNR code status. After<br />

the second episode of unresponsiveness, the continuous telemetry<br />

monitor revealed a wide irregular complex bradycardia without evidence<br />

of a p wave. The digoxin was held, a dig level checked and her<br />

beta blocker stopped as it was determined she was experiencing erratic<br />

complete heart block. She then has a pacemaker placed to control<br />

her bradycardia and heart block while the medications cleared<br />

her system. After her pacemaker placement, she did not experience<br />

any additional episodes of unresponsiveness and was discharged back<br />

to her nursing facility the following week after her renal function recovered<br />

and her medication effects wore off.<br />

Conclusion: In the elderly, medication titration and goals need<br />

to be adjusted from traditional protocols used in younger patients.<br />

With slower medication titration, reduction of polypharmacy, or decrease<br />

doses of home cardiac medications, Mrs. M may have avoided<br />

AGS 2012 ANNUAL MEETING<br />

S135


P OSTER<br />

A BSTRACTS<br />

the episodes of unresponsiveness, subsequent code and pacemaker<br />

placement.<br />

C11<br />

Unmasking PTSD in Dementia.<br />

A. H. Chodos, A. Moreno. <strong>Geriatrics</strong>, UCSF, San Francisco, CA.<br />

Introduction: A new presentation of posttraumatic stress disorder<br />

(PTSD) in the setting of cognitive impairment is increasingly diagnosed<br />

in patients with a history of prior trauma. The effect on caregivers<br />

is not well understood.<br />

Case: Mr. H is an 89-year-old male veteran with hypertension<br />

and glaucoma. At a primary care visit, he had a Montreal Cognitive<br />

Assessment score of 12/30 (normal ≥26) but reported no functional<br />

impairments. A social work and APS evaluation found his home to be<br />

safe and that he lived with his frail wife.<br />

Two months later he was seen by psychiatry, who noted a previous<br />

diagnosis of PTSD two years earlier and that he had since fallen<br />

out of psychiatric care. They documented a history of trauma during<br />

early childhood and WWII. Mr. H reported ongoing symptoms of<br />

nightmares, intrusive thoughts, insomnia and frequently checking the<br />

house at night. He refused any medication.<br />

A neuropsychological battery revealed impaired memory, language<br />

and attention,consistent with dementia.Laboratory tests showed<br />

a B12 of 196, and he was started on B12 supplement. A head MRI<br />

showed volume loss and subcortical white matter hyperintensities.<br />

A month later he presented three times to the ER for nonspecific<br />

symptoms and weight loss, and was admitted on the last visit. He<br />

was discharged home after his symptoms resolved without intervention.<br />

Several days later, he presented to his PMD endorsing severe<br />

anxiety, paranoia about his wife and suicidality. He was admitted to<br />

psychiatry. His suicidality resolved but he remained paranoid about<br />

his family. His providers discovered that prior to his presentation to<br />

his PMD, he had been alone for three days after exhibiting anxious<br />

and paranoid behavior that prompted a stepdaughter to remove his<br />

wife from the home. His family has refused to participate further in<br />

his care, and he awaiting guardianship in the hospital.<br />

Discussion: Mr. H was diagnosed late in life with PTSD in the<br />

setting of cognitive decline. His symptoms worsened as his dementia<br />

progressed and his social environment became strained. His case<br />

demonstrates that protective cognitive strategies may be affected in<br />

dementia, unmasking PTSD symptoms. Evidence also suggests traumatic<br />

memories are better encoded than others and may be preferentially<br />

recalled as dementia impairs recent memory. Older adults diagnosed<br />

with dementia require early social and psychiatric assessment<br />

to prevent harms of unaddressed psychiatric disease, caregiver stress<br />

and social vulnerability.<br />

C12<br />

Foot recognition following amputation.<br />

A. Gupta, 1,2 M. K. Bautista, 1,2 M. Izhar, 1,2 F. Aziz, 1,2 R. J. Beyth, 1,3<br />

K. M. Heilman. 1,4 1. GRECC, NF/SGVHS, Gainesville, FL; 2.<br />

Department of Aging and <strong>Geriatrics</strong>, University of Florida,<br />

Gainesville, FL; 3. Department of Medicine, University of Florida,<br />

Gainesville, FL; 4. Department of Neurology, University of Florida,<br />

Gainesville, FL.<br />

Background: Studies of body knowledge and imagery may help<br />

us understand disorders of the body schema such as phantom limbs<br />

and anosognosia. Following limb amputation there are alterations of<br />

a limb’s cortical representation. This case report attempted to learn if<br />

shortly after an above-knee amputation of the right leg this patient<br />

had a normal or impaired ability to recognize pictures of the right<br />

versus left foot taken from different angles.<br />

Methods: A 56-year right handed man with history of diabetes,<br />

peripheral vascular disease and remote history of right side stoke 10<br />

years ago without residual neurological deficits, developed a diabetic<br />

foot ulcer of the right lower leg and underwent an above-knee amputation<br />

of the right leg. Two weeks after surgery, the right-left foot<br />

recognition task was performed. The patient was shown, in a random<br />

order, a total of 24 images of either right or left foot at 12 different angles<br />

for each foot, and was asked to tell the examiner as rapidly, but as<br />

accurately as possible, if this picture was either the right or left foot.<br />

The subject made 44 errors recognizing the picture of the right foot<br />

and 44 errors recognizing the left foot. The mean reaction time for the<br />

right foot was 1.60±1.19 seconds, and the mean reaction time for the<br />

left foot was 1.52±1.28 seconds. There was no statistical difference in<br />

terms of the reaction time or accuracy in identifying images of the<br />

right foot compared to the left foot.<br />

Discussion: Previous studies using a limb recognition task with<br />

people who had a unilateral hand amputation and unilateral leg pain<br />

revealed increased reaction time and decreased accuracy in identifying<br />

images of the affected limb compared to the unaffected limb.<br />

Contrary to these prior reports this patient with right leg amputation<br />

revealed no difference in identifying images of the right compared to<br />

the left foot. Cortical reorganization occurs over a period of time and<br />

this patient was tested only two weeks after amputation. Further<br />

studies are needed to learn if patients such as this develop an alteration<br />

of their amputated limbs representation and if this interferes<br />

with recognition.<br />

C13<br />

Hip fractures in Elders Nearing End of Life: Is There a Role for<br />

Palliative Surgery?<br />

A. R. Atreya, S. Arora, M. J. Brennan. Medicine, Baystate Medical<br />

Center/Tufts Univ. School of Medicine, Springfield, MA.<br />

Background:<br />

There are 350,000 hip fractures in the US annually, with over<br />

90% of them in elders. Most patients benefit from rapid surgical repair<br />

but decision making can be complex near the end of life. The authors<br />

present a case of a frail dementia patient whose precarious situation<br />

and limited reserves posed a conundrum regarding surgical<br />

repair of his fracture.<br />

Case Report:<br />

An 88 year old retired pediatrician (Dr. R.) with advanced dementia<br />

was found lying on the nursing home bathroom floor. His history<br />

included CAD, a CABG and AVR, DM and HTN. He had lost<br />

weight due to dysphagia; his BMI was 15.6. He had an advanced dementia<br />

and was cachectic, incontinent of stool and urine; and he slept<br />

most of the day. Dr. R. needed assistance with all his ADLs. He still<br />

was able to speak a bit and could walk short distances unaided. An X-<br />

Ray confirmed an intertrochanteric fracture.<br />

In the ER, he was anemic, hypotensive, in rapid AF and had a<br />

creatinine of 1.5; he was admitted to the ICU. The critical care, medical<br />

consult and orthopedic teams were divided about whether to<br />

proceed to an ORIF. All agreed that Dr. R was high risk but some<br />

MDs felt he would have less pain after surgery and that the mortality<br />

risk was justified. <strong>Geriatrics</strong> was consulted to render an opinion regarding<br />

“palliative” surgery and to guide the family through this complex<br />

decision. The family reported that Dr. R. had always valued<br />

quality of life and function highly. He had chosen to have a CABG<br />

and AVR at an advanced age (despite the risks) to decrease symptoms<br />

and improve QOL. The family decided to proceed to surgery<br />

but overnight Dr. R. became stuporous, had an MI, developed pneumonia<br />

and worsening renal failure. Thoughts of surgery were abandoned,<br />

comfort measures intensified and Dr. R. died peacefully 3<br />

days after admission.<br />

Discussion and Conclusion:<br />

A search of the medical literature yields little data on the palliative<br />

outcomes of fracture repair for frail elders like Dr. R. High risk<br />

surgery is unjustified unless there is a real potential palliative benefit.<br />

If patients have better pain control, are able to transfer to chairs and<br />

have a lower requirement for opiates with fewer drug side effects,<br />

S136<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

then the palliative benefits may outweigh the medical risks. This glaring<br />

gap in the evidence calls for a multispecialty collaborative research<br />

effort involving geriatricians, palliative care physicians, hospitalists<br />

and orthopedists.<br />

C14<br />

End-of-life Care in Patients with Advanced Dementia or Severe<br />

Mental Retardation.<br />

B. D. Putnam, 2 Q. Cao, 1 D. Russo. 1 1. Family Medicine, East Carolina<br />

University, Greenville, NC; 2. Brody Medical School, East Carolina<br />

University, Greenville, NC.<br />

Objective 1:<br />

Understand that patients with dementia or mental retardation<br />

may not be able to make end-of-life decisions.<br />

Objective 2:<br />

Recognize the importance of a Health Power of Attorney<br />

(HPoA), and the role it plays in end-of-life decisions regarding a patient<br />

with dementia or mental retardation not capable of acting on his<br />

or her behalf.<br />

Objective 3:<br />

Discuss a particular case in which extraordinary measures were<br />

undertaken to preserve the life of such a patient and the ethical conflicts<br />

that present to health care and behavioral health providers in<br />

these situations.<br />

Abstract:<br />

End-of-life decisions for individuals with dementia or/and mental<br />

retardation may present more complications and uncertainties<br />

than for other patients. Patients who are severely mentally retarded<br />

or demented may have an inability to express themselves in spoken<br />

word or physical movements. Some have never had the mental capacity<br />

to understand what their options are as the end of life approaches.<br />

These decisions are often left up to the individuals named in their<br />

HPoA, often a family member or caregiver. In one particular case, a<br />

woman with severe cerebral palsy and mental retardation had been<br />

treated for eight of her last ten months of life in the hospital after a<br />

large portion of her bowel was resected secondary to obstruction. She<br />

required resuscitation in the medical intensive care unit multiple<br />

times, was maintained via Total Parenteral Nutrition for nine months,<br />

experiencing frequent complications which eventually led to septic<br />

shock and death. The patient’s caregiver, who held the HPoA, insisted<br />

all life-preserving measures be taken and refused hospice or palliative<br />

care despite the patient’s failing physical condition. Added to this<br />

was the concern of her health care providers secondary to the caregiver’s<br />

refusal to consider narcotic pain management for the patient.<br />

The health care team was faced with many moral and ethical issues<br />

including what it meant to “do no harm” or how to address decisions<br />

affecting the patient that they did not believe would improve her care<br />

or prognosis. Models for development of collaboration with medical<br />

and behavioral health team members and those with the HPoA need<br />

to be further developed to answer these difficult dilemmas.<br />

C15<br />

Acute heart failure in an elder with multimorbidities: the “nonlinear<br />

patient trap.”.<br />

B. Gao, 2,1 S. H. Gottlieb. 2 1. <strong>Geriatrics</strong>, Northeast Ohio Medical<br />

University, Rootstown, OH; 2. Medicine, Johns Hopkins University<br />

School of Medicine, Baltimore, MD.<br />

Introduction: Acute decompensated heart failure (HF) is one of<br />

the most frequent reasons for hospitalization among the elderly.<br />

Studies show that HF is often preceded by 2 weeks of worsening<br />

symptoms. Elderly patients may not seek timely treatment for their<br />

HF because they don’t sense or understand the import of premonitory<br />

symptoms. However, elderly patients often suffer from many interacting<br />

problems that cause symptoms to present in a nonlinear,<br />

rapidly evolving course that is difficult to anticipate.<br />

Case: A 73 year old woman with hypertension, hyperlipidemia,<br />

large B cell lymphoma treated with CHOP, right-sided pleural effusions<br />

with pleurodesis, and type 2 diabetes, stopped taking her medications,<br />

olmesartan and hydrochlorothiazide, 6 months before admission<br />

because she was exhausted taking care of her sister who had Lou<br />

Gehrig’s disease and because she ran out of money. Her symptoms of<br />

dyspnea and fatigue increased slowly until one week before admission<br />

when they became progressively worse; on the day of admission<br />

her symptoms became unbearable over 4 hours; when she thought<br />

that she was dying, she called 911 and was taken to the emergency<br />

room. On admission, her echocardiogram showed an ejection fraction<br />

of 20% and NT-ProBNP was 5,288 pg/ml. Troponin I was


P OSTER<br />

A BSTRACTS<br />

paralysis is seen for 36-48 hours then medical therapy is fully acceptable.<br />

In conclusion, the clinical presentation of epidural abscesses is<br />

often non-specific and should be investigated in atypical scenarios.<br />

C17<br />

Case Report: A primary mucinous adenocarcinoma with multiple<br />

recurrences and a 24 year survival.<br />

C. M. Espinal, 1,2 N. K. Patel, 1,2 R. W. Parker. 1,2 1. <strong>Geriatrics</strong>, University<br />

of Texas Health Science Center at SA, San Antonio, TX; 2. <strong>Geriatrics</strong>,<br />

Christus Santa Rosa, San Antonio, TX.<br />

INTRODUCTION: Advanced stage mucinous carcinoma of the<br />

ovary is very rare and is associated with poor overall survival. We report<br />

a case of a patient who has survived 24 years since her diagnosis<br />

of mucinous adenocarcinoma.<br />

CASE REPORT: A 70 year old (y/o) hispanic female with a 24<br />

year history of ovarian mucinous adenocarcinoma diagnosed at 46<br />

y/o in Mexico(1987). She underwent exploratory laparotomy due to<br />

recurrent abdominal discomfort, was diagnosed with mucinous adenocarcinoma<br />

of the left ovary. The patient was managed with<br />

oophorectomy and chemotherapy. Latter in the course of her disease<br />

she had about six laparotomies for removal of recurrent abdominal<br />

mucinous collections. The last recurrence was at the left pleural cavity.<br />

She has three fistulas on her left upper back draining serous fluid<br />

since 2009. The patient presented to our clinic with a desire for surgical<br />

evaluation for possible closure of fistulas, to regain her quality of<br />

life. She is limited in her socialization because of the fistulas and<br />

drainage. A CT of the chest demonstrated prior surgeries as well as<br />

lesions that extend beyond the pleura into the overlying chest wall.<br />

She was referred to a surgeon experienced with the geriatric population<br />

for management of the fistulas and also to an oncologist.<br />

DISCUSSION: Primary mucinous tumors are classified into benign,<br />

borderline, or malignant categories depending on their<br />

histopathology characteristics. For women with regional and distant<br />

disease, 5 year survival rates are 73% and 28%, respectively. These tumors<br />

usually develop in the third to fifth decades of life and typically<br />

cause vague symptoms, such as increasing abdominal girth, abdomino-pelvic<br />

pain, fatigue, constipation, and urinary incontinence.<br />

The patient started experiencing abdominal symptoms in her late<br />

40’s. Fortunately she had appropriate management with frequent interventions<br />

of her abdominal recurrence and pain management. Her<br />

wishes have always been to be able to live and enjoy her family.<br />

CONCLUSION: The survival rates for women with ovarian<br />

cancer and distant-recurrent disease is low, but considering the benefits<br />

versus the risk of cancer management, one should consider not<br />

only the comorbidities and life expectancy but quality of life. The patient<br />

and the family’s preferences should be an important part of the<br />

decision making for the plan of care.<br />

C18<br />

Thirteen courses of ECT over 4 years in an Alzheimer’s patient. Is it<br />

helping?<br />

C. D. Teodoro, M. Leiding, M. Gorbien, J. Olson, M. Bednarczyk.<br />

Section of Geriatric Medicine and Palliative Care, Rush University<br />

Medical Center, Chicago, IL.<br />

Purpose:<br />

To highlight the need for evidence-based practice guidelines in<br />

the use of ECT in persons with dementia and depression.<br />

Background:<br />

Electroconvulsive therapy (ECT) is a widely accepted treatment<br />

for older adults with medication refractory depression. Although<br />

evidence is limited, ECT is presumed to be effective in treating<br />

depression in older adults with dementia. Because patients with<br />

advanced dementia are difficult to interview, surrogate markers for<br />

depression must be used, such as function, oral intake, agitation or aggression.<br />

We present an extreme case of a woman with Alzheimer’s<br />

dementia, who has required repeated admissions for ECT to treat<br />

symptoms presumed to represent depression.<br />

Method: Case report<br />

Case Report:<br />

Mrs. G. is an 81 year-old female with Alzheimer’s dementia, who<br />

has been admitted to the gero-psychiatry unit thirteen times since<br />

Aug 2007 with symptoms of severe anxiety, insomnia and anorexia.<br />

Despite multiple pharmacologic therapies and use of outpatient<br />

maintenance ECT, her depression continues to relapse. She received<br />

a mean of 9 treatments per admission, a minimum of 7 and maximum<br />

of 15. Along with improved sleep and oral intake, one of the clearest<br />

indications ECT is helping Mrs. G. has been the condition of her knitting.<br />

A life-long knitter, she is always admitted with balls of yarn, her<br />

needles, and a hopelessly, tangled, knitted scarf. By discharge, her new<br />

scarf has few to no errors.<br />

Discussion:<br />

In the case of Mrs. G., ECT appears to relieve her depression, albeit<br />

temporarily. However, due to her dementia, ECT’s effect on cognition<br />

cannot be fully evaluated. In addition, observation of surrogate<br />

makers for depression by caregivers is subjective and difficult to standardize.<br />

A review of the literature reveals retrospective chart reviews<br />

and case reports describing ECT efficacy and purport its safe use in<br />

the treatment of depression with co-morbid dementia. However,<br />

these are limited in number, and descriptive in nature. While we acknowledge<br />

ECT’s therapeutic benefit in depressed patients, its use in<br />

those with underlying dementia still necessitates careful consideration<br />

and selection of the patients to be treated.<br />

C19<br />

Alzheimer’s Disease versus Hippocampal Sclerosis (HS): Is There a<br />

Clinical Imperative to Diagnose HS?<br />

D. M. Otero, K. Sharma. Division of <strong>Geriatrics</strong>, Albert Einstein<br />

College of Medicine, Montefiore Medical Center, Bronx, NY.<br />

Hippocampal sclerosis (HS) is a pathologic term used to describe<br />

severe loss of neurons and reactive gliosis in the hippocampus.<br />

HS is associated with hippocampal atrophy, severe amnesia, and<br />

slowly progressive dementia without clinical seizure activity. HS is<br />

found bilaterally in 50% of cases and 25% on the right or left side<br />

only. HS is difficult to distinguish clinically from Alzheimer’s disease<br />

(AD) and is often diagnosed postmortem. In autopsy series, HS is described<br />

in 1-5% of cases as an isolated diagnosis. However, HS has<br />

been described in up to 26% of cases when it occurs in combination<br />

with other vascular and neurodegenerative disorders.<br />

Case: A 78 year old woman was evaluated because the family<br />

had noticed changes in her behavior for 6 months. She had no significant<br />

PMH or toxic habits. The patient, a retired book-keeper with a<br />

high-school education, was no longer paying her bills, her house was<br />

disorganized and dirty and she could no longer use the computer.<br />

General PE: Unremarkable. Neurological: No focal signs. Psychiatric:<br />

No signs or symptoms of depression or personality change. Mental<br />

Status Testing: Clock Drawing Test: 3 (3 or > cognitive deficit); Mini-<br />

Mental State Examination: 21/30. Laboratory data revealed normal:<br />

chemistry, CBC, TSH, B12 and folate levels. Given the atypical presentation<br />

and rapid deterioration, the patient was referred for neuropsychological<br />

(NP) testing. NP testing revealed preserved insight.<br />

Memory was markedly impaired for both verbal and nonverbal material.<br />

However, she displayed a high level of nonverbal reasoning<br />

which was unexpected given her marked memory impairment. Verbal<br />

intelligence was near superior. The patient’s profound memory impairment<br />

in the context of well-preserved reasoning ability is an unusual<br />

profile for AD and HS was considered. MRI showed nonspecific<br />

vascular changes which is often seen in HS.<br />

Discussion: HS is distinguished from AD by the findings of preserved<br />

reasoning in the setting of profound memory loss early in the<br />

disease. HS is currently a pathological diagnosis however new research<br />

suggests that HS can be diagnosed with NS testing.This case il-<br />

S138<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

lustrates how HS and AD could potentially be differentiated clinically<br />

in the earliest stages with NP testing. The etiology and clinical significance<br />

of HS and its associated dementia has to be further elucidated.<br />

C20<br />

Looking Past the Dementia: Anxiety & Tachycardia Induced Seizure<br />

in a Patient with Dementia.<br />

D. Neamtu, L. Grooms, B. Setters. Family & Geriatric Medicine,<br />

University of Louisville, Louisville, KY.<br />

Introduction: Twenty five percent of new onset seizures occur in<br />

individuals over 65 years of age and approximately one fourth of all<br />

persons with epilepsy are elderly. Most seizures in elderly patients are<br />

partial onset, with or without secondary generalization, and are underdiagnosed<br />

especially in patients with dementia. Given the high<br />

quality of life burden seizures cause, it is important to diagnose and<br />

appropriately treat them even among frail elders.<br />

Case report: A 79 yo female with a history of advanced dementia,<br />

hypercholesterolemia, gastro-esophageal reflux disease, urinary<br />

incontinence and osteoarthritis, living in a long-term care facility, had<br />

a witnessed tonic-clonic seizure with no loss of consciousness while<br />

ambulating in the hallway. After the episode the patient had garbled<br />

speech and worsening confusion. By the time she was evaluated in the<br />

emergency department, the aphasia resolved and no neurological<br />

deficits were noted. Diagnostic studies including CMP, CBC, TSH,<br />

toxicology and head CT were normal; EEG showed normal activity<br />

save movement artifact. Telemetry during hospitalization, however,<br />

found the patient was experiencing episodes of sinus tachycardia to<br />

150 beats per minute during restful awake periods. She was unaware<br />

of these symptoms and additional cardiac evaluation including an<br />

echocardiogram was unremarkable. Careful investigation and observation<br />

suggested a relationship between the patient experiencing extreme<br />

anxiety or heightened awareness and resultant sinus tachycardia<br />

which were decreasing cerebral flow and resulting in seizure<br />

activity. The patient returned to the nursing facility with recommendations<br />

for anxiety treatment as a first measure.<br />

Discussion: Patients with dementia are at increased risk of<br />

seizures. Approximately 15% of patients with Alzheimer’s Dementia<br />

will develop seizures, a rate that is ten times higher than expected for<br />

age. No clear etiology was found for the tachycardia occurring during<br />

wakeful periods; this may be secondary to anxiety as postulated, but<br />

may also occur from uncontrolled pain or dementia associated psychosis.<br />

No signs of the latter etiologies were noted in this patient.<br />

Given the high burden of seizures on quality of life even among dementia<br />

patients and those with high comorbid diseases proper diagnosis<br />

and treatment is very important.<br />

C21<br />

Does Living in a Family Slow Cognitive Decline in Dementia?<br />

D. Basu, M. Brennan. Baystate Medical Center/Tufts Univ. School of<br />

Medicine, Springfield, MA.<br />

INTRODUCTION: Cultural norms and family structures may<br />

slow the progression of dementia or even delay its onset. The authors<br />

report a case of a Latino senior with dementia who remained cognitively<br />

stable longer than anticipated due in part to the devotion of his<br />

family.<br />

CASE: In 2008, a 85 year old man with CHF, atrial fibrillation,<br />

CKD, DM, PVD, gait impairment and memory loss for a year was<br />

seen by geriatrics and diagnosed with a moderate stage mixed<br />

Alzheimer’s and vascular dementia. As the years passed, occasional<br />

restlessness, insomnia and hallucinations occurred and he was treated<br />

for depression; occasionally low dose antipsychotics were prescribed.<br />

Overall, he has responded well to reorientation, cueing and cognitive/social<br />

stimulation by his devoted family who never leave him unattended.<br />

His dementia has progressed but he remains verbal, interactive,<br />

recognizes family and enjoys life despite many admissions and<br />

functional decline. He recently even made a trip back to Puerto Rico<br />

to visit relatives.<br />

DISCUSSION: Epidemiological data indicates the incidence<br />

and rate of dementia are higher for socially isolated elders. Studies of<br />

African and Italian patients indicate that social integration and networks<br />

and cognitively challenging leisure activities protect against<br />

dementia and some research suggests that occupational therapy approaches<br />

may slow cognitive decline for dementia sufferers. Emotional<br />

support maintains cognitive reserves and enhances recovery in<br />

stroke patients. However, a search of the literature using standard engines<br />

such as pubmed and google scholar, found no studies analyzing<br />

whether preserved family life can prevent or slow dementia’s inexorable<br />

course.<br />

CONCLUSION: Living with loving families provides personalized<br />

care for frail elders and will decrease the public costs of health<br />

care; strategies to support family-based care in the community thus<br />

may improve quality of life while decreasing the state’s financial burden.<br />

Additionally, elders living with families who involve them in decision<br />

making, problem solving and ongoing social interaction will be<br />

stimulated cognitively and may maintain intellectual reserves longer.<br />

There is a glaring gap in the literature; studies must be done to clarify<br />

whether family life delays the onset or progression of dementia. The<br />

role of families in slowing cognitive decline in dementia patients is<br />

critically important for the field of ethnogeriatrics.<br />

C22<br />

A Request by a Septuagenarian to Stay Young.<br />

D. Chen, 1,2 R. S. Tan. 2,1 1. Medicine/<strong>Geriatrics</strong>, Baylor College of<br />

Medicine, Houston, TX; 2. Houston VA, Houston, TX.<br />

A 77 yo female asked that her last years be of quality. She had<br />

no falls, incontinence, mood instability or memory loss. She requested<br />

hormones be checked due to fatigue, bruising and weakness. PMH:<br />

hysterectomy 40 years ago. She lives by herself, drives and walks 30<br />

minutes daily. She was using no meds.<br />

She had a weight of 125 pounds, height 5 feet 6 inches,<br />

BP:110/70, MMSE:30/30, senile purpura in forearms, mild kyphosis,<br />

genu varus of left knee. Cardio-respiratory exam normal. Body fat by<br />

impedance: 26%.<br />

Labs (with normal ranges): estradiol: pg/mL (>27); testosterone:<br />

11 ng/dL (2-40); undetectable progesterone; IGF-1: 56 ng/mL (34-245,<br />

Z score -1.1). CBC, glucose, cholesterol and TSH were normal. Mammogram<br />

was normal.<br />

After a lengthy discussion of safety and that we have no longterm<br />

data to guide us, and documenting informed consent for offlabel<br />

use, the decision was made to initiate hormone therapy. Reproductive<br />

hormone replacement was achieved through compounding of<br />

estradiol 1mg, testosterone 2 mg and progesterone 40 mg in a topical<br />

gel applied daily. Growth hormone replacement was administered<br />

subcutaneously, initially with 0.3 mg 3 times weekly, and later increased<br />

to 0.5 mg eod, after titrating IGF-1 levels. Therapy was to be<br />

combined with a supervised exercise regimen in the gym.<br />

The patient was followed up monthly. At month 4, she reported<br />

significant changes to her quality of life. Her bruising had disappeared.<br />

She was mentally sharper and felt physically stronger, and<br />

able to ambulate faster and longer. There was no numbness in the<br />

hands, hot flashes or virilism. Physical examination showed redistribution<br />

of body fat to lean body mass as evidenced by constant weight,<br />

but lowering of body fat from 26% to 25%. Her grip strength significantly<br />

improved for both hands (see table). Labs confirm elevation of<br />

estradiol to 32 pg/mL, testosterone to 58ng/dL and progesterone to<br />

1.3 ng/mL. IGF-1 levels remained the same, which may be reflective<br />

of the conservative dosing.<br />

This case illustrates that while considered non-mainstream by<br />

some, geriatricians can help selected septuagenarians improve quality<br />

of life with careful replacement of hormones with aging. Cost and<br />

ethical concerns must be considered.<br />

AGS 2012 ANNUAL MEETING<br />

S139


P OSTER<br />

A BSTRACTS<br />

grip strength change before and after treatment<br />

*p


P OSTER<br />

A BSTRACTS<br />

ratory symptoms such as stridor and airway compromise due to RA.<br />

The patient in this case presented with dysphagia and dysphonia<br />

without any other respiratory symptoms. Also, this case illustrates a<br />

unique presentation of RA in which dysphagia was not only caused<br />

by laryngeal dysfunction but also oropharyngeal dysfunction possibly<br />

related to striated muscle involvement, a phenomenon that has not<br />

been very well described. Further studies are needed to investigate<br />

pathophysiology and treatment of dysphagia and dysphonia in patients<br />

with RA.<br />

C26<br />

Stuck Between a Rock and a Bare Metal Stent: Triple<br />

Antithrombotic Therapy Resulting in a GI Bleed.<br />

F. Longenecker, 2 B. Setters. 1 1. Family & Geriatric Medicine,<br />

University of Louisville, Louisivlle, KY; 2. School of Medicine,<br />

University of Louisville, Louisville, KY.<br />

Introduction: Although the standard of care for PCI with stent<br />

placement and DVT prophylaxis for hip arthroplasty are individually<br />

well established, little evidence exists about what to do for patients<br />

requiring both treatments simultaneously. In such a situation the risk<br />

of bleeding vs. the risk of thrombosis must be used to determine the<br />

individual patient’s treatment course.<br />

Case Report: A 79 y/o WF was admitted with an L femoral neck<br />

fracture after being found down for 48 hours. Preoperative clearance<br />

determined she needed a cardiac catheterization which found a 90%<br />

occlusion of her LAD requiring placement of a bare metal stent. She<br />

was started on clopidogrel and aspirin therapy post stent for a minimum<br />

of 30 days. Discussion ensued with orthopedics and cardiology<br />

about the timing of the patient’s orthopedic procedure now that she<br />

was on anticoagulation. Orthopedics felt that the surgery could be<br />

safely performed on anticoagulants and performed the surgery 3 days<br />

post-stent. She was then started on fondaparinux for DVT prophylaxis<br />

post hip repair.<br />

The patient was discharged to a rehabilitation center four days<br />

post operatively with instructions to monitor for bleeding; Hemoglobin<br />

at discharge was 10.3. Nine days later, she returned to the hospital<br />

with dark, tarry stools worrisome for a GI bleed. Hemoglobin was 7.2<br />

and two units of blood were transfused and pantoprazole was started.<br />

Cardiology was consulted and it was decided the patient would remain<br />

on aspirin but fondaparinux were discontinued to allow for an<br />

upper endoscopic evaluation which was done the next day. She was<br />

diagnosed with antral erosive gastritis without active bleeding. Follow<br />

up Hemoglobin was 9.4 and without evidence of further bleeding,<br />

clopidogrel was resumed. She remained stable and was discharged<br />

back to her rehabilitation center with instructions for continued monitoring<br />

and has done well.<br />

Conclusion: Patients with indications for both DVT prophylaxis<br />

and dual antiplatelet therapy pose a great challenge. In approaching<br />

such cases, providers must assess each patient’s risk and benefit profile<br />

to determine appropriate treatment and monitor for increased<br />

risk of bleeding when combining multiple anticoagulants. Additional<br />

recommendation for treatment and bleeding risks in patients with<br />

bare metal stents who need DVT prophylaxis would be useful for<br />

these cases.<br />

C27<br />

Gastrointestinal Bleeding as a Consequence of Bisphosphonate-<br />

Induced Musculoskeletal Pain.<br />

J. Seguin, 1 F. Chang, 1 K. Yeung. 2 1. School of Pharmacy, University of<br />

Waterloo, Waterloo, ON, Canada; 2. Geriatric Medicine, North York<br />

General Hospital, Toronto, ON, Canada.<br />

Background:<br />

Non-steroidal anti-inflammatory drugs (NSAIDs) are common<br />

causes of gastrointestinal (GI) bleeds in older adults. Bisphosphonates<br />

are first line treatment for osteoporosis, a chronic disease with<br />

increased prevalence with aging. This case discusses how an uncommon<br />

adverse effect associated with bisphosphonate use can be an underlying<br />

cause to GI bleeds in older adults.<br />

Pertinent Case History:<br />

DA, a 79 year old community dwelling woman, was admitted<br />

through the emergency department with acute leg and knee pain and<br />

black stools. She was anemic with low hemoglobin (81 g/L or 8.1<br />

g/dL), but did not require a blood transfusion. Endoscopy revealed 4<br />

small gastric ulcers. Her pain started about 2.5 weeks prior to admission<br />

and she was prescribed naproxen 375mg twice daily as management.<br />

This was switched to diclofenac 75mg twice daily with rabeprazole<br />

5 days prior to admission; however, she did not discontinue<br />

naproxen. Upon investigation, the acute pain started with the initiation<br />

of risedronate 35mg weekly for osteoporosis. The NSAIDs were<br />

discontinued in hospital, and lansoprazole was initiated with acetaminophen,<br />

as well as ferrous gluconate. She was discharged home 4<br />

weeks later, followed by 3 months of outpatient physiotherapy.<br />

Conclusions:<br />

This case illustrates how missed identification of drug-related<br />

adverse events can be harmful for the patient. Potential drug-related<br />

causes should be investigated prior to symptomatic treatment for<br />

pain. Practitioners should consider bisphosphonates in addition to osteoporotic<br />

pain in their differential diagnosis for musculoskeletal<br />

pain in the elderly. While the cause and risk factors for musculoskeletal<br />

pain induced by bisphosphonates remain unclear, one study has<br />

suggested that the effect may be mitigated by starting patients on<br />

low-dose daily treatment before starting the once weekly dose. This<br />

case also reinforces the 2009 recommendation by the <strong>American</strong> <strong>Geriatrics</strong><br />

<strong>Society</strong> to avoid the use of nonselective NSAIDs and COX-2<br />

inhibitors in the elderly with persistent pain without a compelling<br />

reason, and to exercise extreme caution if used. In addition, patient<br />

education and reinforced understanding are pertinent to avoid therapeutic<br />

duplications particularly with switching between agents in the<br />

same high risk medication class.<br />

C28<br />

Terminal Suffering: the Complex Interplay of Pain and Delirium at<br />

End of Life.<br />

G. Sachdeva, 1 M. Brennan. 2 1. Internal Medicine, Baystate Medical<br />

Center / Tufts University School of Medicine, Springfield, MA; 2.<br />

Internal medicine/<strong>Geriatrics</strong> division, Baystate Medical Center/ Tufts<br />

University School of Medicine, Springfield, MA.<br />

A 70 year old man (Mr. F.) had a complex cardiopulmonary history,<br />

anxiety, chronic pain, dysphagia, recurrent pneumonias and a<br />

vascular dementia. Home medications included clonazepam (4 mg<br />

over the day) a 350 mcg fentanyl patch and methadone (15 mg total<br />

daily). He was admitted with lethargy, weakness and confusion and<br />

proved to have a new aspiration pneumonia. His two daughters were<br />

PAs and along with a wife and son were closely involved in decision<br />

making. When he aspirated yet again, all agreed to strictly comfort<br />

goals; family was deeply committed to relieving Mr. F.’s suffering. Despite<br />

explanations that much of his restlessness and moaning was due<br />

to a terminal delirium, the family worried he was in pain and often<br />

declined antipsychotic doses and requested changes in the analgesic<br />

regimen. House officers and covering hospitalists were uncomfortable<br />

with the doses and drugs being used but certainly did not want<br />

the patient to suffer. At times drugs (e.g. methadone) were inappropriately<br />

discontinued but sometimes they were increased too quickly.<br />

One day an escalation of morphine despite renal failure led to early<br />

signs of opioid toxicity and occasional myoclonus. On another occasion,<br />

opioids were switched because fentanyl “wasn’t working.” In<br />

fact, the patient’s restlessness was due to urinary retention and resolved<br />

with a catheter. With careful communication, education and<br />

frequent reassessment, symptoms were controlled and the family<br />

comforted. Mr. F. died calmly several days later.<br />

AGS 2012 ANNUAL MEETING<br />

S141


P OSTER<br />

A BSTRACTS<br />

Discussion/Conclusion<br />

Distress at the end of life may be from treatable factors such as<br />

urinary retention but often results from a complex interplay of delirium,<br />

pain and psychosocial factors. Effective palliation requires a<br />

multimodal approach targeting all sources of suffering. Geriatricians<br />

and palliative care experts have much to learn from each other and to<br />

teach trainees and hospitalists. To ease patients’ final hours and relieve<br />

the guilt of families, the <strong>American</strong> Academy of Hospice and Palliative<br />

Medicine and the <strong>American</strong> <strong>Geriatrics</strong> <strong>Society</strong> should collaborate<br />

on educational and clinical initiatives on end of life care<br />

C29<br />

Galantamine Induced Generalized Myoclonus.<br />

G. Luna, 1 N. Sharma, 2 J. Makela. 3 1. Geriatric, UIC, Chicago, IL; 2.<br />

Geriatric, UIC, Chicago, IL; 3. Geriatric, UIC, Chicago, IL.<br />

Supported By: No financial support provided<br />

Introduction: Myoclonus is a brief, involuntary twitching of a<br />

muscle or a group of muscles characterized by spastic-ballistic disabling<br />

jerking movements. It describes a medical sign and is not itself<br />

a diagnosis. While respiratory myoclonus associated with galantamine<br />

has been previously described, generalized myoclonus second to<br />

galantamine use has not been described before in the published geriatric<br />

literature.<br />

Case: A 87-year-old male with vascular dementia was started on<br />

galantamine for dementia. Four months later, at 16mg dosing, the<br />

caregiver reported that the patient started to experience a fine right<br />

hand tremor, but refused further work-up at the time. The patient<br />

continued on galantamine 16 mg. Nine months after galantamine<br />

therapy was started, the patient came to the clinic complaining of a<br />

new disabling movement disorder. The movements first started three<br />

months previous, as infrequent, short, brief jerks. These episodes did<br />

not follow a day cycle pattern or involve loss of consciousness. On<br />

clinical exam, high amplitude, frequent, multifocal myoclonus was observed.<br />

These jerks involved the whole body; however they were<br />

more prominent in the upper extremities. After discussion with a<br />

movement disorder specialist, who assisted in the assessment, galantamine<br />

was identified as a possible cause of myoclonus. Subsequent<br />

laboratory work-up for other causes was negative. Two weeks after<br />

stopping galantamine all movement symptoms had successfully disappeared,<br />

confirming the suspicion.<br />

Discussion:<br />

In the geriatric practice we see a number of conditions that can<br />

cause generalized myoclonus. Few of these conditions are reversible.<br />

This case report suggest that when we see a patient present with generalized<br />

myoclonus we should consider the possibility of galantamine<br />

induced myoclous, as it is easily reversible. It is important to note that<br />

the development of myoclonus was not abrupt, as might be expected<br />

in a drug reaction. Rather, the myoclonus worsened over the course<br />

of several months while on treatment. However, the rapid resolution<br />

of symptoms after galantamine withdrawal implicated it as a cause.<br />

The insidious onset and progression of myoclonus, as seen in this<br />

case, may hinder recognition of galantamine as a cause. We would encourage<br />

physicians treating generalized myoclonus to consider galantamine<br />

as a possible reversible cause.<br />

C30<br />

Bilateral pulmonary emboli in a patient with renal angiomyolipoma.<br />

G. Ratnarajah, D. Seminara, A. Szerszen . <strong>Geriatrics</strong>, Staten Island<br />

University Hospital, Staten Island, NY.<br />

Renal angiomyolipoma is a benign hamartoma that can rarely<br />

extend into the renal vasculature and subsequently into the inferior<br />

vena cava (IVC) . An even more rare occurrence is embolism of the<br />

tumor from the IVC into the pulmonary circulation<br />

A 72 year old lady with a history of hypertension was found to<br />

have renal insufficiency on routine evaluation by her private medical<br />

doctor. Her physical examination was unremarkable and workup of<br />

the renal insufficiency revealed a mass in the left kidney by ultrasound.<br />

Further inquiry of this renal mass was undertaken with abdominal<br />

computerized tomography ( CT ) scan which revealed a left<br />

sided renal mass with extension into the left renal vein; a preliminary<br />

diagnosis of renal angiomyolipoma was made. The scan also showed<br />

suspicion for a loculated effusion of the left lung. A chest CT scan was<br />

then performed to investigate the pleural effusion which incidentally<br />

revealed bilateral pulmonary emboli. In addition, the right sided embolus<br />

was seen to contain macroscopic fat.<br />

On admission to the hospital, the patient denied any chest pain,<br />

shortness of breath, abdominal pain, or hematuria. Her physical examination<br />

was unremarkable with no signs of tachycardia, fever, hypoxia,<br />

or petechiae. Her labs were significant for a glomerular filtration<br />

rate of 39 ml/min/1.73 m 2 . An echocardiogram was performed<br />

which revealed no signs of right ventricular strain pattern. The patient<br />

was started on intravenous heparin and the decision was made to<br />

bridge her with Coumadin therapy upon discharge. An open radical<br />

nephrectomy was planned on an outpatient basis.<br />

In conclusion, we present an asymptomatic elderly patient with<br />

bilateral pulmonary emboli from renal angiomyolipoma. The extension<br />

of renal angiomyolipoma into the renal vasculature is an uncommon<br />

entity. In these patients, clinicians should be aware of the complication<br />

of embolization and consider further workup to rule out<br />

pulmonary embolism.<br />

C31<br />

Cerebral Infarction: A Rare Presentation of Cryptococcal<br />

Meningoencephalitis in an Immunocompetent Patient.<br />

I. P. Resurreccion. Medicine, UAB Montgomery, Montgomery, AL.<br />

Cerebral cryptococcosis is common fungal opportunistic infection<br />

in immunocompromised, but a rare disease in immunocompetent<br />

patients. We report an unusual case of CNS cryptococcosis as<br />

cerebral infarction in an immunocompetent patient.<br />

A 78-year-old Caucasian male with hypertension, hyperlipidemia<br />

and osteoarthritis was admitted with confusion, left-sided<br />

weakness, dizziness, falls, headache and anorexia. No head trauma nor<br />

fever. On physical, he was disoriented to time and place and decreased<br />

strength on the left side with preserved sensation. Brain CT<br />

was negative. Brain MRI showed subacute infarct in anterior right<br />

middle cerebral territory. Lumbar puncture had normal opening pressure,<br />

showed 18 WBC with 100% mononuclears, high protein<br />

82.5mg/dL, low glucose 18mg/dL, positive India ink and cryptococcal<br />

antigen titer 1:1024. CSF culture grew Cryptococcus neoformans.<br />

HIV screening was negative. Induction therapy initiated with liposomal<br />

amphotericin and flucytosine. He continued to have altered mental<br />

status and headache. He was planned for another lumbar puncture<br />

every 2 weeks or earlier to relieve headaches. He continued to deteriorate<br />

with multi-organ failure and died.<br />

Cerebral infarction is an unusual presentation of CNS cryptococcosis.<br />

Rarely, cryptococcus can cause cerebral infection in immunocompetent<br />

patients. Manifestations include fever, headache, altered<br />

mental status, personality changes and memory loss. Lumbar<br />

puncture is useful for diagnostic and therapeutic. Opening pressure is<br />

elevated and CSF has elevated protein, low glucose with positive<br />

India ink stain, cryptococcal antigen titer and culture. Treatment includes<br />

induction therapy with amphotericin B and flucytosine. Duration<br />

in patients without neurological complications with a negative 2<br />

week CSF culture is 4 weeks and in patients with neurological complications<br />

is 6 weeks. Consolidation therapy with fluconazole is 8<br />

weeks. Maintenance therapy is 6-12 months. The incidence of cerebral<br />

infarction due to cryptococcal meningitis in HIV-negative patients is<br />

4%. Mechanisms include antigen-antibody complexes with vasculitis<br />

and direct toxic effects of viral antigen on vascular endothelium. Poor<br />

prognostic factors are cerebral infarcts, high opening pressure, CSF<br />

WBC


P OSTER<br />

A BSTRACTS<br />

antigen >1:32. Early diagnosis and appropriate management is crucial<br />

to reduce the high morbidity and mortality with CNS cryptococcosis.<br />

C32<br />

WEIGHT LOSS ASSOCIATED WITH SWITCHING<br />

CHOLINESTERASE INHIBITORS.<br />

J. T. Stewart, 1,4 I. Sheyner, 2,5 L. V. George, 3 K. M. Mattox, 3<br />

K. T. Stover. 2 1. Psychiatry, James A Haley VA Hospital, Tampa, FL; 2.<br />

<strong>Geriatrics</strong>, James A Haley VA Hospital, Tampa, FL; 3. Pharmacy,<br />

James A Haley VA Hospital, Tampa, FL; 4. Psychiatry, University of<br />

South Florida College of Medicine, Tampa, FL; 5. Geriatric Medicine,<br />

University of South Florida College of Medicine, Tampa, FL.<br />

Supported By: There was no funding or other support for this work.<br />

BACKGROUND: Weight loss is common in dementia, leading<br />

to poor quality of life and increased mortality. Weight loss is reported<br />

in up to 20% of patients receiving cholinesterase inhibitors. It is not<br />

known which of these agents are more likely to cause weight loss, nor<br />

whether patients who have lost weight on one agent can be treated<br />

with another.<br />

METHODS: Case report, literature review.<br />

RESULTS: An 86 year old man with vascular dementia had<br />

been treated with donepezil for six years; he had improved cognitively<br />

and had never experienced any nausea, anorexia or weight loss.<br />

Galantamine SR was substituted in 2010. Over the next 17 months he<br />

and his daughter reported poor appetite and a loss of 48 pounds.<br />

There was no nausea or vomiting. Ultimately donepezil was reinstated.<br />

His appetite returned and he regained 30 pounds over the<br />

next three months (Figure).<br />

CONCLUSIONS: Cholinesterase inhibitors have modest benefits<br />

in dementia but are not without risk. Weight loss in dementia can<br />

have catastrophic effects on health and quality of life and a reasoned<br />

risk-benefit analysis is essential in all prescribing. The literature does<br />

not guide the clinician when a patient has clear benefit from a<br />

cholinesterase inhibitor but also develops significant weight loss. This<br />

case suggests that weight loss from one agent does not necessarily<br />

predict weight loss from other agents in the class and that switching<br />

to a different agent may be a reasonable strategy. It is not known<br />

whether galantamine is more likely to cause weight loss than other<br />

agents, nor whether its secondary effect of modulating nicotinic receptors<br />

is salient; controlled studies will be necessary to examine<br />

these questions.<br />

C33<br />

A PILOT RANDOMIZED TRIAL OF A BEHAVIORAL SLOW-<br />

BREATHING INTERVENTION TO TREAT URGENCY<br />

INCONTINENCE IN WOMEN.<br />

A. Huang, D. Grady, A. Appa, S. Leslee. University of California, San<br />

Francisco, CA.<br />

Supported By: National Institutes of Health<br />

Background: Urgency urinary incontinence affects up to a quarter<br />

of middle-aged and older women and can have profound adverse<br />

effects on functioning and quality of life. Existing anti-cholinergic<br />

treatments for incontinence are associated with frequent side effects<br />

and high rates of discontinuation in the community. Multiple studies<br />

have indicated that urgency incontinence is associated with increased<br />

levels of perceived stress as well as abnormalities in autonomic nervous<br />

system activity, suggesting that behavioral relaxation interventions<br />

that reduce stress and improve autonomic balance may be helpful<br />

in alleviating this condition.<br />

Methods: Pilot feasibility randomized trial in 20 ambulatory<br />

women with ≥7 episodes of urgency incontinence per week and no<br />

major urologic or neurologic co-morbidities. Women were randomized<br />

to use a portable guided-breathing device (RESPeRATE) to<br />

slow their breathing to


P OSTER<br />

A BSTRACTS<br />

Results: Of 1401 subjects screened at 109 sites, 562 (40%) were<br />

eligible and enrolled. The most common reasons for exclusion were<br />

not meeting VE criteria (226; 27%), low creatinine clearance (114;<br />

14%), and/or too few UUI episodes (82; 10%). 446 subjects (79%)<br />

completed the trial; 116 (21%) discontinued (Table 1). Drop-outs related<br />

to study drug were 8%. Recruitment challenges included access<br />

to fesoterodine without trial participation and subject concerns about<br />

randomization to placebo.<br />

Conclusions: Enrolling/retaining VE in an AM trial is feasible,<br />

with a trial cost of ~$8M. Despite subject vulnerability, retention was<br />

good and drug-related withdrawals were low. Future improvements<br />

for VE trials include allowing assistance with questionnaire completion<br />

and use of home and phone visits for safety assessments and follow-up,<br />

making participation more convenient and less burdensome.<br />

Table 1. Reasons for Subject Discontinuations.<br />

C35 Encore Presentation<br />

Central Nervous System (CNS) Penetration and Memory Effect:<br />

Trospium Chloride vs Oxybutynin in Adults with Overactive<br />

Bladder and Age-Associated Memory Impairment.<br />

C. Tannenbaum, 1 D. Staskin, 2 G. Kay, 3 H. B. Goldman, 4 W. Tong, 5<br />

R. K. Patel. 5 1. Department of Geriatric Medicine, Institut<br />

Universitaire de Gériatrie de Montreal, Montreal, QC, Canada; 2.<br />

Department of Urology, Caritas St. Elizabeth’s Medical Center,<br />

Boston, MA; 3. Cognitive Research Corporation, St. Petersburg, FL; 4.<br />

Glickman Institute, The Cleveland Clinic, Cleveland, OH; 5. Allergan,<br />

Inc., Irvine, CA.<br />

Supported By: Funding for this work was received from Allergan, Inc.<br />

Background: Anticholinergic agents can affect memory due to<br />

CNS penetration, which allows for muscarinic receptor binding in the<br />

brain. Older adults with age-associated memory impairment may be<br />

especially vulnerable. Antimuscarinic agents most likely to cross the<br />

blood-brain barrier are lipophilic tertiary amines. Quaternary amines<br />

are far less lipophilic. This double-blind, placebo-controlled trial<br />

(SMART II) is the first to compare cerebrospinal fluid (CSF) permeation<br />

and memory effects of a quaternary (trospium) and tertiary<br />

(oxybutynin) amine in older adults with overactive bladder and ageassociated<br />

memory impairment.<br />

Methods: Adults ≥60 years were randomized to receive extended-release<br />

(XR) trospium 60 mg QD for 10 days (n=6), or immediate-release<br />

(IR) oxybutynin 5 mg TID for 2 days (n=10). Overactive<br />

bladder was defined by ≥8 voids/day with ≥1 associated with urgency.<br />

CSF was drawn at selected timepoints for bioanalysis. Memory was<br />

measured at baseline and at post-dose plasma steady state using the<br />

Hopkins Verbal Learning Test-Revised (HVLT-R) for total and delayed<br />

recall.<br />

Results: Oxybutynin was detected in the CSF in all oxybutynin<br />

IR subjects (mean age: 68 years; range: 60-76 years). Mean CSF<br />

AUC 0-tau<br />

values were 0.204 ± 0.089 and 1.68 ± 1.06 ng*hr/mL, for oxybutynin<br />

and desethyloxybutynin, respectively. CSF concentrations of<br />

trospium were below the lower limit of quantification of 40 pg/mL at<br />

all timepoints for all trospium XR subjects (mean age: 74 years;<br />

range: 67-84 years). Increased memory impairment on the HVLT-R<br />

delayed was seen with oxybutynin IR (mean baseline score, 9.4; mean<br />

change from baseline, -1.3; p=0.03). Trospium XR had no deleterious<br />

effect on memory (mean baseline score, 8.2; mean change from baseline,<br />

-1.2; p=0.11).<br />

Conclusions: In older adults with overactive bladder and age-associated<br />

memory impairment, oxybutynin and desethyloxybutynin,<br />

but not trospium, were detected in the CSF at steady state. Memory<br />

worsened in adults receiving oxybutynin IR, but not trospium XR.<br />

C36<br />

Falls Assessment In Older Patients Treated With Duloxetine.<br />

C. Nelson, 1 T. M. Oakes, 2 P. Liu, 2 J. Ahl, 2 M. E. Bangs, 2 J. Raskin, 3<br />

D. G. Perahia, 4,5 M. J. Robinson. 2 1. University of California, San<br />

Francisco, CA; 2. Eli Lilly and Company, Indianapolis, IN; 3. Eli Lilly<br />

Canada, Scarborough, ON, Canada; 4. Lilly Research Center,<br />

Windlesham, Surrey, United Kingdom; 5. The Gordon Hospital,<br />

London, United Kingdom.<br />

Supported By: Eli Lilly and Company and subsidiaries, Indianapolis,<br />

IN, USA<br />

Background: In an analysis of spontaneously reported treatment-emergent<br />

adverse events in older patients (≥65 years) (N=3278)<br />

from all placebo-controlled trials across indications, 1.1% of patients<br />

treated with duloxetine had one or more falls compared with 0.4% of<br />

patients treated with placebo. Methods: This was a secondary analysis<br />

of falls data collected at each study visit using a specific soliciting<br />

questionnaire during a 24-week, double-blind, randomized, placebocontrolled<br />

trial of duloxetine for treatment of major depressive disorder<br />

(MDD) in older patients. Patients were randomized to duloxetine<br />

60 mg/day (N=249) or placebo (N=121) for the first 12 weeks (acute<br />

phase), after which the duloxetine dose could be increased and<br />

placebo patients could be switched to duloxetine if not responding.<br />

The difference in frequency of falls with duloxetine treatment vs.<br />

placebo was compared by Fisher’s exact test. The exposure adjusted<br />

incidence rate (EAIR) of falls per patient-year was also estimated<br />

based on the patient’s actual duration of exposure to drug or placebo.<br />

Results: The percentage of patients with a fall in the acute phase was<br />

17.3% with duloxetine 60 mg vs. 11.6% with placebo (p=.170). Over<br />

24 weeks, the percentage of patients with a fall was significantly<br />

higher with duloxetine 60/120 mg (25.3%) vs. placebo (15.7%,<br />

p=.045), and the percentage of patients with a fall while taking duloxetine<br />

60 mg during the 24-week study was 24.1% vs. placebo (15.7%,<br />

p=.078). The EAIR of falls per patient-year during the acute phase<br />

was 0.95 with duloxetine 60 mg and was 0.69 with placebo. Over 24<br />

weeks, the EAIR was 0.79 with duloxetine 60 mg and was 0.54 with<br />

placebo. Between-treatment differences in EAIRs over 12 weeks<br />

(0.26; 95% confidence interval [CI]: -0.20 to 0.72) and over 24 weeks<br />

(0.24; 95% CI: -0.07 to 0.56) were not significant. Conclusions: Although<br />

the EAIR of falls per patient-year associated with duloxetine<br />

treatment was not significantly different than with placebo in this<br />

trial of elderly patients with MDD, the overall higher frequency of<br />

falls during treatment with duloxetine suggests that the increase in<br />

falls may be duloxetine-related.<br />

C37 Encore Presentation<br />

Factors Influencing Time to Resolution of Diarrhea in Patients with<br />

Clostridium difficile Infection Treated with Fidaxomicin or<br />

Vancomycin.<br />

D. Gerding, 1 D. Crook, 2 M. Miller, 3 T. Louie, 4 O. Cornely, 5 T. Peto, 2<br />

S. Gorbach. 6 1. VA Chicago Health Care System, Chicago, IL; 2.<br />

University of Oxford, Oxford, United Kingdom; 3. McGill University,<br />

Montreal, QC, Canada; 4. University of Calgary, Calgary, AB,<br />

Canada; 5. University Hospital of Cologne, Cologne, Germany; 6.<br />

Optimer Pharmaceuticals, Inc., San Diego, CA.<br />

Supported By: This study was funded by Optimer<br />

Pharmaceuticals, Inc.<br />

Background: TTROD, an important endpoint for patients, varies<br />

considerably among CDI patients even when treated with effective<br />

antibiotics. We sought to identify factors that influenced TTROD in a<br />

database of 1105 patients enrolled in two phase 3 studies and treated<br />

with FDX or VAN.<br />

Methods: Patients with CDI confirmed by positive stool toxin<br />

test were randomized to receive oral FDX (200 mg twice daily) or<br />

oral VAN (125 mg 4 times daily) for 10 days. TTROD was determined<br />

S144<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

in hours from first dose of study drug to the time of last unformed<br />

bowel movement. Survival functions were estimated by the Kaplan-<br />

Meier product-limit method with log-rank and Wilcoxon tests to test<br />

equality across strata for each parameter at α=0.05.<br />

Results: Diarrhea resolved 24 h later in patients infected with<br />

the REA type BI strain (median TTROD 78 h; [95% CI [61, 103])<br />

than non-BI strains (54 h, 95% CI [51, 57]); Kaplan-Meier analysis<br />

confirmed the difference (log-rank p24 h difference and<br />

log-rank P


P OSTER<br />

A BSTRACTS<br />

Results: Regional anesthesia as compared to general anesthesia<br />

did not carry excess mortality risk in elderly patients 90 and above (p<br />

= 0.43). There was no association between the type of anesthesia used<br />

and the rate of post-operative complications. The relationship of age<br />

and the type of anesthesia used were also considered. Within this age<br />

group, the choice of anesthesia did not seem to depend on a patient’s<br />

age (p = 0.51).<br />

Conclusion: The type of anesthesia, whether regional or general,<br />

does not affect outcomes in elderly patients undergoing surgery for<br />

hip fractures. Therefore, greater utilization of regional anesthesia in<br />

this population may be a cost effective option, as it deters the need<br />

for extensive preoperative evaluations.<br />

C41<br />

Translating Geriatric Assessment into Community Oncology Clinics:<br />

Comparative Results.<br />

G. R. Williams, 1 A. Deal, 2,3 T. Jolly, 4 S. Alston, 2 B. Gordon, 2 J. Pan, 2<br />

A. Caprio, 1 S. Moore, 5 W. Taylor, 6 H. Muss. 2,4 1. Division of Geriatric<br />

Medicine and Center for Aging and Health, University of North<br />

Carolina at Chapel Hill, Chapel Hill, NC; 2. Lineberger<br />

Comprehensive Cancer Center, University of North Carolina at<br />

Chapel Hill, Chapel Hill, NC; 3. Biostatistics Core Faculty, University<br />

of North Carolina at Chapel Hill, Chapel Hill, NC; 4. Division of<br />

Hematology / Oncology, University of North Carolina at Chapel Hill,<br />

Chapel Hill, NC; 5. Rex Hematology Oncology Associates, Raleigh,<br />

NC; 6. New Bern Cancer Care, New Bern, NC.<br />

Supported By: Supported by University Cancer Research Fund,<br />

Lineberger Comprehensive Cancer Center, Chapel Hill, NC<br />

Background: Emerging results support the value of geriatric assessment<br />

(GA) in determining the risk and benefits of cancer treatment<br />

in older adults. A brief GA tool consisting of valid and reliable<br />

measures has been developed (Hurria et al, J Clin Oncol 29:1290,<br />

2011), but little data exist on the GA of elderly patients in the community.<br />

This study compares the differences between geriatric oncology<br />

patients at academic versus community based oncology practices<br />

in North Carolina.<br />

Methods: From 2009 to 2011 a total of 386 patients were recruited.<br />

283 (73%) were from a tertiary care referral cancer center<br />

(UNC) and 103 (27%) were from community clinics. The two groups<br />

were compared using Fisher’s Exact and Wilcoxon rank sum tests.<br />

Results: Community clinics enrolled older patients (p= 0.004),<br />

with 52% being ≥ 75 years of age, compared to only 33% at UNC. The<br />

Karnofsky performance status as rated by medical staff was significantly<br />

lower at community clinics (60% vs 25% with a score ≤ 90%;<br />

p= 65 years of age hospitalized with pneumonia during fiscal<br />

years 2002 to 2007 in Department of Veterans Affairs hospitals.<br />

Our primary analyses were multilevel regression models that examined<br />

the association between cardiovascular medication classes and<br />

either 90-day mortality or cardiovascular events within 90-days after<br />

adjusting for potential confounders.<br />

Results: Our cohort included 50,064 patients with a mean age of<br />

77.3 years, 98% were male, 23% died within 90 days of admission, and<br />

38% had a cardiac event. Medications associated with decreased<br />

mortality include beta-blockers (OR 0.92, 95% CI 0.87-0.97), statins<br />

(OR 0.67, 95% CI 0.63-0.70), ACE inhibitors (OR 0.81, 95% CI 0.76-<br />

0.86), and ARBs (OR 0.61, 95% CI 0.53-0.70), but an increased number<br />

of cardiovascular events: beta-blockers (OR 1.15, 95% CI 1.10-<br />

1.21), statins (OR 1.02, 95% CI 0.98-1.07), ACE inhibitors (OR 1.14,<br />

95% CI 1.09-1.20), and ARBs (OR 1.20 95% CI 1.08-1.33).<br />

S146<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

Discussion: While cardiovascular medications were associated<br />

with decreased mortality, there was an association with increased<br />

with increased number of cardiovascular events. These results indicate<br />

that cardiovascular medications may have beneficial effects for<br />

the outcomes of patients admitted with pneumonia however not due<br />

only to cardioprotective effects.<br />

C44 Encore Presentation<br />

Lower diastolic blood pressure and increased heart rate are<br />

independent predictors of mortality for 1 year in elderly outpatients:<br />

Data from Frailty in elderly with cardiovascular disease.<br />

A. R. Diniz, A. Frisoli, E. T. Pinto, J. D. Majeski, M. Erlichman,<br />

A. C. Carvalho. UNIFESP- Escola Paulista de Medicina, São Paulo,<br />

Brazil.<br />

Introduction: Increased heart rate (HR) is risk factor for cardiovascular<br />

mortality. Elevated values of diastolic (DBP) and systolic<br />

blood pressure (SBP) have been associated with the same outcomes.<br />

The predict outcomes of low values of DBP and SBP with increased<br />

HF has been poor clarified in elderly.<br />

The goal of this study was to evaluate the association of increased<br />

HR, lower DBP and SBP with mortality for 1 year in elderly<br />

outpatients.<br />

Methods: cross sectional analysis of data from an observational<br />

study of epidemiology of frailty in elderly outpatients with cardiovascular<br />

diseases. DBS, SBP and HF were obtained with the median of<br />

three measures at the first visit. Diagnoses of Heart failure were<br />

made with ejection fraction higher (diastolic heart failure-DHF) or<br />

lower than 50% (systolic heart failure-SHF) and the presence of signs<br />

and symptoms of heart failure (NYHA). Mortality information was<br />

obtained by phone call at 6, 12, 18 and 24 months after.<br />

Results: On May, 2011, 103 patients reached 1 year or died.<br />

74.5% had heart failure, which 48.4% DHF and 51.6% SHF. Female<br />

was 60.2% (n=62) prevalent. The mean age of men was 76.05 (±5.0)<br />

and women 77.71 (±5.5) years old. 60% were Caucasian. Mortality<br />

rate was 8.7% (n=9), which 66.7% had heart failure and 50% DHF.<br />

Among patients who died SBP (119 vs 141mmHg; 0.028) and DBS<br />

(68 vs 88mmHg; 0.003) were significant lower, and HR (96 vs 69bpm;<br />


P OSTER<br />

A BSTRACTS<br />

Conclusions: Conclusions: The results indicate that there may be<br />

a single factor underlying the responses to OHIP-14 questions in<br />

these older adults. The ohip-14 seems not to represent seven separate<br />

dimensions of oral health as originally devised.<br />

C47<br />

Mexican-<strong>American</strong> Elder Post Hip Fracture Survival Study.<br />

D. V. Espino, 1,2 R. C. Wood, 1,2 C. C. Moore. 2,1 1. Family and<br />

Community Medicine, University of Texas Health Science Center at<br />

San Antonio, San Antonio, TX; 2. School of Medicine, University of<br />

Texas Health Science Center at San Antonio, San Antonio, TX.<br />

Supported By: National Institute of Health (NIH)<br />

<strong>American</strong> Federation for Aging Research (AFAR)<br />

University of Texas Health Science Center at San Antonio<br />

(UTHSCSA)<br />

As the world’s population is shifting to an older age due to advances<br />

in medical care, increased numbers of hospital visits, especially<br />

for geriatric hip fractures, are being documented. Despite the<br />

vast research conducted on hip fractures in general, little emphasis<br />

has been made on the effects of hip fractures on Mexican-<strong>American</strong>s.<br />

The Hispanic Established Populations for the Epidemiologic<br />

Study of the Elderly (H-EPESE) compiled data on risk factors for<br />

morbidity and mortality in Mexican-<strong>American</strong>s used to create a<br />

community-based survival analysis of geriatric hip fractures. The H-<br />

EPESE began in 1993 with a contingent of 3050 individuals and is<br />

currently on the seventh wave of the study. Using a Cox Model Regression<br />

Survival Analysis program, significance (p65), gender and presence or<br />

absence of Type II Diabetes Mellitus creating a drastic influence on<br />

mortality rates. Over a 7 year span after sustaining a hip fracture, a<br />

patient meeting the appropriate risk factors noted above had an approximate<br />

fifteen percent increased risk for mortality than a patient<br />

not meeting the criteria. Factors influencing the comorbidities,such<br />

as: osteoporosis in the elderly, post-menopausal hormone imbalances<br />

in women and peripheral neuropathy associated with Type II<br />

Diabetes Mellitus were investigated as contributors to the increased<br />

mortality rates. While this study does not cover the entire spectrum<br />

of comorbidities associated with increased geriatric hip fractures in<br />

the Mexican-<strong>American</strong> population, it does attempt to bridge the literature<br />

gap associated with the Mexican-<strong>American</strong> minority and<br />

create interest for expanding the literature for this subset of the<br />

population.<br />

C48<br />

Lifetime Manic Spectrum Syndromes and All-Cause Mortality: A<br />

26-year Follow-Up of the US National Epidemiological Catchment<br />

Area Study.<br />

C. Ramsey, 1 A. P. Spira, 1 W. W. Eaton, 1 H. B. Lee. 2,1 1. Mental Health,<br />

Johns Hopkins Bloomberg School of Public Health, Baltimore, MD;<br />

2. Psychiatry, Yale University, New Haven, CT.<br />

Background: Increasing evidence suggests a high prevalence of<br />

bipolar spectrum disorders, associated morbidity and mortality.While<br />

research supports the association between depression and mortality,<br />

the role of mania has received less attention. This analysis evaluated<br />

the association between manic spectrum syndromes and risk of mortality<br />

in the community. Methods: Participants in the prospective US<br />

National Epidemiological Catchment Area Study were classified into<br />

mutually exclusive groups based on their responses to the Diagnostic<br />

Interview Schedule items assessing mania in 1981. Those with manic<br />

spectrum syndromes (n=133; mean age: 33.8 +/- 12.6; female: 29.2%)<br />

met one of the following criteria: mania (met DSM-III criteria for a<br />

manic episode; n=36), hypomania (met all DSM-III criteria for a<br />

manic episode except the severity requirement of causing impairment<br />

or help seeking; n=42) and subsyndromal mania (had a euphoric<br />

or irritable mood for a week or more and at least one other<br />

symptom, but did not meet criteria for mania or hypomania; n=55).<br />

Participants without manic spectrum syndromes (n=13,784; mean<br />

age: 48.6 +/- 20.2; female: 53.8%) comprised the control group. Vital<br />

status through the end of follow-up in 2007 was ascertained by<br />

matching individual identifying information with the National Death<br />

Index. Manic spectrum and control groups were compared in terms<br />

of demographics, depressive symptoms, and self-rated health in 1981<br />

using independent samples t-tests and chi-squared tests. To account<br />

for the age difference between groups, a propensity score was used.<br />

Risk of mortality was assessed using a Cox-proportional hazards<br />

model with age in 1981 as the time of entry and age at death or follow-up<br />

as the time of exit. Results: Estimated lifetime prevalence of<br />

manic spectrum syndromes was 0.98%. This group was older than the<br />

controls, had more symptoms of depression, was more likely to be<br />

married and to be Caucasian. After adjusting for these covariates in<br />

the hazard model, manic spectrum syndromes were not a significant<br />

risk factor for all-cause mortality (HR=1.3, p=0.270). Conclusions:<br />

History of manic spectrum syndromes did not increase risk of allcause<br />

mortality. Future studies should evaluate specific causes of<br />

mortality.<br />

C49<br />

Asymptomatic Bacteriuria and Antibiotic Use in Nursing Homes.<br />

D. R. Mehr, 1 C. D. Phillips, 2 L. Adepoju, 2 D. K. Moudouni, 2 N. Stone, 4<br />

O. Nwaiwu, 2 E. Frentzel, 3 S. Garfinkel. 3 1. Family and Community<br />

Medicine, University of Missouri, Columbia, MO; 2. Texas A&M<br />

Health Sciences Center, College Station, TX; 3. <strong>American</strong> Institutes for<br />

Research, Chapel Hill, NC; 4. Centers for Disease Control and<br />

Prevention, Atlanta, GA.<br />

Supported By: Supported by the Agency for Healthcare Research<br />

and Quality<br />

Background: Overuse of antibiotics is a longstanding concern in<br />

nursing homes. As part of a project on antibiotic stewardship, we investigated<br />

the use of antibiotics to treat asymptomatic bacteriuria<br />

(ASB) among nursing home residents with a suspected urinary tract<br />

infection (UTI).<br />

Methods: In 4 central Texas nursing homes, episodes of treatment<br />

for suspected UTI were identified from facility logs. Symptoms<br />

and resident characteristics were abstracted from residents’ records.<br />

Using a multi-level multivariate model, we evaluated resident and facility<br />

characteristics associated with antibiotic use despite the absence<br />

of symptoms and signs suggesting need to treat a UTI (criteria from<br />

Loeb, et al. Infect Control Hosp Epidemiol 2001).<br />

Results: Over 6 months, clinicians ordered antibiotics for suspected<br />

UTI 227 times among 167 residents; 89% had urine studies.<br />

Half (114) of the antibiotic prescriptions occurred in the absence of<br />

any symptoms or signs. In multivariate analyses, resident characteristics<br />

did not differentiate between treated residents with or without<br />

symptoms or signs; however, in the same model, 2 of the 4 facilities<br />

exhibited less treatment of asymptomatic residents (odd ratios and<br />

95% confidence intervals, 0.28 [0.09,0.88] and 0.34 [0.15,0.74]).<br />

Conclusions: This research confirms frequent use of antibiotics<br />

for ASB in nursing homes. Antibiotic stewardship in nursing homes<br />

must address treatment that seems to be based solely on urine findings.<br />

Clinicians’ prescribing behavior was clearly associated with the<br />

S148<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

nursing homes in which they practiced and may be related to, or may<br />

create, the facility’s clinical culture.<br />

C50<br />

Hospital acquired pressure ulcers and markedly decreased survival<br />

after a hip fracture.<br />

E. I. Vidal, 1 D. C. Moreira, 6 R. S. Pinheiro, 2 F. B. Fukushima, 4<br />

P. J. Villas Boas, 1 K. R. Camargo, 3 L. M. Almeida, 5 C. M. Coeli. 2 1.<br />

Internal Medicine Department, UNESP, Botucatu, Brazil; 2. IESC,<br />

UFJR, Rio de Janeiro, RJ, Brazil; 3. IMS, UERJ, Rio de Janeiro, RJ,<br />

Brazil; 4. Anesthesiology Department, UNESP, Botucatu, SP, Brazil;<br />

5. Epidemiology Division, INCA, Rio de Janeiro, RJ, Brazil; 6. Social<br />

and Preventive Medicine Department, UNICAMP, Campinas, SP,<br />

Brazil.<br />

Supported By: This study was funded by the Brazilian National<br />

Council for Scientific and Technological Development (CNPq).<br />

Background: There are few data examining the association between<br />

hospital acquired pressure ulcers and survival after a hip<br />

fracture.<br />

Methods: The medical records of all patients aged 60 years and<br />

older admitted to a public university hospital in the city of Rio de<br />

Janeiro with a primary diagnosis of hip fracture between 1995 and<br />

2000 were reviewed. Stage II or higher hospital acquired pressure ulcers<br />

were identified from medical records. Survival to hospital discharge<br />

and at 1 year was examined.<br />

Results: Among 343 patients included in the study, there were 18<br />

(5.3%) in-hospital deaths, and 297 (86.6%) patients remained alive 1<br />

year after surgery. A hospital acquired stage II or higher pressure<br />

ulcer was recorded in 36 (10.5%) of patients. Incident pressure ulcers<br />

were associated with markedly increased risk of reduced survival to<br />

hospital discharge (hazard ratio [HR] 4.25, 95% CI 1.35–13.36,<br />

p=0.013) and of reduced survival at 1 year after surgery (HR 4.15,<br />

95% CI 2.14–8.06, p


P OSTER<br />

A BSTRACTS<br />

2.47–25.96), and cancer history (RR 3.73, 95% CI 1.28–10.88) at baseline<br />

predicted disability in men only. Women with diabetes (RR 2.97,<br />

95% CI 1.66–5.32), stroke history (RR 2.89, 95% CI 1.07–7.85), and<br />

bodily pain (RR 1.95, 95% CI 1.11–3.41) had higher risk of incident<br />

disability.<br />

CONCLUSIONS: Older women and men with multimorbidity<br />

had different risk factors for incident disability. Among them, several<br />

factors were potentially modifiable. Early screening and targeted intervention<br />

among multimorbid older adults may prevent or delay<br />

disability.<br />

C53<br />

D as in Death - Dietary Vitamin D in Mid-Life and Total Mortality:<br />

The Honolulu Heart Program.<br />

G. Kojima, 1 F. Lui, 1 R. Chen, 2 C. Bell, 1 R. D. Abbott, 1 L. Launer, 4<br />

G. W. Ross, 3,1 J. D. Curb, 1,2 K. H. Masaki. 1,2 1. The John A. Hartford<br />

Foundation Center of Excellence in <strong>Geriatrics</strong>, Department of<br />

Geriatric Medicine, University of Hawaii, Honolulu, HI; 2. Kuakini<br />

Medical Center, Honolulu, HI; 3. Veterans Affairs Pacific Islands<br />

Healthcare System, Honolulu, HI; 4. National Institute on Aging,<br />

Bethesda, MD.<br />

Supported By: The National Heart, Lung, and Blood Institute; the<br />

National Institute on Aging; Veterans Affairs Pacific Islands<br />

Healthcare Systems; John A. Hartford Foundation Center of<br />

Excellence in <strong>Geriatrics</strong>, University of Hawaii.<br />

Background:<br />

Low serum vitamin D levels are associated with total mortality<br />

in previous epidemiological studies. Little is known about effects of<br />

dietary vitamin D intake on mortality. We examined the association<br />

between mid-life dietary vitamin D intake and 45-year total mortality<br />

in Japanese-<strong>American</strong> men.<br />

Methods<br />

The Honolulu Heart Program is a longitudinal cohort study of<br />

8,006 Japanese-<strong>American</strong> men in Hawaii aged 45-68 at baseline in<br />

1965-68. Mid-life dietary vitamin D intake was calculated from 24-<br />

hour dietary recall using the Nutritionist IV v3 software. Subjects<br />

were divided into quartiles of vitamin D intake. Data on total mortality<br />

were available for up to 45 years, through December 2010. Cox<br />

proportional hazards models were used, and analyses were also stratified<br />

for hypertension (HTN) status.<br />

Results<br />

There were 6,972 deaths during the 45 years of follow-up. Ageadjusted<br />

total mortality rates were higher in the lower 3 quartiles of<br />

dietary vitamin D intake compared to the highest (p for trend=0.011).<br />

In Cox regression models, there was a significant inverse association<br />

between dietary vitamin D quartiles and mortality; quartile (Q) 1<br />

hazard ratio (HR)=1.14, 95%CI=1.07-1.22, p30<br />

days, 90 days after last MDS, death, or end of study).<br />

Results: A total of 2144 VTE On Admission cases were identified,<br />

accounting for 3.7% of all admissions (95% CI: 3.5–3.9%). A<br />

total of 757 cases of VTE During Residence were identified (from an<br />

est. 20,586 person–years [PY] at risk), yielding an incidence of 3.68<br />

cases/100 PY During Residence (95% CI: 3.42–3.95). [See table for<br />

full results] Conclusions: VTE incidence during admission and residence<br />

was common in this population; the latter was higher than previously<br />

reported in LTC studies. Furthermore, this rate was 6 times<br />

higher than a similar-age community cohort.1 These incidence rates<br />

merit further investigation as diagnostic improvements may be driving<br />

greater recognition of VTE in LTC.<br />

1. White RH. Circulation 2003;107(23 suppl 1):I4-8.<br />

VTE Incidence by Age Group (95% CI)<br />

C55<br />

TITLE: Vitamin D Levels and Asssociation with Chronic Medical<br />

Conditions in Home Based Primary Care (HBPC).<br />

H. Moiduddin, 1,2 S. N. Imam, 1,2 A. Imran, 1,2 L. Medina Munoz, 1<br />

T. Lee, 1 Q. Syed, 1 P. Karumanchi. 1 1. <strong>Geriatrics</strong> and Extended Care,<br />

Edward Hines Veterans Hospital, Hines, IL; 2. Internal Medicine,<br />

Loyola University Medical Center, Maywood, IL.<br />

Background: Numerous studies suggest that Vitamin D deficiency<br />

is commonplace in the United States and the world at large.<br />

The homebound and frail elderly are at high risk for having Vitamin<br />

D deficiency. Recent research confirms that Vitamin D deficiency<br />

contributes to many common conditions other than the musculoskeletal<br />

system disorders to include falls, chronic pain, diabetes<br />

mellitus, hypertension, depression, cancer and increased overall mortality.<br />

Several studies have shown reduced fall risk with Vitamin D<br />

supplementation and also possible improvement in control of chronic<br />

pain, hypertension, diabetes mellitus, and depression. Despite all this<br />

S150<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

evidence there are currently no guidelines for screening for Vitamin<br />

D deficiency and it remains a largely under diagnosed and under<br />

treated problem. Treatment of Vitamin D deficiency has the potential<br />

to improve the health and thus the quality of life of the elderly.<br />

Purpose: To determine the prevalence of low Vitamin D levels in<br />

Veterans enrolled in a single HBPC program and to mark any association<br />

with depression, diabetes mellitus and cancer.<br />

Methods: This is a retrospective observational cohort study of<br />

Veterans enrolled in HBPC between January 2006 and December<br />

2008. We reviewed medical records of Veterans with documented Vitamin<br />

D levels during the specified time period to assess the following:<br />

Serum 25-hydroxy Vitamin D level, Vitamin D therapy regimen,<br />

length of time to repeat Vitamin D level, post-treatment Vitamin D<br />

level, and correlation with depression, diabetes mellitus and cancer.<br />

Results: Of 560 patients enrolled in HBPC during the study period,<br />

218 (39%) had a Vitamin D level measured. Among these 135<br />

patients (62%) had Vitamin D deficiency. In the Vitamin D deficient<br />

group, the incidence of depression was higher 46% versus 35%, the<br />

incidence of diabetes mellitus was also slightly higher 43% versus<br />

37% and incidence of cancer was lower 30% versus 36%.<br />

Conclusions: Vitamin D levels were measured infrequently in<br />

Veterans enrolled in HBPC program. Vitamin D deficiency is very<br />

common in this population and there is an association of depression<br />

with Vitamin D deficiency.<br />

C56<br />

Is the Geriatric Population Represented to an Appropriate Degree<br />

in Journals of Infectious Disease?<br />

H. Chawla, 1,2 K. Steel, 2 M. Parulekar, 1,2 L. Tank, 1,2 A. Sarkar, 1,2<br />

L. Mansour. 2 1. <strong>Geriatrics</strong>, UNDMJ, Newark, NJ; 2. <strong>Geriatrics</strong>,<br />

HUMC, Hackensack, NJ.<br />

Background: Although advances made in reducing complications<br />

related to infections have been a significant factor in increasing<br />

life expectancy, infections remain a major health care problem for<br />

people in the older age group. Therefore we reviewed the clinical<br />

studies in two infectious disease journals to determine how well the<br />

geriatric population is represented in these trials.<br />

Objective: To determine what percentage of clinical research articles<br />

published in two journals, Clinical Infectious Disease and the<br />

Journal of Infectious Diseases, report on a population with an age<br />

equal to or greater than 65 years of age.<br />

Method: We reviewed 100 consecutive clinical research articles<br />

in the Journal of Infectious Disease published between January, 2011<br />

and May, 2011 and 100 articles in a second journal, Clinical Infectious<br />

Diseases published between January, 2011 and July, 2011.We defined<br />

a geriatric population as individuals age 65 or older. If this information<br />

was not available then the best estimate was made using the median<br />

or mean age provided. A few studies did not provide information<br />

about median or mean age and were therefore considered<br />

“indeterminate”.<br />

Results: In the 200 articles that were reviewed, the site of infection<br />

under study was as follows: lung (25%), skin (11%), central nervous<br />

system (8%) and gastrointestinal tract (7%). The most commonly<br />

seen primary organism was HIV (20%) followed by influenza (17%).<br />

38% of the studies were undertaken in a hospital setting and in 5 %<br />

of studies the duration of stay in the hospital was more than 15 days.<br />

Sepsis was observed in about 6 % of the studies reviewed.<br />

Of the 200 articles published in these two journals during the<br />

time period noted, only 14.5 % focused on an age group 65 years of<br />

age or older. The percentage of death in the age group 65 and older<br />

was provided in only 1 % of the studies.<br />

Conclusion: The top 3 causes of death for the general population<br />

are heart disease, cancer, and stroke. This also holds true for the elderly<br />

population. But infectious diseases are the fourth leading cause<br />

of death in the older population. The data from both the Journal of<br />

Infectious<br />

Diseases and Clinical Infectious Diseases suggest that the geriatric<br />

population is strikingly underrepresented in clinical studies.<br />

Only 14.5 percent of research articles had a study population with a<br />

median age of 65 years or greater.<br />

C57<br />

Potential Barriers to Hospice Referral Among Internal Medicine<br />

Residents and Physicians.<br />

A. Marszalek-Litauska, 1 S. Pereira, 1 M. Kline, 2 A. Kozikowski, 1<br />

R. Pekmezaris, 1 C. Nouryan, 1 G. Wolf-Klein. 1 1. NSLIJ Health<br />

System, New Hyde Park, NY; 2. FIMR, Manhasset, NY.<br />

INTRODUCTION: Only 30% of terminally ill patients are<br />

under hospice care at time of death. We sought to identify physicians’<br />

perceived barriers and approaches to hospice referral.<br />

METHODS: Anonymous surveys were distributed in 5 hospitals<br />

of a large health system in New York. Comparisons across gender and<br />

training were performed using the chi-squared test or Fisher’s exact<br />

test as appropriate. Spearman correlations were calculated to determine<br />

if professional status and years in practice were correlated with<br />

degree of comfort discussing end of life topics with terminal patients.<br />

RESULTS: Of the 264 physicians who responded, 58.3% were<br />

males, and 45% were between the ages of 21-30 years; PGY1 (23%),<br />

PGY-2 (15.8%) and hospital attending /specialists (34%) accounted<br />

for more than half of the respondents. A full 71.4% of respondents<br />

had received palliative/hospice care training and of those, 90% asserted<br />

they had referred the terminally ill to hospice care. However,<br />

on questions that tap knowledge of hospice care, only 40% chose the<br />

correct answer to all three questions. Though 91% of all respondents<br />

stated that ascertaining patient preferences at end of life was important/very<br />

important, over half (53%) believed that the ER attending<br />

is actually responsible for “sorting out patient/family wishes”. Furthermore,<br />

27.3% stated that the palliative care team generally initiates<br />

hospice discussion. In addition, 45% of physicians incorrectly believed,<br />

or were not sure, that patients must have six months prognosis<br />

to be eligible for hospice. Most frequently identified barriers were<br />

fear of patient/family reactions (34.3%), lack of familiarity (23.2%)<br />

and time constraints (18.9%). Yet most physicians had never (21.1%)<br />

or rarely (38.5%) actually experienced anger from their patients<br />

when mentioning hospice. Physicians’ level of comfort discussing several<br />

end of life topics (e.g., prognosis, advanced directives, pain management)<br />

was significantly associated with increasing years of experience<br />

and increasing professional status.<br />

CONCLUSION: Despite palliative care training and experience,<br />

physicians relinquish end-of-life care to emergency room physicians<br />

and palliative care consultants. Exploring unfounded and preconceived<br />

fear of patient and/or family anger in reaction to hospice<br />

referral needs to be integrated into a palliative care curriculum.<br />

C58<br />

Advance Care Planning Documentation: from theory to practice at 2<br />

VA Medical Centers.<br />

E. Clark, 1,2 E. Lindenberger, 2,1 K. Blackstone, 3,4 R. Anderson-<br />

Malico, 1 S. Pandey, 3,4 E. L. Cobbs. 3,4 1. JJ Peters VA Medical Center,<br />

Bronx, NY; 2. Mt. Sinai School of Medicine, New York, NY; 3.<br />

Washington DC VAMC, Washington, DC; 4. George Washington<br />

University School of Medicine, Washington, DC.<br />

Background: Advance Care Planning (ACP) benefits patients<br />

with serious illness. Electronic medical records (EMR) offer promise<br />

for sharing meaningful information about ACP, but clinicians may<br />

lack familiarity with ACP methods or a standardized format for ACP<br />

documentation.<br />

Objective: Ongoing facility-wide implementation of EMR ACP<br />

documentation<br />

Setting: 2 urban VA Medical Centers<br />

AGS 2012 ANNUAL MEETING<br />

S151


P OSTER<br />

A BSTRACTS<br />

Methods:<br />

EMR ACP tool: VAMC 1 - 2000; VAMC 2 - 2009<br />

ACP champions: VAMC 1 - 6 physicians, 9 nurse practitioners;<br />

VAMC2 - 2 physicians, 1 advance practice nurse<br />

Settings for ACP: VAMC 1 - NH, geriatrics clinic, home based<br />

primary care, geriatrics & palliative care (PC)consults; VAMC 2 -<br />

geriatrics & PC consults<br />

Interventions: VAMC 1 - role modeling; monthly orientation for<br />

housestaff; noon conferences for faculty & housestaff; training for fellows<br />

& residents in geriatrics & PC; performance improvement initiatives.<br />

VAMC 2 - large group lectures; small group provider detailing;<br />

role modeling; noon conferences for housestaff; training of geriatrics<br />

& PC fellows<br />

Results: see table<br />

Discussion: Both VAMCs have adopted standardized EMR<br />

ACP documentation. At VAMC 1, where the EMR ACP tool was first<br />

developed in 2000, ACP documentation has grown steadily over a<br />

decade. At VAMC 2, the EMR ACP was introduced in 2009 and has<br />

slowly expanded. Growth factors include a critical mass of committed<br />

champions, ongoing recruitment of champions in other disciplines,<br />

and regular multi-modal education of trainees. The NH may be an important<br />

center of EMR ACP documentation since virtually all NH<br />

residents are living with a serious illness. VAMC 1 has had 100%<br />

EMR ACP documentation in its NH for the past 10 years. New initiatives<br />

at VAMC 2 likely to increase EMR ACP documentation include<br />

a required geriatrics rotation for medical interns; a needs assessment<br />

program in key outpatient clinics and its NH to identify barriers to<br />

ACP; and mentoring of individual providers.<br />

Results: ACP notes completed<br />

C59<br />

Role of Advance Directives in Determining Care for Older Nursing<br />

Home (NH) Residents.<br />

E. Manu, 1,2 S. McNamara, 1,2 B. Lansing, 1,2 L. Mody, 1,2 C. A. Vitale. 1,2<br />

1. Division of Geriatric & Palliative Medicine, Department of Internal<br />

Medicine, University of Michigan Healthcare System, Ann Arbor, MI;<br />

2. <strong>Geriatrics</strong> Research Education and Clinical Center, Veterans Affairs<br />

Ann Arbor Healthcare System, Ann Arbor, MI.<br />

Supported By: Funding source for the study was provided by NIA<br />

K23 AG028943, ASP/AGS T. Franklin Williams Research<br />

Scholarship, NIA R01AG032298 and The Claude D. Pepper Older<br />

<strong>American</strong>s Independence Center and Michigan Institute for Clinical<br />

& Health Research, University of Michigan Pilot Grant Program.<br />

Background:<br />

We aimed to study the effect of advance directives on treatments<br />

received including indwelling devices, hospital transfers, & antibiotics<br />

in NHs.<br />

Methods:<br />

A subgroup analysis of a prospective cohort study of 178 residents<br />

from 15 NHs in southeast MI. Demographic data, Charlson’s<br />

Comorbidity Index (CCI), Functional Score (PSMS, scores 6-30) &<br />

advance directives were obtained at enrollment. At 30 day intervals,<br />

presence of indwelling device, infection rate, antibiotic use & hospitalization<br />

were assessed. Advance directives were divided in 4 groups:<br />

1-comfort measures only, no transfer to hospital; 2- comfort focused<br />

care but may transfer to hospital & receive antibiotics, no CPR; 3-<br />

transfer to acute care hospital for assessment & treatment, no CPR or<br />

ICU admission, 4- full code. Poisson regression was used to calculate<br />

the incidence rate ratios (IRR) of new infections, antibiotic use &<br />

hospitalizations. Risk factors included in the analysis: PSMS, CCI, device<br />

use & advance directive.<br />

Result:<br />

161 (91%) residents had advance directives. 38 (24%) were in<br />

group 1 with comfort care only, 29 (18%) in Group 2, 43 (27%) in<br />

Group 3 & 51 (32%) in Group 4 desiring full code. While Group 4<br />

residents were younger (mean age 76.7 yrs., SD 11, p


P OSTER<br />

A BSTRACTS<br />

C61<br />

New Non-Invasive Technique to Assess Arterial Stiffness.<br />

F. M. Felice, A. K. Reddy, J. D. Taffet, C. J. Hartley, G. E. Taffet.<br />

Baylor College of Medicine, Houston, TX.<br />

Supported By: AFAR,NHLBI,Huffington Center on Aging<br />

Large arteries stiffen with age increasing the risk of cardiovascular<br />

disease. The stiffening causes increased systolic blood pressure,<br />

decreased diastolic blood pressure, and increased pulse wave velocity(PWV).<br />

Yet current techniques only measure PWV at diastolic<br />

pressure when the pulse wave velocity is lowest because the artery is<br />

not fully distended.<br />

Methods: We developed a new technique to measure stiffness<br />

looking at reversals in flow in the radial artery. Using 20 mHz<br />

Doppler probes to assess blood flow velocity in the proximal and distal<br />

radial arteries, sampling at both sites simultaneously to avoid beat<br />

to beat variations. Probes were custom made and interfaced with a<br />

multichannel Doppler Signal processing workstation (Indus Instrument).<br />

Pulse wave velocity was calculated at the start of flow and<br />

when forward flow started after each reversal.<br />

Results: We attempted to assess radial artery flow non-invasively<br />

in 8 subjects ranging in age from 18 to 64. We found that reversals<br />

in blood flow happened in all our subjects, providing timing signals<br />

for calculation. The quality of the signals needed to determine<br />

the second wave PWV was very high so we could not get interpretable<br />

data from 5 out of 8 subjects. We found within the range of<br />

diastolic to systolic blood pressure, PWV increases by 40-80% as<br />

blood pressure increased by 20 to 30 mmHg. Obtaining adequate signals<br />

required significant attention to detail, however with good data,<br />

it was then feasible to create a pressure versus PWV relationship.<br />

Conclusion: With this strategy, the slope of the pressure PWV<br />

relationship more directly defines stiffening and provides novel information<br />

to assess arterial stiffening with aging and perhaps direct risk<br />

reduction for cardiovascular disease for the elderly.<br />

C62<br />

Positive Effect of Restorative Sleep on IL6 and Fibrinogen in<br />

Post-Midlife.<br />

S. Song, 1 F. J. Prerost, 2 M. Sanders, 2 M. Barash, 2 A. Valone. 2 1.<br />

Biomedical Sciences, Midwestern University, Downers Grove, IL; 2.<br />

Family Medicine, Midwestern University, Downers Grove, IL.<br />

BACKGROUND: Treatment of medical illnesses that emphasizes<br />

hereditary and lifestyle etiological factors is often associated<br />

with diverse health outcomes. The research identifying converging<br />

bio-psychosocial pathways reflects this emphasis on disease risk. Proinflammatory<br />

markers are understood as indicative of chronic conditions<br />

including metabolic, autoimmune, and hematologic disorders.<br />

The objective of the current study is to examine the positive effect of<br />

restorative sleep on IL6 and fibrinogen as a protective factor that<br />

might mitigate the onset of aging related decline.<br />

METHODS/DESIGN: Longitudinal, secondary data<br />

SETTING: Midlife in the United States (MIDUS) national sample<br />

of independently dwelling middle-aged and older adults living in<br />

the United States<br />

PARTICIPANTS: Phase II of the MIDUS study comprised the<br />

biomarkers project; a subsample (n = 398) of the original group of<br />

participants between the ages of 35 and 84 underwent biological assessments<br />

over a two-day period<br />

MEASUREMENTS: Actiwatch sleep data collection and fasting<br />

blood specimens of IL6 and fibrinogen biomarkers<br />

RESULTS: Restorative sleep, measured as sleep efficiency, was<br />

inversely related to serum IL6 (r = -.14, p < .001) and blood fibrinogen<br />

(r = -.12, p = .01). Sleep efficiency was not significantly diminished<br />

by the presence of diabetes (84% of participants did not have<br />

diabetes) or physician diagnosed arthritis (F = .102, p >.05), blood<br />

clots (F = .056, p > .05), or bleeding diseases (F = .031, p > .05).<br />

CONCLUSIONS: Participants who exhibited higher amounts<br />

of restorative sleep had lower levels of inflammation measured by<br />

serum IL6 and blood fibrinogen. It was not the case that sleep efficiency<br />

was adversely affected by pre-existing illnesses typically associated<br />

with less healthy markers and subsequent disruptions to circadian<br />

rhythm. Researchers have found that chronic and acute stressors<br />

(i.e. childhood traumas, parental neglect, difficulties in adulthood,<br />

etc.) have generated profiles similar to those of older and oldest<br />

adults. Identifying possible mitigating factors of aged proinflammatory<br />

markers will contribute to the literature and broaden treatment<br />

options.<br />

C63<br />

Attitudes and Knowledge about Resuscitation Discussion in a<br />

Community Hospital: A Survey of Physicians and Nurses.<br />

C. X. Pan, 1 D. A. Acquista, 1 A. Bushan, 1 S. M. Constantine, 1<br />

I. Kariolis, 1 S. Sunday. 2 1. New York Hospital Queens, Flushing, NY; 2.<br />

North Shore- LIJ Health System, Manhasset, NY.<br />

Background: For patients with a serious illness, discussions with<br />

healthcare staff often include resuscitation preference or “code status”<br />

including DNR/DNI (do not resuscitate/do not intubate). This<br />

study assesses health care professionals’ attitudes and knowledge<br />

about resuscitation discussions at a community hospital. The objective<br />

is to examine if health care discipline and level of experience affect<br />

attitudes and knowledge about discussion about resuscitation decisions.<br />

Methods: A 34-question self administered survey was distributed<br />

to attending physicians, nurses and internal medicine residents.<br />

Questions included demographic information, religious beliefs, clinical<br />

vignettes with management options, scales assessing<br />

comfort/competency levels regarding treatment of symptoms in patients<br />

who are full code vs DNR, knowledge of hospice appropriateness,<br />

and perceived need for education about resuscitation discussions.<br />

Results: There were 135 respondents: 30 attendings, 50 nurses<br />

and 55 residents (M=37%; F=63%). Respondents were diverse in<br />

ethnic/racial background. One respondent reported having a religious<br />

reason that prevented discussing DNR/DNI. 83% of attendings,<br />

49% of residents and 52% of nurses felt it was the attendings’<br />

responsibility to discuss code status. When managing symptoms,<br />

>85% of nurses, >75% of attendings and >63% of residents felt “very<br />

comfortable,” while >89%, >63%, and >49% of nurses, attendings,<br />

and residents felt “very competent,” respectively; (p-value for “comfort<br />

level” NS; and “competence” p=0.0002). Attendings correctly<br />

identified hospice appropriate patients in different case scenarios;<br />

nurse and resident responses varied. Both nurses and residents<br />

(>84%) felt they would benefit from more training about resuscitation<br />

discussion. Conclusion: This study found differences in attitudes<br />

and knowledge about resuscitation decisions among health care disciplines<br />

with various levels of experience. Nurses felt more comfortable<br />

and competent in managing symptoms compared to attendings<br />

and residents; and only attendings consistently identified hospice appropriate<br />

patients. Next steps may include: 1) residents and nurses receive<br />

more education regarding resuscitation discussion and hospice<br />

appropriateness, and 2) attendings and residents may benefit from<br />

more training in symptom management.<br />

C64<br />

Weaving Aging Education Into The Surgery Clerkship: an<br />

opportunity to increase future physician awareness of unique issues<br />

in surgical care for the elderly.<br />

A. Macnow, 1 R. Kelz, 1,3 A. Corcoran. 1,2 1. Perelman School of<br />

Medicine, University of Pennsylvania, Philadelphia, PA; 2. Internal<br />

Medicine, University of Pennsylvania, Philadelphia, PA; 3. Surgery,<br />

University of Pennsylvania, Philadelphia, PA.<br />

Supported By: Donald W. Reynolds Foundation<br />

Background: Successful outcomes for geriatric surgical patients<br />

are dependent on a team well versed in the unique issues of the aging<br />

AGS 2012 ANNUAL MEETING<br />

S153


P OSTER<br />

A BSTRACTS<br />

patient population. We report the evaluation of a case-based educational<br />

session for surgical clerks focused on the peri-operative management<br />

of an elderly patient as part of an integrated aging theme<br />

initiative. Methods: Utilizing a clinical scenario involving an elderly<br />

patient with abdomen pain, a 55 minute case-based session was added<br />

into the required lecture schedule. Students were divided into learning<br />

teams and asked to provide group answers to open-ended questions<br />

incorporated as the case unfolded. An anonymous audience response<br />

system was employed to allow learners to assess their<br />

successes in comparison to their peers to voluntary 5 multiple choice<br />

knowledge questions and pre/post self-assessment survey using a<br />

four-point Likert scale (1=very good,4=poor). Descriptive statistics<br />

were performed comparing before and after the session using the<br />

Wilcoxen rank sum test. Results: Thirty students participated in the<br />

pilot. At the end of the case, students responded correctly 85% or<br />

more of the time to the multiple-choice questions. All self-assessment<br />

questions showed statistically significant improvement when responding<br />

to the following: (1) appreciate the unique problems of the<br />

increasing number of older adults undergoing abdominal surgery<br />

(median=3pre/2post,p


P OSTER<br />

A BSTRACTS<br />

other age group (Krisberg 2005). One way to prepare future physicians<br />

for increased demand may be to better integrate geriatrics education<br />

into medical school. The study’s objective was investigate<br />

whether taking a geriatrics elective class improves first-year medical<br />

students’ perceptions and knowledge of geriatrics.<br />

Subjects were 18 first-year medical students, 8 of whom had enrolled<br />

in a 4-month geriatric elective class. Surveys were administered<br />

to students within 1 month of the first class session. The surveys assessed<br />

students’ interest in and comfort level with elderly patients<br />

and included a modified version of Palmore’s Facts on Aging Quiz, a<br />

validated geriatrics knowledge assessment survey (Fabiano 2005).<br />

These surveys will be administered again to students within 1 month,<br />

and again 1 year after the completion of the elective.<br />

There was no significant difference between knowledge survey<br />

scores for geriatrics elective (GE) and non-geriatrics elective (non-<br />

GE) students; the average score was 13.9±0.5 out of 25. On a scale of<br />

1-10 (1 being least and 10 being most interested), GE students’ average<br />

geriatrics interest was 7.4±0.7, which was significantly higher than<br />

that of non-GE students, 4.3±0.4 (p


P OSTER<br />

A BSTRACTS<br />

C71<br />

Outpatient Anticoagulation Management in the Elderly Patients:<br />

Attitude and Knowledge Survey in Geriatric Fellows.<br />

A. S. Gangavati, L. Lipsitz. Gerontology, Beth Israel Deaconess<br />

Medical center, Harvard Medical School, Brookline, MA.<br />

Supported By: Geriatric Academic Career Award<br />

Background: Despite ongoing national initiatives to reduce the<br />

likelihood of patient harm associated with use of anticoagulant therapy,<br />

little or no formal curricula on anticoagulation management in<br />

the elderly are included in the majority of post-graduate training programs.<br />

Methods: Eleven geriatric fellows were sent knowledge and attitude<br />

survey questions in outpatient anticoagulation management in<br />

the elderly patients. Questions were designed based on expert advice<br />

and from comprehensive literature review.<br />

Results:<br />

Attitude Questions: Five out of eleven geriatric fellows (45.5%)<br />

felt that they were “quite often” comfortable with managing anticoagulation<br />

as compared to 54.5% (6/11) who felt that they were “very<br />

often” comfortable with anticoagulation management in the elderly<br />

patients. Seven out of the eleven fellows (63.6%) felt that they have<br />

enough knowledge regarding anticoagulation management as compared<br />

to 36.4% (4/11) who felt that they did not have enough knowledge<br />

regarding anticoagulation management.<br />

Knowledge questions: Table 1 shows results from knowledge<br />

questions that specifically addressed outpatient dose initiation and<br />

monitoring in elderly patients, drug interactions with Warfarin, cultural<br />

influences of diet on Warfarin and dosage/storage of Dabigatran.<br />

Conclusions: Most Geriatric fellows felt that they were comfortable<br />

managing anticoagulation in the elderly patients and only 36.4%<br />

felt that they don’t have adequate knowledge. Most fellows were able<br />

to answer only 50% or less of all the questions. Based on these results,<br />

formal education curriculum addressing the knowledge gaps is being<br />

developed.<br />

Table 1. Knowledge questions on anticoagulation management in<br />

geriatric patients. (n=11)<br />

C72<br />

“<strong>Geriatrics</strong> Fellows’ Most Difficult Case Conference”- Knowledge<br />

Sharing and Teaching through program networking: a one year<br />

experience.<br />

A. Khan, 1,2 T. Howell, 2 M. Malone, 1,2 P. Colon-Nieves, 1 K. Singh. 1,2 1.<br />

Aurora Health Care, Milwaukee, WI; 2. University Of Wisconsin<br />

School of Medicine and Public Health, Madison, WI.<br />

Background:<br />

A monthly “Most Difficult Case Conference” has emerged as a<br />

promising strategy to teach the bio-psycho-social approach to complex<br />

older adults.It has grown to involve 13 geriatrics fellowship programs<br />

in 7 states, networked by simple conference call. The fellowship<br />

teams rotate in selecting and presenting cases experienced as especially<br />

emotionally and cognitively taxing. Teams at the other sites take<br />

turns inquiring about the case, using the “Wisconsin Star Method” as<br />

a format. This involves mapping clinical data onto five domains: medications,<br />

medical, behavioral, personal, and social. Geriatric psychiatry<br />

and medicine faculty from other sites take turns with summary<br />

teaching points, and the discussions conclude with “the rest of the<br />

story” from the presenting team.<br />

Methods:<br />

This is an on-line survey of participants during the second year<br />

of the program. Data was compared to the survey of participants during<br />

the first year.<br />

Results:<br />

The survey was sent to 43 participants and 18 responded. Of<br />

these 56% were faculty, 33% fellows and 11% “other”.<br />

When compared to last year an increased number of respondents<br />

noted that the quality of program was good (72% current year<br />

vs. 59% last year), enjoyed collaborating with colleagues across the<br />

country (89% vs.74%), and would recommend it to their colleagues<br />

(78% vs.69%).<br />

As compared to last year more respondents noted learning<br />

practical strategies for addressing complexity (61% vs.36%) and that<br />

Wisconsin Star Method was effective in assessing complex cases<br />

(61% vs. 49%). Regular use of the Wisconsin Star Method in clinical<br />

practice did not change (18%). Similar to last year, responders found<br />

the discussions of the “hardest part of the case” and the “summary<br />

teaching points” to be most useful.<br />

Participants noted that the conference allows them to a feel part<br />

of a national interdisciplinary team (61%) and half noted that it has<br />

helped build their emotional and cognitive skills.<br />

Conclusion:<br />

“<strong>Geriatrics</strong> Fellows’ Most Difficult Case Conference” has<br />

demonstrated an improvement in participant satisfaction over the<br />

last 2 years. This assessment of the conference will assist in making<br />

the educational case for further dissemination to additional fellowship<br />

programs.<br />

C73<br />

Interprofessional Geriatric Clinical Skills Fair.<br />

B. Salzman, 1 L. Collins, 1 E. Hajjar, 2,1 A. Egras, 2,1 C. Hsieh, 1 L. Hersh, 1<br />

S. Fleegle, 1 D. Snyderman. 1 1. Family & Community Medicine,<br />

Thomas Jefferson University, Philadelphia, PA; 2. Jefferson School of<br />

Pharmacy, Thomas Jefferson University, Philadelphia, PA.<br />

Supported By: This project was supported by funds from the<br />

Department of Health and Human Services (DHHS), Health<br />

Resources and Services Administration (HRSA), Bureau of Health<br />

Professions (BHPr), under Geriatric Academic Career Award number<br />

5K01HP20486.<br />

Background: The need to expand geriatric education for health<br />

professionals at all levels of training has been well described (1). The<br />

purpose of this study was to evaluate the experience of participants in<br />

an Interprofessional Geriatric Clinical Skills Fair.<br />

Methods: The objective of the fair was for learners to gain practical,<br />

evidence-based skills and knowledge pertaining to the care of<br />

older adults. Six interactive stations included cognitive assessment,<br />

gait evaluation, older patient simulation, medication management,<br />

code status conversation, and disposition discussion. Each station ran<br />

for 15 minutes and the entire fair ran for 2 hours. The stations were<br />

led by interprofessional faculty including 4 geriatricians, 1 palliative<br />

care specialist, and 2 clinical pharmacists.<br />

A short survey was administered after the fair to assess learners’<br />

experience. Learners were asked to rate each station on a 5-point<br />

scale. They were asked if there was anything they would change to improve<br />

the fair and whether they learned something at the fair that<br />

would change their clinical practice.<br />

Results:<br />

A sign-in sheet demonstrated 34 participants, including 17 residents<br />

in Family Medicine (FM), 13 medical students on their 3rd-year<br />

S156<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

clerkship in FM, 2 medical students on their 4th-year sub-internship<br />

in Geriatric Medicine, and 2 second-year pharmacy students.<br />

Surveys were distributed to all participants (34), and 28/34<br />

(82%) completed surveys were returned.<br />

On a 5-point scale (ranging from 1=poor, 2=fair, 3=good, 4=very<br />

good, 5=excellent), the average rating for each station ranged from<br />

4.65 to 4.85, with a mean of 4.73.<br />

When asked if they would change anything to improve the program,<br />

2 learners responded that they would have liked more time.<br />

When asked if they learned anything at the fair that would<br />

change their clinical practice, 24 out of the 28 (86%) responders<br />

wrote, “Yes.”<br />

Conclusion:<br />

An Interprofessional Geriatric Clinical Skills Fair was highly<br />

rated by learners at various levels of training. The fair was a fun and<br />

effective method for providing education addressing geriatric competencies.<br />

Reference:<br />

Institute of Medicine of the National Academies. Retooling for<br />

an Aging America: Building the Health Care Workforce. Washington,<br />

DC: The National Academies Press; 2008.<br />

C74<br />

Improving Uptake of a Falls Educational Program by Focusing on<br />

Staff Interactions.<br />

C. Colon-Emeric, 1,2 S. Pinheiro, 1 K. M. Simpson, 2 K. Porter, 1<br />

K. Corazzini, 1 R. A. Anderson. 1 1. Duke University, Durham, NC; 2.<br />

GRECC, Durham VA Medical Center, Durham, NC.<br />

Supported By: VA HSR&D EDU 08-417<br />

NIH R56NR003178–09<br />

Background: Traditional educational programs for nursing<br />

home staff have not resulted in improvements in quality indicators or<br />

fall rates. One potential explanation is that staff lack sufficient connections<br />

with each other to effectively share information and problem<br />

solve.<br />

Methods: Eight nursing homes were block randomized to receive<br />

either a traditional falls education program (FALLS only), or a<br />

program teaching staff to improve their connections and interactions<br />

with co-workers, followed by the traditional falls program (CON-<br />

NECT+FALLS). The education programs were delivered by research<br />

assistants over 3 months, targeted all staff with direct resident<br />

contact (n=674), and used story-telling, role play, relationship mapping,<br />

and coaching. Focus groups (n=16) were conducted with staff<br />

who had participated in at least one intervention component (n=87).<br />

Qualitative analysis identified thematic differences in staff-reports of<br />

organization learning.<br />

Results: Both groups expressed that the FALLS content was familiar,<br />

reminded them about fall risk factors, and helped them engage<br />

in teamwork. However, the CONNECT groups additionally noted: 1)<br />

that relationship mapping sessions helped them identify and correct<br />

communication weaknesses; 2) that improved understanding about<br />

the roles of various disciplines led to a wider fall prevention network;<br />

and 3) that improved job attitudes and cooperation resulted in<br />

greater willingness to stick to interventions such as toileting programs.<br />

One CONNECT participant stated that “with the two, the<br />

CONNECT and the FALLS portion of it…it all flowed together, so it<br />

helped us to understand and learn better.” Participants also mentioned<br />

that the CONNECT intervention would be helpful for learning<br />

about other topics, such as behavior problems.<br />

Conclusions: An educational program focused on improving interactions<br />

among nursing home staff was highly acceptable, and was<br />

reported to enhance the uptake of a traditional falls education program.<br />

Measurement of its impact on resident fall indicators and outcomes<br />

is warranted.<br />

C75<br />

Community Based Advance Care Planning Education for Older<br />

Adults.<br />

C. W. Johnston. Betty Irene Moore School of Nursing, University of<br />

California at Davis, Sacramento, CA.<br />

Supported By: Betty Irene Moore School of Nursing, University of<br />

California at Davis<br />

Senior Citizens of Davis<br />

Background: Advance care planning (ACP) includes health education,<br />

anticipating future care, establishing a plan, choosing a<br />

spokesperson, documenting wishes, and communication. The objective<br />

of this pilot study was to determine whether a community based<br />

educational program for older adults would increase participation in<br />

ACP. Previous research has not shown whether community-based education<br />

improves participation in ACP. Methods: This pilot study targeted<br />

a population of older adults (>65 years), and was performed at<br />

a small public community center. A convenience sample was recruited<br />

and informed consent was obtained prior to the completion of<br />

a pre-education survey to determine baseline knowledge of ACP. A<br />

multi-component presentation was given by the researcher highlighting<br />

CPR survivability and both forms primarily used in ACP; the Advance<br />

Directive (AD) and Physicians Orders for Life Sustaining<br />

Treatment (POLST) form. Results: 23 of the 30 attendees participated<br />

in the survey, with a mean age of 72.9 years. 74% (n=17) were<br />

college educated, with 43% (n=10) reporting their highest level of education<br />

to be a Masters degree. 78% had an awareness of ACP and<br />

had talked with someone about their wishes. 91% had a spokesperson<br />

to make healthcare decisions on their behalf. 52% had a Durable<br />

Power of Attorney (DPOA), and 87% knew what a DPOA was. 74%<br />

(n=17) knew what an AD was and most (n=18, 78%) did not know<br />

what a POLST form was. Most had not filled out an AD and a<br />

POLST form. 96% reported knowing of CPR but 96% failed to correctly<br />

estimate survivability after CPR. Percentages of survival were<br />

on a Likert scale ranging from a score of 1 being equal to a survival<br />

rate of 81-100% to a score of 5 being equal to a rate of 0-20% survival.<br />

Conclusion: Participants were highly educated and indicated<br />

they have made attempts to learn about their health, communicate<br />

with others about their wishes for healthcare, know what CPR is, and<br />

are somewhat aware of the process of ACP. Conversely, most have<br />

not participated in ACP, are not aware of AD and POLST forms, and<br />

are unable to correctly estimate CPR survivability. This pilot study illustrated<br />

a need for more education about the benefits of ACP. More<br />

research is needed to improve participation in ACP among older<br />

adults and future studies should focus on community based ACP education.<br />

Awareness of ACP may improve the likelihood that healthcare<br />

wishes will be communicated and honored at the end of life.<br />

C76<br />

Effect of the Health Mentors Program on Student Attitudes toward<br />

Team Care.<br />

C. Arenson, C. Giordano, K. Lyons, L. Collins, E. Umland,<br />

L. Hewston, K. Smith, R. Antony, M. Rose. Thomas Jefferson<br />

University, Philadelphia, PA.<br />

Supported By: This research was wholly funded by Thomas<br />

Jefferson University, Jefferson InterProfessional Education Center<br />

and the Jefferson Office of Institutional Research.<br />

Background: Interprofessional education (IPE) is a key theme<br />

in preparing the future geriatric workforce, yet there is a lack of robust<br />

data documenting the benefits of IPE. Student attitudes toward<br />

AGS 2012 ANNUAL MEETING<br />

S157


P OSTER<br />

A BSTRACTS<br />

IPE are generally positive and show little change after IPE. Attitudes<br />

toward team care may be a more sensitive interim measure of IPE efficacy<br />

(Rose et al). The Health Mentors Program (HMP) is a 2-year<br />

longitudinal curriculum that brings entry-level interprofessional<br />

teams of students together with a Health Mentor (a person living<br />

with one or more chronic conditions) to learn patient-centered, teambased<br />

care. Nearly 3,000 students have participated; 52% of Health<br />

Mentors are age 60 or over.<br />

Methods: Students entering HMP in Fall 2009 completed the Attitudes<br />

Towards Interdisciplinary Teams scale (Heinemann et al) at<br />

matriculation and at program completion in Spring 2011.<br />

Results: A paired samples t test showed significant improvements<br />

in mean attitude scores (scale 0-5, higher = more positive attitude)<br />

between baseline and program completion in all disciplines<br />

with sufficient sample size. A paired samples t test for students in all<br />

programs (n=173) found significant improvements (p=.000) in attitudes<br />

(baseline mean 3.27 (.45) and 3.75 (.58). ANOVA showed no<br />

significant differences between groups.<br />

Conclusions: The gold standard for measuring impact of IPE is<br />

clearly improvement in patient outcomes. However, given the long<br />

time-delay from entry into health professions training to independent<br />

practice, interim measures to assess program outcomes are essential.<br />

Improved attitudes toward team-based care may be one important<br />

indicator of program success. A limitation of this study is lack of a<br />

control group of students not exposed to formal IPE. Next steps include<br />

measuring attitudes longitudinally during the remainder of<br />

training and into clinical practice.<br />

Rose M, et al. Attitudes of students in medicine, nursing, occupational<br />

and physical therapy toward interprofessional education. J<br />

Allied Health, 38:196-200, 2009.<br />

Heinemann GD, et al. Development of an Attitudes Toward<br />

Health Care Teams Scale. Eval & Health Professions, 22:123-42, 1999.<br />

Discipline Specific Changes in Attitudes to Team-based Care<br />

C77<br />

Do physicians in-training assess for falls among the elderly<br />

population in the outpatient setting?<br />

D. Soto, 1 J. F. Fogel. 2 1. Division of <strong>Geriatrics</strong>, Montefiore Medical<br />

Center Albert Einstein College of Medicine, Bronx, NY; 2. Dept of<br />

Medicine,Division of <strong>Geriatrics</strong>, Beth Israel Medical Center, New<br />

York, NY.<br />

Falls are one of the most common geriatric syndromes threatening<br />

independence and are one of the leading causes of injuries in the<br />

older population. Patients 65 and older account for 39% Internal<br />

Medicine (IM) ambulatory visits. There has been an impetus to incorporate<br />

education on geriatric syndromes into IM residents curriculum.<br />

This study aims to evaluate the assessment for falls and gait instability<br />

provided to vulnerable elders by IM residents in an<br />

ambulatory setting.<br />

A retrospective chart review of total 150 randomly selected patients<br />

followed by IM residents for one year period was conducted.<br />

Inclusion criteria: >65 years of age, attendance at ambulatory clinic<br />

for at least one year and treated only by in-training physicians. The<br />

electronic medical records of these patients were reviewed for any<br />

question regarding falls, past medical history including co-morbidities<br />

and gait abnormalities as a problem, number of falls and consequences,<br />

use of psychoactive medications. Physical exam was reviewed<br />

for evidence of gait assessment.<br />

Documentation of fall inquiry was noted in 25% (38) of records.<br />

Of the 38 records gait was recorded in 12 occasions (P


P OSTER<br />

A BSTRACTS<br />

C79<br />

Interprofessional, Evidence-Based Education to Reduce Falls.<br />

E. Eckstrom, 1 K. Lasater, 1 V. Cotrell, 2 W. Simonson, 3 M. Neal, 2<br />

T. Harvath. 1 1. Oregon Health & Science University, Portland, OR; 2.<br />

Portland State University, Portland, OR; 3. Oregon State University,<br />

Corvalis, OR.<br />

Supported By: Health Resources and Services Administration<br />

Fall prevention in older adults requires an interprofessional, evidence-based,<br />

systems-oriented approach. We implemented a fall prevention<br />

protocol for medical, nursing, social work, and pharmacy professionals.<br />

Methods: Interprofessional project faculty met monthly to develop<br />

the protocol and train ourselves in teamwork, motivational interviewing,<br />

and content expertise. Interprofessional workshops were<br />

offered onsite for ambulatory, long term care, hospital, and home<br />

health practices focused on: (1) screening patients over 75 for falls, (2)<br />

Vitamin D supplementation, (3) exercise prescription (tai chi), (4) environmental<br />

assessment, and (5) medication review and reduction.<br />

Study team members (“coaches”) partnered with each practice site to<br />

develop an individualized action plan to implement a fall prevention<br />

protocol. Outcomes data will be collected for one year at each site.<br />

The study is ongoing.<br />

Results: 1) Team members were reminded of the important roles<br />

all professions play in fall prevention (e.g., social workers are trained<br />

to reduce fear of falls but are rarely used for this role); 2) We needed<br />

a shared lexicon on motivational interviewing for use both in training<br />

of practice sites and in coaching individual teams, requiring multiple<br />

training sessions; 3) Team members can be cross trained to deliver<br />

content from other professions, enhancing the flexibility of the<br />

“coach”/practice team pairings; 4) Practice settings have varying degrees<br />

of “team-ness” and this impacts successful implementation of<br />

the protocol; 5) Solutions to implementing evidence-based action<br />

plans vary between practice sites, are innovative, and deserve further<br />

research, e.g., adapting tai chi exercises for use by CNAs; 6) “Champions”<br />

for practice change come from any profession; 7) Rural communities<br />

can coordinate efforts effectively across inpatient, outpatient,<br />

and long-term care settings, thereby facilitating culture change and<br />

setting a new community standard.<br />

Conclusions: Interprofessional education takes commitment<br />

and training but can lead to effective evidence-based practice adoption.<br />

Team member roles are often narrowly defined, and better identification<br />

of expertise can improve team effectiveness. Interprofessional<br />

teaching enhances everyone’s experience; the impact on<br />

patient outcomes remains to be determined.<br />

C80 Encore Presentation<br />

The effect of a delirium e-learning program on nurses’ knowledge of<br />

delirium.<br />

E. Detroyer, 1,2 D. Debonnaire, 1 F. Dobbels, 1 J. Gommers, 2 K. Irving, 3<br />

E. Joosten, 4 K. Milisen. 1,4 1. Center for Health Services and Nursing<br />

Research, Katholieke Universiteit Leuven, Leuven, Belgium; 2.<br />

Department of Health Service, Katholieke Hogeschool Limburg,<br />

Hasselt, Belgium; 3. Department of Nursing, Dublin City University,<br />

Dublin, Ireland; 4. Department of Geriatric Medicine, University<br />

Hospitals Leuven, Leuven, Belgium.<br />

BACKGROUND: Delirium is a common complication among<br />

hospitalized elderly patients, but remains frequently unrecognized by<br />

healthcare workers. Despite the evidence that educational packages<br />

can improve awareness and knowledge of delirium among nurses, no<br />

research testing e-learning in this area was found. This study determined<br />

the effect of a delirium e-learning program on nurses’ knowledge<br />

about delirium.<br />

METHODS: A convenience sample of 56 nurses from a university<br />

hospital (60% bachelor degree, all computer literate) were included,<br />

and completed two validated questionnaires to assess their<br />

knowledge about delirium and their ability to identify delirium before<br />

and after the educational intervention. The intervention consisted<br />

of (1) a one-hour information session with instructions on how<br />

to use the e-learning program and (2) a two-month learning period<br />

given access to the delirium e-learning program. This e-learning program<br />

is organized into 11 submodules of approximately 10 minutes<br />

each. It provides information about the epidemiology, the clinical<br />

presentation, the risk factors, the causes and the prevention, screening<br />

and treatment strategies of delirium in combination with case<br />

studies, videos and tests for self-assessment.<br />

RESULTS: Nurses’ knowledge about delirium was significantly<br />

improved in the after-education period compared to the before-education<br />

period (mean score (SD) of correct answers on the 23 items of<br />

the questionnaire = 19.68 (SD 2.08) versus 17.61 (SD 3.52); p


P OSTER<br />

A BSTRACTS<br />

the outpatient setting. Our ultimate goal is to enhance the abilities of<br />

medical students to work collaboratively with the disciplines of nursing<br />

and pharmacy to consider the needs of older adults using an interdisciplinary<br />

learning methodology.<br />

C82<br />

Geriatric Relocation Syndrome: A Marker for Frailty in Older<br />

Adults?<br />

A. Ahmed, S. Friedman, K. McCormick. University of Rochester,<br />

Rochester, NY.<br />

Background: Demographic changes have created a new dynamic<br />

which results in substantial late life geographic relocation<br />

within the United States. The aim of this study was firstly to assess if<br />

there was a difference between patients who relocated and patients<br />

who did not in terms of their overall health, and secondly to gauge<br />

whether relocation contributed to risk of mortality longitudinally.<br />

Methods: A convenience sample was obtained of 440 patients<br />

who were newly enrolled in a Geriatric outpatient practice attached<br />

to a university hospital in Rochester, NY. Subjects were identified as<br />

having moved at least 60 miles in the past year (n= 64) or not<br />

(n=376). Demographics, functional status, self-reported health, and<br />

comorbidities were recorded. Comparisons were made between “relocators”<br />

and “non-relocators” via Chi square and t-test analysis as<br />

appropriate. A Cox Proportional Hazard analysis was completed to<br />

assess impact of relocation status on mortality for the 429 subjects<br />

who had complete data on mortality and death date.<br />

Results: Subjects’ self report of health was more likely to be<br />

“fair” or “poor” for relocated patients (27.0% vs 19.1%, P


P OSTER<br />

A BSTRACTS<br />

Conclusions: Although participants with PD demonstrated a<br />

trend toward improved functional mobility after intensive training,<br />

no change occurred in the frequency of urinary symptoms and participants<br />

reported greater bother related to overactive bladder. Multicomponent<br />

strategies are needed to impact both motor and nonmotor<br />

symptoms of PD.<br />

C85 Encore Presentation<br />

Outcomes after Discontinuation of Proton Pump Inhibitor Therapy<br />

in Geriatric Outpatients.<br />

C. Eisenhower, 1 H. Sakely, 1,2 F. D’Amico, 1 S. Rana. 1,2 1. University of<br />

Pittsburgh Medical Center St. Margaret, Pittsburgh, PA; 2. University<br />

of Pittsburgh Medical Center St. Margaret Geriatric Care Center,<br />

Pittsburgh, PA.<br />

Chronic use of proton pump inhibitors (PPIs) in the geriatric<br />

population without a clear indication creates opportunities for longterm<br />

adverse events and drug interactions. A 2009 quality initiative at<br />

University of Pittsburgh Medical Center Geriatric Care Center enrolled<br />

eleven patients for a trial discontinuation of PPI therapy. Many<br />

of the patients did not have a documented indication for a PPI, and<br />

six patients were successfully discontinued. The purpose of this extension<br />

study was to evaluate geriatric patients after discontinuation of<br />

PPI therapy to determine rate of discontinuation and confirm that<br />

the intervention did not worsen gastrointestinal (GI) symptoms or<br />

quality of life.<br />

From 10/2010 to 3/2011, charts were reviewed at the Geriatric<br />

Care Center prior to routine appointments. Eligible patients were<br />

aged 60 years and older, currently taking a PPI, or a new patient potentially<br />

taking a PPI. Based on indication, current GI symptoms, and<br />

concomitant medications, physicians determined whether PPI use<br />

was still appropriate. Telephone follow-up was conducted by the<br />

pharmacy resident for three months with each enrolled patient. Patient<br />

charts were reviewed and pertinent demographic information<br />

analyzed. Rate of discontinuation was calculated with 95% confidence<br />

intervals using Poisson Distribution.<br />

A total of 175 patients were seen at the geriatric clinic. Nine patients<br />

were enrolled by their physician and five did not restart their<br />

PPI therapy at any time after discontinuation. The rate of discontinuation<br />

was estimated to be 0.076 (95% CI, 0.033-0.165). Duration of<br />

therapy was estimated for many enrolled patients to be less than 10<br />

years. GI symptoms continued after discontinuation for three patients,<br />

began anew for one patient, and resolved for three patients.<br />

Due to small sample size, a relationship could not be established between<br />

PPI therapy and long-term adverse events, although history of<br />

osteoporosis, B-12 deficiency, and hypomagnesmia were present in<br />

some patients.<br />

The majority of patients were successfully discontinued from<br />

their PPI therapy, and persisting GI symptoms were controlled by alternative<br />

treatments. While no significant adverse drug events occurred,<br />

it is unknown whether the use of step-down therapy would<br />

have resulted in a greater number of successful discontinuations.<br />

C86 Encore Presentation<br />

Factors associated with the care burden experienced by caregivers of<br />

older patients.<br />

C. Y. Yeo, 1 W. K. Ng, 2 W. Wong. 1 1. Geriatric Medicine, Tan Tock Seng<br />

Hospital, Singapore, Singapore; 2. Nursing Service, Tan Tock Seng<br />

Hospital, Singapore, Singapore.<br />

Supported By: Nil.<br />

Background: Caregiver burden experienced by caregivers of<br />

older adults is expected to increase with the aging population. The<br />

aim of this study was to determine the factors associated with caregiver<br />

burden experienced by caregivers of a cohort of elderly patients<br />

attending an outpatient geriatric clinic.<br />

Methods: This was a cross-sectional study of caregivers of patients<br />

referred to an outpatient geriatric clinic. Demographic information,<br />

medical history, functional and psychosocial status of patients<br />

were recorded. The relationship of the caregivers to the patients was<br />

also recorded. Caregiver burden was assessed using the short-form of<br />

the Zarit Burden Inventory (ZBI).<br />

Results: 240 caregivers were included in the study. 68.3% were<br />

female. 19.6% of the caregivers were spouses, 55.8% were children<br />

and children-in-law, 4.2% were other relatives and 20.4% were domestic<br />

helpers. Mean ZBI score was 16.15. Spousal caregivers had the<br />

highest ZBI score (mean 18.04), followed by other relatives (mean<br />

16.70), children and children-in-law (mean 16.56), and domestic<br />

helpers (mean 13.14). Using multivariate analysis, factors that were<br />

significantly associated with higher ZBI scores were male patients<br />

(Beta coefficient = 3.14, 95% CI 0.50 to 5.78), patients who were independent<br />

in feeding (Beta coefficient = 3.51, 95% CI 0.39 to 6.64),<br />

patients who were dependent in grocery shopping (Beta coefficient =<br />

2.11, 95% CI 0.23 to 4.00), patients with behavior problems (Beta coefficient<br />

= 2.85, 95% CI 0.37 to 5.33) and spousal relationship with<br />

patient (Beta coefficient = 1.70, 95% CI 0.57 to 2.83). There were no<br />

significant association between the ZBI score and patients’ diagnosis<br />

of dementia or depression, nor with caregivers’ gender.<br />

Conclusion: Patient factors that were associated with higher<br />

burden of care in our study include male gender, independence in<br />

feeding, dependence in grocery shopping and presence of behavioral<br />

problems. Familial relationship between caregivers and patients was<br />

also associated with higher care burden. Further research can be<br />

done to explore carer stress among spousal caregivers for elderly and<br />

their coping abilities and utilisation of family and community resources,<br />

given our aging population and low birthrate resulting in<br />

smaller families.<br />

C87<br />

Effects of Sub-acute Care on Hospital Acquired Anemia in the<br />

Elderly.<br />

C. Bocirnea, M. V. Corrigan, S. K. Sandhu. MetroHealth Medical<br />

Center, Cleveland, OH.<br />

OBJECTIVES: To determine if sub-acute care results in further<br />

hemoglobin decrease in elderly patients with hospital acquired anemia<br />

and if there is an association between development of anemia<br />

and patient demographic characteristics, medical conditions, medications,<br />

and length of stay.<br />

DESIGN: Retrospective observational study.<br />

SETTING: Academic medical center.<br />

PARTICIPANTS: Patients over the age of 65 admitted to an academic<br />

hospital based sub-acute care unit, post hospitalization for a<br />

medical illness from January 2007 to July 2011. Exclusion criteria: patients<br />

transferred from ICU, those who underwent surgical procedures,<br />

had documented blood loss, active leukemia or recent<br />

chemotherapy.<br />

MEASUREMENTS: Demographics; chronic medical conditions<br />

and medications; hemoglobin levels; number of blood tubes<br />

drawn; length of stay.<br />

RESULTS: Of 835 patients transferred to sub-acute care after a<br />

medical hospitalization between 01/2007-07/2011, 393 met the inclusion<br />

criteria. Median age was 78 years, 65% Caucasian, 65% female.<br />

Nearly half had heart disease, one third heart failure, and 85% hypertension.<br />

Median length of stay was 7 days for acute care and 13 days<br />

in sub-acute care. Anemia was present on hospital admission in 57%<br />

of patients, with 80% of patients anemic upon sub-acute care discharge.<br />

43% of patients did not have anemia on admission; at discharge<br />

from sub-acute care this group had a mean decrease in Hgb of<br />

1.9 g/dL, significantly greater compared with anemic patients. Factors<br />

predicting a significant drop in Hgb levels of more than 2.0 g/dl(25%<br />

of patients) were longer los in acute care (p 0.002), number of tests<br />

obtained during sub-acute stay (p 0.001), presence of cognitive<br />

deficits (p 0.009), coronary artery disease (p 0.02) and lower BMI (p<br />

AGS 2012 ANNUAL MEETING<br />

S161


P OSTER<br />

A BSTRACTS<br />

0.03). Age and subsequent admission to the sub-acute unit did not influence<br />

the presence of anemia.<br />

Conclusions: A high percentage of elderly patients were admitted<br />

to the sub-acute unit with anemia; nearly 30% of these patients<br />

acquired anemia during the hospitalization. However, subsequent<br />

blood draws during sub-acute care did not worsen underlying anemia.<br />

Patients admitted without anemia experienced more significant<br />

decrease in hemoglobin level during both acute and sub-acute stay.<br />

This finding warrants further investigation. Judicious testing, use of<br />

pediatric tubes and elimination of routine ordering may decrease the<br />

risk of anemia.<br />

Key words; anemia; elderly; sub-acute; hospitalization<br />

C88<br />

C-Reactive Protein Fails to Predict Geriatric Depression: The<br />

Cardiovascular Health Study.<br />

D. C. Hsu, 1,2 D. Tancredi, 3,4 C. Hirsch. 1,4 1. Internal Medicine,<br />

University of California, Davis, Sacramento, CA; 2. Psychiatry,<br />

University of California, Davis, Sacramento, CA; 3. Pediatrics,<br />

University of California, Davis, Sacramento, CA; 4. Center for<br />

Healthcare Policy and Research, University of California, Davis,<br />

Sacramento, CA.<br />

Background: Although depression and inflammation are associated<br />

with an increased risk of cardiovascular outcomes (CVO), the<br />

extent to which depression is in the causal pathway between inflammation<br />

and CVO is unknown. Our objective was to assess whether<br />

higher levels of C-reactive protein (CRP) are associated with greater<br />

increases in depressive symptoms among older persons up to eight<br />

years after baseline measurement.<br />

Methods: We performed a retrospective analysis of data from<br />

the Cardiovascular Health Study (CHS), a prospective cohort study<br />

of 5,888 persons 65 and older from four communities in the U.S. They<br />

included Forsyth County in North Carolina, Washington County in<br />

Maryland, Sacramento County in California, and Allegheny County<br />

in Pennsylvania. 5201 men and women aged 65 and older enrolled in<br />

the original cohort group of 1989, along with 687 African-<strong>American</strong><br />

participants in 1992 and 1993. Levels of CRP were obtained at baseline<br />

and year 5 of the study, and depression was evaluated with the 10-<br />

item Center for Epidemiologic Studies Depression Scale. Selected via<br />

directed acyclic graphs, variables for demographics, chronic medical<br />

diseases, medications, and life events were controlled in the multiple<br />

linear regression models for changes in depression score.<br />

Results: No statistically significant association between CRP<br />

and mean changes in depression score was found in this cohort. CRP<br />

levels showed only modest within-person correlation (r=0.25) from<br />

baseline to year 5.<br />

Conclusions: Infrequently assessed levels CRP cannot help predict<br />

geriatric depression up to eight years after initial measurement.<br />

Further study of the relationship between inflammatory markers and<br />

geriatric depression is needed.<br />

C89<br />

Under the radar - previously undocumented dementia among older<br />

veterans on an inpatient medical service.<br />

E. Clark, 1,2 J. Burns, 3,4 L. Leon, 5 E. Gottesman, 1 E. Livote. 1 1. JJ<br />

Peters VA Medical Center, Bronx, NY; 2. Mt. Sinai School of<br />

Medicine, New York, NY; 3. Union Square Family Health, Somerville,<br />

MA; 4. Harvard Medical School, Boston, MA; 5. Staywell Health<br />

Center, Waterbury, CT.<br />

Background: Dementia compromises individuals’ abilities to<br />

live independently and to manage their healthcare and thus often<br />

confounds safe hospital discharge. With advancing age, the incidence<br />

of dementia and the complexity of medical problems increase yet dementia<br />

frequently remains unrecognized.<br />

Objectives: Identify likely cases of previously undocumented<br />

dementia among inpatient older veterans at a VA medical center<br />

Methods:<br />

1) Brief battery of cognitive and functional assessment tools<br />

performed within 48 hours of admission to a general medical service,<br />

January – March 2009<br />

2) Chart review of the electronic medical record (EMR) for<br />

documentation of dementia, memory loss or cognitive impairment<br />

during the year prior to study enrollment<br />

Subjects:<br />

Convenience sample of 50 veterans: all male; median age 77.5<br />

(range 65-91);26.7% did not graduate from high school, 28.9% were<br />

high school graduates, and 44.4% had at least some college.<br />

Results:<br />

Of the 50 subjects, 32 (64%) had no EMR documentation of<br />

memory loss, dementia, or cognitive impairment during the prior<br />

year. Among these, 2 (6.7%) had a Mini Mental Status Exam score <<br />

20/30; 22 (71%) had an abnormal Clock; 8 (25%) named few than 12<br />

animals in 60 seconds. Only 9 (28%) of these 32 subjects had no abnormalities<br />

on cognitive testing. Of the 40 total subjects with at least<br />

1 abnormal cognitive test, 25 (62.5%) reported 2 or more deficits in<br />

IADLs.<br />

Of the 32 subjects with no prior documentation of cognitive impairment,<br />

only 2 had documentation of prior formal cognitive testing.<br />

Of the 18 subjects who did have prior diagnosis of cognitive impairment,<br />

15 (83%) had documentation of prior testing.<br />

Discussion: Cut offs for abnormal test values were chosen to be<br />

consistent with cognitive impairment independent of educational attainment.<br />

While this was a small pilot study, the high prevalence of<br />

abnormal results on cognitive testing coupled with self reported<br />

deficits in IADLs among hospitalized subjects with no prior documentation<br />

of memory loss, cognitive impairment or dementia, supports<br />

the contention that cognitive impairments often go unrecognized<br />

among older veterans. Further studies are needed to assess the<br />

true extent of dementia under-recognition in this population.<br />

C90<br />

Outpatient medication reconciliation: Does accuracy improve if<br />

patients “brown bag” their medications?<br />

E. Sarzynski, S. Zhou, C. Rios-Bedoya, C. Luz. Michigan State<br />

University, East Lansing, MI.<br />

Background: Most medication reconciliation research conducted<br />

in outpatient settings has focused on general medical patients,<br />

where average age is 50-60. Among this cohort, medication discrepancies<br />

are prevalent. Studies often rely on multiple methods to determine<br />

what medications patients are actually taking, including patient<br />

recall, “updated” medication lists, medication containers (“brown<br />

bag” review), and phone interviews. There is little data to suggest that<br />

lists generated by these methods are equivalent.<br />

Methods: A study was conducted to assess whether providerdocumented<br />

medication lists were more accurate among patients that<br />

bring their medications to outpatient appointments (“brown-baggers,”<br />

BBs) compared with patients who do not bring their medications<br />

to appointments (“non-brown-baggers,” NBBs). Subjects were<br />

patients at a community geriatric clinic. Three medication lists were<br />

generated for each subject: 1) a provider-documented list in the patient’s<br />

chart (recorded list); 2) an immediate post-appointment list<br />

(point-of-care list); and 3) a post-appointment telephone interview<br />

(reported list, gold standard). Investigators identified prescriptions<br />

from other providers, non-oral medications, and over-the-counter<br />

medications in order to generate the most robust lists. Completeness<br />

and correctness 1 among these lists were compared between BBs and<br />

NBBs.<br />

Results: The study enrolled 46 cognitively intact elders who<br />

managed their own medications. Average age was 79.8 and 33% were<br />

men. Overall, 89% of subjects self-reported that their physician reviewed<br />

medications during the office visit, although significantly<br />

S162<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

fewer NBBs (62%) reported the same. Subjects reported taking an<br />

average of 9.9 medications, of which 5.7 were prescription drugs. Of<br />

the 46 subjects, 34 brought at least 1 of their medications to their office<br />

visit (BBs). Among BBs, only 38% brought all of the medications<br />

they reported taking. Additional analyses are pending, including assessment<br />

of recorded lists for completeness, correctness, errors of inclusion/exclusion,<br />

and comparison of recorded list accuracy between<br />

BBs and NBBs.<br />

Conclusions: Among elderly patients who “brown bag” their<br />

medications for outpatient primary care visits, most do not bring all of<br />

the medications that they report taking. Additional conclusions are<br />

pending.<br />

1 Nassaralla et al. Qual Saf Health Care. 2007. 16: 90-94.<br />

C91 Encore Presentation<br />

Group Medical Visits for Alzheimer’s Dementia Patients and Their<br />

Caregivers.<br />

G. Fujikami, S. Lai. Santa Clara Valley Medical Center, San Jose, CA.<br />

Introduction: Alzheimer’s Dementia (AD) is a growing terminal<br />

disease that affects not only the patients but also their loved ones and<br />

caregivers. Caregiver burden is common and can manifest as mental,<br />

physical, social, and financial problems. Current outpatient models of<br />

care poorly address dementia-related issues. Outpatient group visits<br />

for a variety of chronic diseases have been studied. We applied a similar<br />

model to a group of AD patients and their caregivers. Our hypotheses<br />

were that patients’ behavioral problems and caregiver burden<br />

would be more adequately managed and improved with a<br />

structured group medical visit facilitated by a physician and social<br />

worker.<br />

Methods: 10 patients diagnosed with AD and their caregivers<br />

from a community geriatric clinic agreed to participate in this observational<br />

study. Participants met monthly for 1.5 hours for 1 year.<br />

Group medical visits began with an educational talk of interest to the<br />

group followed by a series of interval histories focused on one patient-caregiver<br />

dyad at a time facilitated by the physician and medical<br />

social worker. Caregivers filled out the Zarit Caregiver Burden Interview<br />

and Neuropsychiatric Inventory Questionnaire before and after<br />

the year-long intervention to assess caregiver stress and the severity<br />

of patient’s behavioral problems. Paired t-tests were employed.<br />

Results: 5 patient-caregiver dyads had complete data sets. There<br />

was a trend toward decrease in caregiver burden and stress as well as<br />

in severity of patients’ behavioral problems at the conclusion of the<br />

group meetings although the results were not statistically significant<br />

(p=0.43 and p=0.09, respectively). 4 of the 5 dyads experienced improvement<br />

in caregiver stress and patient’s neuropsychiatric score. If<br />

the remaining outlier dyad was excluded, scores became statistically<br />

significant (p=0.05 and p=0.02, respectively). Even though that particular<br />

dyad experienced worsening of behavior and caregiver stress, the<br />

caregiver expressed an appreciation for the support from the group.<br />

Caregivers also felt more knowledgeable about AD and about resources<br />

in the community.<br />

Conclusion: Outpatient group medical visits focusing on AD education<br />

and care may be beneficial for reducing both patient behavioral<br />

problems and caregiver stress. Future directions include focusing<br />

on specific ethnic groups and assessing for differences in health<br />

care usage and medical costs.<br />

C92<br />

Gait Speed in Older Patients Admitted to an Acute Care for Elders<br />

Hospital Unit.<br />

G. Ostir, I. Berges. UTMB, Galveston, TX.<br />

Supported By: (R01-AG031178) from the National Institute on Aging<br />

Background. Assessment of mobility on geriatric hospital units<br />

relies primarily on subjective observation or patient self-reports. We<br />

objectively examined the gait speeds of hospitalized older patients.<br />

Methods. Prospective study of 322 patients aged ≥65 years admitted<br />

to a geriatric hospital unit from the community between<br />

March, 2008 and October, 2009. Associations between gait speed<br />

(m/s) and ADLs on length of stay and home discharge were examined<br />

in multivariable logistic and generalized linear regression models.<br />

Results. About two-thirds (206/233) of older patients completed<br />

the walk with a mean gait speed of 0.53 m/s. A strong gradient of association<br />

was found between increasing gait speed and shorter hospital<br />

stays. Older patients unable to complete the walk or with gait<br />

speeds


P OSTER<br />

A BSTRACTS<br />

C94<br />

Exploring the Relationship between Computerized Measures of<br />

Gait and Lower Extremity Function, Balance and Fear of Falling.<br />

E. McGough, H. J. Thompson, T. Le, S. Chaudhuri, G. Demiris.<br />

University of Washington, Seattle, WA.<br />

Background: Up to 40% of elders experience a fall at least annually,<br />

and of those who fall, up to 10% have a significant injury. Even<br />

when no injury occurs, older adults may develop fear of falling, resulting<br />

in self-imposed activity restriction, increasing the risk of falling.<br />

The present study explored the extent to which features of gait measured<br />

by computerized gait analysis system were correlated to measures<br />

of lower extremity function, balance, and self-reported fear of<br />

falling. The goal was to determine if the system was feasible to implement<br />

and would be a useful addition to the clinical armamentarium.<br />

Methods: Community dwelling elders were observed during the<br />

completion of the Short Performance Battery (SPPB), and the Berg<br />

Balance Scale (BBS). Participants were asked to walk at 1) usual pace<br />

and 2) as quickly as possible on the GAITRite walkway. Measures<br />

obtained included gait velocity, cadence, double support time, swing<br />

time variability, and stride length variability. Subjects completed the<br />

Falls Efficacy Scale (FES). Correlations between measures were analyzed.<br />

Results: Mean age of subjects was 88.4 years, 37.5% were male<br />

(N=16). Average SPPB score was 8.06 (SD 2.95) and average BBS<br />

score was 43.75 (SD 11.7). The average FES score reported was 9 (SD<br />

0.97) indicating low concern about falls in this sample despite an average<br />

score on the BBS indicating balance impairment (


P OSTER<br />

A BSTRACTS<br />

C98<br />

Effect of level of education on regular physical activity in an elderly<br />

population within a Military Health System.<br />

H. Kumar, T. Combest, S. George. Internal Medicine, Walter Reed<br />

National Military Medical Center, Bethesda, MD.<br />

Supported By: No funding to disclose<br />

Background:Previous research has shown that those with higher<br />

levels of education are also more physically active.The effect of level<br />

of education and participation in regular physical activity is currently<br />

unknown among patients aged 60 and older in a military health system.We<br />

conducted a descriptive study utilizing survey data from participants<br />

of a fall prevention program to determine the effect of level<br />

of education on physical activity.<br />

Methods:The study involved surveys of 135 community dwelling<br />

older adults aged 60 and older who were falls clinic participants. The<br />

surveys were conducted over three years.Physical activity and exercise(Regular<br />

physical activity, consisting of 3 days a week for 30 minutes<br />

and at least 2 days with muscular conditioning) was self reported<br />

in the initial screening of all participants in the falls clinic.Demographic<br />

information was analyzed using means and simple frequencies.<br />

Univariate analysis was performed using chi square and the<br />

Fisher Exact test where appropriate, with the primary outcome being<br />

reported exercise.Groups were stratified according to level of education<br />

(high school or less, college education, and graduate level education).Results:135<br />

surveys were collected over the three year study period.<br />

There were almost equal proportions of males (43%) and<br />

females (57%). The average age was 80 years. About one third of the<br />

participants (33%, n=46) reported that were exercising. Of those surveyed,<br />

47% (n=63) reported a high school education, 39% (n=53) a<br />

college education, and 14% (n=19) a masters degree or above.<br />

Among those that reported a high school education, 25% (n=16)<br />

were exercising; those with a college education, 45% (n=24) were exercising;<br />

and those with a masters or higher, 37% (n=7) were exercising.<br />

Univariate analysis did not show a significant difference among<br />

those that reported exercising based on gender (p=0.92). This held<br />

true when analyzed according to exercise and gender among those<br />

with a high school education (p=1.0), college education (p=1.0), and<br />

masters education (p=0.47). Univariate analysis was significant<br />

among groups stratified by education (p=0.03).<br />

Conclusion: Level of Physical activity was positively associated<br />

with the level of education amongst those over sixty in this military<br />

medical system. Lowest level of physical activity was associated with<br />

the high school and lower level education from the three groups.<br />

C99<br />

Can a real-time checklist, automatically generated by the electronic<br />

medical record, predict 30-day readmissions in hospitalized elderly?<br />

A. Khan, 1,2 K. Padua, 1 M. Malone, 1,2 M. Volbrecht, 1 P. Pagel. 1 1.<br />

Aurora Health Care, Milwuakee, WI; 2. University Of Wisconsin<br />

School of Medicine and Public Health, Madison, WI.<br />

Background<br />

Approximately one-fifth of Medicare beneficiaries are readmitted<br />

within 30 days. A software called “ACE Tracker” enables the<br />

health care team to quickly view risk factors that may be correlated<br />

with readmission at the bedside and identify vulnerable seniors in the<br />

hospital.<br />

Research Question<br />

Can a real-time “ACE Tracker” tool embedded in the electronic<br />

medical record (EMR) predict 30-day readmissions?<br />

Description of ACE Tracker and readmission risk tool:<br />

The Acute Care for Elders (ACE) Tracker is a real-time report<br />

that captures relevant data from the electronic medical record of<br />

older patients including: readmission risk score, number of medications,<br />

Morse fall score, urinary catheter usage, functional status,<br />

Braden and pain score.<br />

The readmission risk score is generated from the electronic<br />

medical record ranging from 0-20 based on presence of following risk<br />

factors.<br />

1) Admitting diagnoses: congestive heart failure (CHF), psychosis,<br />

other vascular surgeries, chronic obstructive pulmonary disease<br />

(COPD), pneumonia, gastrointestinal problems 2) Chronic diseases:<br />

CHF, COPD, diabetes mellitus, shortness of breath, skin ulcers,<br />

cirrhosis, leukemia, peripheral vascular disease, stroke, metastatic<br />

cancer, malnutrition, acute respiratory failure, rheumatoid arthritis,<br />

hypertension. 3) Demographics: hospital admission in prior 6 months,<br />

length of stay. 4) Social factors: functional status, medicaid, living situation<br />

and educational barriers.<br />

Validation of readmission risk tool<br />

The readmit risk score was determined for 227 patients at four<br />

hospital on one day and those patients were followed for thirty days<br />

afterwards.<br />

Forty one percent had a value score of 7 or more. Using a cutoff<br />

value of 7, sensitivity was 61%, specificity= 22%, positive predictive<br />

value=12%, negative predictive value= 77%. The positive and negative<br />

likelihood ratios were 0.8 and 1.8.<br />

Univariate and multivariate analyses were performed on variable<br />

predictors available on “ACE Tracker”. The risk of readmission<br />

was correlated with number of medications (p=0.03).<br />

Conclusion<br />

The number of medications variable on “ACE Tracker” correlates<br />

with readmission. The readmission risk score is better in identifying<br />

those who are not at risk for readmission.<br />

C100<br />

Evaluation of a computerized physician order entry (CPOE) alert<br />

program on prescribing of selected drugs among the elderly.<br />

L. E. Rios Rojas, 1,2 I. H. Gomolin, 1,2 P. Lester. 1. Geriatric Medicine,<br />

Winthrop University Hospital, Mineola, NY; 2. Medicine, State<br />

University of New York, Stony Brook, NY.<br />

Background:<br />

Emphasis is placed on reducing adverse drug reactions<br />

(ADR)among elderly. Knowledge of predisposition to ADRs or poor<br />

efficacy may improve prescribing. Diphenhydramine is commonly<br />

prescribed to decrease transfusion reactions or as a hypnotic. Studies<br />

show no efficacy for these indications and use predisposes to ADRs 1 .<br />

Antipsychotics are commonly prescribed in the hospital with potential<br />

for continued treatment despite increased risk of death associated<br />

with their use.<br />

Methods:<br />

Winthrop Hospital is a community teaching institution. CPOE<br />

became operational by 2009. In January 2011, a series of alerts were<br />

built into CPOE for selected medications and include links to relevant<br />

papers. We evaluated the effect of alerts on prescribing frequency<br />

by comparing the number of patients for whom these medications<br />

were prescribed during second quarters of 2009 and 2010 to<br />

the second quarter of 2011. Alerts were created for diphenhydramine,<br />

metoclopramide and all antipsychotics. Prescribing patterns<br />

were evaluated by ascertaining the pharmacy database which contained<br />

all medication orders since the introduction of CPOE. Frequency<br />

was adjusted for total admissions among those over 65 years<br />

during each quarter of interest. Chi square was used to compare pre<br />

and post frequencies.<br />

Results:<br />

Diphenhydramine prescriptions were reduced when comparing<br />

2011 vs. 2010 (38% reduction, RR 0.63, 95% CI = 0.58 to 0.67) p<br />


P OSTER<br />

A BSTRACTS<br />

with the least efficacy and greatest potential for short term<br />

ADR(e.g.diphenhydramine) may be most amenable to this type of<br />

alert system. Follow up studies to test such systems are warranted.<br />

Ref:<br />

1. Kennedy LD et al. Double-blind trial of acetaminophen vs<br />

diphenhydramine pretransfusion. Transfusion 2008;48:2285-91.<br />

2011 vs 2010 and 2009<br />

C101<br />

Assessment of knowledge gaps relevant to antibiotic stewardship<br />

among health care workers in long term care facilities.<br />

A. Krishna, 1,2 C. Biedron, 2 L. Mody, 5 P. Lichtenberg, 3 R. Severson, 2<br />

C. Cassidy, 3 C. M. Pickney, 4 K. S. Kaye, 1,2 T. Chopra, 1,2 M. Johnson. 4 1.<br />

Infectious Disease, Detroit Medical Center, Detroit, MI; 2. Infectious<br />

Disease, Wayne State University, Detroit, MI; 3. Nexcare Health<br />

System, Westland, MI; 4. Dominican Life Center, Westland, MI; 5.<br />

University of Michigan, Ann Arbor, MI.<br />

Background: Long Term Care Facilities (LTCFs) provide a<br />

major reservoir for multi-drug resistant organisms (MDROs), however<br />

standard Antibiotic Stewardship Programs (ASPs) are lacking in<br />

most LTCFs. The objective of our survey was to identify knowledge<br />

gaps of health care workers [HCWs] relevant to antibiotic stewardship<br />

(AS) at LTCFs.<br />

Methods: A 71 item voluntary survey was completed by health<br />

care workers in August 2011 at two LTCFs (Dominican Life Center a<br />

174 bed facility and Nexcare Health System, a 111 bed facility) in<br />

South East Michigan.<br />

Results: 44 HCWs (36 nurses, 4 infection control professionals, 2<br />

physician assistants and 1 staff physician) responded to the survey.<br />

Mean age of respondents was 42 + 14 and 93% were females. 61% of<br />

respondents believed that over prescribing of antibiotics was a very<br />

important cause of antibiotic resistance. Most respondents believed<br />

that prescriber education [51%], institution specific guidelines [54%]<br />

or accessible advice from infectious disease physician [58%] were effective<br />

interventions in reducing antibiotic resistance.<br />

100% of the respondents were familiar with methicillin-resistant<br />

Staphylococcus aureus [MRSA], 73% were familiar with vancomycin-resistant<br />

enterococci [VRE], 34% were familiar with Klebsiella<br />

pneumoniae carbapenemase [KPC] and 27% were familiar with<br />

extended-spectrum beta lactamase [ESBL]. Percentage of respondents<br />

confident in caring for a patient with MRSA, VRE, KPC and<br />

ESBL were 98, 95, 56 and 47 respectively. 30% and 26% of the respondents<br />

were not familiar with differences between definitions of<br />

colonization and infection respectively.<br />

Conclusions: Significant knowledge gaps among HCWs remain,<br />

specifically related to treating infections with KPCs and ESBLs. Educating<br />

HCWs on the differences between colonization and true infection<br />

is crucial. Formal ASPs are urgently needed in LTCFs to optimize<br />

antibiotic use and decrease colonization pressure by MDROs.<br />

C102<br />

Staff Responses to Resident-to-Resident Elder Mistreatment in<br />

Nursing Homes: Results of a Multi-Site Survey.<br />

A. Rosen, 1,2 M. S. Lachs, 1 K. Pillemer, 3 J. Teresi. 4,5 1. Medicine,<br />

<strong>Geriatrics</strong>, Weill Cornell Medical College, New York, NY; 2. Emegency<br />

Medicine Residency, New York Presbyterian Hospital, New York, NY;<br />

3. Human Development, Cornell University, Ithaca, NY; 4. Research<br />

Division, Hebrew Home at Riverdale, Riverdale, NY; 5. Columbia<br />

University Stroud Center and New York State Psychiatric Institute,<br />

New York, NY.<br />

Background: Resident-to-resident elder mistreatment (RREM)<br />

in nursing homes is a likely frequent phenomenon that may lead to<br />

severe outcomes for victims and perpetrators. Nursing home staff actions<br />

in response to this behavior may significantly mitigate its impact,<br />

but little is known about prevention and management strategies.<br />

Objective:To identify the most common staff responses to RREM<br />

Methods: We conducted this study as part of a large, multisite<br />

NIA-funded study attempting to estimate the prevalence of RREM<br />

in long term care facilities. For this project, the behavior of 1,688 residents<br />

of 5 nursing homes in New York City was evaluated. Certified<br />

nursing assistants primarily responsible for the care of residents<br />

under study in the parent project were asked about their responses to<br />

RREM during the previous two weeks. A modification of a validated<br />

instrument initially created to measure behavioral problems in nursing<br />

home residents was used.<br />

Results: Staff reported taking some action for RREM incidents<br />

involving 277 residents (16.4%) during the previous two weeks, and<br />

22 different responses were described. Most common responses were:<br />

physically intervening / separating residents (84), talking calmly to<br />

settle residents down (65), and verbally intervening to defuse the situation<br />

(59). Not included among staff responses was requesting consultation<br />

of a physician or psychiatrist.<br />

Conclusion: RREM is a potentially common and dangerous occurrence,<br />

and nursing home staff report many varied responses to it.<br />

Despite this, physicians and psychiatrists are seldom called upon to<br />

assist in RREM prevention and management. The effectiveness of existing<br />

responses and the potential for physician contribution needs to<br />

be examined in greater detail, and comprehensive evidence-based interventions<br />

should be developed.<br />

C103<br />

Care Delivery Consequences of Poor Quality Hospital-to-Skilled<br />

Nursing Facility Transitions: A Qualitative Study.<br />

B. King, 1 A. Kind, 2 A. Gilmore, 1 R. Roiland, 1 K. Pecanac, 1<br />

M. Hovanes, 1 N. Husain, 2 B. Bowers. 1 1. Nursing, University of<br />

Wisconsin, Madison, WI; 2. Medicine, University of Wisconsin,<br />

Madison, WI.<br />

Supported By: This study is funded by a NIA Beeson K23 Award<br />

Background: Poorly executed, transitions from the hospital to<br />

home can result in care fragmentation and lapses in patient safety.<br />

Research has focused on transitions from hospital to home with few<br />

studies on the highly vulnerable population: older adults transferring<br />

from the hospital to a Skilled Nursing Facility (SNF). Nurses in SNFs<br />

design a resident’s plan of care based on orders/information received<br />

from the hospital physician and nursing staff. The purpose of this<br />

study is to explore how nurses in SNFs transition care of residents admitted<br />

from hospitals, the barriers they experience and their views of<br />

the consequences of poor quality care transitions.<br />

Methods: This qualitative study utilized Grounded Dimensional<br />

Analysis, a variant of Grounded Theory. Registered nurses (n=9) employed<br />

at 3 SNFs in Wisconsin participated in focus groups with indepth<br />

interviews. Constant comparisons were used to expand the<br />

richness of the data. Data was analyzed using open, axial and selective<br />

coding.<br />

Results: Nurses in SNFs engage in a complex process of getting<br />

prepared to transition residents from hospital-to-SNFs. Despite this<br />

complex preparation, the information SNF nurses receive from the<br />

hospital is often incorrect or incomplete. Nurses cited multiple inadequacies<br />

of hospital discharge information, including regular problems<br />

with medication orders (including the lack of opiod prescriptions for<br />

pain), little information on resident’s psychosocial/functional history,<br />

and inaccurate information regarding the resident’s current health<br />

status. These inadequacies necessitated repeated call backs to the discharging<br />

hospital, created delays in care delivery to SNF residents<br />

(including delays in pain control), increased SNF staff stress and frustrated<br />

patients/family members. SNF nurses identified a specific list<br />

of information/components that they need to initiate a high-quality<br />

SNF plan of care.<br />

S166<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

Conclusions: Nurses in SNFs identify multiple quality deficiencies<br />

in hospital-to-SNF transitions, which they feel impact care. Future<br />

qualitative work with SNF nurses will assist in designing interventions<br />

to improve hospital-to-SNF care transitions.<br />

C104<br />

Primary Care Providers’ Experiences of Assessing and Minimizing<br />

Treatment Burden of Multimorbid Older Adults.<br />

B. Limm, 1 T. B. Hughes, 2 C. Boyd, 2 C. Rand. 2 1. John A. Burns<br />

School of Medicine, University of Hawaii, Honolulu, HI; 2.<br />

Department of Medicine, Johns Hopkins University School of<br />

Medicine, Baltimore, MD.<br />

Supported By: The Robert Wood Johnson Foundation Physician<br />

Faculty Scholars Program, and the Paul Beeson Career<br />

Development Award Program (NIA K23 AG032910, AFAR, The<br />

John A. Hartford Foundation, The Atlantic Philanthropies, The Starr<br />

Foundation and an anonymous donor).<br />

Purpose: Comorbidity is associated with poor outcomes including<br />

worse quality of life, mortality, disability, and complications from<br />

treatment. Older patients with multiple chronic conditions present<br />

substantial challenges to delivering medical care that is both patientcentered<br />

and guideline-based. Patients are often overwhelmed by the<br />

aggregate weight of all the actions and resources that they must devote<br />

to maintain their health. To gain insight into the experience of<br />

managing and treating multimorbid older adults, focus groups were<br />

conducted with 20 primary care physicians. Methods: Participants<br />

were asked to discuss how treatment burden affected the treatment<br />

plans and adherence of older adults with multiple chronic conditions,<br />

and how they made decisions with these patients. Focus group sessions<br />

lasted one to two hours in duration, were audio-taped and transcribed.<br />

Content analysis of data was performed for emergent themes<br />

by two independent investigators utilizing Atlas.ti 5.2. Results: Nearly<br />

all respondents reported challenges in the treatment of patients with<br />

multiple chronic conditions, particularly among patients with complex<br />

medication regimens, financial constraints, inadequate social<br />

support, and those in need of prolonged visits. Findings revealed the<br />

following emergent themes: physicians prioritized treatment decisions<br />

based on patient preferences, level of motivation, finances, disease<br />

severity, and level of social support; system regulations were barriers<br />

to the provision of comprehensive care; and non-physician office<br />

staff was a link to better patient care. Conclusions: Treatment burden<br />

presented challenges by affecting decision-making, actual treatment<br />

plans, and adherence among primary care providers. Research findings<br />

will contribute to the development of a screening tool for health<br />

care providers to assess the burden of prescribed treatments and recommendations<br />

among patients, promote communication between patients<br />

and physicians, and guide medical decision-making regarding<br />

treatment regimens.<br />

C105<br />

For a seat at the table, bring the table: A transdisciplinary model for<br />

aging-related advocacy in non-health policy.<br />

B. Williams, 1 C. Ahalt, 1 D. Faigman. 2 1. UCSF, San Francisco, CA; 2.<br />

UC Hastings, San Francisco, CA.<br />

Supported By: The Langeloth Foundation and The UCSF Program<br />

for the Aging Century<br />

Background: Policy decisions that are not health-specific may<br />

increasingly cause unintended health consequences for older adults.<br />

As a result, broader reaching geriatrics advocacy is needed. Health<br />

Impact Assessment (HIA) is an emerging conceptual model for identifying<br />

the health consequences of policies and communicating that<br />

information to policymakers. Using the HIA transdisciplinary approach,<br />

we convened a roundtable of national experts in geriatrics,<br />

correctional health, and the law to assess “Realignment,” a new criminal<br />

justice policy in California that will redistribute thousands of<br />

older adults from prisons to jails and community corrections. We explored<br />

HIA as a platform for geriatrics advocacy to develop recommendations<br />

to minimize the adverse consequences of Realignment<br />

for older adults.<br />

Methods: The 26 Roundtable participants received a short crossdisciplinary<br />

lecture to convey basic knowledge in 3 areas: geriatrics,<br />

older prisoner health, and Realignment. Next, transdiscipline working<br />

groups brainstormed critical issues to address.Facilitators grouped highpriority<br />

issues into 4 “topic areas” and assigned each to a transdisciplinary<br />

group to develop recommendations. Each group then presented<br />

their policy recommendations to the Roundtable to achieve consensus.<br />

Results: 26 of 32 (81%) invitees participated: Correctional physical<br />

or mental health providers (4), Law professors (4), Public Defenders<br />

or District Attorneys (3), Pre-Trial Diversion or Probation officials<br />

(2), Community service providers for the formerly incarcerated (2),<br />

Criminal justice experts (4), and Academic physicians/geriatricians<br />

(7). Consensus was reached on 6 recommendations: Collect age-stratified<br />

data; Improve access to incarceration alternatives; Develop geriatric<br />

assessments for arrest and incarceration; Expand peer-mentoring<br />

for older inmates; Improve transitions of care; Expand geriatric training<br />

for professionals in contact with older correctional populations.<br />

Each recommendation incorporated the expertise of multiple disciplines.<br />

95% of participants would participate in a similar future event.<br />

Conclusion: While many policy changes could affect older<br />

adults’ health, policymakers in non-health related fields rarely reserve<br />

a “seat at the table” for geriatricians. Our findings show that the<br />

HIA approach works as a mechanism for achieving transdiciplinary<br />

geriatrics advocacy in non-health-specific policy.<br />

C106<br />

Knowledge of and perceived need for evidence-based educational<br />

materials about antipsychotic medication safety by nursing home staff.<br />

C. Lemay, S. Foy, K. Mazor, L. R. Harrold, J. Donovan, A. Kanaan,<br />

B. A. Briesacher, J. Gurwitz, J. Tjia. <strong>Geriatrics</strong>, University of<br />

Massachusetts Medical School, Worcester, MA.<br />

Supported By: This study was funded by the Agency for Healthcare<br />

Quality and Research.<br />

Background: Given the widespread overuse of antipsychotic<br />

medications among US nursing home (NH) residents, we sought to<br />

identify knowledge of and perceived need for the AHRQ Comparative<br />

Effectiveness Research Summary Guide (CERSG) “Off-Label<br />

Use of Atypical Antipsychotic Drugs”.<br />

Methods: We conducted a baseline needs assessment with 12<br />

NHs participating in a randomized controlled trial evaluating evidence<br />

dissemination strategies. Using a mixed-methods approach, we<br />

conducted in-depth assessments of knowledge, attitudes, and practice<br />

behavior using telephone interviews with NH leadership (administrators,<br />

directors of nursing [DONs], and medical directors), and questionnaires<br />

with NH leadership, consultant pharmacists and direct care<br />

staff. Interviews were transcribed and verbatim responses were coded<br />

independently by 2 project staff. The coding scheme was revised after<br />

each round until substantial agreement (85%) was reached.<br />

Results: Interviews revealed that 70% of medical directors and<br />

46% of DONs & administrators believed that antipsychotics decreased<br />

agitation and controlled harmful behavior; 50% of medical<br />

directors and 7% of DONs & administrators reported knowledge of<br />

the increased risk of morbidity amd mortality due to atypical antipsychotics.<br />

Half of administrators and DONs expressed interest in receiving<br />

information for NH staff pertaining to understanding dementia<br />

and dementia-related behaviors, and 42% believed families would<br />

benefit from information about antipsychotic use for dementia-related<br />

behaviors. Questionnaire results were similar. When leaders<br />

were asked to list any risks associated with antipsychotic use for residents<br />

with dementia, only 17% reported death as a possible adverse<br />

event; licensed nursing staff (RN and LPNs) reported death 5% of<br />

the time. Over half of consultant pharmacists reported that their<br />

biggest barrier to improving medication use in challenging NHs was<br />

AGS 2012 ANNUAL MEETING<br />

S167


P OSTER<br />

A BSTRACTS<br />

physician resistance to accepting prescribing recommendations, including<br />

gradual dose reductions.<br />

Conclusions: The responses of the NH leaders, staff and consultant<br />

pharmacists suggest widespread knowledge gaps regarding antipsychotic<br />

benefits and risks, and suggest a need for increase evidence<br />

dissemination and broad organizational change.<br />

C107<br />

A Discrete Choice Analysis of Older Adults’ Preferences for<br />

Colorectal Cancer Screening Tests.<br />

C. E. Kistler, 1 T. Hess, 2 M. Pignone, 1 S. Hawley, 3 C. Lewis. 1 1.<br />

University of North Carolina at Chapel Hill, Chapel Hill, NC; 2.<br />

North Carolina State University, Raleigh, NC; 3. University of<br />

Michigan, Ann Arbor, MI.<br />

Supported By: This study was supported by the Agency for<br />

Healthcare Research and Quality K12 HS19468-01 (Kistler) and institutional<br />

support from the University of North Carolina at Chapel<br />

Hill and North Carolina State University.<br />

Background: Tailoring colorectal cancer (CRC) screening tests<br />

to older adults’ preferences may improve adherence to CRC screening.<br />

Given the heterogeneity of health status among older adults, different<br />

attributes other than mortality reduction may be key factors<br />

when deciding upon a preferred CRC screening test. This study aims<br />

to describe older adults’ preferences for colorectal cancer screening<br />

test attributes via a discrete choice analysis.<br />

Methods: We conducted a discrete choice analysis among adults<br />

aged 70 and older who volunteered at either a local Family Medicine<br />

clinic or a local research site. Participants were first asked to rank<br />

four key attributes in order of importance: mortality reduction, risk of<br />

complications, test frequency, and testing procedure. Next, in 10 different<br />

scenarios, they were asked to choose between two hypothetical<br />

CRC screening tests. Each hypothetical test contained varying levels<br />

of the four key attributes. Responses were used to calculate the overall<br />

importance of these attributes. These results were then compared<br />

to the initial ranking exercise.<br />

Results: Preliminary results include 63 participants with a mean<br />

age of 76 years (range 70-90) of whom 51 were White, 11 African<br />

<strong>American</strong>, and 1 <strong>American</strong> Indian. All but 3 participants had been<br />

screened at least once for colorectal cancer. Initially, 44% of participants<br />

(28/63) ranked mortality reduction as the most important test<br />

attribute; 44% (28/63) ranked risk of complications second; 40%<br />

(25/63)ranked test frequency third; and 48% (30/63) ranked testing<br />

procedures as the least important attribute. A discrete choice analysis<br />

determined the attribute importance from most to least was: testing<br />

procedure (28%), test frequency (27%), risk of complications (23%),<br />

and mortality reduction (23%).<br />

Conclusion: Older adults appear to have differing preferences<br />

for CRC screening test attributes depending on how the information<br />

is presented. A discrete choice analysis appears to shift older adults’<br />

preference away from prioritizing mortality reduction and towards<br />

other test attributes.<br />

C108<br />

Qualitative Approach to Understanding Medication Challenges<br />

among Older Adults after Hospital Discharge.<br />

D. Liu, 1,2 S. Rennke, 1 H. Chi, 1 M. Steinman. 1,2 1. Internal Medicine,<br />

UCSF, San Francisco, CA; 2. <strong>Geriatrics</strong>, SF VA Medical Center, San<br />

Francisco, CA.<br />

Supported By: Supported in part by NIH grant 1K23-AG030999<br />

(PI: Steinman, M)<br />

Background: Patients age 65 years and older have a 19% risk of<br />

30 day readmission after hospital discharge, and medication safety<br />

plays an important role in reducing this risk. We piloted a telephonebased<br />

qualitative study to better understand the needs older adults<br />

have with medications after recent hospital discharge.<br />

Methods:The study population included patients 2-4 weeks after<br />

discharge from the general medicine service at an academic teaching<br />

hospital. Inclusion criteria were age ≥65 years, English-speaking, and<br />

discharged home with ≥ 5 medications. We used semi-structured,<br />

open-ended questions assessing problems with medication since discharge,<br />

resources patients have, and what additional help they need.<br />

Transcriptions were analyzed from a grounded theory approach.<br />

For participants who answered “no problems,” we used common scenarios<br />

based on the medical literature as prompts. Concurrent with<br />

our study, hospital discharge nurses attempted to reach all participants<br />

with a standard post-discharge telephone call that included 2<br />

medication questions (Did you fill your prescriptions? Did you understand<br />

your medication instructions?).<br />

Results: We have conducted 9 interviews. All interviewees endorsed<br />

some medication-related problem including adherence, titration,<br />

side effects, and financial difficulty. Three initially denied any<br />

problems, but in response to prompts did endorse at least one. Six of<br />

the participants received the standard post-discharge phone call, but<br />

none of these revealed any medication problems. Participants identified<br />

needs at discharge along themes of lack of communication (“I<br />

don’t think anyone has any time to discuss with me before I left”) and<br />

inclusion of family in discharge planning. Four participants denied<br />

needing any additional help at discharge with reasons being family<br />

support or confidence in self ability. The latter group, however, qualified<br />

their response by saying they did “not yet” need assistance.<br />

Conclusion: Our study suggests that the brief post-discharge<br />

phone call after discharge fails to identify common medication problems<br />

among older patients. The themes of family and communication<br />

suggest focal points for future study and design of discharge programs.<br />

Even participants who denied needing assistance still qualified<br />

their response with a “yet,” suggesting needs are a moving target.<br />

C109<br />

Effects of a randomized controlled trial comparing reimbursement<br />

of care coordination to pay-for-performance in primary care.<br />

D. A. Dorr, 1 G. S. Olsen, 1 M. Pierre-Jacques Williams, 1<br />

C. P. Brunker. 2,3 1. Medical Informatics & Clinical Epidemiology,<br />

OHSU, Portland, OR; 2. <strong>Geriatrics</strong>, Intermountain Healthcare, Salt<br />

Lake City, UT; 3. <strong>Geriatrics</strong>, University of Utah, Salt Lake City, UT.<br />

Supported By: The John A. Hartford Foundation, AHRQ<br />

Background:Addressing patients’ longitudinal coordination needs<br />

may reduce hospitalizations and improve quality while lowering costs,<br />

particularly for older adults with multiple chronic illnesses. Yet, most<br />

payment structures are fee-for-service or quality measure-based rather<br />

than coordination-based. We tested the hypothesis that incentives for<br />

care coordination would increase coordination activities and reduce utilization<br />

more than traditional quality measure-based pay-for-performance<br />

in a cluster randomized controlled trial of 6 primary care clinics.<br />

Methods: Clinics were randomized into two arms: 3 received payment<br />

for improvement on a self-selected set of 5 validated quality measures<br />

(quality) and 3 received payment for assessment, education, goal<br />

setting, motivational interviewing, and communication activities (coordination).<br />

All clinics had designated, trained care managers and health<br />

IT that provided interactive quality reports, tracked and reminded<br />

about services, and facilitated risk-based population management. Patients<br />

were eligible if seen twice during the 3 year study period. Patients<br />

were analyzed in two groups: 1) preselected based on risk of hospitalization<br />

and death; 2) enrolled by the care manager. Descriptive statistics<br />

were computed to compare quality and care coordination encounters.<br />

Results: 27,001 patients were eligible for the study; 18% were<br />

preselected as high risk; 15% were enrolled in care management. In<br />

all, 20% of patients were >65; however, they were 50% of high risk<br />

and 36% of referred patients. Coordination clinics performed 1.8<br />

times the coordination activities, including 4.3 times the education,<br />

3.1 times the communication, and 3.9 times the motivational interviewing<br />

as quality clinics. Quality clinics increased their absolute performance<br />

on selected quality measures by 10.8% vs 5.1%.<br />

S168<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

Conclusion: The focus of incentives motivated clinic activity, but<br />

the impact of care coordination incentives was greatest. Information<br />

about which had greater effect on utilization, patient outcomes, and<br />

clinic quality metrics is required to determine how to alter health policy.<br />

C110<br />

Person and Organizational Correlates of HEDIS High-Risk Drug<br />

Utilization within Veteran’s Administration Nursing Homes.<br />

D. M. Dosa, 2,1 O. Intrator, 2,1 G. Kochersberger, 3 P. Katz. 4 1. Medicine,<br />

Brown University, Providence, RI; 2. Providence Research<br />

Enhancement Award Program, Providence VA Medical Center,<br />

Providence, RI; 3. Canandaigua VAMC, Rochester, NY; 4. Baycrest<br />

Hospital, Toronto, ON, Canada.<br />

Supported By: Veteran’s Administration<br />

Objectives: A common error described in the literature is the<br />

utilization of high risk medications in the elderly—a population most<br />

likely to experience morbidity. This study evaluates the use of medications<br />

classified by the Healthcare Effectiveness Data Information<br />

Set (HEDIS) as high risk in VA Nursing Homes (NHs) and identifies<br />

any patient/organizational correlates of high use.<br />

Methods: Minimum Data Set (MDS) records from 2009 were<br />

merged with VA Pharmacy Data to identify residents of VA NHs who<br />

received at least one medication on the HEDIS high risk list. Utilizing<br />

HEDIS medication use as a quality indicator (QI), the MDS was<br />

then used to identify patient specific correlates of high use (e.g. demographics,<br />

cognitive status, and functional status.) Organizational<br />

practices within specific NHs were identified from a 2010 VA NH<br />

medical director survey. Descriptive statistics (Chi- Square, t-tests)<br />

were used to test associations between person level variables and a<br />

Poisson Regression analysis was conducted to test associations of organizational<br />

characteristics with the QI.<br />

Results: Of 43,577 veterans residing in any of 132 NHs, 2666<br />

(6.4%) received at least 1 HEDIS medication. Females were more<br />

likely to receive a HEDIS drug (10.5 versus 5.9%). Those with better<br />

cognition (7.1%) were more likely to receive a HEDIS drug compared<br />

to those with intermediate(4.6%) or severe cognitive status (4.0%).<br />

Conversely, residents were more likely to get a HEDIS medication as<br />

their functional status declined on a 28-point scale. Among organizational<br />

correlates, increased HEDIS medication use was noted at<br />

homes with increased hospice care, short stay rehabilitation, low cognitive<br />

impairment, and higher acuity. Decreased HEDIS use was associated<br />

with the perception of greater physician supervision by the medical<br />

director (Estimate: -0.69, 95% confidence interval (CI) -0.94 to<br />

-0.43) and by the perception of better NH leadership (Estimate: -0.47;<br />

95% CI: -0.73 to -0.21).All estimates were significant at less than 1%.<br />

Conclusions: The HEDIS QI appears to be important in targeting<br />

veterans receiving high risk medications in VA NHs. Certain subpopulations<br />

are at higher risk for receiving HEDIS medications and<br />

can be targeted for quality improvement efforts.<br />

C111<br />

Food Access in Aging Adults with Impaired Mobility.<br />

D. L. Huang, 1,2 D. E. Rosenberg, 3 S. D. Petz, 4 B. Belza. 4,5 1. Veterans<br />

Affairs Puget Sound Health Care System, Seattle, WA; 2. Division of<br />

Gerontology and Geriatric Medicine, University of Washington,<br />

Seattle, WA; 3. Group Health Research Institute, Seattle, WA; 4. School<br />

of Nursing, University of Washington, Seattle, WA; 5. Health<br />

Promotion Research Center, University of Washington, Seattle, WA.<br />

Supported By: FUNDING: CDC Prevention Research Centers<br />

Program, through a grant to the University of Washington Health<br />

Promotion Research Center (cooperative agreement #U48-DP001911).<br />

Dr. Huang receives salary support from the Department of Veterans<br />

Affairs Advanced Fellowship in <strong>Geriatrics</strong>.<br />

BACKGROUND: Food access is essential and may be difficult<br />

for aging adults, especially those with impaired mobility. Many aging<br />

adults may not live near locations where they can access food outside<br />

their residence, such as grocery stores. The purpose of this study was<br />

to determine where aging adults access food and built environment<br />

factors affecting their ability to access food.<br />

METHODS: Thirty-five older adults living in the Seattle, WA<br />

metropolitan area who used assistive mobility devices completed<br />

in-depth interviews focusing on built environment barriers and facilitators<br />

in their neighborhood and wore a Global Positioning System<br />

(GPS) device for 3 days. Qualitative data analysis of 20 interviews<br />

to date was completed to date by 2 researchers using Atlas.ti<br />

software.<br />

RESULTS: Participants’ mean age was 66.8 years (range 50-86<br />

years), 9 (25.7%) lived in low-income ( 80 years<br />

old, but evidence-based guidelines specific to the elderly are scarce.<br />

OBJECTIVES To correlate serious episodes of hypoglycemia<br />

(blood sugar < 65 with symptoms) with patient-specific factors and<br />

medication use. METHODS Prospectively designed retrospective<br />

explicit electronic chart review of 140 patients randomly selected out<br />

of a pool of 525 consecutive patients with diabetes that visited our<br />

clinic 8/1-10/30/2010. We excluded subjects as follows: age < 65<br />

(n=3), mislabeled as diabetics (n=6), no follow up visit<br />

4/1–10/30/2011 (n=6), or no follow up HbA1c after enrollment<br />

(n=8). Serious hypoglycemia was defined as blood sugar less than 65<br />

with reported symptoms. Chi 2 and logistic regression techniques<br />

were used to investigate the efficacy (levels of HbA1c, LDL) and<br />

safety (serious hypoglycemia) of chosen medication classes and<br />

achieved therapeutic goals. RESULTS The mean age was 78±8 years<br />

(range 65-100). Other baseline characteristics and univariate results<br />

are shown in table 1. 96% were on statins, yet only 32% had an LDL<br />


P OSTER<br />

A BSTRACTS<br />

Table 1. Effect of co-morbidities and medications on 1-year rate of<br />

hypoglycemia in elderly patients<br />

§ Comparison of hypoglycemia rates with vs. without factor<br />

C113<br />

Baby Boomers Caring for Aging Parents: Pilot Data from a<br />

Validated Survey Measuring Caregiving Effect on Attitudes,<br />

Expectations and Healthcare Practices of Caregivers.<br />

D. Kaplan, 1 L. Kaplowitz, 2 M. Reid, 1 E. Finkelstein. 1 1.<br />

Medicine/<strong>Geriatrics</strong>, Weill Cornell Medical College, New York, NY; 2.<br />

State University of New York, Buffalo, NY.<br />

Purpose: Over 45 million adult children provide informal care<br />

to aging parents. The effect of caregiving on caregiver’s health and<br />

well-being has been well documented. However, little information exists<br />

regarding how providing care for an aging parent affects caregivers’<br />

attitudes, expectations and behaviors toward their own aging.<br />

This study uses a novel, validated survey instrument that aims to expand<br />

our knowledge of caregiving and its effects in those particular<br />

domains. Pilot data are reported here.<br />

Methods: The Caregiver’s Aging Trajectory Survey (CATS) is a<br />

41-item instrument that measures respondents’ attitudes of and expectations<br />

for aging, plans for aging and healthcare practices of caregivers<br />

providing or who have provided care to aging parents. CATS<br />

also captures relevant data about caregivers and the quality and extent<br />

of the caregiving experience. Participants are being recruited at<br />

an urban academic geriatric practice, as well as at local caregiver support<br />

groups. Our target “n” is 100 caregivers and 100 non-caregiver<br />

controls.<br />

Results: As of 12/5/11, we have collected data from 58 adult<br />

child caregivers. Mean age is 56 (SD +/- 5), 82% female, 58% married,<br />

77% Caucasian. Time spent caregiving ranges from 40 hrs/wk.<br />

Participants are well-educated (64% college graduates), 58% rate<br />

their own health as excellent or very good; 40% report feeling depressed.<br />

Caregiver strain was reported as severe in 55% of participants<br />

using the Caregiver Strain Index (> or = 7 on a scale of 1-13).<br />

Caregiver’s expectations regarding aging (as per Expectations Regarding<br />

Aging Survey-12, which is on a scale of 0-100, 0=lowest) are<br />

low overall – mean of 34 for physical health and 36 for cognitive function.<br />

Though 78% reported having a routine check-up in the past<br />

year, only 10% reported having advanced directives, 24% a living<br />

will, and 29% a health care proxy. 24% of participants indicated that<br />

they had long-term care insurance, and of those who had not, only 18<br />

indicated that they may plan to in the future.<br />

Conclusions: The purpose of the present study is to gain a better<br />

understanding of the nuanced effects of caregiving on the aging<br />

child caregiver. This can in turn help the health care system provide<br />

better care to the growing number of baby boomers who are informal<br />

caregivers.<br />

C114<br />

How similar are Medicaid’s PACE payments to its outlays on<br />

alternative long-term care for comparable patients?<br />

G. D. Wieland, 1 B. Kinosian, 2 E. Stallard. 3 1. U South Carolina,<br />

Columbia, SC; 2. Department of Medicine, University of Pennsylvania<br />

School of Medicine, Philadelphia, PA; 3. Center for Population Health<br />

and Aging, Duke University, Durham, NC.<br />

Supported By: None to declare.<br />

Background. In rebalancing from nursing homes [NH], states<br />

are increasing access of NH-certified dual eligibles to aged/disabled<br />

waiver programs, and—in 29 states—PACE. Evaluations using community<br />

controls suggest Medicaid’s [MA] PACE capitation exceeds<br />

its spending for alternative fee-for-service [FFS] care. By design, these<br />

studies did not compare PACE payments to outlays for patients with<br />

equivalent health deficits/needs in both waiver and NH. <strong>Here</strong>, we develop<br />

a multiattribute model of PACE-eligible admissions to waiver,<br />

NHs and PACE to test whether MA PACE payments are lower than<br />

FFS outlays for equivalent controls. Methods. Using grade-of-membership<br />

methods, we model health deficits for duals >= 55 admitted<br />

from 1997 to 2005 (n=3,988) using SC data. Pure patient types, membership<br />

vectors, and program type prevalences are described. We calculate<br />

a PACE blend-—fitting PACE between waiver & NH entrants.<br />

FFS utilization was measured to 1-year from admission and converted<br />

to attrition-adjusted FY05$ outlays. The PACE blend locates<br />

FFS estimates for PACE entrants between mean waiver and NH payments,<br />

adding the waiver base cost. PACE’s capitation is then compared<br />

to the expenditure prediction. Results. Four clinical types describe<br />

population health deficits/service needs. The waiver cohort is<br />

most represented among the least impaired type (1: 47.1%), NH entrants<br />

in the most disabled (4: 38.5%). PACE’s highest prevalences<br />

were in Types 3 (32.7%) & 2 (32.3%). PACE’s blend probabilities are:<br />

Waiver—0.5602; 95% c.i., 0.5472, 0.5732, and NH—0.4398; 0.4268,<br />

0.4528. MA attrition-adjusted 1-year per capita payments for waiver<br />

& NH were $4,177 & $77,945. The PACE blend is 43.98% of the difference<br />

atop the waiver base, i.e., $36,620 (95% c.i.: $35,662, $37,580).<br />

PACE’s MA capitation was $27,648—28% below the lower limit of<br />

predicted FFS payments for the PACE cohort. Discussion. PACE entrants<br />

in SC comprise a 56/44% blend of the health deficits/service<br />

needs of waiver & NH patients. PACE’s capitation was well below<br />

outlays for equivalent patients in alternative placement—a substantial<br />

savings for the MA program. Further, our methods provide an element<br />

of PACE rate setting which states presently lack.<br />

C115<br />

Hospitalizations and Emergency Room Visits in Older Adults<br />

Receiving Care Transition: a Cohort Study.<br />

H. Syed, K. Swanson, A. Rahman, J. Naessens, N. Shah, G. Hanson,<br />

P. Takahashi . Mayo Clinic, Rochester, MN.<br />

Background: Management of care transitions from the hospital<br />

to home is an important area of need for older adults. It has been<br />

widely recognized that older adults are readmitted to the hospital at<br />

high rates which can potentially be reduced. Our clinical practice has<br />

initiated a nurse practitioner (NP) care transitions program (CTP) to<br />

help address the immediate needs of the patient after hospital stay.<br />

The aim of this study was to determine the change in number of hospitalizations<br />

from the 60 days prior to enrollment in CTP to 60 days<br />

after enrollment in CTP.<br />

Methods: This was retrospective cohort study of patients within<br />

CTP from March 2011-September 2011. Patients discharged from the<br />

hospital were selected for CTP based on risk stratification using the<br />

elder risk assessment index. The intervention included a home visit by<br />

the NP after discharge (within 7 days as goal). Primary outcomes included<br />

a within group comparison of average hospitalizations, number<br />

of hospital days and average emergency room visits for all subjects.<br />

McNemars test or paired t tests were used for analysis.<br />

Results: 95 subjects were enrolled in the cohort. The average<br />

number of hospitalizations prior to CTP enrollment was 1.03 (SD<br />

0.7) compared to 0.38 (SD 0.6) after enrollment (p value


P OSTER<br />

A BSTRACTS<br />

flect the natural course of healing for these individuals. This within<br />

group study points to a potentially better model of care for at-risk<br />

older adults.<br />

C116<br />

Discharge, Drugs, and Discrepancies: The Pharmacological<br />

Intervention in Late Life (PILL) Project.<br />

A. M. Paquin, 1,2 T. Kostas, 1,3 M. Salow, 1,2 J. L. Rudolph. 1,3 1. Geriatric<br />

Research Education and Clinical Center (GRECC), VA Boston<br />

Healthcare System, Boston, MA; 2. Pharmacy Department, VA<br />

Boston, Boston, MA; 3. Aging, Brigham and Women’s Hospital,<br />

Boston, MA.<br />

Supported By: Department of Veterans Affairs, Office of <strong>Geriatrics</strong><br />

and Extended Care (GEC) Patient-Centered Alternatives to<br />

Institutional Care Initiative<br />

Background: Hospital discharge, polypharmacy, and medication<br />

discrepancies pose risks for elders, especially when they occur simultaneously.<br />

The Pharmacological Intervention in Late Life (PILL)<br />

Project is a quality improvement program that provides proactive<br />

medication follow-up after a hospital stay. We aim to reduce acute<br />

care utilization by addressing medication discrepancies and difficulties<br />

in older patients.<br />

Methods: This project targeted veterans >65 years old with<br />

cognitive impairment, who were discharged home after an inpatient<br />

admission at VA Boston. Patients received PILL pharmacist followup<br />

after discharge which included: telephone medication review<br />

and evaluation of regimen for pharmaceutical care issues (i.e. dosing,<br />

drug interactions, etc.) and medication discrepancies. Medication<br />

discrepancies were collected by comparing discharge medication<br />

lists and actual medication orders. Patients were followed 60<br />

days after discharge for the primary outcome of acute care utilization<br />

(readmission, emergency department or urgent care visit) or<br />

death.<br />

Results: Of 285 eligible veterans, 242 patients with a mean age<br />

of 78.9 ± 8.0 were reached by PILL pharmacist after discharge. Patients<br />

with PILL follow-up were not significantly different than<br />

those without (n=43) with respect to age, number of medications,<br />

length of stay, or discrepancies. The mean number of discharge medications<br />

was 15.1 ± 5.8, with 2.9 ± 2.3 medication changes per patient.<br />

Among veterans receiving PILL intervention, fifty-nine percent<br />

(59%, n=143) had at least 1 medication discrepancy, with an<br />

average of 1.5 ± 2.1 discrepancies per patient. After adjustment for<br />

number of medications and discrepancies, patients with PILL follow-up<br />

had a 24% relative risk reduction in acute care utilization or<br />

death compared to those with usual care (RR 0.76, 95% CI 0.58-<br />

0.98).<br />

Conclusion: Cognitively-impaired elders were discharged<br />

home with medication lists characterized by polypharmacy, frequent<br />

medication changes, and discrepancies. The PILL Project<br />

demonstrated that pharmacist telephone medication review and<br />

reconciliation results in a significant reduction in acute care utilization<br />

or death after hospital discharge. Pharmacist post-discharge<br />

medication follow-up shows promise as a successful model<br />

of care.<br />

C117<br />

The VA Coordinated-Transitional Care (C-TraC) Program: A<br />

Registered Nurse Telephone-Based Initiative to Improve Transitions<br />

for Hospitalized Veterans with Dementia and Other High-Risk<br />

Conditions.<br />

A. J. Kind, 1,2 L. Jensen, 2 S. Barczi, 1,2 A. Bridges, 1,3 R. Kordahl, 3<br />

M. Smith, 1 S. Asthana. 1,2 1. Univ of Wisconsin, Madison, WI; 2.<br />

Madison VA Geriatric Research Education and Clinical Center<br />

(GRECC), Madison, WI; 3. William S Middleton VA Hospital,<br />

Madison, WI.<br />

Supported By: This project was supported by a VA Transformation-<br />

21 Grant and by a National Institute on Aging Beeson Career<br />

Development Award (K23AG034551, National Institute on Aging,<br />

The <strong>American</strong> Federation for Aging Research, The John A.<br />

Hartford Foundation, The Atlantic Philanthropies and The Starr<br />

Foundation). Additional support was provided by the University of<br />

Wisconsin School of Medicine and Public Health’s Health<br />

Innovation Program, and the Community-Academic Partnerships<br />

core of the University of Wisconsin Institute for Clinical and<br />

Translational Research (UW ICTR), grant 1UL1RR025011 from<br />

the Clinical and Translational Science Award (CTSA) program of<br />

the National Center for Research Resources, National Institutes of<br />

Health.<br />

Background: The Accountable Care Act encourages dissemination<br />

of evidence-based transitional care programs designed to improve<br />

patient safety and outcomes after hospital discharge, but no existing<br />

program fully addresses the challenges of distance, dementia<br />

and patient vulnerability common in a Veterans Affairs (VA) hospital<br />

setting. Our objective was to test the feasibility of C-TraC — a low-resource,<br />

nurse-led, telephone-based program which builds upon Coleman’s<br />

transitional care model and is designed to improve care coordination<br />

and outcomes in hospitalized veterans with dementia and<br />

other high-risk conditions.<br />

Methods: C-TraC launched at Madison VA Hospital in April<br />

2010. Hospitalized veterans discharged to community settings had<br />

to have dementia/delirium/cognitive impairment, or had to live<br />

alone or have prior hospitalizations and be >65 years to be eligible.<br />

Veteran characteristics, process measures and outcomes were<br />

abstracted from the medical record for all eligible patients during<br />

the 6 months prior to the intervention launch (N=144) and for patients<br />

enrolled in C-TraC during its first 6 months of operation<br />

(N=116).<br />

Results: In the first 6 months, C-TraC successfully enrolled 116<br />

veterans using 1.0 FTE nursing staff. No patients refused enrollment.<br />

52% of C-TraC veterans had medication discrepancies detected/rectified<br />

during the 48-72-hour post-discharge phone call, averaging 2 discrepancies/veteran<br />

(range 0-9). As compared to usual care, C-TraC<br />

veterans were more likely to leave the hospital with a scheduled follow-up<br />

appointment (85% vs 60%, p


P OSTER<br />

A BSTRACTS<br />

C118<br />

Patient and Family-Centered Rounds on a Geriatric Inpatient<br />

Service: Patient Perspectives.<br />

A. M. Stecher, 1 J. D. Schlaudecker. 1,2 1. University of Cincinnati,<br />

Cincinnati, OH; 2. Department of Geriatric Medicine, University of<br />

Cincinnati, Cincinnati, OH.<br />

Supported By: Funded with support from a Geriatric Academic<br />

Career Award and the <strong>American</strong> Federation of Aging Research<br />

Medical Student Training in Aging Research.<br />

Background: While well studied in the pediatric setting, little is<br />

known about the application of patient- and family-centered rounds<br />

(PFCR) to the geriatric population, but the potential for care improvement<br />

is great. PFCR is a model for empowering patients and<br />

families and improving communication and care in the hospital. In<br />

contrast to traditional rounding, PFCR occurs at the bedside and actively<br />

includes patients and families as well as other members of the<br />

healthcare team.<br />

Methods: Fourteen adults (mean = 68 years) admitted to the<br />

Christ Hospital received either traditional care (n=4) or PFCR<br />

(n=10) during their stay. Patients and their families were asked to<br />

participate in semi-structured interviews focused on:<br />

-communication with physicians<br />

-satisfaction<br />

-clarity of DC instructions<br />

Follow-up interviews via phone were performed two to four<br />

weeks following discharge.<br />

Results: Statistical comparison of the Likert ratings between patients<br />

receiving PFCR and traditional care were inconclusive due to<br />

small sample sizes; however, descriptive statistics found no apparent<br />

differences between these groups. During the interviews, patients expressed<br />

very positive opinions about care under PFCR.<br />

“I felt I wasn’t alone and someone was in my corner, trying to<br />

find out what was happening in my body. It was great to get an update<br />

on a daily basis…It was comforting, really, to have so many heads in<br />

on it.”<br />

Patient 514 - PFCR<br />

“In the past, you get one doctor and you feel like you are taking<br />

up their time, whereas when there are a lot of people here you feel<br />

like they are here as a group to answer questions…I really like that!”<br />

Daughter 511 - PFCR<br />

Conclusions: The positive responses of those receiving PFCR indicate<br />

that PFCR can lead to positive care experiences for geriatric<br />

patients and their families. The similar Likert ratings of care quality<br />

statements between those receiving PFCR and traditional care<br />

demonstrates that PFCR is at least as effective in providing quality<br />

care as traditional care. However, the positive interview responses of<br />

patients and families receiving PFCR suggest that PFCR may result<br />

in higher satisfaction among geriatric patients and their families.<br />

More research is needed with a larger sample to investigate how<br />

PFCR outcomes and satisfaction compare to traditional care.<br />

C119<br />

The PACE Approach to Keeping Older Adults with Dementia in<br />

Private Homes.<br />

A. Dunbar, 1,2 K. Ward, 1 A. Beeber. 1,3 1. Cecil G Sheps Center for<br />

Health Services Research, Chapel Hill, NC; 2. School of Medicine, The<br />

University of North Carolina at Chapel Hill, Chapel Hill, NC; 3.<br />

School of Nursing, The University of North Carolina at Chapel Hill,<br />

Chapel Hill, NC.<br />

Supported By: AFAR Medical Student Training in Aging Research<br />

Program 2010 (Recipient: Anne Dunbar), NC TraCS CTSA Pilot<br />

Award (Awardee: Dr. Beeber), Building Interdisciplinary Careers in<br />

Women’s Health K12 Career Development Award (Awardee: Dr.<br />

Beeber)<br />

Background: Evidence suggests that the multidisciplinary care<br />

provided by Programs of All-inclusive Care for the Elderly (PACE)<br />

can postpone or prevent nursing home placement for older adults.<br />

PACE participants with dementia are one of the most challenging<br />

subpopulations within PACE because they require complex care<br />

management. Thus, we aim to examine the challenges PACE sites<br />

face and the services they have found to be the most useful in successfully<br />

keeping PACE participants with dementia in private homes.<br />

Methods: This analysis examines the data from a web-based survey<br />

of 32 PACE sites from 19 different states. The survey respondents<br />

were composed of leadership personnel within the PACE sites. Three<br />

independent coders performed a qualitative content analysis, reviewing<br />

text responses from two questions: 1)What are the biggest challenges<br />

your program faces when trying to keep participants with dementia<br />

in a private home? and 2)What have you found to be the most<br />

useful for helping these participants stay at home? The text responses<br />

were coded for similarities and then were categorized. The research<br />

team met to discuss similarities and differences found during coding<br />

and reached consensus on the main categories for each question.<br />

Results: Survey respondents reported that issues relating to<br />

family caregiving are the biggest challenges faced when trying to<br />

keep participants with dementia in a private home. Availability and<br />

commitment of the family, stress and burden of caregiving, caregiver<br />

burnout, and PACE providing support for the family were all identified<br />

as challenges. Respondents identified safety concerns, behavioral<br />

changes, medication management, cost, staffing, PACE in-home services,<br />

importance of early enrollment, and care plan compliance as barriers<br />

to keeping these participants in private homes. Respondents reported<br />

that day center attendance was the most useful for helping<br />

participants with dementia stay at home as well as home health, family<br />

caregiver support, personal companions, dementia specific strategies,<br />

and respite services.<br />

Conclusions: The results from this work will provide information<br />

about the types of services used to provide care for PACE participants<br />

with dementia. Conclusions will include recommendations for<br />

future practice and research.<br />

C120<br />

Interventions to Prevent Hospitalizations of Elderly Patients:<br />

Quality Care with Cost Benefit.<br />

A. Kaul, M. Bansal, R. Bhandari. Wyckoff Heights Medical Center,<br />

Brooklyn, NY.<br />

Background:<br />

Repeated hospitalizations of geriatric patients stigmatize the<br />

quality of care and place an added strain on the economics of healthcare<br />

delivery. Over the past two years at Wyckoff Heights Medical<br />

Center (WHMC), we have established three different heath care delivery<br />

goals for our geriatric patients; 1) extend services to home<br />

bound patients, 2) carefully survey and manage nursing home (NH)<br />

residents, and 3) promote palliative care services and counseling.<br />

These agendas provide high quality care and have significant cost<br />

benefit in preventing futile hospitalizations and unnecessary aggressive<br />

treatment.<br />

Methods:<br />

1) HOPE Program: Conduct visits for home bound elderly patients<br />

by geriatric MD or NP, closely monitor functional decline and<br />

medication compliance, provide certain lab/radiology services and<br />

preventive management; and avoid progression to long term care facility.<br />

2) INTERACT II Program: Established modified clinical pathways<br />

for early recognition and management of patients at the NH to<br />

decrease ER transfers and subsequent inpatient admissions. Formed<br />

a partnership between healthcare providers at the NH and WHMC<br />

through coordinated care and communication, allowing for ER evaluation<br />

and management of certain acute care conditions (eg. PICC<br />

line, peg tube replacements) without admission. 3) Enhancing Palliative<br />

Care: Expanding palliative care service at WHMC by dedicating<br />

hospital beds and advocating physician accountability through policy<br />

changes and awareness.<br />

S172<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

Results:<br />

The HOPE program has 175 enrolled patients, showing 25% reduction<br />

in acute care hospitalizations, only 5% readmission rate, and<br />

a cost saving of $1.3million/year. The INTERACT II program has<br />

generated a saving of at least $500,000/year in avoided inpatient admissions.<br />

The Enhanced Palliative Care program is estimated to reflect<br />

a cost avoidance of $600,000 over the first two years by minimizing<br />

aggressive management.<br />

Discussion:<br />

In today’s climate of healthcare reform, our approach seeks to<br />

improve patient care quality with cost effective implications. We present<br />

a three pronged intervention of managing the most vulnerable<br />

geriatric population through patient centric home monitoring, integrated<br />

care of NH residents, and appropriate evaluation for terminal<br />

care needs. We hope to expand our pilot programs to suit the need of<br />

a managed or accountable care organization.<br />

C121<br />

Transitions Bundle: Ensuring smoother transitions at hospital<br />

discharge.<br />

A. Hayward, 1 R. Rastogi, 2 T. J. Hillstrom, 2 C. A. Barnes. 1 1. Care<br />

Management Institute, Kaiser Permanente, Portland, OR; 2. Sunnyside<br />

Medical Center, Kaiser Permanente, Clackamas, OR.<br />

Supported By: Project undertaken as quality improvement activity<br />

by Kaiser Permanente<br />

Background: Across the US one in five Medicare patients is<br />

readmitted to the hospital within 30 days after discharge. Some readmissions<br />

are preventable. After discharge, patients don’t always know<br />

whom to call with questions, what medicines to take, or how to obtain<br />

follow-up care. Those physicians and clinicians responsible for providing<br />

post-hospital care don’t always receive timely, accurate, and<br />

complete information about these patients.<br />

Methods: Kaiser Permanente’s Sunnyside Medical Center created<br />

a process to improve the transition for all patients discharged to<br />

post-hospital care. First, a diagnostic evaluation identified that 10 to<br />

40% of readmissions were preventable. Next, a design team including<br />

staff and patient input developed, tested and implemented a “transition<br />

bundle”, the aim of which was to improve care for every patient<br />

after hospital discharge. Thirty-day readmission rates were measured<br />

before and after implementation. Components of the “bundle” included<br />

the following:<br />

1. risk assessment and care tailored to likelihood of re-hospitalization<br />

2. standardized discharge summary completed on the day of discharge<br />

and available in the electronic medical record<br />

3. pharmacist’s review of medications, followed by a phone call<br />

to those patients at high risk, as well as review for all patients discharged<br />

to a skilled nursing facility<br />

4. first follow-up appointment scheduled before discharge for all<br />

patients: within five days for those identified at high risk, within 10<br />

days for those at medium risk, and within 30 days for all others<br />

5. follow-up RN phone call within 72 hours of discharge for all<br />

high risk patients<br />

6. discharge instruction sheet with dedicated phone number for<br />

all questions<br />

Results: Overall year-to-date readmission rates at Sunnyside<br />

Medical Center decreased from 12 to 9.8% in 2011 and rates for<br />

Medicare members from 14 to 13%. More than half of patients discharged<br />

were seen for a follow-up visit within five days. Ninety-two<br />

per cent of discharged patients reported that they received written<br />

information.<br />

Conclusions: A transitions bundle composed of six elements improved<br />

continuity of care for patients discharged from the hospital<br />

and has been associated with a decrease in readmission rate.<br />

C122<br />

Changing the norms for trainees to prevent inappropriate<br />

emergency room referrals.<br />

N. K. Patel, 1,2 C. M. Espinal, 1,2 U. T. Efoevobokhan, 1,2 R. W. Parker. 1,2<br />

1. <strong>Geriatrics</strong>, University of Texas Health Science Centera at SA, San<br />

Antonio, TX; 2. <strong>Geriatrics</strong>, Christus Santa Rosa, San Antonio, TX.<br />

Background: Transfers between settings of care are referred to<br />

as transitions. Emergency Room (ER) transfers of patients from<br />

nursing homes(NH) for inappropriate reasons is expensive, worsens<br />

patient outcomes, hastens functional decline and decreases the quality<br />

of life. The average wait time in an ER in San Antonio is 4-6 hours.<br />

The average local ER visit for a geriatric patient costs anywhere from<br />

$4,000-$6,000. This project done at the University of Texas Community<br />

<strong>Geriatrics</strong> directed nursing homes where residents in family<br />

medicine are the first called for the group. On reviewing call center<br />

calls it was noted that many residents from NH were being sent to the<br />

emergency room for inappropriate reasons, majority of the referrals<br />

were afterhours and by trainee residents who were unfamiliar with<br />

the patients, lacked the confidence, knowledge and skill of managing<br />

frail elders.<br />

Objectives:To sustain the norm of preventing inappropriate ER<br />

transfers of patients by trainees from UT Medicine nursing homes by<br />

100% in response to after hour calls. This project also sought to open<br />

a dialogue between the NH, clinical staff, the residents, and the after<br />

hour call center to facilitate better care for the residents in the nursing<br />

homes.<br />

Design: Quality improvement project.<br />

Metric: ER visits of NH patients obtained from call center logs,<br />

calls tracker and chart reviews.<br />

Study Period: July 2010 to June 2011.<br />

Intervention: The norm was changed. All residents in training<br />

could not send a patient to ER without discussing the patient with the<br />

attending on call. The on call team maintains a call tracker and the<br />

call center maintains a log.<br />

Results: Tracking the calls and following the intervention decreased<br />

the number of inappropriate ER visits to zero.The norm is sustained<br />

even beyond a year because of reinforcement and monitoring.<br />

Conclusions: Changing the norm of residents in training helped<br />

reduce the inappropriate ER visits. This also influenced the faculty<br />

behavior. Total number of calls reduced with the use of the SBAR<br />

tool and fact that calls were being tracked.<br />

Next Step: The call logs will continue to be collected from the<br />

clinical staff on call after hours. Complement with the Interact II<br />

program, track day time calls and education of families regarding<br />

ER transfers vs. treatment either in NH or direct admission to the<br />

ACE unit.<br />

C123<br />

Facilitating Geriatric-focused Primary Care Electronically: A<br />

Follow-up.<br />

C. Gardner. Elder Care, Kaiser Permanente, Atlanta, GA.<br />

Kaiser Permanente Georgia recognizes the importance of identifying<br />

and meeting older patients’ needs. In 2010 we developed and<br />

implemented interventions for non-geriatricians to easily address<br />

topics not routinely discussed with younger patients, leveraging our<br />

electronic medical record. A template is used at new patient and annual<br />

40-minute visits for patients 65 and older. This decision support<br />

tool prompts primary care physicians to assess, discuss, and appropriately<br />

document actions re: topics including functional status, incontinence,<br />

falls, cognition, and advance directives. It provides options for<br />

interventions and prompts ordering recommended screenings and referring<br />

to <strong>Geriatrics</strong>. Patient instructions important in older people<br />

(e.g., regarding screenings, fall prevention, incontinence) automatically<br />

print. The elder-focused review of systems and patient instructions<br />

are also available to all clinicians for use in patients not scheduled<br />

for a comprehensive primary care visit.<br />

AGS 2012 ANNUAL MEETING<br />

S173


P OSTER<br />

A BSTRACTS<br />

We monitor the template’s use and encourage physicians not<br />

using it to do so. Performance on quality measures such as HEDIS,<br />

which include topics addressed in the template, is measured annually<br />

and has improved. For example, glaucoma screening increased from<br />

54.84% in 2010 to 60.88% in 2011. For a sub-group of our population,<br />

metrics include annual discussion of advance directives, medication<br />

review, assessment of functional status and comprehensive pain<br />

screening. Along with other initiatives, template implementation was<br />

associated with improvements between 2010 and 2011: Advance Care<br />

Planning increased from 22.14% to 70.07%; Medication Review<br />

74.94% to 98.30%; Functional Status Assessment 13.63% to 91.48%;<br />

and Pain Screening from 39.42% to 95.13%. Referrals to our <strong>Geriatrics</strong><br />

team increased with template use, from 21 to 35 per month. Issues<br />

identified for referral included previously unrecognized cognitive<br />

disorder/dementia and gait problems/falls.<br />

Because our physicians are now familiar with the need to address<br />

these topics, we recently modified the template and developed<br />

and refined workflows to enable nursing staff to ask many of the<br />

screening questions. This will increase efficiency and better enable<br />

physicians to focus on evaluating and treating the problems identified.<br />

Overall, implementation of the tool appears to be an effective<br />

means of improving primary care physicians’ awareness of, attention<br />

to, and appropriate referral for, issues important in older patients.<br />

C124<br />

Care of the Older Adult Continuing at Home (COACH):<br />

Optimizing Medical Resident Understanding of the patient at home.<br />

D. C. Hayley, 1,2 J. Kalender-Rich, 1,2 B. Lowry, 1 M. Brimacombe. 3 1.<br />

Internal Medicine, University of Kansas, Kansas City, KS; 2. Landon<br />

Center on Aging, University of Kansas School of Medicine, Kansas<br />

City, KS; 3. Biostatistics, University of Kansas School of Medicine,<br />

Kansas City, KS.<br />

Supported By: Landon Center on Aging<br />

Purpose-To determine differences between what Internal Medicine<br />

residents expect to find and what they actually observe on posthospitalization<br />

home visits of frail elderly.<br />

Methods—Internal Medicine Residents on their month of <strong>Geriatrics</strong><br />

rotation make a home visit through COACH (Care of the<br />

Older Adult Continuing at Home) on an elderly patient discharged<br />

from the hospital in the last month. After chart review, the resident<br />

completes a pre-visit questionnaire with questions on discharge diagnosis,<br />

predicted functional status, number of medications and support<br />

at home. After the home visit and primary data collection in these<br />

same domains, a post-visit questionnaire is completed including<br />

quantitative and qualitative differences between what was expected<br />

and what was found.<br />

Results—Of the 12 residents who have completed this study<br />

thus far, 10 reported that there was NO difference between diagnosis<br />

on the hospital discharge summary and the patient/family report. In<br />

all cases, the patients had someone with them at all times and 4 residents<br />

reported that this was more supervision than expected. Patient<br />

functional status was different than expected in 5 of 12 cases. There<br />

were from 0 to 16 differences in number of medications at home as<br />

compared to expected and in only one case was it reported that there<br />

were no discrepancies. 10 of 12 residents reported the experience was<br />

superior. Qualitative responses regarding suggestions on discharge of<br />

elderly patients to home include attending to patient’s social support,<br />

functional status and medications. There were repeated requests for<br />

more of this experience in residency.<br />

Conclusions—Residents did a fair job of predicting discharged<br />

patient’s supervision and functional status but still missed many important<br />

issues at home, especially medications the patient is actually<br />

taking. Most residents acknowledged the importance of these aspects<br />

in elderly patients and request more of this geriatrics and home visit<br />

experience in residency. They found this was useful for their learning<br />

and improving optimal discharge practices in the frail elderly.<br />

C125<br />

Safety profile of high dose statin therapy in geriatric patients with<br />

stroke.<br />

D. Manocha, N. Bansal, Z. El Zammar, S. Brangman. SUNY Upstate<br />

Medical University, Syracuse, NY.<br />

Introduction: Use of high dose statins in patients with stroke has<br />

become a standard clinical practice after the SPARCL study in 2006.<br />

Although the mean age of population in SPARCL study was around<br />

63 years, scientific evidence derived from the same has been extrapolated<br />

to much older patients in clinical practice. Very little data is<br />

available on the magnitude of adverse effects of high dose statin therapy<br />

in geriatric patients. Methods: This single-center retrospective<br />

study was conducted at Upstate Medical University, Syracuse, NY.<br />

The goal was to define the magnitude of side effects of high dose<br />

statins in our selected geriatric study population. We reviewed<br />

records of 120 patients between the ages of 65-89 years to collect demographic,<br />

clinical, laboratory & adverse drug reaction data. Data<br />

were compared between patients on high dose statin therapy (cases)<br />

vs. those on regular doses (controls) using Chi square, Fisher exact<br />

test & Student T test. P value


P OSTER<br />

A BSTRACTS<br />

b) the frequency and number of emergency room visits, hospitalizations,<br />

readmissions, and nursing home placements, c) the presence of<br />

a health care proxy and the formulation of advanced directives, d) the<br />

types and extent of services the patient receives from DOROT and e)<br />

instruments to assess patient satisfaction with overall healthcare and<br />

perception of their quality of life. Data will also be collected on patients<br />

cared for under our house call program, using retrospective<br />

data going back to 2007 (n=251) and prospective data on patients currently<br />

being cared for (n=82).<br />

Results and Conclusion: To date, the collaboration has been involved<br />

in the care of 40 patients. In addition, data is being collected<br />

on all 82 patients currently cared for with our house call program and<br />

retrospectively on about 250 patients who had been cared for by our<br />

house call program since 2007. It is hoped that by comparing the information<br />

obtained on the two groups of patients that we can better<br />

understand the impact of providing a comprehensive care program<br />

offered by agencies like DOROT.<br />

C127<br />

A Qualitative Review of Exercise Interventions to Reduce Falls in<br />

Older Adults.<br />

E. Trieu, 1 V. Shier, 2 D. Ganz. 3,1 1. David Geffen School of Medicine at<br />

UCLA, Los Angeles, CA; 2. RAND, Santa Monica, CA; 3. Greater LA<br />

VAMC, Los Angeles, CA.<br />

Supported By: This project is funded by the Archstone<br />

Foundation/USC Fall Prevention Center of Excellence. DAG is supported<br />

by a VA HSR&D Career Development Award. ET was supported<br />

by the UCLA Medical Student Training in Aging Research<br />

program.<br />

Background<br />

Systematic reviews demonstrate that exercise containing balance<br />

training is particularly effective in reducing falls in communitydwelling<br />

elders. However, the best strategy for implementing a balance<br />

program is unknown.<br />

Methods<br />

Two reviewers independently screened 114 full text articles<br />

from 6 systematic reviews of RCTs to prevent falls. Fourteen RCTs of<br />

exercise programs in a medical setting and involving a balance training<br />

component were selected for further review. We identified related<br />

articles that provided experiential insight into the exercise program<br />

of each included RCT by searching the references in, and articles citing,<br />

the RCT. Two reviewers independently abstracted data from the<br />

14 RCTs and their related articles. Data were analyzed using qualitative<br />

data analysis software.<br />

Results<br />

Exercise programs were heterogeneous across target population<br />

and baseline risk of falling, program approach and setting, and exercise<br />

intensity and duration. Many programs were successful in improving<br />

strength, mobility, and/or endurance, in addition to balance.<br />

Facilitators to uptake of exercise programs reported in at least one<br />

study included involvement of health practitioners in the recruitment<br />

process, supervision of exercise (resulting in reduced feelings of isolation),<br />

and individualized training (resulting in recruitment of a<br />

broader participant group). Studies also reported factors that contributed<br />

towards a lack of success in reducing falls or falls risk factors<br />

including the population being too healthy or lacking balance problems,<br />

lack of supervised exercise, and low adherence due to an unhealthy<br />

population. Authors mentioned the positive effects of group<br />

training on promoting adherence and group cohesion. Convenient locations,<br />

opportunity for social interaction and pleasant environments,<br />

and overall enjoyment were also noted as factors that promote adherence.<br />

Several programs reported patient enjoyment but did not<br />

necessarily show high adherence.<br />

Conclusions<br />

Exercise programs to prevent falls are not “one-size-fits-all”<br />

programs. Because patient adherence is an important aspect of an exercise<br />

program’s success, special consideration to a patient population’s<br />

baseline health measures, needs, and interests improves participant<br />

enjoyment, potentially resulting in greater effectiveness.<br />

C128<br />

The high diagnostic yield of an outpatient geriatric clinic.<br />

F. Moret, H. Jaccard-Ruedin, C. Bula, S. Monod. Service of geriatrics<br />

medicine and geriatric rehabilitation, Epalinges, Switzerland.<br />

Background: Primary care physicians have limited time to perform<br />

comprehensive geriatric assessment. Interdisciplinary outpatient<br />

geriatric clinic might assist primary care physicians in early<br />

recognition and management of geriatric syndromes. The objectives<br />

of this study were 1) to determine characteristics of patients referred<br />

to an outpatient geriatric clinic; 2) to determine the prevalence of<br />

geriatric syndromes in this population; 3) to identify main recommendations<br />

made to primary care physicians.<br />

Method: Database from the outpatient clinic of the service of<br />

geriatric medicine was analyzed. It includes demographic, social,<br />

functional and medical data, as well as recommendations made for<br />

primary care physicians.<br />

Results: Subjects (N=146) were all community-dwelling older<br />

patients (79.1±7.4 years, 56.2% women, 50.7% living alone, 34.9% receiving<br />

home care), referred by a primary care physician, an hospitalist<br />

or a family member (79%, 15% and 6% respectively). Main reasons<br />

for referral were request for comprehensive assessment,<br />

cognitive evaluation, and mobility assessment (41.8%, 28.1%, and<br />

15.8%, respectively). Mean performances at Katz’s Basic ADL and<br />

Lawton’s instrumental ADL were 5.3±1.1 and 4.7±2.8, respectively,<br />

and 54.1% of patients reported a fall over the past year. Overall,<br />

74.7% of patients were newly diagnosed with gait and balance impairment,<br />

71.9% with cognitive impairment, 52.7% with affective disorder,<br />

52.1% with osteoporosis, 43.8% with urinary incontinence,<br />

32.2% with orthostatic hypotension, and 55.5% with polypharmacy<br />

(≥6 different drugs; median 6±3.9, IQR 1-11). A mean number of<br />

12.7±4.2 recommendations was made for each patient. Overall, 87.6<br />

% of patients were given recommendations about fall prevention:<br />

walking aid adaptation (54% of all patients), vitamine D prescription<br />

(53%), home hazards assessment (52%), and exercise prescription<br />

(46%). Half (51.7%) of the patients received a recommendation for<br />

referral to a memory clinic. Treatment modifications were proposed<br />

in 80.8% of patients with polypharmacy (mostly psychotropic drugs<br />

discontinuation).<br />

Conclusion: In this population of elderly outpatients, polypharmacy,<br />

mobility and cognitive impairments were highly prevalent. Outpatient<br />

geriatric consultation is a good opportunity to identify new<br />

geriatric syndromes and to propose interventions aiming at functional<br />

decline prevention.<br />

C129<br />

The Fracture Care and Prevention Program: an integrated model of<br />

care to prevent reoccurrence of minimal trauma fractures.<br />

G. Loza-Diaz, 1 E. Thembani, 1 O. Demontiero, 1,2 A. Sharma, 2<br />

G. Duque. 1,2 1. Ageing Bone Research Program, The University of<br />

Sydney, Penrith, NSW, Australia; 2. Geriatric Medicine, Nepean<br />

Hospital, Penrith, NSW, Australia.<br />

Supported By: Servier, Sanofi-Aventis, Novartis, Nepean Medical<br />

Research Foundation<br />

BACKGROUND: Patients that experience a minimal trauma<br />

fracture are at higher risk of experiencing another fracture. Yet, very<br />

few patients, especially the elderly, are identified and provided with<br />

an appropriate plan to prevent further fractures.<br />

OBJECTIVE: To describe the implementation and evaluation<br />

of an osteoporotic fracture prevention in a geriatric setting.<br />

AGS 2012 ANNUAL MEETING<br />

S175


P OSTER<br />

A BSTRACTS<br />

PROGRAM STRUCTURE AND PROCESS: The Fracture<br />

Care and Prevention Program is a model of care designed to intervene<br />

when the first minimal trauma fracture occurs. A nurse coordinator<br />

(attached to a geriatrics department) identifies patients with<br />

minimal trauma fractures in hospital wards, rehab department, emergency<br />

department and local health centres. This coordinator provides<br />

patients with educational materials about osteoporosis and fractures,<br />

provides recommendations for vitamin D and calcium supplementation,<br />

encourages exercise and explains the specific treatment for osteoporosis.<br />

Patients are also referred to bone density testing. The patients’<br />

family doctor is informed of the assessment to reiterate the<br />

recommendations provided to the patient, and for referral to a specialist<br />

at the Falls and Fractures Clinic.<br />

PROGRAM OUTCOMES: From January to August 2011, 82<br />

patients were registered with the Fracture Care and Prevention Program.<br />

At follow-up post-discharge from hospital (8 weeks), 51% of<br />

patients were referred to the Falls and Fractures Clinic (13% attended),<br />

32% started gentle exercise, and 40% read the educational<br />

materials provided. The number of patients taking vitamin D increased<br />

from 12% to 40%. The number of BMD tests increased 25%.<br />

In addition, 28% had a discussion with their physician about osteoporosis<br />

and treatments. Finally, the number of prescription for osteoporosis<br />

treatment increased in 32%.<br />

CONCLUSIONS: The Fracture Care and Prevention program<br />

is an effective model of intervention to increase awareness of the importance<br />

of falls and fractures prevention in older persons, not only<br />

to the patients but also to their physicians. This model, run by a nurse<br />

coordinator, is cost effective and easily implemented in a geriatric<br />

setting.<br />

C130<br />

Profiles and Characteristics Associated with Rehospitalization of<br />

Patients in a Sub-Acute Rehabilitation Facility.<br />

H. Guzik, 1 N. Sharma, 1 A. Gupta, 1 N. Arif, 1 C. Nouryan, 1<br />

R. Pekmezaris, 1 M. Lesser, 2 G. Wolf-Klein. 1 1. North Shore-LIJ<br />

Health System, New Hyde Park, NY; 2. Feinstein Institute for Medical<br />

Research, Manhasset, NY.<br />

Background: Reduction of unnecessary rehospitalization of patients<br />

has been identified as an important goal in geriatric medicine.<br />

We studied hospital readmission patterns of patients receiving care at<br />

a 258-bed sub acute rehabilitation facility.<br />

Methods: Retrospective chart review of 100 patients (50 rehospitalized<br />

[RH] and 50 not rehospitalized [NRH] within 60 days of admission),<br />

randomly selected between 1/2011 and 9/2011.<br />

Results: When comparing RH and NRH, demographic analysis<br />

revealed a significant difference with regard to age (80.6 vs 75.7 respectively,<br />

p


P OSTER<br />

A BSTRACTS<br />

medical assistant. We work closely with all community agencies to<br />

help maintain the patient in the community as long as possible.<br />

Methods: Home visit patients (N=590) were identified by a log<br />

maintained by home visit staff. The patients were linked to hospital<br />

information system data by medical record number to obtain demographic<br />

and hospital encounter information (N=539). Only patients<br />

with identifiable hospital admissions prior to or post 180 days to the<br />

program entry were included in the before and after comparison<br />

(N=387). A comparison group (N=1273) was defined as Medicare patients<br />

with 3 or more inpatient admissions in calendar year 2008 who<br />

were not enrolled in HV program. Primary outcome measures were<br />

ED visits, hospital admissions, and length of stay at 30 and 180 days<br />

pre- and post-home visit enrollment. Secondary measures were patient<br />

days in the HV program and discharge disposition.<br />

Results: Approximately 55% of the HV patients had death as<br />

their primary reason for discharge from our program. Average number<br />

of patient days in the HV program was 285 days.<br />

Patients had worse primary outcome measures prior to enrolling<br />

in the HV program. After entering the HV program, 30 day<br />

ED visits and inpatient admissions were reduced by 26% and 34% respectively.<br />

At the 180 day interval, this effect was still sustained with<br />

ED visits reduced by 9% and inpatient admissions by 28%. When<br />

compared to the non-HV comparison group, the HV outcomes were<br />

favorable as the comparison group had a 55% 180 day readmission<br />

rate. Of note, our case mix index (1.74) was higher than the comparison<br />

group (1.66).<br />

Length of stay for our cohort of patients prior to the HV program<br />

was 8.0 days. After enrollment, LOS was 6.2 days which again<br />

compares favorably to the non-HV comparison group with a LOS of<br />

7.5 days.<br />

Conclusion: A HV program is an effective model of care that reduces<br />

ED visits, readmission rates, and length of stay. Hospital systems<br />

looking to improve their transitions of care process should look<br />

to partner with HV programs to improve similar outcome measures.<br />

The average length of time a patient stays in our program is<br />

roughly 9.5 months. By serving such a frail population, a HV program<br />

can and should be viewed as an outpatient palliative care program.<br />

C133<br />

The Effect of Medication on Brain Size: Polypharmacy is Associated<br />

with Gray Matter Atrophy.<br />

A. Toussi, 1 O. V. Meulenbroek, 2 S. A. Studenski, 1 M. G. Olde<br />

Rikkert. 2 1. University of Pittsburgh School of Medicine, Pittsburgh,<br />

PA; 2. Alzheimer Centre Nijmegen, Radboud University Nijmegen<br />

Medical Centre, Nijmegen, Netherlands.<br />

Supported By: NIH Grant 5 T32 AG 021885-09<br />

Background: Cognitive decline is a frequent problem encountered<br />

in the geriatric population and it is associated with the use of<br />

polypharmacy. In addition, the elderly are more susceptible to adverse<br />

drug reactions, especially neuropsychiatric effects (e.g. delirium)<br />

due to aging changes in the neurochemistry of the brain, pharmacodynamics,<br />

and pharmacokinetics. The combined effect of aging<br />

and polypharmacy may be detrimental to the brain function and<br />

structure. We investigated the burden of polypharmacy on the structure<br />

of the brain, specifically on the amount of gray and white matter,<br />

in a population of patients who were referred to our memory clinic.<br />

Methods: We selected consecutive patients who visited the<br />

Radboud University Nijmegen Medical Centre memory clinic<br />

from 2007 to 2010 database. Baseline variables included demographics,<br />

medication list, and information on relevant co-morbidities.<br />

The level of education was scored by the system of Verhage.<br />

The structural MRI scans were segmented into gray matter (GM),<br />

white matter (WM) and CSF using the VBM toolbox in SPM5, and<br />

volumes were extracted. We calculated the GM and WM fraction<br />

by dividing the GM or WM volume by the intracranial volume<br />

(GM+ WM+CSF). The number of current, regularly-taken medication<br />

with a known systemic effect was counted. Topical, “as<br />

needed”, and supplemental medications (vitamins, minerals, and<br />

herbals) were excluded. We used a linear regression model to investigate<br />

the correlation between GM fraction, WM fraction and<br />

amount of medication, while controlling for age, sex, education and<br />

diagnosis.<br />

Results: We found a significant correlation between polypharmacy<br />

and GM (Pearson r = -0.149, p=0.002). These effects were independent<br />

of sex, age, education and diagnosis. For WM fraction, there<br />

was no correlation.<br />

Discussion: Our results indicate that the more medications a patient<br />

is taking, the more GM atrophy is present. However, further investigation<br />

of the effects of medications on brain atrophy is warranted.<br />

Physicians already should be cognizant of this association<br />

when treating elderly patients.<br />

C134<br />

MOCA & MMSE Comparison in Detection of Cognitive<br />

Impairment & Change in Very Old Age.<br />

A. Mohammed, 1 S. Kabsoun, 1 B. Leonard, 2 W. Nieri. 1,2 1. Geriatric,<br />

Banner Geriatric Fellowship Program, Sun city, AZ; 2. Banner Health<br />

Research Institute, Sun City, AZ.<br />

Background<br />

The Mini Mental State Exam (MMSE) is the most widely used<br />

screening test for dementia. However, research shows that it can underestimate<br />

cognitive impairment, varies within the population by<br />

age & education, and probably has limitations in assessing progressive<br />

cognitive decline. The Montreal Cognitive Assessment (MOCA)<br />

test may be superior to the MMSE in early detection of Alzheimer’s<br />

disease (AD), but little research has been done with it using very old<br />

subjects. We determined the efficacy of the MMSE and MOCA in detecting<br />

early signs of cognitive impairment and change in healthy subjects<br />

70-105 years old. We also determined whether level of physical<br />

activity was related to cognitive performance.<br />

Methods<br />

Subjects were in the longevity project at the Center for Healthy<br />

Aging, BSHRI. They were 70 years old or older with no dementia at<br />

enrollment, and had completed baseline, 2nd and 3rd annual assessments<br />

in cognitive, medical, and psychosocial domains. One hundred<br />

and forty-eight subjects met these criteria and were stratified by age<br />

decade. To assess relative efficacy, MMSE & MOCA scores were plotted<br />

for each subject, and the proportion performing at, below, or<br />

above standard cutoff scores was determined. To assess decline over<br />

1-year, difference scores were calculated separately for the MMSE &<br />

MoCA. Level of activity was measured with the Rapid Assessment of<br />

Physical Activity (RAPA), and scores were correlated with MoCA<br />

performance.<br />

Results<br />

A fair number of healthy 70, 80, 90 and 100 year-old subjects<br />

performed above the cutoffs on both the MMSE & MoCA. With increasing<br />

age, however, an increasing proportion performed below the<br />

MoCA cutoff while scoring above the cutoff for the MMSE, supporting<br />

previous findings of superiority of the MoCA over the MMSE in<br />

the younger old. In the same groups, 1-year change was negligible for<br />

the MMSE, while for the MoCA, scores were on average 1.3 points<br />

lower. Subjects who were more physically active scored higher on the<br />

MoCA, but only for 90- and 100-year olds.<br />

Conclusion<br />

This study suggests that the MoCA is a better instrument for detecting<br />

cognitive impairment compared to MMSE, even in the oldest<br />

old. The MoCA can be a good tool for monitoring cognitive changes<br />

over time, and thus can aid care planning in early dementia. Finally,<br />

increased physical activity may mitigate cognitive decline often associated<br />

with aging.<br />

AGS 2012 ANNUAL MEETING<br />

S177


P OSTER<br />

A BSTRACTS<br />

C135 Encore Presentation<br />

Wheelchair Wrist Drop among Nursing Home Residents.<br />

A. Komiyama. General Internal Medicine, Kawasaki Municipal Tama<br />

Hospital, Kawasaki, Japan.<br />

Background: In 1982 Hartigan first reported radial neuropathy<br />

in nursing home residents that was associated with the use of a wheelchair<br />

and later termed “wheelchair wrist drop”. Two additional case<br />

reports have been published, bringing the total to 14 patients. Unfortunately,<br />

the most recent study published in 2009 was unaware of previous<br />

ones; thus wheelchair wrist drop appears to remain underrecognized.<br />

Furthermore, although cases of wheelchair wrist drop may be<br />

relatively common and overlooked in nursing homes, neither its frequency<br />

nor demographics of the study population has been documented.<br />

Objectives: To prospectively delineate frequency and contributing<br />

factors of wheelchair wrist drop as well as clinical characteristics<br />

of the study population in a nursing home.<br />

Methods: Subjects were 311 elderly residents, mean age 81.9 and<br />

female 63.7%, admitted to a nursing home from February 2005 to December<br />

2008. During this period of 47 months the residents were subjected<br />

to a comprehensive geriatric assessment at admission and 3-<br />

month intervals and watched for any adverse events. Radial nerve<br />

palsy was diagnosed clinically by the characteristic features including<br />

selective weakness of wrist and finger extensors; precise sensory findings<br />

were difficult to interpret in this population. The residents with<br />

wheelchair wrist drop did not undergo an EMG in consideration of<br />

their overall condition.<br />

Results: Examination of the study population shows moderate<br />

dementia with a mean Mini-Mental State Examination score of<br />

10.6/30 and impaired mobility and dependence with a mean score of<br />

29.6/91 on the motor domain of Functional Impairment Measure; 193<br />

residents (62.1%) routinely used wheelchair. Several months after<br />

admission, five female residents (2.6% of wheelchair users) developed<br />

radial neuropathy, resulting from leaning against the armrest.<br />

The contributing factors appeared to be immobility and lateral body<br />

tilt due to frailty in three and those due to parkinsonism in two. All<br />

but one improved one month later; one markedly frail resident experienced<br />

recurrence with residual weakness. For 23 months from February<br />

2007 no more wrist drop occurred in wheelchair users.<br />

Conclusion: 2.6% of wheelchair users suffered from wrist drop in<br />

the first half of the observation period in a nursing home. Recognition<br />

of wheelchair wrist drop and its risk factors among care staffs could<br />

likely have prevented from further development of this syndrome.<br />

C136<br />

The contribution of executive function and brain volume to gait<br />

speed in older adults with and without cerebral infarction.<br />

B. Manor, V. Novak. Harvard Medical School, Boston, MA.<br />

Background: Gait impairment is common in older adults, especially<br />

following cerebral infarction. The compensatory role of central<br />

locomotor circuits on the control of gait remains unclear. We examined<br />

the dependence upon executive function and non-infarcted regional<br />

brain tissue volumes for the control of gait speed in healthy<br />

older adults and those with right or left-hemisphere middle cerebral<br />

artery (MCA) infarct. Methods: Healthy older adults (n=55,<br />

age=65±8 years) and individuals with right MCA infarct (n=19,<br />

age=65±8 years, 7±6 years post-stroke) or left MCA infarct (n=20,<br />

age=65±8 years, 7±6 years post-stroke) were recruited. Gait speed<br />

was calculated from an indoor walk at preferred speed. Executive<br />

function was measured with the trail making test. Cortical gray matter<br />

volumes within non-infarcted brain regions (i.e., the cerebellum<br />

and occipital lobes) were quantified from anatomical 3T MRIs. Results:The<br />

right and left infarct groups had similar infarct volumes and<br />

time since stroke. Gait speeds were slower (p


P OSTER<br />

A BSTRACTS<br />

C138<br />

Improvement in Functional Independence Measure (FIM) scores of<br />

dementia patients on a Medical Psychiatric Unit.<br />

C. A. Fabrizio, 1 C. G. Lyketsos, 2 E. S. Oh. 2 1. University of Medicine<br />

and Dentistry of New Jersey- School of Osteopathic Medicine,<br />

Stratford, NJ; 2. Psychiatry, Medicine, Pathology, The Johns Hopkins<br />

University School of Medicine, Baltimore, MD.<br />

Supported By: 2011 MSTAR Program at Johns Hopkins<br />

Background:Physical therapy may be effective for functional recovery<br />

in older patients with dementia, yet research on this topic has<br />

been limited. The goal of this study is to examine the association between<br />

number of physical therapy sessions and improvement in functional<br />

outcomes on an interdisciplinary medical psychiatry unit.<br />

Methods:Retrospective data (1/2008 to 6/2011) were collected<br />

from medical records. Patients were categorized as having movement<br />

disorder (MD, N=8) or “no movement disorder”(NMD,N=27). FIM<br />

scores included transfer (FIM BCW–Bed, Chair, Wheelchair:1-7),<br />

ambulation distance (FIM D–Distance:1-3), and level of independence<br />

in ambulation (FIM DS–Distance Score:1-7). Statistics were<br />

performed using GraphPad Prism and STATA.<br />

Results:Compared to the admission FIM scores, scores in all<br />

three categories significantly improved in both groups with exception<br />

of FIM BCW score in MD (Table 1). Linear regression adjusting for<br />

age, gender, number of physical therapy sessions, comorbidities, medication<br />

and MMSE scores did not change the effect sizes.<br />

Conclusion:Although dementia patients in our medical psychiatry<br />

unit improved in most measures of the FIM, we did not find a specific<br />

association between these outcomes and a number of clinical<br />

variables including the number of physical therapy sessions. Further<br />

analyses are being conducted to investigate the effects of other clinical<br />

variables at this time. However, these effects may also be the result<br />

of the comprehensive care that they receive from geriatricians,<br />

geriatric psychiatrists, therapists, and nurses on the interdisciplinary<br />

team, rather than one specific intervention.<br />

Table 1 Improvements in Functional Independence Measure Scores<br />

at Discharge<br />

C139<br />

Practice effects: A unique cognitive variable?<br />

C. Callister,K.Duff.Neurology, University of Utah, Salt Lake City, UT.<br />

Supported By: AFAR MSTAR Summer 2011 grant; National<br />

Institute on Aging<br />

BACKGROUND:<br />

Practice effects are improvements in cognitive performance due<br />

to repeat testing with the same materials. These improvements are<br />

present in cognitively normal older adults, but mostly absent in patients<br />

with dementia. Practice effects can also predict further decline<br />

in patients with Mild Cognitive Impairment. However, it is unclear<br />

what variables (e.g., demographic, patient characteristic, other cognitive<br />

abilities) moderate practice effects. We hypothesized that practice<br />

effects would be related to age, education, and baseline cognitive<br />

functioning.<br />

METHODS:<br />

268 community-dwelling older adults (mean age=77.3 years,<br />

mean education=15.3 years) participated in this study. During a baseline<br />

visit, demographic information (age, gender, education), patient<br />

characteristics (depression, premorbid IQ, global cognition), and<br />

baseline cognitive measures of memory, executive functioning, and<br />

processing speed were collected. The participants returned a week<br />

later and repeated the same battery of cognitive tests. To quantify<br />

practice effects, 1-week scores were divided by baseline scores. Correlates<br />

of practice effects and demographic, patient characteristic and<br />

other cognitive variables were examined with Pearson correlations<br />

and chi-square tests.<br />

RESULTS:<br />

Practice effects were not significantly related to age, gender, education,<br />

depression, cognitive status, or pre-morbid IQ. Overall,<br />

practice effects were also not related to baseline cognitive performances.<br />

CONCLUSIONS: Practice effects were not related to most demographics,<br />

patient characteristics, and baseline cognitive measures.<br />

This suggests that practice effects may be a unique cognitive variable<br />

that is not confounded by variables that typically influence other cognitive<br />

performances. Overall, this makes the interpretation of practice<br />

effects more straightforward.<br />

C140<br />

Validity of Computer-Based Mental Status Exam Screening in the<br />

Geriatric Population.<br />

C. L. Duncan, T. K. Malmstrom, G. T. Grossberg, J. E. Morley.<br />

Division of <strong>Geriatrics</strong> - Internal Medicine, Saint Louis University<br />

School of Medicine, St. Louis, MO.<br />

Supported By: Medical Student Training in Aging Research<br />

(MSTAR) program 2011 summer scholarship awarded by <strong>American</strong><br />

Federation for Aging Research (AFAR) to Catherine L. Duncan<br />

B.S. (SLU SOM MSII)<br />

Background: Dr. Oz developed a computerized mental status<br />

exam based on the Saint Louis University Mental Status (SLUMS)<br />

Exam and made it readily available on his website<br />

(http://www.doctoroz.com/quiz/memory-quiz). We have examined<br />

the validity of his screen against the SLUMS along with another<br />

computerized version developed by Saint Louis University (SLU)<br />

for the initial screening of cognitive impairment in the geriatric<br />

population.<br />

Methods: The SLUMS exam was administered to 100 participants<br />

recruited from SLU Geriatric Medicine and Geriatric Psychiatry<br />

clinics, followed by one of two randomly chosen computerized<br />

adaptations (50% given the Dr. Oz Memory Quiz and 50% given the<br />

Self-Administered VA-SLUMS Exam) to those scoring ≥ 12/30 on<br />

the SLUMS after a designated duration (minimum t=15 minutes, median<br />

t =65 minutes).<br />

Results: Neither computerized exam showed positive sensitivity<br />

or specificity compared to the paper SLUMS (AUC≤0.5), but positive<br />

correlations were seen between the total scores of both the Self-Administered<br />

VA-SLUMS and the Dr. Oz computerized versions compared<br />

to the paper SLUMS (r=0.726 and r=0.691, respectively). Additionally,<br />

the Self-Administered VA-SLUMS showed a modest<br />

increase in the weighted measures of agreement (κ=0.38) compared<br />

to the Dr. Oz Memory Quiz (κ=0.29).<br />

Conclusions: While neither computerized exam showed positive<br />

sensitivity or specificity compared to the paper SLUMS, positive correlations<br />

were seen between the total scores, with the Self-Administered<br />

VA-SLUMS showing a modest increase in both measure of<br />

agreement and correlation of total scores compared to the Dr. Oz<br />

Memory Quiz. Specific modifications to each computerized exam are<br />

recommended as well as an increase in sample size and in the duration<br />

of wait time between paper and computerized testing. Further<br />

study with implementation of the suggested changes is necessary with<br />

the hope of refining these computerized SLUMS exams to become<br />

valid and useful preliminary screens for cognitive impairment in the<br />

geriatric population.<br />

AGS 2012 ANNUAL MEETING<br />

S179


P OSTER<br />

A BSTRACTS<br />

C141<br />

Contribution of brain imaging to the understanding of Alzheimer<br />

disease-related gait disorders, a systematic review.<br />

C. Annweiler, 1,2 O. Beauchet, 2 R. Bartha, 3 M. Montero-Odasso. 1 1.<br />

Department of Medicine, Division of Geriatric Medicine, The<br />

University of Western Ontario, London, ON, Canada; 2. Department<br />

of Internal Medicine and <strong>Geriatrics</strong>, Angers University Hospital,<br />

Angers, France; 3. Center for Functional and Metabolic Mapping,<br />

Robarts Research Institute, London, ON, Canada.<br />

Background. Although Alzheimer disease-related gait disorders<br />

(ADRGD) are common, determining their origin is a goal yet to be<br />

reached. In particular, which brain structures and underlying lesions<br />

are involved in ADRGD remains unknown. Our objective was to systematically<br />

review all published data that examined the associations<br />

between gait disorders and brain imaging in patients with Alzheimer<br />

disease (AD).<br />

Methods. We conducted a Medline and Cochrane Library search<br />

indexed under the MeSH terms “Gait” OR “Gait Disorders, Neurologic”<br />

OR “Walking” combined with “Brain Mapping” OR “Magnetic<br />

Resonance Imaging” OR “Tomography, X-Ray Computed” OR “Tomography,<br />

Emission-Computed, Single-Photon” OR “Positron-Emission<br />

Tomography” OR “Nuclear Medicine” OR “Brain” combined<br />

with “Alzheimer disease” OR “Dementia”.<br />

Results. Of the 465 selected studies, 3 observational studies met<br />

the selection criteria. The number of participants ranged from 2 to 42<br />

community-dwelling AD patients (29% to 100% female). ADRGD<br />

(i.e., shorter stride length) were associated with a high visual score of<br />

white matter lesions, mainly in the medial frontal lobes and basal ganglia.<br />

The nigrostriatal dopamine system was unaffected. Finally,<br />

ADRGD (i.e., shorter stride length and higher stride length variability)<br />

correlated with lower hippocampal volume and function.<br />

Conclusions. ADRGD could be explained by a high burden of<br />

subcortical hyperintensities on the frontal-subcortical circuits together<br />

with hippocampal atrophy and hypometabolism.<br />

C142<br />

Does the Veterans Affairs Saint Louis University Mental Status<br />

(SLUMS) Exam predict the course of cognitive impairment?<br />

D. M. Cruz, 1 C. M. Allen, 1 T. K. Malmstrom, 1 N. Tumosa, 1,2 J. E. Morley<br />

. 1 1. <strong>Geriatrics</strong>, Saint Louis University, St. Louis, MO; 2. GRECC, St<br />

Louis VAMC Jefferson Barracks Division, Saint Louis, MO.<br />

Supported By: No financial disclosure.<br />

Background: The Veterans Affairs Saint Louis University Mental<br />

Status (SLUMS) exam is a screening tool developed for the detection<br />

of cognitive impairment which showed better sensitivity and<br />

specificity for the detection of both dementia and mild cognitive impairment<br />

(MCI) than the Mini-Mental State Exam (MMSE). This<br />

study explores the SLUMS exam’s potential to identify the clinical<br />

course of MCI and dementia in patients with cognitive impairment<br />

after 7.5-years.<br />

Methods: Patients (N=533) at the Geriatric Research, Education<br />

and Clinical Center at the Veterans Affairs Hospital St. Louis,<br />

MO were screened for cognitive dysfunction in 2003 using both the<br />

SLUMS exam and the MMSE. In 2010 the rates of mortality, institutionalization<br />

and change in SLUMS exam score were evaluated as<br />

outcome measures. In this longitudinal study the associations between<br />

outcome measures, MMSE and SLUMS exam total scores, individual<br />

item scores, and cognitive status were examined using Kaplan-Meier<br />

curves and Cox proportional-hazards regression.<br />

Results: Five hundred thirty three charts were reviewed:<br />

176/533(33%) patients had died and 31/526 (6%) were institutionalized<br />

during the 7.5-year follow-up period. All subjects were male,<br />

with a mean age of 75 years, and most had high school education or<br />

greater (71%). MMSE dementia and SLUMS exam dementia<br />

(p34%) was found among stroke caregivers.<br />

To understand caregiver depression, we investigated depression<br />

risk factors among stroke patients and their caregivers.<br />

Method: In the national telephone survey for stroke caregivers’<br />

experience,we indentified caregivers ofVeterans who had the first-time<br />

stroke during 2000 and 2006. The level of depression was measured by<br />

the 10-item CESD scale.The social support measure was the sum of 12<br />

items. Bivariate analyses identified significant risk factors with depression.<br />

Adjusting for covariates, logistic regression was applied to assess<br />

the relationship between social support and depression; and ordinal repeated<br />

measure analysis was used to test for interaction effects between<br />

social support and race on 10 items of depression scale simultaneously.<br />

Results: Among 261 caregiver-Veteran dyads, there were 62%<br />

whites, 17% blacks, and 21% Puerto Ricans caregivers (mean<br />

age=65). An increased likelihood of being depressed was found in the<br />

following caregivers’ characteristics (p values ranged from


P OSTER<br />

A BSTRACTS<br />

ever, whether these cognitive impairments are due to effects of surgery,<br />

anesthesia, or perioperative confounders is unknown. In order<br />

to study these associations, appropriate behavioral neuroscience experiments<br />

must be characterized to reliably model the effects of anesthesia<br />

in laboratory animals. The primary objective of this study was<br />

to determine if isoflurane anesthesia was associated with spatial reference<br />

memory deficits in young or aged rats.<br />

METHODS: Eleven 12-week-old and eleven 20-month-old<br />

male Fischer 344 rats were randomly assigned to anesthesia for 2<br />

hours with 1.2% isoflurane or a control group that breathed 30%<br />

oxygen alone. Twenty-four hours following anesthesia, retention<br />

memory was evaluated using a Morris Water Maze (MWM) task.<br />

RESULTS: While there were differences in the performance of<br />

young when compared to aged rats, there were no significant differences<br />

between isoflurane and control groups on any measure of the<br />

MWM performance at either age. These data suggest that isoflurane<br />

anesthesia does not lead to reference memory deficits in young or<br />

aged rats as investigated using a MWM task.<br />

CONCLUSIONS: This study demonstrates that some memory<br />

domains are not impaired following isoflurane anesthesia in young or<br />

aged rats.<br />

C145<br />

Self-reported school performance and risk for Alzheimer’s disease in<br />

older adults.<br />

E. Guh, A. E. Sanders, MD MS. Albert Einstein College of Medicine,<br />

Bronx, NY.<br />

Supported By: Ms. Guh is supported by the Medical Student<br />

Training in Aging Research program of the <strong>American</strong> Federation<br />

for Aging Research (MSTAR-AFAR).<br />

Dr. Sanders receives salary and research support from the Einstein<br />

CTSA Grant UL1 RR025750 and KL2 RR025749 and TL1<br />

RR025748 from the National Center for Research Resources<br />

(NCRR), a component of the National Institutes of Health (NIH),<br />

and NIH roadmap for Medical Research.<br />

The Einstein Aging Study is funded by the NIH/NIA (P01<br />

AG03949; PI Richard Lipton, MD).<br />

The contents of this manuscript are solely the responsibility of the<br />

authors and do not necessarily represent the official view of the<br />

NCRR or NIH.<br />

Background: Previous research has shown a low level of education<br />

to be a risk factor for Alzheimer’s disease (AD). The Aging, Demographics,<br />

and Memory Study identified self-assessed below-average<br />

school performance as a possible risk factor for AD. We<br />

attempted to replicate these findings in a diverse urban cohort.<br />

Methods: The Einstein Aging Study is a community-based longitudinal<br />

study of aging and cognition in the Bronx, NY. Participants<br />

self-reported previous school performance (A student, B student,<br />

etc.) and were categorized into groups of “above average,” “average,”<br />

“below average,” and those who stated they “did not know.” Reading<br />

level was measured by the WRAT-3 reading subscore. Using ‘average’<br />

performance as the reference group, we used univariate logistic regression<br />

to examine the risk of AD in the ‘above average’ and ‘below<br />

average’ groups. A subsequent nested logistic regression model adjusted<br />

for age, sex, race, years of education, and reading level.<br />

Results: Of the 1,520 participants with data on self-reported<br />

school performance (mean age, 78.2 years; 61% female; 27% black),<br />

67 developed AD. At baseline, 342 (23%) reported ‘above-average’<br />

school performance, 785 (52%) were ‘average,’ 359 (24%) were<br />

‘below-average,’ and 34 (2%) ‘did not know.’ In the univariate model,<br />

participants who had ‘below average’ school performance were 2.2<br />

times more likely to develop AD than those with ‘average’ performance<br />

(odds ratio (OR) 2.2, 95% confidence interval (CI) 1.2-4.1,<br />

p=0.01). A second model that adjusted for age, sex, race, and years of<br />

formal education revealed a similar risk (OR 2.2, 95% CI 1.2-4.3,<br />

p=0.02). It also showed a relationship between years of formal education<br />

and risk for AD (OR 0.9, 95% CI 0.9-1.0, p=0.15). However, additional<br />

adjustment for reading level attenuated the risk and decreased<br />

the statistical significance for ‘below average’ performers<br />

developing AD (OR 1.9, 95% CI 1.0-3.8, p=0.06). The relationship between<br />

years of formal education and risk for AD also was no longer<br />

present (OR 1.0, 95% CI 0.9-1.1, p=0.79). In all models, there was no<br />

significant risk associated with ‘above average’ performance when<br />

compared to ‘average’ performance.<br />

Conclusion: Participants who reported ‘below average’ school<br />

performance had an increased risk in developing AD. We suggest<br />

reading level may be a mediator of the relationship between self-reported<br />

school performance and risk for AD.<br />

C146<br />

Incidence, Predictors and Prognosis of Delirium in a Geriatric<br />

Cardiac Intensive Care Unit.<br />

E. Mossello, L. Pecorella, C. Giulietti, G. Toffanello, F. Caldi,<br />

S. Fumagalli, P. Valoti, M. Cavallini, N. Zaffarana, M. Belladonna,<br />

S. Francini, M. Rimediotti, A. Mello, N. Marchionni, M. Di Bari. Unit<br />

of Gerontology and Geriatric Medicine, Department of Critical Care<br />

Medicine and Surgery, University of Florence, Florence, Italy.<br />

Supported By: Foundation Cassa di Risparmio di Pistoia e Pescia<br />

Background: In patients admitted to an Intensive Care Unit<br />

(ICU), delirium has a prevalence from 20% to 80% and a definite<br />

negative prognostic impact. Few data are available on the specific setting<br />

of Cardiac ICU (CICU). Aims of the study were to: 1) estimate<br />

prevalence and incidence of delirium in a Geriatric CICU, 2) identify<br />

its risk factors, and 3) assess its prognostic impact.<br />

Methods: The presence of delirium was identified with the systematical<br />

application of Confusion Assessment Method-ICU. On admission<br />

pre-morbid disability, dementia (Informant Questionnaire on<br />

Cognitive Decline, IQCODE), multimorbidity (Charlson Index, CI),<br />

and acute physiologic derangement on admission (APACHE II) were<br />

assessed. Invasive procedures were recorded.<br />

Results: Out of 373 patients (mean age 79 years; pre-existing dementia<br />

26%), 18% showed delirium (8% prevalent on admission,<br />

10% incident during hospital stay). In a logistic regression model, independent<br />

predictors of delirium (OR, 95%CI) included age (1.07,<br />

1.02-1.13), APACHE-II (1.10, 1.04-1.16), dementia (2.97, 1.58-5.60),<br />

CI (1.22, 1.05-1.41) and clinical diagnosis [ST-elevation myocardial<br />

infarction (STEMI) (6.40, 2.40-17.07) or respiratory failure (8.49,<br />

1.54-46.85) vs. Non-STEMI]. Predictors of incident delirium were the<br />

same, though dementia had a reduced predictive value. The use of invasive<br />

procedures (arterial and central venous catheter, nasogastric<br />

tube, urinary catheter, intra-aortic balloon counterpulsation, and orotracheal<br />

intubation) was associated with subsequent delirium, independently<br />

of clinical status on admission. Delirium, especially its incident<br />

form, was associated with prolonged hospitalization (p


P OSTER<br />

A BSTRACTS<br />

nal process can present as hip pain, though usually with neurological<br />

and systemic symptoms.<br />

CASE: An 80 year old Caucasian man with a history of sarcoidosis,<br />

pulmonary embolism, and atrial fibrillation on anticoagulation,<br />

was admitted to the hospital with progressive left hip pain. He<br />

had been treated initially with pain medications by his primary physician<br />

for presumed osteoarthritis. His pain worsened over several<br />

months and became associated with left lower extremity swelling, difficulty<br />

walking with left foot drop, and generalized weakness. His<br />

physical exam was remarkable for mildly distended abdomen with<br />

firmness in the left lower quadrant without hepatosplenomegaly, mild<br />

left lower extremity edema, decreased hip range of motion without<br />

pain, and mild weakness with left dorsiflexion. Digital rectal exam<br />

showed bright red blood. His labs revealed leukocytosis of 12,000,<br />

anemia with a hemoglobin of 11, normal platelet count, and<br />

supratherapeutic INR of 6.5. A lower extremity ultrasound revealed<br />

an acute proximal left lower extremity DVT. A large left retroperitoneal<br />

mass involving the iliopsoas muscle and surrounding vasculature<br />

was found on CAT scan of the abdomen and pelvis. He also had<br />

bowel wall thickening in the distal sigmoid colon and at the splenic<br />

flexure. A colonoscopy was performed and showed two separate<br />

masses involving the colon. Biopsies done via both ultrasound guidance<br />

and colonoscopy were positive for Burkitt lymphoma. He received<br />

chemotherapy and was discharged home under hospice care.<br />

DISCUSSION: Burkitt lymphoma is rare in older adults. It usually<br />

occurs in adults less than 35 years of age. It often presents with<br />

abdominal symptoms such as pain, ascites, or gastrointestinal bleeding.<br />

The left hip pain, swelling, and leg weakness in this patient was<br />

atypical and was due to the involvement of the left iliopsoas muscles<br />

and surrounding nerves and vasculature.<br />

CONCLUSION: In an elderly patient with chronic unilateral<br />

hip pain and atypical clinical signs and symptoms such as foot drop,<br />

leg swelling and focal weakness, consider an intra-abdominal or<br />

pelvic infiltrative process.<br />

C149<br />

Pulse wave velocity varies within the cardiac cycle.<br />

A. K. Reddy, 1 C. J. Hartley, 1 G. E. Taffet. 1,2 1. Medicine (CVR),<br />

Baylor College of Medicine, Houston, TX; 2. Medicine (<strong>Geriatrics</strong>),<br />

Baylor College of Medicine, Houston, TX.<br />

Supported By: NIH<br />

Aortic pulse wave velocity (PWV), an index of arterial stiffness,<br />

is measured using the foot-to-foot (Ff) pulse transit time (PTT) of the<br />

flow velocity waveform at two aortic sites and the separation distance<br />

(Sd) between these sites (PWV=Sd/PTT). It has been shown that<br />

PWV is directly proportional to pressure (Kim et al., J Human Hypertens,<br />

21:141-48, 2007), from a low at end-diastole to a high at endsystole<br />

within each cardiac cycle. But the velocity foot occurs at enddiastolic<br />

pressure and therefore Ff-PWV may underestimate the<br />

overall PWV (and stiffness). PWV can also be determined from aortic<br />

impedance (Imp) as PWV = Zc/ρ, where Zc = average of impedance<br />

moduli from 2nd-10th harmonics (see figure) (Reddy et al., Am<br />

J Physiol HCP, 285:H1464-70, 2003). Since Imp-PWV is determined<br />

from several harmonics we believe that it is a better representation of<br />

vessel stiffness than Ff-PWV.<br />

We determined Imp-PWV (figure) in 5 young (lower dashed<br />

line; 282±10) and 6 old (upper dotted line; 444±59) mice and Ff-PWV<br />

in 3 young (286±14) and 3 old (416±22) mice. PWV determined by<br />

both methods was not significantly different in the young mice because<br />

at young age lower overall PWV may be closer to Ff-PWV. In<br />

the old mice Imp-PWV was higher but was not significant perhaps<br />

due to large variability. Higher values Imp-PWV in old mice may represent<br />

the increase in the magnitude of the higher harmonics caused<br />

by stiffer arteries in old age.<br />

C148<br />

Association of Vitamin D deficiency and In-Hospital Mortality in<br />

Elderly Patients with Heart Failure.<br />

A. Ali, N. Abi Rafeh, A. Abdo, J. Ross, V. Hak, D. P. Seminara,<br />

A. Szerszen. <strong>Geriatrics</strong>, Staten Island University Hospital, Staten<br />

Island, NY.<br />

Background: Vitamin D deficiency has been implicated in the<br />

pathogenesis of symptomatic heart failure. Low levels of 25-Hydroxyvitamin-D<br />

(25(OH)D) are associated with poor long term prognosis<br />

in heart failure. The relationship of low 25(OH)D levels and in-hospital<br />

mortality in elderly patients admitted with acute heart failure is<br />

not well studied.<br />

Objective: The study aims to assess the association of 25(OH)D<br />

deficiency and in-hospital mortality in elderly population admitted<br />

with heart failure and to determine the association between<br />

25(OH)D levels and Ejection Fraction (EF), Brain Natriuretic Peptide<br />

(BNP), and New York Heart Association (NYHA) functional<br />

classification.<br />

Methods and Results: This was a cross-sectional observational<br />

pilot study. Twenty patients with acute heart failure were recruited in<br />

the study. The mean age of the patients was 84 (65-96) yrs. Subjects<br />

were divided into two groups based on their 25(OH)D levels of less<br />

than 20mg/dl or more than 20mg/dl. There was a trend towards higher<br />

BNP level in the 25(OH)D deficiency group (1946 ± 1531 pg/ml vs.<br />

808 ± 302 pg/ml; p= 0.07). There was no correlation between<br />

25(OH)D levels and EF or NYHA functional class. However, Sixty<br />

two percent of patients died in-hospital in 25(OH)D deficiency group<br />

as compared to none in normal 25(HO)D levels group (p=0.026).<br />

Conclusion: A low 25(OH)D level is associated with high inhospital<br />

mortality in elderly patients admitted with acute heart failure.<br />

The 25(OH)D level may be used as a prognostic maker for inhospital<br />

mortality in elderly patients with heart failure.<br />

C150<br />

Antibiotic Utilization in ICU Patients Requiring Mechanical<br />

Ventilation.<br />

B. Chen, M. Restrepo. School of Medicine, UTHSCSA, San<br />

Antonio, TX.<br />

Supported By: MSTAR program through the National Institute<br />

of Aging<br />

PURPOSE: Infection is a major concern in health care but especially<br />

in the ICU and those on mechanical ventilation. There are limited<br />

data available regarding antibiotic utilization and the impact on<br />

clinical outcomes in the ICU setting, but particularly on patients requiring<br />

mechanical ventilation. We Assess antibiotic utilization and<br />

the impact on clinical outcomes in hospitalized ICU patients who required<br />

mechanical ventilation.<br />

S182<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

METHODS: We conducted a retrospective observational cohort<br />

study of VA MICU patients in the year of 2007. We included patients<br />

who were on >18 years and on mechanical ventilators for >24<br />

hrs. We looked into the antibiotic use and microbial culture to ultimately<br />

evaluate the clinical outcomes (length of stay and mortality)<br />

of these patients. [|11|]<br />

RESULTS: We identified 157 ICU patients who required mechanical<br />

ventilation. 95% of the patients received at least one dose of<br />

antibiotic therapy. The most common antibiotics were vancomycin<br />

and pip/tazo and tobramycin. The use of antibiotic was related to positive<br />

microbial cultures (p= 0.04). Adequate therapy is associated<br />

with positive cultures (p


P OSTER<br />

A BSTRACTS<br />

project, we attempt to understand some of the barriers against the efficacy<br />

of skin cancer prevention strategies.<br />

METHODS<br />

A 26 question survey-based descriptive and prospective study<br />

was performed on 140 Mohs surgery-treated patients at UCSD. Data<br />

was analyzed using percentages and estimated confidence intervals<br />

for population proportions.<br />

RESULTS<br />

51% of participants mentioned their doctor as a source of skin<br />

cancer prevention information. 73% of the 140 study participants<br />

were aware of sunblock as a protective strategy, and 76% of people in<br />

this group report current usage of sunblock. Participants who were<br />

able to name ≥2 preventative strategies had higher self-ratings of utilization<br />

of those strategies than people who could only name 1 preventative<br />

strategy. 43% of the people not using sunblock were unsure<br />

that sunblock actually works, and 52% of them thought it was too<br />

messy and oily. 65% of all participants improved in their self-rating of<br />

utilization of preventative strategies post skin cancer diagnosis.<br />

CONCLUSIONS<br />

The results of our survey study show that the majority of people<br />

who know of successful protective strategies are actually using them,<br />

and an awareness of a larger number of preventative strategies is related<br />

to a higher chance of utilization. However, most of the behavior<br />

improvement occurred after diagnosis of skin cancer, which suggests<br />

that people are not considering their risk of skin cancer as an imminent<br />

threat during early life. Therefore, in order to set up a future<br />

framework to decrease the incidence of skin cancer in the aging population,<br />

we recommend increasing the number of sun safety educational<br />

campaigns as well as encouraging physicians to be more active<br />

at educating patients on skin cancer risk.<br />

C155<br />

Maintaining and Respecting an Older Adults’ Life While It Is<br />

Ending: Challenges Faced by Family Members.<br />

C. R. Van Son, S. Izumi. College of Nursing, Washington State<br />

University, Spokane, WA.<br />

Supported By: <strong>American</strong> Nurses Foundation<br />

Hospice and Palliative Nurses Association<br />

Background: Efforts towards the improvement of end of life<br />

care must be accelerated to meet the needs of our rapidly aging society.<br />

Older adults with chronic conditions experience a longer trajectory<br />

with acute exacerbations and recovery, with progressive functional<br />

declines occurring over months and years. Palliative care<br />

adaptations are still needed to meet the needs of older adults going<br />

through prolonged and uncertain trajectory at the end of life. A gap<br />

exists between the focus on palliative care by healthcare<br />

providers/systems and the need for maintaining and optimizing daily<br />

life for older adults. The objective of this presentation is to describe<br />

the gap from the family member’s perspective.<br />

Methods: Qualitative descriptive study using semi-structured interviews<br />

with 23 family members of deceased older adults with various<br />

chronic conditions. Secondary analysis of the interview data was<br />

conducted using qualitative thematic analysis approach.<br />

Results: Family members shared the challenges they faced while<br />

they were facilitating the care of older family members who were<br />

dying. Although families were aware of the downward decline, they<br />

still recognized the importance of keeping daily routines to maintain<br />

the quality and function of the older adult’s life. However, once an acknowledgement<br />

of dying was made by the healthcare provider/system,<br />

the palliative care approach was instituted and not always<br />

adapted to optimize function and daily routines of older adults. Families<br />

reported that healthcare providers often: 1) relegated the older<br />

adult to a bedbound status while they were still able to be actively<br />

mobile; 2) failed to inquire about or respond to daily routines that<br />

would enhance daily life; 3) dismissed older adults as being cognitively<br />

impaired when they were not; and 4) neglected to prevent or<br />

address treatable geriatric conditions such as delirium.<br />

Conclusions: End of life for older adults occurs over weeks,<br />

months, and even years. Therefore, palliative care approaches must<br />

consider this longer trajectory and adapt to meet the older adults’<br />

and their family members’ needs.<br />

C156<br />

Impact of financial exploitation on the health of older women.<br />

C. P. Mouton. Dean’s Office, Meharry Medical College, Nashville, TN.<br />

Supported By: National Institutes of Health<br />

Background: Financial abuse (FA) and exploitation is a growing<br />

problem. Nationally, an estimated 12.3 % of elder abuse victims are<br />

victims of FA. However, little is known about the effects of FA on independently<br />

functioning older women.<br />

Objectives: To determine the effect of FA on health status and<br />

quality of life in a cohort of functionally independent older women.<br />

Design: Cross-sectional survey<br />

Setting: The local Observational Study Cohort of the Women’s<br />

Health Initiative in San Antonio, Texas<br />

Participants: Using this cohort, we surveyed over 1200 women,<br />

aged 50-79 years old.<br />

Measurements: We asked these women about their exposure of<br />

FA prior to the survey and currently. Women were also asked about<br />

their health status using the SF-36.<br />

Results: Of the 1271 women surveyed, 2.9% being forced to sign<br />

documents they did not understand, 3.6% were forced to give up<br />

property, 32% had money borrowed, and 2% had finances controlled<br />

against their wishes. Being forced to sign documents was associated<br />

with lower role-physical, pain, general health and physical component<br />

summary scores. Giving up property was associated with lower<br />

role-physical, social functioning, role-emotional, mental health, and<br />

mental component summary scores. Having money borrowed was associated<br />

with lower role-physical, role-emotional, and mental component<br />

summary scores. Having finances controlled was associated with<br />

lower social functioning, role-emotional, and mental component summary<br />

scores.<br />

Conclusion: Experiencing financial abuse is associated with<br />

lower sexual health status and poor quality of life in older women.<br />

C157<br />

Micronutrient Deficiencies in Palliative Care Patients.<br />

C. Petit, A. F. Leone. Palmetto Health - USC School of Medicine,<br />

Columbia, SC.<br />

Background: As health providers attempt to mitigate and ease<br />

discomfort, suffering and pain in the palliative care patient, it becomes<br />

imperative to investigate and treat all factors that might be<br />

contributing to distress. Unconsciously, we tend to assume that nutritional<br />

deficiencies are isolated to populations from third world countries,<br />

those who underwent bariatric weight loss procedures or those<br />

with know malabsorption syndromes. Current studies are proving this<br />

idea to be a myth.<br />

Methods: In an effort to provide comprehensive care, patients<br />

with symptoms suggestive of deficiency states, who were expected to<br />

live for at least one month, underwent a nutritional assessment to<br />

screen for micronutrient deficiencies seen by a single provider of a<br />

Palliative Care Consultant Service. It was the intent to replace any<br />

nutritional paucity. Those who underwent screening, directed by<br />

symptom constellation, underwent analysis of various micronutrients<br />

including Vitamins B1, B2, B3, B6, B12, C, Vitamin D, ascorbic acid,<br />

CoQ10, Zinc, pre-albumin and albumin.<br />

Results: 58 sequential referrals in May and June of this year underwent<br />

chart reviewed. 13 were suspected to have a life expectancy<br />

S184<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

of less than 1 month and did not undergo nutritional assessment beyond<br />

protein malnutrition. The remaining underwent targeted evaluation<br />

based on symptom constellation. 82.9% were found to have at<br />

least one identified nutritional deficiency. Of those, 38.2% had a single<br />

nutrient deficiency. 23.5% had two, 32.4% had three and 5.9%<br />

had 4 deficiencies.<br />

Conclusions: Micronutrient deficiencies are more prevalent in<br />

the Palliative care population than previously believed. Appropriate<br />

testing allows targeted, evidence based, replacement which should in<br />

turn ameliorate suffering. All too often palliative care is perceived as<br />

an approach that limits curative care focus, but resolution of deficiencies<br />

seems to establish a bridge of trust between the practitioner, the<br />

patient and the family who perceive the health practitioner to be fully<br />

invested in the care of the patient.<br />

C158<br />

Aging with Disabilities: Comparing symptoms and quality of life<br />

indicators of individuals aging with disabilities to U.S. general<br />

population norms.<br />

D. Amtmann, S. Borson, R. Salem, K. L. Johnson, A. Verrall.<br />

Rehabilitation Medicine, University of Washington, Seattle, WA.<br />

Supported By: The contents of this abstract were developed under a<br />

grant from the Department of Education, NIDRR grant number<br />

H133B080024. However, those contents do not necessarily represent<br />

the policy of the Department of Education, and you should not assume<br />

endorsement by the Federal Government.<br />

Background: Advances in medical care and rehabilitation have<br />

extended the lifespan of people with long-term physical disabilities.<br />

However, quantifying the excess burden of symptoms in persons<br />

aging with disabilities has been hindered by lack of common metrics<br />

across measures and clinical populations. The NIH-funded PROMIS<br />

initiative used modern psychometric methods to develop instruments<br />

that do use a common metric and provide US population<br />

norms for many important domains. The objective of the current<br />

study was to construct profiles of symptoms and QoL indicators in<br />

persons aging with a long-term disability and to compare them to US<br />

population norms.<br />

Methods: PROMIS short forms measuring 7 symptoms or QoL<br />

indicators (fatigue, pain interference with activities, physical and social<br />

function, depression, and sleep and wake disturbance) were completed<br />

by individuals with muscular dystrophy (264), multiple sclerosis<br />

(481), post-polio syndrome (445), and spinal cord injury (323)<br />

(total N=1513) participating in an ongoing longitudinal survey. Individuals<br />

aged 45-94 were included in this analysis. Scores for the overall<br />

sample, by diagnostic group and by age categories, were compared<br />

to the PROMIS US population norms.<br />

Results: Compared to the US general population, individuals<br />

aging with disabilities reported a higher symptom burden and<br />

poorer QoL on 6 of 7 measures (all p


P OSTER<br />

A BSTRACTS<br />

Methods: Two hundred and four volunteers at McLaren Regional<br />

Medical Center in Flint, Michigan, in May 2011, were<br />

mailed an anonymous survey. The RAND 36–Item Health Survey<br />

(Version 1.0) was used as the instrument for quality of life measurement.<br />

The demographic questions included: gender, age, marital<br />

status, ethnicity, completed level of education and house–hold<br />

income. The responses were collected for eight weeks. We analyzed<br />

demographic variables and compared them between our<br />

mean and those of the general elderly volunteering population,<br />

obtained from the literature. Analysis of quality of life data is<br />

pending.<br />

Results: One hundred and three participants returned completed<br />

surveys, resulting in a 45% response rate. 91% were female,<br />

ages 65 to 94, with the majority (38%) in the 75-84 range. 91% were<br />

Caucasian; 55% were single, as opposed to residing with someone or<br />

married. Majority had either completed the 12th grade (38%) or<br />

some college (35%). 28% had an annual income range in the<br />

$20–34,000, though a significant proportion chose not to provide this<br />

information.<br />

Conclusion: National data tends to group older volunteering<br />

adults into one large category of 65 years and older, however, we<br />

were able to break this group down and revealed the demographic<br />

variables. Additionally, as opposed to the current research which suggests<br />

that those with higher educational and income levels make up<br />

the general volunteering population, our research indicates that it is<br />

those which fall in the middle range on both items who choose to participate<br />

in volunteering activity.<br />

C161<br />

The Relationship Between Body Weight and Quality of Life in<br />

Older Adults with Medicare Supplement Insurance.<br />

K. Hawkins, 1 F. G. Bottone Jr, 1 S. Musich, 1 R. J. Ozminkowski, 1,2<br />

Y. Cheng, 1 R. J. Migliori, 2 C. S. Yeh. 3 1. Advanced Analytics,<br />

OptumInsight, Ann Arbor, MI; 2. UnitedHealth Group Alliances,<br />

Minnetonka, MN; 3. AARP Services, Inc., Washington, DC.<br />

Supported By: UnitedHealth Group and AARP Services, Inc. (ASI).<br />

The objective of this study was to estimate the relative impact<br />

that each body mass index (BMI) category has on health-related<br />

quality of life. A mail survey was sent to 60,000 adults with an<br />

AARP®-branded Medicare Supplement Insurance (i.e. Medigap)<br />

plan provided by UnitedHealthcare Insurance Company (for New<br />

York residents, UnitedHealthcare Insurance Company of New York)<br />

in 10 states. The Medicare Health Outcomes Survey instrument was<br />

used, but renamed the Health Update Survey, for use with a Medigap<br />

sample. Casemix-adjusted comparisons were made between each<br />

BMI category versus those with normal BMI.A total of 22,827 (38%)<br />

eligible sample members responded to the survey. Respondents had<br />

the following BMI categories: 2.2% were underweight, 37.0% were<br />

overweight, 18.5% were obese, 1.9% were morbidly obese, 38.5% had<br />

a normal BMI and 1.9% were missing BMI information. Factors associated<br />

with being underweight or carrying excess body weight were<br />

generally consistent with past reports. Quality of life was assessed<br />

using the average physical component scores (PCS) and mental component<br />

scores (MCS) obtained from the VR-12 health status tool. Respondents’<br />

PCS values were 5.01, 0.16, 3.60 and 9.50 points lower on<br />

average, respectively, for the underweight, overweight, obese and<br />

morbidly obese BMI categories, compared to the normal BMI group.<br />

Respondents’ MCS values were 3.28, +0.52, 0.32 and 1.39 points<br />

lower on average, respectively for the underweight, overweight,<br />

obese and morbidly obese BMI categories, compared to the normal<br />

weight group. The greatest impact on quality of life was on those in<br />

the underweight and morbidly obese categories, with the greater negative<br />

impacts were on the physical rather than mental aspects of quality<br />

of life.<br />

C162<br />

The Responsiveness of Quality of Life Measures in Patients with<br />

Alzheimer’s Disease: Results from the Canadian Alzheimer’s<br />

Disease Quality of Life Study.<br />

G. Naglie, 1,2 D. Hogan, 5 M. Krahn, 3,4 S. Black, 4 M. Freedman, 4<br />

L. Beattie, 6 M. Borrie, 7 A. Byszewski, 8 C. MacKnight, 9 C. Patterson, 10<br />

H. Bergman, 11 J. Irvine, 12 P. Ritvo, 12 D. Streiner, 10 J. Comrie, 12<br />

M. Kowgier, 4 G. Tomlinson. 3,4 1. Baycrest, Toronto, ON, Canada; 2.<br />

Toronto Rehab, Toronto, ON, Canada; 3. Toronto General Research<br />

Institute, Toronto, ON, Canada; 4. University of Toronto, Toronto, ON,<br />

Canada; 5. University of Calgary, Calgary, AB, Canada; 6. University<br />

of British Columbia, Vancouver, BC, Canada; 7. University of Western<br />

Ontario, London, ON, Canada; 8. University of Ottawa, Ottawa, ON,<br />

Canada; 9. Dalhousie University, Halifax, NS, Canada; 10. McMaster<br />

University, Hamilton, ON, Canada; 11. McGill University, Montreal,<br />

QC, Canada; 12. York University, Toronto, ON, Canada.<br />

Supported By: Canadian Institutes of Health Research, Alzheimer<br />

<strong>Society</strong> of Canada and the University Health Network Geriatric Fund.<br />

Purpose: To assess the responsiveness of a variety of generic and<br />

disease-specific quality of life (QOL) measures in patients with<br />

Alzheimer’s disease (AD).<br />

Methods: We recruited 272 community-living AD patients and<br />

their caregivers from clinics across Canada. Patients with MMSE<br />

scores > 10 rated their QOL using the EQ-5D, Quality of Well-Being<br />

scale, a visual analogue scale and the QOL in AD (QOL-AD) instrument.<br />

Caregivers rated patient’s QOL using these measures as well as<br />

the Health Utilities Index (HUI) and Short-Form-36. QOL and patients’<br />

cognition (AD Assessment Scale-Cognitive), function (Disability<br />

Assessment for Dementia) and neuropsychiatric symptoms<br />

(Neuropsychiatric Inventory and Geriatric Depression Scale) were<br />

assessed at baseline, 6, 12 and 24 months. We evaluated internal responsiveness<br />

using the standardized effect size and the standardized<br />

response mean. We assessed external responsiveness using receiver<br />

operating characteristic (ROC) curves for the QOL measures based<br />

on a decline or no decline in a composite score based on the first principal<br />

component of the core dementia symptoms.<br />

Results: At baseline, patients’ mean age was 82.8, 50.2% were<br />

female and mean MMSE was 20.2. For patient self-ratings, the QOL<br />

measures did not exhibit meaningful responsiveness over time. For<br />

caregiver ratings of patient QOL: the internal responsiveness of the<br />

QOL measures at 12 and 24 months was small (0.12 to 0.28) and small<br />

to moderate (0.22 to 0.59), respectively; the external responsiveness<br />

at 12 and 24 months was greatest for the EQ-5D, QOL-AD and HUI,<br />

with areas under the ROC curves of 0.67 to 0.77.<br />

Conclusions: Over 24 months of follow-up, patient self-ratings of<br />

QOL did not exhibit meaningful responsiveness, while caregiver ratings<br />

of patient QOL with the QOL-AD, HUI and EQ-5D exhibited<br />

moderate responsiveness.<br />

C163<br />

Physical Therapy Interventions Utilizing Dual Task Phenomenon to<br />

Decrease Cognitive-motor Interference in a Person Status-post<br />

Intercerebral Hemorrhage: a Case Report.<br />

A. Tilsley, G. L. Raymond. Physical Therapy, Samuel Merritt<br />

University, Oakland, CA.<br />

BACKGROUND: Cognitive-motor interference (CMI) is a<br />

phenomenon in which the simultaneous performance of a motor and<br />

cognitive task interferes with the performance of one or both tasks.<br />

CMI can occur after a stroke, increasing a person’s risk of falls as they<br />

may be unable to react to unexpected challenges during ambulation.<br />

The objective of this case report is to demonstrate how the theory of<br />

CMI was used to develop interventions aimed at decreasing a patient’s<br />

fall risk.<br />

DESIGN: Case report.<br />

SETTING: Acute rehabilitation in Northern California.<br />

S186<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

PARTICIPANT: 57-year-old female with a hemorrhage in the<br />

basal ganglia.<br />

INTERVENTION: Interventions were aimed at addressing balance<br />

and gait. CMI was addressed during functional activities that required<br />

multitasking. Dual task challenges include carrying objects in<br />

her hands, carrying a tray with various items, and talking or answering<br />

questions while ambulating. Dual task challenges progressed along<br />

with gait interventions by utilizing different surfaces and environments.<br />

MEASUREMENTS: Timed Up and Go (TUG), TUG manual,<br />

TUG cognitive, Dynamic Gait Index (DGI).<br />

RESULTS: TUG improved from 14 to 10 seconds, TUG manual<br />

from 15 to 10 seconds, TUG cognitive from 21 to 13 seconds. Dynamic<br />

Gait Index increased from 14 to 21.<br />

CONCLUSION: After using the dual task paradigm to create<br />

interventions focused on decreasing the extent of CMI without deterioration<br />

of either motor or cognitive task, the patient showed improvements<br />

in independence and safety during ambulation and transfers<br />

and decreased risk of falls.<br />

C164 Encore Presentation<br />

Functional Trajectories of Elderly Patients admitted in a Geriatric<br />

Rehabilitation Unit after discharge of acute hospitalization.<br />

E. Martínez, 1,2 J. Sánchez Rodríguez, 1 N. Albiol Tomàs, 1 R. Audi<br />

Ferrer, 1 J. García Navarro. 2 1. Geriatric Department, Hospital de la<br />

Santa Creu, Tortosa, Tarragona, Spain; 2. Grup Sagessa, Reus,<br />

Tarragona, Spain.<br />

Background:The aim of this study is to analyze which factors<br />

evaluated during the Comprehensive Geriatric Assessment(CGA),<br />

performed at acute care by a geriatric team, predict functional trajectories<br />

in elderly patients transferred to a Geriatric Rehabilitation<br />

Unit(GRU).<br />

Methods: Prospective study. All acute hospitalized patients evaluated<br />

(June - December 2010) and transferred to our GRU were included<br />

and followed-up till discharge. Collected data: age, sex, diagnostic<br />

groups (orthopedics, stroke, others); functional status –<br />

activities of daily living (ADLs) previous to acute hospitalization,in<br />

acute care and at discharge (Barthel index,BI). Comorbidity (modified<br />

Charlson Index),dementia,delirium in acute care, length of stay<br />

in acute and rehabilitation units,laboratory data (Hematocrit,Albumin,Total<br />

Proteins, ESR,CRP),polipharmacy and if patient lives<br />

alone.<br />

Statistical Analysis: Characteristics of ability in ADLs patients<br />

groups were compared using t-test to evaluate differences in means<br />

and chi-square test to evaluate differences in percentages; and multivariate<br />

analysis by logistic regression.SPSS v.17 software.<br />

Results: 174 patients evaluated; 12.6 % died; Mean age: 77 years<br />

(±17.5); 48.3% male. Length stay in acute care:12.3 days (± 10.4),<br />

length in GRU: 56 days (± 51.9). Previous BI mean 78.6 (± 22.3);BI in<br />

acute care mean 27.2 (±26.2);BI at discharge 49.2 (± 36.3). Independent<br />

ability to walk: previous: 70.7%, in acute care: 3.4%, at discharge:<br />

37.9%. Patients with dementia: 25.3%,delirium: 25.9%; polipharmacy:<br />

71.3%,living alone 35.6%. Diagnosis groups: Orthopedic<br />

33.5%, stroke 22.9%, cardiovascular and others 32.9%. Modified<br />

Charlson Index: mean 1.8 (±1.2).<br />

In multivariate analysis, factors related to walk independent<br />

were absence of dementia and short lengths of stay in GRU. Dementia,Cardiopathy<br />

and long length of stay in acute care were associated<br />

with poor functional prognosis. The functional decline in acute care<br />

should explain 15% of functional trajectory (Pearson coeff. correlation<br />

0.38).<br />

Conclusions: The probability to walk independent was low in<br />

demented patients with long length of stay in the GRU. The best ability<br />

in ADLs was achieved in patients with a short length of stay in<br />

acute care, with orthopedic diagnosis on admission and no comorbidity<br />

as dementia, delirium and heart disease.<br />

C165<br />

Factors associated with acute care readmissions from a skilled<br />

nursing facility.<br />

R. Y. Blake, K. Fairfield, H. Wierman, R. Marino. <strong>Geriatrics</strong>, Maine<br />

Medical Center, Portland, ME.<br />

Background:<br />

Readmission from skilled nursing facilities (SNF) to acute care<br />

hospitals is costly, disruptive, and may serve as a marker of poor quality<br />

care. This study was designed to investigate risk factors for readmission<br />

in a single small, suburban skilled nursing facility.<br />

Methods:<br />

We conducted a retrospective chart review of all admissions to a<br />

SNF in Maine within a one year period (N=130). We excluded four<br />

patients with incomplete data (final N=126). Data collected included<br />

patient age, gender, day and month of admission, days from SNF admission<br />

to first physician contact, and admitting primary and secondary<br />

diagnoses. For patients who were readmitted to an acute care facility<br />

within 30 days, we reviewed hospital admission records to<br />

determine primary readmission diagnosis. We used descriptive statistics<br />

(chi square, t-test) for data analyses.<br />

Results:<br />

The mean age of the population was 82 years, with a range of 50-<br />

99. The majority were women (79/126, 63%). The overall 30-day readmission<br />

rate was 13% (17/126). A significantly higher proportion of<br />

men were readmitted vs. women (21% vs. 9%, p=0.05). 63% (12/17)<br />

of readmissions were attributable to patients admitted during the<br />

months of December, January, and March. There was a mean of 1.8<br />

+/- 1.7 days from SNF admission to initial physician contact, and this<br />

was similar for readmitted vs. non-readmitted patients (2.3 +/-1.8 vs.<br />

1.8 +/- 1.7, p=0.35). Specific primary diagnoses associated with the<br />

highest readmission rates included GI bleed (2/5, 40%), pneumonia<br />

(3/9, 33%), CAD (1/3, 33%), UTI (3/10, 30%), and CHF (2/9, 22%).<br />

At the time of acute hospital readmission, top diagnoses were similar,<br />

also including pneumonia (4/17, 24%), CHF (2/17, 12%), and GI<br />

bleed (12%), with the addition of multifactorial delirium (12%). Patients<br />

who were ultimately readmitted had significantly more active<br />

comorbidities (8.0 +/- 2.7) than those were not readmitted (6.3 +/-<br />

2.3), p=0.02.<br />

Conclusions:<br />

In this population, patients at higher risk for readmission include<br />

males, those with a higher number of active comorbidities, and<br />

patients with a primary diagnosis of GI bleed, infection (UTI, pneumonia),<br />

or cardiovascular disorder (CAD, CHF). Closer attention to<br />

these higher risk patients, in conjunction with strict adherence to established<br />

guidelines and standards of care, may help to minimize unnecessary<br />

acute care hospital readmissions in the future.<br />

Poster Session D<br />

Friday, May 4<br />

3:00 pm – 4:30 pm<br />

D1<br />

Amiodarone-induced Rhabdomyolysis.<br />

E. C. Ong, 1 N. Maheshwari, 1 A. Sy, 1 E. Roffe, 2 S. Chaudhari, 1,2<br />

D. Kumari, 2 S. Mushiyev. 1 1. Internal Medicine, Metropolitan Hospital<br />

Center, New York, NY; 2. Geriatric Medicine, Metropolitan Hospital<br />

Center, New York, NY.<br />

Introduction: Rhabdomyolysis is a condition characterized by<br />

muscle necrosis causing release of muscle enzymes into the circulation,<br />

resulting in elevated serum creatinine kinase (CK) levels. It is<br />

rarely caused by Amiodarone. We present a case of an elderly male<br />

with amiodarone-induced rhabdomyolysis.<br />

AGS 2012 ANNUAL MEETING<br />

S187


P OSTER<br />

A BSTRACTS<br />

Case: A 78 year-old male with history of coronary artery disease,<br />

hypertension and chronic atrial fibrillation was admitted following a<br />

fall without major injury. He presented with a two-month history of<br />

progressive muscle weakness and pain resulting in difficulty in ambulation.<br />

He underwent coronary artery bypass graft two months prior.<br />

Medications included cardizem, digoxin, warfarin, simvastatin, amiodarone.<br />

Physical examination was remarkable for generalized muscle<br />

tenderness and decreased muscle strength of 3-4/5 in all four extremities.<br />

Laboratory tests showed elevated CK of 10,280, aspartate<br />

aminotransferase of 563, alanine aminotransferase of 403, alkaline<br />

phosphatase of 99, normal renal function. Urinalysis showed large<br />

blood with 5-10 red blood cells. Simvastatin was stopped and patient<br />

was started on intravenous hydration. His CK level transiently decreased<br />

to 8,900, but on the third day it increased to 11,600. Intravenous<br />

hydration was continued and bicarbonate drip was started.<br />

Patient’s family later reported that amiodarone was just recently<br />

started after the bypass graft two months prior. Amiodarone was<br />

stopped and the patient’s clinical status steadily improved. By day<br />

seven, his CK level dropped to 700.<br />

Discussion: The severity of rhabdomyolysis ranges from asymptomatic<br />

elevations in serum muscle enzymes to life-threatening cases<br />

with extreme enzyme elevations, electrolyte imbalances and renal<br />

failure. Classic presentation includes myalgia, red to brown urine due<br />

to myoglobinuria, and elevated serum CK levels. Many drugs are<br />

known to cause rhabdomyolysis including statins, colchicine, and cocaine.<br />

Few cases of amiodarone-induced rhabdomyolysis have been<br />

reported. In this case, the patient continued showing worsening CK<br />

levels in spite of stopping the statin. His clinical status and CK level<br />

dramatically improved upon discontinuation of amiodarone. Physicians<br />

must keep in mind that amiodarone can be one of the uncommon<br />

causes of rhabdomyolysis.<br />

D2<br />

Chronic Subdural Hygroma presenting as Dementia.<br />

E. C. Ong, 1 N. Maheshwari, 1 E. Roffe, 2 S. Chaudhari, 1,2 D. Kumari, 2<br />

M. Belal. 1 1. Internal Medicine, Metropolitan Hospital Center, New<br />

York, NY; 2. Geriatric Medicine, Metropolitan Hospital Center, New<br />

York, NY.<br />

Introduction: Chronic subdural hygroma is common among elderly<br />

individuals. It is a lesser-known potentially reversible cause of<br />

dementia. We present a case of an elderly male with chronic subdural<br />

hygroma presenting as dementia.<br />

Case: An 81 year-old male with medical history of mild hypertension<br />

was brought in by his daughter to Geriatric clinic to establish<br />

medical care. Patient was recently seen by psychiatry and neurology<br />

due to insomnia and agitation (especially at night), started on Memantine<br />

and Donepezil for diagnosis of Dementia. Physical examination<br />

was unremarkable except for disorientation to place and time, inability<br />

to do three-item recall, and Mini-mental state examination<br />

score of 17/30. Laboratory tests were normal including thyroid functions,<br />

vitamin B12, and Syphillis IgG. CAT scan of the brain revealed<br />

chronic subdural hygroma overlying the right cerebral convexity with<br />

midline shift, moderate cerebral and cerebellar atrophy. Patient was<br />

referred to neurosurgery clinic, however patient and family refused to<br />

undergo any neurosurgical intervention. Repeat brain CAT scan<br />

showed increase in subdural hygroma with possible subacute and/or<br />

acute component, but patient had no worsening of clinical<br />

signs/symptoms on subsequent clinic follow-ups. Patient will be followed<br />

in neurosurgery, neurology and geriatric clinic with serial brain<br />

CAT scan.<br />

Discussion: Chronic subdural hygroma is a subdural collection<br />

of cerebrospinal fluid (CSF). This results from sudden decrease in<br />

pressure by ventricular shunting leading to leak of CSF from the subarachnoid<br />

space into the subdural space especially in cases with moderate<br />

to severe brain atrophy. Elderly patients are prone to develop<br />

hygromas owing to frequent falls sustaining head trauma, and significant<br />

cerebral atrophy related to old age. Large hygromas may cause<br />

secondary localized mass effects on the adjacent brain parenchyma<br />

causing neurologic symptoms. Global deficits such as disturbances of<br />

consciousness are more common than focal deficits. Brain CAT scan<br />

would show crescent-shaped extra-axial lesions. Surgical evacuation<br />

is recommended if there is evidence of moderate to severe cognitive<br />

impairment or progressive neurologic deterioration. Physicians<br />

should recognize chronic subdural hygroma as a reversible cause of<br />

dementia among the geriatric population.<br />

D3<br />

Actinomyces israelii - A rare cause of prosthetic joint infection in<br />

the elderly.<br />

G. Gulati, S. Gulati, D. Powell. Internal Medicine, The Reading<br />

Hospital and Medical Center, West Reading, PA.<br />

INTRODUCTION: Actinomyces prosthetic joint infections are<br />

extremely rare, described in only half a dozen case reports in medical<br />

literature. Our case describes a patient who presented with new onset<br />

prosthetic joint infection with no identifiable local or systemic source<br />

or trauma.<br />

CASE PRESENTATION: A 72 year old male with a history of<br />

left total hip replacement in 2002 presented to the hospital with a one<br />

month history of night sweats and progressively worsening pain in the<br />

left leg. He denied any fever, trauma or injury to the affected side. On<br />

physical exam, he had a temperature of 38.7 degrees Celsius and a<br />

pulse of 115 per minute. Musculoskeletal examination was significant<br />

for a tender left hip joint at the groin with limited range of motion.<br />

On laboratory work up, he had an ESR of 82mm/sec, CRP of 15<br />

mg/dL and leukocytosis of 31,300/cu mm with 90% neutrophils. CT<br />

scan of the hip revealed an attenuated fluid-filled distended region<br />

anterior to the hip prosthesis and muscular asymmetry suspicious for<br />

an abscess. Surgical arthrotomy of the left hip joint with debridement<br />

was done. On histopathology, the specimen showed granulation tissue<br />

with acute-on-chronic inflammation and grew Actinomyces israelli<br />

on cultures. He was started on ampicillin and later switched to doxycycline<br />

due to a significant allergic reaction to the former for 6 weeks.<br />

He was discharged with instructions for outpatient follow up for prosthesis<br />

removal.<br />

DISCUSSION: Actinomyces israelii, a gram positive anaerobic<br />

bacterium, causes infections involving the oral cervicofacial area,<br />

lungs and abdomen. Involvement of the musculoskeletal system is<br />

rare and attributable to adjacent soft tissue infections, occasionally to<br />

local trauma or hematogenous spread. Late infections of prosthetic<br />

joints have been described in literature as spread from an extra articular<br />

site. Diagnosis is established by bacteriological identification<br />

using sterile cultures showing characteristic appearance and sulfur<br />

granules. Penicillins are the mainstay of treatment, and use of tetracycline<br />

class has been reported in cases of penicillin allergy. A combination<br />

of medical and surgical therapy with consideration for prosthesis<br />

removal needs to be considered. Some experts recommend prolonged<br />

antibiotic courses for better results. Early recognition of this<br />

entity even in the absence of an obvious predisposing cause is required<br />

for early diagnosis and institution of therapy.<br />

D4<br />

Confusion, ataxia and psychosis - amphetamine toxicity in the<br />

elderly.<br />

G. Gulati, S. Gulati. Internal Medicine, The Reading Hospital and<br />

Medical Center, West Reading, PA.<br />

INTRODUCTION: Amphetamine abuse is the primary cause<br />

of emergency visits in 73,400 patients per year in the United States.<br />

Classic presentations include psychosis, agitation and sympathomimetic<br />

signs.<br />

CASE PRESENTATION: A 62 year old male with a past history<br />

of recreational drug abuse presented with acute onset unsteady<br />

S188<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

gait, word finding difficulty and erratic speech, with mild confusion<br />

and confabulation. Fixed delusions were also noted, as well as visual<br />

and auditory hallucinations. He and his accompanying family denied<br />

any recent alcohol use. On physical exam, he had a blood pressure of<br />

186/105, and neurological examination revealed hypertonia, positive<br />

Romberg’s test and abnormal heel to toe test as well as incoordination<br />

of movements. He also had some cog wheeling and would fall<br />

backwards on standing, which did not change with eyes being open or<br />

closed. Laboratory evaluation revealed stable CBC with differential,<br />

normal electrolytes, mild transaminitis, a negative blood alcohol level,<br />

negative Lyme test and RPR serology. It was however positive for<br />

amphetamines in the urinary drug screen. The patient was treated<br />

with as needed lorezapam and haloperidol. Over the next day or two<br />

he improved significantly and his problems including ambulatory<br />

dysfunction had resolved.<br />

DISCUSSION: Confusion, ataxia and psychosis are symptoms<br />

common to alcohol withdrawal, drug ingestion and other rarer medical<br />

conditions. Elucidating a cause becomes vital in the elderly where<br />

this triad may be a common presentation. It is important to remember<br />

to obtain a drug screen in a patient where symptoms don’t fit in<br />

and common diagnoses such as alcohol withdrawal seem less likely,<br />

even in extremes of age. Early interventions with atypical antipsychotics<br />

and benzodiazepines are warranted and bring about improvement<br />

in symptoms.<br />

D5<br />

An Interesting Case of Ankle Pain in an Arthritic Older Adult.<br />

I. Sulapas, D. S. Edwards, B. G. Jones. Family & Community Medicine,<br />

Texas Tech University Health Sciences Center, Lubbock, TX.<br />

Supported By: This project has received no funding.<br />

Introduction: Osteochondritis dissecans (OCD) of the talus is<br />

more commonly seen in the adolescent and young male population,<br />

but should be in the differential for ankle pain in an older adult.<br />

History: A 60-year-old Hispanic male presented with complaints<br />

of left ankle pain for the last 3 months. He has a long past medical history<br />

of diabetes (HbA1c 7.0%), coronary artery disease with stents,<br />

hypertension, osteoarthritis, stroke, and peripheral vascular disease.<br />

He is poorly compliant with his medications. The patient stated that<br />

he has never had an evaluation of his left ankle and denied any<br />

trauma to the foot. He is currently wheelchair bound secondary to a<br />

stroke four years ago. An angiogram two months prior to initial visit<br />

showed that his lower legs are well perfused. He described the ankle<br />

pain as sharp, located in the left medial ankle region with swelling,<br />

non-radiating, and pain only when he is bearing any weight. He denied<br />

any tingling sensation to his feet, as well as any locking or catching<br />

of his left ankle. Findings: On physical exam, there was 1+ edema<br />

on the medial portion of left ankle, 2+ pulses on left posterior tibialis<br />

and dorsalis pedis arteries, and brisk capillary refill noted. There was<br />

tenderness on both the tibiotalar joint and the medial malleolus, and<br />

full ankle passive and active range of motion. His sensation was intact,<br />

and 3/5 motor strength. A radiograph of the left ankle revealed a<br />

large subchondral bone defect extending into the articular surface of<br />

the talar dome and joint effusion (Stage IIb). A subsequent MRI<br />

showed a 1.5 cm osteochondral defect of the medial portion of the<br />

talus extending to the articular surface without definite evidence of<br />

collapse.<br />

Discussion: Clinicians should include OCD in the differential diagnosis<br />

for chronic ankle pain in an older adult. OCD is a relative<br />

rare disorder that is characterized by an area of subchondral bone<br />

that undergoes necrosis. The adult form of OCD is commonly seen in<br />

patients from 16 to 50 years of age. Knee joints are most common,<br />

with 75% of cases reported, followed by the elbow (6%), then ankle<br />

4%). The talus supports the axial load during weight-bearing, so it<br />

plays a vital role in ankle motion. Treatment involves immobilization<br />

and observation, however if symptoms persist or grinding or catching<br />

develops, an orthopedic consult is warranted for arthroscopic drilling<br />

versus bone graft.<br />

D6<br />

“Doc, I want to die”: the ethical dilemma of a patient’s right to<br />

refuse life-saving treatment due to a death wish.<br />

J. K. Yuen, 1 K. Covinsky, 1,2 R. Sudore. 2,1 1. <strong>Geriatrics</strong>, UCSF, San<br />

Francisco, CA; 2. VAMC, San Francisco, CA.<br />

Case: A 64 year-old recently widowed man presented with fever,<br />

weight loss and abdominal pain. CT scan revealed multiple liver abscesses.<br />

Infectious Disease thought that drainage and antibiotics<br />

would be curative and that no treatment would be fatal. The patient<br />

initially consented to drain placement but later refused further drain<br />

manipulation, antibiotics and antidepressants stating, “I have nothing<br />

to live for” and “I want to die.” Psychiatry evaluation revealed that he<br />

had a long history of depression and refusal of medical and psychiatric<br />

treatment. Multiple discussions took place over two weeks between<br />

the patient and his primary team, Palliative Care, and Psychiatry.<br />

All providers agreed that he expressed a clear choice and<br />

understood the risks of his decision. Yet, there were conflicting opinions<br />

regarding his decision-making capacity. Some providers were<br />

deeply disturbed by the patient’s irrational choice and felt that his depression<br />

and passive suicidal ideation rendered him incapable of<br />

making decisions. Others felt that the patient retained valid internal<br />

reasoning as evidenced by his clear and consistent thought process.<br />

The ethics committee deliberated and deferred the capacity determination<br />

to the primary team who felt the patient retained capacity. The<br />

patient opted for comfort care, antibiotics were discontinued, and the<br />

patient was transferred to an inpatient hospice unit.<br />

Discussion: This case highlights the dilemma between the ethical<br />

principles of beneficence and honoring patients’ autonomy to refuse<br />

treatment – in this case, for a curable and otherwise fatal condition in<br />

the setting of depression and a wish to die. A diagnosis of depression<br />

is not sufficient to render someone incapable of decision making. To<br />

have capacity, patients must demonstrate reasoning as defined as consistency<br />

of choice and the ability to weigh the risks, benefits and consequences<br />

of decisions. Disagreement arises over whether the determination<br />

of intact reasoning should be based upon a patient’s<br />

internal values and worldview or whether the external rationality of<br />

the patient’s decision in the context of societal norms should also be<br />

considered. Although the patient in this case made a choice that is<br />

considered highly irrational by many, it was determined that he<br />

demonstrated intact reasoning and the capacity to refuse treatment.<br />

D7<br />

Rapid Onset Hyponatremia After Initiating TMP/SMX and<br />

Citalopram.<br />

J. M. Redding, 1 S. Nichols, 2 S. Hallen. 1 1. Dept. of <strong>Geriatrics</strong>, Maine<br />

Medical Center, Portland, ME; 2. Dept. of Pharmacy, Maine Medical<br />

Center, Portland, ME.<br />

TMP/SMX-induced hyponatremia, while rare, is a likely underdiagnosed<br />

event. By decreasing aldosterone-mediated sodium reabsorption<br />

in the collecting duct, TMP/SMX, in synergy with other<br />

serum sodium-lowering medications, such as selective serotonin reuptake<br />

inhibitors (SSRIs), may cause severe hyponatremia.<br />

A 79-year-old female was admitted with weakness, confusion,<br />

and a serum sodium of 119mEq/L (140 mEq/L 10 days prior to admission.)<br />

Citalopram and TMP/SMX had been initiated 7 and 3 days<br />

prior, respectively. On exam, the patient appeared euvolemic. Laboratory<br />

data revealed hypotonic hyponatremia (serum osmolality=248mOsm/kg)<br />

with a creatinine clearance of 36ml/min. A head<br />

CT was normal. Both medications were discontinued on admission.<br />

Initial therapy with 0.9% NaCl resulted in a decreased sodium level<br />

of 117mEq/L after 4 hours. A slow infusion of 3% NaCl then increased<br />

her sodium to 129meq/L (12mEq/L in 24hrs). She was transitioned<br />

to a fluid restriction of 1.5L/day and her sodium increased further<br />

to 136mEq/L by hospital day 4, with resolution of her symptoms.<br />

The patient developed severe, rapid onset hyponatremia after<br />

initiating TMP/SMX in addition to citalopram. We hypothesize that<br />

AGS 2012 ANNUAL MEETING<br />

S189


P OSTER<br />

A BSTRACTS<br />

two synergistic mechanisms caused the hyponatremia. The first was<br />

the syndrome of inappropriate antidiuretic hormone (SIADH) secondary<br />

to citalopram. Her presentation is consistent with SIADH as<br />

evidenced by euvolemia, low serum osmolality, and worsening hyponatremia<br />

with a normal saline challenge. We find support for a second<br />

mechanism from the unusually rapid and severe onset of the<br />

SSRI-induced SIADH. The addition of TMP/SMX may have worsened<br />

the hyponatremia through trimethoprim-mediated aldosterone<br />

antagonism. Consistent with this hypothesis, the patient showed rapid<br />

improvement of her hyponatremia by hospital day 4, when citalopram<br />

was still present in her serum while TMP/SMX was already<br />

eliminated. (Given the patient’s age and renal function, TMP/SMX’s<br />

T½=18hrs and citalopram’s T½=50hrs.)<br />

The potential synergism between TMP/SMX and citalopram, as<br />

observed in this case, merits a warning as a potential drug interaction.<br />

Providers should take care when adding TMP/SMX to a regimen containing<br />

other potentially hyponatremia-inducing medications, particularly<br />

in cases of renal dysfunction.<br />

D8<br />

Missed Diagnosis of Waldenstrom’s Macroglobulinemia and<br />

Systemic Amyloidosis in a Patient Diagnosed as Follicular<br />

Lymphoma.<br />

J. Silvestre, S. Saad. Montefiore Medical Center / Albert Einstein<br />

College of Medicine, Bronx, NY.<br />

Supported By: No financial disclosures<br />

Waldenstrom’s Macroglobulinemia (WM) is a rare lymphoplasmacytoid<br />

malignancy present in 2.5/million/year. Of these, < 5% develop<br />

systemic amyloidosis (AL). We present a case of WM complicated<br />

by AL, erroneously diagnosed as a benign follicular lymphoma.<br />

Cardiac amyloidosis and WM were found on postmortem pathology.<br />

Case: A 79 year old male was transferred from a nursing home<br />

because of fever and hypotension.<br />

His past medical history included hypertension, seizure disorder,<br />

anemia, peptic ulcer disease, Parkinson’s disease. Patient had an excellent<br />

functional and cognitive status until diagnosed with follicular<br />

center lymphoma with M-gammopathy by biopsy 15 months before<br />

presentation. On retrospective analysis, flow cytometry was CD10+,<br />

CD19+, and CD20+. PET CT scan showed minimal involvement of<br />

retroperitoneal lymph nodes but no hepatosplenomegaly. Bone scan<br />

was negative, IgM > 5 g/dL, and beta-2-microglobulin was elevated.<br />

He had received one month of rituximab. Soon afterwards, he developed<br />

diverticular perforation requiring colostomy. Later, a delayed<br />

colostomy reversal surgery was complicated by sepsis and acute kidney<br />

injury, needing dialysis. Subsequent clinical course worsened with<br />

functional decline and multiple admissions due to urinary tract infections,<br />

C. difficile diarrhea, and health care associated pneumonia.<br />

Hospital Course: On the Emergency Department, the patient<br />

was hypotensive and unresponsive. Laboratory data showed pyuria,<br />

leukocytosis, and anemia. Electrocardiogram showed normal sinus<br />

rhythm. Chest X-ray showed mild congestive heart failure. Prior<br />

echocardiogram showed normal function but left ventricular hypertrophy.<br />

The patient was fluid resuscitated and treated with broad<br />

spectrum antibiotics for presumed sepsis. Later he defervesced and<br />

stabilized, however his heart failure worsened. His overall prognosis<br />

remained poor. Palliative care was instituted and he expired 12 days<br />

after admission.<br />

On postmortem pathology, extensive systemic amyloidosis was<br />

found and significant cardiac involvement was reported. Lymphoplasmacytoid<br />

cells were identified, suggestive of WM.<br />

Discussion -<br />

When patients with lymphoma and gammopathy develop symptoms<br />

of heart failure, AL should be suspected since it drastically reduces<br />

the survival. Expression of CD10 and CD23 may be found in 10<br />

to 20% of cases and should not exclude WM. Coexistence of WM and<br />

AL carry a grim prognosis.<br />

D9<br />

Topical clindamycin phosphate use for chest wall follicultis<br />

complicated by severe Clostridium difficle infection.<br />

J. Palla, 1 S. M. Imam, 1,2 S. B. Johnson. 3,4 1. <strong>Geriatrics</strong>, Edward Hines<br />

VA Hospital, Hines, IL; 2. Internal Medicine, Loyola university<br />

Hospital, Maywood, IL; 3. Infectious Disease, Edward Hines VA<br />

Hospital, Hines, IL; 4. Infectious Disease, Loyola university Hospital,<br />

Maywood, IL.<br />

Back ground: Topical application of clindamycin is not a well<br />

recognized risk for Clostridium difficile infection (CDI) but the association<br />

has been reported. We report a rare case of severe CDI following<br />

topical clindamycin phosphate use.<br />

Case report: A 62 year old male resident of a nursing home was<br />

transferred to the emergency room with fever, hypotension and<br />

tachycardia. He had history of Hartmann’s Colostomy done 4 months<br />

ago for recurrent diverticulitis followed by severe CDI. No history of<br />

exposure to antibiotics in the past 4 months or any other symptoms<br />

were elicited. Medication review did show 1% clindamycin phosphate<br />

ointment prescribed 3 weeks ago for chest wall folliculitis.<br />

Physical exam was non-contributory. Initial workup showed leukocytosis<br />

and a normal chest x-ray. Although bacterial sepsis was suspected<br />

initially, he developed loose colostomy output shortly after<br />

presentation and the white blood count increased to 23000 per cc 3 .<br />

Oral vancomycin treatment was started for suspected CDI and the diagnosis<br />

was confirmed by stool C.difficile toxin assay. The leukocytosis<br />

and loose colostomy output improved within 48 hrs. He was transferred<br />

back to the nursing home, where the clindamycin ointment was<br />

identified as a possible trigger for the colitis and was discontinued.<br />

Discussion: Twenty cases of topical clindamycin related diarrhea<br />

and two case reports of proven CDI were published from 1978 to<br />

1986. Pharmacokinetic and pharmacodynamic studies after topical<br />

clindamycin application have shown detectable serum concentrations<br />

and presumptive effects on intestinal flora. Animal studies have<br />

shown that the lethal dose applied topically to hamsters was similar to<br />

doses given to humans for treatment of acne. It is important to recognize<br />

this potential side effect of topical administration of clindamycin<br />

and use it cautiously, particularly in patients at high risk for CDI.<br />

D10<br />

Uncommon causes of intractable hallucinations in the demented<br />

elderly.<br />

K. Alagiakrishnan. Medicine, University of Alberta, Edmonton, AB,<br />

Canada.<br />

Introduction: Hallucinations are false sensory perceptions or experiences<br />

that a person sees, hears, smells or feels something but do<br />

not exist. It can be the result of the brain changes in dementia or as a<br />

result of medical problems. In this report, three uncommon causes of<br />

hallucinations in dementia patients are presented.<br />

Case reports:<br />

Case 1:<br />

A 75 year old female came for cognitive assessment. She had<br />

cognitive decline for the past two years. For the past four months, patient<br />

smelled sour gas (olfactory hallucinations) in the basement and<br />

it was thought to be due to confusion, which was secondary to dementia.<br />

A short course of antipsychotics did not help with the symptom.<br />

On one occasion, patient called the police for this problem. At<br />

that time a neurologist saw the patient in the ER and was sent home<br />

with a suspicion of query small stroke. During our assessment, we<br />

found no history of epilepsy or psychiatric disorders. There was no evidence<br />

of delirium or no neurological deficits were seen. MRI of the<br />

head showed large infiltrating mass involving both cerebral hemispheres<br />

and the differential diagnosis was an astrocytoma or possible<br />

lymphoma.<br />

Case 2:<br />

S190<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

An 80 year old woman, with a known history of dementia for<br />

the past five years, came for assessment of visual hallucinations (seeing<br />

a man through her bedroom window daily for the past nine<br />

months). No history of vision problems or psychiatric disorders.<br />

Cholinesterase inhibitor and antipsychotic treatment did not help<br />

with the visual hallucinations. A CT head taken at that time compared<br />

with the previous CT scan taken before one year showed an<br />

occipital lobe infarct, which might be contributing to these visual<br />

hallucinations.<br />

Case 3:<br />

An 84 year old male with a known history of dementia for the<br />

past 3 years came with a history of buzzing sound in the head (auditory<br />

hallucinations) for the past 5 months. Antipsychotic management<br />

did not help with the problem. A complete assessment including<br />

CT scan did not show any acute findings, except decreased hearing in<br />

both ears. Patient was sent to an audiologist and with the help of<br />

hearing aids, patient’s symptom got better.<br />

Conclusion:<br />

Psychotic behaviors may pose more challenges than cognitive<br />

decline for the demented patients as well as their caregivers. When<br />

demented patients present with intractable hallucinations, not responding<br />

to medical management, rare and unusual causes of hallucinations<br />

should be considered.<br />

D11<br />

Effect of language in cognitive testing of a bilingual older adult.<br />

K. Berg, 1 S. Mejnartowicz, 1 B. Olmedo, 1 L. Walke. 1,2 1. Yale School of<br />

Medicine, New Haven, CT; 2. VA Connecticut, West Haven, CT.<br />

Supported By: The authors have no financial disclosures to report<br />

Objective: Recognize potential language bias in cognitive testing<br />

of bilingual older adults<br />

Case: An 80-year-old Hispanic veteran was brought to the geriatrics<br />

consult clinic for a cognitive assessment. He graduated high<br />

school in Puerto Rico and had worked in English speaking settings in<br />

the United States for over 60 years. During the initial visit, he scored<br />

18/30 on the English language Mini-Mental State Examination with<br />

deficits in orientation (-8), recall (-3) and constructional praxis (-1).<br />

Three months later we administered the Saint Louis University Mental<br />

Status in English to better evaluate executive function. He scored<br />

13/30 with deficits in story comprehension (-6), recall (-4), orientation<br />

(-2), animal generation (-2), reverse digit span (-1), and clock drawing<br />

(-2) and was started on a cholinesterase inhibitor. At his 6-month<br />

visit, we repeated both tests in Spanish. Using the validated Spanish<br />

MMSE his score improved from 18/30 to 21/30 with changes in orientation<br />

(+2) and constructional praxis (+1). An on-site certified translator<br />

converted the SLUMS into Spanish making two cultural<br />

changes to the content: the characters “Jack and Jill” were changed to<br />

“Maria and Jose” and instead of a stockbroker, Maria was described<br />

as a businesswoman who owned a factory. On the Spanish version of<br />

the SLUMS, the patient’s score improved from 13/30 to 22/30 with the<br />

greatest changes in story comprehension (+4), clock drawing (+2), animal<br />

generation (+1), recall (+1) and attention (+1).<br />

Discussion: The 9-point difference on the SLUMS and 3-point<br />

difference on the MMSE illustrate several understudied issues regarding<br />

cognitive testing and among bilingual older adults. First, the<br />

effect of language may be more pronounced in tests of executive dysfunction,<br />

language generation and comprehension, which are core<br />

domains of cognition. Second, little is known about the effect of bilingualism<br />

on the aging brain or if there is a differential impact of cognitive<br />

deficits on the languages spoken by bilingual older adults, and<br />

these areas merit research. Lastly, because testing in the patient’s<br />

non-native language may misrepresent cognitive deficits, clinicians<br />

should attempt to administer language appropriate cognitive tests before<br />

making diagnostic and therapeutic decisions.<br />

D12<br />

Acute Encephalopathy as a complication of Small Bowel<br />

Obstruction.<br />

K. P. McIntosh, C. Rommesser, T. Caprio. Medicine, University of<br />

Rochester School of Medicine & Dentistry, Rochester, NY.<br />

Supported By: HRSA GTPD Grant #D01HP08792<br />

Background:<br />

We present a case of acute encephalopathy seen in a patient<br />

with a small bowel obstruction. The gastrointestinal tract has been<br />

classically seen as the main source of circulating and excretion of ammonia.<br />

This small molecule crosses the blood-brain barrier and is absorbed<br />

and metabolized by the astrocytes, a population of cells in the<br />

brain that constitutes 30% of the cerebral cortex. It is hypothesized to<br />

be a minor contributor in the cascade leading to encephalopathy associated<br />

with acute illness.<br />

Case Presentation:<br />

A 74 year old female nursing home resident with a history of f<br />

incisional and umbilical hernia repair was acutely admitted to the<br />

hospital with abdominal pain, nausea, and bilious vomiting and subsequently<br />

found to have a complete small bowel obstruction on CT<br />

scan. During her hospital course as the patient’s obstruction was<br />

medically managed via decompression, she ultimately developed significantly<br />

elevated ammonia levels, diffuse encephalopathy, and ultimately<br />

developed status epileptic. Her ammonia level at the time of<br />

her coma presentation was 193 mcg/dL. Her status epilepticus resolved<br />

with antiepileptic medications and with resolution of her small<br />

bowel obstruction she was treated with lactulose to help mitigate additional<br />

production of toxic ammonium metabolites. She improved<br />

significantly with concurrent rapid resolution of her elevated ammonia<br />

levels.<br />

Discussion:<br />

This case presents a unique presentation that shows an uncommon<br />

but likely complication of having an acute small bowel obstruction.<br />

Traditionally focus has been on hepatic impairments in clearance<br />

of ammonia containing metabolites as the primary cause of<br />

encephalopathy. However, it is necessary to be mindful of the significant<br />

role the small bowel plays in eliminating and producing toxic<br />

levels of ammonia. This case also illustrated the challenge of trying to<br />

reduce ammonia products with laxative in the setting of an immotile<br />

bowel due to the obstruction. The question of whether surgical correction<br />

a small bowel obstruction would have lessened the risk of encephalopathy<br />

is also a question that needs to be addressed in this setting.<br />

There needs to be a timeline developed of how long to pursue<br />

the medical management that addresses correcting the obstruction<br />

while simultaneously attempting to mitigate the toxin production<br />

contributing to a worsening encephalopathy.<br />

D13<br />

When a Good Story Gives the Wrong Impression: An Atypical<br />

Presentation of Complete Heart Block.<br />

K. James, I. Kopits. Department of Medicine-Section of <strong>Geriatrics</strong>,<br />

Boston University Medical Center , Boston, MA.<br />

Introduction: Syncope is a common clinical event in geriatric<br />

medicine and increases three-fold in patients over 80 years of age.<br />

The ability to risk stratify patients to outpatient versus inpatient management<br />

is critically important.<br />

Case Report: An 89 year old man with a history of diverticular<br />

bleeds, hypertension and an MI 15 years prior, presented for evaluation<br />

of nausea and dry heaves. His symptoms began suddenly and persisted<br />

episodically throughout the day. He was unable to take any<br />

food or medications by mouth and developed mild diffuse abdominal<br />

pain. He denied dizziness, palpitations or chest pain and had no postural<br />

changes in blood pressure or pulse. In clinic he began belching<br />

loudly. He then became pale and diaphoretic followed shortly by loss<br />

of postural tone. He was unresponsive for approximately 10 seconds<br />

AGS 2012 ANNUAL MEETING<br />

S191


P OSTER<br />

A BSTRACTS<br />

then awoke spontaneously and continued to wretch. His mental status<br />

was at baseline and he reported feeling well as he was taken to the ED<br />

for further evaluation. EKG was notable for first degree AV block<br />

(PR interval 224ms, unchanged from prior). Results of a CBC, serum<br />

chemistries, Echocardiogram (done one month prior), and abdominal<br />

CT scan were normal. He was able to eat and drink and had no further<br />

syncopal episodes during 8 hours of observation in the ED. Our<br />

clinical impression was reflex mediated vasovagal syncope secondary<br />

to significant upper gastrointestinal distress. Despite this benign explanation<br />

of his syncope, the ED physician admitted him to a telemetry<br />

bed. Hours later he displayed multiple episodes of complete heart<br />

block (CHB), with one episode resulting in loss of consciousness followed<br />

by vomiting.A temporary pacing wire was placed followed by a<br />

permanent pacemaker the next day. He experienced complete resolution<br />

of his GI symptoms following pacemaker implantation.<br />

Conclusion: Current practice guidelines emphasize the preeminence<br />

of an accurate history in determining the etiology of syncope.<br />

This patient’s atypical presentation of CHB mimicked reflex mediated<br />

vasovagal syncope. His age and remote history of MI led to his<br />

admission, though it seems likely that many physicians would have<br />

discharged this patient. This case demonstrates the importance of<br />

maintaining a high index of suspicion for atypical presentations of arrhythmic<br />

syncope in very elderly patients with cardiac risk factors.<br />

D14 Encore Presentation<br />

A fatal case of treatment resistant C. difficile colitis.<br />

K. S. Malik, M. Reisner ( AGS-F ). internal medicine, jersey city medical<br />

center, Jersey City, NJ.<br />

Introduction: C.diff colitis is frequently associated with previous<br />

antibiotic use especially in the elderly population and those with recent<br />

exposure to hospitals, nursing homes and daycare centers. The<br />

“National Prevalence Study of C.Diff in U.S. Healthcare Facilities”<br />

indicates that 13 out of every 1,000 inpatients were either infected or<br />

colonized with C.Diff. Mortality rate as high as 25% in elderly patients<br />

who are frail and immuno-compromised.<br />

Recurrence occurs in approximately 25 percent of cases. Oral<br />

vancomycin is the preferred therapy for severe or refractory cases.<br />

Combination of oral vancomycin and intravenous metronidazole for<br />

patients of C. diff with ileus is shown to be very effective. Efficacy of<br />

this treatment in geriatric population is still questionable.<br />

We present a treatment resistant case of C.diff colitis.<br />

Case Description: Ms L was a 95 year old female with a history<br />

of dementia and recent appendectomy who presented with C.diff colitis<br />

to the hospital. Her colitis resolved after 10 days course of<br />

Metronidazole.<br />

Approximately 4 weeks later Ms. L developed watery diarrhea,<br />

five to six times a day associated with weight loss. There were no<br />

symptoms of nausea, vomiting, abdominal pain, fever, chills or rash.<br />

Upon arrival in ER, she was thermodynamically stable, Normal<br />

physical exam with leukocytosis of 16. Patient was admitted and<br />

Metronidazole restarted.<br />

Stool for C.diff toxin was positive. Within 48 hours, her condition<br />

deteriorated. WBC rose from 16 to 50 and progressed to septic shock.<br />

Ms L was transferred to MICU and aggressive intravenous fluid therapy<br />

with vasopressors and oral vancomycin was added to the regimen.<br />

Subsequently she developed diffuse abdominal tenderness.<br />

WBC further increased to 112 with lactic acidosis of 11. Despite the<br />

classic presentation of C.Diff, leukocytosis of 112 prompted an evaluation<br />

for acute leukemia, and a flow cytometry was done which was<br />

normal.<br />

CAT scan of the abdomen revealed diffuse pseudomembranous<br />

colitis; developed multiorgan failure, ARDS and deceased within 96<br />

hours of admission.<br />

Conclusion:<br />

C. diff colitis is associated with significant mortality in the geriatrics<br />

patients. Extensive leukocytosis is associated with poor prognosis.<br />

Decreased immunity and multiple co morbidities are responsible<br />

for this increased incidence in the elderly population. The clinical syndrome<br />

of chronic C. diff and the best treatment options in this population<br />

group needs to be further investigated.<br />

D15<br />

Diabetes is Associated with Functional Impairments in HIV+ Older<br />

Adults.<br />

K. Shah, 1 T. N. Hilton, 2 A. E. Luque, 1 W. J. Hall. 1 1. Medicine,<br />

University of Rochester, Rochester, NY; 2. Physical therapy, Ithaca<br />

College, Rochester, NY.<br />

Supported By: This abstract was supported in part by the University<br />

of Rochester Developmental Center for AIDS Research (NIH<br />

P30AI078498)and John A Hartford Foundation Center for<br />

Excellence in Geriatric Medicine and Training.<br />

BACKGROUND: The prevalence of glucose intolerance and<br />

diabetes in HIV+ patients has increased dramatically following the<br />

widespread use of highly active antiretroviral therapy and the improved<br />

survival rate in this population. The risk is further exacerbated<br />

as this population ages. Although it is known that HIV+ patients<br />

are at increased risk of frailty, little is known regarding the<br />

impact of diabetes on physical function in HIV+ older adults (HOA).<br />

PURPOSE: To explore the nature of functional impairment in HOA<br />

with glucose intolerance status as measured by having diabetes.<br />

METHODS: Twenty HOA (mean age=60 y; 30% female) participated<br />

in a case-control study at an urban HIV clinic. Ten HOA with<br />

diabetes were matched to ten HOA controls without diabetes on age,<br />

gender and BMI. Subjective and objective measures of functional status<br />

were evaluated using the Physical Performance Test (PPT),<br />

graded treadmill test, isokinetic dynamometer, gait speed, balance<br />

and functional status questionnaires (FSQ). Body composition was<br />

evaluated using DXA. Muscle quality was evaluated by determining<br />

the ratio of leg strength to leg lean mass. RESULTS: The two groups<br />

were comparable in duration of HIV, CD4 count and viral load. Compared<br />

with matched controls, the case patients had lower scores in<br />

PPT, peak aerobic power, and FSQ (p


P OSTER<br />

A BSTRACTS<br />

agent has been rarely described in female residents of long-term care<br />

facilities.<br />

Case<br />

74 year old woman with moderate dementia admitted from<br />

home because of need for increased supervision. The patient developed<br />

more frequent episodes of urinary incontinence and she was<br />

treated for two urinary tract infections. About nine months after admission,<br />

a urogynecology nurse practitioner recommended a regimen<br />

of treatment including tamsulosin. In addition geriatrics staff reviewed<br />

the case and recommended stopping nortriptyline, which the<br />

patient was taking for depression. The tamsulosin was well-tolerated,<br />

and the patient had decreased daytime incontinence and the patient<br />

felt she was able to void more easily.<br />

Discussion:<br />

Tamsulosin (“Flomax”) is an alpha-blocker, thought to function<br />

at the bladder neck, leading to improved urine flow. Its use is controversial<br />

in women: there are few high quality studies involving women<br />

and many geriatricians have concerns about the potential side effects<br />

(e.g. orthostatic hypotension, increased congestive heart failure incidence).<br />

Tamsulosin has been recommended by some urologists in<br />

certain women with functional or anatomical bladder outlet obstruction,<br />

but its use has been rarely described in older women in nursing<br />

facilities.<br />

Conclusion:<br />

In this case, tamsulosin was used as part of a multidisciplinary<br />

intervention lead by a urogynecology nurse practitioner involving a<br />

search for causes, behavioral modifications, and medication adjustment.<br />

While this woman’s symptoms improved on tamsulosin, and the<br />

medication was well-tolerated, its role in the care of women with<br />

functional and anatomical obstruction remains controversial, and<br />

there is little good evidence demonstrating its benefits. Further research<br />

is needed to determine which women will most benefit from<br />

its use.<br />

D17<br />

Breast implant herniation masquerading coronary heart disease in<br />

an elderly woman.<br />

L. C. Andrade, 1 M. Raji, 1 J. G. Alamo. 2 1. Internal Medicine/<br />

<strong>Geriatrics</strong>, UTMB, Galveston, TX; 2. None, Pearland, TX.<br />

INTRODUCTION: Breast Implant complications and symptoms<br />

of coronary heart disease are rarely considered to have features<br />

in common. This report describes a case of a 69 year old Caucasian female<br />

with past medical history relevant for hyperlipidemia and overweigh,<br />

who presented with symptoms resembling coronary heart disease.<br />

Results of the physical examination were relatively benign. A<br />

Dobutamine Stress Test showed normal Ejection Fraction of 55%<br />

and was negative for inducible ischemic and wall motion abnormality.<br />

The patient had a Mammogram which showed bilateral<br />

silicone/saline implants and herniation medially of the left implant.<br />

She subsequently underwent bilateral breast implant removal with<br />

no complications.<br />

By this case presentation we want to discuss the evidence linking<br />

late breast implant complications with associated coronary symptoms.<br />

DISCUSSION: This case report illustrates that breast implant<br />

complications can present with atypical symptoms in the elderly<br />

which can mimic coronary heart disease. The elderly represent the<br />

fastest-growing segment of the <strong>American</strong> population and one that<br />

had breast implants inserted when younger. Breast reconstruction<br />

has also become a standard part of the care for female patients with<br />

breast cancer, the incidence of which increases with age. It is especially<br />

important not to confuse angina-like symptoms related to herniating<br />

breast implants with those related to heart disease. Heart disease<br />

is the number one killer of women. However, like our patient, if<br />

the stress and other cardiac tests are negative, breast implant herniations<br />

should be considered as part of the differential diagnosis of<br />

chest pain in older women with implant.<br />

CONCLUSIONS: Our patient with chest pain secondary to herniated<br />

breast implant presented with several misleading features of<br />

coronary syndrome. Negative workup with regard to coronary artery<br />

disease prompted us to look for integrity of the breast implants, which<br />

led to the correct diagnosis and guided the patient’s intervention.<br />

Late complications of breast implants should be a consideration on<br />

the differential diagnosis in patients with a history of breast implants<br />

presenting with chest pain. However, coronary heart disease work up<br />

should always be considered and cardiac causes ruled out first, prior<br />

to assuming the problem is solely due to the breast implant or some<br />

other non-cardiac problems.<br />

D18<br />

Insidious TB Meningitis in the Elderly.<br />

M. Chelagiri, A. Date, J. Shimonov, D. Asnis, A. Vela, D. Dave,<br />

H. Sharma, J. Campanova. <strong>Geriatrics</strong> Division, Flushing Hospital<br />

Medical Center, Flushing, NY.<br />

Introduction : Tuberculosis (TB) is a major global public health<br />

issue. Although pulmonary TB has declined in the last decade in US,<br />

the number of central nervous system (CNS)TB has remained the<br />

same. It accounts for 6% of all extra-pulmonary infection and 1% of<br />

all cases of TB diagnosed in the US. CNS TB includes: meningitis, tuberculoma<br />

and abscess. In the elderly, CNS TB can be subtle; leading<br />

to death in weeks if untreated.<br />

Case Report: 66 y/o healthy Asian Indian male, presented with<br />

progressive malaise, weakness, intermittent headache, high grade<br />

fevers, chills and productive cough for 12 days. Recent immigrant denies<br />

sick contacts. CT Chest revealed bilateral diffuse nodular inflammatory<br />

lesions consistent with miliary pattern. PPD and HIV were<br />

negative; quantiferon was positive. Sputum AFB x 3 were negative.<br />

Pleural biopsy showed necrotizing granulomas with AFB stain positive.<br />

RIPE was prescribed for miliary TB. The neurological status deteriorated<br />

with progressive malaise, headache, seizures, and confusion.<br />

CT Head revealed hydrocephalus. He was started on keppra,<br />

corticosteroids and intubated. Ventriculostomy drain was placed to<br />

relieve intracranial pressure. CSF analysis: low glucose, elevated protein,<br />

lymphocytic pleocytosis. AFB stain negative. MTB by PCR negative<br />

but AFB cultures in broth grew Mycobacterium tuberculosis by<br />

DNA probe. MRI brain confirmed meningeal disease and hydrocephalus.<br />

Subsequently, he was extubated and mental status improved,<br />

although residual neurological sequelae remained.<br />

Discussion: The BMRC classification is useful for prognosis and<br />

therapy: Stage 1-Lasts 2-3 weeks, malaise, lassitude, fever, anorexia,<br />

headache and personality change, Stage 2–Meningeal irritation, protracted<br />

headache, vomiting and cranial nerve palsies, and Stage 3-<br />

Clouding of sensorium, stupor, coma, seizures and hemiparesis. Risk<br />

factors are immigration from TB prevalent areas, crowded living,<br />

HIV, drug resistance. The worst prognostic factor for TB meningitis is<br />

the level of consciousness during the time treatment commenced.<br />

Conclusion: The most important determinant for the development<br />

of CNS TB has always been age. CNS TB is often not diagnosed<br />

promptly due to the nonspecific and subtle clinical features. Geriatricians<br />

must consider reactivation of TB in patients presenting with<br />

neurological symptoms from endemic regions. Early recognition and<br />

timely treatment is critical to prevent mortality and morbidity.<br />

D19<br />

Avoiding snap judgments: decreased oral intake resulting in<br />

admission to a geropsychiatric unit.<br />

M. Bednarczyk, 1 J. Chang, 2 M. Gorbien, 1 J. C. Olson, 1 M. J. Leiding. 1<br />

1. <strong>Geriatrics</strong>, Rush University Medical Center, Chicago, IL; 2. Family<br />

Medicine, Mt. Sinai Hospital, Chicago, IL.<br />

Background: Decreased oral intake and weight loss are common<br />

symptoms in the elderly, frequently attributed to depression,<br />

AGS 2012 ANNUAL MEETING<br />

S193


P OSTER<br />

A BSTRACTS<br />

cancer, non malignant GI disorders, and medication side effects. In a<br />

quarter of patients, no identifiable cause is found. However, somatic<br />

diseases may be mislabeled as a psychiatric disorder because specific<br />

organic symptoms may be overlooked or misinterpreted by physicians,<br />

psychiatrists, or by the patients themselves.<br />

Design/Methods: Case Reports of three patients admitted in a<br />

Geriatric Psychiatry Unit at RUMC<br />

Results:<br />

Patient #1: 95 y.o. female with decreased hearing and visual acuity,<br />

GERD admitted following suicide attempt by ingesting a bottle of<br />

Advil, complaining of regurgitation, cough and dysphagia. Videofluoroscopic<br />

swallow study showed large air filled esophagus and lack of<br />

peristaltic movement concerning for Zenker’s diverticulum. Patient<br />

declined further work up, her symptoms were managed conservatively.<br />

Patient #2: 74 y.o. female with HTN, DM2 presented with weakness,<br />

weight loss, sore throat, recurrent emesis for 2 months. She expressed<br />

paranoid thoughts of “aliens in her stomach.” Her family believed<br />

she was anorexic. She was diagnosed with gastric<br />

adenocarcinoma compressing the esophagus, necessitating G- tube<br />

and esophageal stent placement.<br />

Patient #3: 80 y.o. female nursing home resident with weight loss,<br />

depression, complaining of food sticking in her chest. Although a barium<br />

swallow was concerning for an esophageal stricture, EGD was<br />

negative. Ultimately, her symptoms resolved as her depression was<br />

treated.<br />

Relevance: Unintentional weight loss may lead to significant<br />

morbidity and mortality in elderly patients if left untreated. Although<br />

this is frequently attributed to an underlying psychiatric disorder,<br />

these diagnoses require absence of somatic disease. Two of these patients<br />

had a somatic cause for their illness, while in the last patient<br />

medical work up was necessary to verify a psychiatric cause of her decline.<br />

As geriatricians, we are taught to not overlook psychosocial<br />

causes of these symptoms. Nevertheless, a careful medical investigation<br />

to exclude a possible somatic disease mimicking a psychiatric disorder<br />

in elderly patients is essential.<br />

D20<br />

A Suspicious Case of Syncope: Can Factitious Disorder Occur in<br />

Persons with Dementia?<br />

M. Grammas, A. Donahue, M. Drickamer. Yale University School of<br />

Medicine, New Haven, CT.<br />

CASE: An 88-year-old man with a history of atrial fibrillation,<br />

dementia and depression presented with frequent episodes of loss of<br />

consciousness. He had several prior negative evaluations. Patient was<br />

OX3 and had a normal physical exam. He had mild, asymptomatic<br />

postural BP changes. CXR, head CT, ECG, echocardiogram and labs<br />

were normal. He scored 24/30 on MMSE with deficits in short-term<br />

recall and visual-spatial domains. His clock drawing showed perfect<br />

planning and ordering of numbers but incorrect hand placement.<br />

During the hospitalization, he had several episodes of loss of<br />

consciousness, some while supine, others when arising to stand. Vital<br />

signs, telemetry review, pacemaker interrogation, and continuous<br />

video EEG monitoring revealed no explanation.After emerging from<br />

one episode, the patient remarked, “You know I am faking all of this.<br />

I like to see you people come around.” Psychiatry consult stated that<br />

due to his dementia, he did not have the capacity to feign an illness.<br />

DISCUSSION: Transient loss of consciousness is not an uncommon<br />

presenting symptom among older adults. The most common<br />

causes are orthostasis, carotid hypersensitivity and cardiac abnormalities.<br />

Nonsyncopal causes include seizures, metabolic, intoxication<br />

and psychogenic. History and physical reveals the diagnosis in approximately<br />

half of cases. Imaging, cardiac and neurologic evaluations<br />

should be performed as indicated. While the spectrum of<br />

feigned medical illnesses are diagnoses of exclusion, they should also<br />

be considered when symptoms persist despite adequate evaluation.<br />

Simulated diseases arise from either unconscious or conscious behaviors.<br />

Among the conscious simulated diseases is factitious disorder,<br />

the intentional production of symptoms for a primary gain, to achieve<br />

the sick role. It is estimated that factitious disorder may account for<br />

as many as 5% of all physician visits with neurologic symptoms being<br />

among the most common. There is scant literature on whether factitious<br />

disorders occur in patients with dementia. Based on fMRI studies,<br />

the act of deception is associated with increased activity in prefrontal<br />

and anterior cingulate cortices, areas involved in executive<br />

function. Our patient, independent of ADLs and some IADLs and<br />

able to follow multiple step instructions, demonstrated a number of<br />

behaviors supporting executive function sufficient to consciously<br />

feign symptoms of illness.<br />

D21<br />

An unexpected death over 3000 miles from home: the importance of<br />

advance care planning.<br />

M. Koya. Internal Medicine, University of Washington, Seattle, WA.<br />

Case: A 66-year-old woman walked in with her husband to the<br />

emergency department complaining of dyspnea. Within an hour of arriving,<br />

the patient became hypoxemic and hypotensive requiring intubation<br />

and initiation of vasoactive agents. Workup revealed severe<br />

biventricular failure with an atrial septal defect (ASD) and a large<br />

right to left shunt. The patient was admitted to the cardiac intensive<br />

care unit (CICU). The husband stated to the on-call resident that they<br />

were visiting from New York, and her only past medical history was a<br />

remote history of breast cancer. They had never discussed advanced<br />

care planning. Efforts were made to contact her primary oncologist to<br />

obtain records; however this was unsuccessful. The husband asked the<br />

resident to “do whatever is necessary” and the patient underwent<br />

intra-aortic balloon pump and Swan-Ganz catheter placement. When<br />

she still did not improve, the team prepared for an ASD repair, but<br />

the patient was too unstable to leave the CICU. With the team’s recommendation,<br />

the husband and other family members who telephoned<br />

from New York agreed to withdraw care and the patient died<br />

immediately.<br />

After her death, medical records from her oncologist revealed<br />

that the patient was diagnosed with Stage II breast cancer over 10<br />

years ago and was status post chemotherapy. She was then lost to follow-up.<br />

Recently, she was discovered to have metastatic disease and<br />

heart failure with a cardiac shunt. Although she was prescribed cardiac<br />

medications, the patient declined to take them. She had never informed<br />

her husband about her cardiac condition.<br />

Discussion: This case illustrates the importance of advance care<br />

planning. The patient was more than 3000 miles away from her home,<br />

became critically ill very rapidly, and had not discussed her medical<br />

conditions or her wishes with her legal next of kin, her husband. Advance<br />

care planning helps ensure that patients have their wishes followed<br />

in the event they are unable to make their own decision at time<br />

of acute illness. In a study of adults 60 years or age or older, subjects<br />

who had living wills were more likely to want and receive limited care<br />

or comfort care than all care possible(1). Given her history of noncompliance<br />

with medical recommendations, there is a strong possibility<br />

that the patient would not have wished for many of the interventions<br />

that were administered. (1) Silverira et al. N Engl J Med. 2010<br />

Apr 1;362(13):1211-8<br />

D22<br />

Not Your Ordinary Syncopal Event: A Case of Aortocaval Fistula.<br />

M. Wirt, L. Cox-Vance. UPMC, Pittsburgh, PA.<br />

Syncope, a common presenting symptom, challenges providers<br />

to determine the underlying cause and any increased risk for death.<br />

Abdominal aortic aneurysm (AAA) rupture and related complications<br />

can be missed if not considered in the patient presenting with<br />

syncope.<br />

A 76 yo man with hypertension, coronary artery disease and<br />

atrial fibrillation presented to the emergency room after a syncopal<br />

S194<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

episode. He was alert and coherent but noted to be diaphoretic,<br />

tachycardic and hypotensive with an irregular pulse. EKG revealed<br />

supraventricular tachycardia which converted to sinus tachycardia<br />

with IV adenosine. His hypotension remained refractory to normal<br />

saline boluses and a norepinephrine infusion was added with resultant<br />

blood pressure stabilization. Initial laboratory evaluation revealed<br />

normal electrolytes, hematocrit of 40%, WBC 14.8 x 10^9 /L,<br />

Troponin I 0.10ng/ml and INR 1.4. A repeat EKG showed atrial fibrillation<br />

with diffuse ST depression. Chest x-ray was without acute<br />

changes. The patient was transferred to the intensive care unit (ICU)<br />

with preliminary diagnoses of hypotension, elevated troponin and<br />

atrial fibrillation.<br />

During initial ICU assessment, a pulsatile abdominal mass was<br />

noted. Urgent CT angiography revealed an 8.7 X 8 cm infrarenal<br />

AAA with contrast leaking into the right common iliac vein and inferior<br />

vena cava. The patient underwent emergent open repair of the<br />

ruptured AAA and aortocaval fistula with grafting of the right iliac<br />

and left common femoral arteries. The bowel was noted to be dusky<br />

necessitating urgent left hemicolectomy and sigmoidectomy.<br />

The patient returned to the intensive care unit where he remained<br />

intubated but responsive. He continued to require pressor<br />

support and required massive blood product transfusion. Within several<br />

hours, evidence of ongoing bowel ischemia was noted with discussion<br />

of further debridement of the bowel. The patient’s family declined<br />

further aggressive care and the patient died approximately 30<br />

hours after the initial syncopal event.<br />

This case illustrates the importance of careful differential diagnosis<br />

and thorough physical examination in the evaluation of patients<br />

presenting with syncope. AAA rupture, with or without the rare complication<br />

of aortocaval fistula, must be considered in the syncope differential<br />

as the rapidity of diagnosis and surgical intervention significantly<br />

impacts survival.<br />

D23<br />

Dementia and “Delirium” Due to Whole Brain Radiation in a<br />

Cancer Survivor.<br />

M. Elarabi, M. Brennan. Baystate Medical Center, Springfield, MA.<br />

Introduction<br />

Radiation therapy (RT) is important in treating CNS tumors.<br />

Sufficient doses of RT eradicate neoplasms but will inexorably damage<br />

normal tissue. Controversy persists around the impact of RT on<br />

the adult brain. The authors report a case of a patient with recurrent<br />

admissions for “delirium” that proved to be due to ongoing radiation<br />

induced damage.<br />

Case<br />

A 67 year old man had a craniopharyngioma resection and RT<br />

25 years ago; he had hypopituitarism, stroke, and dementia and was<br />

admitted twice in a month with profound stupor and excessive daytime<br />

sleepiness. On the first occasion he was intubated for airway protection.<br />

The geriatrics team was asked to assess his delirium. His physical<br />

examination was only remarkable for gait ataxia. His MMSE was<br />

28/30; a Geriatric Depression Scale was negative but a urinalysis was<br />

positive. An MRI revealed atrophy, old lacunar infarcts and chronic<br />

white matter changes suggesting small vessel ischemia. A video EEG<br />

revealed mild to moderate diffuse cerebral dysfunction. A<br />

polysomnogram showed mild OSA and an irregular sleep cycle. His<br />

cognitive impairment, hypersomnolence and loss of circadian rhythm<br />

proved to be due to a damaged hypothalamic pituitary axis as a result<br />

of his tumor and RT induced brain injury.<br />

Discussion<br />

There are 3 types of radiation injury: acute, early delayed and<br />

late delayed. Late delayed injury is irreversible, occurs 6 months to<br />

many years later and primarily damages the white matter causing atrophy,<br />

leukoencephalopathy, neurocognitive decline and hypothalamic-pituitary<br />

and endocrine dysfunction. The proposed etiology is<br />

vascular and likely results from damage to capillary endothelial cells,<br />

increased microvascular permeability and impaired blood brain barrier<br />

integrity leading to ischemia. Analyzing the impact of RT is confounded<br />

by injury from cerebrovascular disease, baseline impairments<br />

in cognition and multifactorial interactions of tumor, surgery,<br />

chemotherapy and steroids.<br />

Conclusion<br />

Tools to measure and identify radiation effects are underdeveloped.<br />

Long term studies that carefully assess baseline cognition and<br />

changes over time are critically needed or the eventual result of high<br />

dose RT may be a demented, bedridden patient who is cancer free.<br />

With more aggressive forms of RT and improved survival rates, geriatricians<br />

will be seeing increasing numbers of elders with RT induced<br />

cognitive injury. Geriatricians must learn to recognize and manage<br />

the resulting deficits.<br />

D24<br />

Severe Consequence of Acquired Diaphragmatic Hernia After<br />

Reconstructive Surgery for Chest Wound Dehiscence After<br />

Coronary Artery Bypass Surgery.<br />

M. Izhar, 1,2 A. Gupta, 1,2 F. Aziz, 1,2 R. J. Beyth, 1,3 M. K. Bautista. 1,2 1.<br />

GRECC, NF/SGVHS, Gainesville, FL; 2. Dept of Aging and<br />

<strong>Geriatrics</strong>, University of Florida, Gainesville, FL; 3. Dept of Medicine,<br />

University of Florida, Gainesville, FL.<br />

Introduction: Diaphragmatic hernia is a rare surgical complication<br />

of reconstructive surgery for wound dehiscence after coronary<br />

artery bypass surgery (CABG). This case illustrates anterior chest<br />

wall hernia, a severe consequence of diaphragmatic hernia in an older<br />

patient after CABG.<br />

Case: A 70 year old man had CABG in 2007 which was complicated<br />

by sternal wound dehiscence after severe coughing. Six days<br />

after CABG, he underwent sternal debridement, omental transposition<br />

and secondary closure of the mediastinum. Three weeks later, he<br />

developed diaphragmatic hernia with the small bowel displaced into<br />

the anterior mediastinum. He also developed anterior chest wall hernia<br />

which grew over time to the size of 6x8 cm. In 2011 he was hospitalized<br />

for acute cholecytitis. Two days after undergoing percutaneous<br />

cholecystostomy tube placement, he developed acute abdomen. Exploratory<br />

laparotomy revealed the cholecystostomy tube traversing<br />

through the small bowel. The cholecytectomy tube was removed and<br />

the small bowel was resected. Over the next 10 days, his anterior chest<br />

wall hernia enlarged significantly to the size of 20x16 cm. CT scan of<br />

chest revealed a large diaphragmatic hernia with the small bowel extending<br />

up to the clavicles. He was not felt to be a surgical candidate<br />

due to lack of acute respiratory distress and his significantly altered<br />

anatomy. He was treated conservatively with indefinite use of the<br />

chest binder and discharged home.<br />

Discussion: Diaphragmatic hernia is a rare but recognized complication<br />

after cardiothoracic surgery. Its published rates range from<br />

2.7 % to 11.7%. During surgery, the omentum is transposed either<br />

through an incision in the anterior diaphragm or through the upper<br />

end of the laparotomy incision and a subcutaneous tunnel. The omentum<br />

can reach the suprasternal notch, thereby allowing the reconstruction<br />

of an extensive defect. In this case the surgical incision in<br />

the anterior diaphragm may have been too large resulting in the gastrointestinal<br />

herniation into the chest wall. Future studies are needed<br />

to evaluate the risks and benefits of surgery such as this among older<br />

adults who may have a high risk for post-operative complications<br />

after CABG.<br />

D25<br />

The role of PC-MRI in the differential diagnosis between<br />

Alzheimer’s disease and NPH.<br />

J. Zmudka. Amiens University Hospital, Amiens, France.<br />

Introduction:<br />

AGS 2012 ANNUAL MEETING<br />

S195


P OSTER<br />

A BSTRACTS<br />

The diagnosis of Alzheimer’s disease (AD) and normal pressure<br />

hydrocephalus (NPH), as several neurodegenerative diseases, mainly<br />

based on clinical examination, neuropsychological assessment and<br />

conventional imaging, remains difficult.<br />

The aim of this study is to demonstrate the role of Phase-contrast<br />

magnetic resonance imaging (PC-MRI) in the assessment of<br />

cerebral flows, and in consequence in the differential diagnosis between<br />

AD and NPH.<br />

Materials and methods:<br />

Our population consisted of 20 AD patients (mean age: 80 ± 5<br />

years) and 13 NPH (mean age: 70 ± 6 years). Patients were categorized<br />

during a special consultation by a neuropsychologist and a geriatrician.<br />

All the patients underwent cerebral MRI using a 3T-scanner including<br />

PC-MRI imaging for CSF and blood flows quantification.<br />

They were compared with a population (n = 12) of age-matched<br />

healthy elderly (HE) (mean age: 71 ± 9 years) with normal neurological<br />

and neuropsychological screening results (MMSE).<br />

PC-MRI acquisition was then performed in addition of classical<br />

morphological sequences. The PC-MRI sections were positioned at<br />

the cervical level to investigate cerebral vascular input flows from internal<br />

carotids and vertebral vessels. PC-MRI was also performed at<br />

the aqueductal and cervical levels to measure the CSF flows. Afterwards,<br />

PC-MRI images were analyzed to calculate global arterial flow<br />

curves during cardiac cycle (cc). NPH, MA, HE populations were<br />

compared.<br />

Results:<br />

There was no statistical difference of the mean arterial CBF between<br />

the 3 groups (in ml/min): MA (495 ± 84), NPH (450 ± 129) and<br />

HE (509 ± 108).<br />

Cervical CSF flow analysis showed also similar values for all<br />

3 groups (in μl/cc): MA (530 ± 210), NPH (455 ± 133) and HE<br />

(457 ± 154).<br />

In contrast, NPH presented significantly the highest aqueductal<br />

CSF stroke volume (167 μl/cc ± 89) compared to AD (50 ± 30) and<br />

HE (34 ± 17) (P < 0, 05).<br />

Conclusion:<br />

CSF flows quantification can be helpful for aetiological and differential<br />

diagnosis between AD and NPH, especially in case of enlargement<br />

of lateral ventricles.<br />

D26<br />

The First Intervention Study in Elder Self-Neglect: A Randomized<br />

Clinical Trial to Improve Vitamin D Levels.<br />

J. Burnett, 1,4 A. E. Hochschild, 1,4 S. M. Smith, 2,4 A. L. Stotts, 1,4<br />

P. M. Diamond, 3,4 C. B. Dyer. 1,4 1. Internal Medicine, UT Health,<br />

Houston, TX; 2. National Aeronautics and Space Administration<br />

(NASA), Houston, TX; 3. Health Promotoin and Behavioral Sciences,<br />

UT, School of Public Health, Houston, TX; 4. Texas Elder Abuse and<br />

Mistreatment Institute (TEAM), Houston, TX.<br />

Supported By: The National Institute on Aging. Grant # 1R21<br />

AG033261-01A1<br />

Background: Despite high mortality rates, elder self-neglect is<br />

characterized by refusal of medical and social interventions. To date<br />

there have been no tested clinical interventions in elders who selfneglect.<br />

Previous TEAM Institute research has shown significantly<br />

low vitamin D levels in this population. This study aimed to determine<br />

the feasibility of a clinical intervention. Replacement of vitamin<br />

D was chosen because of its ease of administration and favorable<br />

safety profile. Methods: A randomized clinical trial using directly observed<br />

therapy of vitamin D was conducted using 50 elders, >65 years<br />

of age, with Adult Protective Services (APS) validated self-neglect. A<br />

staggered intervention with waiting controls was used to maximize<br />

statistical power. One-third (n=17) of the group was administered<br />

50,000 IU vitamin D2 (ergocalciferol) monthly and the remainder<br />

(n=33) were administered 400 IU monthly. Serum 25-OH vitamin D<br />

was assessed at baseline and 5-months. Results: 69% agreed to participate<br />

in the study and of those n=40 (80%) remained at 5-months. At<br />

baseline, 12% (n=7) were deficient in vitamin D (


P OSTER<br />

A BSTRACTS<br />

D28<br />

Interactive video dance and cognition: baseline data.<br />

J. Jovancevic- Misic, S. A. Studenski, Y. Zheng, S. Perera. University<br />

of Pittsburgh, Pittsburgh, PA.<br />

Supported By: The research reported in this abstract was supported<br />

by NIH- Claude D Pepper Older <strong>American</strong>s Independence Center<br />

Grant, P30 AG024827, and by T32 grant (AG21885).<br />

Purpose: Though some evidence exists that physical exercise has<br />

the potential to affect cognitive function, the majority of evidence relates<br />

to the cognitive effects of fitness training. There is evidence that<br />

video games may induce cognitive improvement and generalize to<br />

daily function, but mostly do not involve physical exercise. Little is<br />

known of how combining these two types of training might impact<br />

cognition, or the role of participants’ cognitive status on their success.<br />

The purpose of this study is to examine the role of visual attention in<br />

learning to process visual info in interactive video dance. Relative<br />

value of participants’ previous experience with video games and<br />

some types of leisure activities in predicting their performance on the<br />

video dance was also investigated.<br />

Methods: This is a cross sectional analysis of the baseline data<br />

from a RCT Adherence and health effects of video dance exercise<br />

and brisk walking in postmenopausal women. We focus on the baseline<br />

data of the interactive video dance group. Participants were 46<br />

overweight, sedantary women aged 50-65. Repeatable Battery for the<br />

Assessment of Neuropsychological Status (RBANS) test, the Useful<br />

Field of View (UFOV) test and Leisure activity questionnaire were<br />

administered at baseline. Participants’ previous experience with<br />

video games, and ability to master the basics of interactive video<br />

based dance on the first day was noted.<br />

Results: We analyzed the association between two cognitive domains<br />

(attention and visuo-spatial) as measured by RBANS and attention<br />

deployment and visuo-spatial skills (UFOV). All domains<br />

were correlated (Table 1).<br />

Performance on cognitive tests as predictors of success in finishing<br />

video dance lessons the first day was analyzed. The test of divided<br />

attention (UFOV) and RBANS (attention) score tended to have an<br />

impact, though only RBANS effect was significant (p=0.03). Previous<br />

experience with dance and video games was found to have no effect<br />

on the success of video dance performance.<br />

Conclusions: Baseline data indicates that UFOV reflects some<br />

RBANS factors and as such may be related to early success with<br />

learning video dance. Further it would appear that no prior experience<br />

playing video games or dancing is necessary for mastering this<br />

new skill.<br />

D30 Encore Presentation<br />

Skeletal muscle sampling in elderly research participants with<br />

chronic disease.<br />

M. F. Lyles, J. L. Demons, K. M. Murphy, B. J. Nicklas. Internal<br />

Medicine, Wake Forest School of Medicine, Winston Salem, NC.<br />

Supported By: Claude Pepper Older <strong>American</strong>s Independence<br />

Center (1P30 AG21332, WFU General Clinical Research Center<br />

(M01-RR07122), National Institute on Aging (R37 AG018915)<br />

Deficits in skeletal muscle metabolism and function are major<br />

contributors to development of disability in older adults. The conduct<br />

of in vitro experiments of muscle metabolism and function is important<br />

for advancing understanding of aging-related disability progression.<br />

Percutaneous muscle biopsy techniques are widely utilized in<br />

studies of young and/or healthy persons, but are underutilized in the<br />

elderly, especially those with chronic illness, who are at the highest<br />

risk of becoming disabled. The goal of this project was to determine<br />

the feasibility, safety and tissue yield of muscle biopsies performed in<br />

older adults with common chronic diseases enrolled in several clinical<br />

trials. A total of 324 biopsies were performed in research participants<br />

with COPD, CHF, osteoarthritis or obesity, who were enrolled in clinical<br />

trials of weight loss and/or exercise training. Only minor modifications<br />

in safety procedures, such as adjustment of table position,<br />

were needed for biopsy performance in these patients. The average<br />

tissue yield of for all biopsies was 157±90 mg. Participants in which<br />

muscle was obtained (81%) were compared to those in which only<br />

adipose tissue was obtained (19%; Table 1). Successful acquisition of<br />

skeletal muscle was more challenging in women and in more obese<br />

participants. The return rate for post-intervention biopsy was >90%.<br />

Percutaneous muscle biopsy is a feasible, safe and acceptable procedure<br />

in older adults with chronic diseases and provides a tool to understanding<br />

the development of disability in this group.<br />

Characteristics of participants with and without muscle tissue yield<br />

*Average yield = 157±90 mg<br />

D31 Encore Presentation<br />

Extended-release memantine (28 mg, once daily) and sustained<br />

cognitive improvement: Post hoc responder analysis from a<br />

randomized trial in patients with moderate to severe Alzheimer’s<br />

disease.<br />

M. Tocco, 1 S. Hendrix, 2 M. L. Miller, 3 V. Pejovic, 3 S. M. Graham. 1 1.<br />

Forest Research Institute, Jersey City, NJ; 2. Pentara Corporation,<br />

Salt Lake City, UT; 3. Prescott Medical Communications Group,<br />

Chicago, IL.<br />

Supported By: Supported by Forest Laboratories, Inc.<br />

Background: Alzheimer’s disease (AD) trials routinely report<br />

mean score differences between treatment groups; however, it is also<br />

important to compare percentages of patients who respond to treatment.<br />

An extended-release (ER) formulation of memantine (28 mg,<br />

once daily) was recently approved in the US based on a 24-week, randomized,<br />

placebo-controlled trial (NCT00322153) in patients with<br />

moderate to severe AD concurrently taking a cholinesterase inhibitor.<br />

Memantine ER-treated patients significantly outperformed<br />

placebo-treated patients on several outcome measures, including the<br />

Severe Impairment Battery (SIB), an instrument for assessing cognition<br />

in severely demented patients. In this post hoc analysis, we determined<br />

the percentages of patients who achieved a positive response<br />

on the SIB and maintained it throughout the trial.<br />

Methods: Five SIB response levels to double-blind treatment<br />

were selected (improvements of ≥0, ≥5, ≥10, ≥15, and ≥20 points), corresponding<br />

to 0, 0.5, 1.0, 1.5, and 2.0 standard deviations of the observed<br />

baseline-to-endpoint score change. Numbers of patients (observed<br />

cases) in each group who attained such responses at Weeks 4,<br />

8, 12, or 18 and maintained them through Week 24 (Endpoint) were<br />

compared using Fisher’s exact test, without correcting for multiple<br />

comparisons.<br />

Results: The mean (± SD) Baseline SIB score for the intent-totreat<br />

population (N=661) was 76.1 ± 18.4. A total of 523 patients (memantine<br />

ER, 261; placebo, 262) had available SIB data at all visits.<br />

Significantly more patients in the memantine ER group than the<br />

placebo group maintained Week 8 SIB responses of ≥5 points (26.1%<br />

vs 17.0%; P=0.014) and ≥10 points (14.6% vs 7.6%; P=0.012) through<br />

Endpoint. Similar differences in response maintenance were observed<br />

for responses attained at Week 12 (≥5 points: 28.5% vs 19.9%,<br />

P=0.025; ≥10 points: 16.3% vs 8.2%, P=0.005; ≥15 points: 9.5% vs<br />

4.1%, P=0.015) and Week 18 (≥10 points: 18.8% vs 10.0%, P=0.004;<br />

≥15 points: 10.9% vs 4.5%, P=0.006). No other significant betweengroup<br />

differences were observed.<br />

Conclusions: In this post hoc analysis, memantine ER was associated<br />

with cognitive improvement attained after 8-18 weeks and sustained<br />

through study endpoint.<br />

AGS 2012 ANNUAL MEETING<br />

S197


P OSTER<br />

A BSTRACTS<br />

D32<br />

Comparison of Three Screening Tools to Predict Hospital<br />

Readmission and Mortality in Older Adults.<br />

M. Deschodt, 1,2 J. Flamaing, 2 N. Wellens, 1 S. Boonen, 2 P. Moons, 1<br />

K. Milisen. 1,2 1. Center for Health Services and Nursing Research,<br />

Katholieke Universiteit Leuven, Leuven, Belgium; 2. Department of<br />

Geriatric Medicine, University Hospitals Leuven, Leuven, Belgium.<br />

Purpose: To compare the diagnostic characteristics of the Identification<br />

of Seniors At Risk (ISAR), the Flemish version of the Triage<br />

Risk Screening Tool (TRST), and the Variable Indicative of Placement<br />

Risk (VIP) to predict hospital readmission, alone or in combination<br />

with mortality, in hospitalized patients aged 75 years or older.<br />

Methods: Multicenter prospective cohort study with 30 days follow-up<br />

in 25 general hospitals in Belgium. Baseline data were gathered<br />

within 72 hours of admission. Readmission was defined as an unplanned<br />

hospital stay of at least 24 hours. Information was gathered<br />

by a nurse through patient or proxy interview at admission and<br />

through phone-call at follow-up. Eight hundred and sixty-eight questionnaires<br />

with complete screening were returned. Data of hospital<br />

readmission was available for 72.6% (n=630) of the patients. Besides<br />

analyses in surviving patients only (n=588), combined endpoint<br />

analyses (readmitted or dead) were performed.<br />

Results: Respectively 12.2% (n=72/588) and 6.7% (n=42/630) of<br />

the patients were readmitted or died within 30 days after hospital discharge.<br />

Sensitivity and NPV to predict readmission was high for<br />

ISAR cut off ≥2 (86% and 90%, resp.), TRST cut off ≥2 (71% and<br />

86%, resp.) and VIP cut off ≥1 (60% and 89%, resp.). Increasing the<br />

cut off score with one point had a positive effect on the specificity, but<br />

at the expense of the sensitivity for all three screening tools (69% for<br />

ISAR, 60% for VIP and 40.4% for TRST). Results of the combined<br />

endpoint analyses are shown in the table.<br />

Conclusion: All screening instruments showed good sensitivity<br />

and NPV, the two major characteristics for good screening tools, but<br />

hospital readmission alone or in combination with mortality in older<br />

patients seemed to be most accurately predicted by using the ISAR<br />

cut off ≥3. False positives could be filtered out according to the clinical<br />

expert opinion of a care team.<br />

D33<br />

Increased risk of hospital admission in Patients 65 years and older<br />

presenting to the emergency department.<br />

M. S. Radeos, I. Kariolis, A. Wasserman, K. Joshi, Z. Huang.<br />

Emergency Medicine, New York Hospital Queens, Flushing, NY.<br />

Background: US Emergency department (ED) visits by those 65<br />

years and older account for an estimated 17.5 million visits, or approximately<br />

15% of all visits. About 10.6 million of these are by those<br />

75 years and older.<br />

Objective: We sought to determine factors increase the risk of<br />

hospital admission among adults aged 65 years and older who present<br />

to the ED.<br />

Methods: Research associate (RA) administered a survey to a<br />

convenience sample of adults 65 years and older presenting to a<br />

Level I trauma center. We collected demographic and clinical variables.<br />

We present data as percentages and medians with interquartile<br />

range (IQR). We tested the<br />

univariate association with admission using t-test. Kruskal-Wallis,<br />

chi-square and fisher exact test as appropiate. We ran logistic regression<br />

models with 95% confidence intervals (CI).<br />

Results: We enrolled 1,329 subjects between 1/2010 and 11/2011.<br />

376 (28%) were age 65-74 and 953 (72%) were 75 and older. 59%<br />

were female, and 80% had either Medicare or Medicare plus a supplement.<br />

Race/ethnicity was 61% White, 12% Black, 11% Latino, and<br />

13% Asian. 15% had limited English proficiency. 56% of patients<br />

were admitted. 90% of patients lived independently. 92% had a PMD<br />

or regular health care provider (HCP). In a logistic model that included<br />

age categorory (65-74 versus 75+) sex, race, mode of arrival,<br />

living independently and prior visit to and ED or urgent care center<br />

within the previous week, only the previous ED or urgent care visit in<br />

the previous week was statistically significant, [OR 1.63, 95% CI<br />

[1.08, 2.44) P=0.019]<br />

Conclusion: Older patients who present to the ED have a very<br />

high admission rate suggesting a high acuity. Those who return to the<br />

ED within a week of ED or urgent care visit are at increased risk of<br />

admission to the hospital. This finding underestimates the true acuity,<br />

as many patients receive acute care and may be safely discharged<br />

to home. Future research should focus on interventions in this high<br />

risk group.<br />

D34<br />

Psychiatric Emergencies in the Suburbs: An EMS Response to the<br />

Distressed Senior.<br />

J. J. Bernick, 1,2 D. Dalbey, 2 M. Lester. 2 1. Internal Medicine, San<br />

Jacinto Methodist Hospital, Baytown, TX; 2. Emergency Medical<br />

Service, Health Department, City of Baytown, TX.<br />

Background: When confronted with the confused and agitated<br />

senior patient appreciation of their history and immediate medical<br />

status supply essential insight for patient stabilization. Geriatric patients<br />

with various chronic conditions, multiple medications, and limited<br />

functional reserve display increased susceptibility to psychiatric<br />

problems. The EMS frequently provides the initial evaluation of the<br />

distressed patient manifesting behavioral disorders. This study objective<br />

proposed to review and convey an awareness of the initial assessment<br />

of seniors with diverse psychiatric emergencies.<br />

Methods: This investigation examined the records of a suburban<br />

EMS in Harris County, Texas during a 46 month period commencing<br />

in January, 2008. The field encounters of community residing patients<br />

at least 60 years old receiving evaluation for psychiatric emergencies<br />

were analyzed. The EMS team recorded patient’s primary symptoms,<br />

history and physical findings, procedures performed, and response to<br />

their initial treatment. Event chronology considered the decision to<br />

transport the patient to the hospital.<br />

Results: During the study period, 206 geriatric patients obtained<br />

evaluation for psychiatric emergencies accounting for 11% of psychiatric<br />

calls. Anxiety disorders were the most common diagnosis presenting<br />

in (64)seniors (31% of calls) and the majority required hospital<br />

transport. The EMS treated patients (33) for both drug overdose<br />

and medication withdrawal. The presence of suicidal ideations(13%<br />

of calls), psychotic behavior(12%), and delirium(12%) affected a significant<br />

proportion of seniors requiring EMS care. The EMS attended<br />

an unexpected number of patients (8) threatening a weapon assault.<br />

Approximately 35% of patients receiving EMS triage acknowledged<br />

previous psychiatric disorders.<br />

Conclusion: The appearance of psychiatric symptoms in geriatric<br />

patients develops with dementia,adverse medication reactions,and family<br />

disputes. However, diminishing functional capacity creates an opportunity<br />

for behavioral issues to arise without prior warning. Caregivers<br />

often rely upon the EMS as the initial responder to meet their crisis.<br />

Health professionals early recognition and treatment of senior’s psychiatric<br />

issues enhances support to caregivers, promotes accurate physician<br />

treatment, and improves coordination of care among the health team.<br />

D35<br />

Emergency Department Prescribing and Continuity.<br />

L. Ragsdale, 1 C. Horney, 2 K. Schmader, 2 S. N. Hastings. 2 1. Surgery,<br />

Duke University, Durham, NC; 2. Medicine, Duke University,<br />

Durham, NC.<br />

Supported By: This research was conducted while Dr. Hastings was<br />

supported by a VA HSR&D Career Development Award (RCD<br />

06-019).<br />

Background<br />

S198<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

More than ½ of all older patients treated and released from the<br />

emergency department(ED) receive one or more prescriptions. The<br />

goals of this study were to describe medication prescribing and continuity<br />

of care for older patients treated and released from the ED.<br />

Methods<br />

We examined health system records of 308 patients ≥ 65 years old<br />

treated and released from an urban academic ED with 77,000 annual<br />

visits. Patients were excluded if they did not have at least one PCP visit<br />

in the 12 months preceding the index ED visit. Data were collected<br />

using a standardized chart abstraction tool. Medications were categorized<br />

according to the VA Medication Classification System, and continuity<br />

measures (1) ED contact with PCP; (2) ED visit acknowledgement<br />

by PCP; and (3) discharge drug documentation by PCP were<br />

based on Acute Care of the Elderly (ACOVE) Quality Indicators.<br />

Results<br />

Of 308 patients, 163 (53%) were prescribed at least one medication<br />

(total 260 drugs); 23.3% were prescribed 2 medications and 8%<br />

were prescribed ≥ 3. Overall, 89.2% of prescriptions were new medications<br />

for the patient. The most commonly prescribed drug class<br />

was central nervous system (CNS) medications (32.3%); 86.9% of<br />

these were opioid containing. Other commonly prescribed drug<br />

classes were antimicrobials (21.9%) and gastrointestinal medications<br />

(11.9%). Common indications for medications included non-urinary<br />

infections (17.3%), musculoskeletal pain (17.3%) and trauma<br />

(16.5%). The majority of prescriptions were written for a time limited<br />

course (91.1%); 46.6% had a specified schedule and 53.4% were as<br />

needed (prn). Of the scheduled drugs, the median days supply was 7<br />

(mode 7). Among prn drugs, the median days supply was 5 (mode 3).<br />

The ED provider note documented communication with patients’<br />

outpatient provider in 14.5% of visits (2.2% PCP; 12.3% specialist).<br />

Overall, 72.4% of patients had a PCP follow-up within 90 days of<br />

their ED visit. The PCP note acknowledged the ED visit in 46.1% of<br />

patients. Among patients prescribed medications in the ED (n=163),<br />

the PCP note acknowledged the new medications in 25.4% of cases.<br />

Conclusions<br />

ED providers frequently prescribe new CNS and antimicrobial<br />

medications for older patients treated and released from the ED.<br />

Lack of communication between providers in the care for this patient<br />

population was common. Further research is needed to determine<br />

how best to improve communication between the ED and PCPs.<br />

D36<br />

Vitamin D deficiency is associated with fall-related risk factors in<br />

home-bound older adults.<br />

J. L. Demons, 1 J. A. Tooze, 1 B. R. Davis, 1 R. Shertzer-Skinner, 1<br />

L. Kearsley, 2 R. Gottlieb, 2 J. D. Williamson, 1 D. K. Houston. 1 1. Sticht<br />

Center on Aging, Wake Forest University School of Medicine,<br />

Winston-Salem, NC; 2. Senior Services, Inc, Winston-Salem, NC.<br />

Supported By: Supported by the Wake Forest Translational<br />

Science Institute, Center for Integrative Medicine and Pepper<br />

Center (P30-AG21332)<br />

Background: Falls in the elderly are known to be costly to both<br />

the function of seniors and the medical system. Risk factors for falls<br />

that can be intervened upon, such as vitamin D deficiency, are sought<br />

by physicians. Older home-bound persons eligible to receive meals<br />

from a home meal delivery program (Meals on Wheels (MOW)) are<br />

at high risk for vitamin D deficiency due to the very nature of being<br />

home-bound and inability to provide their own nutrition. They are<br />

likely also at higher risk for falls considering their inability to move<br />

about in the community. We assessed several aspects of falls and fallrelated<br />

risk factors to determine if they were associated with vitamin<br />

D levels in MOW participants.<br />

Methods: 25-hydroxyvitamin D levels were assessed in seventytwo<br />

seniors being served by MOW in Forsyth Co, NC as part of baseline<br />

assessments for a vitamin D intervention study (mean age 77.3<br />

yrs; 76% women, 76% black). History of falls in the prior year and the<br />

seriousness of any fall that occurred were obtained by recall. Fear of<br />

falling and the Pepper Assessment Tool for Disability (PAT-D) were<br />

also obtained.<br />

Results: Vitamin D insufficiency (10-


P OSTER<br />

A BSTRACTS<br />

D38<br />

The burden of comorbid conditions and symptoms affecting quality<br />

of life in nursing home patients with dementia.<br />

J. M. Checchi, D. Peterson, J. Tjia. <strong>Geriatrics</strong>, University of<br />

Massachusetts Medical School, Worcester, MA.<br />

Supported By: This study was funded by a grant from the Agency<br />

for Healthcare Quality and Research.<br />

Background: While over 50% of nursing home (NH) residents<br />

in the US have dementia, the burden of comorbid conditions and<br />

symptoms affecting quality of life in this population is understudied.<br />

Further, comorbidity and symptom burden differences by severity of<br />

dementia remain unclear. The study aim is to describe differences in<br />

the prevalence of comorbidites and bothersome symptoms in a<br />

large, population-based sample of NH residents with differing stages<br />

of dementia.<br />

Methods: Data from the first full assessment of the Minimum<br />

Data Set (MDS) was used to identify a population of NH residents<br />

with dementia (Alzheimer’s type or other causes) from 5 states (PA,<br />

MA, CA, FL, MN) in 2008-2009. We used the Cognitive Performance<br />

Scale (CPS) to identify residents with mild-to-moderate (CPS 1-4)<br />

and advanced dementia (CPS 5-6), and to compare differences in the<br />

prevalence of comorbidites and bothersome symptoms (including<br />

pain, eating difficulties, and conditions indicative of potentially druginduced<br />

syndromes [e.g. dehydration, delusions, vertigo, syncope, unsteady<br />

gait, and vomiting]) using a χ2 test.<br />

Results: The study sample included 271,589 residents with mildmoderate<br />

dementia and 96,346 with advanced dementia (total<br />

n=367,935). The 10 most frequently reported comorbid conditions<br />

were hypertension (70.6%), osteoporosis (31.6%), arthritis (31.0%),<br />

anemia (29.7%), diabetes (27.3%), congestive heart failure (20.6%),<br />

hypothyroidism (20.4%), cerebrovascular accident [CVA] (19.2%),<br />

arrhythmia (18.6%), and COPD (17.2%). Residents with mild-moderate<br />

dementia had a higher incidence of each of these comorbidities<br />

except CVA (p


P OSTER<br />

A BSTRACTS<br />

patients transferred from acute care hospital to a GRU. The poorest<br />

prognosis is showed in hypoalbuminemic patients with delirium and<br />

the best in orthopaedic diagnosis group patients.<br />

D41<br />

Symptom Burden in Frail Hemodialysis Patients.<br />

K. Christianer, 1 R. Shengelia, 1 B. M. Eiss, 1 J. E. Roberts, 1 M. C. Reid, 1<br />

R. D. Adelman, 1 N. Berman. 1,2 1. Weill Cornell Medical College, New<br />

York, NY; 2. Rogosin Institute, New York, NY.<br />

Supported By: Supported by the Henry Adelman Fund for Medical<br />

Student Education in <strong>Geriatrics</strong> and the Jewish Foundation for the<br />

Education of Women<br />

Background: In 2008, there were 110,000 incident cases of<br />

ESRD, of which the fastest growing group are patients ages 65+.<br />

Many ESRD patients are placed on aggressive hemodialysis (HD)<br />

treatment, regardless of their comorbidities. Patients with ESRD experience<br />

high symptom burden, even when compared with other<br />

chronic, debilitating conditions, and HD itself can be associated with<br />

side effects (e.g. excess blood volume removal causing fatigue). This<br />

project investigated which symptoms are deemed most burdensome<br />

by HD patients and whether some symptoms may be related to HD<br />

treatment.<br />

Method: Participants were recruited from two outpatient dialysis<br />

clinics in New York City. All patients were receiving HD and categorized<br />

as “frail” (i.e. ineligible for transplant) by their treating<br />

nephrologist. Other eligibility criteria included fluency in English and<br />

intact cognition. Participants were interviewed using the Dialysis<br />

Symptom Index (DSI) and the MOS SF-36. Chart reviews identified<br />

comorbidity using the Charlson Comorbidity Index (CCI).<br />

Results: Of the 31 participants enrolled as of 12/1/11, the mean<br />

age is 71 (range 44-89); 39% are female and the mean CCI Score is 6.4<br />

(range 1-15). Patients reported a mean of 14 symptoms of the 30 that<br />

were asked. Symptoms with high prevalence were Feeling Tired or<br />

Lack of Energy (90%), Dry Skin (70%), Trouble Staying Asleep<br />

(65%), and Nausea (48%). Results of Worrying (61%) and Feeling<br />

Sad (58%) within the past week suggest high rates of depression.<br />

When asked which symptoms were felt to be HD treatment related,<br />

the most common responses were Feeling Tired or a Lack of Energy<br />

(93%), Muscle Cramps (90%), Feeling Anxious (77%) and Lightheadedness<br />

(67%).<br />

Our sample demonstrated higher symptom burden when compared<br />

with a general HD population 1 , with double-digit differences in<br />

prevalence of 20 symptoms, the most prominent being Feeling Sad<br />

(58% vs. 30%), Dry Skin (70% vs. 42%) and Dyspnea (48% vs. 21%).<br />

Conclusion: Frail ESRD patients receiving HD experience immense<br />

symptom burden, even when compared to the general HD<br />

population, and patients attributed many symptoms to HD itself.<br />

Many of the symptoms may be reduced by modifying treatment (e.g.<br />

reducing the time spent in HD).These pilot data support future efforts<br />

to investigate palliative care interventions in this target population.<br />

References:<br />

1 Abdel-Kader K, et al. Clin J Am Soc Nephrol 2009;4:1057-64<br />

D42<br />

Characteristics and Economic Burden of Elderly Patients with<br />

Hospital-Acquired Clostridium-difficile in a Managed Care Setting.<br />

M. E. Strauss, 1 R. Quimbo, 2 S. Palli, 2 J. Singer. 2 1. MESTRA<br />

Consulting, Inc.,White Plains, NY; 2. HealthCore, Inc.,Wilmington, DE.<br />

Supported By: Optimer Pharmaceuticals, Inc.<br />

BACKGROUND: Hospital-acquired C. difficile associated disease<br />

(CDAD) results in an estimated $1.3 billion in excess costs in the<br />

US. Elderly individuals ≥65 are at especially high risk of CDAD and<br />

its recurrence due to diminished immune response, multiple comorbidities,<br />

and increased exposure to health care facilities. This study describes<br />

the incremental economic burden of CDAD in hospitalized<br />

patients ≥65 from a managed care perspective. METHODS: Hospitalized<br />

patients ≥65 years of age with a 12 month pre-index eligibility<br />

between 1/1/2005 and 10/31/2010 were identified within the Health-<br />

Core Integrated Research Database (HIRD SM ). Cases with an inpatient<br />

diagnosis of CDAD (ICD 008.45) were matched to hospitalized<br />

controls without CDAD on a 1:3 match ratio based on: age±10, gender,<br />

and baseline/in-hospital comorbidities. Mean length of stay<br />

(LOS) and costs were calculated using multivariate GLM with a<br />

gamma distribution. Covariates were determined from univariate<br />

analysis of baseline characteristics. RESULTS: 10933 CDAD patients<br />

were matched to 32799 controls. While age (mean 80 (±7.9)), gender<br />

(62% female), and major comorbidity groups were well balanced,<br />

post-match disparities persisted (p


P OSTER<br />

A BSTRACTS<br />

rate was 21.9% for community dwellers and 34.4% for nursing home<br />

residents. Readmission rates for specific diagnoses among community-dwelling<br />

and nursing home patients were, respectively: 19% and<br />

43% for CHF, 12.8% and 22.5% for pneumonia, 13.6% and 35% for<br />

UTI, and 23.5% and 28% for GI bleed.<br />

Conclusions: Nursing home patients have a higher rate of readmission<br />

and in-hospital mortality than community-dwelling patients.<br />

Readmission rates for major diagnoses were uniformly higher for<br />

nursing home patients than for community dwellers.<br />

D44 Encore Presentation<br />

High Blood Pressure is Associated with Mortality only in Faster<br />

Walking Elderly Adults.<br />

M. Odden, 1,2 C. A. Peralta, 2 M. Haan, 3 K. Covinsky. 2 1. Public<br />

Health, Oregon State University, Corvallis, OR; 2. Medicine,<br />

University of California, San Francisco, San Francisco, CA; 3.<br />

Epidemiology and Biostatistics, University of California, San<br />

Francisco, San Francisco, CA.<br />

Supported By: Dr. Odden was supported by a Ruth L. Kirschstein<br />

National Research Service Award (T32HP19025).<br />

Background: The association between high blood pressure (BP)<br />

and risk of death varies by age and appears to be attenuated in some<br />

elderly adults. Walking speed is an excellent measure of functional<br />

status and may identify which elders may be most at risk for the adverse<br />

consequences of hypertension. We aimed to determine if the association<br />

between BP and mortality differed by walking speed in elderly<br />

adults.<br />

Methods: The study population included 2,340 persons ≥ 65<br />

years, with measured BP, in the National Health and Nutrition Examination<br />

Survey (NHANES) waves 1999-2000 and 2001-2002. Mortality<br />

data was linked to death certificate data in the National Death<br />

Index. Walking speed was measured over a 20-foot walk; 243 (8%)<br />

did not complete the walk for various safety and logistical reasons.<br />

Participants with walking speed above the mean (2.7 ft/sec) were<br />

classified as faster walkers. Potential confounders included age, sex,<br />

race, survey year, lifestyle and physiologic factors, chronic health conditions,<br />

and antihypertensive use.<br />

Results: There were 589 deaths recorded through December<br />

31st, 2006. Among faster walkers, those with elevated systolic BP<br />

(≥140 mmHg) had a higher mortality rate compared to those with<br />

systolic BP


P OSTER<br />

A BSTRACTS<br />

pare; (3) to get a sense of patient’s goals of care. Common reasons not<br />

to discuss included: (1) respect for patient’s cultural values; (2) patient’s<br />

lack of mental capacity to understand implications of prognosis;<br />

(3) difficulty estimating prognosis with non-specific disease/comorbidity.<br />

11 clinicians were not willing to discuss 5-year prognosis<br />

because they felt that they could not accurately prognosticate on that<br />

time frame and they did not think it would be useful for patients to<br />

receive uncertain information. All clinicians were willing to discuss<br />

prognosis with patients who have less than 1 year to live because it<br />

helps patients make critical decisions about their end of life care.<br />

CONCLUSIONS: Clinicians balance individual patient factors<br />

when deciding to discuss prognosis with their frail older patients. Clinicians<br />

identified a lack of accurate prognostic information as a barrier<br />

to discussing long-term prognosis with frail elders.<br />

D47<br />

Assessment of Advanced Care Planning Documentation for Patients<br />

Discharged to Hospice Care.<br />

M. E. Young, 1 E. Hurwitz, 2 S. H. Chao, 1 V. Parker, 1 W. Suen. 1 1.<br />

<strong>Geriatrics</strong>, Boston University, Boston, MA; 2. Internal Medicine,<br />

Boston University, Boston, MA.<br />

Background: Three components of advanced care planning<br />

(ACP) include choosing a health care agent, determining resuscitation<br />

wishes and delineating goals of care. During transitions of care,<br />

these three wishes should be documented in one place where the receiving<br />

providers can easily access the information. Methods: We performed<br />

an assessment of ACP documentation at our hospital. From<br />

2005-2010, 289 patients, 65 years of age and older, were discharged<br />

from Boston Medical Center to hospice care. Of these patients, fifty<br />

randomly selected discharge summaries were reviewed to look for<br />

the presence of the three defined components of ACP. If the ACP elements<br />

were not documented in the discharge summary, we searched<br />

the entire medical record for the location of documentation. Results:<br />

The majority (n=43) of the charts we reviewed did not include all<br />

three components of ACP in the discharge summary. When examining<br />

the entire medical record, we found at least one ACP element<br />

missing in 42% (n=21) of the charts. The discharge summary author<br />

most commonly missed documenting the health care agent. Patients<br />

with a documented palliative care consultation had more complete<br />

documentation of ACP than those without a palliative care consultation.<br />

Conclusions: Documentation of ACP is poor at the time of discharge.<br />

A palliative care consultation is associated with more complete<br />

documentation of ACP. We plan to implement an educational<br />

and technological intervention to encourage clearer and more complete<br />

documentation of ACP.<br />

D48<br />

Assessing the wish to die in elderly people.<br />

S. Monod, 1 E. Rochat, 2,1 C. Bula, 1 A. Durst, 1 B. Spencer. 3 1. Service of<br />

geriatric medicine, University of Lausanne Medical Center, Epalinges,<br />

Switzerland; 2. Chaplaincy Service, University of Lausanne Medical<br />

Center, Lausanne, Switzerland; 3. Institute of Social and Preventive<br />

Medicine, University of Lausanne, Lausanne, Switzerland.<br />

Background: The wish to die has mainly been studied in terminally-ill<br />

young adults. In elderly persons, factors associated with the<br />

wish to die are likely to differ from those observed in younger people.<br />

Since the most frequently used scale -“The Schedule of Attitudes Toward<br />

Hastened Death” (SAHD, Rosenfeld et al., 2000)- was previously<br />

used in terminally ill cancer or AIDS patients, its use in elderly<br />

people suffering from multiple comorbidities is problematic. The objectives<br />

of this study were 1) to adapt the SAHD for use in elderly<br />

people, 2) to develop a new instrument to assess patients’ attitudes towards<br />

death 3) to test the relevance/acceptability of these instruments.<br />

Methods:An adapted version of the SAHD to the elderly population<br />

(SAHD-OLD) was obtained by analyzing all items of the instrument<br />

in an interdisciplinary group of experts in geriatric care.<br />

Items were modified according to their relevance in elderly population.<br />

An instrument to assess patients’ attitudes towards death was<br />

built on previous qualitative work performed by Schroepfer. These 2<br />

instruments were subjected to cognitive testing in a convenience sample<br />

of 11 community-dwelling people (median age = 82 years; range<br />

76-91).<br />

Results: The SAHD-OLD was obtained by modifying those<br />

items addressing palliative care issues (eg. irreversible consequences<br />

of stopping treatment) and systematically replacing “illness/disease”<br />

by “health problems”. We expressed in statements the 6 categories<br />

identified by Schroepfer, and created instructions asking respondents<br />

to describe their current attitude towards death (Adapted<br />

Schroepfer). During cognitive testing, our sample assessed the<br />

SAHD-OLD and the Adapted Schroepfer as relevant for elderly<br />

people. Respondents judged these 2 instruments acceptable and appreciated<br />

the direct manner in which they addressed end of life issues.<br />

The opportunity to speak openly on this topic was welcomed.<br />

Conclusions: The SAHD-OLD and the Adapted Schroepfer<br />

seem promising instruments to assess the wish to die in elderly people<br />

suffering from multiple comorbidities. Preliminary results show good<br />

comprehension, high relevance and acceptability. Psychometric properties<br />

of the SAHD-OLD are currently being tested in a large sample<br />

of patients.<br />

D49<br />

ROS-Induced NADPH Oxidase Changes and the Aging Heart.<br />

M. E. DuMond. 1,2 1. Pathology, University of Washington, Seattle, WA;<br />

2. Stony Brook University, Stony Brook, NY.<br />

Supported By: MSTAR<br />

The aim of this work was to investigate the effects of increased<br />

Reactive Oxygen Species (ROS) on the levels of NADPH Oxidase 4<br />

(Nox4) and Nox4D in heart tissue. Nox4 is expressed in cardiomyocyte<br />

mitochondria, and its splice variant Nox4D localizes to the nucleus.<br />

Both are ROS generators suspected to be involved in redox signaling.<br />

Cellular damage incurred by chronic ROS overproduction is<br />

the causative agent of an alarming number of diseases and is the underlying<br />

culprit of aging. Understanding the redox signaling that mediates<br />

cellular changes induced by ROS is an important step in intervening<br />

in disease and aging. Potential mechanisms for the antioxidant<br />

effects of the mitochondrial-acting SS31 peptide (Szeto, H, 2006)<br />

were also investigated in this study. SS31 peptide has been shown to<br />

reduce the damaging effects of ROS in mitochondria and elsewhere<br />

in the cell, but its mechanism of action in mitochondria is currently<br />

unknown. In this study, wildtype mice were treated with Angiotensin<br />

II (AngII) using osmotic minipumps for drug delivery. AngII simulates<br />

aging and heart failure by inducing ROS-mediated tissue<br />

changes. Animals were treated with AngII, AngII + SS31 peptide, or<br />

saline. The heart tissue was collected at three timepoints: 3 day, 1<br />

week, and 4 weeks. The results were then evaluated by Western Blot<br />

and protein quantification, comparing treatment to saline controls.<br />

Nox4 was shown to be transiently decreased in AngII + SS31 peptidetreated<br />

mice early in treatment, but after 4 weeks of treatment, Nox4<br />

levels were elevated in both the AngII and AngII + SS31 peptide<br />

mice, suggesting that the rescuing antioxidant effects of SS31 peptide<br />

are eventually overcome by continuous ROS stimulation in response<br />

to AngII. These data suggest that there may be a critical window<br />

where the effects of increased ROS production are reversible, but<br />

over-induction of redox signaling for a prolonged period of time may<br />

result in a state of cellular immunity to the effects of SS31 peptide<br />

and intervening antioxidants. The roles of Nox4 and Nox4D in redox<br />

signaling are obfuscated by the apparent opposing early and late effects.<br />

However, one hypothesis to be further investigated is that a<br />

shift from one Nox4 splice variant to the other in response to increased<br />

ROS is a modulator of redox signaling, and this may be interrupted<br />

by SS31 peptide action.<br />

AGS 2012 ANNUAL MEETING<br />

S203


P OSTER<br />

A BSTRACTS<br />

D50<br />

A Pilot Study of Teaching Medical Interns to Compute Number-<br />

Needed to Treat (NNT) and Outcome Assessment.<br />

H. Cheng. Medicine, University of Virginia, Charlottesville, VA.<br />

Supported By: HRSA: Geriatric Academic Career Award<br />

Background: Communicating drug benefits is an important<br />

process in patient-centered decision making. Relative risk reduction<br />

(RRR) is usually reported in drug trials and is favorably used by patients<br />

and providers despite RRR is misleading. NNT, a better way to<br />

measure the drug effect size and potentially help patients and<br />

providers to make decision, is less reported, more difficult to be understood<br />

and less favorably used by patients and providers. Therefore,<br />

training medical interns to learn computing NNT can be very<br />

important.<br />

Methodology: A new 4 week mandatory geriatric EBM curriculum<br />

was offered for all medical interns, which was described previously<br />

(A57: 2009 AGS). Teaching computing NNT was the part of this<br />

EBM curriculum and briefly summarized in the following. 1. Needs<br />

assessment by pretest. Medical interns answered yes or no to the<br />

question, “I know how to compute NNT” and then asked to compute<br />

NNT based on a drug trial. 2. Computing NNT using another drug<br />

trial was taught to interns in a didactic lecture. 3. Interns practiced<br />

computing NNT using another drug trial and were asked to apply<br />

NNT in their required 2 geriatric presentations. 4. Outcomes were assessed<br />

by repeating pretest and computing NNT from a drug trial.<br />

McNemar test was used to compare the pre and post test of competence<br />

in computing NNT. κ was used to measure agreement between<br />

self-perceived competence and actual performance. 0.05 was chosen<br />

as statistical significance. SPSS was used for data analysis.<br />

Results: About half of 165 medical interns from 2007 to 2010<br />

completed pre and post-test. Improvement of self-perceived competence<br />

in computing NNT was much bigger than actual performance.<br />

There was slight agreement between self-perceived competence and<br />

actual performance (Table). 32% (28/87) interns overestimated their<br />

competence.<br />

Conclusions: The EBM curriculum improved the medical intern’s<br />

competence in computing NNT. However, actual performance<br />

test should be used to assess the teaching outcome.<br />

Perceived competence and actual performance on computing number-needed<br />

to treat (NNT)<br />

*pretest versus post-test either in self-perceived competence or actual<br />

performance<br />

** Agreement between self-perceived and actual performance in<br />

pre-test phase<br />

D51<br />

Will Learners Rate the Curriculum Differently When the Course<br />

Instructor Did the Evaluation? A Pilot Study of a New Geriatric<br />

Evidence-based Medicine (EBM) Curriculum.<br />

H. Cheng. Medicine, University of Virginia, Charlottesville, VA.<br />

Supported By: Geriatric Academic Career Award<br />

Background: There are different ways to evaluate a curriculum.<br />

Online evaluation or anonymous evaluation by the instructor or an<br />

evaluator has been used. However, it is unknown which way is accurate.<br />

The learners might say good things and might be falsely rated<br />

the curriculum when the course instructor does the evaluation. Consequently,<br />

this will have a negative effect on improving the curriculum.<br />

In this pilot study, I hypothesized that the medical interns might<br />

falsely rate a new geriatric EBM curriculum when the course instructor<br />

(Author) does the evaluation compared to the evaluation done by<br />

another person.<br />

Methodology: A new 4 week geriatric EBM curriculum was provided<br />

for all medical interns during the mandatory geriatric rotation,<br />

which was described previously (A57: 2009 AGS). At the end of rotation,<br />

each intern was asked to anonymously rate the educational<br />

value of the EBM curriculum done by the course instructor. The educational<br />

value of the curriculum was assessed with Likert scales (1-5)<br />

ranged from extremely valuable (5), very valuable (4), somewhat<br />

valuable (3), and minimally valuable (2) to not at all valuable (1). Another<br />

person who was not aware of this study did the same anonymous<br />

evaluation at the end of the rotation. Chi-square was used to<br />

test significance of two evaluations with SPSS (p


P OSTER<br />

A BSTRACTS<br />

derstanding the patient’s medical history, baseline cognitive and<br />

physical functionality, home medications, and social situation.<br />

Conclusion:<br />

CIR served as a useful tool to assess interns’ learning in a geriatrics<br />

rotation. Interns appear to be gaining knowledge and skills in<br />

keys areas of <strong>Geriatrics</strong> and are able to articulate how they would<br />

use these knowledge and skills in the future to better care for elderly<br />

patients.<br />

D53<br />

WWAMI Residency Graduates’ Self-reported Preparedness and<br />

Practice Before and After Implementation of a Family Medicine<br />

Residency Continuity Nursing Home Requirement.<br />

J. Raetz, J. Osborn, P. Ford, N. Stevens. Family Medicine, University of<br />

Washington, Seattle, WA.<br />

Background:<br />

Current GME programs will not produce enough geriatricians<br />

to meet the needs of the aging population. Primary care physicians<br />

must receive adequate training to fill this gap. In 2005 the Accreditation<br />

Council for Graduate Medical Education revised the requirements<br />

for family medicine residency training programs to include a<br />

two year continuity nursing home experience. Residents must care<br />

for at least two nursing home patients over a minimum of 24 consecutive<br />

months. The WWAMI Network consists of 18 family medicine<br />

residencies in Washington, Wyoming, Alaska, Montana, and Idaho.<br />

The WWAMII region routinely surveys graduates from the residency<br />

network to characterize preparedness and practice. We examined this<br />

survey data to see if any measurable change could be seen in graduate<br />

preparedness and practice after implementation of the new nursing<br />

home continuity requirement.<br />

Methods:<br />

We examined responses to the questions, “prepared for practice?”<br />

(5 point likert scale) and, “part of my practice?” (yes/no) under<br />

the section, “care of adults: nursing home” for graduates between the<br />

years 1997 and 2009. We then compared responses of physicians who<br />

graduated in 2007 or later with those who graduated prior to 2007.<br />

Results:<br />

Overall self-reported preparedness for nursing home practice<br />

was good and improved slightly after implementation of the ACGME<br />

requirement for a nursing home continuity experience. 795 graduates<br />

between 1997 and 2006 reported level of preparedness for nursing<br />

home care on the five point likert scale (average 3.51). 243 graduates<br />

between 2007 and 2009 reported level of preparedness for nursing<br />

home care on the five point likert scale (average 3.81). Practice in<br />

nursing homes decreased in the same time period. Of the 738 responses<br />

of graduates between 1997 and 2006, 46.39% practiced in<br />

nursing homes. Of the 233 responses of graduates between 2007 and<br />

2009, 28.01% practiced in nursing homes.<br />

Conclusions:<br />

A two year continuity nursing home experience in residency is<br />

associated with improvement in self-reported preparedness to practice<br />

in nursing homes. However, in the same time period fewer graduates<br />

are practicing in nursing homes. More research is needed to identify<br />

factors that increase the number of physicians practicing in<br />

nursing homes to better serve our aging population.<br />

D54<br />

Preferences, Availability, And Quality Of Interactive Teaching<br />

Materials Used By Geriatric Educators.<br />

J. D. Schlaudecker, 1 S. Talebreza, 2 W. Suen, 3 K. Anderson. 2 1.<br />

<strong>Geriatrics</strong>, University of Cincinnati, Cincinnati, OH; 2. <strong>Geriatrics</strong>,<br />

University of Utah, Salt Lake City, UT; 3. <strong>Geriatrics</strong>, Boston<br />

University, Boston, MA.<br />

Supported By: Reynolds Foundation<br />

GACA<br />

Background:<br />

The use of an interactive educational format has been shown to<br />

improve integration of learned material. However few studies have<br />

evaluated if geriatric educators are actually embracing this philosophy,<br />

utilizing interactive teaching techniques in educational venues,<br />

and which techniques are more commonly used.<br />

Methods:<br />

A cross-sectional sampling, using a 26-question Internet ‘Survey<br />

Monkey’ survey, of geriatric educators contacted through <strong>American</strong><br />

<strong>Geriatrics</strong> <strong>Society</strong> listservs was performed. Participant demographics<br />

and attitudes towards use of interactive educational modalities such<br />

as video clips, games, role-play, and creative writing were assessed<br />

during a two-week period in November 2011. Data was analyzed<br />

across response categories.<br />

Results:<br />

141 physicians responded. 64% had a CAQ in Geriatric Medicine.<br />

43% were past/present GACA recipients. 42% spent between ¼<br />

and ½ of time teaching a broad array of learners. 99% agreed with the<br />

statement: “I believe that trainees prefer interactive educational activities.”<br />

Results demonstrated a very high preference for interactive<br />

educational formats, but a much lower rating of quantity and quality<br />

of available resources. For example: 95% agreed with the statement:<br />

“I believe video clips may capture the trainees attention better than<br />

traditional lecture format”, but 63% felt the videos currently available<br />

were of insufficient quantity and quality, and 31% had created<br />

their own video materials. We will also present differences between<br />

GACA awardees, geriatricians, and different academic ranks in use of<br />

interactive educational techniques.<br />

Conclusion:<br />

Educators in graduate medical education routinely utilize a variety<br />

of interactive teaching techniques in diverse teaching settings,<br />

yet the majority of educators felt the number of interactive resources<br />

available were insufficient to meet their teaching needs. Promoting<br />

online educational resource sites, such as POGOe, and encouraging<br />

educators to submit interactive teaching material to these sites may<br />

facilitate the increased use of more effective interactive teaching<br />

techniques.<br />

D55<br />

A Training Model to Strengthen Team-based Primary Care for<br />

Older Rural Veterans.<br />

J. L. Howe, 1,2 J. L. Griffith. 1,2 1. <strong>Geriatrics</strong> and Palliative Medicine,<br />

Mount Sinai School of Medicine, New York, NY; 2. GRECC, James J.<br />

Peter VAMC, Bronx, NY.<br />

There is a severe shortage of healthcare professionals and interdisciplinary<br />

teams trained to provide services for the growing population<br />

of older <strong>American</strong>s. Forty percent of Veterans live in rural areas<br />

and require specialized geriatrics care, but rural practitioners are<br />

often not equipped with the knowledge and team training needed to<br />

serve complex healthcare needs. The Rural Interdisciplinary Team<br />

Training (RITT) Program, a component of the VHA Office of Rural<br />

Health Geriatric Scholars Program, strengthens interprofessional<br />

teams to better serve older adults at rural VA Community Based<br />

Outpatient Clinics (CBOCs) through a multi-modal educational intervention.<br />

Potential RITT training sites are identified through Scholars<br />

who participate in the educational program which includes attendance<br />

at an intensive geriatrics course and a quality improvement<br />

project. CBOC staff participate in team-based training to enhance<br />

communication, leadership, collaboration, conflict resolution, and<br />

problem solving skills in the care of older Veterans. Piloted in 2011,<br />

the RITT Program trained a total of 68 providers from five separate<br />

teams in rural clinics located in NYS, AZ, CA, WI and AR. The validated<br />

Team Development Measure is disseminated 30 days before<br />

and 30 days after the training intervention in order to assess team cohesion,<br />

communication, roles, and goals. For the RITT in WI, there<br />

was an average increase of 15.4% on practitioners’ self-rated levels of<br />

team development. Practitioners also complete a form 30 days after<br />

the training asking what changes are made in their practice as a result<br />

AGS 2012 ANNUAL MEETING<br />

S205


P OSTER<br />

A BSTRACTS<br />

of the education intervention. In WI, team members made changes in<br />

their practice by convening with the team, discussing options, and<br />

slowing down. The main barrier to implementation of the project is<br />

not enough support, time constraints, and staff absences. In 2012,<br />

RITT will be implemented at 10 additional sites with more clinical<br />

geriatric teaching content. In conclusion, RITT led to team-based<br />

practice changes in rural clinics and reinforced the other educational<br />

activities of the Geriatric Scholars Program. It also had a “spill over”<br />

effect by taking team training “on the road” to rural clinics where the<br />

Scholars’ colleagues did not have the opportunity to participate.<br />

D56<br />

G-FACTS - Point of Care Geriatric Resources with a Basic<br />

Science Twist.<br />

E. H. Duthie, 1 J. Rehm, 2 K. Denson, 1 S. Denson, 1 B. Wessel, 1<br />

D. Brown, 2 D. Simpson, 2 G. Colloborrative. 2 1. Medicine, Medical<br />

College of Wisconsin, Milwaukee, WI; 2. Academic Affairs<br />

Educational Services, Medical College of Wisconsin, Milwaukee, WI.<br />

Supported By: Reynolds Foundation; Health Services Resources<br />

Administration Geriatric Education Center; Department of<br />

Veterans Affairs; MCW Injury Research Center<br />

Introduction:<br />

<strong>Geriatrics</strong> related clinical training of residents and fellows continues<br />

to be in the crosshairs of competing forces ranging from new<br />

duty hour limitations and required ACGME/RRC topics to escalating<br />

clinical productivity expectations for teachers. Trainees now expect<br />

immediate access to point of care clinical resources to inform assessment,<br />

diagnosis and management decisions. Currently an array of<br />

e-based clinical resources are available but these resources often omit<br />

the underlying basic sciences to inform action and are highly variable<br />

in quality, level of evidence-based guidance and technology accessibility<br />

(e.g., instant search, access, down load ).<br />

Methods:<br />

Since 2000, Medical College of Wisconsin has successfully provided<br />

just-in time, point-of-care instruction through its End of<br />

Life/Palliative Care Resource Center (EPERC) Fast Fasts. These<br />

concise, practical, peer-reviewed, and evidence-based summaries on<br />

key topics have demonstrated an increase in intern medical knowledge<br />

and self-reported preparedness in symptom management skills.<br />

Adopting this model for geriatrics a blueprint of relevant topics was<br />

identified by a multi-specialty work group and agreement regarding<br />

format/layout to meet our criterion for point of care actional intelligence<br />

emerging from the sciences underlying medicine. Authored by<br />

multi-specialty team including medical students, residents, fellows<br />

and faculty, the fast facts cross specialties.<br />

Results:<br />

An interactive, searchable website houses the geriatric fast facts<br />

(<strong>Geriatrics</strong> Fast Facts) indexed by common geriatrics topics, ACGME<br />

competencies, organ system, and diseases. Fast facts are keyed as assessment,<br />

etiology, diagnosis, and/or management focused. Download<br />

time is seamless as file sizes and layout adapt to web or mobile devices.<br />

Examples of <strong>Geriatrics</strong> Fast Facts include rib fractures, pharmacologic<br />

aspects of drug clearance in elderly patient with reduced function,<br />

gait and balance assessment, and hypertension with positive<br />

reviews from faculty and residents alike.<br />

Discussion:<br />

<strong>Geriatrics</strong> Fast Facts address the“mobile access now”point-of-care<br />

needs of trainees and faculty alike.The incorporation of the sciences underlying<br />

geriatrics provides a unique and added value for residency/fellowship<br />

programs seeking to fulfill ACGME RRC requirements.<br />

D57<br />

Confusion about Delirium.<br />

J. Defillo Draiby, M. Drickamer. <strong>Geriatrics</strong>, Yale School of Medicine,<br />

New Haven, CT.<br />

Delirium is an important clinical syndrome in the elderly and<br />

is related to increased mortality and hospital length of stay, long<br />

term functional and cognitive decline and institutionalization. Despite<br />

being responsible for higher mortality rates than sepsis or<br />

myocardial infarction, delirium is often not diagnosed or improperly<br />

addressed. We evaluated resident’s level of knowledge and<br />

confidence in regards to delirium in order to inform future formative<br />

interventions.<br />

Methods: A web-based questionnaire was given to third year<br />

medical residents. Chief Residents emailed all residents with information<br />

on the nature of the survey with a brief explanation of the importance<br />

of delirium. The 15 questions were designed to elicit basic<br />

knowledge in diagnosis, predisposing and precipitating factors; prevalence,<br />

prevention, management, attitudes and beliefs. The responses<br />

were tabulated in tables and interpreted by consensus.<br />

Results: 30 0f 45 residents completed the survey. 72 % had never<br />

used a delirium assessment tool. 50 % did not feel they have a good<br />

working knowledge of the diagnosis of delirium. 49% thought they<br />

did not have adequate training in delirium with only 33% feeling<br />

comfortable managing it. Half thought delirium is under-recognized<br />

in the emergency department. 77% of resident thought that staffing<br />

constraints augment the need for restraints. 1/3 of our participants<br />

would use a high dose haloperidol or benzodiazepine to control hyperactive<br />

delirium. Delirium features was described as altered level<br />

of consciousness and fluctuating in 67% of the respondent. The predisposing<br />

factors most frequently recognized were age (27%) and<br />

baseline cognitive status (27%). Of precipitating factors, acute illness<br />

was the most recognized (77%) followed by medications (67%) and<br />

environment (60%).<br />

Conclusion: The study illustrates the deficits of third year medical<br />

residents in regards to delirium. They expressed concern about<br />

the adequacy of their baseline knowledge and most were unaware of<br />

any validated instrument to diagnose delirium. Half felt that they did<br />

not have enough training in delirium and only 1/3 of the residents felt<br />

confident in managing delirium. This lack of confidence is accompanied<br />

by lack of awareness of predisposing and precipitating factors of<br />

delirium all of which impact the care of the hospitalized elderly. The<br />

study is important in creating future educational interventions to solidify<br />

Geriatric teaching in our institution.<br />

D58<br />

Living the Life of an Older Adult Resident in a Nursing Home:<br />

Applying Learning by Living© Methods.<br />

K. F. Janes, 1 M. R. Gugliucci. 2 1. School of Social Work, University of<br />

Maine, Orono, ME; 2. College of Osteopathic Medicine, University of<br />

New England, Biddeford, ME.<br />

Supported By: Lakewood Continue Care Center<br />

University of New England College of Osteopathic Medicine<br />

Background: Only three percent of social work students choose<br />

a career in the aging field and yet between 8,000 and 10,000 people<br />

are turning 65/day. There is a critical need for social workers to be<br />

trained in gerontology. This study determined if Learning by Living©<br />

research protocols could be applied to enhance learning for an MSW<br />

student about aging.<br />

Methods: A qualitative ethnographic/biographic research design<br />

was applied, whereby a social work student volunteered to live as an<br />

elder resident in a nursing home for 12 days, 24/7, complete with medical<br />

diagnoses and “standard” procedures of care (toileting, transferring,<br />

bathing, feeding, etc). Qualitative data (field notes) included<br />

subjective and objective reporting of observations and experiences.<br />

Field notes were analyzed applying content analysis, thematic categorization<br />

and coding using manual analysis methods, and QSR N-Vivo<br />

Research Software.<br />

Results: Data stages included: Pre-admission; daily life; the<br />

“Ahaa” moment; and discharge. Themes included: Frustration, de-<br />

S206<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

pendence, depression, social dynamics; dignity, and friendships.<br />

Learning outcomes from living the life of an older nursing home resident<br />

included increased understanding and knowledge about patient/resident<br />

resilience, cross-generational relationships, verbal/ nonverbal<br />

communication skills and thorough professional development.<br />

These insights far exceed what is taught in the classroom.<br />

Conclusions: This life altering experience strengthened the student’s<br />

knowledge, compassion, and empathy for the aging population.<br />

Living as an older adult, aided in acquiring effective communication<br />

skills, confidence to relate with nursing home residents as individuals,<br />

and has advanced learning regarding the intricate levels of family dynamics<br />

in relation to professional caregivers.<br />

D59<br />

Development of an Interdisciplinary Curriculum in Frailty.<br />

K. Thompson, M. Huisingh-Scheetz, L. Mailliard, P. Rush. Section of<br />

<strong>Geriatrics</strong> and Palliative Medicine, University of Chicago, Chicago, IL.<br />

Supported By: Health Resources and Service Administration,<br />

Geriatric Academic Career Award<br />

Background:<br />

Frailty is a geriatric syndrome characterized by exhaustion,<br />

weakness, weight loss, slow gait speed, and low activity. Identifying<br />

frailty improves prognostication and decision-making in older<br />

adults. Internal medicine (IM) resident education on frailty and interdisciplinary<br />

(ID) teams, a vital component of care for frail patients,<br />

is limited.<br />

Methods<br />

An ID curriculum in frailty was created using Kern et al.’s approach<br />

to curriculum development. Problem identification and needs<br />

assessment was performed, including: 1.) Meeting with the IM residency<br />

program director to assess curricular content and gaps. 2.)<br />

Group meetings with residents to assess pre-curriculum exposure to<br />

frailty and ID teams. Goals and objectives for curriculum were based<br />

on needs assessment. Educational strategies were developed to reflect<br />

goals and objectives. Curriculum was implemented for IM residents<br />

and other learners. Evaluation and feedback from learners was<br />

collected.<br />

Results:<br />

Needs Assessment: IM residents received no exposure to frailty<br />

in their formal curriculum and had minimal opportunity to work with<br />

an ID team.<br />

Objectives: After participation, IM residents will be able to:<br />

1.) Define frailty, identify frail patients; 2.) Perform functional<br />

and cognitive assessment; 3.) Appreciate importance of ID care<br />

for frail patients; 4.) Appreciate relevance of frailty to future<br />

practice.<br />

Educational Strategies: Didactic lecture, observed clinical experience<br />

and ID team experience with feedback, pre/post-testing.<br />

Implementation: From July 1 to December 31, 2011, 22 learners<br />

completed curriculum: 17 IM residents, 1 PM&R resident, 2 social<br />

work interns, 1 physical therapist, 1 medical student.<br />

Evaluation and Feedback: Learner satisfaction survey results<br />

centered on awareness of frailty as a geriatric syndrome and appreciation<br />

of ID care. Representative quotes include: “I had never heard of<br />

frailty. Now I not only know what frailty is, I have completed a frailty<br />

evaluation,” and “I really enjoyed participating in the [ID] team<br />

meeting. I learned about a lot of options for patients that I never<br />

knew existed.”<br />

Conclusions<br />

This ID Curriculum in Frailty is an innovative forum for residents<br />

to learn about frailty and practice ID care. Results suggest that<br />

satisfaction with this educational experience is high. Future work will<br />

quantify improvements in knowledge, skills, and attitudes, and expand<br />

evaluation to other learners.<br />

D60<br />

ASSESSING 5 GERIATRIC DRIVEN BASIC SCIENCE<br />

CONCEPTS IN GME.<br />

K. Denson, 1,2 D. Steven, 1,2 E. H. Duthie, 1,2 D. Braza, 4,2 S. Gehl, 3,2<br />

B. Vasudev, 1,2 T. Webb, 5,2 A. Witt, 3,2 D. Brown, 2 J. Rehm, 2 B. Wessel, 1,2<br />

D. Simpson, 2,3 G. Colloborative. 2 1. Medicine, Medical College of<br />

Wisconsin, Milwaukee, WI; 2. Educational Services Academic Affairs,<br />

Medical College of Wisconsin, Milwaukee, WI; 3. Family and<br />

Community Medicine, Medical College of Wisconsin, Milwaukee, WI;<br />

4. Physical Medicine and Rehabilitation, Medical College of<br />

Wisconsin, Milwaukee, WI; 5. Surgery, Medical College of Wisconsin,<br />

Milwaukee, WI.<br />

Supported By: Reynolds Foundation; Health Services Resources<br />

Administration Geriatric Education Center; Department of<br />

Veterans Affairs<br />

Purpose/Objective:<br />

Geriatric quality care requires that residents/fellows solutions<br />

are based on strong basic science underpinnings. We were unable to<br />

identify reliable or valid clinically-oriented, basic science-related<br />

knowledge assessment tools. In response, we created an examination,<br />

to assess underlying basic science concepts/themes linked to clinically<br />

oriented conditions.<br />

Method:<br />

We identified five basic science geriatrics concepts: impaired<br />

homeostasis; connective tissue changes; post-mitotic tissue predilection<br />

for age changes; cellular replication and control of mitotic<br />

processes; and immunosenescence. We then developed a test blueprint<br />

with two dimensions: five “cross-cutting” geriatric related basic<br />

science themes and 13 common geriatric conditions/diseases/illnesses.<br />

We then generated 26 multiple choice questions (MCQ’s) as 13-<br />

item pairs: the first question assessed the clinical condition/disease/illness<br />

and the second question in the pair assessed the associated underlying<br />

basic science. The examination was piloted using third-year<br />

medical students (N=68). Using item statistics selected questions<br />

were revised. The examination was then administered to<br />

residents/fellows in family medicine, general surgery, nephrology, and<br />

physical medicine and rehabilitation.<br />

Results:<br />

Fifty (50) residents/fellows completed the examination. Average<br />

time to complete was < 25 minutes. Mean performance was 57.7%<br />

correct (range 34% - 77%). There was no significant difference between<br />

clinical and basic science items scores (p > .05) nor were there<br />

significant differences between specialties. The overall exam reliability<br />

is in moderate range (> .71).<br />

Conclusions:<br />

A paired clinical and underlying science MCQ type examination<br />

provides a reliable assessment of residents’ and fellows’ knowledge of<br />

clinical geriatric medicine content in relationship to five underlying<br />

basic science associated geriatric concepts. The no differences finding<br />

between specialties or by item type (clinical versus basic science)<br />

adds further evidence to support examination generalizability across<br />

specialties.<br />

D61<br />

A Three-Year Competency-Based <strong>Geriatrics</strong> Curriculum for<br />

Internal Medicine Residents.<br />

K. Callahan, K. B. Feiereisel, J. Williamson, F. S. Watkins,<br />

H. H. Atkinson. Wake Forest University School of Medicine, Winston-<br />

Salem, NC.<br />

Background: Graduate medical educators struggle to meet the<br />

Accreditation Council for Graduate Medical Education (ACGME)<br />

competencies; geriatricians have a unique opportunity to infuse<br />

geriatrics content while helping to meet ACGME requirements. We<br />

describe a 3-year geriatrics curriculum that incorporates ACGME<br />

AGS 2012 ANNUAL MEETING<br />

S207


P OSTER<br />

A BSTRACTS<br />

and geriatrics competencies for Internal Medicine (IM) residents<br />

and engages residents in self-reflection and quality improvement activities.<br />

Methods: Along with IM residency leaders, a curriculum was<br />

developed in 2008 employing spaced learning in geriatrics across<br />

three years. Interns complete an Ambulatory <strong>Geriatrics</strong> Experience<br />

(AGE): nursing home, primary care, consultations, house calls<br />

and palliative care. PGY-2 residents staff the Acute Care for the<br />

Elderly (ACE) unit; they also conduct a chart audit and patient<br />

survey on their own ambulatory panel through the ABIM Practice<br />

Improvement Module for the Care of the Vulnerable Elderly<br />

(CoVE PIM). In the capstone activity, PGY-3 residents utilize<br />

clinic site-based aggregate CoVE PIM data to reflect on their performance<br />

gaps in quality of care for older adults. Each site develops<br />

a clinic-specific QI intervention targeting systemic, sustainable<br />

improvement.<br />

Results: As of spring 2011, 84 residents completed AGE, 56 completed<br />

ACE, and 28 completed the CoVE PIM. Interns’ satisfaction<br />

score averages 6.9 out of 9 and PGY-2 residents rank the ACE unit<br />

6.75 out of 9 (satisfactory-superior). Residents expressed confidence<br />

in “assessing functional status” with a “more complete approach to<br />

patient care”. Comparison of CoVE PIM quality measures between<br />

the 2006 and 2010 cohorts yielded no significant difference in patient<br />

satisfaction or physician communication scores. Screening practices<br />

for cognitive impairment (2% to 19%) and falls (8% to 30%) improved<br />

at one resident clinic (p=0.01), but not the other.<br />

Conclusions: A 3-year residency curriculum in geriatrics that<br />

meets all ACGME and geriatrics competencies was well received by<br />

residents, who feel they learn key elements of geriatrics. The CoVE<br />

PIM prepares residents for independent self-reflective practice and<br />

supports the institutional QI mission. After one CoVE PIM cycle, residents’<br />

screening behaviors improved in one of two clinics; future<br />

measures will assess the impact of this continued curriculum on<br />

learner knowledge, patient QOC and satisfaction with care.<br />

D62<br />

ICE: Introducing First-Year Medical Residents to<br />

Interprofessional Teams.<br />

K. D. Sheppard, C. R. Ford, K. Foley, L. Mitchell, C. Harada,<br />

A. Rothrock, P. Sawyer, C. S. Ritchie. University of Alabama at<br />

Birmingham, Birmingham, AL.<br />

Introduction:<br />

Interprofessional education (IPE) occurs “when students from<br />

two or more professions learn about, from, and with each other to enable<br />

effective collaboration and improved health outcomes”. The<br />

IPE Collaborative Expert Panel identified core competencies for IPE<br />

which is the foundation of the Interprofessional Clinical Experience<br />

(ICE) at UAB. The ICE was developed to educate trainees from multiple<br />

healthcare professions on the importance of interprofessional<br />

team meetings for effective patient care. The experience’s objectives<br />

include: introducing trainees to other healthcare professions; participating<br />

in an interprofessional team meeting; and providing trainees<br />

with the opportunity to develop a patient-centered care plan. This<br />

study describes the differences between first year medical residents’<br />

attitudes and those of other disciplines’ trainees.<br />

Methods:<br />

Six disciplines participate in ICE: dentistry, medicine, nutrition,<br />

occupational therapy (OT), optometry, and social work. Each discipline<br />

sends 1-2 trainees to interview an identified nursing home resident<br />

over a 1-week period. Trainees then convene for a preceptor-led<br />

team meeting to present findings and assemble a patient care plan.<br />

Trainees complete a 10-item survey which assesses the trainees’ interpretation<br />

of the various team roles and the need for effective communication.<br />

Results:<br />

Preliminary results over seven sessions have shown that medical<br />

residents highly ranked the importance of the roles of medicine, nursing,<br />

OT, physical therapy and social work as 4.57/5 for older adult<br />

healthcare. Other disciplines differed by listing nutrition and pharmacy<br />

as highly important as well as medicine, nursing, and OT. Both<br />

medical residents and other trainees highly valued interprofessional<br />

team meetings and interprofessional care as well as the importance<br />

of effective communication with older adults and healthcare professionals.<br />

Conclusion:<br />

Both medical residents and other trainees value interprofessional<br />

team meetings. The medical residents have differing interpretations<br />

of the roles of healthcare professionals. This presentation will<br />

delineate the difference in the residents’ attitudes versus the other<br />

participating disciplines towards interprofessional teams and the<br />

need for effective communication.<br />

D63<br />

Medical student geriatric education and mentorship: the Student-<br />

Senior Connection Project.<br />

L. K. Byerly, 1 K. Anderson, 1 J. Zelaya, 1 A. Dworkin, 1 M. Anthony, 1<br />

H. McNett, 1 S. Devarajan. 1,2 1. School of Medicine, Oregon Health &<br />

Science University, Portland, OR; 2. Family Medicine, Oregon Health<br />

& Science University, Portland, OR.<br />

Background: <strong>Geriatrics</strong> focusing on healthy seniors is an underrepresented<br />

topic in medical school education. An elective focusing<br />

on the relationship between medical students and community<br />

dwelling independently living seniors has never been offered at Oregon<br />

Health & Science University School of Medicine (OHSU<br />

SOM), and the Student-Senior Connection Project (SSCP) was created<br />

to pair OHSU medical students and senior “mentors” from the<br />

community with the goal of fostering relationships and learning<br />

partnerships.<br />

Methods: First and second year OHSU SOM students (n=11;<br />

30.2±6 years, 55% female, 82% White) voluntarily participated in<br />

the yearlong program in which they were randomly paired with a<br />

mentor (n=15; 84.5±9 years, 66% female, 100% White) at a local<br />

continuing care retirement community (CCRC). Over the course<br />

of 8 months, mentors and students met for 6 afternoon sessions<br />

that included formal didactic instruction and informal mentoring.<br />

A variety of professionals lectured on topics including: Quality of<br />

Life, Exercise, Perceptions of Aging, Transitions of Care, Nutrition,<br />

and Death & Dying. Students also took part in CCRC events.<br />

At the end of the program, students completed reflective feedback<br />

forms.<br />

Results: Program completion was 100%. Feedback showed<br />

the “Perceptions of Aging” session was both the most important<br />

and interesting topic for students’ medical education, and (60%)<br />

of students were affirmed in the prospect of including geriatrics in<br />

their primary care practices or amongst their specialty choices.<br />

Student reflections demonstrated several overarching themes: a<br />

deeper understanding of aging well, appreciation of exposure to<br />

an active retirement community, and the value of student-mentor<br />

relationships.<br />

Conclusions: This program was a unique elective experience for<br />

OHSU medical students and the first of its kind for medical students<br />

in the Northwest. The pilot year of the program demonstrated the<br />

utility of introducing students to a group of lively, older adults. Students<br />

expressed a strongly positive view of aging upon program completion.<br />

As the students spent time in their mentors’ community, they<br />

formed meaningful relationships as well as an appreciation of the<br />

strengths and talents of a population that is not well-represented in<br />

their medical school education.<br />

S208<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

D64<br />

Hospice and Palliative Medicine Toolkit of Assessment Methods.<br />

L. J. Morrison, 1,2 E. Carey, 3 E. Chittenden, 4,5 S. Block. 4,6 1. Baylor<br />

College of Medicine, Houston, TX; 2. The Methodist Hospital,<br />

Houston, TX; 3. Mayo Clinic, Rochester, MN; 4. Harvard Medical<br />

School, Boston, MA; 5. Massachusetts General Hospital, Boston, MA;<br />

6. Dana Farber Cancer Institute, Boston, MA.<br />

Supported By: Dr. Morrison’s work was supported by funds from<br />

the Division of State, Community, and Public Health, Bureau of<br />

Health Professions (BHPr), Health Resources and Services<br />

Administration (HRSA), Department of Health and Human<br />

Services (DHHS), under grants K01 HP 00077 and K01 HP 00117,<br />

Geriatric Academic Career Award. The information or content and<br />

conclusions are those of the author and should not be construed as<br />

the official position or policy of, nor should any endorsements be inferred<br />

by the BHPr, HRSA, DHHS or the U.S. Government.<br />

Background: Hospice and Palliative Medicine (HPM) was recognized<br />

as an ACGME subspecialty in 2006. As existing fellowship<br />

programs transitioned to the ACGME framework, the HPM Competencies<br />

Project Workgroup defined competencies and measureable<br />

outcomes in line with the ACGME Outcome Project (1). The final<br />

step was to develop an assessment toolkit to guide HPM fellow evaluation.<br />

Methods: The Workgroup reviewed candidate assessment tools<br />

organized by ACGME competency domain from within and outside<br />

the field. This included known unpublished tools, published tools, and<br />

tools from evaluation websites. HPM educators were invited to submit<br />

tools in a call to the field. In reviewing instruments, the Workgroup<br />

used characteristics of a good instrument (1,2) and developed<br />

criteria to inform HPM-specific tool selection.<br />

Results: Sixty-four tools were identified, but most had very poor<br />

fit with criteria. Very few were specific to HPM. Many key HPM subcompetencies<br />

were not evaluable with the instruments. Most importantly,<br />

tool validation was lacking. We identified, by consensus, the<br />

two best assessment methods for each ACGME competency domain<br />

and 18 instruments for inclusion in the Toolkit. Ten were newly created<br />

by the Workgroup and eight were adapted from existing tools.<br />

The Workgroup developed the Master Assessment Table. This new<br />

tool lists the most important, representative subcompetencies for<br />

each ACGME competency per Workgroup consensus. These are considered<br />

exemplar skills that will reflect broader mastery of the entire<br />

competency domain. Recommended assessment methods are also indicated.<br />

Conclusions: The Toolkit of Assessment Methods provides guidance<br />

to HPM fellowship directors and faculty in assessing competency-based<br />

performance for fellows. Psychometric evaluation is<br />

needed. New tools are also needed to address competency areas not<br />

covered by existing tools. Despite these limitations, the Toolkit has<br />

the potential for broad application and can be used flexibly to guide<br />

assessment of learners by ACGME competency domain across levels,<br />

disciplines, and fields.<br />

References:<br />

1. ACGME Outcome Project Web site. Available at:<br />

www.acgme.org/Outcome. Accessed December 5, 2011.<br />

2. Epstein RM. Assessment in medical education. N Engl J Med.<br />

2007;356:387-396.<br />

D65<br />

Training health professionals to screen, manage and report age<br />

related driving disorders (ARDDs).<br />

L. Hill, 1 J. Rybar, 1 T. Styer, 1 R. Coimbra, 2 K. Patrick. 1 1. Family and<br />

Preventive Medicine, UCSD, San Diego, CA; 2. Surgery, University of<br />

California, San Diego, San Diego, CA.<br />

Supported By: State of California Office of Traffic Safety<br />

Background: Older adults have a higher prevalence of health<br />

and functional impairments that interfere with their ability to drive<br />

safely. If left unaddressed, these problems pose a risk of driving-related<br />

injury, not only to the individuals themselves, but also to their<br />

families and to others who share the road with them. Physicians and<br />

other health professionals receive little training on research and management<br />

of ARDDs. Research suggests that the topic is often avoided<br />

by both parties, and that physicians are not aware of the AMA guidelines,<br />

posted online since 2003, or the mandated reporting required in<br />

some states. The purpose of this report is to describe the results of a<br />

professional training curriculum addressing this issue.<br />

Methods: The curriculum was developed and administered over<br />

the last 4 years to 1202 health professionals. The training was developed<br />

and modified from the <strong>American</strong> Medical Association (AMA)<br />

2003 guidelines for physicians (http://www.nhtsa.dot.gov/people/injury/olddrive/OlderDriversPlan).<br />

Training was provided in a variety<br />

of formats, from in-office seminars to grand rounds. The interactive<br />

program included pocket guides, case studies, resources and videos.<br />

Results: Confidence in the ability to screen seniors increased<br />

from 17% to 72%. The change from baseline screening to intent to<br />

screen increased from 27% to 55%. Ninety one percent of participants<br />

agreed or strongly agreed that they had a better understanding<br />

of California’s mandated reporting laws post training. Ninety two<br />

percent of participants post training agreed or strongly agreed that<br />

they had a better understanding of the medical conditions and medications<br />

that may impair older adults’ ability to drive safely.<br />

Attitudes on California’s mandated reporting laws for lapses of<br />

consciousness (LOC) were favorable, though baseline comprehensive<br />

of the laws was low. While California is one of only 9 states that<br />

mandates LOC reporting (including dementia), physicians felt supported<br />

by the laws.<br />

Conclusions: Physicians responded favorably to training on<br />

ARDDs and mandated reporting, with increases in understanding<br />

and intent to change behavior.<br />

D66<br />

An Innovative Approach to Teaching Delirium Using Standardized<br />

Patients.<br />

L. Wilson, E. Roberts, A. Caprio, G. Winzelberg, J. Busby-Whitehead.<br />

UNC Chapel Hill, Chapel Hill, NC.<br />

Supported By: Supported by: The Donald W. Reynolds Foundation<br />

BACKGROUND: Delirium is a serious, under-diagnosed medical<br />

condition that affects up to 1/3 of hospitalized elders. Physicians<br />

from specialties outside of <strong>Geriatrics</strong> need the skill set to prevent, diagnose,<br />

evaluate, and treat delirium. Attending physicians in specialty<br />

fields may have the opportunity to teach their learners about delirium,<br />

but they may not have the knowledge base for this task. PUR-<br />

POSE: To develop an innovative curriculum using standardized patients<br />

(SPs) for specialty faculty learners (FLs) in order to solidify<br />

their knowledge and increase their confidence in teaching about<br />

delirium. METHODS: FLs designated as Reynolds Specialty Faculty<br />

Scholars on the UNC-CH Donald W. Reynolds Foundation grant,<br />

“Next Steps in Physicians’ Training in <strong>Geriatrics</strong>,” participated in this<br />

workshop. Small groups of FLs rotated through 3 different stations of<br />

delirious SPs. Prior to “seeing” each patient, the FLs reviewed the<br />

“chart,” learning the SP’s past medical history, recent labs and vitals,<br />

and medication administration record. Using this information, they<br />

determined a pretest probability that the SP would have delirium and<br />

identified predisposing and precipitating factors for this condition.<br />

One FL in each group interviewed the patient using the Confusion<br />

Assessment Method to diagnose delirium while being observed by<br />

others in the group and a consulting Geriatrician. A family member<br />

of the SP answered questions to provide information about the SP’s<br />

baseline functional status and risk factors for delirium. After the interview,<br />

the FLs developed a management plan and identified a oneminute<br />

teaching point from the case to instruct learners about delirium.<br />

The consulting Geriatrician provided feedback and made<br />

recommendations. OUTCOMES: Eighteen FLs from Hematology-<br />

Oncology, Physical Medicine and Rehabilitation, Trauma and Critical<br />

AGS 2012 ANNUAL MEETING<br />

S209


P OSTER<br />

A BSTRACTS<br />

Care Surgery, Emergency Medicine, Hospital Medicine, and the Office<br />

of Graduate Medical Education completed the workshop. Feedback<br />

was overwhelmingly positive. These high level academic leaders<br />

in their specialty fields all acknowledged that the direct hands on<br />

learning session enhanced their skills for recognizing and diagnosing<br />

delirium as well as gave them the tools for teaching others. CON-<br />

CLUSION: This curriculum provides an active learning environment<br />

with SPs to teach FLs about delirium. These sessions may be replicated<br />

in other settings and with other disciplines.<br />

D67<br />

Simulation Fosters Interprofessional Skills among Nursing,<br />

Pharmacy and Medical Students.<br />

L. C. Hutchison, 1,3 P. S. Ragsdale, 2 S. N. Berryman, 2 T. J. Bilbruck. 4 1.<br />

College of Pharmacy, University of Arkansas for Medical Sciences,<br />

Little Rock, AR; 2. College of Nursing, UAMS, Little Rock, AR; 3.<br />

Donald W. Reynolds Institute on Aging, UAMS, Little Rock, AR; 4.<br />

College of Medicine, UAMS, Little Rock, AR.<br />

Background: Opportunities to learn effective team skills in the<br />

entry-level curricula are sparse. We integrated human patient simulators<br />

into an interprofessional education experience to train nursing,<br />

pharmacy and medical students interprofessional skills in their geriatric<br />

curricula.<br />

Methods: Two unfolding cases provide simulations for nursing<br />

students (N4s) in their geriatric course. N4s alternatively perform assessments<br />

on the simulated patient or watch via remote camera. Following<br />

this, pharmacy (P4s) and medicine (M4s) students join the N4s<br />

for a simulated staff meeting. N4s present their findings and assessment,<br />

answering questions from the other disciplines. The staff meeting<br />

ends with a delineated plan of care for the patient. The case unfolds<br />

with the patient’s arrival at the simulated emergency<br />

department. N4s perform initial assessment of the simulated patient<br />

and are joined by the P4s and M4s to continue assessment and implementation<br />

of a new plan of care. The simulation ends with initiation<br />

of antibiotics for treatment. At the conclusion of the simulation students<br />

meet to discuss what went well and what could be improved.<br />

Results: 69 students participated in 6 sessions of 9-13 students.<br />

There were 53 N4s, 7 P4s, 3 post-graduate year 1 pharmacy residents<br />

and 6 M4s.Student evaluations of the experience are shown in the table.<br />

Conclusions: Combining high-fidelity simulations of geriatric<br />

patients with interprofessional interactions was well-received by students<br />

from nursing, pharmacy and medicine. This process allows students<br />

from multiple professions to learn and practice different team<br />

skills prior to beginning their professional practice.<br />

D68<br />

Hazards of Hospitalization: A Novel <strong>Geriatrics</strong> Curriculum for<br />

Internal Medicine Interns.<br />

L. Martinez, M. T. Heflin. Department of Medicine, Division of<br />

<strong>Geriatrics</strong>, Duke University, Durham, NC.<br />

Introduction: Older hospitalized adults are susceptible to complications,<br />

termed “hazards of hospitalization” (HOH), which are associated<br />

with poor patient outcomes including increased mortality.<br />

Despite these adverse outcomes, house staff knowledge about their<br />

patient’s risk factors for developing HOH is lacking. The goal of this<br />

novel curriculum is to improve Internal Medicine (IM) intern knowledge<br />

and skills about HOH in elderly inpatients in order to ultimately<br />

improve patient care and patient outcomes.<br />

Methods: We implemented this curriculum at our institution for<br />

IM interns rotating on the <strong>Geriatrics</strong> Inpatient Consult service. Instructional<br />

content and references are posted online and a pocketcard<br />

is provided for review on 10 hazards (delirium, pressure ulcers,<br />

urinary issues, functional decline, falls, polypharmacy,<br />

dehydration/malnutrition, infection, depression, and goals of care).<br />

For each patient the intern follows on the consult service, a topic<br />

checklist is completed by the intern and reviewed by the <strong>Geriatrics</strong><br />

attending and/or fellow to ensure all HOH have been discussed. They<br />

are also directly observed performing the Confusion Assessment<br />

Method (CAM). Knowledge and self-efficacy towards HOH are<br />

measured in pre- and post-tests (knowledge) and pre- and post- self<br />

efficacy surveys (5 point Likert scale: 1= No confidence to 5=Completely<br />

confident).<br />

Results: To date, 8 learners have completed the curriculum. All<br />

demonstrated increased confidence in their ability to manage HOH<br />

after completion of the curriculum, with the most dramatic increases<br />

seen in delirium (pre 2.50 to post 4.00), urinary issues (2.10 to 3.60),<br />

and functional decline (2.00 to 3.75). Interns are able to more accurately<br />

define HOH as well as identify the correct components of the<br />

CAM. Prior to the rotation, all interns either strongly disagreed (5/8)<br />

or disagreed (3/8) that they felt confident in performing the CAM<br />

compared to afterwards in which all either agreed (1/8) or strongly<br />

agreed (7/8).<br />

Conclusion: Implementation of this curriculum has demonstrated<br />

improvement in intern knowledge and self-efficacy regarding<br />

HOH. While a relatively small number of interns have participated to<br />

date, we anticipate reaching up to 38 by the end of the current academic<br />

year. Next steps include measuring application of these principles<br />

through review of documentation of HOH in older adults cared<br />

for by interns in future inpatient rotations.<br />

D69<br />

Incorporating Evidence-Based Medicine in a Geriatric Medicine<br />

Clerkship.<br />

M. van Zuilen, 1 J. C. Palacios, 1,2 M. J. Mintzer. 1,2 1. University of<br />

Miami Miller School of Medicine, Miami, FL; 2. GRECC, VA Health<br />

Care System, Miami, FL.<br />

INTRODUCTION:<br />

As part of a 4-week geriatric medicine clerkship, students at the<br />

UMMSM complete an evidence-based medicine assignment on a<br />

clinical question arising during rounds in the medical, psychological,<br />

social, economic, or functional domains. This paper presents the structure<br />

and components of this assignment, student performance data,<br />

and feedback from students.<br />

METHODS:<br />

During the clerkship orientation, students receive an overview<br />

of the EBM assignment with sample PICO questions from several<br />

domains. They are instructed to frame a clinical question for one of<br />

their patients, search for the best evidence, critically appraise the validity<br />

and clinical relevance of the evidence, and apply it to their patient.<br />

Students submit a structured critical appraisal of topic form and<br />

deliver a 10-minute slide presentation to their peers and course faculty,<br />

followed by a brief Q&A and feedback session. To promote<br />

group participation, student peers ask questions before faculty members<br />

comment and provide feedback. An 8-item evaluation form is<br />

used to rate students’ performance with 5 scorable categories (unsatisfactory<br />

– excellent) for each item. Although we evaluate the basic<br />

EBM skills (framing a question and conducting a search), emphasis is<br />

placed on the critical appraisal and the discussion of patient specific<br />

factors (risks, values, preferences) in applying the evidence.<br />

RESULTS:<br />

Since 2010, 203 students have completed the EBM assignment.<br />

Although most clinical questions pertained to the medical domain,<br />

students have also addressed issues in the psychological, social, economic<br />

and functional domains. The overall quality of the presentations<br />

has been high (average score is 89.8; range is 68-100). The main<br />

contributors to poor performance are formulating a question that is<br />

not clinically meaningful and failing to address patient specific fac-<br />

S210<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

tors. Student feedback indicates they recognize the value of enhancing<br />

their EBM skills, but that they find the assignment time consuming<br />

and the presentation difficult to deliver effectively in 10-minutes.<br />

DISCUSSION:<br />

The EBM assignment in our clerkship builds on prior course<br />

work and paper-based EBM exercises in the pre-clinical years. Students<br />

are able to effectively deliver a clinically meaningful presentation<br />

in a relatively short amount of time. This approach can be easily<br />

adapted by other programs seeking to incorporate EBM into their<br />

curricula.<br />

D70 Encore Presentation<br />

Hearing impairment in the elderly – unheard of in basic and further<br />

nursing education.<br />

M. Decker-Maruska, 2 M. Lerch. 1 1. Geriatric Dept., Protestant<br />

Hospital Bethanien, Iserlohn, Germany; 2. Geriatric Depart., St.<br />

Barbara Hospital, Attendorn, Germany.<br />

Introduction: With nearly 1 million dementia patients, focus on<br />

the special demands of these patients in nursing education grows.<br />

Compared to its high prevalence (approx. 13 Million) hearing impairment<br />

patients are still not recognized in all stages of nursing education.In<br />

the current education, still centred on the anatomy and physiology<br />

of the ear, rarely featuring the basic concept of a hearing aid,<br />

the auditive sensory loss and its consequences is often not an issue,<br />

neither in basic nor in further education.<br />

Methods: After developing a practice oriented educational concept<br />

for the care of hearing impaired geriatric patients, the authors interviewed<br />

105 certified nursing staff from different fields of care (35<br />

from a geriatric ward, a nursing home, a normal hospital ward) with a<br />

minimum working experience between one and four years with a<br />

standardized questionnaire (prevalence, detection, problem recognition<br />

and focus in formal education) before and 3 month after a 2 day<br />

training in specialized care for hearing impaired elderly patients.<br />

Results: In all fields the perceived prevalence grew after the<br />

training workshop (36%=> 67%). The ability to recognize a patient<br />

with a hearing impairment increased significantly in the nursing<br />

home and geriatric sub-group. Especially the ability to evaluate required<br />

repetitions and frequent misunderstandings as signs of hearing<br />

impairment picked up (23%=> 52%). We found a difference between<br />

staff from nursing homes and the geriatric ward opposed to<br />

staff from the normal ward in addressing the major care problems in<br />

hearing impaired elderly patients. Nursing home and geriatric ward<br />

staff recognized the time requirements of handicap-oriented communication<br />

as the core problem, where as the normal ward staff put their<br />

emphasis on technical aids.<br />

Evaluating how much effort was spent on the teaching of sensory<br />

deficiencies overall and on hearing impairment and the conceptual<br />

requirements linked to it in education, especially the staff from<br />

the geriatric wards and the normal wards saw the urgent need for further<br />

nursing education in that particular field.<br />

Conclusion:<br />

To improve the quality of the care process our interviews revealed<br />

the need for more practice-oriented educational concepts developing<br />

competence in recognition, handicap-oriented communication,<br />

and the handling of technical aids required by the auditory<br />

impaired elderly.<br />

D71<br />

Teaching Safe Transitions of Care: An Interdisciplinary Case Based<br />

Approach.<br />

R. K. Miller, E. Goren, C. Whitehouse, A. Norris, J. S. Myers.<br />

Medicine, University of Pennsylvania, Philadelphia, PA.<br />

Background:<br />

Coordinating transitions of care at hospital discharge is essential<br />

to achieve safe, high quality, patient-centered care. The requisite<br />

knowledge and skills in how to execute such a transition are not traditionally<br />

taught to medical trainees. In our experience when they are<br />

taught, they rarely take advantage of the expertise of the interdisciplinary<br />

teams which coordinate these transitions. We sought to design,<br />

implement, and assess an interdisciplinary-led, case-based curriculum<br />

in safe hospital discharge transitions for internal medicine<br />

interns.<br />

Methods:<br />

The curriculum included a brief lecture and case-based session.<br />

The 15 minute lecture reviewed key concepts in hospital discharge<br />

transitions, introduced the interdisciplinary care team roles, and provided<br />

a brief introduction to upcoming small group session. The 40<br />

minute case-based session was conducted with small groups of 6-8 interns..<br />

Each group included a physician moderator, social worker,<br />

clinical pharmacist, and a home care nurse. Two cases were presented,<br />

highlighting the roles of each professional, and emphasizing key high<br />

risk discharge issues.<br />

Results:<br />

Fifty-six interns participated in the curriculum and completed a<br />

satisfacation survey using a 5 point LIkert scale. 24 (42.8%) agreed<br />

and 31 (55.3%) strongly agreed that the session enhanced their ability<br />

to identify threats to a safe hospital discharge. 33 (58.9%) agreed<br />

and 23 (41%) strongly agreed that, after attending the session, they<br />

felt more confident in understanding the roles of other health care<br />

professionals who participate in the discharge process. 8 (14.2%)<br />

agreed and 48 (85.7%) strongly agreed that they believe that the use<br />

of other healthcare professionals to teach this topic was effective.<br />

Conclusion: An interdisciplinary curriculum on teaching safe<br />

transitions of care was well received by internal medicine interns and<br />

resulted in increased confidence in knowledge of discharge transitions,<br />

ability to identify threats to a safe hospital discharge, and the<br />

roles of the physician and other healthcare professionals in the discharge<br />

process. Future directions include expanding the curriculum<br />

to include other residency programs and developing other novel ways<br />

to incorporate interdisciplinary teaching into graduate medical education<br />

training.<br />

D72<br />

Internal Medicine Resident Senior Community Service Learning<br />

Experience.<br />

R. K. Miller, G. True, J. Groce-Martin, J. C. Johnson. Medicine,<br />

University of Pennsylvania, Philadelphia, PA.<br />

Supported By: Donald W. Reynolds Foundation<br />

Background: We developed, piloted, and evaluated a program to<br />

provide a service-learning and community-based, interactive experience<br />

focused on Geriatric Medicine and ACGME core competencies<br />

to medical residents. Service-based learning promotes core competencies<br />

by enriching learners’ experiences, promoting understanding<br />

of community resources and cultural norms, providing help to service<br />

agencies and communities, and developing leadership and professional<br />

skills.<br />

Methods: We developed and piloted a service-based community<br />

learning program with 20 Internal Medicine residents of the University<br />

of Pennsylvania. The program, which consisted of a half-day<br />

morning session, was embedded in a local senior center or senior<br />

housing facility. A community outreach coordinator of the Division of<br />

<strong>Geriatrics</strong> orchestrated program implementation, assisted in site selection,<br />

and facilitated communication between the project leader<br />

and key contacts at each site. At the site, residents toured the facility,<br />

learned about the mission and activities of the site, and gave a supervised<br />

presentation or “brown-bag” review for the seniors on a <strong>Geriatrics</strong><br />

topic. A ten-minute presentation on local senior resources<br />

ended the experience.<br />

Results:<br />

Resident evaluation of the community based learning and service<br />

experience was administered electronically via an IRB-approved<br />

AGS 2012 ANNUAL MEETING<br />

S211


P OSTER<br />

A BSTRACTS<br />

survey using the internal medicine evaluation system. Of 19 evaluations<br />

received, 84% (16) of the internal medicine residents found the<br />

tour of the facility informative; 42% (8) of the residents agreed or<br />

strongly agreed that the service they performed expanded their<br />

knowledge of senior health issues; 68% (13) of the residents agreed<br />

or strongly agreed that this interaction with the seniors helped them<br />

learn more about communicating with older patients. Themes from<br />

open-ended questions included increased knowledge in senior community<br />

resources and facilities, enjoyment of interactions and learning<br />

from seniors outside a hospital setting.<br />

Conclusion:<br />

Overall, this pilot program of service-based community learning<br />

provided residents with insight into the lived environment and<br />

community resources available to seniors while increasing awareness<br />

of the importance of effective communication with seniors. Future<br />

directions include having all trainees perform an aging presentation,<br />

expansion of topics, and obtaining evaluations from the seniors at<br />

the sites.<br />

D73<br />

Pilot Formative Hybrid Simulation for Sub Interns.<br />

S. McGee, 1 W. Gammon, 1 M. Keough, 1 C. Burnham, 1 S. Chimienti, 1<br />

M. Yazdani, 1 J. Gallagher, 1 J. Reidy, 1 M. Zanetti, 1 A. Fabiny, 2<br />

J. Gordon, 2 J. Gurwitz, 1 M. Pugnaire. 1 1. OEA, UMMS, Worcester,<br />

MA; 2. Harvard Medical School, Boston, MA.<br />

Supported By: A University of Massachusetts Medical School<br />

(UMMS) initiative supported by the Donald W. Reynolds<br />

Foundation<br />

Background/Method: Building on the work of our Reynolds<br />

partners at Harvard Medical School, this Pilot Formative Hybrid<br />

Simulation OSCE experience was developed to incorporate more<br />

formative clerkship experiences within the new UMMS curriculum.<br />

This simulation, which utilizes both standardized patients and a mannequin,<br />

involves a case of an elderly patient presenting to the ED in<br />

respiratory distress with end stage COPD who no longer wishes life<br />

prolonging interventions such as bipap or intubation. Students work<br />

in teams of two: one student assesses the patient in the ED and then<br />

completes a hand-off to the second student who assesses the patient<br />

in the ICU . Students are assessed on their ability to conduct a focused<br />

interview, develop an appropriate differential diagnosis and<br />

identify the goals of care. The experience concludes with students debriefing<br />

with 2 faculty, a geriatrician and a hospitalist or palliative<br />

care specialist.<br />

Methods: Medical sub interns at one UMMS clinical site participate<br />

in this experience as part of the required 4 week medical sub internship.<br />

Students complete an evaluation immediately following the<br />

debriefing session.<br />

Results: Fifty-eight sub-interns have participated in the experience<br />

to date. Preliminary analysis of a small sample of learners<br />

(n=10) demonstrated that: 1) 100% felt that the session was “presented<br />

in a way that helped me integrate knowledge, ideas and skills<br />

with other disciplines” and; 2) 90% found it “useful to debrief and review<br />

[their] own performance.” Selected responses from students regarding<br />

the strength of this experience included, “Challenging experience.<br />

Worthwhile to see these kind of scenarios in a consequence free<br />

environment” and “…practicing end of life discussions in a ‘safer’ setting<br />

than the hospital”.<br />

Conclusions: Sub-interns viewed the Pilot Formative Hybrid<br />

Simulation OSCE experience as valuable. Preliminary data suggest<br />

that they valued the opportunity to practice interviewing skills and<br />

medical decision making at the end-of -life in the safe environment of<br />

the UMMS Simulation Center.<br />

AAMC Geriatric Competencies: #19 Assess and provide initial<br />

management of pain and non-pain symptoms based on patient’s goals<br />

of care<br />

D74<br />

Faculty Development Program for Non Geriatricians: Evaluation of<br />

Gait and Fall Risk, Function and Cognition.<br />

S. McGee, J. Gurwitz, C. Burnham, M. Keough, S. Pasquale,<br />

B. L. Robuccio, M. Pugnaire. OEA, UMMS, Worcester, MA.<br />

Supported By: A University of Massachusetts Medical School<br />

(UMMS) initiative supported by the Donald W. Reynolds<br />

Foundation<br />

Background: As part of the UMMS Donald W Reynolds funded<br />

initiative at UMMS a 60 min interactive faculty development program<br />

was developed and piloted for a diverse group of faculty serving<br />

as mentors/advisors to UMMS medical students. This program included<br />

the Competency Certification in Gait and Fall Risk<br />

Evaluation© workshop materials presented at the 2010 AGS Annual<br />

meeting as well as commonly used functional and cognitive assessment<br />

tools.<br />

Methods: Faculty completed surveys rating their knowledge of<br />

the importance and components of gait and fall risk assessment, functional<br />

and cognitive assessment, and their confidence in performing<br />

these assessments prior to and immediately following the faculty development<br />

workshop. Self-selected into two groups, faculty attended<br />

two sequential workshop presentations: Gait and Fall Risk Assessment,<br />

and Functional Assessment and the Mini-Cog.<br />

Results: Thirteen faculty attendees represented multiple specialties<br />

and subspecialties including psychiatry, pediatrics, radiation oncology<br />

and gynecology. Overall, faculty reported significantly increased<br />

knowledge specific to the importance of performing gait and<br />

fall risk assessment, and their confidence to do so, as a result of the<br />

workshop session. Eighty-five percent of those in attendance reported<br />

the session to be valuable to both their clinical and teaching<br />

responsibilities.<br />

Conclusions: A brief faculty development program for a diverse<br />

group of faculty serving as medical student mentors/advisors was very<br />

well received, and improved their knowledge and confidence in performing<br />

commonly used assessment tools for older adults.<br />

AAMC Geriatric Competencies: #7 Perform and interpret a<br />

cognitive assessment, #9 Assess and describe baseline and current<br />

functional abilities and #12 Ask about falls and watch a patient rise<br />

from a chair and walk then record and interpret the findings.<br />

D75<br />

Frailty and Body Mass Index in Community Dwelling<br />

Octogenarians, Nonagenarians and Centenarians.<br />

J. Ceimo, 1 N. Bravo, 1 B. Leonard, 1 T. Minani, 1 K. O’Connor, 1<br />

L. Evans, 1 D. Coon, 2 W. Nieri. 1 1. Center for Healthy Aging, BSHRI,<br />

Sun City, AZ; 2. College of Nursing and Health Innovation, ASU,<br />

Phoenix, AZ.<br />

Background: Research in frailty has attempted to determine<br />

both a consensual diagnosis and its component parts. Prior studies<br />

show frailty associated with extremes of BMI (U-shaped curve). Not<br />

everyone with BMIs < 20 or > 30 is frail. We propose that stable BMI<br />

through mid- and late adult life (age 50 and up) may identify a subset<br />

> 80 years in whom outlying BMIs were a less significant contributor<br />

to frailty.<br />

Methods: This cross-sectional study on community dwelling 80+<br />

year olds is part of a larger longitudinal study on healthy aging (O’-<br />

Connor et al, 2009). Participants lived in Arizona, were interviewed in<br />

person, and had an MMSE >17.<br />

Height/weight was taken from the initial and second annual<br />

exams (year three). Height/weight data at age 50 was based on participants’<br />

recall. Body Mass Index (BMI) was divided into four categories:<br />

1) < 20, 2) 20-25, 3) 26-30, and 4) > 30. Frailty was determined<br />

from 34 selected deficits associated with physiologic decline and increased<br />

mortality.An individual’s total points divided by total number<br />

of deficits yielded a Frailty Index (FI) from 0.0 to 1.0; higher scores in-<br />

S212<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

dicated greater frailty. Descriptive and non-parametric statistical<br />

analysis was performed using SPSS software and Mann Whitney U.<br />

Results: 202 subjects living independently (62% female, mean<br />

age 92) were included. 61 were octogenarians, 69 nonagenarians, and<br />

10 centenarians. Initial mean BMI ranged from 25.2 in octogenarians<br />

to 22.4 in centenarians with no significant drift between years one and<br />

three. Correlated to BMI at age 50, those with < one SD were less<br />

likely to be frail or were less frail. We confirmed prior observations<br />

that strength training correlated with decreased frailty across all ages.<br />

A U shaped curve correlating frailty/BMI held true for subjects up to<br />

age 89. BMI flattened after age 90, suggesting the impact of BMI on<br />

frailty is less.<br />

Conclusions: Frailty correlates with advancing age; BMI does<br />

not. Much effort is spent to obtain/maintain normal BMIs in the elderly.<br />

Our study identifies a subset of elders with outlying BMIs in<br />

whom BMI is not a significant contributor to frailty. Prolonged activity<br />

at a stable BMI may produce physical conditioning that is beneficial.<br />

Avoidance of frailty in this group should stress continued activity<br />

over caloric manipulation.<br />

D76<br />

Orthostatic Hypotension, its risk factors, and the need for its<br />

measurements in the hospital.<br />

J. Chohan, K. Samtani, E. Baum, S. Snyder, N. Kayani, L. Benedict,<br />

S. Hazelet. Post Acute and Senior Services, Summa Health System,<br />

Akron, OH.<br />

Objectives: To investigate the correlation between falls and orthostatic<br />

hypotension (OH) and to examine the benefits of measuring<br />

orthostatic vital signs on admitted patients at high risk for a fall. Design:<br />

Cross-sectional study. Measurements: Patients at high risk included<br />

those: > 65 years old who have fallen in the last 2 months or<br />

had an admitting diagnosis of a fall, syncope, or pre-syncope. Blood<br />

Pressure (BP) was measured in the supine position and after 2 minutes<br />

of sitting and 2 minutes of standing within 24 hours of admission.<br />

Orthostatic hypotension was defined as 20-mmHg decline in Systolic<br />

BP and/or a 10-mmHg decline in diastolic BP from a supine to sitting,<br />

or sitting to<br />

standing position. Results: While 200 people qualified for the<br />

study, only 99 people had orthostatic vital signs measured and of<br />

those 30 people were orthostatic positive. Only five of the 30 were<br />

non-community dwelling patients. 84% of patients had documented<br />

hypertension, 37% had documented heart failure, 23% had anemia<br />

(HgB90) on admission. Of<br />

those who were orthostatic positive, only 1 had a documented fall<br />

while hospitalized. Conclusion: We saw no correlation between falls<br />

and OH, however, anti-hypertensive medications were held on admission<br />

for OH positive patients and a thorough medication reconciliation<br />

was done on discharge through interdisciplinary communication<br />

and physician notification. These results suggest that orthostatic<br />

vital signs should be measured on patients who are at high risk for a<br />

fall to improve their in-patient admission and discharge medication<br />

assessment.<br />

D77<br />

A comparison of different target criteria for geriatric care.<br />

J. van Kempen, 1 H. Schers, 2 R. Melis, 1 M. Olde Rikkert. 1 1.<br />

Department of Geriatric Medicine, Radboud University Nijmegen<br />

Medical Centre, Nijmegen, Netherlands; 2. Department of Primary<br />

Care, Radboud University Nijmegen Medical Centre, Nijmegen,<br />

Netherlands.<br />

Background: There are several instruments for the identification<br />

of frail elderly. None of these aims to identify frail elderly in primary<br />

care to select them for integrated care. Therefore, we developed a<br />

pragmatic identification method, the Easycare-TOS (Two-step Older<br />

people Screening). It optimally uses information that is readily available<br />

to the family physician and takes health and psychosocial aspects<br />

into account. We studied how frail elderly identified with Easycare-<br />

TOS scored on other criteria for geriatric care: disability, multimorbidity<br />

and Fried Frailty criteria.<br />

Methods: Elderly from 4 health centers were included (n=591,<br />

mean age 77 (SD5), 56% women). They were screened with Easycare-TOS.<br />

Additional data were collected for determining multimorbidity<br />

(CIRS-G score ≥2 on ≥2 items), disability (KATZ15 ≥4) and<br />

Fried frailty criteria. We compared the results on the different criteria<br />

in our study population using a Venn diagram.<br />

Results: Figure 1 shows the Venn diagram. The group frail according<br />

to just Easycare-TOS (n=139) had a mean CIRS-G score of<br />

10 (SD4) compared to 14 (SD4) in the group frail according to Fried<br />

(n=58).There was no difference in psychosocial status.The group with<br />

comorbidity and no frailty (n=222) had a mean CIRS-G of 9 (SD3).<br />

Conclusion: Elderly who were frail according to Fried were<br />

more physical frail than elderly who were frail according to Easycare-<br />

TOS solely. Elderly with merely comorbidity had least physical problems.<br />

Follow-up data should show whether Easycare-TOS is able to<br />

identify elderly who will benefit from integrated care.<br />

D78<br />

Fall Stop...MOVE STRONG program to reduce fall risk among<br />

community dwelling older adults.<br />

J. Prager, J. Kardachi, C. Carlucci, S. M. Bradley. <strong>Geriatrics</strong>, Mount<br />

Sinai Hospital, New York, NY.<br />

Background: Falls is a leading cause of injury and death in older<br />

adults. Approximately, one third of community-dwelling people over<br />

65 years of age fall each year resulting in a significant source of morbidity<br />

and mortality, an important threat to patient safety. Exercise<br />

programs have been shown to reduce rate of falls. The Fall<br />

Stop…MOVE STRONG program is an exercise and education based<br />

fall prevention program. The core content of the program includes a<br />

graduated individualized exercise program, which targets strengthening,<br />

coordination, flexibility, and balance with concurrent education<br />

about personal and environmental fall risk factors and safety strategies<br />

lasting 75 minutes each session. The purpose of this study is to<br />

evaluate if Fall Stop…MOVE STRONG decrease fall risk in community<br />

dwelling older patients.<br />

Methods: Fall Stop...MOVE STRONG if offered over a 12 week<br />

period three times a year in an urban geriatric academic practice. Patients<br />

were approached for participation and consent was obtained.<br />

The measures of functional assessment, falls risk, and fear of falling<br />

were obtained before and after falls prevention program including<br />

The Functional Reach Test, The Four Square Step Test, The Timed Up<br />

AGS 2012 ANNUAL MEETING<br />

S213


P OSTER<br />

A BSTRACTS<br />

& Go Test, and The Modified Fall Efficacy Scale. Questions about<br />

medications, depression, functional status, and history of previous<br />

falls were asked.<br />

Results: 14 patients thus far have completed the Fall<br />

Stop…MOVE STRONG program. Average age of population is 79<br />

years old. Functional Reach Test improved 2 cm. 77% of the participants<br />

at high or moderate risk for falls (


P OSTER<br />

A BSTRACTS<br />

P


P OSTER<br />

A BSTRACTS<br />

binge drinking daily. One week prior to admission he slipped on wet<br />

concrete floor suffering a small forehead laceration but refused medical<br />

attention.Admission vital signs were within normal limits.The patient<br />

was alert and well oriented,but agitated,rude,cursing and laughing.He<br />

made self-deprecating comments, dirty jokes and mocked<br />

physicians of “being stupid”.The pupils were anisocoric but reactive<br />

to light and the extraocular movements were intact. He had a regular<br />

cardiac rhythm, and clear lungs. Strength was 5/5 in the upper extremities<br />

and 4/5 in the lower extremities.Cranial nerves II-XII were<br />

grossly intact and the DTR’s +2 throughout. He had a Glasgow coma<br />

scale of 15/15,a MMSE of 28/30 and a normal Geriatric Depression<br />

Scale.Laboratory work up revealed slight hyponatremia<br />

(132mmol/L),a compensated metabolic alkalosis and mild hypoxemia.A<br />

brain CT scan demonstrated a right chronic subdural<br />

hematoma with evidence of re-bleeding. Haldol 2 mg every 12 hours<br />

was administered that controlled his aggressiveness and hallucinations,but<br />

his inappropriate behavior and bouts of laughter continued.<br />

Eight hours after the hematoma was evacuated all inappropriate behavior<br />

resolved.Involuntary emotional expression disorder is a distressing<br />

disorder that is frequently overlooked and misdiagnosed.The<br />

clinical impact can be severe,with unremitting and persistent symptoms<br />

that can be disabling to patients.<br />

D85 Encore Presentation<br />

Psychoeducational Interventions for Caregivers of Seniors: A<br />

Systematic Review.<br />

K. Aung, K. Stevens. UT Health Science Center at San Antonio, San<br />

Antonio, TX.<br />

Supported By: This research was supported by the MESA Center<br />

for Health Disparities, which was funded by a grant from the<br />

National Institute for Nursing Research.<br />

Background: Psychoeducational interventions are structured<br />

programs designed to train caregivers to effectively deal with problems<br />

associated with caregiving. By teaching specific skills to manage<br />

stress on an ongoing basis, such interventions could improve caregiver<br />

depression, caregiver burden, the level of perceived stress, anxiety,<br />

and coping skills. Objective: To assess the effects of psychoeducational<br />

interventions compared to the standard levels of knowledge<br />

provision in enhancing the support and guidance offered to caregivers<br />

of seniors. Methods: Electronic searches of Medline, EM-<br />

BASE, the Cochrane Central Register of Controlled Trials, the<br />

CINAHL, and PsycINFO were undertaken, supplemented by crossreference<br />

searching. All relevant randomized controlled trials were<br />

selected. Quasi-randomized trials, non-randomized trials and observational<br />

studies were excluded. Data were extracted from included<br />

papers. Risk of bias in the included studies was assessed using the<br />

methodology of the Cochrane Collaboration. Data from all trials<br />

were synthesized and summarized. Results: All included trials involved<br />

caregiving to seniors with dementia. Inadequate reporting of<br />

incomplete outcome data increases the risk of attrition bias. Failure to<br />

report allocation concealment led to difficulty in judging the risk of<br />

selection bias. The nature of intervention, duration of intervention<br />

and tools used for measurement of outcomes were different across<br />

the trials. Marked heterogeneity of interventions and outcome measures<br />

across the trials precluded pooling of data and conducting metaanalysis.<br />

Psycho-educational intervention probably has a positive effect<br />

on caregiver depression and possibility has positive effects on<br />

caregiver burden, coping, perceived stress, and anxiety but the effects<br />

were not consistent across the studies. Most of the intervention programs<br />

resulted in improvement of some domains of caregiver outcomes<br />

rather than globally. Conclusions: Psychoeducational interventions<br />

could be potentially useful but interventions should be<br />

customized in accordance with the particular needs of the individual<br />

caregivers. Lack of consistency of beneficial effects on some outcomes<br />

across different studies and the potential risks for selection<br />

and attrition bias prohibited us from drawing firm conclusions. More<br />

well-designed, conducted and reported randomized studies investigating<br />

the effectiveness of psychoeducational interventions are<br />

needed.<br />

D86 Encore Presentation<br />

Medication Reconciliation in Transition of Care: Broken Telephone<br />

or Patient Safety Goal?<br />

L. Sinvani, 1 J. Beizer, 4 M. Akerman, 2 L. Lutsky, 3 C. Cal, 3 Y. Dlugacz, 3<br />

K. Masick, 3 R. Shah, 1 G. Wolf-Klein. 1 1. NSLIJ Health System, New<br />

Hyde Park, NY; 2. Feinstein Institute for Medical Research,<br />

Manhasset, NY; 3. Krasnoff Quality Mgt. Institute, Great Neck, NY; 4.<br />

College of Pharmacy, St. John’s University, Queens, NY.<br />

BACKGROUND: There has been a dearth of studies on the<br />

transition of older patients from hospital admission to subacute rehabilitation<br />

and discharge home. We studied medication discrepancies<br />

across a large Health Care system.<br />

METHODS: Chart review utilizing randomized electronic medical<br />

records (EMR) and paper chart medication reconciliation lists<br />

across three transitions: hospital admission to discharge (time I), hospital<br />

discharge to sub-acute rehab (time II) and sub-acute rehab admission<br />

to discharge home or long term care (time III). Medication<br />

discrepancies were grouped as intentional or unintentional.<br />

RESULTS: In the 44 charts analyzed, average age was 71.4<br />

(range: 41-91), with 68% female, 77.3% surgery versus 22.7% medicine.<br />

Median stay in the hospital was 5.5 days and 14.5 days in skilled<br />

facilities. Total number of medications documented at time I, II, and<br />

III were 284, 472, and 545 respectively. Total medication discrepancies<br />

were 358 (time I), 318 (time II), and 330 (time III); 100% of patients’<br />

records had drug discrepancies and 58% were unintentional.<br />

When analyzing average number of medications per patient at each<br />

transition, time I increased from 6.5 to 10.7 (p


P OSTER<br />

A BSTRACTS<br />

was determined in a cohort of older adults seeking care in an outpatient<br />

incontinence clinic.<br />

Methods: Medication consumption was analyzed from 142 older<br />

patients aged 60+ participating in a longitudinal cohort study of urge<br />

and mixed incontinence recruited from outpatient incontinence clinics.<br />

The International Consultation on Incontinence Questionnaire-<br />

ICIQ-UI-SF was used to detect the severity of incontinence. Descriptive<br />

statistics were used to analyze prevalence of drug use. Regression<br />

analyses sought to determine an association between any putative<br />

medication use and the severity of incontinence.<br />

Results: Participants had a mean age of 71 ± 7years and 83%<br />

were female. The mean number of comorbid conditions was 5±3, and<br />

patients consumed on average 7± 4 different medications. The prevalence<br />

of medications precipitating lower urinary tract symptoms was<br />

54%. Overall, 21% of patients used benzodiazepines, 13% ACE inhibitors,<br />

12% calcium channel blockers, 11% estrogens, 10% other<br />

antidepressants, 5% NSAIDS, 4% other GABAergic medication, 3%<br />

loop diuretics, and 1% alpha-blockers,. There was no association between<br />

the severity of incontinence and any medication use.<br />

Conclusion: The prevalence of use of medications potentially<br />

causing or exacerbating lower urinary tract symptoms in the elderly is<br />

high. Discontinuation or substitution of these medications should be<br />

attempted as part of the first-line treatment approach for older adults<br />

seeking care for bladder symptoms.<br />

KEY WORDS: Older adult, lower urinary tract symptoms,<br />

medication<br />

D88<br />

Association of executive function impairment, history of falls and<br />

physical performance: a population-based study in Eastern France.<br />

S. W. Muir, 1 O. Beauchet, 3 C. Annweiler, 1,3 M. Speechley, 2<br />

M. Montero Odasso. 1,2 1. Geriatric Medicine, University of Western<br />

Ontario, London, ON, Canada; 2. Epidemiology & Biostatistics,<br />

University of Western Ontario, London, ON, Canada; 3. Neuroscience,<br />

University of Angers, Angers, France.<br />

Background: An emerging area of interest in falls research is impaired<br />

cognition that disturbs higher levels of control of balance and<br />

gait on fall risk. Postural stability is a complex skill involving the coordination<br />

of motor and sensory systems in perceiving environmental<br />

stimuli and responding to perturbations to control body movement.<br />

Executive function (EF) is required for divided attention and responding<br />

to changes within the environment. The objectives of this<br />

study were to estimate: 1) the prevalence of impaired EF, 2) the association<br />

between impaired EF and falls, and 3) the association of impaired<br />

EF and physical function used in the evaluation of fall risk.<br />

Methods: Cross-sectional study of 5097 older adults without dementia<br />

received a comprehensive geriatric assessment (July 2008 to December<br />

2010). The assessment included cognitive testing (Clock<br />

Drawing Test, CDT), physical performance testing (Timed Up & Go<br />

Test (TUGT) and grip strength), and self-report of falls in the previous<br />

12 months. A modified Poisson regression evaluated the association<br />

between impaired EF and falls. Linear regression evaluated the<br />

association between impaired EF and the TUGT and grip strength.<br />

Results: Using the CDT, 25% had impaired EF. The prevalence of any<br />

fall in the last year was 27% and 35% among those with and without<br />

abnormal EF respectively. In the adjusted modified Poisson analysis,<br />

impaired EF was associated with any fall [RR=1.13, 95%CI (1.03,<br />

1.25)], serious fall-related events [RR=1.30, 95%CI (1.02, 1.66)], but<br />

recurrent falls was not significant [RR=1.13, 95%CI (0.93, 1.37)]. In<br />

the adjusted linear regression, impaired EF was associated with a<br />

longer time to complete the TUG, indicating a worse performance,<br />

and diminished grip strength compared to people with normal EF.<br />

Conclusions: Impaired EF in the absence of dementia was prevalent,<br />

one quarter of studied sample of community-dwelling older adults,<br />

and has a strong association to falls, fall-related injuries and decreased<br />

ability on physical performance testing. The use of the clock<br />

drawing test is a reliable and easy to administer EF test that can be<br />

used routinely in comprehensive fall risk evaluations.<br />

D89<br />

A comparison of cognitive and manual dual-task challenges on gait<br />

in people with Mild Cognitive Impairment: a cross-sectional study.<br />

S. W. Muir, 1,3 K. Gopaul, 3 M. Montero Odasso. 1,2 1. Geriatric<br />

Medicine, University of Western Ontario, London, ON, Canada; 2.<br />

Epidemiology & Biostatistics, University of Western Ontarion,<br />

London, ON, Canada; 3. Gait & Brain Lab, Lawson Health Research<br />

Institute, London, ON, Canada.<br />

Background: Gait impairment is a prevalent feature among<br />

older adults with cognitive impairment. Assessing gait using the dualtask<br />

paradigm, a secondary cognitive or manual task, evaluates the interaction<br />

between cognition and mobility. Dual-task testing also provides<br />

a valid means to identify fall risk by exposing mobility deficits.<br />

Comparative studies on differential effects by the type of dual-tasks<br />

have been restricted to cognitive tests on gait. The objective was to<br />

evaluate the effect of manual and cognitive dual-task challenges on<br />

gait in people with Mild Cognitive Impairment (MCI). Methods:<br />

Cross-sectional study of 57 adults with MCI (mean age=75.4 (6.4))<br />

and 25 cognitively normal controls (mean age=71.5 (4.1)). Gait was<br />

assessed using an electronic walkway under single, dual-task (counting<br />

backward from 100 by ones, counting backwards from 100 by sevens,<br />

and carrying a glass of water) and multi-task test conditions. Gait<br />

velocity and dual-task cost were the main outcome measures. An adjusted<br />

repeated measure ANOVA was performed to assess the effect<br />

of cognitive group and walking condition. Results: Gait velocity was<br />

significantly slower in the MCI group in all tests. The manual dualtask<br />

confers a challenge not different from the cognitive dual-task of<br />

counting backwards by ones while walking for people with MCI and<br />

normal cognition. Performance of the more complex cognitive task of<br />

serial seven subtractions produced a significant reduction in gait velocity<br />

in both groups, but there was a greater dual-task cost in the<br />

MCI group at 31.8%. Dual-task costs are additive under simple manual<br />

and cognitive challenges. The addition of the simple manual task<br />

to serial seven subtraction while walking did not add to dual-task gait<br />

costs but did negatively affect the cognitive performance in people<br />

with MCI.<br />

Conclusions: This study has demonstrated that not all dual-task<br />

challenges are equivalent in their ability to challenge an individual<br />

and identify deficits. This lack of interchangeability of tasks, between<br />

manual and cognitive secondary tasks and among cognitive tasks, is<br />

important for translating research into clinical practice by providing a<br />

graded progression of task difficulty.<br />

D90<br />

CHARACTERISTICS OF FRAIL PATIENTS IN A GERIATRIC-<br />

HIV PROGRAM: THE EXPERIENCE OF AN URBAN<br />

ACADEMIC CENTER AT ONE YEAR FOLLOW-UP.<br />

M. A. Ruiz , E. Aguilar, P. Sirisha, M. Frontini, C. Cefalu . Medicine,<br />

Louisiana State University Health Sciences Center, New Orleans, LA.<br />

Purpose of Study:<br />

To determine the prevalence and severity of frailty and its associated<br />

factors in patients >60 infected with HIV in an urban academic<br />

center.<br />

Methods Used:<br />

A total of 80 patients > 60 years infected with HIV were<br />

screened and 26 patients were transferred to our newly created <strong>Geriatrics</strong>-HIV<br />

Frailty program. We divided this group of already frail patients<br />

in three different subgroups; the mildly, moderately and the<br />

very frail groups based on the number of domains failed during the<br />

initial geriatrics screening.<br />

Summary of Results:<br />

AGS 2012 ANNUAL MEETING<br />

S217


P OSTER<br />

A BSTRACTS<br />

The percentages of mildly, moderately, and severely frail elderly<br />

patients in our cohort were 20% 50% and 30% respectively. Cognitive<br />

impairment (30%), multiple co-morbidities (60%), and history of<br />

AIDS-related opportunistic infections (40%) were correlated with<br />

frailty status. Smoking was highly prevalent in all groups. The average<br />

number of medications used per patient was 8.1 with 65% of patients<br />

being compliant with their regimens.<br />

Conclusions:<br />

We found that cognitive impairment, presence of co-morbidities,<br />

high number of medications used, and past history of any opportunistic<br />

infection are factors prevalent in severely frail patients infected<br />

with HIV in our cohort. The significance of these factors in<br />

development and progression of frailty syndrome in HIV-positive patients<br />

needs to be elucidated.<br />

D91<br />

Outcomes for elderly breast cancer patients in Louisiana.<br />

M. A. Ruiz , D. Williams, C. Cefalu. Medicine, Louisiana State<br />

University Health Sciences Center New Orleans, New Orleans, LA.<br />

Introduction: Breast cancer is common in the United States and<br />

Europe. Worldwide, the incidence of breast cancer has increased at<br />

annual rate of 3.1% and mortality from breast cancer has increased at<br />

an annual rate of 1.8%. Elderly breast cancer patients are diagnosed<br />

with a higher stage of disease, undergo less surgery and receive hormonal<br />

treatment as monotherapy more frequently This population<br />

also has a decreased relative survival. This study was designed to review<br />

differences if any in diagnosis, treatment modalities and survival<br />

between elderly >65 and young


P OSTER<br />

A BSTRACTS<br />

Results: 22 (33.9%) of the subjects were non-frail, 31 (47.7%)<br />

were pre-frail, and 12 (18.5%) were frail. 39 (60%) were female and<br />

the mean age was 80.6 ±6.4. Transferrin (ng/mL) increased significantly<br />

by frailty status (non-frail: 43.4 ±11.4, pre-frail: 54.3 ±11.9, frail:<br />

58.3 ±10.2, p


P OSTER<br />

A BSTRACTS<br />

other forms of technology. Interviews were recorded and transcribed.<br />

Responses were analyzed qualitatively using grounded theory.<br />

Results: 10 participants comprised the analytic sample. Mean<br />

age of participants was 71 years. 80 percent were female. All identified<br />

as Asian, Black, or Latino. Three main themes emerging from the<br />

interviews included: (1) enhanced social engagement, (2) intellectual<br />

stimulation, and (3) empowerment derived from social and cultural<br />

integration. A majority of participants expressed interest in using the<br />

Internet for communication purposes. Many of the respondents felt<br />

there was educational value to be gained from using the Internet to<br />

find information; respondents expressed a desire to continue learning<br />

through use of the computer at home or taking additional courses.<br />

Most reported self-perceived improvement in confidence and competency<br />

in using a new tool. Participants reported feeling they belonged<br />

to a community from which they were once excluded after completing<br />

the course. Perceived sense of enhancement to their cognitive and<br />

functional abilities also emerged as a major theme.<br />

Conclusion: The use of computers and the Internet can produce<br />

functional, psychological, and social effects unique to elders entering<br />

a world of new languages, structures, and social interactions. Further<br />

exploration into quality of life impacts for isolated elders using the<br />

computer and Internet is needed.<br />

D97 Encore Presentation<br />

What are Hospice Providers Doing to Reach African <strong>American</strong>s . . .<br />

and what works?<br />

K. S. Johnson, 1,2 M. N. Kuchibhatla, 2 J. A. Tulsky. 2 1.<br />

Medicine/<strong>Geriatrics</strong>, Duke University, Durham, NC; 2. Center for<br />

Aging, Duke University, Durham, NC.<br />

Supported By: Beeson Career Development Award in Aging<br />

Research (5K08AG028975)<br />

National leaders recommend that hospices develop practices<br />

and policies which increase access to care for minorities.The extent to<br />

which hospices employ strategies to reach African <strong>American</strong>s, a group<br />

historically underrepresented in hospice, has not been well-described.<br />

Objective: To describe hospice providers’ strategies to increase<br />

service to African <strong>American</strong>s.<br />

Methods: Survey of North and South Carolina hospices. We<br />

used Spearman correlations to examine the association between<br />

provider practices and: (1) commitment to increasing service to<br />

African <strong>American</strong>s; (2) % of African <strong>American</strong>s served by the hospice<br />

based on 2008 Medicare Data.<br />

Results: Of 80 hospices (65% response rate) surveyed, 78% reported<br />

strategies to increase service to African <strong>American</strong>s, but only<br />

20% reported that strategies were reviewed to determine effectiveness.<br />

Most participated in education/outreach: 73% with nursing<br />

homes; 68% with churches; 56% with physicians; 55% with hospitals;<br />

20% with civic groups. Hospices endorsing greater commitment to increasing<br />

service to African <strong>American</strong>s more often participated in outreach<br />

to churches and civic groups (r=0.28 – 0.36, p


P OSTER<br />

A BSTRACTS<br />

of all strokes in the elderly. Warfarin anticoagulant therapy reduces<br />

annual ischemic stroke risk by about two thirds in AF patients. With<br />

institution of coverage for medications by Medicare Part D program<br />

introduced in 2006, we wanted to know whether rates of warfarin use<br />

were higher than previously reported after institution of the program.We<br />

also used the Medicare Part D prescription drug data to examine<br />

national warfarin use by patient characteristics and geographic<br />

location.<br />

Methods: We conducted a retrospective cohort study of 41,447<br />

Medicare beneficiaries aged 66 and older with at least 2 atrial fibrillation<br />

diagnoses in 2008 and at least 1 in 2008. All subjects were enrolled<br />

in Medicare Part D by 2008. Chi-square test was used to examine<br />

differences in warfarin use (defined as 2 warfarin prescriptions in<br />

2008) by patient characteristics (age, ethnicity, sex, Medicaid eligibility,<br />

entering Part D coverage gap, comorbidities, having contraindications<br />

to warfarin, and seeing a cardiologist or a PCP) and by Hospital<br />

Referral Regions. Hierarchical generalized linear models were used<br />

to examine how patient characteristics impact the likelihood of warfarin<br />

use only among patients with no warfarin contraindications, a<br />

sample size of 34,947.<br />

Results: The overall use rate was 66.8%. In bivariate analysis,<br />

patients who received warfarin therapy were more likely [P


P OSTER<br />

A BSTRACTS<br />

D102<br />

Clinician’s perception of infections and laboratory utilization at a<br />

long term care facility.<br />

J. Kopacz, 1,5 P. D. Sychangco, 2 D. Russo, 2,5 Z. Huang, 2,5 N. Mariano, 1,3<br />

C. Urban, 1,3 S. Segal-Maurer. 1,4 1. Infectious Diseases Section, NYHQ,<br />

Flushing, NY; 2. <strong>Geriatrics</strong> Division, NYHQ, Flushing, NY; 3.<br />

Microbiology, NYHQ, Flushing, NY; 4. Medicine, Weill Cornell<br />

Medical College, New York, NY; 5. SCNR, Briarwood, NY.<br />

Introduction<br />

Infectious Diseases (ID) consults are not readily available in<br />

long term care facilities (LTCFs). This study assesses clinician perception<br />

of incidence and prevalence of infections, laboratory utilization<br />

and use of antibiotics at a LTCF.<br />

Materials and Methods<br />

A two-step study was conducted at a 320-bed, hospital-affiliated<br />

LTCF: 1. Six month retrospective analysis of all microbiologic specimens<br />

; 2. 14 question IRB approved survey assessing number of patients<br />

treated, use of diagnostic tests, perceived frequency of infections,<br />

and choice of antibiotics. Answer choices included “never,<br />

rarely, sometimes, often, always.” Clinicians did not have access to retrospective<br />

laboratory data collection.<br />

Results<br />

All 11 LTCF healthcare (HCWs) providers (9 MDs, 2 RNP)<br />

completed the survey. Blood tests were ordered with a change in<br />

physical exam by 8 HCWs “often” and 3 “always” (chest radiographs<br />

infrequently). All HCWs stated urine infections were most common<br />

and they “always” ordered urinalysis (UA) to accompany urine cultures<br />

(UCx). Of 435 UCx specimens, 264 (61%) were positive. Of<br />

these, 236 (89.4%) had an accompanying UA (85% positive). Six<br />

HCWs ordered blood cultures (BCx) “often” and all stated “sometimes”<br />

or “rarely” found the results helpful. Of 167 patients who had<br />

BCxs, 13 (7.7%) were positive with 3 (1.8%) considered true bacteremia<br />

(6 of 13 patients received unnecessary treatment). Perceived<br />

C difficile infection (CDI) prevalence was over 25% and all HCWs<br />

“often” ordered CDI assays. Of 889 CDI assays sent, 94 (11%) were<br />

positive (by ELISA). In spite of CDI concern, fluoroquinolones were<br />

the most frequently prescribed antibiotics. All HCWs stated they<br />

would use an antibiogram if available.<br />

Conclusions<br />

Positive UAs correlated well with positive UCx, obviating use of<br />

routine UAs for all patients. BCx were rarely positive and not clinically<br />

useful, consistent with clinicians’ impression (cost savings<br />

$1,895). CDI rates may be underestimated with ELISA assay and education<br />

is required to limit use of CDI associated antibiotics. HCW<br />

education via an antibiotic stewardship program would improve laboratory<br />

utilization and antibiotic use, help reduce nosocomial infections,<br />

and lead to cost savings.<br />

D103<br />

Nursing home improvement collaborative to reduce potentially<br />

avoidable hospital transfers.<br />

R. Tena-Nelson, 4 K. Santos, 4 L. Herndon, 5 E. Weingast, 2 S. Amrhein, 4<br />

K. S. Boockvar, 2,1 J. Ouslander. 3 1. JJP VA Medical Center, Bronx,<br />

NY; 2. Jewish Home Lifecare, New York, NY; 3. Florida Atlantic<br />

University, Boca Raton, FL; 4. Continuing Care Leadership<br />

Coalition, New York, NY; 5. Massachusetts Senior Care Foundation,<br />

Boston, MA.<br />

Supported By: New York State Departments of Health and Labor<br />

Background: Nursing home (NH) residents experience frequent<br />

hospital transfers, some avoidable. Interventions to Reduce Acute<br />

Care Transfers (INTERACT) provides tools and strategies to assist<br />

NH staff in early identification, communication, and documentation<br />

of changes in resident status.<br />

Objective: To implement INTERACT among members of Continuing<br />

Care Leadership Coalition (CCLC), a NY metropolitan area<br />

NH provider association, and evaluate educational and hospitalization<br />

impacts.<br />

Methods: Funding was obtained from a NY State health workforce<br />

training grant. Members of CCLC were invited to participate<br />

regardless of their baseline transfer rate. 13 education sessions (7 inperson)<br />

were conducted over 1 year. Sessions engaged NH executives,<br />

department heads, front-line nursing staff and their labor union,<br />

and staff from NHs’ partner hospitals. Topics included the INTER-<br />

ACT implementation process; use of simple standardized communication<br />

tools, advance care planning tools, care paths, and change in<br />

condition support tools; quality review of hospital transfers; exercises<br />

for refining clinical skills; teamwork; and lessons learned. One session<br />

used a high-fidelity patient case simulator.<br />

Results: There were 150 participants from 32 facilities. 94% of<br />

NHs were non-profit with 331 beds on average. After training 84%<br />

of participants responded that they were more confident in educating<br />

others about interventions to reduce preventable hospitalizations.<br />

Eighty percent indicated that their organization had a plan in<br />

place to coordinate INTERACT efforts in the next 3 months with a<br />

referring hospital. NHs reported high acceptance of, and compliance<br />

with, use of INTERACT tools. To date, two NHs reported 37% and<br />

18% reductions in hospital transfers as compared to the year prior to<br />

implementation.<br />

Conclusions: Use of a collaborative model among a group of<br />

urban nursing homes resulted in good acceptance and uptake of the<br />

INTERACT intervention. The program has the potential to impact<br />

NH resident care through standardized approaches to communication,<br />

early identification of clinical issues, decision-support, and support<br />

for stronger partnerships between acute and post-acute care<br />

providers.<br />

D104<br />

The PEACE Pilot Study: Convergence of <strong>Geriatrics</strong> and<br />

Palliative Care.<br />

K. R. Allen, 1,2 S. M. Radwany, 2,3 D. J. Kropp, 3,2 D. Ertle, 4<br />

S. Fosnight, 2,3 P. Moore, 2 S. E. Hazelett. 2 1. <strong>Geriatrics</strong> & LifeLong<br />

Health, Riverside Health System, Newport News, VA; 2. Summa<br />

Health System, Akron, OH; 3. DFCM, NEOMED, Rootstown, OH; 4.<br />

Area Agency on Aging 10B, Uniontown, OH.<br />

Supported By: National Palliative Care Research Center<br />

(NPCRC)and<br />

The Summa Foundation<br />

Background: Although geriatrics and palliative care are distinct<br />

disciplines, the populations they serve often overlap, especially for<br />

home-bound patients with chronic life-threatening illness.<br />

Purpose: To describe the feasibility of a randomized pilot study<br />

testing the effectiveness of a geriatrics/palliative care (PC) hybrid intervention<br />

to deliver early in-home interdisciplinary care management<br />

to improve the quality of PC in Ohio’s community-based longterm<br />

care Medicaid waiver program, PASSPORT.<br />

Methods: New PASSPORT enrollees were randomized to the<br />

intervention (n=40) or usual care (n=40). The intervention involves<br />

an in-home geriatrics/PC needs assessment by a trained PASSPORT<br />

case manager (CM). The CM presents the findings to an interdisciplinary<br />

team who devise an individualized care plan based on the consumer’s<br />

goals and best practice guidelines. The CM implements the<br />

plan with the consumer, family and primary care physician (PCP).<br />

The primary outcomes upon which we expected our intervention to<br />

have a positive effect include: 1) Symptom management, 2) Quality of<br />

life, 3) Mood, 4) Decision making/care planning, and 5) Spirituality.<br />

Results: No significant differences were found between groups<br />

regarding baseline demographics. At 6 months no differences were<br />

found in performance of ADLs or IADLs. Mean differences and 95%<br />

confidence intervals were calculated for each of the primary outcomes.<br />

All confidence intervals included zero indicating no significant<br />

S222<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

difference between groups. We have demonstrated the feasibility of<br />

the PEACE intervention with respect to enrollment rate, appropriateness<br />

of the inclusion/exclusion criteria, ability of CMs to implement<br />

the intervention and willingness of PCPs to participate. Elements<br />

requiring revision in larger RCT include selection of different<br />

outcome measures, the use of dedicated palliative care CMs and incorporation<br />

of in-home evaluations by pharmacists, pastoral care and<br />

palliative care RN team members.<br />

Discussion: The outcome measures used in this pilot appeared<br />

to be more appropriate for a population at the end of life. More appropriate<br />

outcomes for our population would include medication appropriateness,<br />

goal attainment, completion/honoring of ADs, quality<br />

of life and symptom assessment tools with less focus on end of life.<br />

D105<br />

Prevalence of Very Low Bed Use to Prevent Bed-Related Fall-<br />

Injury in Hospitals: Preliminary Findings.<br />

L. C. Mion, 1 R. I. Shorr, 2 A. F. Minnick, 1 M. Dietrich, 1 G. Hunt, 1<br />

B. Donaghey. 1 1. Vanderbilt University, Nashville, TN; 2. University of<br />

Florida, Gainesville, FL.<br />

Background: Annually 1 million hospital patients fall with a<br />

10% injury rate. Hospital fall prevention has been only modestly effective<br />

despite >20 years effort. Very Low Beds (VLB) have been<br />

used in long term care settings and expert panels suggest VLBs to<br />

prevent fall injury for hospitals. Only one study exists of VLBs in hospitals<br />

and found no impact on fall-injury rates. Further, a growing<br />

number of reports indicate adverse events for patients, staff and families.<br />

Objective: To determine prevalence of VLB use in NICHE hospitals<br />

(Nurses Improving Care of Hospitalized Elders), impact on<br />

fall-injury rates, and adverse events to patients, families and staff.<br />

Methods: A web-based survey was distributed to 288 NICHE Coordinators<br />

in November 2011. Survey items determined VLB prevalence,<br />

criteria for use, types of units deployed, effect on fall-injury rates, and<br />

adverse events as a direct result of VLB. Descriptive analyses were<br />

performed using SPSS.<br />

Results: To date, there have been 131 responses (45%). Of these,<br />

29 sites (22%) used VLBs; 17 (59%) with padded floor mats. 41%<br />

own and 59% rent VLBs. Most (74%) do not track patient use or<br />

number of bed-days of use (88%). Only 19% track effectiveness of<br />

VLB. General medical and surgical units were the most frequent<br />

users (56%); 31% used in ICUs. Most (60%) have used VLBs for 3+<br />

years. Most (63%) have no policy or procedure for use. 52% of sites<br />

reported at least one patient VLB-event with falls (21%). Staff events<br />

included: injury (10%), falling/tripping (20%), and difficulty maneuvering<br />

equipment (24%). 35% of the sites noted family VLB-events.<br />

52% believe VLB benefits outweigh VLB risks for adults 65. Fall rates ranged from 1 to 4.5 and fall-injury<br />

rates ranged from 0.5 to 1.5/1000 patient-days. Added comments expressed<br />

concerns over costs and staff consistent use of the beds because<br />

of ‘hassles’ for nurses in procurement and transfers.<br />

Conclusions: Less than 1/4 of NICHE respondents use VLBs.<br />

No consistent criteria or procedure was evident. Few track use or effectiveness.<br />

However, most believe the benefits outweigh the risks for<br />

older patients. Adverse events occurred in up to 52% of the sites. Similar<br />

to studies on hip pads, staff adherence was a concern. Carefully<br />

designed studies are necessary prior to policy changes to incorporate<br />

VLBs in acute care settings.<br />

D106<br />

Geriatric Home Care Reduces Hospitalizations in Very Frail Elderly<br />

in Toledo, Spain.<br />

C. Castillo, C. Rodriguez, C. García, A. Bartolomé, M. Diaz de Cerio,<br />

C. Gómez, M. Cuadrado, M. Gomez, B. Aguirre, A. Carbonell.<br />

<strong>Geriatrics</strong>, Hospital Virgen del Valle, Toledo, Toledo, Spain.<br />

Authors: C.Castillo, C.Rodriguez, C.García,A.Bartolomé, M.Diaz<br />

de Cerio, C.Gómez, M.Cuadrado, M.Gomez, B.Aguirre,A. Carbonell<br />

Institution: Hospital Virgen del Valle, Spain<br />

Introduction: The goal in Geriatric Home Care (GHC) is to improve<br />

quality of life for patients and their families when they face a<br />

non-curable life threatening disease. It is not easy to keep patients<br />

with multiple chronic diseases at home because of their complex<br />

treatments and the difficulty determining terminality; therefore, patients<br />

are frequently hospitalized and very often die in the hospital.<br />

We studied the functional status and the number of hospitalizations<br />

of non-oncologic patients admitted in our GHC Unit.<br />

Methods: We reviewed the charts of 519 patients. We excluded<br />

oncologic patients. In the analysis we included main diagnosis, reason<br />

for admission in our GHC Unit, the New York Heart Association<br />

scale (NYHA), use of home oxygen, the Global Deterioration Scale<br />

(GDS), the Barthel index, the number of hospitalizations 12 months<br />

before and 12 months after admission in GHC, the presence of<br />

anorexia and/or disfagia, and the Charlson Index.<br />

Results: 238 patients were non-oncologic. 32% were admitted as<br />

non-oncologic palliative patients. Mean age was 85.53 (SD 5.6) mean<br />

time of stay in GHC was 5.2 months (SD 5.5). 20% of the 238 patients<br />

had a NYHA of III-IV. 24% of the patients were on home oxygen. Severe<br />

dementia was present in 18% of the patients. Severe dependency<br />

was found in 52%. Anorexia and/or disfagia were present in 25% of<br />

the patients. Charlson index above three was found in 31% of individuals.<br />

Before admission in GHC mean number of hospitalizations<br />

was 1.94 (SD 1.84; 95% CI 1.61-2.07) and after GHC it was 0.8 (SD<br />

1.4; 95% CI 0.7-1.075), therefore we achieved a 55% reduction in the<br />

number of hospital admissions. 52% of patients died during their stay<br />

in GHC, of which 32% died at home.<br />

Conclusions: In our GHC Unit Geriatricians manage very old<br />

patients with severe advanced chronic diseases who are hospitalized<br />

very often. After being evaluated by GHC the number of hospitalizations<br />

is reduced and an important percentage of patients die at home,<br />

reducing inadequate use of health system resources. In the future, we<br />

should potentiate care giver support at home in order to improve our<br />

goal of reducing hospital use by this population.<br />

D107<br />

Palliative Oncologic Patients Die at Home and Palliative Nononcologic<br />

Patients Die in the Hospital.<br />

C. Castillo, C. Rodriguez, C. García, A. Bartolomé, M. Diaz de Cerio,<br />

C. Gómez, M. Cuadrado, M. Gómez, B. Aguirre, A. Carbonell.<br />

<strong>Geriatrics</strong>, Hospital Virgen del Valle, Toledo, Toledo, Spain.<br />

Background: It is relatively easy to determine terminality in an<br />

oncologic disease, but it is difficult with non-oncologic diseases, therefore<br />

patients are frequently hospitalized and very often die in the<br />

hospital. In our Geriatric Home Care Unit (GHC) our goal is to improve<br />

the quality of life of our patients, and prevent inadequate use of<br />

health care resources. We studied the number of hospitalizations of<br />

oncologic and non-oncologic patients admitted in our GHC.<br />

Methods: We reviewed the charts of oncologic and non-oncologic<br />

patients followed in our GHC between 2008 and 2010 and collected<br />

demographic data such as age and sex, time followed by GHC,<br />

the number of hospitalizations 12 months before and 12 months after<br />

admission in GHC, the number of deaths and where the patients died.<br />

Results: We studied 519 patients of which 281 were oncologic<br />

and 238 were non-oncologic. Of the oncologic patients, mean age was<br />

83 (SD 5.2), 64% were men and their mean time in GHC was 4<br />

months (SD 4.2). Mean number of hospitalizations 12 months before<br />

admission in GHC was 1.34 (SD 1.32; 95% CI 1.16-1.46) and 12<br />

months after admission was 0.5 (SD 0.9; 95% CI 0.44-0.65); this result<br />

represented a 60% reduction in the number of hospitalizations. 90%<br />

of patients died, and 76% of deaths were at home. Of the non-oncologic<br />

patients, mean age was 85.5 (SD 5.6), 56% were women and<br />

mean time in GHC was 5.25 months (SD 5.5). Mean number of hospitalizations<br />

12 months before GHC was 1.94 (SD 1.84; 95% CI 1.61-<br />

2.07) and 12 months after GHC it was 0.8 (SD 1.4; 95% CI 0.7-1.075);<br />

AGS 2012 ANNUAL MEETING<br />

S223


P OSTER<br />

A BSTRACTS<br />

this result represented a 55% reduction in the number of hospitalizations.<br />

52% of the patients died and 32% died at home.<br />

Conclusions: Even though oncologic patients and frail patients<br />

with multiple chronic advanced diseases share similar symptoms at<br />

the end of life, it is easier to keep oncologic patients at home till they<br />

die. Most likely, this is because in non-oncologic patients it is more<br />

difficult to determine whether a relapse is irreversible or not. We believe<br />

that with better support and education to main care givers we<br />

can improve achieving goals of management.<br />

D108<br />

Improving care Through Collaboration: The Development of a Post-<br />

Acute Care Coordination Network.<br />

J. Chohan, W. Zafirau, S. Hazelet. Post Acute and Senior Services,<br />

Summa Health System, Akron, OH.<br />

Background: Healthcare reform is going to require integration<br />

of services across the continuum of care to improve both efficiency<br />

and quality.<br />

Purpose: This paper describes a unique collaboration between<br />

an acute care hospital and 26 neighboring skilled nursing facilities<br />

(SNF) whose purpose was to improve communication between these<br />

providers in an effort to improve quality of care, reduce hospital<br />

length of stay, optimize transitions and reduce readmission rates for<br />

at risk patients.<br />

Methods: Formation of the Care Coordination Network (CCN)<br />

which implemented electronic communications between facilities, a<br />

standardized transfer form from the hospital to SNF, and a standardized<br />

change in condition form for transfer from the SNF to the<br />

hospital.<br />

Results: The hospital’s average length of stay was reduced from<br />

7.52 days in 2002 to 7.2 days in 2010. Furthermore, the 31 day readmission<br />

rate for post acute patients who were discharged to a skilled<br />

facility dropped from 26% to 20% in 2010. The mortality rate for<br />

cases readmitted to the hospital began at 9% in 2003 and has fluctuated<br />

over the years studied between 12.5% to as low as 7%. At the<br />

end of the study, the readmission rate was at 9% in 2010.<br />

Conclusions: Participation in a Care Coordination Network is<br />

mutually beneficial for hospitals, SNFs, and at risk patients. Hospitals<br />

benefitted from a shorter length of stay, improved bed capacity, and<br />

fewer readmission rates. SNFs benefitted by having increased referrals<br />

from the hospital, more streamlined census management, as well as<br />

improved ability to classify patients into Resource Utilization Groups<br />

due to improved information exchange. Finally, patients were clearly<br />

provided with improved quality of care with these implementations.<br />

D109<br />

A Transformational Model of Caring for independent older adults -<br />

The COLLAGE and Vitality 360 Program.<br />

J. Fonseka, 1 R. Schreiber, 1,3 A. Russotto, 2 R. Jones, 2 A. Rosenberg, 2<br />

M. Bryan, 2 J. Morris. 2 1. Department of Medicine, Hebrew Senior<br />

Life, Boston, MA; 2. Institute For Aging Research, Hebrew Senior<br />

Life, Boston, MA; 3. Medicine, Harvard Medical School, Boston, MA.<br />

Supported By: Hebrew SeniorLife<br />

Background: Vitality 360 is an innovative program of self engagement<br />

that was developed at Hebrew SeniorLife and piloted at<br />

Orchard Cove (OC), a continuing care community (CCRC) in Canton,<br />

MA. OC is part of a consortium of housing and CCRC sites<br />

called COLLAGE .COLLAGE utilizes the Community Health Assessment<br />

(CHA) measurement tool, to identify opportunities of<br />

health and wellness programs to meet the ever changing needs of<br />

older adults living independently. The CHA is administered yearly<br />

and was developed by InterRAI (An International organization of<br />

clinicians and researchers). It is a comprehensive assessment of an individuals’<br />

physical, mental, spiritual, vocational and social status.<br />

After the CHA is done, the patient is offered access to the Vitality<br />

360 program. A Vitality Coach (VC) works with the individual to understand<br />

what their life goals are, and identifies barriers to reaching<br />

these goals. A Vitality plan is developed and monitored collaboratively<br />

over the year.<br />

Methods: 189 residents at OC Independent living were enrolled<br />

in COLLAGE. Out of the 189 residents, 90 patients were identified<br />

but only 69 could be matched on the basis of baseline characteristics<br />

to residents from comparison COLLAGE sites, where Vitality 360<br />

was not available.The broad categories of goals identified by the Vitality<br />

Coach were physical and mental health, volunteering, lifelong<br />

learning, spiritual and life enrichment<br />

Results: Outcomes monitored included changes in residents<br />

self-reported mood problems, health status, satisfaction with life and<br />

fitness participation. There were significant improvements in some of<br />

these parameters and overall quality of life.<br />

Conclusions: Based on these findings, the COLLAGE and Vitality<br />

360 program can positively impact residents’ quality of life by empowering<br />

them to focus on goals that are most important to them.<br />

This resulted in improved satisfaction with life. This model of engagement<br />

warrants further study as an intervention in community<br />

dwelling older adults to enhance quality of life.<br />

D110<br />

Patient- And Family-Centered Rounds On A Geriatric Inpatient<br />

Service: Resident And Staff Perspectives Of Bedside Rounds.<br />

J. D. Schlaudecker, 1 A. Stecher, 2 K. Meganathan. 1 1. <strong>Geriatrics</strong>,<br />

University of Cincinnati, Cincinnati, OH; 2. University of Cincinnati<br />

College of Medicine, Cincinnati, OH.<br />

Supported By: GACA<br />

Reynolds Foundation<br />

Background: Patient- and family-centered rounds (PFCR) is a<br />

model for empowering patients and families and improving communication<br />

and care in an academic, inpatient setting. While well studied<br />

in the pediatric setting, little is known about the application of PFCR<br />

to the geriatric population.<br />

Methods: In summer 2011, 86 unique encounters of 13 residents<br />

and 10 staff were surveyed immediately following a beside PFCR experience.<br />

For comparison, 71 unique encounters of 11 residents and<br />

14 staff on another service that does not use PFCR completed the<br />

survey.<br />

Results: 94% of residents experiencing PFCR found the process<br />

beneficial to patients, compared to 80% of residents practicing traditional<br />

rounds. 92% of residents experiencing PFCR found the process<br />

beneficial to other residents, compared to 80% practicing traditional<br />

rounds. 90% of residents participating in PFCR said the process improved<br />

relationships with patients and families. 63% of residents in<br />

PFCR agreed that PFCR improved resident education, compared to<br />

traditional rounds. 84% of residents in PFCR gained a “better understanding<br />

about patients compared to traditional rounds”. 96% of this<br />

group agreed they were working as a part of a team, compared to<br />

70% of residents in traditional rounds. 100% of residents in the<br />

PFCR group agreed with the idea that PFCR “enhances my ability to<br />

communicate with patients”.<br />

100% of staff in the PFCR group agreed “my questions were answered<br />

about the patient”, “I am working as a part of a team”, “I understand<br />

the patients care plan for the rest of the day better than had<br />

I not participated in PFCR”, “PFCR enhances my ability to address<br />

fears and worries of patients”, and “PFCR improves communication<br />

between the members of the care team.”<br />

Conclusions: The positive responses of those participating in<br />

PFCR indicate that PFCR can lead to positive care experiences for<br />

resident and staff of geriatric patients. Compared to traditional<br />

rounds, PFCR is at least as beneficial for both residents and staff in<br />

enhancing communication, education, and teamwork. More research<br />

is needed with a larger sample to investigate how PFCR outcomes<br />

S224<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

and satisfaction compare to traditional care, but the potential for care<br />

improvement, enhanced education, and improved resident and staff<br />

satisfaction in inpatient geriatric care is great.<br />

D111<br />

Implementation of a Community-Hospital Partnership to Improve<br />

Transitions from Hospital to Home.<br />

J. L. Thorud, 1 A. K. Hochhalter, 1,2 A. B. Stevens, 1,2 H. R. McGhee. 3 1.<br />

Scott & White Healthcare, Temple, TX; 2. Texas A&M Health Sciences<br />

Center, Temple, TX; 3. Central Texas Aging and Disability Resource<br />

Center, Belton, TX.<br />

Supported By: Project is supported by grants from the U.S.<br />

Administration on Aging and the Center for Technology and Aging.<br />

Background: The objective of the Texas ADRC Evidence-Based<br />

Care Transition Program is to reduce hospital readmissions by educating<br />

and empowering patients to manage their healthcare needs. The<br />

program employs the evidence-based Care Transitions Intervention®.<br />

Methods: Eligible patients, age 60 or older and hospitalized at<br />

the participating hospital, are identified through referrals from hospital<br />

personnel and auto-generated reports of electronic medical record<br />

data. Intervention services are offered to eligible patients in the hospital<br />

or by phone after discharge. The free, 30-day program consists of<br />

a home visit and two follow-up phone calls which focus on goal setting<br />

and four “pillars”: creating an accurate medication list, preparing<br />

for and attending a follow-up medical appointment, identifying signs<br />

of exacerbation (“red flags”), and using a personal health record. The<br />

program evaluation follows the RE-AIM framework to assess the potential<br />

value of the program for improving the health of communities;<br />

aspects of program reach into the target population and program<br />

adoption are described in this presentation.<br />

Results: After six months of operation, 39% (467/1183) of patients<br />

referred to the program were eligible and 35% (N=165) enrolled.<br />

The average age of enrollees was 73; 85% were white; 14%<br />

were Hispanic or Latino; 59% were female; and 93% lived in a small<br />

metro area with fewer than one million residents. The Patient Activation<br />

Assessment, a coach-rated assessment of the degree to which patients<br />

participated in the program, showed that over 50% of participants<br />

were actively engaged in the program. Of the 89% of patients<br />

who set a goal, 67% either met or made “a lot of progress” in meeting<br />

it. Readmissions to the same hospital within 30 days were 13.6% for<br />

patients who completed all intervention contacts compared to 23.4%<br />

for those who were eligible but did not enroll.<br />

Conclusions: To date, the program has successfully reached a<br />

large number of patients. The evaluation reveals a need to either increase<br />

program uptake among eligible patients or offer different<br />

types of care transitions interventions for those who choose to decline<br />

services. The next phase will expand the program into additional<br />

hospitals and embed additional coaches within the ADRC offices in<br />

communities.<br />

D112<br />

The Inpatient Hospital Experience of Caregivers of Older Adults: A<br />

Qualitative Study.<br />

J. A. Steimle, 1 J. Colburn, 2 C. Christmas. 2 1. Ohio University Heritage<br />

College of Osteopathic Medicine, Athens, OH; 2. Division of Geriatric<br />

Medicine and Gerontology, Johns Hopkins University School of<br />

Medicine, Baltimore, MD.<br />

Supported By: <strong>American</strong> Federation for Aging Research and<br />

National Institute on Aging<br />

Purpose: The purpose of this study is to interview caregivers of<br />

older adults to learn more about their experiences of having their loved<br />

ones in the hospital, and to suggest ways to improve that experience.<br />

Methods: Caregivers were referred by the patient’s geriatricians<br />

or solicited via flier posted in the clinic and were administered semistructured,<br />

recorded, and transcribed interviews to better understand<br />

their perceptions of the hospital experience.<br />

Results: 25 interviews were analyzed. The average age of patients<br />

was 83 and that of caregivers was 59. 16 caregivers were daughters<br />

or daughters-in-law, 5 were spouses, 2 were sons, 1 was a niece,<br />

and 1 was a state provided caregiver.<br />

On a burden scale with a maximum 16 points, 15 caregivers(60%)<br />

reported low levels of burden (0-8) while 10 (40%) reported<br />

high levels of burden (9-16). Caregivers performed an average<br />

of 6.5 activities of daily living (ADLs) in the home setting but 3.2<br />

in the hospital setting. The majority of caregivers rated the transition<br />

to home very highly according to the 3 question Care Transition<br />

Measure.<br />

6 themes emerged from the analysis of the semi-structured interviews<br />

with caregivers: communication, hospital setting, quality of<br />

care, outpatient care and transition, caregiver involvement, and sensitivity<br />

to the patient’s unique medical conditions.A range of comments<br />

within each theme suggested heterogeneity of experience for the<br />

caregivers. The most common suggestions to improve the hospital experience<br />

when directly asked was to improve communication as well<br />

as to have patience and understanding with patients and caregivers.<br />

Conclusions: In this study of caregivers of older adults after a recent<br />

hospitalization, we found that there remain many challenges<br />

around communication between caregivers and the medical team<br />

both during the hospital stay and at discharge. This analysis suggests<br />

that interventions designed to enhance the education of hospital<br />

providers about communicating with caregivers and about the special<br />

needs of older adults could improve the hospital experience for older<br />

adults and their caregivers.<br />

D113<br />

Identifying Waste in a <strong>Geriatrics</strong> Home Care Practice’s Laboratory<br />

Ordering Process Using Lean Techniques.<br />

J. A. Eng, 1,2 R. M. Zitnay, 1 K. James, 1 M. Sissoko, 1 M. Young, 1<br />

G. Gupte, 2 W. Suen. 1 1. Medicine-<strong>Geriatrics</strong>, Boston University School<br />

of Medicine, Boston, MA; 2. Boston University School of Public<br />

Health, Boston, MA.<br />

Supported By: John A. Hartford Foundation, Health Resources and<br />

Services Administration<br />

Background: “Lean” is a quality improvement philosophy that<br />

focuses on maximizing customer value while minimizing waste<br />

throughout a system. Eliminating waste, or non-value-added steps,<br />

decreases cost, time, and resources needed to perform services. The<br />

main aim of this study is to identify ways to improve the routine laboratory<br />

ordering process in a geriatrics home care practice using the<br />

lean techniques of process mapping and identifying wastes. Methods:<br />

The authors identified and contacted various stakeholders to map the<br />

routine laboratory ordering process from when the clinician placed<br />

an order until receipt of results. The authors collected time stamped<br />

data for 8 key steps in orders placed by two clinicians over 30 days.<br />

The authors analyzed the time data, identified non-value added steps,<br />

and further refined athe process map. Results: The authors collected<br />

data on 23 laboratory orders. Examples of non-value added steps<br />

identified from the process map included creation of a printed order<br />

sheet, walking the printed order sheet from the printer to the secretary’s<br />

bin, waiting for the secretary to pick up the order sheet, having<br />

variation in secretarial verification of account status, faxing of the<br />

order to thean outside laboratory, and waiting for the fax confirmation.<br />

Of the 8 steps tracked, authors identified order wait time in the<br />

secretary’s bin (average 29.89 hours, range from 0.08 to 74.90 hours,<br />

n=16) as the non-value added step that would be most readily modified.<br />

Conclusion: Lean techniques, such as using process mapping and<br />

identifying non-value added steps, are useful for recognizing the inefficiencies<br />

in home care laboratory ordering practices. Future plans include<br />

restructuring the process and better utilizing electronic medical<br />

records systems to reduce waste in the routine home care laboratory<br />

ordering process.<br />

AGS 2012 ANNUAL MEETING<br />

S225


P OSTER<br />

A BSTRACTS<br />

D114<br />

Fall Reduction in an ACE Unit-A Model for Quality Improvement<br />

1,2 J.R Ortiz, 1,2T. Efeovbokham, 1 C.Stephens-Kelly, I,Rohner<br />

1,2Theodore Suh 1 UT Health Science Center in San Antonio &<br />

2CSRHCC.<br />

J. R. Ortiz, 1,2 T. Efeovbokham, 1,2 C. Stephens-Kelly, 1 I. Rohner, 2<br />

T. Suh . 1,2 1. <strong>Geriatrics</strong>, UTHSCSA, San Antonio Texas, TX; 2.<br />

<strong>Geriatrics</strong>, Cristus Santa Rosa, San Antonio, TX.<br />

PURPOSE: Identifying specific risk factors for those who fall in<br />

a hospital Acute Care of the Elderly (ACE) Unit can lead to a targeted<br />

intervention to prevent falls among hospitalized older adults.<br />

BACKGROUND: Falls are a common problem in hospitalized<br />

older adults, with about a third of hospital falls resulting in injuries<br />

such as fractures, head and soft tissue trauma, which contribute to increased<br />

length of stay (LOS), impaired rehabilitation, greater comorbidity,<br />

more transitions to long-term care and greater hospital costs.<br />

The main risk factors for falls in the hospital include gait instability,<br />

confusion, urinary incontinence, previous falls and certain drugs.<br />

METHODS: At the start of this study, our 10-bed ACE Unit at<br />

Christus Santa Rosa Hospital-City Centre had the highest fall rate in<br />

the hospital at just over 10 /1000 bed days. Our goal was to lower the<br />

fall rate to 3.4 /1000 bed days. The ACE team developed a multicomponent<br />

intervention, consisting of differentiating very high from high<br />

fall risk patients, hourly rounding and mandatory use of bed alarms<br />

for very high fall risk patients, and an incentive for ACE Unit nurses<br />

consisting of a free lunch at the end of a month without any falls.<br />

RESULTS: This intervention began on March 1/2011. For over 4<br />

consecutive months (March-June), there were no falls in our ACE<br />

Unit. We had one fall each in the months of July-Sept. and no falls in<br />

Oct. For the last quarter (July-Oct.), the fall rate for our ACE Unit<br />

was 3.5 /1000 bed days. The estimated cost to implement this change<br />

was $850, plus $100 monthly to maintain it. If a fall adds an average of<br />

4 days to the LOS, each prevented fall saves ~$12,800. If one conservatively<br />

estimates that 2 falls were prevented monthly with this intervention,<br />

then the annual projected cost savings is over $307,000.<br />

CONCLUSION: Specific strategies to reduce falls in hospitalized<br />

older adults have been successful. Differentiating those at highest<br />

risk for falls is essential. Increased nurse rounding and diligent<br />

bed alarm use for those at highest fall risk can reduce falls. A nominal<br />

reward to nursing staff for their efforts to reduce falls was also effective.<br />

There are potentially large cost savings to hospital from the prevention<br />

of falls and resulting injuries.<br />

D115<br />

CARE: A Volunteer Approach to Reducing Delirium in the<br />

Emergency Department.<br />

J. Arnold, M. Sanon, A. Chun. Department of <strong>Geriatrics</strong> and Palliative<br />

Medicine, Mount Sinai School of Medicine, New York, NY.<br />

Supported By: The Medical Student Training in Aging Research<br />

program of the the <strong>American</strong> Federation for Aging Research<br />

The emergency department is a critical point of care for the elderly<br />

and delirium is of particular concern in the chaotic ED environment.<br />

Patients who develop delirium in the ED have been shown to<br />

be at increased risk of adverse outcomes, have a more complicated<br />

clinical course, and a higher likelihood of being sedated to control agitation.<br />

The Care and Respect for Elders with Emergencies (CARE)<br />

program is an ongoing effort jointly developed by the Department of<br />

Geriatric and Palliative Medicine and Department of Emergency<br />

Medicine at The Mount Sinai Medical Center specifically designed to<br />

reduce the incidence of delirium in the ED. CARE adapts the successful<br />

approaches from inpatient volunteer programs to the ED environment.<br />

The goals of this retrospective cohort study were to understand<br />

which elderly ED patients were being visited by CARE<br />

volunteers and to characterize their clinical outcomes compared the<br />

the general elderly ED population for evidence that the volunteer<br />

program was having an impact on delirium. We looked at EMR data<br />

from 8009 visits to the ED by elderly patients over an 11 month period<br />

which included 104 volunteer visited patient visits. We found significant<br />

differences in the ethnic composition of the volunteer visited<br />

and non-visited populations with volunteers less likely to visit Hispanic<br />

patients. Volunteer visited patients had lower ESI scores at<br />

triage (were more urgently ill), had significantly longer ED lengths of<br />

stay, were significantly more likely to be admitted to the hospital and<br />

more likely to return to the ED within 30 days. Despite a seemingly<br />

more complicated clinical course, volunteer visited patients were less<br />

likely to be sedated during their ED visit. The results of this study<br />

agree with the expectation that volunteers are visiting more acutely<br />

ill patients but also raise questions about the selection bias that warrants<br />

further investigation. While the intentional and potentially unintentional<br />

volunteer assignment bias limits the value of comparing<br />

clinical course, the difference in sedation rate suggests that the<br />

CARE volunteer program may be reducing the incidence of delirium<br />

in the ED.<br />

D116<br />

Palliative Care Interventions in Advanced Chronic Diseases: A<br />

Systematic Review.<br />

J. E. Roberts, M. C. Reid, R. D. Adelman. Weill Cornell Medical<br />

College, New York, NY.<br />

PURPOSE: Palliative care’s (PC) potential to improve quality<br />

of life and provide symptom relief has received increased attention,<br />

but it remains unclear how commonly such interventions target diverse<br />

chronic illnesses. This study determines the occurrence and efficacy<br />

of PC interventions for chronic non-cancer and cancer disorders.<br />

METHODS: PubMed, MEDLine, CINAHL and Abstracts in<br />

Social Gerontology were searched (1/80-10/11) where terms included<br />

palliative care, chronic obstructive pulmonary disease (COPD), end<br />

stage renal disease (ESRD), advanced heart disease (AHD) and cancer.<br />

Studies were limited to English-language papers reporting on<br />

multi-component PC interventions for adults with cancer, COPD,<br />

ESRD or AHD. Study quality was assessed.<br />

RESULTS: 1613 citations were identified. 41 met eligibility criteria<br />

and described 35 unique interventions. 21 targeted patients with<br />

cancer, and fewer targeted patients with AHD (n=4), ESRD (n=6), or<br />

multiple diseases (n=4). No study enrolled COPD patients exclusively,<br />

but multiple disease interventions included COPD patients.<br />

Five were RCTs and 30 were observational studies. Four of 30 observational<br />

studies and 4 of 5 RCTs were of high methodologic quality.<br />

Interventions were delivered in inpatient units (43%), outpatient<br />

clinics (51%), and home visits (46%), and by nurses (34%), physicians<br />

and nurses (17%), physicians (6%), or multidisciplinary teams<br />

(43%). The mean number of intervention components was 3.8 (range<br />

2-7), common components included symptom management (77%),<br />

advance care planning (49%), psychological support (49%), and care<br />

coordination (43%). Symptom burden was the most common outcome<br />

(46%), followed by medical care utilization (34%) and care satisfaction<br />

(31%). Fifteen studies reported improvements on all or<br />

most outcomes, 12 reported some improvements, and 1 showed no<br />

improvements. The most common symptom improvements were in<br />

pain (n=9) and nausea (n=7). Advance care planning increased as a<br />

result of interventions in 6 studies spanning all disease categories.<br />

CONCLUSIONS: Most PC interventions continue to target patients<br />

with cancer. While 77% report positive effects, methodologic<br />

quality was judged to be poor and only 14% employed an RCT design.<br />

Over half lacked data on the schedule and intensity of the intervention<br />

sufficient for replication. Research on multi-component PC<br />

interventions targeting chronic non-cancer illnesses and employing<br />

rigorous research methods is urgently needed.<br />

D117<br />

Home Based Transitional Care.<br />

J. Leland, J. Cariaga, D. Davis. James A Haley VA, Tampa, FL.<br />

June Leland MD, Jose Cariaga MD, Darlene Davis MHA<br />

S226<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

James A. Haley VA Tampa FL<br />

Background:<br />

Nationally, 20% of veterans discharged from a VA inpatient<br />

care unit are readmitted within 60 days of discharge. As a quality improvement<br />

program, the Tampa VA initiated a Home Based Transitional<br />

Care Program to support discharged veterans during the first<br />

28 days following a hospital discharge.<br />

Program Description:<br />

The program is consult based and provides for an in home visit<br />

by an RN and Kinesiotherapist. The RN visit which occurs within 4<br />

days of discharge includes medication reconciliation, review and reinforcement<br />

of discharge orders, identification of clinical status changes,<br />

offering and coordination of enrollment for chronic care programs<br />

such as CCHT, HBPC, MFH and/ or purchased home care services.<br />

The RN provides follow-up care and case management for up to 28<br />

days. The kinesiotherapist performs a home safety evaluation (environmental<br />

and functional assessments); fall risk assessment, and recommends<br />

or orders necessary equipment for home safety. The team<br />

members provide follow-up care and education for up to 28 days.<br />

Outcomes:<br />

Veterans serve as their own baseline for rate of readmission for<br />

a maximum of 6 months prior to the index discharge during which the<br />

HBTC consult was placed. A readmission rate is established for each<br />

veteran during a time frame equal to the amount of time that has<br />

passed since the veteran was seen by the HBTC team for up to a maximum<br />

of 6 months.<br />

Analysis was completed on 120 patients seen Oct 2010 thru Sept<br />

2011. Readmission rates were reduced by 28% at 14 days, 33% from<br />

15-30 days, and 68% over 30 days. There was a 50% reduction in bed<br />

days of care.<br />

For those evaluated, 53% had medication errors identified, 56%<br />

were recommended additional home services, 39% were issued nursing<br />

supplies, 73% were issued DME, and 100% were educated regarding<br />

medication and home safety.<br />

From program participant surveys:<br />

85% felt comfortable after hospital discharge.<br />

100% felt HBTC staff was professional.<br />

30% claimed HBTC staff taught them something new.<br />

100% endorsed that medications were explained thoroughly.<br />

95% stated that HBTC increased their satisfaction with the VA.<br />

55% claimed that their HBTC visits prevented them from going<br />

back into the hospital.<br />

100% of veterans who were provided with supplies stated that<br />

the usage of equipment or supplies was properly demonstrated.<br />

D118<br />

Multi-faceted effort to improve Hospitalized senior care at a large<br />

Tertiary teaching medical center.<br />

S. Soryal, 1 K. Padua. 2 1. <strong>American</strong> <strong>Geriatrics</strong> <strong>Society</strong>, Milwaukee, WI;<br />

2. geriatrics, Aurora health care, milwukee, WI.<br />

Supported By: non<br />

Our model of care was created to improve senior care in a large<br />

tertiary care hospital focusing on three different efforts.<br />

The first effort is implementing the ACE Concept on almost all<br />

hospital floors. The Acute Care for The Elders concept focuses on<br />

prepared environment with standard equipment for seniors, patientcentered<br />

interdisciplinary care, medical review by a geriatrician as<br />

part of the interdisciplinary team, and early discharge planning. Our<br />

ACE Concept was implemented on sixteen different medical floors<br />

(fourteen of them were medical surgical floors, one medical intensive<br />

care unit, and one inpatient rehab unit).<br />

Geriatricians lead the team utilizing an innovative electronic<br />

medical record tool called ACE tracker, which in real-time identifies<br />

high risks patients for complications in the hospital.<br />

The second effort was the collaboration with the hospitalist<br />

group by attending the morning rounds once a week in a geriatric<br />

hospitalist rounds discussing patients who are in the hospital who are<br />

80 years and older. The geriatrician will also use ACE tracker to identify<br />

high risks patients for complications and use the opportunity as<br />

an educational time for group of nine hospitalist.<br />

The third effort was to start ACE consult service and accept referrals<br />

from admitting physicians to help manage complex patients in<br />

the hospital. Most of the reasons for referrals were to manage delirium,<br />

agitation, dementia, functional decline, frailty, polypharmacy,<br />

identify goals and plans of care, and discharge planning. Physicians<br />

who requested referrals were hospitalist, family practices physicians,<br />

internal medicine physicians, cardiologists, physiatrists, critical care<br />

specialists, neuro-surgeons, and orthopedic surgeons.<br />

After one Year the ACE program showed improvement in<br />

processes of care by decreasing Foley catheter use, reducing restraint<br />

use for non-ICU floors and increase in PT/OT and social<br />

service referrals.<br />

The <strong>Geriatrics</strong> hospitalist round have helped the hospitalists as<br />

they care for seniors and they expressed their satisfaction thru a survey<br />

conducted.<br />

The ACE program has seen 478 consults in its first Year and<br />

Geriatricians were able to show cost savings for patients seen on consult<br />

service( 252 $ per patient ) and reducing length of stay by one day.<br />

D119<br />

Using Cognitive Screens to Predict Pillbox Organizational Skills.<br />

K. J. Anderson, 1,2 A. Huie-Li, 3 C. Willmore. 4 1. Clinical Pharmacy,<br />

Cross Road Medical Center, Glennallen, AK; 2. Pharmacists Int’l<br />

Consulting Specialists, University Place, WA; 3. Clinical Pharmacy, VA<br />

Connecticut Healthcare System, New Haven, CT; 4. Pharmacology,<br />

Union University, Jackson, TN.<br />

Supported By: This study was funded by Blue and You Foundation<br />

for a Healthier Arkansas.<br />

Background:Proactive assessment of medication management<br />

skills can mitigate adverse medication-related events thereby reducing<br />

incidence of emergent care or exacerbation of chronic<br />

disease.Brief cognitive/pillbox skill screens were correlated with pillbox<br />

loading accuracy for predictive value using the patient’s medications.Methods:We<br />

conducted a prospective, cross-sectional, pilot<br />

study in a rural primary care clinic.Inclusion criteria:diagnosis of diabetes<br />

and ability to load a pillbox with >1 medication. Cognitive/literacy/pillbox<br />

skills screens were administered during 3 visits over a ~6<br />

mo period.Pillbox assessment (personal medications loaded in a 28-<br />

compartment pillbox) was initiated when the patient presented with<br />

medications. Average completion time was ~30 min scored by Pillbox<br />

Fill (PBF) method.Screens administered: Mini-Cog=Three Item Recall<br />

and Clock Draw Test (short and long-term memory); Medication<br />

Transfer Screen=MTS (decipher 4 prescriptions, sequence and locate<br />

pills in a pillbox, count); Medi-Cog=Mini-Cog+MTS, Medication<br />

Safety Screen=MEDScreen (Three Item Recall and MTS SF - abbreviated<br />

2-question MTS); 4 o’clock screen=FIR+CDT+AFS (Four Item<br />

Recall, Clock Draw Test, and Animal Fluency Screen); and MTS-<br />

Bean Fill=MTS BF (decipher 4 prescriptions, sequence and locate<br />

beans in a pillbox, count).Results: Forty-nine patients completed the<br />

study: ave age 60, (range 36-84 yrs); 55% AA and 45% White; 71% F;<br />

47% with


P OSTER<br />

A BSTRACTS<br />

D120<br />

Geropsychiatric NP Practice in LTC: Not Just a Med Check.<br />

K. A. Bickerstaff, G. Rogers, C. Chaperon. Community Based<br />

Health, University of Nebraska Medical Center College of Nursing,<br />

Omaha, NE.<br />

Supported By: HRSA Grant 1 D62 HP 15054-01-00<br />

Purpose: This pilot study examined the effectiveness of a<br />

Geropsychiatric Nurse Practitioner in a Long Term Care facility.<br />

Background: Older residents of long term care facilities have<br />

numerous challenging unmet physical and mental health needs. Medications<br />

are frequently used as a rapid resolution to manage mood<br />

and behavioral symptoms. Studies have shown that many of the medications<br />

available are not appropriate for a population over the age of<br />

65. Among the adverse effects can be delirium, life-threatening side<br />

effects, and serious drug-drug interactions as well as a decrease in active<br />

socialization.<br />

Methods: Core interventions that all participants received were<br />

a gold standard comprehensive psychiatric exam and review of all<br />

psychotropic medications. Validated tools used included MDS3<br />

BIMS, MDS3 Behavior, MDS3 Mood, and MDS3 ADLs during time<br />

period of one year.<br />

Design: Retrospective Chart Review of 10% of randomly selected<br />

residents seen by a Geropsychiatric NP in a long term care facility<br />

over a one year period.<br />

Setting: A corporately owned, 150 bed, inner city skilled nursing<br />

home in a large mid-western city.<br />

Population: N=14 long term care facility residents over age 65<br />

seen after referral by staff for evaluation and treatment of cognition,<br />

mood, or behavioral symptoms.<br />

Outcomes:<br />

1. Numbers and types of psychotropic medications used.<br />

2. Mental health modalities ordered by Geropsychiatric NP:<br />

non-pharmacological interventions, cognitive therapy, and increased<br />

socialization.<br />

3. MDS3 Domains of Cognition, Behavior, and ADL function<br />

over a one year period.<br />

Preliminary Results: Analysis of MDS3 records for 3 residents<br />

show positive trends of improved mood and behavior while maintaining<br />

cognition and function. Overall unnecessary psychotropic medications<br />

were eliminated or doses reduced on average of one med discontinued<br />

and 1.3 dose reductions per resident. Each resident had<br />

one added psychotropic medication during the year appropriate for<br />

current symptoms at the time. Each resident received individualized<br />

cognitive, behavioral, and socialization therapy on a monthly basis by<br />

a Geropsychiatric NP.<br />

Conclusion: Geropsychiatric NP intervention may decrease unnecessary<br />

medication use among elderly residents of long term care<br />

facilities and improve both mood and social behaviors.<br />

Key Words: geropsychiatric, nursing, practice<br />

D121<br />

The importance of medication reconciliation in post-hospitalization<br />

patients in an ambulatory geriatric clinic in Singapore.<br />

K. Tan, T. Tan. Department of Geriatric Medicine, Tan Tock Seng<br />

Hospital, Singapore, Singapore.<br />

Even though medication reconciliation is an essential part of<br />

clinical practice, it is often neglected in a busy ambulatory practice.<br />

Older adults who had a recent hospitalization for acute illnesses often<br />

had their medications changed or doses adjusted during the hospital<br />

stay. With these changes, older adults may face medication-related<br />

problems which may lead to poor outcomes if not addressed.<br />

Objective:<br />

To investigate the incidence of medication discrepancies and<br />

medication related problems in older adults post hospitalization.<br />

Methods:<br />

All patients with scheduled appointment at the outpatient geriatric<br />

medicine clinic at Tan Tock Seng Hospital were screened for a<br />

recent admission (within the prior 3 months).<br />

Patients identified were interviewed by a clinical pharmacist on<br />

the day of the appointment prior to their doctor’s consultation. Any<br />

medication discrepancies as compared to the discharge medication<br />

list and medication-related problems noted during the interview will<br />

be highlighted to the patient’s physician. These issues will be examined<br />

in this pilot study.<br />

Results:<br />

295 patients (65.4% female, mean [S.D.] age, 82.3 [7.8] years)<br />

were reviewed between the months of November 2010 to June 2011.<br />

146 patients (49.5%) have 1 or more medication discrepancies detected<br />

during the interview by the pharmacist.<br />

Medication discrepancies due to medication changes by patients<br />

or their caregivers accounted for 58.9% of the discrepancies identified.<br />

These discrepancies include omission of medications that should<br />

be continued (54.3%), failure to discontinue medications that were<br />

stopped during the admission (22.8%), and administering medications<br />

at the wrong doses or frequency (22.8%).<br />

The remaining 41.1% of the medication discrepancies were secondary<br />

to prescribing or dispensing errors made during hospitalization<br />

(40.0%) or changes made by physicians from another specialty<br />

(21.7%) or institution (38.3%) after the discharge from the hospital.<br />

Conclusion:<br />

Medication discrepancies are highly prevalent in older adults in<br />

the post-hospitalization period. Medication reconciliation is an essential<br />

tool at identifying these discrepancies so that it can be addressed<br />

to improve patient safety and quality of patient care.<br />

D122<br />

Clostridium difficile-Associated Disease Recurrence in US Long<br />

Term Care Facilities.<br />

H. Friedman, 1 P. Navaratnam, 1 G. Reardon, 2 K. P. High, 3 M. Strauss. 4<br />

1. DataMed Solutions LLC, Hillard, OH; 2. Informagenics, LLC,<br />

Columbus, OH; 3. Wake Forest School of Medicine, Winston Salem,<br />

NC; 4. Optimer Pharmaceuticals, Inc, San Diego, CA.<br />

Supported By: Optimer Pharmaceuticals provided funding for<br />

this study.<br />

Howard Friedman, Prakash Navaratnam, and Gregory Reardon are<br />

paid consultants engaged by Optimer. Marcie Strauss is an employee<br />

of Optimer. Kevin P. High served on the Optimer Advisory<br />

Council and is a consultant for Optimer.<br />

BACKGROUND: Predictors of recurrent Clostridium difficileassociated<br />

disease (rCDAD) and its association with patient characteristics,<br />

resource utilization, and outcomes in the long term care<br />

(LTC) setting were assessed. METHODS: Demographics, Minimum<br />

Data Set (MDS) 2.0 assessments, and pharmacy records of residents<br />

were analyzed (AnalytiCare LTC database). Residents with an MDS<br />

CDAD code (1/01/07–9/30/10; earliest=index date), ≥1 MDS assessment<br />

≤120 days both pre-and post-index, and metronidazole (MET)<br />

or vancomycin (VAN) received ±7 days of index date were included.<br />

Patients were censored at the earliest of: discharge with no re-admission<br />

≤30 days, latest MDS+90 days, end of study, or death. rCDAD<br />

was defined as MET or VAN being dispensed after >28 day washout<br />

after last fill/refill for the initial episode. Descriptive statistics were<br />

used to compare patient characteristics and resource utilization between<br />

rCDAD and non-rCDAD cohorts. Cox proportional hazard<br />

analysis of index drug cohorts were constructed to identify predictors<br />

of time to recurrence. RESULTS: Of 1145 selected CDAD patients,<br />

225 (19.7%) had ≥1 rCDAD before censoring. Mean age (77–78 y)<br />

and Charlson Comorbidity Index scores (mean=3.0) were similar for<br />

both rCDAD and non-rCDAD cohorts. Prevalence of 26 different comorbidities<br />

was also similar for rCDAD and non-rCDAD cohorts;<br />

most common were recent urinary tract infection (54% and 51%, re-<br />

S228<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

spectively), diabetes mellitus (40% and 45%), and congestive heart<br />

failure (31% and 37%). The rCDAD cohort had an 86% longer preindex<br />

length of stay (LOS) in the LTC facility (P


P OSTER<br />

A BSTRACTS<br />

In addition to 7 specific factors that patients identify as probable<br />

cause, a miscellaneous category exists for qualitative explanation.<br />

Furthermore, objective factors such as number of prescribed medications,<br />

primary care visit between hospitalizations, and mental health<br />

or cognitive diagnoses are also tracked for these individuals.<br />

Results: While no specific factors have been isolated as a primary<br />

cause for readmission, patient feedback such as pre-mature discharge,<br />

quality of post-discharge care, and medication issues are<br />

being reviewed. Preliminary results show patients believe their condition<br />

will require readmission (28.33%) while some patients believe<br />

they were discharged prematurely (26.67%). When paired with the<br />

objective data collected as noted above, we surmise that embracing<br />

the patient and family perspective in discharge planning may reduce<br />

the likelihood of their readmission.<br />

Conclusions: Bringing the patient and family’s perspective into<br />

care promotes a holistic approach to healthcare that enhances successful<br />

discharge planning. The role of social work in completing<br />

these assessments from a psychosocial perspective has been a successful<br />

model in our institution in obtaining this information as they<br />

are then also able to implement clinical interventions and connect<br />

persons with appropriate resources that will reduce the likelihood of<br />

a readmission.<br />

D126<br />

Identification of medication discrepancies in discharge paperwork<br />

among patients in the CO-OPERATE <strong>Geriatrics</strong>/Surgery comanagement<br />

program.<br />

L. M. Walke, 1,2 R. A. Rosenthal, 1,2 M. F. Perkal, 1,2 S. Jeffery, 1,3<br />

M. Maiaroto, 1 R. Marottoli. 1,2 1. VA Connecticut, West Haven, CT; 2.<br />

Yale School of Medicine, New Haven, CT; 3. Univ of CT, Storrs, CT.<br />

Background: Accurate communication regarding medication<br />

regiments is critical to efforts to decrease preventable rehospitalizations<br />

as older adults transition across treatment environments. Electronic<br />

medical records (EMR) can improve communication between<br />

providers and patients but discrepancies in medication list documentation<br />

may thwart these efforts.<br />

Aim: To describe the prevalence of medication discrepancies in<br />

the documentation provided to surgical patients and nursing agencies<br />

or facilities at discharge.<br />

Methods: Surgery patients aged ≥70 years with an expected<br />

peri-operative course ≥ 48 hours are eligible for CO-OPERATE, a<br />

co-management program between geriatrics and surgery. The geriatrics<br />

team consists of a geriatrician, geriatric NP and clinical pharmacist.<br />

We examined the EMR of CO-OPERATE patients discharged<br />

home with nursing services or to nursing facility for<br />

discrepancies in the medication lists included in the patient discharge<br />

instructions and the W10. A medication discrepancy was defined as<br />

the omission of a medication on either list or differing dosing instructions.<br />

Various surgical subspecialties participate in CO-OPERATE<br />

including General Surgery, Cardiothoracic, Orthopaedics, Plastics,<br />

Urology, and Vascular.<br />

Results: The average age of our patients was 83.5 years. All were<br />

discharged on ≥5 medications; 65% received ≥10 medications. In the<br />

first year of the program, ≥1 medication discrepancy between the<br />

W10 and patient discharge instructions was noted for 30% of patients<br />

regardless of the number of medications prescribed. Discrepancies in<br />

documentation occurred most frequently for pain medications, antidepressants,<br />

and vitamins to supplement deficiencies.<br />

Conclusion: Almost two thirds of the surgical patients in our comanagement<br />

program were discharged with ≥10 medications; discrepancies<br />

in documentation varied by medication class. Determining<br />

if other factors contribute to discrepancies, and grading the severity<br />

of discrepancies, may help target our quality improvement efforts.<br />

Redesigning the EMR to alert clinicians of discrepancies in discharge<br />

documentation could improve communication between providers<br />

while aiding efforts to decrease adverse drug effects and preventable<br />

hospitalizations among older adults transitioning through the continuum<br />

of care.<br />

D127<br />

Breaking Down the Silos in Geriatric Inpatient Care.<br />

L. Tank, M. Parulekar, J. Previdi, N. Benoit, A. Sarkar, L. Mansour.<br />

<strong>Geriatrics</strong>, Hackensack University Medical Center, Hackensack, NJ.<br />

Background: Incidence of delirium is high in elderly patients<br />

and it is associated with increased mortality and morbidity and increases<br />

length of stay.<br />

Objective: To integrate Hospital Elder Life program (HELP) in<br />

Geriatric Service Line (GSL) to improve perceptions of care, treatment<br />

and services for geriatric patients (age 70yrs and over) by preventing<br />

delirium, functional decline and length of stay (LOS) in hospital<br />

setting.<br />

Method: The GSL with HELP presented a proposal for disease<br />

specific certification (DSC) for Joint Commission on the Accreditation<br />

of Healthcare Organization (JCAHO).Random sample of 40 patients<br />

per month on 6 HELP units were enrolled using the inclusion<br />

criteria (70 year or older with at least one risk factor such as cognitive<br />

impairment, mobility impairment, vision impairment, hearing<br />

impairment, dehydration, and should be able to communicate verbally<br />

or in writing) through nursing assessment, in multidisciplinary<br />

rounds, and/or by chart review. Metrics included were number of indwelling<br />

urinary catheter days, fall and pressure ulcer rate and use of<br />

psychotropic medication (Haldol, Ativan, Ambien, and Benadryl)<br />

and LOS.<br />

Results: Data was collected from January–August 2011.The<br />

mean indwelling Foley days was 3.4, mean fall rate was 0.6%, pressure<br />

ulcer rate was 0.3%, mean rate of psychotropic meds used was<br />

13.75% and LOS was 3.7 on HELP units as compared to 6.2 on other<br />

units (40% reduction).<br />

Conclusion: The GSL in addition to the multidisciplinary team<br />

has HELP volunteers which has made this a unique model and has<br />

received the distinct honor by JCAHO for disease specific certification<br />

in geriatrics, 1st in the nation.<br />

D128<br />

MEDICAL SERVICE USE IN DEPRESIVE PATIENTS<br />

RECRUITED AT A COLLABORATIVE CARE<br />

MANAGEMENT PROGRAM IN AMBULATORY ELDERLY.<br />

M. Schapira, M. Smietniansky, M. F. Albornoz, P. Hernan,<br />

D. Matusevich, C. Guerra, J. Esteban, M. E. Ramos, L. Camera.<br />

Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.<br />

Supported By: Hospital Italiano de Buenos Aires<br />

CONTEXT: Depression is a common disorder among older<br />

adults sustaining high morbidity, mortality and health care utilization.<br />

Nonetheless, depression remains underdiagnosed and undertreated<br />

leading to adverse outcomes.<br />

In a previous interventional study, we demonstrated that using a<br />

managed care approach depression a reduction of the depressive<br />

symptoms in our population. However, we did not evaluated outcomes<br />

related to medical service use.<br />

OBJETIVES: To determine the rates of medical services utilization<br />

including consults and in depressive patients recruited from our<br />

“Collaborative Care Management Program”.<br />

METHODS: A before/after study was designed to assess the impact<br />

of multifactorial interventions in older adults with depression.<br />

PARTICIPANTS: 91 patients aged 65 and older referred to the<br />

program by primary care physician, with a diagnosis of clinical depression<br />

at baseline assessment. Age mean 77 years. Female 72%.<br />

Intervention: Patients were recruited for an initial comprehensive<br />

geriatric evaluation. Intervention patients had bimonthly followup<br />

visits, social evaluation, access to psychiatric consultation, support<br />

S230<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

of antidepressant management and/or psychotherapy, weekly phone<br />

interviews to assess the course of the symptoms and/or detect any<br />

other problem, and weekly round case discussion with multidisciplinary<br />

team.<br />

Main outcomes measures: Medical records were reviewed from<br />

one year prior to and one year after the recruitment in order to<br />

measure overall consultations, consultations wih primary care physicians<br />

and specialists, consultations to emergency room (ER) and<br />

hospitalizations.<br />

RESULTS: Overall the following outcomes were significantly<br />

reduced in the intervention group: consultations (p=0.001); consultations<br />

with primary care (P=0.001);consultations with specialists<br />

(P=0.002) and admission at ER (P=0.004) . There was not significantly<br />

reduced in hospitalizations.<br />

CONCLUSIONS: Our findings suggest that the intervention<br />

could be effective in reducing health care utilization. These findings<br />

are beyond the improving achieved in depressive symptoms as was<br />

previously proved in our setting.<br />

D129<br />

Does a Palliative Care Consult decrease the cost of caring for<br />

hospitalized patients with Dementia?<br />

M. Araw, 1 C. Araw, 1 T. Mir, 1 T. Liberman, 1 M. Saad, 2 L. Corrado, 1<br />

C. Sison, 3 G. Wolf-Klein. 1 1. NSLIJ Health System, New Hyde Park,<br />

NY; 2. St. John’s University, Queens, NY; 3. Feinstein Institute for<br />

Medical Research, Manhasset, NY.<br />

Introduction: Caring for the 5.4 million <strong>American</strong>s with<br />

Alzheimer’s dementia (AD) is estimated at 183 billion dollars/year.<br />

The study aims to compare the impact of a Palliative Care Consult<br />

(PCC) on the pharmacy cost in hospitalized AD patients.<br />

Methods: Retrospective study of hospitalized elderly patients<br />

with end stage dementia who received a PCC between January 1,<br />

2010 and October 1, 2011. Statistical methods used were Signed-rank<br />

test and McNemar’s test.<br />

Results: Of the 60 patients studied, average age was 86 (range:<br />

70-100) with 27% male and 73% female, 54% white and 20% black.<br />

Eighty seven percent were discharged; 37% of the discharged patients<br />

were transferred to skilled nursing facilities and 22% went<br />

home with home care services or with home hospice (18%). Most patients<br />

(70%) had DNR with 38% signing after PCC. Median time between<br />

date of admission and PCC was 3 days (range: 1-25). When<br />

comparing pharmacy cost before and after PCC, the average cost per<br />

patient per day prior to PCC was $31.16 ± $24.71 and $20.83 ± $19.56<br />

post PCC (p=.003). When looking specifically at pharmacy cost per<br />

category before and after PCC, antibiotic class cost was $9.32 ± $14.94<br />

vs. $6.42 ± $10.65; cardiac medication class cost was $1.15 ± $2.75 vs.<br />

$0.71 ± $1.36; analgesic class cost was $1.36 ± $5.07 vs. $2.35 ± $5.35<br />

(p


P OSTER<br />

A BSTRACTS<br />

D132 Encore Presentation<br />

A multicomponent delirium management program improves<br />

functional outcomes in hospitalized older persons.<br />

M. Chong, 1 M. Chan, 1 L. Tay, 1 J. Kang, 2 H. Han, 2 Y. Ding, 1 T. Tan. 1 1.<br />

Department of Geriatric Medicine, Tan Tock Seng Hospital,<br />

Singapore, Singapore; 2. Nursing Service, Tan Tock Seng Hospital,<br />

Singapore, Singapore.<br />

Supported By: This study was funded by Ministry of Health<br />

(Singapore) Health Quality Improvement Fund (HQIF)<br />

Introduction:<br />

Delirium is associated with poor survival, functional outcomes<br />

following acute hospitalisation episode. The Geriatric Monitoring<br />

Unit (GMU) models after the Delirium Room with adoption of core<br />

interventions from Hospital Elder Life Program and use of evening<br />

bright light therapy to consolidate circadian rhythm and improve<br />

sleep. This study set out to examine if this multicomponent GMU<br />

program improved outcomes in delirious elderly patients compared<br />

to usual care.<br />

Methods:<br />

We studied delirious patients (pre-GMU) admitted to geriatric<br />

department one-month before GMU implementation (n=47) and recruited<br />

GMU patients over an 11-month period (n=84). Baseline demographics,<br />

Charlson comorbidity and severity of illness index (SII),<br />

duration of delirium, functional status (modified Barthel Index<br />

(MBI) on admission/ discharge), falls, physical injuries, pressure ulcer<br />

and nosocomial infection rate were collected.<br />

Results:<br />

Significant male preponderance were noted with slightly higher<br />

Charlson comorbidity (3.6 vs 2.1), SII score (2.2 vs 2.1) and pre-existing<br />

dementia (72.3% vs 66.7%) in GMU patients. GMU patients had<br />

significantly shorter delirium period compared to pre-GMU patients<br />

(7.6 vs 15.1 days). GMU patients showed greater functional improvement<br />

on MBI (19.3+1.9) compared to pre-GMU patients (7.5+11.2).<br />

No patients in GMU were physically restrained compared to 44.7% in<br />

the pre-GMU group. Falls rates were similar in both groups with no<br />

injuries sustained. GMU patients had a significantly lower pressure<br />

ulcer (61.7% vs 1.2%) and nosocomial infection rate (23.4% vs 1.2%).<br />

Conclusion:<br />

This study shows initial evidence for benefits of multicomponent<br />

delirium management program. It adheres to geriatric principles<br />

of restraint-free environment while addressing patient safety concerns.<br />

Clinical benefits included shorter delirium duration, increased<br />

functional gains with decreased complications of immobility.<br />

D133<br />

Innovative Home-Visit Based Medicine Resident Curriculum<br />

Decreases CHF Patients’ 30-Day Readmissions & Improves Patient<br />

Education.<br />

O. B. Lahoud, 1 A. Siddique, 1 S. Goldberg, 1 M. Hecht. 1,2 1. Internal<br />

Medicine, Maimonides Medical Center, Brooklyn, NY; 2. Division of<br />

<strong>Geriatrics</strong>, Maimonides Medical Center, Brooklyn, NY.<br />

Background: Improving transitional care from hospital to home<br />

has been a focus of CMS to reduce costs and readmissions. Naylor<br />

and Coleman showed improvements in transitional care in chronic<br />

care patients; a review by Buchanan outlines teaching interventions<br />

involving residents. Record reported decreased readmissions in CHF<br />

patients via a resident education curriculum involving phone call follow-ups<br />

to patients post-discharge. We propose a resident curriculum<br />

model focused on patient education and home visits.<br />

Methods: Maimonides Medical Center developed an 8-week<br />

curriculum for medicine residents with 3 primary goals: 1)Improve<br />

patient education via IHI Teach Back Method using a 4-item questionnaire,<br />

2)Educate residents on optimal CHF management based<br />

on ACC/AHA guidelines, 3)Involve residents in PI, 4)Visit patients at<br />

home to ensure safe transition and provide further patient education.<br />

Results: We demonstrated 1)Improved patient education, 2)Decreased<br />

CHF patients 30-day readmissions, 3)Improved Resident<br />

transitional care knowledge (data not shown).<br />

Conclusion: A curriculum focused on transitional care can be<br />

implemented in a residency program to improve CHF patient education<br />

and readmission rate via emphasis on teach back and home visits.<br />

We are currently investigating this model in other chronic diseases.<br />

References: Jencks et al. NEJM 2009;360(14):1418-1428.<br />

Naylor et al. J Am Geriatr Soc. 2004;52(5):675-684.<br />

Coleman. J Am Geriatr Soc. 2003;51(4):549-555.<br />

Buchanan et al. Acad Med. 2011;86:628-639.<br />

Record et al. Arch Int Med. 2011;117(9):858-859.<br />

D134<br />

Geriatric Palliative Care- A two year review of a new service.<br />

M. Lerch. Geriatric Dept., Protestant Hospital Bethanien Iserlohn,<br />

Iserlohn, Germany.<br />

Background:The demographic change does not only alter the<br />

approach to rehabilitation and geriatric care but also indicates the<br />

need for a different view concerning end-of life policies for the elderly<br />

and the oldest old. In conventional palliative care settings elderly<br />

patients and there needs are not rarely insufficiently represented.<br />

Therefore two years ago our clinic implemented a new geriatric<br />

palliative care service on a redesigned 6 bed ward to cater for this<br />

clientele bringing together the geriatric team effort and the palliative<br />

knowledge and training for the senior patient<br />

Methods: Review of the geriatric palliative patients considering<br />

age, sex, main diagnosis, main symptoms that led to the admission,<br />

number of admissions and discharges in to home care, scores<br />

for self-sufficiency (Barthel), disease progress (ECOG), pain (VAS),<br />

depression(GDS), cognition (MMST, Clock completion) and nutrition<br />

(MNA)<br />

Results: From September 2009 until September 2011, 91 palliative<br />

care patients (52 male, 39 female) with a mean age of 72,4, were<br />

admitted into the new service, with a return rate of 1,6. 58 were able to<br />

return to a self-determined life.The mean stay was 12,4 days.Approx.<br />

91 % of the admissions were due to a cancer (lung 20,9%, abdominal<br />

17,3%, prostate 12,7%, 41 % various cancer varieties), 5,4 % were<br />

due to cardiovascular diseases and 2,7 % due to end-stage dementia.<br />

The main symptoms that led to the admission were pain, nausea<br />

and cachexia. The mean Barthel score at admission was 50,2 and 52,1<br />

at discharge, the mean GDS was 6,79, the mean MMST 21,1 and the<br />

clock completion test 3,6, where as the nutrition was low with a MNA<br />

of 6,31<br />

Conclusions:Geriatric patients with an end-of life situation, especially<br />

those without a cancer, are in need of a multiprofessional<br />

geriatric team to address immobility and lack of self-sufficiency and<br />

the cognitive decline as well as the pain relief, symptom control and<br />

S232<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

nutrition. In this combination a temporal or permanent return to the<br />

home care setting and a self-determined life is feasible even in the<br />

oldest patients and the growing number of patients with cardiovascular<br />

diseases and dementia<br />

D135<br />

A Retrospective Case Control Study Comparing Actual Total Costs<br />

of Acute Care for Elders (ACE) Interdisciplinary Consult Team<br />

Patients with Matched Controls at the University of Wisconsin<br />

Hosptial and Clinic (UWHC).<br />

M. J. Siebers, 1,2 M. Brenny-Fitzpatrick, 3 A. Bhattacharya. 3 1. Division<br />

of <strong>Geriatrics</strong> and Gerontology, University of Wisconsin School of<br />

Medicine and Public Health, Madison, WI; 2. GRECC, Middleton VA<br />

Hosptial, Madison, WI; 3. University of Wisconsin Hosptial and<br />

Clinics, Madison, WI.<br />

The ACE interdisciplinary team has consulted on patients at the<br />

UWHC since 2006. The UWHC is a teriary care teaching hospital.<br />

The ACE consult team sees hospitalized patients over the age of 64<br />

years at the request of the attending physician on each ward service.<br />

The ACE team consists of a full-time advanced practice RN and a<br />

part-time team pharmactist, social worker, geriatrician and physical<br />

therapist. The geriatrician’s time is supported by billings from the<br />

ACE consult; other team members are supported by the UWHC. The<br />

ACE team consults on patients 5 days a week and meets weekdays to<br />

review each ACE consult patient both for the initial evaluation and<br />

follow-ups. The ACE program has seen 1807 ACE consult patients<br />

through June 2011. From the 1192 intial ACE team consults on<br />

unique patients, 382 ACE consult patients were matched with hospitalized<br />

control patients for age within 5 years, gender, severity of illness<br />

(3M APRDGR), primary DGR and year of hosptial stay. The<br />

cases and contols were compared by activity based accounting for actual<br />

total costs and length of stay (LOS). The average actual total cost<br />

for the hospital stay was $3,039 less for the patients seen by the ACE<br />

interdisciplinary consult team than it was for the matched controls (pvalue=0.006).<br />

The LOS was 0.13 days less for the ACE interdisciplinary<br />

consult patients compared to controls (NS). For the 1194 unique<br />

ACE consult patients seen, the ACE team consultation saved<br />

$3,622,488 in total actual costs since 2006 or $695,295.20 in cost reductions<br />

per year. The savings for the hospital was over $500,000 per<br />

year when the cost of the ACE interdisciplinary program (primarily<br />

the salaries of the professionals on the ACE team) was taken into account.<br />

The total actual cost savings for the ACE team consult is<br />

clearly not all related to reduction in the LOS. Medication changes<br />

for the ACE consults are the most common recommendation. They<br />

may account for some of the ACE interdisciplinary consult team’s reduction<br />

in total actual cost for each elderly patient seen in the hospital.<br />

We believe that geriartic care is improved at UWHC, not just<br />

money saved, by the ACE consult.<br />

D136<br />

Delirium Prevention Protocol Implementation in the Acute Care for<br />

the Elderly (ACE) Unit: Using a Culturally Competent Approach<br />

and Quality Improvement Tools.<br />

M. Dang, 1 S. Oakes, 1,2 I. Rohner. 2 1. School of Medicine, UTHSCSA,<br />

San Antonio, TX; 2. Acute Care of the Elderly (ACE) Unit, Christus<br />

Santa Rosa- City Centre, San Antonio, TX.<br />

Supported By: MSTAR, AFAR.<br />

Aim: To increase the utilization of the cognition and mobility<br />

components of the delirium prevention protocol to 90% in the next 3<br />

months at the ACE unit at Christus Santa Rosa City Centre by using<br />

a culturally competent approach.<br />

Background: Delirium is a major problem in hospitals. Prevention<br />

is a key component and using quality improvement tools and culturally<br />

competent approaches to prevent delirium enhances patient<br />

care. Interdisciplinary teams are vital in order to make sustainable<br />

changes towards patient safety. Due to the lack of attention in preventing<br />

delirium, especially in culturally Hispanic settings, this project<br />

focuses on engaging both English and Spanish speaking patients and<br />

their families.<br />

Methods: An inter-professional task force was formed at the<br />

ACE unit. Using quality improvement tools, pre and post intervention<br />

methods were as follows: a “fish bone” analysis was done to identify<br />

barriers in delirium prevention and observations on the staff’s<br />

cognition and mobility strategies were measured. After team analysis,<br />

a focus on education and family involvement were chosen for interventions<br />

consisting of nurse training sessions on utilization of the<br />

mini-cog exam. Furthermore, medical students were trained to do the<br />

CAM (confusion assessment method) on all admissions and bilingual<br />

white boards with the 6 areas of the prevention protocol to use as<br />

part of the hourly rounds were designed to educate patients and caregivers<br />

as well as bilingual brochures on delirium.<br />

Results: Compliance increased for the mobility protocol from<br />

0% to 80%. Engaging the patient/family in stimulating activities increased<br />

from 0% to 67%. Using the CAM to screen for delirium increased<br />

the least from 0% to 23%. Compliance in orienting the patient<br />

to date and/or location increased from 0% to 58% with the<br />

second highest increase and compliance in orienting the patient to<br />

person increased from 28% to 68%.<br />

Conclusions: The prevention protocol relies heavily on individuals<br />

rather than being inherent to the system, as seen in compliance to<br />

the CAM. Results also showed that families are more involved if the<br />

language barriers are addressed. Tools that are bilingual can facilitate<br />

care of the patient and standardization of educational tools for the<br />

student learners rotating in the ACE unit is vital.<br />

D137<br />

Prevalence and Correlates of Alcohol Use Among Older Taiwanese<br />

Adults: Analyses of the 2005 Taiwan National Health Interview<br />

Survey (NHIS).<br />

J. C. Lin, 1 A. A. Moore. 2,3 1. Internal Medicine, Cheng Ching Hospital,<br />

Taichung, Taiwan; 2. David Geffen School of Medicine, UCLA, Los<br />

Angeles, CA; 3. Integrated Substance Abuse Programs, UCLA, Los<br />

Angeles, CA.<br />

Background: Correlates of alcohol use have been examined extensively<br />

among younger adults and older adults; however, most studies<br />

have not included large samples of older Asian adults. This study<br />

evaluated the prevalence, socio-demographic, and health-related correlates<br />

of alcohol use among older Taiwanese adults using data from<br />

a national survey.<br />

Methods: Study sample included 2,727 individuals 65 years and<br />

older who participated in the 2005 NHIS, a cross-sectional survey of<br />

nationally representative household samples in Taiwan. Alcohol use<br />

was categorized into abstainers, infrequent drinkers (1-2 times per<br />

month), weekly drinkers (1-3 times per week), and daily drinkers.<br />

Due to small sample sizes, a category of frequent drinkers was created<br />

that combined weekly and daily drinkers for regression analyses.<br />

Multinominal logistic regression was performed to determine the<br />

socio-demographic and health-related correlates of the different categories<br />

of alcohol use.<br />

Results: Almost 80% of older Taiwanese adults were abstainers,<br />

10.2% were infrequent drinkers, 3.5% were weekly drinkers, and<br />

6.5% were daily drinkers. Individuals who were younger, male, those<br />

with good or better self-perceived health, and current smokers had<br />

increased odds of being drinkers. Individuals with more years of education<br />

had increased odds of being infrequent drinkers compared to<br />

those with lower education; however, this association was not observed<br />

among the frequent drinkers. Individuals who were former<br />

smokers or current betel nut users had increased odds of being frequent<br />

drinkers compared to abstainers.<br />

AGS 2012 ANNUAL MEETING<br />

S233


P OSTER<br />

A BSTRACTS<br />

Conclusions: There were similarities between the socio-demographic<br />

and health-related correlates of alcohol use among older Taiwanese<br />

adults and older adults from other ethnicities. Former or current<br />

use of other substances was also associated with more frequent<br />

alcohol use. Future studies should evaluate whether the effect of alcohol<br />

use on health-related outcomes among older Asian adults<br />

would differ from older adults of other ethnicities.<br />

D138<br />

Quality of Hospice Care for Patients with Dementia.<br />

J. Albrecht, 1 J. C. McGregor, 2,3 E. K. Fromme, 3 D. S. Lee, 2,3<br />

J. P. Furuno. 2,3 1. University of Maryland, Baltimore, MD; 2. Oregon<br />

State Univeristy, Portland, OR; 3. Oregon Health & ScienceUniveristy,<br />

Portland, OR.<br />

Background: Patients with dementia comprise an increasing<br />

percentage of hospice recipients; yet research on the quality of hospice<br />

care for patients with dementia is lacking. We used data from the<br />

2007 National Hospice and Home Care Survey (NHHCS) to compare<br />

quality of care in dementia patients to all other hospice patients.<br />

Methods: The 2007 NHHCS is a nationally-representative sample<br />

of 4,733 U.S. hospice discharges. Data were collected through inperson<br />

interviews with agency directors and staff and patient medical<br />

records. A current primary diagnosis of dementia was defined as<br />

ICD-9 codes: 290.0, 290.42, 294.8, 294.9, 331.0, 331.11, 331.4, 331.82,<br />

and 331.9. Quality indicators were compared between patients with<br />

and without dementia. These include: transfer to hospice in the last 3<br />

days of life, tube feeding, depression, absence of an advanced directive<br />

or do not resuscitate (DNR) order, stage II or greater pressure<br />

ulcers, use of emergent care, antibiotic receipt, continuity of residence<br />

and pain reported at last assessment. All estimates were weighted to<br />

account for the survey’s complex sampling design. Chi-square and<br />

Student’s t-tests were used for comparisons, and statistical significance<br />

was defined as p


P OSTER<br />

A BSTRACTS<br />

physicians. Implementation of strategies to improve recognition of<br />

cognitive impairment may improve care of these patients, particularly<br />

at the time of hospital discharge.<br />

D141<br />

Arizona Alzheimer’s Registry: Strategy and Outcomes.<br />

K. T. Saunders, 1 C. Holt, 2 J. B. Langbaum, 2 W. Chen, 2 N. High, 2<br />

C. Langlois, 2 M. Sabbagh, 3 P. N. Tariot. 2 1. College of Medicine,<br />

University of Arizona, Phoenix, AZ; 2. Banner Alzheimer’s Institute,<br />

Phoenix, AZ; 3. Banner Sun Health Research Institute, Sun City, AZ.<br />

Supported By: NIA ADCC P30 AG19610, State of Arizona<br />

Medical Student Training in Aging Research (MSTAR) Program<br />

Background: The Arizona Alzheimer’s Consortium (AAC) is a<br />

statewide Alzheimer’s disease (AD) research consortium funded by<br />

NIA and the state of Arizona. In 2007 the AAC created a screening<br />

and referral process for people interested in participating in AD related<br />

research, as well as a relational database called the Arizona<br />

Alzheimer’s Registry (AAR). The goals of the AAR were to increase<br />

awareness of AD research and accelerate enrollment into AAC clinical<br />

research projects. The AAR matched Registrants to AAC research<br />

according to interest, location, and eligibility.<br />

Methods: Enrollment was by open invitation to volunteers age<br />

50 and older. Registrants were recruited by community outreach,<br />

mass mailings, earned and paid media, and the Internet. Those interested<br />

received a welcome packet, consent, and questionnaire, which<br />

were reviewed by trained staff via telephone prior to brief cognitive<br />

screening. Evaluation of medical history, cognitive status, and interests<br />

resulted in the Registrant being referred to existing AAC studies<br />

or being held for future referral.<br />

Results: 2263 people contacted the AAR; all but 231 were given<br />

a welcome packet. 1257 consented and 1182 underwent an initial cognitive<br />

screening. Earned media was the most effective recruitment<br />

strategy. Participants had a mean age of 68.1 (SD 10.6), 97% were<br />

Caucasian, had 15.2 (SD 2.7) mean years of education, and 60% were<br />

female. 30% reported a family history of dementia, 20% reported a<br />

diagnosis of cognitive impairment or dementia, and 70% subjectively<br />

reported normal cognition. The initial telephone assessment revealed<br />

681 with no impairment, 269 with possible cognitive impairment, and<br />

234 with possible dementia. 301 were referred to AAC sites.<br />

Conclusion: The AAR exceeded its goals of increasing awareness,<br />

Registry recruitment and research referral. This model was well<br />

received by the community and served as a mechanism for volunteers<br />

to explore their own cognitive status while making a contribution to<br />

the scientific community. The established infrastructure and experiences<br />

gained from the AAR will serve as the prototype for the webbased<br />

Alzheimer’s Prevention Registry, a national registry focusing<br />

on AD prevention research.<br />

D142<br />

Prevalence of Disruptive Behaviors Among PACE Participants.<br />

K. Kwak, 1 M.Trahan, 2 M. McNabney. 2 1. Stony Brook University<br />

School of Medicine, Stony Brook, NY; 2. Division of Geriatric<br />

Medicine and Gerontology, Johns Hopkins University, Baltimore, MD.<br />

Supported By: Johns Hopkins University; MSTAR Program<br />

Background: Disruptive behaviors occur in approximately 63%<br />

of adult day center participants. The Program for the All-inclusive<br />

Care of the Elderly (PACE) is a capitated and comprehensive service<br />

delivery system for older adults. PACE participants attend an adult<br />

day center where all care is coordinated and provided in order for<br />

participants to continue living in the community. The rate of disruptive<br />

behaviors among a PACE population is unknown.<br />

Objective: To study the frequency and type of disruptive behaviors<br />

typically displayed among PACE participants.<br />

Methods: This study took place at one PACE location in Maryland.<br />

To measure disruptive behaviors in PACE participants, we used<br />

the Cohen-Mansfield Agitation Inventory-Community (CMAI-C),<br />

consisting of 36 agitation items.<br />

Results: One hundred forty-two PACE participants (79% female)<br />

were included in the study. Dementia was present in 67<br />

(47%) participants. Among all the participants attending the PACE<br />

day center, 35.9% (45% with dementia and 28% without dementia)<br />

displayed at least one disruptive behavior once a week. The<br />

most frequently rated disruptive behavior was verbally non-aggressive<br />

behaviors (e.g., constant, unwarranted requests for attention,<br />

restless).<br />

Conclusions: PACE dementia participants display less disruptive<br />

behavior than seniors attending traditional day centers and residents<br />

living in nursing homes. From a psychosocial perspective, these<br />

results suggest that PACE might be better equipped to meet the physical,<br />

emotion, or social needs of participants when compared to traditional<br />

models of care.<br />

D143<br />

Guideline quandary in VTE prophylaxis management in elective<br />

joint replacement.<br />

J. Prager. <strong>Geriatrics</strong>, Mount Sinai Hospital, New York, NY.<br />

Introduction:<br />

Managing VTE prophylaxis from an evidence based approach,<br />

guidelines have been created from within both the <strong>American</strong> College<br />

of Chest Physicians (ACCP) and the <strong>American</strong> Academy of Orthopedic<br />

Surgeons (AAOS). Elective joint replacement epitomizes multidisciplinary<br />

care between orthopedics and internists to manage VTE prophylaxis<br />

concurrently while following conflicting recommendations.<br />

Case:<br />

An 85 year old female with a history of osteoarthritis presented<br />

to a tertiary care center for a scheduled left total hip arthroplasty for<br />

worsening symptoms of osteoarthritis. Patient was admitted to the orthopedic<br />

service. Post-operative day 0, patient was started on aspirin<br />

325mg BID for 35 days for VTE prophylaxis. On post-operative day<br />

9, patient’s hemoglobin had steadily decreased to 8.3 g/dl from a<br />

baseline of 12.7 g/dl. Patient was transfused 1 unit of packed red<br />

blood cells. Patient was discharged home with instructions to follow<br />

up with primary physician. Prior to patient’s appointment, patient<br />

called the primary physician’s office on a Saturday reaching the on<br />

call provider describing asymmetric leg swelling of post-operative<br />

leg. The on-call physician recommended for the patient to go to emergency<br />

room for evaluation for VTE, which was negative on ultrasound.<br />

Discussion:<br />

The ACCP recently updated VTE prophylaxis in 2008 categorizing<br />

elective joint replacement as a high risk procedure necessitating<br />

low molecular weight heparin i.e. enoxaparin, fondaparinux, or warfarin<br />

with an INR goal of 2.5. ACCP recommends against aspirin as<br />

VTE prophylaxis for elective joint replacement. Orthopedic concerns<br />

rest heavily on the underestimation of bleeding complications with<br />

evidence showing a 9% bleeding risk with 10 day course of ACCP<br />

recommended VTE prophylaxis coupled with 4.7% readmission rate<br />

in a study of 290 patients. AAOS recommendations are founded on<br />

evaluating patient’s risk of VTE combined with risk of bleeding. Aspirin<br />

remains as a treatment despite randomized controlled trials<br />

demonstrating superiority of low molecular weight heparin in secondary<br />

outcomes. Who should manage VTE prophylaxis? The longstanding<br />

internist or the current orthopedic surgeon? With the advent<br />

of newer agents i.e. rivaroxaban, the interest of patient safety is paramount<br />

to arrive at a unifying management protocol to decrease VTE<br />

post elective joint replacement while minimizing peri-operative<br />

bleeding.<br />

AGS 2012 ANNUAL MEETING<br />

S235


P OSTER<br />

A BSTRACTS<br />

D144<br />

The Use of 308nm Excimer Laser as an Effective and Safe<br />

Treatment for Psoriasis in the Geriatric Population.<br />

J. W. Wong, 1,2 J. Koo. 2 1. University of Utah School of Medicine, San<br />

Francisco, CA; 2. Dermatology, University of California San<br />

Francisco, San Francisco, CA.<br />

Supported By: Photomedex supports this research.<br />

Introduction: In dermatology, one of the most common and miserable<br />

skin conditions is psoriasis. Geriatric patients suffer from psoriasis<br />

with a greater proportion than any younger age group because<br />

psoriasis is a chronic disease. Psoriasis is one condition which tends to<br />

become more generalized and severe with age. The worst and most<br />

miserable type of psoriasis is generalized plaque psoriasis, which is almost<br />

uniformly treated with immunosuppressants such as methotrexate,<br />

cyclosporine, and biologic agents. However, geriatric patients are<br />

most at risk for lifelong systemic immunosuppression. Due to the risk<br />

of cancer, infection, heart disease, and other comorbidities, there is a<br />

great need to find a way to treat geriatric patients with generalized<br />

psoriasis that is not immunosuppressive and with less systemic risks.<br />

Excimer laser is an ideal treatment. It is more powerful than traditional<br />

UVB or PUVA phototherapy because it is a targeted treatment<br />

that only exposes thick psoriasis plaques to therapy and is not<br />

limited to side effects such as causing noninvolved skin to burn. Thus,<br />

more aggressive amount of energy can be delivered to the plaques.<br />

Our study has shown that the use of the 308nm excimer laser in combination<br />

with topical therapy achieves better therapeutic efficacy<br />

than any available biologic agents in half of the time with no possibility<br />

of systemic side effects. Methods: Moderate-to-severe psoriasis patients<br />

have been recruited for the study. 308 nm excimer laser is used<br />

twice weekly until reaching 75% or better improvement according to<br />

the psoriasis area and severity index (PASI 75) for a maximum of 12<br />

weeks. Patients are instructed to apply clobetasol spray twice daily<br />

for the first 4 weeks (Weeks 1-4), then calcitriol ointment for the next<br />

4 weeks (Weeks 5-8), and finally, both clobetasol spray and calcitriol<br />

ointment for the last 4 weeks (Weeks 9-12). Results: Of the 14 patients<br />

enrolled, 85% have achieved great improvement (PASI 75) in<br />

only 6 weeks as compared to etanercept, adalimumab, and ustekinumab<br />

where no more than 68% achieve PASI 75 in double the time<br />

(12 weeks). Conclusion: Our study shows promising results that geriatric<br />

patients with generalized psoriasis can be treated most conveniently<br />

with an external therapeutic modality with essentially no systemic<br />

side effects and no immunosuppression.<br />

D145<br />

Cardiac structure and function and renal insufficiency in the oldest old.<br />

J. Stessman, 1 Y. Maaravi, 1 J. M. Jacobs, 1 D. Leibowitz. 2 1. Institute for<br />

Aging Research, Department of <strong>Geriatrics</strong> and Rehabilitation,<br />

Hadassah-Hebrew University Medical Center, Jerusalem, Israel; 2.<br />

Heart Institute, Hadassah-Hebrew University Medical Center,<br />

Jerusalem, Israel.<br />

Background:<br />

People over the age of 85 are the world’s most rapidly growing<br />

age group and have a high incidence of both cardiovascular disease<br />

and chronic kidney disease (CKD). The relationship of abnormalities<br />

in cardiac structure and function and renal insufficiency in this age<br />

group is unclear. The objective of this study was to examine the association<br />

between renal function and cardiac structure and function in<br />

an age-homogenous, community-dwelling population of subjects<br />

born in 1920-1921.<br />

Methods:<br />

Subjects were recruited from the Jerusalem Longitudinal Cohort<br />

Study. Echocardiography was performed with a portable<br />

echocardiograph at the subjects place of residence. Standard<br />

echocardiographic assessment of cardiac structure and function was<br />

performed. Glomerular filtration rate (GFR) was assessed by the<br />

Cockroft-Gault formula with abnormal GFR defined as ≤ 60<br />

ml/min/1.73 m2.<br />

Results:<br />

310 subjects (146 males, 164 females) were enrolled in the study.<br />

There were no significant differences between subjects with normal<br />

and abnormal GFR in indices of cardiac structure. Ejection fraction<br />

(57.0 ± 10.4% vs. 54.4 ± 10.3%; p < 0.08) and indices of diastolic function<br />

(E:e’ 12.4 ± 5.0 vs. 12.3 ± 4.6; p = 0.89) were not significantly different<br />

between the two groups.<br />

Conclusions:<br />

Our study did not demonstrate an association between reduced<br />

GFR and echocardiographic indices of systolic and diastolic function<br />

in a community-dwelling population of the oldest old.<br />

D146<br />

Mass Houdini:The Case of the Disappearing Duodenal Mass.<br />

L. M. Thomas, A. Prakash, K. Ramasamy, J. Smith, H. Choudhry.<br />

Bayonne Medical Center, Bayonne, NJ.<br />

Case Presentation:This is a case of 72 year old female presenting<br />

to the ER with right upper quadrant abdominal pain radiating to the<br />

back and vomiting for the past 3 weeks.She had difficulty in tolerating<br />

food due to the vomiting.No history of diarrhea,fever,chills or urinary<br />

complaints.Her past history was significant for uterine cancer diagnosed<br />

15 years ago,treated with hysterectomy and brachytherapy,CAD<br />

s/p CABG and osteoarthritis for which she is on NSAIDS for the past<br />

10 years.Her physical examination was unremarkable.CBC,amylase,lipase<br />

and liver function tests were within normal limits.Her K(5.8)and<br />

creatinine(2.4)levels were elevated.CT abdomen showed diffuse,infiltrative<br />

mass encircling the duodenum,invading the pancreatic head and<br />

gallbladder.With a working diagnosis of adenocarcinoma arising from<br />

the duodenum,infiltrating the pancreas and gall bladder,a biopsy was<br />

done.Biopsy samples showed extensive chronic duodenitis with gastric<br />

heterotopias and gastric mucus cell metaplasia.With a benign result on<br />

biopsy,a diagnosis of penetrating duodenal ulcer was made.The patient<br />

was kept NPO and was started on TPN and IV PPIs.She responded<br />

well and was symptomatically better. After one week,she was started<br />

on a diet and was able to tolerate the intake.Repeat CT scan done two<br />

months later, showed complete resolution of the previously seen duodenal<br />

mass and she remains asymptomatic till now.Discussion:Peptic<br />

ulcer disease in the elderly can present as an intra abdominal mass simulating<br />

malignancy due to penetration of surrounding tissues leading to<br />

inflammation and adhesions.Studies show that even though the prevalence<br />

of active duodenitis is low in chronic NSAIDS users,local ulceration<br />

can take place and is dose dependent. Conclusion:This case illustrates<br />

that awareness of this uncommon complication of peptic gastro<br />

duodenal ulcer disease is helpful in the diagnosis of this benign lesion.<br />

An unnecessary invasive procedure and incorrect treatment strategy<br />

can be avoided by making a firm diagnosis with the help of biopsy.<br />

D147<br />

The effect of cholinesterase inhibitors on cardiovascular health.<br />

M. George, 1 G. Azhar, 1 A. Balamurugan, 2 J. Wei. 1 1. <strong>Geriatrics</strong>,<br />

University of Arkansas for Medical Sciences, Little Rock, AR; 2.<br />

Family and Preventive Medicine, University of Arkansas for Medical<br />

Sciences, Little Rock, AR.<br />

Background: Cholinesterase inhibitors (donepezil, rivastigmine,<br />

galantamine) are often prescribed to slow the progression of demen-<br />

S236<br />

AGS 2012 ANNUAL MEETING


P OSTER<br />

A BSTRACTS<br />

tia in geriatric patients, but they may be associated with cardiovascular<br />

side effects that increase morbidity. Currently, there are few specific<br />

criteria to assess the risks and benefits of cholinesterase inhibitors<br />

and there is insufficient data regarding monitoring for<br />

potential cardiovascular side effects.<br />

Methods: We sought to evaluate cardiovascular side effects such<br />

as bradycardia, syncope, near-syncope, dizziness or falls that might be<br />

associated with taking cholinesterase inhibitors. The electronic medical<br />

records (EMR) of all patients from the Reynolds Institute on<br />

Aging (RIOA) who completed a clinic visit during the period of August<br />

1, 2009 to October 31st 2009 and who were taking cholinesterase<br />

inhibitors were reviewed. The medical history of these patients before<br />

and after initiation of cholinesterase inhibitors was examined.<br />

Results: The EMR of 82 patients who were taking<br />

cholinesterase inhibitor were retrospectively reviewed. The mean age<br />

of patients was 81 years. The patients were predominantly female<br />

(73%) and were white (79%). Memory loss/disorder (59%) was the<br />

most common reason for initiation of cholinesterase inhibitor, followed<br />

by Alzheimer’s disease (21%) and some form of dementia<br />

(17%). Four patients were deceased since the index clinic visit (5%).<br />

The common new cardiovascular symptoms reported after the initiation<br />

of cholinesterase inhibitor were: bradycardia – 9% (N=7); atrial<br />

fibrillation or arrhythmia – 5% (N=4); syncope or near syncope– 4%<br />

(N=3); sick sinus syndrome – 2.4% (N=2). Dizziness was reported in<br />

13 % of the patients (N=11). Falls were reported by 11% of the patients<br />

(N=9). Sinus bradycardia (15%) (N=12) was the most common<br />

new EKG finding, followed by bundle branch block (7%) (N=6) and<br />

atrial fibrillation (4%) (N=3).<br />

Conclusions: Cardiovascular side effects of cholinesterase inhibitors<br />

are common, morbid and under-appreciated. More studies<br />

are needed to better understand this problem. Monitoring for potential<br />

cardiovascular side effects of cholinesterase inhibitors will enhance<br />

compliance and maximize benefits in vulnerable older patients<br />

with cognitive impairment while preventing potentially devastating<br />

cardiovascular complications.<br />

D148<br />

Screening, Diagnosis, and Treatment of Osteoporosis in Patients<br />

with Dementia.<br />

L. J. Gleason, K. R. McCormick, J. Frankel, S. M. Friedman.<br />

Department of Medicine, University of Rochester, Highland Hospital,<br />

Rochester, NY.<br />

Background: Older adults with dementia are at higher risk for<br />

fractures than cognitively intact individuals and some studies have<br />

shown that these patients are less frequently screened and receive<br />

fewer treatments for osteoporosis.<br />

Objective: To examine rates of screening, diagnosis, and treatment<br />

of osteoporosis in older adults with and without dementia at an<br />

academic outpatient geriatric clinic.<br />

Methods: We performed a retrospective chart review of 440 patients<br />

ages ≥ 65 who entered into the Geriatric and Medicine Associate<br />

Practice (GAMA) between January 2000 and December 2007.<br />

Baseline characteristics were recorded including age, gender, body<br />

mass index (BMI), self-reported health status, and activities of daily<br />

living (ADLs). Patients with dementia were compared to those without<br />

cognitive impairment, with respect to the screening, diagnosis,<br />

and treatment of osteoporosis.<br />

Results: Of the 440 patients included in the study, the average<br />

age was 78.9 years old, 304 (69%) were women, 89% of patients were<br />

able to complete 5/5 ADLs, and 53 (12%) were diagnosed with dementia.<br />

We found that only 53 patients (12%) had a recorded DEXA<br />

scan within six months of enrollment in the clinic, and those with dementia<br />

were less likely to have had a DEXA scan (11.3% vs. 25.3%,<br />

p


P OSTER<br />

A BSTRACTS<br />

Methods: Cross-sectional analysis of a subset of the Canadian<br />

Study of Health and Aging (1996 wave) that completed a diagnostic<br />

cognitive assessment. Non-cancer pain was measured<br />

using the 5-point verbal descriptor scale, dichotomized into<br />

“no/very mild” versus “moderate” or greater pain. Cognitive status<br />

was clinically assessed and categorized as NCI, cognitive impairment<br />

no dementia (CIND), Alzheimer’s Disease (AD), and<br />

vascular dementia (VaD). Multivariable logistic regression was<br />

utilized to analyze the relationship between pain report and cognitive<br />

diagnosis controlling for covariates (demographics, comorbidity,<br />

IADL’s, and depression).<br />

Results: 1,658 (96.7%) of participants that completed a diagnostic<br />

cognitive assessment had their cognitive status designated and a<br />

pain measure completed. Overall, the frequency of pain report varied<br />

with cognitive status among the four groups, (Chi-square 9.16,<br />

p=0.02). 34.7% (263/757) of persons with NCI reported moderate or<br />

greater pain, compared to 39.1% (223/570) CIND (p=0.11), 28.5%<br />

(73/256) AD (p=0.08), and 40% (26/65) VaD (p=0.42). In the fullyadjusted<br />

multivariate model, compared with persons with NCI, the<br />

odds of reporting moderate or higher pain was not significantly different<br />

among persons with CIND OR=0.86 (0.65,1.13; p=0.28), AD<br />

OR=0.68 (0.44,1.04; p=0.08), or VaD OR=0.80 (0.36,1.80; p=0.59).<br />

Conclusion: A noteworthy proportion of older adults with and<br />

without dementia report moderate or greater pain and did not vary<br />

with cognitive status. Given that dementia represents a consistent risk<br />

factor the under identification and undertreatment of pain, efforts to<br />

improve pain management in this vulnerable population remain a<br />

high priority for future research.<br />

D151<br />

Help seeking for incontinence by adults with heart failure.<br />

K. Lindeman, 1 Y. Li, 2 M. H. Palmer. 2 1. University of North Carolina<br />

School of Medicine, Chapel Hill, NC; 2. School of Nursing, University<br />

of North Carolina, Chapel Hill, NC.<br />

Supported By: Detrol Clinical Research Program, 2005-2007;<br />

MSTAR, 2011 <strong>American</strong> Federation for Aging Research<br />

Background: Urinary incontinence (UI) and heart failure (HF)<br />

are both prevalent conditions that have significant impact on quality<br />

of life, but little information is available about HF patients seeking<br />

help for urinary incontinence. The objective of this study is to identify<br />

patient factors associated with help-seeking for UI in HF patients.<br />

Methods: This study is a secondary analysis of cross-sectional<br />

data collected between 2005 and 2007 in a 22 bed hospital unit and 2<br />

out-patient clinics for HF. Two hundred ninety six men and women<br />

that were 20 years or older with HF diagnosis participated in the original<br />

81-item survey. UI help-seeking was defined as an affirmative response<br />

to a single item on reporting UI to a doctor or nurse. Incontinence<br />

Impact Questionnaire-7 (IIQ-7) and the Urogenital Distress<br />

Inventory-6 (UDI-6) were used to assess level of impact of UI on<br />

quality of life.<br />

Results: 134 (45%) participants (median age 62 years; 45.5%<br />

male) had UI, 60 (44.8%) had at least two other urinary symptoms,<br />

and 45 (34%) sought help for UI. Bivariate analyses revealed that<br />

IIQ-7, UDI-6, presence of other urinary symptoms, and interaction<br />

between sex and age were significantly associated with help-seeking<br />

at p


P OSTER<br />

A BSTRACTS<br />

Results: For the first aim, time of day and mobility were significant<br />

predictors of positive affect displays;gender,age,and education were significant<br />

predictors of negative affect displays. The results of the second<br />

aim showed three distinctive trajectory groups for positive affect and<br />

two groups for negative affect. Positive affect comprised three groups: 1)<br />

a low stable group; 2) a fluctuating group displaying afternoon peaking;<br />

and 3) a fluctuating group displaying morning peaking. Negative affect<br />

included two groups: 1) a low stable group; and 2) a fluctuating group.<br />

Conclusions: The present study showed that people with dementia<br />

showed not only a considerable range of affect displays but also significant<br />

within-person variation in positive and negative affects.Therefore,<br />

a tailored intervention considering variations of affect display may<br />

be required to improve emotional well-being of people with dementia.<br />

D154<br />

Stress in Adult Children Caring for Older Parents with Dementia: A<br />

Pilot Study.<br />

L. M. Solberg, 1 L. B. Solberg, 2 E. N. Peterson. 1 1. Internal Medicine,<br />

Vanderbilt University, Nashville, TN; 2. Office of Research, Meharry<br />

Medical College, Nashville, TN.<br />

Supported By: Robert E. Wise M.D. Research & Education<br />

Institute, Lahey Clinic, Burlington, MA<br />

Background: Adults caring for parents and their own children<br />

are the “sandwich generation”. Their stress is noted in the behavioral<br />

sciences, but largely absent in medical literature. Clinical experiences<br />

showed adult children accompanying parents with dementia on clinic<br />

visits verbalized distress. The objective of this IRB-approved descriptive<br />

survey was to determine among a convenience sample of adult<br />

children caring for their parent with dementia the prevalence and<br />

severity of emotional and social changes and financial burden since<br />

assuming caregiver role.<br />

Methods: The study took place at a geriatric private practice.<br />

Adult children caregivers completed a 51-item survey (Cronbach’s<br />

alpha .80) on impact of the caregiving role on emotion, stress, and finances<br />

and coping mechanisms. Of those surveyed 85/95(89%) were<br />

returned. 45/85(47%) respondents were primary caregivers of demented<br />

elderly parents and 18/45(47%) were of the “sandwich generation.”<br />

Descriptive statistics were conducted using SPSS.<br />

Results: On average caregivers were 54 years old, 36/45(80%)<br />

women, 28/45(62%) were married, 38/45(84%) had children,<br />

18/45(47%) were “sandwich generation.” There was no significant difference<br />

in mean caregiver burden between the sandwich generation and<br />

non-sandwich generation adult children. Caregivers reported little impact<br />

on their professional lives. Over a third reported stress in caring for<br />

the older adults’ daily needs, felt more irritable, and more feelings of<br />

anxiety. 53% reported taking their parent to doctors’ appointments was<br />

emotionally difficult. Participating in activities of interest/hobbies decreased,<br />

but not time spent with friends. Helpful services were seminars<br />

on care of demented parents (58%),meetings with social workers for resource<br />

availability (63%), and seminars on coping mechanisms (53%).<br />

Conclusions: Adult children caring for demented parents experienced<br />

stress, anxiety, and sadness. Caregivers’ emotions were negatively<br />

impacted but not their finances or careers. Emotional stress decreased<br />

activities of interests, but not social interactions. Clinicians<br />

need to direct attention to the caregivers’ emotional well being as<br />

part of routine care of the elderly. Helpful coping mechanisms were<br />

identified by the respondents. Further program development to support<br />

adult children caregivers may be beneficial.<br />

D155<br />

Driving Habits of Seniors Over 80 and the Perceptions of Their<br />

Relatives: When and How Should They Stop?<br />

M. Majid, 1 N. Arif, 1 M. Akerman, 2 C. Nouryan, 1 G. Wolf-Klein. 1 1.<br />

North Shore-LIJ Health System, New Hyde Park, NY; 2. Feinstein<br />

Institute for Medical Research, Manhasset, NY.<br />

INTRODUCTION: The safety of older drivers has become an<br />

increasing issue of concern in today’s environment. We surveyed drivers<br />

over 80 years old and family members to explore driving habits<br />

and comfort levels of both.<br />

METHODS: Surveys were distributed in a geriatric outpatient<br />

practice and subacute rehab facility to patients over the age of 80 who<br />

were still driving and who were accompanied by a family member.<br />

RESULTS: Of the 74 surveys completed, drivers were, on average,<br />

85.5 yo, male (57%), and college or graduate school educated<br />

(69%); 81% rated driving as important or essential. Half (49%) reported<br />

driving with passengers. Most (65%) drove at least 5 days a<br />

week, and on highways (81%), in rain (78%), at night (59%) or in<br />

snow (41%). A quarter (24%) admitted getting lost and 27% reported<br />

having a fall. When asked who they would rely on if they could<br />

no longer drive, 43% indicated children, 26% friends, 16% car service,<br />

and 14% spouse.<br />

When comparing surveys between octogenarian drivers and relatives,<br />

81% rated themselves as “good” or “excellent” drivers while<br />

relatives rated them significantly less (58%, p=0.0342). When asked if<br />

the subject should still be driving, 11% of drivers and 42% of relatives<br />

answered “no” or “not sure” (p=0.0027).<br />

When asked which medical conditions would force driving cessation,<br />

drivers had lower percentages than their relatives for all answers<br />

except visual loss as follows: worsening medical conditions<br />

(32% v 62% respectively, p=0.0104); hearing loss (14% v 32%,<br />

p=0.0531); mobility issues (35% v 54%, p=0.1016); and visual loss<br />

(59% v 59%, p=1.00). When asked whether “anyone ever recommended<br />

that you/they stop driving”, 13.5% of drivers and 23% of relatives<br />

answered “yes” to the question (p=0.3594). Drivers reported<br />

that recommendations to stop driving only came from children<br />

(100%), but their relatives reported that spouses (11%), children<br />

(67%) and friends (22%) had all advised in on the subject.<br />

CONCLUSION: In general, octogenarian drivers were rarely<br />

told to stop driving. They rated themselves as significantly better drivers<br />

than their relatives did, and seldom admitted that they should not<br />

be driving, despite their relatives’ opinion.<br />

D156<br />

Evidence for “accelerated aging” in older adults with disability?<br />

I. R. Molton, M. C. Goetz, M. Jensen, A. M. Verrall. Rehabilitation<br />

Medicine, University of Washington, Seattle, WA.<br />

Supported By: This project is supported by a grant from the<br />

Department of Education, NIDRR grant number H133B080024.<br />

BACKGROUND: Improvements in medical care have led to<br />

longer life-spans for people with disabilities acquired early in life.<br />

However, there is some evidence that these improvements in<br />

longevity are offset by increased rates of medical conditions, due to a<br />

more rapid decline of organ system functioning in persons with disability.<br />

This phenomenon has been called “accelerated aging.” However,<br />

the existence of this phenomenon has not been adequately established<br />

in large samples with adequate age-matched controls.<br />

METHODS: The present study assessed self-reported rates of<br />

certain medical conditions in a large national sample of people with<br />

either spinal cord injury (n=540), post-polio syndrome (446), muscular<br />

dystrophy (382) or multiple sclerosis (640), and compared them to<br />

normative data taken from the National Health Interview Survey<br />

(NHIS) of more than 21,000 adults. Health conditions assessed included<br />

hypertension, coronary artery disease, cancer, diabetes, pain<br />

conditions, and vision trouble. Comparisons were conducted in four<br />

age bands: 18-44, 45-65, 65-75, 75+. Chi-square and independent samples<br />

t-tests were used for all analyses.<br />

RESULTS:Participants in the experimental sample were primarily<br />

Caucasian (92%) and female (63.3%), with an average age of 54.5 years.<br />

Results suggested that, across age bands, individuals with disabilities reported<br />

greater rates of hypertension, arthritis, joint pain and difficulties<br />

with vision (all p values < 0.05). However, in more advanced age bands<br />

(65-75 and 75+), adults with disabilities also reported greater frequency<br />

of organ system diseases (diabetes, coronary artery disease, and cancer)<br />

than were present in age matched national norms (all p values < 0.01).<br />

AGS 2012 ANNUAL MEETING<br />

S239


P OSTER<br />

A BSTRACTS<br />

CONCLUSIONS: These results lend support to the idea of “accelerated<br />

aging” of organ systems in persons growing older with longstanding<br />

physical disabilities. Health care providers should be aware<br />

of the special medical needs associated with organ system decline in<br />

these individuals.<br />

D157<br />

Brain Grey Matter Volume of the Putamen and Clinical Correlates<br />

of Motor Skill in Walking.<br />

J. M. VanSwearingen, 1 S. Perera, 2 C. Rosano, 3 H. J. Azenstein, 4<br />

J. S. Brach, 1 S. A. Studenski. 2 1. Physical Therapy, University of<br />

Pittsburgh, Pittsburgh, PA; 2. Geriatric Medicine, University of<br />

Pittsburgh, Pittsburgh, PA; 3. Epidemiology, University of Pittsburgh,<br />

Pittsburgh, PA; 4. Psychiatry, University of Pittsburgh, Pittsburgh, PA.<br />

Supported By: Pittsburgh Older <strong>American</strong>’s Independence Center, 1<br />

P30 AG024827; K23 AG026766<br />

Background: Grey matter volume (GMV) of the whole brain<br />

and regions has been associated with age-related changes in gait and<br />

motor sequence learning. It is unclear if whole brain or regional<br />

GMV relates to motor skill of walking. We examined the relation of<br />

GMV in the putamen, involved in selection, timing and automaticity<br />

of well-learned motor sequences, with clinical correlates of motor<br />

skill in walking in older adults with mobility limitations.<br />

Methods: We used baseline data from a RCT of exercise interventions<br />

in older adults with slow gait who also completed structural<br />

brain imaging (n=41, mean age 76.7±5.6).Automatic labeling pathway<br />

method was used to determine total brain volume, whole brain GMV<br />

and GMV of the putamen and additional brain regions associated<br />

with age-related changes in gait from the structural MRI. The GMV<br />

in the additional regions was included to determine if a relation to the<br />

putamen was unique or generalized. Motor skill in walking (energy<br />

cost of walking, stance time variability [STV] and the Figure of 8 Walk<br />

[F8W] cadence) and gait speed were recorded in a different session.<br />

Partial correlations, controlling for age, gait speed and total brain volume<br />

(GMV+WMV+CSF) were used to determine the adjusted correlations<br />

(r) between brain GMV and motor skill in walking.<br />

Results: Controlling for age, gait speed and total brain volume,<br />

putamen GMV was related to all measures of motor skill in walking:<br />

energy cost of walking (r=-.33, p=.040), STV (r=.37, p=.020), and<br />

F8Wcadence (r=-.44, p=.005). Whole brain GMV was related only to<br />

F8W cadence (r=-.38, p=.016). The only other regions associated with<br />

motor skill in walking were the precentral region related to STV<br />

(r=.33, p=.029), and the hippocampus related to F8W cadence (r=-.33,<br />

p=.046).<br />

Conclusion: GMV in the putamen was associated with most clinical<br />

measures of motor skill in walking. Age-related changes in brain<br />

circuits for motor sequence task performance may be a central contributor<br />

to the timing and coordination difficulties in gait of older<br />

adults. The putamen may be an important brain region of interest in<br />

future studies to determine whether interventions that improve<br />

motor skill in walking also change the brain.<br />

D158<br />

Aging with Longstanding Physical Disability: A Focus Group Study.<br />

K. Yorkston, A. Verrall, K. L. Johnson. Rehabilitation Medicine,<br />

University of Washington, Seattle, WA.<br />

Supported By: This project was funded by a grant from the<br />

Department of Education, NIDRR grant number H133B080024.<br />

Background: People aging with longstanding physical disability<br />

must deal with competing trajectories. Physical function is declining<br />

while confidence in the ability to cope is improving. Social support is<br />

likely to decline with retirement & aging significant others while<br />

medical management is improving thus increasing life expectancy.<br />

Methods: Four focus groups were conducted soliciting advice for<br />

health care teams seeing patients aging with a longstanding disability.<br />

Participants included people with spinal cord injury (N = 7), postpolio<br />

syndrome (N = 7), multiple sclerosis (N = 5), and muscular dystrophy<br />

(N = 4). All were at least 45 years of age and living with their<br />

disability for at least 8 years. Focus groups transcripts were reviewed<br />

and coded using Atlas.ti and a framework of themes was developed.<br />

Results: Four major themes emerged which are described in<br />

Table 1.<br />

Conclusions: Health care providers should acknowledge the<br />

skills that people with longstanding disability bring to the task of prioritizing<br />

their goals and managing their condition. Healthcare<br />

providers can assist them in developing individualized self-management<br />

interventions that help to maintain function and independence<br />

as they age.<br />

Table 1. Focus Group Themes<br />

D159<br />

Motor Learning Ability in Walking Relates to Physical Function in<br />

Older Adults.<br />

M. Zaldana, 2 J. M. VanSwearingen, 1 S. A. Studenski, 2 J. S. Brach. 1 1.<br />

Physical Therapy, University of Pittsburgh, Pittsburgh, PA; 2.<br />

Geriatric Medicine, University of Pittsburgh, Pittsburgh, PA.<br />

Supported By: Research/Grant Support: Pittsburgh Older<br />

<strong>American</strong>’s Independence Center, 1 P30 AG024827; Pitt Clinical<br />

Research Training- <strong>Geriatrics</strong>/Gerontology T32 AG021885; K23<br />

AG026766<br />

Background: Motor learning is important in the recovery or<br />

adaptation of performance in daily life after age-related changes in<br />

neuromotor function. Backward walking is a motor task with a similar<br />

motor sequence and complexity as forward walking but less practiced<br />

(ie less skilled). We examined the relation of changes in gait<br />

variability, an indicator of motor skill learning, over repeated trials of<br />

backward walking to physical function in older adults.<br />

Methods: Community-dwelling older adults (77.1 years±6.1,<br />

n=67) independent in ambulation performed 4 repeated trials of<br />

straight path backward walking and usual walking over a computerized<br />

walkway. Mean backward and usual walking gait speed and<br />

mean gait variability (stance time standard deviation, STV) for the<br />

first two and last two trials of backward walking were calculated.<br />

Mean percent change in STV between the first and last two trials of<br />

backward walking represented motor learning ability. Physical function<br />

in daily life, the Late-Life Function and Disability Instrument<br />

overall functioning (LLFDI total) was recorded in the same session.<br />

A linear regression model was used to examine the contribution of<br />

motor learning in walking ability to physical function in daily life,<br />

controlling for age, usual gait speed and backward walking gait speed.<br />

Results: Motor learning ability in walking independently contributed<br />

to physical function, while controlling for age, usual and<br />

backward gait speed. The mean percent change in STV contributed<br />

(β=-.22, p=.03) to the variance in LLFDI total beyond age and usual<br />

gait speed (β=.53, p


P OSTER<br />

A BSTRACTS<br />

D160<br />

Outcome of Older Patients Undergoing Total Hip or Total Knee<br />

Arthroplasty.<br />

R. V. Samala, 1 J. O. Ciocon, 2 P. Patel, 3 D. Galindo, 2 J. Loquias. 2 1. The<br />

Harry R. Horvitz Center for Palliative Medicine, Cleveland Clinic,<br />

Cleveland, OH; 2. <strong>Geriatrics</strong>, Cleveland Clinic Florida, Weston, FL; 3.<br />

Orthopedics, Cleveland Clinic Florida, Weston, FL.<br />

Background: In spite of the proven benefits of total joint arthroplasty,<br />

doubts about pain relief, progression of ambulation, and maintenance<br />

or improvement of functional capacity pervade. The present<br />

study aimed to determine the outcome of older patients undergoing<br />

primary elective total hip (THA) or total knee arthroplasty (TKA)<br />

for osteoarthritis<br />

Methods: A cross-sectional study was done at Cleveland Clinic<br />

Florida which included adults 65 years and older who underwent<br />

THA or TKA between July 1, 2010 and February 28, 2011. Patients<br />

with other inflammatory joint diseases, acute fracture, or revision surgery<br />

were excluded. Medical records were reviewed and telephone<br />

interviews were conducted at 6 and 12 weeks post-surgery. Outcome<br />

measures were pain level, living condition, ambulation status, and<br />

functional status.<br />

Results: Fifty three participants completed the study; mean age<br />

was 73 years, 49% were female, and 43% had THA. There were significantly<br />

more patients who were pain-free, neither bound to wheelchair<br />

nor bed, and independently functional at home by 12 weeks.<br />

There were significantly more THA patients who ambulated independently<br />

than those who required an aid (p


P OSTER<br />

A BSTRACTS<br />

Aggressive treatment of many cancers includes surgical interventions,<br />

with accompanying risks of morbidity and mortality. There is<br />

substantial heterogeneity in older adults’ functional reserve and ability<br />

to tolerate and recover from major physiological stressors. Geriatric<br />

assessment has developed in the gerontology literature as an important<br />

prognostic tool to risk-stratify community-dwelling older<br />

adults. These principles have been explored with the goal of identifying<br />

patient-level risk factors for adverse surgical outcomes. In this review,<br />

we examined the utility of components of a Comprehensive<br />

Geriatric Assessment (CGA) as predictors of adverse outcomes<br />

among older patients undergoing major surgery.<br />

Methods: Medline, EMBASE, and the Cochrane Library were<br />

searched for prospective studies examining components of CGA<br />

among geriatric patients undergoing elective surgery. Outcome parameters<br />

included 30 day postoperative complications and mortality,<br />

and discharge to a non-home care institution. Within and across the<br />

studies, we evaluated which CGA components were associated with<br />

the outcome(s) of interest.<br />

Results: The initial search identified 125 potentially relevant articles,<br />

of which ten articles based on seven studies met criteria for<br />

evaluation. Across the studies, chronological age was consistently<br />

found not to be an independent predictor of poor outcomes. Dependencies<br />

in ADLs and cognitive impairment were associated with increased<br />

incidence of complications and mortality. Impairment in<br />

IADLs was also associated with discharge to non-home care institutions<br />

in two studies.<br />

Conclusions: Across a diversity of surgical settings and patient<br />

populations, the results of these studies support an association between<br />

poor functional status and adverse geriatric surgical outcomes.<br />

These consistent results argue for inclusion of focused geriatric assessment<br />

as part of routine presurgical care in older adults. In addition,<br />

the development of targeted interventions for vulnerable individuals<br />

so identified may provide innovative means of mitigating the<br />

risk of major surgical interventions for this increasing proportion of<br />

the population.<br />

D164 Encore Presentation<br />

A Pooled Analysis of Surgical Complications: Results from the<br />

RECORD Program.<br />

M. R. Lassen, 1 M. Gent, 2 A. K. Kakkar, 3,4 B. I. Eriksson, 5<br />

S. D. Berkowitz, 6 A. Turpie. 2 1. Glostrup Hospital, Glostrup,<br />

Denmark; 2. McMaster University, Hamilton, ON, Canada; 3.<br />

Thrombosis Research Institute, London, United Kingdom; 4.<br />

University College London, London, United Kingdom; 5. Sahlgrenska<br />

University Hospital, Mölndal, Sweden; 6. Bayer HealthCare<br />

Pharmaceuticals, Montville, NJ.<br />

Supported By: This research was funded by Bayer HealthCare<br />

Pharmaceuticals Inc. and Janssen Research and Development, LLC.<br />

Background: Surgical complications after total hip or total knee<br />

arthroplasty (THA or TKA) are a primary concern for surgeons and<br />

can increase the cost and length of hospitalization, re-admission rates,<br />

and incur additional surgeries. Such complications include a wide<br />

range of conditions including bleeding, infection, and hemarthrosis.<br />

The phase III RECORD program investigated the oral, direct Factor<br />

Xa inhibitor rivaroxaban for the prevention of venous thromboembolism<br />

after THA (RECORD1, 2) or TKA (RECORD3, 4). The<br />

focus of this analysis from the pooled data from the four RECORD<br />

studies was to investigate whether rivaroxaban regimens are similar<br />

to enoxaparin regimens in the incidence of surgical complications<br />

after THA and TKA.<br />

Methods: Patients (N=12,729) were randomized to receive rivaroxaban<br />

10 mg once daily for 35±4 days or enoxaparin 40 mg once<br />

daily for 35±4 days (RECORD1) or 12±2 days followed by placebo<br />

(RECORD2). In RECORD3 and 4 patients received prophylaxis for<br />

12±2 days with rivaroxaban 10 mg once daily or enoxaparin 40 mg<br />

once daily (RECORD3) or enoxaparin 30 mg twice daily<br />

(RECORD4). Surgical safety outcomes were analyzed in the safety<br />

population over the total treatment duration pool.<br />

Results: The incidence of serious adverse events related to surgery,<br />

such as post-procedural infection, operative hemorrhage, wound<br />

dehiscence, postoperative wound infection, incision site hemorrhage,<br />

and hemarthrosis, was similar in the rivaroxaban (30/6,183: 0.49%)<br />

and enoxaparin (35/6,200: 0.56%) groups.<br />

Conclusions: These data suggest that surgical safety outcomes<br />

are unlikely to differ between rivaroxaban and enoxaparin<br />

regimens.<br />

S242<br />

AGS 2012 ANNUAL MEETING


A UTHOR<br />

Abadir, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B55, B61<br />

Abarca-Gomez, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C39<br />

Abbott, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B122<br />

Abbott, R D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B124, C53<br />

Abdo, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C148<br />

Abi Rafeh, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C148<br />

Abraham, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A125<br />

Abrams, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P39<br />

Abreu Lanfranco, O E . . . . . . . . . . . . . . . . . . . . . . . . . . . .A48*<br />

Abreu-Lanfrranco, O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B35<br />

Acquista, D A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C63<br />

Adachi, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A51<br />

Adelman, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P36<br />

Adelman, R D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D41, D116<br />

Adeniye, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C147*<br />

Adepoju, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C49<br />

Ador-Dionisio, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C147<br />

Africa, B L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A3*, A4*<br />

Agarwal, S J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A163*<br />

Agbor-Bawa, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A100<br />

Agnew, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B25*<br />

Aguilar, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D90<br />

Aguirre, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D106, D107<br />

Ahalt, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C105<br />

Ahl, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C36<br />

Ahmad, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A63*<br />

Ahmed, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C82*<br />

Ahmed, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A117<br />

Ahmed, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B77<br />

Ahsan, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B68<br />

Aizenstein, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B163<br />

Ajmal, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C112<br />

Akerman, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D86, D155<br />

Akintan, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A28<br />

Akintan, A I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C5*<br />

Al-Mallah, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A161<br />

Alagiakrishnan, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D10*<br />

Alamo, J G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D17<br />

Albaba, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B23*, B24*<br />

Albiol Tomàs, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C164, D40<br />

Albornoz, M F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D128<br />

Albrecht, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D138*<br />

Alessi, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B89, B158<br />

Alexandra, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A51<br />

Algase, D L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D153<br />

Ali, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C148*<br />

Alirhayim, Z . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A161<br />

Allegre, A A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A62<br />

Allen, C M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C142*<br />

Allen, K R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D104*<br />

Allman, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B127<br />

Allman, R M . . . . . . . . . . . . . . . . . . . . . . . . . . .A50*, B92, P13<br />

Almeida, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B148*<br />

Almeida, L M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C50<br />

Alston, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A37, C41<br />

Alweis, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A17<br />

Alwine, L K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A34<br />

Amdur, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A95<br />

Aminbakhsh, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A104*<br />

Amjad, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B52*<br />

I NDEX<br />

Ammann, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B58*<br />

Amrhein, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D103<br />

Amtmann, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C158*<br />

Amuan, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A45<br />

Anand, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B12, C3<br />

Anderson, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C45<br />

Anderson, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D54, D63<br />

Anderson, K J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D119*<br />

Anderson, R A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C74<br />

Anderson-Malico, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C58<br />

Andrade, L C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D17*<br />

Andresen, E M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P32<br />

Andrew, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B149, D150<br />

Ang, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A15, A32*<br />

Angeles, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A3, A8, B16<br />

Anger, J T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B80<br />

Ankuda, C K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B50*<br />

Annweiler, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C141*, D88<br />

Anthony, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D63<br />

Antony, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C76<br />

Appa, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C33<br />

Arabelo, H . . . . . . . . . . . . . . . . . . . . . . . . . . . .A3, A4, A8, C16<br />

Arabelo, H A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B16<br />

Arai, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C42<br />

Arakawa, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A94*<br />

Araujo, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A49<br />

Araw, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D129<br />

Araw, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D129*<br />

Archbald-Pannone, L . . . . . . . . . . . . . . . . . . . . . . . . . . . .B137*<br />

Ard, K L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A96<br />

Arenson, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A84, C76*<br />

Argento, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A101<br />

Arif, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C130, D155<br />

Arling, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B110<br />

Arnold, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D115*<br />

Aronson, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P39<br />

Arora, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A6<br />

Arora, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A19*, C13<br />

Arshad, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B16*<br />

Arya, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P25<br />

Ashraf, M S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A146*<br />

Ashton-Miller, J A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D80<br />

Asik, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A141<br />

Aslam, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B21*<br />

Asnis, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D18<br />

Assal, M F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A25<br />

Asthana, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C117<br />

Atkinson, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A72<br />

Atkinson, H H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D61<br />

Atreya, A R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C13*<br />

Atwood, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A138<br />

Aubry-Rozier, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D149<br />

Audi Ferrer, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C164<br />

Auerbach, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P37<br />

Aung, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B38*, D85*<br />

Aung, Z . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A104<br />

Austin, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A80<br />

Avelino-Silva, T J . . . . . . . . . . . . . . . . . . . . .A54*, A55*, A81*<br />

Awasthi, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C3<br />

Azenstein, H J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D157<br />

*Indicates presenting author<br />

AGS 2012 ANNUAL MEETING<br />

S243


A UTHOR<br />

I NDEX<br />

Azhar, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D147<br />

Aziz, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C12, C25*, D24<br />

Bachuwa, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A148<br />

Bae, S Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A143*<br />

Bai, X . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B123<br />

Baiduc, B Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C16*<br />

Baillargeon, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D99<br />

Bakchine, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D27<br />

Baker, L D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />

Baker, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C65<br />

Balamurugan, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D147<br />

Ball, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A125<br />

Balzi, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B41<br />

Bangalore, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A52*<br />

Bangs, M E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C36<br />

Banks, W A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A131<br />

Bansal, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C120<br />

Bansal, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B13*, C125<br />

Barash, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C62<br />

Barchielli, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B41<br />

Barco, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B92*<br />

Barczi, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C117<br />

Barlow, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B30*<br />

Barnes, C A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C121<br />

Barnes, D E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A149<br />

Baron, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A75, A76, A79<br />

Barr, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B168<br />

Barre, L K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B37<br />

Barrett, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A64<br />

Barrick, A L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A38<br />

Barrientos-Calvo, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C39<br />

Bartels, S J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B37<br />

Bartha, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C141<br />

Bartolomé, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D106, D107<br />

Basic, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A116<br />

Basu, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C21*<br />

Bateman, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A38<br />

Batsis, J A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B37*<br />

Bauer, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B48<br />

Bauer, D C . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B49, B81, B109<br />

Baum, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D76<br />

Bautista, M K . . . . . . . . . . . . . . . . . . . . . . . . . . . .C12, C25, D24<br />

Bavendam, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C34<br />

Bayer-Carter, J L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />

Bea, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P31<br />

Beaman, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P14<br />

Beattie, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />

Beauchet, O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C141, D88<br />

Beben, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A25*<br />

Becker, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B131<br />

Becker, Y T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D162<br />

Bednarczyk, M . . . . . . . . . . . . . . . . . . . . . . .A5, A6, C18, D19*<br />

Beeber, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C119<br />

Beeber, A S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B113, B114<br />

Beizer, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D86<br />

Belal, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C3, D2<br />

Bell, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B122, B124, C53<br />

Bell, C L . . . . . . . . . . . . . . . . . . . . . . . . . . . .B68, B120*, B157*<br />

Belladonna, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />

*Indicates presenting author<br />

S244<br />

AGS 2012 ANNUAL MEETING<br />

Bellantoni, M R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D98*<br />

Bellantonio, S . . . . . . . . . . . . . . . . . . . .A1, A2, A15, B17, D16<br />

Bellelli, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D27<br />

Belleville, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C137<br />

Belza, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C111<br />

Benedict, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D76<br />

Benigno, D G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B8*<br />

Benizry, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A47<br />

Bennett, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B170<br />

Benoit, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D127<br />

Bentov, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P19<br />

Berg, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D11*<br />

Berger, A E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B139<br />

Berges, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C92<br />

Bergman, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />

Bergman, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A109<br />

Berkowitz, S D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D164<br />

Berlowitz, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B167<br />

Berman, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D41<br />

Bernick, J J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D34*<br />

Berry, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P33<br />

Berryman, S N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D67<br />

Berthoud, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D149<br />

Bertrand, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B113, B114<br />

Betz, M E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B145*, P6*<br />

Beyea, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B63*<br />

Beyth, R J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C12, C25, D24<br />

Bhagavan, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A1*, A2*<br />

Bhandari, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C120<br />

Bharel, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A90, A96<br />

Bhat, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C16<br />

Bhattacharya, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D135<br />

Bhattacharya, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A78<br />

Bhattacharya, S B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A78*<br />

Bickerstaff, K A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D120*<br />

Bickmore, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P9<br />

Biedron, C . . . . . . . . . . . . . . . . . .A43*, A44*, A48, B35, C101<br />

Bierrenbach, A L . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A54, A55<br />

Bilbruck, T J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D67<br />

Black, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />

Black, S E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D27<br />

Blackstone, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A121, C58<br />

Blake, R Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C165<br />

Blanchard, G P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A68, C81*<br />

Blaum, C . . . . . . . . . . . . . . . . . . . . . . . . . . . .B47, B78, B112, P8<br />

Blazey-Martin, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A96<br />

Bliwise, D L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B76<br />

Bloch, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A149<br />

Block, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D64<br />

Bocirnea, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C87*<br />

Boersma, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P15<br />

Boeve, B F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D92<br />

Bogaisky, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D43<br />

Boling, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A120, D95<br />

Bonavitacola, P J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A68*<br />

Bonner, L M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />

Bonsall, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B67<br />

Boockvar, K S . . . . . . . . . . . . . . . . . . . . . . . . . . . .A126, D103*<br />

Bookhart, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C54, C93<br />

Boonen, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D32


A UTHOR<br />

I NDEX<br />

Bopp, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B159, B164<br />

Borker, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A69*<br />

Borrie, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />

Borson, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A135, C158<br />

Boscardin, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B31<br />

Boscardin, W J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P1<br />

Bottone Jr, F G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C161*<br />

Boudreau, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B36<br />

Boudreau, R M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B109, P30<br />

Bouldin, E L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P32*<br />

Boustani, M A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A47, A88<br />

Bowers, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C103<br />

Bowling, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B127*<br />

Boxer, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P22*<br />

Boyd, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C104<br />

Brach, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B161, B163, B166<br />

Brach, J S . . .A158, B79, B156, B165, D157, D159, P24*, P30<br />

Bradley, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P25<br />

Bradley, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P12<br />

Bradley, S M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D78<br />

Brangman, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B13, C125<br />

Braun, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B157<br />

Braun, U . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A27, D83<br />

Bravo, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D75<br />

Braza, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D60<br />

Breeding, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D93<br />

Brennan, M . . . . . . . . . . . .A32, B14, B19, C21, C23, C28, D23<br />

Brennan, M J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A19, C13<br />

Brenny-Fitzpatrick, M . . . . . . . . . . . . . . . . . . . . . . . . . . . .D135<br />

Bresee, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B80<br />

Brett, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P37<br />

Bridges, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C117<br />

Briesacher, B A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C106<br />

Brignole, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A86<br />

Brimacombe, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C124<br />

Broce, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B138<br />

Brooks, D B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A82<br />

Brown, A F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A98<br />

Brown, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B92<br />

Brown, C J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P13*<br />

Brown, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D56, D60<br />

Brown, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P25<br />

Brown, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B121<br />

Brown, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B99*<br />

Brown, R T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A90*, A96*<br />

Brummel-Smith, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C65<br />

Brunker, C P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C109<br />

Brunson, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C45<br />

Brunton, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B146<br />

Bryan, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D109<br />

Buchbinder, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B27<br />

Bueno, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B152<br />

Bukata, S v . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A20<br />

Bula, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B84, C128, D48<br />

Burgio, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B132<br />

Burke, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C10*<br />

Burkett, J G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D95*<br />

Burleson, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A138<br />

Burnett, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B75, B93, D26*<br />

Burnham, C . . . . . . . . . . . . . . . . . . . . . . . .A68, C81, D73, D74<br />

Burns, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C89<br />

Burrows, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P37<br />

Bursztyn, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B134<br />

Burton, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D92<br />

Busby-Whitehead, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D66<br />

Bushan, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C63*<br />

Buslovich, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A123*<br />

Butler, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B151<br />

Byerly, L K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D63*<br />

Bylow, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P4<br />

Bynum, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B6<br />

Byszewski, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />

Cabral, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B167<br />

Cagle, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B98*<br />

Cal, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A117, D86<br />

Caldi, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />

Callaghan, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />

Callahan, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A99, B110<br />

Callahan, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A72, D61*<br />

Callister, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C139*<br />

Camargo, K R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C50<br />

Camera, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D128<br />

Campanova, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D18<br />

Campbell, K H . . . . . . . . . . . . . . . . . . . .B111*, D152*, D162*<br />

Campbell, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A47*, A88*<br />

Campbell, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A83<br />

Campusano, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C40<br />

Canaday, D H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B57<br />

Cao, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C1<br />

Cao, Q . . . . . . . . . . . . . . . . . . . . . . . . . .A80, B71*, B154*, C14<br />

Caprio, A . . . . . . . . . . . . . . . . . . . . . . . . . . .B20, B63, C41, D66<br />

Caprio, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B62, D12<br />

Caprio, T v . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A20<br />

Caprio, T V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A12<br />

Caputo, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D27<br />

Carbonell, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D106, D107<br />

Cardona, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B9*, C152*<br />

Carey, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D64<br />

Cariaga, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D117<br />

Carlini, A R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A162<br />

Carlson, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A63<br />

Carlson, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P12<br />

Carlucci, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D78<br />

Carnahan, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P31<br />

Carr, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B98<br />

Carrabba, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B41<br />

Carson, J L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B168<br />

Carthen, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A4<br />

Caruso, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P37<br />

Carvalho, A C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C44<br />

Caserotti, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P30<br />

Cassidy, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C101<br />

Castillo, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D106*, D107*<br />

Castillo, R C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A162<br />

Catuogno, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C34<br />

Cauley, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B48<br />

Cauley, J A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P31<br />

Cavallini, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />

Cefalu, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D90, D91<br />

*Indicates presenting author<br />

AGS 2012 ANNUAL MEETING<br />

S245


A UTHOR<br />

I NDEX<br />

Ceimo, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D75*<br />

Celeste, R K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C46<br />

Cha, S S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B23, B24, D92<br />

Chakka, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B4*, C8<br />

Chakka, A K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B64<br />

Chami, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A43, A44<br />

Chan, K C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C159<br />

Chan, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D132<br />

Chang, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B104<br />

Chang, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C27*<br />

Chang, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D19<br />

Chang, M T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D92*<br />

Chang, S S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B45*<br />

Chao, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B15, P37<br />

Chao, S H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D47<br />

Chaperon, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D120<br />

Charness, A L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D139<br />

Charvat, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A160<br />

Chataut, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A5*, A6*<br />

Chatterjee, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A89*<br />

Chatterjee, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B161<br />

Chau, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A104<br />

Chaudhari, S . . . . . . . . . . . . . . . . . . . . . .A9, B12, C24, D1, D2<br />

Chaudhry, A H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A92<br />

Chaudhry, S I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D140<br />

Chaudhuri, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C94<br />

Chauhan, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B104*<br />

Chaves, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B1, B2<br />

Chawla, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C56*<br />

Cheadle, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B139<br />

Checchi, J M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D38*<br />

Chelagiri, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D18*<br />

Chen, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C150*<br />

Chen, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C22*<br />

Chen, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B57<br />

Chen, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B132<br />

Chen, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B119<br />

Chen, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B122, C53<br />

Chen, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D141<br />

Chen, X . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A38<br />

Chen, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A127*<br />

Cheng, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P9<br />

Cheng, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D50*, D51*<br />

Cheng, H S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A93<br />

Cheng, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B61*<br />

Cheng, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C161<br />

Chenna, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A72*<br />

Cherr, G S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B146<br />

Cheung, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D100<br />

Cheung, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A98*<br />

Chew, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B167<br />

Chez, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A154<br />

Chi, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C108<br />

Chiao, Y A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B142<br />

Chikwe, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A164<br />

Chimienti, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D73<br />

Chippendale, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B26*<br />

Chittenden, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D64<br />

Cho, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A107<br />

Chodos, A H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C11*<br />

*Indicates presenting author<br />

S246<br />

AGS 2012 ANNUAL MEETING<br />

Chodosh, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B105<br />

Chohan, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D76*, D108*<br />

Chong, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C40<br />

Chong, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D132*<br />

Chongkrairatanakul, N . . . . . . . . . . . . . . . . . . . . . . . . . .A156*<br />

Chopra, T . . . . . . . . . . . . . . . . . . . . . . . . .A43, A44, A48, C101<br />

Choudhry, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D146<br />

Christianer, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D41*<br />

Christmas, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D112<br />

Chun, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D115<br />

Chung, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A107<br />

Cigolle, C . . . . . . . . . . . . . . . . . . . . . . . . . .B47, B78*, B112, P8<br />

Ciocon, J O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A14, D160*<br />

Civin, C I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B139<br />

Clark, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B51<br />

Clark, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B101, C58*, C89*<br />

Clark, E M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A70<br />

Clarrett, D M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B169*<br />

Cleinman, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P29*<br />

Clevenger, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A40*<br />

Clough-Gorr, K M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P3<br />

Cluff, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C132<br />

Cobbs, E L . . . . . . . . . . . . . . . . . . . . . . . .A112, A121, C58, C68<br />

Cobian, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D100<br />

Cocanour, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C45<br />

Cochran, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A146<br />

Cochrane, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A150, B44<br />

Coeli, C M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C50<br />

Cohen, C I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A39<br />

Cohen, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A38<br />

Coimbra, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D65<br />

Colburn, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D112<br />

Coll, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A26<br />

Collins, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C73, C76<br />

Colloborative, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D60<br />

Colloborrative, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D56<br />

Colon Cartagena, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B19*<br />

Colon-Emeric, C . . . . . . . . . . . . . . . . . . . . . . . .B28, C74*, P45<br />

Colon-Nieves, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C72<br />

Combest, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C98<br />

Comrie, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />

Conell-Price, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P1<br />

Conley, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B36<br />

Connor, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B105<br />

Constantine, S M . . . . . . . . . . . . . . . . . . . . . . . . . . . .A97*, C63<br />

Coon, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D75<br />

Cooper, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A73<br />

Cooper, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C132<br />

Corazzini, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C74<br />

Corbie-Smith, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A94<br />

Corcoran, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C64<br />

Cordts, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B117<br />

Cornejo, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A68<br />

Cornell, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B62*<br />

Cornely, O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C37<br />

Corrado, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A117, D129<br />

Corrigan, M V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C87<br />

Cotrell, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C79<br />

Counsell, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P14<br />

Counsell, S R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A84, P44


A UTHOR<br />

I NDEX<br />

Covinksy, K E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A105<br />

Covinsky, K . . . . . . . . . . . . . . . . . . . . . . . . . .B31, B98, D6, D44<br />

Cox-Vance, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D22<br />

Craft, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />

Crist, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B155<br />

Croft, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A164<br />

Crook, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C37<br />

Crosby, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C144<br />

Crowe, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A50<br />

Cruz, D M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C142<br />

Cruz, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A41<br />

Cruz, N M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B139*<br />

Cruz-Knight, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C67<br />

Cuadrado, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D106, D107<br />

Culley, D J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C144<br />

Cummings, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B154<br />

Cummings, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D27*<br />

Curb, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B120, B157<br />

Curb, J D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C53<br />

Curcio, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C38<br />

D’Agostino, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B128<br />

D’Amico, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C85<br />

D’Silva, K A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B136*<br />

D’Souza, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B118*<br />

Dahiya, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A30, A141*<br />

Dahm, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B136<br />

Dalal, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A140*<br />

Dalbey, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D34<br />

Dale, W . . . .A103, A110*, B3, B91, B111, B149, B150, B171,<br />

D150, D152, D162, P4<br />

Daly, J W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A25<br />

Damaraju, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C54, C93<br />

Damodarasamy, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P19<br />

Dang, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D136*<br />

Dang, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D100*<br />

Daniels, M J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P32<br />

Danve, A S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C3*<br />

Darvin, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D93<br />

Date, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D18<br />

Dave, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D18<br />

Davis, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P23<br />

Davis, B R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D36<br />

Davis, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D117<br />

Davis, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B157<br />

Davis, K L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A102, B153<br />

Dayanand, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D100<br />

De Beritto, T V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A136*<br />

De Marchi, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C46<br />

de Rekeneire, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B43*<br />

Deal, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A37, C41<br />

Deban, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A109<br />

Debonnaire, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C80<br />

DeCaria, J E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B82*<br />

DeCherrie, L V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D101<br />

Decker-Maruska, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D70<br />

Defillo Draiby, J . . . . . . . . . . . . . . . . . . . . . . . . . . .D57*, D82*<br />

DeGolia, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A69<br />

DeJesus, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A114*<br />

delCarmen, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A77<br />

Demiris, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C94<br />

Demons, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A72<br />

Demons, J L . . . . . . . . . . . . . . . . . . . . . . . . . . . .D30, D36*, P23<br />

Demontiero, O . . . . . . . . . . . . . . . . . . . . . . . .B140*, C129, P15<br />

Dennis, R a . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B164<br />

Dennis, R A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B159<br />

Denson, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D56, D60*, P35<br />

Denson, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D56<br />

Dentino, A N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C69*<br />

Desai, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D162<br />

Desai, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A105<br />

Deschodt, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D32*<br />

Dethmers, D L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A103<br />

Detroyer, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C80*<br />

Devarajan, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D63<br />

Dey, A B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A89, A157<br />

Di Bari, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B41*, C146<br />

Diamond, P M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D26<br />

Diaz de Cerio, M . . . . . . . . . . . . . . . . . . . . . . . . . . .D106, D107<br />

Dietrich, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D105<br />

DiGuiseppi, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P6<br />

Dillon, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A39<br />

Dimaano, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B85*<br />

Dinescu, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A112, C68*<br />

Ding, Q . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C1*<br />

Ding, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D132<br />

Diniz, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B1, B2<br />

Diniz, A R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C44*<br />

Diniz, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B1, B2<br />

Dlugacz, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A117, D86<br />

Dobbels, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C80<br />

Doberman, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B117<br />

Dobracki, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B73*<br />

Dodson, J A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D140*, P2*<br />

Dohrenwend, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C160<br />

Dolansky, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A160<br />

Donaghey, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D105<br />

Donahue, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D20<br />

Dong, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A73<br />

Dong, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B66<br />

Dong, X . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A111*<br />

Donohue, J M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B49, B109<br />

Donovan, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B22, C106<br />

Dorr, D A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C109*<br />

dos Santos, C M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C46*<br />

Dosa, D M . . . . . . . . . . . . . . . . . . . . . . . . .B34*, B121*, C110*<br />

Dowal, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B119<br />

Downs, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D27<br />

Drickamer, M . . . . . . . . . . . . . . . . . . . . . . .B65, D20, D57, D82<br />

Drost, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B69<br />

Dubbert, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B164<br />

DuBeau, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A64, A65, B5<br />

DuBeau, C E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C34*<br />

Dubin, L J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D125*<br />

Dubina, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B80*<br />

Duff, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C139<br />

Duggal, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A105<br />

DuMond, M E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D49*<br />

Dunbar, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C119*<br />

Duncan, C L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C140*<br />

*Indicates presenting author<br />

AGS 2012 ANNUAL MEETING<br />

S247


A UTHOR<br />

I NDEX<br />

Dunn, C M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A126<br />

Dunton, N E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P32<br />

Duque, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B140, C129, P15*<br />

Durst, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D48<br />

Duthie, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P35, P35<br />

Duthie, E H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D56, D60<br />

Dworkin, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D63<br />

Dyer, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A46, B75<br />

Dyer, C B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B93, D26<br />

Eaton, W W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C48<br />

Ebbert, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A78<br />

Echt, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P33*<br />

Eckmann, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A166<br />

Eckstrom, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C79*<br />

Edes, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A108*, B115, P10<br />

Edwards, D S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D5<br />

Efeovbokham, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D114<br />

Efeovbokhan, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A23<br />

Efeovbokhan, U T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A31<br />

Efoevobokhan, U T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C122<br />

Efron, D T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A162<br />

Egras, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C73<br />

Eisenhower, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C85*<br />

Eiss, B M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D41<br />

El Zammar, Z . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C125<br />

Elarabi, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D23*<br />

Ely, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A47<br />

Emmett, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A99<br />

Eng, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P40<br />

Eng, J A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A85, D113*, P3*<br />

Eng, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A78<br />

Engel, P A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A113*<br />

Engelberg, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B51<br />

Erickson, M A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A131<br />

Eriksson, B I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D164<br />

Erlichman, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C44<br />

Ernst, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B32*<br />

Ersek, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B149, D150<br />

Erslon, M G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A163<br />

Ertle, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D104<br />

Escamilla, A G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A43, A44<br />

Escarce, J J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A98<br />

Eskildsen, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B67*<br />

Espinal, C M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C17*, C122*<br />

Espino, D V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C47<br />

Espinoza, S . . . . . . . . . . . . . . . .A87, A119*, C96, D93*, D94*<br />

Esteban, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D128<br />

Evans, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D75<br />

Evans, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A122*<br />

Fabiny, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D73<br />

Fabrizio, C A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C138*<br />

Faigman, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C105<br />

Fain, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A125<br />

Fairfield, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C165<br />

Fan, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B72<br />

Fan, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B3, B91<br />

Farber, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A18, D124<br />

Farber, M O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A47<br />

*Indicates presenting author<br />

S248<br />

AGS 2012 ANNUAL MEETING<br />

Farias, L L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A81<br />

Farrell, T W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A82*, A83*<br />

Faselis, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A95<br />

Faulk, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A146<br />

Faurot, MPH, PA, K R . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A36<br />

Fedarko, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B59<br />

Federman, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P43<br />

Feiereisel, K B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D61<br />

Feldman, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C38<br />

Feldman, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B108<br />

Felice, F M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C61*<br />

Felix, M.D., A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A36<br />

Feng, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C143<br />

Feng, M A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D163*<br />

Feng, Z . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B121<br />

Fernandes, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A147*<br />

Fernandez, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B123<br />

Fernandez, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C66<br />

Fernández Aviles, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B152<br />

Ferrucci, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B99, P29, P30<br />

Finkelstein, E . . . . . . . . . . . . . . . . . . . . . . . . . . . .C113*, C126*<br />

Fischman, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A18<br />

Fiutem, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P22<br />

Flacker, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A124<br />

Flamaing, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D32<br />

Fleegle, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C73<br />

Fletcher, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A95<br />

Fogel, J F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C77<br />

Foley, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D62<br />

Foley, K T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P13<br />

Fong, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B124<br />

Fonseka, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D109*<br />

Ford, C R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D62<br />

Ford, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D53<br />

Forman, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A144, C151*<br />

Fortinsky, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B151<br />

Fosnight, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D104<br />

Fox, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B111, B146<br />

Fox, C S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B128<br />

Foy, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C106<br />

Fracchia, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B41<br />

Fraenkel, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P28<br />

Francini, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />

Franco, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C24*<br />

Franco, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P35<br />

Francois, S J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B165*<br />

Frankel, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B95, D148<br />

Fraser, S A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A109<br />

Freedman, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />

Frentzel, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C49<br />

Fried, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B52, B53, P2<br />

Friedman, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D122, D123<br />

Friedman, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C82<br />

Friedman, S M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A20, D148<br />

Friedman MD, MPH, AGSF, S M . . . . . . . . . . . . . . . . . . . .B95<br />

Frisoli, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B1*, B2*, C44<br />

Frölich, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D27<br />

Fromme, E K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D138<br />

Frontini, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D90<br />

Fuez, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P5


A UTHOR<br />

I NDEX<br />

Fujikami, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C91*<br />

Fukushima, F B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C50<br />

Fuller, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C126<br />

Fumagalli, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />

Fung, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B89<br />

Fung, C H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B158*<br />

Furman, C D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A22<br />

Furuakwa, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C42<br />

Furuno, J P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D138<br />

Gagnon, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B86<br />

Galecki, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B47<br />

Galicia-Castillo, M C . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B148<br />

Galindo, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D160<br />

Gallagher, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D73<br />

Gallego, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C51*, D39<br />

Galli, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B72<br />

Galvez, A M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B67<br />

Galvin, J E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A139<br />

Gammon, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D73<br />

Gan, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P41<br />

Ganem, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A54, A55<br />

Ganesan, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P41<br />

Gangavati, A S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C71*<br />

Ganz, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C127<br />

Ganz, D A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B106<br />

Gao, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C15*<br />

Gao, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A88<br />

Garcia, C H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C96*<br />

Garcia, N I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A59*<br />

García, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D106, D107<br />

García - Cárdenas, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C51<br />

García Navarro, J . . . . . . . . . . . . . . . . . . . . . . . . . . . .C164, D40<br />

García-Cardenas, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D39<br />

Gardner, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C123*<br />

Garfinkel, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C49<br />

Garner, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B164<br />

Garner, K K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B159<br />

Garrido, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B4<br />

Garrido, A I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C8*<br />

Gau, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A144, C151<br />

Gaubert-Dahan, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A33<br />

Ge, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C1<br />

Gehl, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D60<br />

Gelfman, L P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C66<br />

Genao, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B40*<br />

Gensini, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B41<br />

Gent, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D164<br />

George, L V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C32<br />

George, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D147*<br />

George, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C98<br />

Gerding, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C37*<br />

Gi, B H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A93<br />

Gil, L A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A54, A55, A81<br />

Gill, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B43<br />

Gill, T M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B45, P28<br />

Gilliam, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B20<br />

Gilligan, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A125<br />

Gilmore, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C103<br />

Giordano, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C76<br />

Giulietti, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />

Givens, J L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B50<br />

Gleason, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B132<br />

Gleason, L J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D148*<br />

Gleich, G J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B135<br />

Goedken, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B115<br />

Goel, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A125<br />

Goetz, M C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D156<br />

Gold, M S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A34<br />

Goldberg, R J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B46<br />

Goldberg, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D133<br />

Goldenberg, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C153*<br />

Goldenheim, A M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B102*<br />

Goldman, H B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C35<br />

Goldstein, D J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B125<br />

Goldstein, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P2<br />

Golightly, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B133<br />

Golightly, Y M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B21<br />

Gomez, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D106<br />

Gómez, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D106, D107<br />

Gómez, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D107<br />

Gomez-Marin, O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D100<br />

Gommers, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C80<br />

Gomolin, I H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C100<br />

Gonzales, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A116*<br />

Goode, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B132<br />

Goodson, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A149*<br />

Goodwin, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D99<br />

Goodwin, J S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B107*, P11*<br />

Gopalraj, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C6<br />

Gopaul, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D89<br />

Gorawara-Bhat, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A103*<br />

Gorbach, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C37<br />

Gorbien, M . . . . . . . . . . . . . . . . . . . . . . . . . . .A5, A6, C18, D19<br />

Gordon, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A37, C41<br />

Gordon, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D73<br />

Goren, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D71<br />

Gorospe, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B56*<br />

Gosian, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A155<br />

Gottesman, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C89<br />

Gottesman, E M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A126<br />

Gottlieb, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D36, P23<br />

Gottlieb, S H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C15<br />

Gottschalk, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D161<br />

Goubran, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B162<br />

Gould, E M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A35<br />

Grady, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C33<br />

Graham, S M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D31<br />

Grammas, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D20*<br />

Grandinetti, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B157<br />

Grandinetti, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B157<br />

Graves, A D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B64<br />

Gray, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P31<br />

Gray, S L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B81<br />

Green, P S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />

Greene, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B11<br />

Greene, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B87*<br />

Gregg, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P29<br />

Gregory, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P25<br />

Greysen, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A105*<br />

*Indicates presenting author<br />

AGS 2012 ANNUAL MEETING<br />

S249


A UTHOR<br />

I NDEX<br />

Griebling, T L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C34<br />

Griffith, J L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D55<br />

Grissom, C K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P20<br />

Griswold, M E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P29<br />

Groce-Martin, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D72<br />

Grooms, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C20<br />

Grossberg, G T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C140<br />

Grossman, S N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A128<br />

Gruber-Baldini, A L . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B168*<br />

Gruenewald, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B32<br />

Gryczynski, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B117<br />

Guerra, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D128<br />

Guerrant, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B137<br />

Gugliucci, M R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D58<br />

Guh, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C145*<br />

Gulati, G . . . . . . . . . . . . . . . . . . . . . . . . . . .A16, A17, D3*, D4*<br />

Gulati, S . . . . . . . . . . . . . . . . . . . . . . . . . . .A16*, A17*, D3, D4<br />

Guo, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A104<br />

Guo, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A87*<br />

Gupta, A . . . . . . . . . . . . . . . . . . .B143*, C12*, C25, C130, D24<br />

Gupta, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A16<br />

Gupte, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A85, D113<br />

Gure, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B47*, B78<br />

Gurnani, A S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A139<br />

Gurwitz, J . . . . . . . . . . . . . . . .A64, A68, C81, C106, D73, D74<br />

Gurwitz, J H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B46<br />

Gutierrez, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B152<br />

Gutkoski, T P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A57*<br />

Guzik, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C130*<br />

Gyurmey, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A26*<br />

Ha, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B47, B78<br />

Haan, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D44<br />

Habegger, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A38*<br />

Hackney, M E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C84<br />

Haddon, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B114<br />

Hade, E M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B120<br />

Haider, A H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A162<br />

Hajduk, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B46<br />

Hajjar, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C73<br />

Hak, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C148<br />

Halade, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A87, D93<br />

Hall, M H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B94<br />

Hall, W J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D15<br />

Hallen, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D7<br />

Halm, E A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A60<br />

Halphen, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B93<br />

Hambridge, H L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A162<br />

Hamdan, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A86, B90<br />

Hameed, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A118*<br />

Hamrick, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B71<br />

Han, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D132<br />

Han, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P28<br />

Hanlon, J T . . . . . . . . . . . . . . . . . . . . . . . . . . . .B49, B81, B109*<br />

Hanoi, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B12<br />

Hans, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B84, D149<br />

Hanson, A J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18*<br />

Hanson, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C115<br />

Hanson, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B20<br />

Hanson, L C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B116<br />

*Indicates presenting author<br />

S250<br />

AGS 2012 ANNUAL MEETING<br />

Harada, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D62<br />

Hardy, S E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A52, A159*<br />

Haring, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B100*<br />

Harrigan, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B157<br />

Harris, E S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P20<br />

Harris, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A137*, B48<br />

Harris, T B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P30<br />

Harrold, L R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C106<br />

Hartley, C J . . . . . . . . . . . . . . . . . . . . . . . . . . . .A62, C61, C149<br />

Hartvigson, P E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A131*<br />

Harvath, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C79<br />

Harvey, S M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A134*<br />

Hasan, O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B103<br />

Hashim, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A92*<br />

Hastings, S N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A42*, D35<br />

Hathaway, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B6*<br />

Haukoos, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P6<br />

Hausman, D B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B48<br />

Hausman, S P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C132<br />

Haut, E R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A162<br />

Hava, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A36*<br />

Hawkins, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C161<br />

Hawley, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C107<br />

Hayashi, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B60*, C1<br />

Hayes, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A80, B71<br />

Hayley, D C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C124*<br />

Hayward, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C121*<br />

Hazelet, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D76, D108<br />

Hazelett, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A67, B69<br />

Hazelett, S E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D104<br />

Hazuda, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C96, D94<br />

Hecht, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D133*<br />

Heckler, C E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B3<br />

Hede, S V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A62*<br />

Heflin, M T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D68<br />

Heh, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A144*, C151<br />

Heilman, K M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C12<br />

Heim, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A132<br />

Heinen, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A74, A106<br />

Hemmerich, J A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B171*<br />

Henault, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P9<br />

Hendrix, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D31<br />

Herbert, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D81*<br />

Herman, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A155<br />

Hernan, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D128<br />

Herndon, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D103<br />

Herr, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B149, D150<br />

Hersh, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C73<br />

Hess, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P25<br />

Hess, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C107<br />

Hesse, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A156<br />

Hewston, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C76<br />

Hibbs, R M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A158*<br />

High, K P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D122*, D123*<br />

High, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D141<br />

Higuchi, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B122*<br />

Hile, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B96<br />

Hile, E S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B79*, P30*<br />

Hilgert, J B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C46<br />

Hill, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D65*


A UTHOR<br />

I NDEX<br />

Hillstrom, T J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C121<br />

Hilton, T N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D15<br />

Hirani, S A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A162*<br />

Hirano, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C95<br />

Hirsch, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C88<br />

Hirsch, C H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C45*<br />

Hobgood, C D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B29<br />

Hobgood, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A120*<br />

Hochhalter, A K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D111<br />

Hochschild, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B75<br />

Hochschild, A E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D26<br />

Hodroge, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A91*<br />

Hogan, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />

Holcombe, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P16<br />

Holcroft, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A109<br />

Holland, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A28, C5<br />

Holmes, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A39<br />

Holt, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D141<br />

Holtz, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B144<br />

Hoover, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A145<br />

Hopper, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B53*<br />

Horney, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A42, D35<br />

Hornyak, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P24<br />

Hornyak, V A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B166*<br />

Horton, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A41*, A45*<br />

Horwitz, L I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A105<br />

Hosler, M R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A23<br />

Hossain, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P10<br />

Houston, D K . . . . . . . . . . . . . . . . . . . . . . . . . . .B48, D36, P23*<br />

Hovanes, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C103<br />

Howard, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B11*<br />

Howe, J L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D55*<br />

Howell, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B132<br />

Howell, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C72<br />

Hshieh, T T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B119*<br />

Hsieh, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C73<br />

Hsu, D C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C88*<br />

Hu, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B70<br />

Huang, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C33*, P25*<br />

Huang, D L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C111*, C159*<br />

Huang, E S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D152<br />

Huang, Z . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D33, D102<br />

Hubbs, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D161*<br />

Hughes, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B123*<br />

Hughes, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C4<br />

Hughes, T B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C104<br />

Hugo, F N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C46<br />

Hui, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B130<br />

Hui, S L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A47<br />

Huie-Li, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D119<br />

Huisingh-Scheetz, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D59<br />

Hummel, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B47<br />

Hung, W W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A126*, P43*<br />

Hunold, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B27<br />

Hunt, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D105<br />

Hurwitz, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D47<br />

Husain, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C103<br />

Hutchison, L C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D67*<br />

Hwang, U . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B30<br />

Hyde, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B34, P39<br />

Hyer, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B121<br />

Hylek, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B167<br />

Ifon, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A121<br />

Iloabuchi, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B4, C8<br />

Iloabuchi, T C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P44*<br />

Iloputaife, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B86<br />

Imam, S M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D9<br />

Imam, S N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C55<br />

Imran, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C55<br />

Ina, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B60<br />

Inaba, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B68, B124*<br />

Inghan, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B1<br />

Inouye, S K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B119<br />

Into, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A138<br />

Intrator, O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B34, C110<br />

Ioannidis, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A51<br />

Iraqi, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C4*<br />

Ireton, E S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A59<br />

Irvine, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />

Irving, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C80<br />

Isaacs, C G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B27*<br />

Isabelle, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A109<br />

Islam, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B74*, C83*<br />

Itticheria, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C6*<br />

Iturrino, D M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D84<br />

Iwata, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D52*<br />

Izhar, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C12, C25, D24*<br />

Izumi, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A151*, C155<br />

Jaber, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B14*<br />

Jaccard-Ruedin, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C128<br />

Jackson, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P37<br />

Jacob-Filho, W . . . . . . . . . . . . . . . . . . . . . . . . . . .A54, A55, A81<br />

Jacobs, J M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B134*, D145<br />

Jahn, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A155<br />

Jain, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B59<br />

James, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A85, D13*, D113<br />

James, T C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A84*<br />

Jamshed, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A66*, B70<br />

Janardhanan, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A39*<br />

Janes, K F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D58*<br />

Jaume-Anselmi, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C152<br />

Javelot, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D37<br />

Jawad, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D130*<br />

Jeffery, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D126<br />

Jenkins, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B7*<br />

Jennings, J R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A132<br />

Jensen, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C117<br />

Jensen, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D156<br />

Jerome, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A39<br />

Jette, A M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B160<br />

Jetter, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A86, B90<br />

Jiang, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C153<br />

Jinhui, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A51<br />

Johansen, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A68<br />

John, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B138<br />

John, P M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D152<br />

Johnson, E F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B88<br />

Johnson, J C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D72<br />

*Indicates presenting author<br />

AGS 2012 ANNUAL MEETING<br />

S251


A UTHOR<br />

I NDEX<br />

Johnson, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A124, P25<br />

Johnson, K L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C158, D158<br />

Johnson, K S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A42, D97*<br />

Johnson, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C101<br />

Johnson, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P6<br />

Johnson, S B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D9<br />

Johnson, T M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C34<br />

Johnson, II, T M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B76<br />

Johnston, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B108<br />

Johnston, C W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C75*<br />

Jolly, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A37*, C41<br />

Jonas, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A154<br />

Jones, B G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C69, D5<br />

Jones, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A95, D109<br />

Joosten, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C80<br />

Jordan, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B133<br />

Jordan, J M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B21<br />

Jordan, Q . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A124<br />

Joseph, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B17<br />

Josephson, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B89, B158<br />

Josephson, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D162<br />

Joshi, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D33<br />

Jouldjian, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B89, B158<br />

Jovancevic- Misic, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D28*<br />

Juncos, J L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B76<br />

June, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A155<br />

Justice, A C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A105<br />

Kabsoun, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C134<br />

Kaiser, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A112, C68<br />

Kakkar, A K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D164<br />

Kakwan, U . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A27*<br />

Kalayjian, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B141*<br />

Kalender-Rich, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C124<br />

Kalender-Rich, J L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B66*<br />

Kalva, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P20<br />

Kamal, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B124<br />

Kamholz, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B118<br />

Kamm, A M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B171<br />

Kanaan, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B22, C106<br />

Kang, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D132<br />

Kaplan, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C113<br />

Kaplowitz, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C113<br />

Kapoor, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B167*<br />

Karanam, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D100<br />

Kardachi, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D78<br />

Kariolis, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C63, D33*<br />

Karter, A J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D152<br />

Karumanchi, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C55<br />

Karunadharma, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P19<br />

Kashan, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A148*<br />

Kashyap, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D87*<br />

Katon, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A135<br />

Katon, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B42<br />

Katz, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B167<br />

Katz, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C110<br />

Kaul, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C120*<br />

Kaushik, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A29*<br />

Kawai, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B147*<br />

Kay, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C35<br />

*Indicates presenting author<br />

S252<br />

AGS 2012 ANNUAL MEETING<br />

Kayani, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D76<br />

Kayani, N A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A67*, B69*<br />

Kaye, K S . . . . . . . . . . . . . . . . . . . . .A43, A44, A48, B35, C101<br />

Kearsley, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D36, P23<br />

Kelley, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B104<br />

Kelley, A S . . . . . . . . . . . . . . . . . . . .A70, C66*, D101, P7*, P43<br />

Kelley, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A142*<br />

Kelley, S D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A163<br />

Kelz, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C64<br />

Kennedy, G J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A123<br />

Kennedy, R E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A50<br />

Kenny, A M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P22<br />

Kenny, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B72<br />

Keough, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D73, D74<br />

Kerins, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D140<br />

Kerr, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B112, P8<br />

Kerr, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B155<br />

Khalid, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A161<br />

Khalili, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A40<br />

Khan, A . . . . . . . . . . . . . . . . . . . . . . . . . .A68, B80, C72*, C99*<br />

Khan, B A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A47<br />

Khan, S A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P21<br />

Kheirbek, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A95*<br />

Khoo, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A116<br />

Khosla, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A19<br />

Khosravanipour, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B67<br />

Kiel, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P33<br />

Kiely, D K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A90, A96<br />

Kikuchi, E L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A81<br />

Kilpatrick, B S . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A102, B153<br />

Kim, D H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B33*<br />

Kim, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C95*, D80<br />

Kim, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C95<br />

Kim, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A164*<br />

Kind, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C103<br />

Kind, A J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C117*<br />

Kindler, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P4<br />

King, A C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A149<br />

King, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C103*<br />

King, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A155<br />

kinosian, b . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B115*, P10*<br />

Kinosian, B . . . . . . . . . . . . . . . . . . . . . . . . . . .A108, C114, P40*<br />

Kinzie, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A146<br />

Kirk, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A63<br />

Kirschenbaum, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B126<br />

Kistler, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B113, B114<br />

Kistler, C E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B27, C107*<br />

Kitt, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C23*<br />

Kitzman, D W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B48<br />

Klay, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D16<br />

Klepac, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A108<br />

Kline, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C57<br />

Knebl, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A134<br />

Knell, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A100<br />

Knight, S J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P5<br />

Knoefel, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B162<br />

Ko, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A18<br />

Kochersberger, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C110<br />

Kodama, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C42<br />

Koh, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P41


A UTHOR<br />

I NDEX<br />

Kohn, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B143<br />

Kojima, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C53*<br />

Kojima, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C95<br />

Komiyama, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C135*<br />

Koo, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D144<br />

Kopacz, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D102*<br />

Kopits, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D13<br />

Kopits, I M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B160*<br />

Korc-Grodzicki, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A165<br />

Kordahl, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C117<br />

Kosc, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C132<br />

Kostas, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C116<br />

Kostas, T R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B97*<br />

Kothari, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A11*<br />

Kotwal, A A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A110<br />

Kowgier, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />

Koya, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D21*<br />

Kozikowski, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C57<br />

Krahn, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />

Krall, D M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C144*<br />

Kraus, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P25<br />

Kraus, S R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C34<br />

Kraus, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B133<br />

Kraus, V B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B21<br />

Kravvariti, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C112*<br />

Kressig, R W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D27<br />

Krieg, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D149<br />

Krieg, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B84, D149*<br />

Krishna, A . . . . . . . . . . . . . . . . . . . . . . . . . . . .A43, A44, C101*<br />

Kristof, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B151*<br />

Kritchevsky, S B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B48<br />

Kropp, D J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D104<br />

Kuchibhatla, M N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D97<br />

Kulkarni, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A9<br />

Kulkarni, S P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C3<br />

Kuller, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B36<br />

Kumar, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C98*<br />

Kumar, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A157<br />

Kumar, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A157*<br />

Kumari, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A9, B12, D1, D2<br />

Kunik, M E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B54<br />

Kuo, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B107, D99, P11<br />

Kurata, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A61*<br />

Kusz, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C160<br />

Kwak, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D142*<br />

Lachs, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P42*<br />

Lachs, M S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C102<br />

LaCroix, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B44, B120, P31<br />

LaCroix, A Z . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A150<br />

Lagoo-Deenadayalan, S . . . . . . . . . . . . . . . . . . . . . . . . . . .B170<br />

Lahoud, O B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D133<br />

Lai, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C91<br />

Laird, R D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B116<br />

Laiteerapong, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D152<br />

LaMantia, M A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B29*<br />

LaMori, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C54, C93<br />

Lampert, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P2<br />

Lamy, O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B84, D149<br />

Landay, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B141<br />

Landerman, L R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A42<br />

Lands, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A91, A142, A143<br />

Lane, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B130<br />

Langa, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B47<br />

Langa, K M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A56<br />

Langbaum, J B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D141<br />

Langlois, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D141<br />

Lansing, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C59<br />

Lapane, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D95<br />

Lapid, M I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D92<br />

Lasater, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C79<br />

Lassen, M R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D164*<br />

Laszlo, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B84<br />

Lathia, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C147<br />

Lau, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B149<br />

Launer, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B122, C53<br />

Laura, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B63<br />

Le, M T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B125*<br />

Le, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C94<br />

Leal, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A152, A153<br />

Leavitt, J A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D92<br />

Lecea, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A148<br />

Lederman, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B141<br />

Lee, D S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D138<br />

Lee, H B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C48<br />

Lee, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D153*, P39<br />

Lee, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B105, P38<br />

Lee, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B78<br />

Lee, R H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P45*<br />

Lee, S . . . . . . . . . . . . . . . . . . . . . . . . . . .A15*, A32, B17*, D130<br />

Lee, S J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P1*<br />

Lee, T . . . . . . . . . . . . . . . . . . . . . .A80*, A107*, B71, C55, D79<br />

Lehana, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A51<br />

Leibowitz, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D145<br />

Leiding, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A5, A6, C18<br />

Leiding, M J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D19<br />

Leiferman, K M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B135<br />

Leiter, A C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B126*<br />

Leland, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D117*<br />

Lemay, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C106*<br />

Leng, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A63<br />

Leo-Summers, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B43, P28<br />

Leon, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C89<br />

Leonard, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C134, D75<br />

Leone, A F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C157<br />

Leong, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A104<br />

Lepcha, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A112*<br />

Lerch, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D70*, D134*<br />

Leslee, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C33<br />

Lessard, D M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B46<br />

Lesser, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C130<br />

Lester, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D34<br />

Lester, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C100<br />

Leucker, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A24*<br />

Levenson, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B103*<br />

Leverenz, J B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />

Levey, A I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B11<br />

Levin, M A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P27<br />

Levin, S N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B46*<br />

Levine, A C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B126<br />

*Indicates presenting author<br />

AGS 2012 ANNUAL MEETING<br />

S253


A UTHOR<br />

I NDEX<br />

Levine, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D45*<br />

Levine, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P37*<br />

Levy, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B115<br />

Lewis, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C107<br />

Li, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A63<br />

Li, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C132*<br />

Li, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B169<br />

Li, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A129<br />

Li, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D151<br />

Liang, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B78<br />

Liang, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A98<br />

Liao, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A57<br />

Liberman, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A117, D129<br />

Lichtenberg, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A44, C101<br />

Lidsky, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B170<br />

Limaye, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A75*, A76*, A79<br />

Limm, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C104*<br />

Lin, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B55<br />

Lin, F R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B169<br />

Lin, H M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P27<br />

Lin, J C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D137*<br />

Lin, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A128*<br />

Lin, P S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A93<br />

Lin, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A39<br />

Lin, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C24<br />

Lin, S M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A81<br />

Lin, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D99<br />

Lindeman, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D151*<br />

Lindenberger, E . . . . . . . . . . . . . . . . . . . . . . . . .B101, C58, C66<br />

Lindsey, M L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A87, B142<br />

Lingler, J H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A71<br />

Lipman, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C60*<br />

Lipsitz, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B86, C71<br />

Lipsitz, L A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B33<br />

Lisse, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A145<br />

Litrivis, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D124<br />

Little, M B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A166<br />

Liu, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C67*<br />

Liu, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B128*<br />

Liu, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C108*<br />

Liu, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P32<br />

Liu, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C36<br />

Livote, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B101, C89, P43<br />

Loehrer, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B130<br />

Logio, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A77, P36<br />

Long, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C131<br />

Longenecker, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C26*<br />

Longstreth, W T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A98<br />

Loquias, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D160<br />

Lough, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B86*<br />

Louie, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C37<br />

Lowenstein, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B145, P6<br />

Lowery, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D99*<br />

Lowman, J D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P13<br />

Lowry, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C124<br />

Lowry, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B161*<br />

Loza-Diaz, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C129*, P15<br />

Lu, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C52*<br />

Lu, P H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A136<br />

Lui, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C53<br />

*Indicates presenting author<br />

S254<br />

AGS 2012 ANNUAL MEETING<br />

Lum, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C7*<br />

Luna, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C29*<br />

Luo, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C1<br />

Luong, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D124*<br />

Luque, A E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D15<br />

Lutsky, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D86<br />

Luz, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C90<br />

Lyass, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B128<br />

Lyketsos, C G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C138<br />

Lyles, M F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D30*<br />

Lyons, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C76<br />

Ma, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B168<br />

Maaravi, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D145<br />

MacKenzie, T A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B37<br />

Mackin, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P39<br />

MacKnight, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />

MacLean, E W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B129*<br />

Macnow, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C64*<br />

Madan, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A115*<br />

Madero, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A133<br />

Madrigal-Leer, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C39*<br />

Magaziner, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B168<br />

Maheshwari, N . . . . . . . . . . . . . . . . . . . . . . .A9*, B12*, D1, D2<br />

Mahnken, J D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B66<br />

Mahoney, J F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A71<br />

Maiaroto, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D126<br />

Mailliard, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D59<br />

Majeski, J D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C44<br />

Majid, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D155*<br />

Major, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B84*<br />

Makela, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C29<br />

Makris, U E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P28*<br />

Malik, K S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D14*<br />

Mallon, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D100<br />

Malmstrom, T K . . . . . . . . . . . . . . . . . . . . . . . . . . . .C140, C142<br />

Malone, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C72, C99<br />

Manchester, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A65<br />

Manini, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B120<br />

Manocha, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B13, C125*<br />

Manor, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B86, C136*<br />

Manov, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A13<br />

Mansour, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C2, C56, D127<br />

Manu, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C59*<br />

Manwani, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A63, B61<br />

Manwani, B R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B55*<br />

Marallag, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P19*<br />

Marcantonio, E R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B168<br />

Marchionni, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B41, C146<br />

Marcum, Z A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B49*<br />

Mariano, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D102<br />

Marino, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C165<br />

Marottoli, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D126<br />

Marottoli, R A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A49*<br />

Marszalek, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A117<br />

Marszalek-Litauska, A . . . . . . . . . . . . . . . . . . . . . . . . . . . .C57*<br />

Martelli, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A109*<br />

Martin, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B89, B158<br />

Martinez, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B123<br />

Martinez, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D52, D68*


A UTHOR<br />

I NDEX<br />

Martínez, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C164*<br />

Martínez Almazán, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D40<br />

Masaki, K . . . . . . . . . . . . . . . . . . . . . . . .B68, B120, B122, B157<br />

Masaki, K H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C53<br />

Masick, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D86<br />

Massaro, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B128<br />

Mather, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A119<br />

Matining, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B141<br />

Matti-Orozco, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A8, C16<br />

Mattox, K M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C32<br />

Matusevich, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D128<br />

Mazor, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C106<br />

McBride, J M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B116*<br />

McCann, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B62<br />

McCormick, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C82<br />

McCormick, K R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D148<br />

McCormick MD, PhD, K R . . . . . . . . . . . . . . . . . . . . . . . . .B95<br />

McCranor, B J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B139<br />

McCreath, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B106<br />

McCullough, L B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B54<br />

McCullough, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B18*<br />

McDonough, C M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B160<br />

McGarry, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P7<br />

McGee, S . . . . . . . . . . . . . . . .A64, A65, A68, C81, D73*, D74*<br />

McGhee, H R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D111<br />

McGlann, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A43, A44<br />

McGough, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C94<br />

McGregor, J C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D138<br />

McIntosh, K P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D12*<br />

McLean, S A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B27<br />

McMahan, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P5<br />

McMahon, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D79<br />

McNabney, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D142, P40<br />

McNamara, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C59<br />

McNett, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D63<br />

Medina Munoz, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C55<br />

Meeks, W M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P29<br />

Meganathan, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D110<br />

Mehr, D R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C49*<br />

Mehta, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A77, P36<br />

Mejnartowicz, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D11<br />

Melis, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A74, A106, D77<br />

Mello, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />

Melstrom, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B171<br />

Men, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P20<br />

Mendieta F., M G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B152*<br />

Merkin, S S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A98<br />

Messina, F C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B29<br />

Meulenbroek, O V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C133<br />

Meyers, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A102<br />

Meyers, J L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B153<br />

Mi, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P44<br />

Miao, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B31<br />

Migliori, R J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C161<br />

Milisen, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C80, D32<br />

Miller, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B67<br />

Miller, B L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A128<br />

Miller, D K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B29<br />

Miller, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C37<br />

Miller, M L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D31<br />

Miller, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A27<br />

Miller, R K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D71*, D72*<br />

Mills, W L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A155*, B54*<br />

Min, L . . . . . . . . . . . . . . . . . . . . . . .B39*, B47, B78, B112*, P8*<br />

Minani, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D75<br />

Minnick, A F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D105<br />

Mintzer, M J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D69<br />

Mion, L C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D105*, P32<br />

Mir, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A117, D129<br />

Mitchell, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B113, B114<br />

Mitchell, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D62<br />

Mitchell, S L . . . . . . . . . . . . . . . . . . . . . . . . . . . .A90, A96, B50<br />

Mitnitski, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A122<br />

Modak, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B138<br />

Mody, L . . . . . . . . . . . . . . . . . . . . . . .A44, B35, B39, C59, C101<br />

Moed, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B160<br />

Moffett, H H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D152<br />

Mohammed, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C134*<br />

Mohile, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B3, B91<br />

Mohile, S G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A110<br />

Mohler, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A125<br />

Moiduddin, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C55*<br />

Mold, J W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B111<br />

Molinuevo, J L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D27<br />

Molton, I R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D156*<br />

Moncada, L V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B8<br />

Monette, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A109<br />

Monette, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A109<br />

Monod, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B84, C128, D48*<br />

Montero Odasso, M . . . . . . . . . . . . . . . .B74, C83, D88*, D89*<br />

Montero-Odasso, M . . . . . . . . . . . . . . . . . . . . . . . . . .B82, C141<br />

Montine, T J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />

Montz, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B144<br />

Moodhe, N E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A126<br />

Moons, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D32<br />

Moore, A A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A57, D137<br />

Moore, C C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C47*<br />

Moore, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D104<br />

Moore, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A37, A160, C41<br />

Mor, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B121<br />

Morano, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A126<br />

Moreira, D C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C50<br />

Moreno, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C11<br />

Moret, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C128*<br />

Morgan, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A113<br />

Morgan, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A73<br />

Morgan, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B132<br />

Morley, J E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C140, C142<br />

Morris, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D109<br />

Morrison, L J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D64*<br />

Morrow, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B3<br />

Mossello, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146*<br />

Moudouni, D K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C49<br />

Mouton, C P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C156*<br />

Moye, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A155, B54<br />

Moylan, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P39<br />

Muir, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B74, C83<br />

Muir, S W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D88, D89<br />

Mulgund, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A51<br />

Mulligan, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A155<br />

*Indicates presenting author<br />

AGS 2012 ANNUAL MEETING<br />

S255


A UTHOR<br />

I NDEX<br />

Mulsant, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C137<br />

Mungthin, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A130<br />

Muntner, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B127<br />

Murabito, J M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B128<br />

Murphy, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A65<br />

Murphy, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A46<br />

Murphy, K M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D30<br />

Murray, M D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A88<br />

Mushiyev, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B12, D1<br />

Musich, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C161<br />

Muss, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A37, C41<br />

Mustian, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B3<br />

Myers, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P25<br />

Myers, J S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D71<br />

Mysiw, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B120<br />

Nace, D A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A71<br />

Nadkarni, N K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B163*<br />

Naeim, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B91<br />

Naessens, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C115<br />

Naessens, J M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A127<br />

Nagaraja, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A125*, A145*<br />

Naglie, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162*<br />

Naik, A D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A155, B54<br />

Najm, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A154*<br />

Nakagawa, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A18*, B101*<br />

Nanda, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A83<br />

Naqvi, S S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A22*<br />

Nassef, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A38<br />

Nathan, S N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A21*<br />

Nau, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B36<br />

Navaratnam, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D122, D123<br />

Nazir, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B64*, C8<br />

Neal, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C79<br />

Neamtu, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C20*<br />

Neiberg, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B48<br />

Nelson, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B133<br />

Nelson, A E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B21<br />

Nelson, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C36*<br />

Neukam, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B155*<br />

Newman, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B36, B49<br />

Newman, A B . . . . . . . . . . . . . . . . . . . . . . . . . . .B81, B109, P30<br />

Newman, D K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C34<br />

Newman, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B108*<br />

Newman, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A80<br />

Newton, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B33<br />

Ng, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B140<br />

Ng, W K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C86<br />

Nguyen, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P35*<br />

Nguyen, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A128<br />

Ni, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B160<br />

Nicholas MD, MPH, J A . . . . . . . . . . . . . . . . . . . . . . . . . . . .B95<br />

Nichols, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D7<br />

Nicklas, B J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D30<br />

Nicolas, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B87<br />

Nidadavolu, L S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P21*<br />

Niedernhofer, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B36<br />

Niedernhofer, L J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P21<br />

Nielsen, M E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D163<br />

Nieri, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C134, D75<br />

*Indicates presenting author<br />

S256<br />

AGS 2012 ANNUAL MEETING<br />

Nijgha, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D83<br />

Nitta, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C42*<br />

Nnodim, J O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D80*<br />

Nonnenmacher, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D37<br />

Norman, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P34*<br />

Norris, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D71<br />

Norris, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A39<br />

Nouryan, C . . . . . . . . . . . . . . . . . . . . . . . . . . . .C57, C130, D155<br />

Novak, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C136<br />

Nurpeisov, V . . . . . . . . . . . . . . . . . . . . . . . . . . .A28*, A58*, C5<br />

Nutescu, E A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C54, C93<br />

Nwaiwu, O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C49<br />

Nye, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B71<br />

O’Brien, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P1<br />

O’Connor, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D75<br />

O’Halloran, A M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B72*<br />

O’Leary, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B53<br />

O’Toole, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A69<br />

Oakes, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A115, D136<br />

Oakes, T M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C36<br />

Oates, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B102<br />

Obering, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A78, A100<br />

Odden, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D44*<br />

Ogbevire, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B150<br />

Oh, E S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C138<br />

Ohl, M E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A105<br />

Ohuabunwa, U . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B67<br />

Ohuabunwa, U K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A124*<br />

Okoronkwo, S M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B142*<br />

Okura, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A56*<br />

Olde Rikkert, M . . . . . . . . . . . . . . . . . . . . . . . .A74, A106, D77<br />

Olde Rikkert, M G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C133<br />

Oleson, E . . . . . . . . . . . . . . . . . . . . . . . . . .A64*, A65*, B5, C81<br />

Olmedo, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D11<br />

Olsen, G S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C109<br />

Olson, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A5, A6, C18<br />

Olson, J C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D19<br />

Omonte, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C51, D39*<br />

Ong, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A9, B12<br />

Ong, E C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D1*, D2*<br />

Ooi, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A30*, A141<br />

Ootsuki, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C42<br />

Oreja, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C51, D39<br />

Ornstein, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D101<br />

Orso, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B41<br />

Ortiz, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D39<br />

Ortiz, J R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D114*<br />

Ortiz - Alonso, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C51<br />

Orwig, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B168<br />

Osborn, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D53<br />

Ostfeld-Johns, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B95*<br />

Ostir, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C92*<br />

Otero, D M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C19*<br />

Otsuka, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A12*<br />

Ouchida, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A77, P36*<br />

Ouslander, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D103<br />

Ouslander, J G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C34<br />

Owens, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A132<br />

Ozminkowski, R J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C161


A UTHOR<br />

I NDEX<br />

Paasche-Orlow, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P9*<br />

Pacchia, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B90<br />

Pacchia, C F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A86<br />

Padala, K P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B159, B164<br />

Padala, P R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B159, B164*<br />

Padilha, D P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C46<br />

Padua, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C99, D118*<br />

Pagel, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C99<br />

Palacios, J C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D69<br />

Palla, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D9*<br />

Palla, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D79<br />

Pallan, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A51*<br />

Palli, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D42<br />

Palmer, M H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D151<br />

Palsson, O S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B129<br />

Pan, C X . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A118, C63<br />

Pan, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A37, C41<br />

Pandey, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A121*, C58<br />

Pandya, N . . . . . . . . . . . . . . . . . . . . . .A102*, B153*, C54, C93<br />

Panzer, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A138*<br />

Paolo, A M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B66<br />

Papademetriou, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A95<br />

Pappas, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B170<br />

Paquin, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B97<br />

Paquin, A M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C116*<br />

Pardasaney, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B160<br />

Park, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B42*, B89*<br />

Parker, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B57*<br />

Parker, M M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D152<br />

Parker, R W . . . . . . . . . . . . . . . . . . . . . . . . . . . .A31, C17, C122<br />

Parker, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B102, D47<br />

Parson, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D95<br />

Parulekar, M . . . . . . . . . . . . . . . . . . . . . . . . . . .C2, C56, D127*<br />

Pasquale, D A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A7<br />

Pasquale, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D74<br />

Patel, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C5<br />

Patel, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A96<br />

Patel, N K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C17, C122<br />

Patel, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D160<br />

Patel, R K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C35<br />

Patel, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A119<br />

Patrick, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D65<br />

Patrick, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B162*<br />

Patterson, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />

Paul, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C67<br />

Paulk, M E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A60<br />

Payne, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B67<br />

Pearman, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A91<br />

Pecanac, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C103<br />

Pecorella, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />

Peddagovindu, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B5*<br />

Peduzzi, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A49<br />

Pejovic, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D31<br />

Pekmezaris, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C57, C130<br />

Pena, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P17*<br />

Peña-Cruz, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B139<br />

Pénard, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B72<br />

Penfield, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B56<br />

Peng, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B105*<br />

Peniston, J H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A34<br />

Penmetsa, G K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B10*<br />

Penrod, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P43<br />

Perahia, D G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C36<br />

Peralta, C A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D44<br />

Pereira, F A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P17<br />

Pereira, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B27<br />

Pereira, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A117*, C57<br />

Perera, S . . . . . . .B49, B79, B81, B94, B96, B156, B161, B163,<br />

D28, D157, P24<br />

Pereyra, N F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B152<br />

Perez, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B4, C8<br />

Pergolizzi, J V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A35<br />

Periyakoil, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B147<br />

Perjar, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B133*<br />

Perkal, M F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D126<br />

Perkins, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A47<br />

Peron, E P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B81*<br />

Perry, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A74, A106<br />

Peterson, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B85<br />

Peterson, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D38<br />

Peterson, E N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D154<br />

Peterson, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A78<br />

Petit, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C157*<br />

Peto, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C37<br />

Petrella, R J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B82<br />

Petrovitch, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B122, B124<br />

Pettinger, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P31<br />

Petz, S D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C111<br />

Pham, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A62<br />

Phelan, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D81<br />

Phillips, A T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P27*<br />

Phillips, C D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C49<br />

Philp, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C131*<br />

Pickens, S L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B93*<br />

Pickney, C M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C101<br />

Piecre, J R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B88<br />

Pierre-Jacques Williams, M . . . . . . . . . . . . . . . . . . . . . . . .C109<br />

Pignone, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C107<br />

Pillemer, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C102, P42<br />

Pina, I L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P22<br />

Pinheiro, R S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C50<br />

Pinheiro, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C74, D52<br />

Pinidbunjerdkool, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A130<br />

Pinkerton, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B137<br />

Pinto, E T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C44<br />

Planoutis, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P16<br />

Platts-Mills, T F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B27<br />

Poddig, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D79<br />

Polite, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P4<br />

Pomidor, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C65*<br />

Poole, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A38<br />

Poon, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D83<br />

Poorzand, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A128<br />

Porter, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C74<br />

Powell, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D3<br />

Prager, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D78*, D143*<br />

Prakash, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D146<br />

Prerost, F J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C62*<br />

Previdi, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D127<br />

Protas, E J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D139<br />

*Indicates presenting author<br />

AGS 2012 ANNUAL MEETING<br />

S257


A UTHOR<br />

I NDEX<br />

Pschirer, J P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A71<br />

Psillides, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C2*<br />

Pugh, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B38<br />

Pugh, M J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A45<br />

Pugnaire, M . . . . . . . . . . . . . . . . . . . .A64, A68, C81, D73, D74<br />

Punjabi, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B59<br />

Putnam, B D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C14*<br />

Puymbroeck, M V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C143<br />

Quimbo, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D42<br />

Qureshi, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A161*<br />

Rabinovitch, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P19<br />

Radeos, M S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D33<br />

Radke, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A53<br />

Radwany, S M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D104<br />

Raetz, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D53*<br />

Ragsdale, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B28*, D35*<br />

Ragsdale, P S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D67<br />

Rahbar, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A48, B35*<br />

Rahgoshay, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A12, A20*<br />

Rahman, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C115<br />

Rahman, A S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A127<br />

Raji, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D17, D99<br />

Raju, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A166*<br />

Ramasamy, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A48, B35<br />

Ramasamy, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D146<br />

Ramaswamy, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A70*<br />

Ramirez, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B106<br />

Ramirez-Rivera, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C152<br />

Ramos, M E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D128<br />

Ramsaroop, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A77*, P36<br />

Ramsdale, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P4*<br />

Ramsden, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P34<br />

Ramsey, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C48*<br />

Ramsey, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A146<br />

Rana, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A13*, C85<br />

Rana, S S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A13<br />

Rand, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C104<br />

Rankin, K P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A128<br />

Rao, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P14<br />

Rashad, M A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A8*<br />

Raskin, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C36<br />

Rastogi, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C121<br />

Rasu, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A100<br />

Ratnarajah, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C30*, C40*<br />

Rawl, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B130<br />

Raymond, G L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C163<br />

Raziano, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P40<br />

Reardon, G . . . . . . . . . . . . . . . . . . . . .C54*, C93*, D122, D123<br />

Reckrey, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B18<br />

Reckrey, J M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D101*<br />

Recto, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C112<br />

Redding, J M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D7*<br />

Reddy, A K . . . . . . . . . . . . . . . . . . . . . . . . . . .A62, C61, C149*<br />

Reed, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P19<br />

Regev, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B54<br />

Rehm, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D56*, D60<br />

Reichstadt, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A25<br />

Reid, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C113, D45<br />

*Indicates presenting author<br />

S258<br />

AGS 2012 ANNUAL MEETING<br />

Reid, M C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D41, D116<br />

Reidy, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D73<br />

Reisner ( AGS-F ), M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D14<br />

Renner, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B133<br />

Renner, J B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B21<br />

Rennke, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C108<br />

Resnick, N M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B81, B94<br />

Restrepo, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C150, D130<br />

Resurreccion, I P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C31*<br />

Reuben, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B112, P8<br />

Reuben, D B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B106*, P38<br />

Rhodes, R L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A60*<br />

Rianon, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A46*, A100*<br />

Richardson, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D93<br />

Richardson, J K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D80<br />

Richter, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P25<br />

Richter, H E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B132*<br />

Riggs, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B130*<br />

Rigler, S K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B66<br />

Rimediotti, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />

Rimler, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B67<br />

Rios, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A51<br />

Rios Rojas, L E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C100*<br />

Rios-Bedoya, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C90<br />

Ritchie, C S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D62<br />

Ritchie, E K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C38*<br />

Rittman, M R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C143<br />

Ritvo, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />

Rivara, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B131<br />

Rivera, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P39*<br />

Rivera, K B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D84*<br />

Rizzoli, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B58<br />

Robben, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A74*, A106*<br />

Roberts, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D66<br />

Roberts, J E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D41, D116*<br />

Robertson, I H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B72<br />

Robinson, M J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C36<br />

Robison, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B151<br />

Roboz, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C38<br />

Robuccio, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C81<br />

Robuccio, B L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D74<br />

Rochat, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D48<br />

Rochat, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B84<br />

Rockwood, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A122<br />

Rodgers, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A101*<br />

Rodriguez, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D106, D107<br />

Roffe, E . . . . . . . . . . . . . . . . . . . . . . . . . . .A9, B12, C3, D1, D2<br />

Rogers, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D120<br />

Rogers, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P25<br />

Roggin, K K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B171<br />

Rohan, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C38<br />

Rohner, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D114, D136<br />

Roiland, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C103<br />

Rommesser, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D12<br />

Rondina, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P20*<br />

Roos, B A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D100<br />

Rosano, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B163, D157<br />

Rose, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C76<br />

Rosen, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C102*, P42<br />

Rosen, H J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A128


A UTHOR<br />

I NDEX<br />

Rosenberg, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D109<br />

Rosenberg, D E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C111<br />

Rosenthal, R A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D126<br />

Ross, G W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C53<br />

Ross, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C148, D130<br />

Ross, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B122<br />

Ross, W G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B124<br />

Rosso, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A78<br />

Roth, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B106<br />

Roth, D L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P13<br />

Rothenberg, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B117*<br />

Rothrock, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D62<br />

Rowan, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D83<br />

Rowe, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B63<br />

Roy, C N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B139<br />

Ruby, C M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B81<br />

Rudolph, J L . . . . . . . . . . . . . . . . . . . . . . . . . . . .B83, B97, C116<br />

Rue, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B131<br />

Ruiz, M A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D90*, D91*<br />

Rummans, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D92<br />

Rush, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D59<br />

Russell, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B102<br />

Russell, M Q . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D131*<br />

Russo, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C14, D102<br />

Russo, D J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A118<br />

Russotto, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D109<br />

Rustgi, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P12*<br />

Rybar, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D65<br />

Rye, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B11<br />

Saad, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A117, D129<br />

Saad, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D8<br />

Sabbagh, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D141<br />

Sabillo, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A14*<br />

Sachdeva, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C28*<br />

Sachs, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B110<br />

Sachs, G A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B144<br />

Saczynski, J S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B46<br />

Sadak, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A135*<br />

Saengwanitch, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A130<br />

Saifan, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C40<br />

Saito, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C95<br />

Sajid, S S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B3*<br />

Sakely, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C85<br />

Salem, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C158<br />

Salow, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B83, C116<br />

Salter, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A63<br />

Salzman, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C73*<br />

Samala, R V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A14, D160<br />

Samtani, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D76<br />

Sánchez G., E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B152<br />

Sánchez Rodríguez, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C164<br />

Sánchez Rodríguez, J L . . . . . . . . . . . . . . . . . . . . . . . . . . .D40*<br />

Sanchez-Reilly, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D130<br />

Sanders, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B36*<br />

Sanders, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B40<br />

Sanders, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C62<br />

Sanders, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A86*, B90*<br />

Sanders, P W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B127<br />

Sanders, MD MS, A E . . . . . . . . . . . . . . . . . . . . . . . . . . . .C145<br />

Sandhu, S K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C87<br />

Sangarlangkarn, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B65*<br />

Sanon, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D115<br />

Santoro, G M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B41<br />

Santos, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D103<br />

Santos-Modesitt, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A149<br />

Sarkar, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C2, C56, D127<br />

Sarkar, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A134<br />

Sarzynski, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C90*<br />

Satchidanand, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B146*<br />

Satterfield, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P30<br />

Saunders, K T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D141*<br />

Sawyer, P . . . . . . . . . . . . . . . . . . . . . . . . . .A50, B92, B127, D62<br />

Scarborough, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B170*<br />

Schancupp, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D139*<br />

Schapira, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D128*<br />

Scheider, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A120<br />

Schein, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C54, C93<br />

Schers, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A74, A106, D77<br />

Schillerstrom, J E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B125<br />

Schlaudecker, J D . . . . . . . . . . . . . . . . . . . .C118, D54*, D110*<br />

Schmader, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B40, D35<br />

Schmotzer, B J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P22<br />

Schneider, E B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A162<br />

Schnittker, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D98<br />

Schreiber, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D109<br />

Schubert, C C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P14*<br />

Schwartz, A V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P30<br />

Schwartz, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B144<br />

Schwartz, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B145, P6<br />

Segal-Maurer, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D102<br />

Seguin, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C27<br />

Selvage, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D79*<br />

Selwyn, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A46<br />

Seminara, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C30, C40<br />

Seminara, D P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C148<br />

Serra, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C51, D39<br />

Setters, B . . . . . . . . . . . . . . . . . . . .A24, C6, C9, C10, C20, C26<br />

Severson, R . . . . . . . . . . . . . . . . . . . . . . . . . . . .A43, A44, C101<br />

Sevilla, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B80<br />

Sewell, D D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A25<br />

Shah, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B18<br />

Shah, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D15*<br />

Shah, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C115<br />

Shah, N D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A127<br />

Shah, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D86<br />

Shah, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A124, B59*<br />

Shany-Ur, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A128<br />

Sharma, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C129, P15<br />

Sharma, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D18<br />

Sharma, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C19<br />

Sharma, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B143, C29, C130<br />

Sharma, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D16<br />

Shawn, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A133<br />

Shea, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B48<br />

Shega, J . . . . . . . . . . . . . . . . . . . . . . . . . . .B149*, B150*, D150*<br />

Shega, J W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B111<br />

Sheikh, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A146<br />

Shengelia, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D41<br />

Sheppard, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C160*<br />

*Indicates presenting author<br />

AGS 2012 ANNUAL MEETING<br />

S259


A UTHOR<br />

I NDEX<br />

Sheppard, K D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D62*<br />

Sherer, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A73<br />

Sheridan, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A129*<br />

Sherman, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C112<br />

Shertzer-Skinner, R . . . . . . . . . . . . . . . . . . . . . . . . . . .D36, P23<br />

Sheyner, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C32*<br />

Shi, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B133<br />

Shi, S M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A73*<br />

Shi, X . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B21<br />

Shield, R R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A83<br />

Shier, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C127<br />

Shimonov, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D18<br />

Shipley, A J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B154<br />

Shirley, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B88*<br />

Shirley, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A133<br />

Shklar, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A165<br />

Shorr, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B49<br />

Shorr, R I . . . . . . . . . . . . . . . . . . . . . . . . .B81, B109, D105, P32<br />

Shreve, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A108<br />

Siddique, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D133<br />

Sideman, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B9<br />

Sieber, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D161<br />

Siebers, M J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D135*<br />

Siegler, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A77, P36<br />

Silliman, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B102, B167, P9<br />

Silliman, R A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P3<br />

Silverstein, J H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P27<br />

Silvestre, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D8*<br />

Simon, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B117<br />

Simon, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P32<br />

Simonsick, E . . . . . . . . . . . . . . . . . . . . . . . . .B49, B99, P29, P30<br />

Simonsick, E M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B81, B109<br />

Simonson, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C79<br />

Simpkins, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A134<br />

Simpson, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D56, D60<br />

Simpson, K M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C74<br />

Sims, R V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A50<br />

Singer, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D42<br />

Singh, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A48, B35<br />

Singh, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A26, C72<br />

Sinha, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A66<br />

Sinha, S K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B70, P34<br />

Sink, K M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A72, B48<br />

Sinvani, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D86*<br />

Sirisha, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D90<br />

Sison, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D129<br />

Sissoko, M . . . . . . . . . . . . . . . . . . . . . . . . . . .A85, B138*, D113<br />

Sithinamsuwan, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A130*<br />

Siu, A L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P43<br />

Skarf, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B83<br />

Skinner, J S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P7<br />

Skopeljia, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A88<br />

Sloane, P D . . . . . . . . . . . . . . . . . . . . . . . . . .A38, B113*, B114<br />

Sloane, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A42<br />

Smietniansky, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D128<br />

Smiley-Oyen, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B161<br />

Smith, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B98<br />

Smith, A K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B31*, D46<br />

Smith, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D146<br />

Smith, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C76<br />

*Indicates presenting author<br />

S260<br />

AGS 2012 ANNUAL MEETING<br />

Smith, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C117<br />

Smith, S G . . . . . . . . . . . . . . . . . . . . . . . . .A75, A76, A79, B111<br />

Smith, S M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D26<br />

Smoller, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B120<br />

Snyder, E A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B20*<br />

Snyder, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D76<br />

Snyderman, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C73<br />

Sobel, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A43, A44<br />

Sobie, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A140<br />

Soch, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A59<br />

Solberg, L B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D154<br />

Solberg, L M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D154*<br />

Somogyi, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D27<br />

Song, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C62<br />

Sori, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B41<br />

Soria, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C51, D39<br />

Soryal, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D118<br />

Soto, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C77*<br />

Speechley, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D88<br />

Speice, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B62<br />

Spencer, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D48<br />

Spencer, F A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B46<br />

Spencer, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A113<br />

Spini, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B41<br />

Spira, A P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C48<br />

Spritzler, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B141<br />

Sreenivas, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A157<br />

Stallard, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C114<br />

Staskin, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C35<br />

Stecher, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D110<br />

Stecher, A M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C118*<br />

Steel, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C2, C56<br />

Steimle, J A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D112*<br />

Stein, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B67<br />

Stein, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B96*<br />

Steinman, M . . . . . . . . . . . . . . . . . . . . . . . . . . .B87, C108, D43*<br />

Steinman, M A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B85<br />

Stephens-Kelly, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D114<br />

Stessman, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B134, D145*<br />

Steven, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D60<br />

Stevens, A B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D111<br />

Stevens, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D85<br />

Stevens, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D53<br />

Stewart, J T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C32<br />

Stieglitz, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A60<br />

Stijacic-Cenzer, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P1<br />

Stoll, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D149<br />

Stone, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C49<br />

Stotts, A L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D26<br />

Stover, K T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C32<br />

Strauss, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D122, D123<br />

Strauss, M E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D42*<br />

Streiner, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />

Strohmaier, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D27<br />

Strong, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B123<br />

Strotmeyer, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B49<br />

Strotmeyer, E S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B109, P30<br />

Studenski, S . . . . . . . . . . . . . . . . . . . . . . . . . . . .B96, B166, P24<br />

Studenski, S A . . . . . . . .A158, A159, B79, B156, B163, B165,<br />

C133, D28, D157, D159, P30


A UTHOR<br />

I NDEX<br />

Stump, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B110<br />

Styer, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D65<br />

Subak, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P25<br />

Sudore, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D6<br />

Sudore, R L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P5*<br />

Suelzer, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P14<br />

Suemoto, C K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A81<br />

Suen, W . . . . . . . . . . . . . . . . . . . . . . . . .A85*, D47, D54, D113<br />

Suh, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D114<br />

Suh, T T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A23*, B9<br />

Sulapas, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D5*<br />

Sullivan, D H . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B159*, B164<br />

Sun, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C34<br />

Sun, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A165*<br />

Sunday, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A117, C63<br />

Supiano, M A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A82<br />

Suraj, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A133*<br />

Suriyaarachchi, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P15<br />

Sustakoski, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B156*<br />

Sutter, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P14<br />

Suzuki, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C95<br />

Swami, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A53*<br />

Swanson, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B161, C115<br />

Swanson, K M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A127<br />

Sweeney, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P39<br />

Sy, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D1<br />

Sychangco, P D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D102<br />

Syed, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A127, C115*<br />

Syed, Q . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A10*, C55<br />

Szerszen, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C30, C40, C148<br />

Szychowski, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B132<br />

Szydlowski, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P40<br />

Tadd, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C131<br />

Taffet, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D83<br />

Taffet, G E . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A62, C61, C149<br />

Taffet, J D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C61<br />

Tai, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A124<br />

Takahashi, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C115<br />

Takahashi, P Y . . . . . . . . . . . . . . . . . . . . . . . . . .A127, B23, B24<br />

Takenaka, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B157<br />

Talati, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A69<br />

Talebreza, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D54<br />

Talsania, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A1<br />

Tamblyn, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B77<br />

Tamura, B K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B68<br />

Tan, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B107<br />

Tan, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D121*<br />

Tan, R S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C22<br />

Tan, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D121, D132<br />

Tancredi, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C88<br />

Tank, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C2, C56, D127<br />

Tannenbaum, C . . . . . . . . . . . . .B25, B77*, C35*, C137*, D87<br />

Tanner, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B124<br />

Tariot, P N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D141<br />

Tay, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D132<br />

Taylor, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B162<br />

Taylor, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A37, C41<br />

Tegeler, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A99*, B64<br />

Temkin-Greener, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P40<br />

Tena-Nelson, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D103<br />

Teng, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A136<br />

Teodoro, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A6<br />

Teodoro, C D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C18*<br />

Teresi, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C102, P42<br />

Terrien, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C81<br />

Terrin, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B168<br />

Terriquez, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A145<br />

Thai, J N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D46*, D96*<br />

Thaipisuttikul, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A139<br />

Thembani, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C129<br />

Thomas, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B121<br />

Thomas, L M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D146*<br />

Thomas, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A117<br />

Thompson, H J . . . . . . . . . . . . . . . . . . . . . . . . . . . .B131*, C94*<br />

Thompson, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D59*<br />

Thornton, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B7<br />

Thorpe, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B99<br />

Thorud, J L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D111*<br />

Tian, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B160<br />

Tidwell, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D130<br />

Tillou, A K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A57<br />

Tilsley, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C163*<br />

Tims, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A48, B35<br />

Tingus, K D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A136<br />

Tiwari, S C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A157<br />

Tjia, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B22*, C106, D38<br />

Tocco, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D31*<br />

Toffanello, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />

Tomlinson, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />

Tong, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C35<br />

Tooze, J A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B48, D36, P23<br />

Toscano, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A54, A55<br />

Toussi, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C133*<br />

Towle, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B52<br />

Towle, V R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D140<br />

Trahan, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D142<br />

Trieu, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C127*<br />

Trochimowicz, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C132<br />

Troke, A M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B144*<br />

Trotti, L M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B76<br />

True, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D72<br />

Truong, T N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D140<br />

Tryzelaar, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D16*<br />

Tsai, E C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />

Tseng, T J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A93*<br />

Tu, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B110, P44<br />

Tubach, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A33<br />

Tucker, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C9*<br />

Tulsky, J A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D97<br />

Tumosa, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C142<br />

Tuqan, A T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P38*<br />

Turker, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P16*<br />

Turner, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B75*<br />

Turner, B J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B38<br />

Turner, M S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B129<br />

Turpie, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D164<br />

Twersky, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B118<br />

Tyagi, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B94*<br />

*Indicates presenting author<br />

AGS 2012 ANNUAL MEETING<br />

S261


A UTHOR<br />

I NDEX<br />

Ukritchon, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A130<br />

Umland, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C76<br />

Unroe, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B110*<br />

Unverzagt, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A88<br />

Uphold, C R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C143*<br />

Urban, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D102<br />

Valades, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C51, D39<br />

Valcour, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B87<br />

Valley, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P6<br />

Valone, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C62<br />

Valoti, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />

van den Heuvel, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B25<br />

Van Hala, S N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A82<br />

van Kempen, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D77*<br />

Van Ness, P H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P2<br />

van Nieuwenhuijzen, L . . . . . . . . . . . . . . . . . . . . . . . . . . . .A74<br />

van Reenen, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P40<br />

Van Son, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A151<br />

Van Son, C R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C155*<br />

Van Swearingen, J M . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B163<br />

van Zuilen, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D69*<br />

Vanguri, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A68<br />

vanLondon, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B96<br />

VanSwearingen, J . . . . . . . . . . . . . . . . . . . . . .B79, B161, B166<br />

VanSwearingen, J M . . . . . . . .A158, B156, D157*, D159, P24<br />

Varma, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A9<br />

Vassar, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B105<br />

Vassar, S D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A98<br />

Vasudev, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D60<br />

Vaughan, C P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B76*, C84*<br />

Vaynshteyn, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C40<br />

Vela, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D18<br />

Vernon, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P19<br />

Verrall, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C158, D158<br />

Verrall, A M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D156<br />

Verscheure, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P34<br />

Vest, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P22<br />

Vickrey, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B105<br />

Vidal, E I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C50*<br />

Vidán, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D39<br />

Vidan - Astiz, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C51<br />

Vidán A., M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B152<br />

Vig, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B51*<br />

Vij, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B143<br />

Villareal, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A78<br />

Villarreal, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D130<br />

Villas Boas, P J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C50<br />

Vitale, C A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C59<br />

Voisine, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A2<br />

Volbrecht, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C99<br />

von Humboldt, S . . . . . . . . . . . . . . . . . . . . . . . . .A152*, A153*<br />

Wagle, K C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D83*<br />

Waite, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A138<br />

Walder, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A155<br />

Walke, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D11<br />

Walke, L M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D126*<br />

Walker, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A7*<br />

Walston, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B55, B61<br />

*Indicates presenting author<br />

S262<br />

AGS 2012 ANNUAL MEETING<br />

Walter, B K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />

Walter, L C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D46, P1<br />

Wan, Z . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C1<br />

Wang, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B56<br />

Wang, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P41<br />

Ward, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C119<br />

Washington, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A115<br />

Wasilenko, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B155<br />

Wasmund, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B90<br />

Wasmund, S L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A86<br />

Wasserman, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D33<br />

Waters, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A112<br />

Waters, T M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P32<br />

Watkins, F S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D61<br />

Watson, G S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />

Wayne, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B86<br />

Webb, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D60<br />

Weber, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P45<br />

Wee, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P41*<br />

Wei, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D147<br />

Wei, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A102, B153<br />

Weiner, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B149, D150<br />

Weiner, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B130<br />

Weingast, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D103<br />

Weintraub, N T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P38<br />

Weir, C R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A82<br />

Wellens, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D32<br />

Wenger, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B112, P8<br />

Wenger, N S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B106<br />

Wert, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B166, P24<br />

Wessel, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D56, D60<br />

Wessell, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B63<br />

Westmoreland, G R . . . . . . . . . . . . . . . . . . . . . . . . . . .A84, B64<br />

Westphal, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D37*<br />

Wetle, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A83<br />

Wey, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B123<br />

Weyrich, A S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P20<br />

Wheaton, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D16<br />

White, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C45<br />

White, S E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D46<br />

White-Chu, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C78*<br />

Whitehead, W E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B129<br />

Whitehouse, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D71<br />

Whitson, H E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A42, B40<br />

Wieland, G D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C114*<br />

Wieman, M S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A34*, A35*<br />

Wierman, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C165*<br />

Wiggins, J E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D125<br />

Wilkinson, C W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />

Williams, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A70<br />

Williams, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C105*<br />

Williams, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D91<br />

Williams, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A37<br />

Williams, G R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C41*<br />

Williams, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A121<br />

Williams, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A75, A76, A79*<br />

Williams, PhD, S W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A36<br />

Williamson, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B48, D61<br />

Williamson, J D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D36, P23<br />

Willmore, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D119


A UTHOR<br />

I NDEX<br />

Wilson, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D66*<br />

Wilson, N L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B54<br />

Wilson, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B171<br />

Wilson, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B48*<br />

Windham, B G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P29<br />

Winter, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B102, P9<br />

Winzelberg, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B63, D66<br />

Wirt, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D22*<br />

Wirtz, H S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P31*<br />

Witt, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D60<br />

Wo, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A132*<br />

Wolf-Klein, G . . . .A117, B143, C57, C130, D86, D129, D155<br />

Wolmark, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A33*<br />

Wong, C L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B136<br />

Wong, J W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B135*, D144*<br />

Wong, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A129<br />

Wong, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C86<br />

Wongvarcharoen, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B122<br />

Wood, R C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C47<br />

Woods, N F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A150*, B44<br />

Wright, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C132<br />

Wright, R M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A71*<br />

Wroe, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B91*<br />

Wu, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C43*<br />

Wu, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C52<br />

Wyman, J F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C34<br />

Xuan, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A60<br />

Yadlosky, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A132<br />

Yaffe, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A149<br />

Yamaguchi, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B60<br />

Yan, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A98<br />

Yanamadala, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B118<br />

Yang, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B55<br />

Yang, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P30<br />

Yang, Z . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A40<br />

Yao, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B126<br />

Yazdani, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D73<br />

Ye, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A31*, A115<br />

Yechoor, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A62<br />

Yeh, C S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C161<br />

Yeh, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A160*<br />

Yeo, C Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C86*<br />

Yeung, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C27<br />

Yin, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B70*<br />

Yorkston, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D158*<br />

Yoshida, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C95<br />

Yoshida, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C95<br />

Young, B A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C159, D152<br />

Young, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A101<br />

Young, L J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C143<br />

Young, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A85, D113<br />

Young, M E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D47*<br />

Yuasa, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B68*<br />

Yuen, J K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D6*<br />

Yulico, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A165<br />

Zaas, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B40<br />

Zafar, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A80<br />

Zaffarana, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />

Zafirau, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D108<br />

Zaldana, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D159*<br />

Zamrini, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B10<br />

Zanetti, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A64, C81, D73<br />

Zaslavsky, O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A150, B44*<br />

Zeballos, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A66<br />

Zelaya, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D63<br />

Zerah, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A33<br />

Zhang, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C1, P18<br />

Zhang, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A154<br />

Zhang, X . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C1<br />

Zheng, Y . . . . . . . . . . . . . . . . . . . . . .B49, B81, B96, B109, D28<br />

Zhou, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C90<br />

Zickmund, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B79<br />

Zierath, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B131<br />

Zimmerman, G A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P20<br />

Zimmerman, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B83*<br />

Zimmerman, S . . . . . . . . . . . . . . . . . . . . . . . .A38, B113, B114*<br />

Zirker, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B73<br />

Zitnay, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B15*<br />

Zitnay, R M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A85, D113<br />

Zmudka, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D25*<br />

Zone, J J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B135<br />

Zulifiqar, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B75<br />

Zweig, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A139*<br />

*Indicates presenting author<br />

AGS 2012 ANNUAL MEETING<br />

S263


K EYWORD<br />

25-hydroxyvitamin D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P23<br />

30 day readmission . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B102<br />

α-synuclein . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B123<br />

AAMC Geriatric Competencies . . . . . . . . . . . . . . . .A75, A79<br />

Accelerometer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B165<br />

Access . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A108, A127<br />

Accidental Falls . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P32<br />

ACE inhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B85<br />

Ace unit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D114<br />

Acetylcholinesterase inhibitors . . . . . . . . . . . . . . . . . . . . .D82<br />

ACGME Competencies . . . . . . . . . . . . . . . . . . . . . . . . . . .D61<br />

ACGME competency . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A70<br />

Achalasia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A7<br />

Acinetobacter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C152<br />

ACOVE measures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D35<br />

Actinomyces israelli . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D3<br />

Action Potential Duration . . . . . . . . . . . . . . . . . . . . . . . .A140<br />

Activity of Daily Living . . . . . . . . . . . . . . . . . . . . . . . . . . . .B33<br />

Acupuncture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C2<br />

Acute . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D118<br />

Acute Care . . . . . . . . . . . . . . . . . . . . . . . . . . .C51, D115, D135<br />

Acute Care consults . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A120<br />

Acute care transfers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A115<br />

Acute coronary syndromes . . . . . . . . . . . . . . . . . . . . . . . . .B41<br />

Acute illness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D39<br />

Acute leukemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C38<br />

Acute musculoskeletal pain . . . . . . . . . . . . . . . . . . . . . . . .B27<br />

Adenocarcinoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C17<br />

Adjustment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A152, A153<br />

ADLs/IADLs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B98<br />

Admission . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D33<br />

ADR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C100<br />

Adult Protective Services . . . . . . . . . . . . . . . . . . . . . . . . . .B93<br />

Adult Still’s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B17<br />

Advance care planning . . . .A80, B52, B53, B63, B101, B104,<br />

C58, C75, P5<br />

Advance directive . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C59<br />

Advanced care planning . . . . . . . . . . . . . . . . . . . . . . . . . . .D21<br />

Adverse health outcomes . . . . . . . . . . . . . . . . . . . . . . . . . .A93<br />

Advocacy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C105<br />

African <strong>American</strong> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D95<br />

Age . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D80<br />

Age differences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A166<br />

Aged . . . . . . . . . . . . . . . .A33, A54, A90, A96, B49, B109, C46<br />

Aggression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P42<br />

Aging . . . . . . . . .A49, A152, B55, B60, B79, C39, C158, D156,<br />

D158, P5, P30<br />

Aging research . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P16<br />

Alcohol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A57, D137<br />

Aldosteronism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B8<br />

ALLOPURINOL . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A11, C5<br />

ALS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A13<br />

Altered mental status . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C16<br />

Alzheimer’s disease . . . . . . . . .A129, A134, C141, C162, D25,<br />

D27, D31, P18<br />

Ambulatory Curriculum . . . . . . . . . . . . . . . . . . . . . . . . . . .A65<br />

Amiodarone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D1<br />

Amputation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C12<br />

I NDEX<br />

Amyloid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C3, P18<br />

Amyloid-beta . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A131<br />

Analgesia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B27<br />

Anatomy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A68<br />

Anemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C87<br />

Anemia of inflammation . . . . . . . . . . . . . . . . . . . . . . . . . .B139<br />

Anesthesia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C40<br />

Anesthesiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P27<br />

Anesthetics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C144<br />

Angiodysplasia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A6<br />

Angiomyolipoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C30<br />

Animal model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B58<br />

Anosognosia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A128<br />

Antibiotic Resistance . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C101<br />

Antibiotic resistant organisms . . . . . . . . . . . . . . . . . . . . . .B39<br />

Antibiotic Stewardship . . . . . . . . . . . . . . . . . . . . . .C101, D102<br />

Antibiotics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C150<br />

Antibiotics use . . . . . . . . . . . . . . . . . . . . . . . . . .A43, A44, C49<br />

Anticholinergic medications . . . . . . . . . . . . . . . . . . . . . . .B168<br />

Anticholinergics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C35, P31<br />

Anticoagulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C71<br />

Antipsychotics . . . . . . . . . . . . . . . . . . . .A101, B22, C106, D37<br />

Anxiety . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A103, C20<br />

Aortic impedance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C149<br />

Apache score . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C152<br />

Aphasia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A22<br />

ApoE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B36<br />

Apolipoprotein E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />

Apoptosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A129<br />

Appropriate documentation . . . . . . . . . . . . . . . . . . . . . . . . .A2<br />

Arrhythmia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A17, A140<br />

Arterial stiffness . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C61, C149<br />

Arteriovenous malformation . . . . . . . . . . . . . . . . . . . . . . . .A9<br />

Arthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B92, C25<br />

Arthroplasty . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D164<br />

Asian . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A97<br />

Aspergilloma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A23<br />

Aspirin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D143<br />

Assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C77, D52<br />

Assessment Tools . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B70<br />

Ataxia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D4<br />

Atheroclerosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B36<br />

Athlete . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A27<br />

Atrial fibrillation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B12<br />

Atrial Fibrillation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C45<br />

Attention . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D28<br />

Atypical antipsychotic . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D79<br />

AUSCAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B21<br />

Autoimmune skin disease . . . . . . . . . . . . . . . . . . . . . . . . .B135<br />

Autoinmune . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C8<br />

Automobile driving . . . . . . . . . . . . . . . . . . . . . . .A49, B145, P6<br />

Autonomic dysfunction . . . . . . . . . . . . . . . . . . . . . . . . . . . .B90<br />

Autophagy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P17<br />

B 12 deficiency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A58<br />

Babesiosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B14<br />

Back Pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P28<br />

Balance confidence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B96<br />

Barriers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C57<br />

Basal Insulin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A102<br />

S264<br />

AGS 2012 ANNUAL MEETING


K EYWORD<br />

I NDEX<br />

Behavioral intervention . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P9<br />

Behavioral Symptoms of Dementia . . . . . . . . . . . . . . . . .B118<br />

Benzodiazepines . . . . . . . . . . . . . . . . . . . . . . . . . . . .A101, B89<br />

Bereavement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D130<br />

Bilateral . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B9<br />

Bilingualism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D11<br />

Biomarker . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B21, B59<br />

Biomarkers . . . . . . . . . . . . . . . . . . . . . . . . . . . .B133, C62, D93<br />

Bipolar disorder . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C48<br />

Bisphosphonates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C27<br />

Bladder dysfunction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C35<br />

Blisters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C8<br />

Blood pressure . . . . . . . . . . . . . . . . .A26, A132, C44, D44, P29<br />

BMI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D75<br />

Bone metastases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B126<br />

Bone mineral density . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A51<br />

Bone Mineral Desity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B23<br />

BOO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B136<br />

Botulinum toxin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A7<br />

BPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B136<br />

BPSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C42<br />

Bradycardia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A62, D147<br />

Brain imaging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D157<br />

Brain mapping . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C141<br />

Brain Tumors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A25, D23<br />

Breast cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D91, P3<br />

Breast Implant Herniation . . . . . . . . . . . . . . . . . . . . . . . . .D17<br />

Built environment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C111<br />

Bullous pemphigoid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B135<br />

C-reactive protein . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C88<br />

C.diff . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D14<br />

CADASIL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A24<br />

Calcium channel blocker . . . . . . . . . . . . . . . . . . . . . . . . . . .B60<br />

Caloric-restriction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P19<br />

Cancer . . . . . . . . . . . . . . . . . . . . . . . .A155, B51, B91, B96, C41<br />

Cancer screening . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B144<br />

Capacity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B54<br />

Capacity to consent . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A159<br />

Capgras syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A139<br />

Cardiac . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A160<br />

Cardiac aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B142<br />

Cardiac amyloidosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D8<br />

Cardiac function . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D145<br />

Cardiac surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A164<br />

Cardiothoracic surgery . . . . . . . . . . . . . . . . . . . . . . . . . . .A166<br />

Cardiovascular . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C61<br />

Cardiovascular Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . .B48<br />

Cardiovascular Medications . . . . . . . . . . . . . . . . . . . .B81, C43<br />

Care coordination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P41<br />

Care management . . . . . . . . . . . . . . . . . . . . . . . . . .A113, C109<br />

Care transition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A127, P41<br />

Care Transitions . .A126, B67, B103, C103, C115, C116, D111<br />

Caregiver . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C143, D112<br />

Caregiver burden . . . . . . . . . . . . . . . . .B151, C86, D101, D154<br />

Caregiver experience . . . . . . . . . . . . . . . . . . . . . . . .B151, C113<br />

Caregiver health . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C113<br />

Caregiver stress . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C91, D85<br />

Caregivers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B98<br />

Caregiving . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D85<br />

Case Report . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A8, C17<br />

Case study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D5<br />

Case-based learning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B65<br />

Catheter Directed Thrombolysis (CDT . . . . . . . . . . . . . .A18<br />

Cause of death . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A56<br />

Cellular senescence . . . . . . . . . . . . . . . . . . . . . . . . . . .B56, P21<br />

Census Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D108<br />

Cerebral . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C3<br />

Cerebral cortical thickness . . . . . . . . . . . . . . . . . . . . . . . .A132<br />

Charles Bonnet Syndrome . . . . . . . . . . . . . . . . . . . . . . . . .D92<br />

Charlson index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B95<br />

Chemotherapy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C38<br />

CHF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C148<br />

Chief resident . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P37<br />

China . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A73<br />

Cholinesterase inhibitor . . . . . . . . . . . . . . . . .D27, D83, D147<br />

Cholinesterase inhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . .C32<br />

Chronic ankle pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D5<br />

Chronic bronchiectasis . . . . . . . . . . . . . . . . . . . . . . . . . . . .A23<br />

Chronic care model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A125<br />

Chronic disease . . . . . . . . . . . . . .A108, B49, C104, D30, D106<br />

Chronic disease management . . . . . . . . . . . . . . . . . . . . . .D100<br />

Chronic hip pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C147<br />

Chronic Illness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A154, B53<br />

Chronic kidney disease . . . . . . . . . . .B111, B127, B128, D152<br />

Chronic obstructive pulmonary disease . . . . . . . . . . . . . . .B45<br />

Chronic pain . . . . . . . . . . . . . . . . . . . . . . . . . . .A166, B38, D45<br />

Citalopram . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D7<br />

Clinical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C19<br />

Clinical Course . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C150<br />

Clinical Economics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P10<br />

Clinical outcome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B137<br />

Clinical trial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A149, C34<br />

Clinical Trials . . . . . . . . . . . . . . . . . . . . . . . . . . .A94, B25, D141<br />

Clinics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P15<br />

Clostridium difficile . . . . . . .B137, C37, D9, D42, D122, D123<br />

CNS aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A137<br />

Co-management program . . . . . . . . . . . . . . . . . . . . . . . . .D126<br />

Co-morbidity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B112, P8<br />

Cochlear implantation . . . . . . . . . . . . . . . . . . . . . . . . . . . .B169<br />

Code status . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B65<br />

Code Status Discussions . . . . . . . . . . . . . . . . . . . . . . . . . . .A59<br />

Cognition . . . . . . . . . . . . . . . . . . . . . . . . .C136, D28, D31, D88<br />

Cognitive Abilities Screening Instrument . . . . . . . . . . . . .D11<br />

Cognitive assessment . . . . . . . . . . . . . . . . . . . . . . . .B108, D11<br />

Cognitive Complications . . . . . . . . . . . . . . . . . . . . . . . . . .A163<br />

Cognitive decline . . . . . . . . . . . . . . . . . . . . . . .C21, C133, C137<br />

Cognitive Dysfunction . . . . . . . . . . . . . . . . . . . . . . . . . . . .D161<br />

Cognitive function . . . . . . . . . . .A107, A159, B32, B122, B166<br />

Cognitive impairment . . . . . .A47, A56, A88, A123, B46, B47,<br />

B78, C89, D140<br />

Cognitive screening . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D119<br />

Cognitive tests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A50<br />

Cognitive-motor interference . . . . . . . . . . . . . . . . . . . . . .C163<br />

Collaboration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A74<br />

Collaborative care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A114<br />

Collagen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P19<br />

Colon cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A28, B130<br />

Colon cancer prevention . . . . . . . . . . . . . . . . . . . . . . . . . . .P16<br />

Colorectal Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P4<br />

AGS 2012 ANNUAL MEETING<br />

S265


K EYWORD<br />

I NDEX<br />

Colorectal cancer screening . . . . . . . . . . . . . . . . . . . . . . .C107<br />

Communication . . . . . . . . . . . . . . . . . . . . . . . .A151, B100, C66<br />

Communication skills . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A70<br />

Community . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B54<br />

Community dwelling elderly . . . . . . . . . . . . . . . . . . . . . . . .D43<br />

Community Education . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C75<br />

Community partnerships . . . . . . . . . . . . . . . . . . . . . . . . . .D111<br />

Community programs . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D72<br />

Community-dwelling elderly . . . . . . . . . . . . . . . . . . .B80, D36<br />

Comorbidities . . . . . . . . . . . . . . . . . . . . .B45, B129, D38, D139<br />

Comorbidity . . . . . . . . . . . . . . . . . . . . . . . . . . . .B42, B167, C82<br />

Comorbidity index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B95<br />

Competence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D57<br />

Competency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C65<br />

Complex patient . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P43<br />

Complexity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A84, C72<br />

Complications of hospitalization . . . . . . . . . . . . . . . . . . . .D68<br />

Comprehensive Geriatric Assessment . .C164, D40, D163, P4<br />

Computational Models . . . . . . . . . . . . . . . . . . . . . . . . . . .A140<br />

Computerized Cognitive Assessment . . . . . . . . . . . . . . .C140<br />

Confusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D4<br />

Congestive heart failure . . . . . . . . . . . . . . . . . . . . . . . . . .D140<br />

Congnitive impairement . . . . . . . . . . . . . . . . . . . . . . . . . .C134<br />

Conjoint analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C107<br />

Constipation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A3<br />

Consultation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A113<br />

Consultation Service . . . . . . . . . . . . . . . . . . . . . . . .A116, A120<br />

Consults . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D135<br />

Consumer-targeted information . . . . . . . . . . . . . . . . . . . . .B77<br />

Continence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B25<br />

COPD severity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B45<br />

Copyright . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B108<br />

Coronary Artery Disease . . . . . . . . . . . . . . . . . . . . . . . . . .D17<br />

Cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A108<br />

Cost-effectiveness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P45<br />

COVE-PIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A64<br />

CPOE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C100<br />

Creutzfeldt-Jakob disease . . . . . . . . . . . . . . . . . . . . . . . . . .B10<br />

Cryptococcal Meningoencephalitis . . . . . . . . . . . . . . . . . .C31<br />

CSF protein 14.3.3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B10<br />

CT scan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B140<br />

Curriculum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A69, B68, C68<br />

Curriculum evaluation . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P35<br />

Curriculum in skin and wound care . . . . . . . . . . . . . . . . . .C78<br />

Deacetylase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P17<br />

Death at home . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D107<br />

Decision making . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B144<br />

Decision making capacity . . . . . . . . . . . . . . . . . . . . . . . . . .C60<br />

Decision-making . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B20, P5<br />

Decision-making capacity . . . . . . . . . . . . . . . . . . . . . . . . . . .D6<br />

Deep vein thrombosis (DVT . . . . . . . . . . . . . . . . . . . . . . .A18<br />

Delirium . . . . .A165, B83, B119, B168, C23, C80, C146, D40,<br />

D57, D66, D83, D115, D127, D132<br />

Delirium screening . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B29<br />

Demented Parents, Stress . . . . . . . . . . . . . . . . . . . . . . . . .D154<br />

Dementia . . . .A22, A39, A40, A99, A107, A130, A135, A138,<br />

A157, B20, B50, B105, B121, B122, B125, B148, C5, C11,<br />

C14, C18, C20, C21, C32, C42, C89, C91, C117, C138, C142,<br />

C145, D2, D10, D20, D38, D83, D129, D142, D147, D148,<br />

D150, D153<br />

Dementia behaviors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C102<br />

Dementia care . . . . . . . . . . . . . . . . . . . . . . . .B118, C119, D138<br />

Dementia with Lewy Bodies . . . . . . . . . . . . . . . . . . . . . . .A139<br />

Demetia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C19<br />

Demyelinating . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A16<br />

Dental care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A39<br />

Dental residency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C68<br />

Depression . . . . . . . . . .A114, C9, C18, C55, C88, C143, D128<br />

Depressive symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B26<br />

Design . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D95<br />

Desire for hastened death . . . . . . . . . . . . . . . . . . . . . . . . . .D48<br />

Diabetes . . . . . . . . . .A50, A102, B140, C112, D15, D94, D152<br />

Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C159<br />

Diagnosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A33, B136<br />

Diastolic dysfunction . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B142<br />

Diastolic function . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A62<br />

Diclofenac . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A34<br />

Dietary vitamin D intake . . . . . . . . . . . . . . . . . . . . . . . . . . .C53<br />

Diffuse Lewy Body Dementia . . . . . . . . . . . . . . . . . . . . . .B13<br />

Diphragmatic Hernia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D24<br />

Direct observation . . . . . . . . . . . . . . . . . . . . . . . . . . . .C66, P36<br />

Disability . . . .B31, B33, B158, B160, C52, C158, D156, D158<br />

Discharge Communication . . . . . . . . . . . . . . . . . . . . . . . .C103<br />

Disruptive Behavior . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D142<br />

Driving . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D155<br />

Driving assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A133<br />

Driving cessation . . . . . . . . . . . . . . . . . . . . . . . . . . . .A49, B145<br />

Driving clinic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A133<br />

Driving safety . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D65<br />

Drug addiction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A10<br />

Drug prescribing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D35<br />

Drug Reaction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C7<br />

Drug-induced stuttering . . . . . . . . . . . . . . . . . . . . . . . . . . .A14<br />

Dual eligible population . . . . . . . . . . . . . . . . . . . . . . . . . .A125<br />

Dual Stiffness flooring . . . . . . . . . . . . . . . . . . . . . . . . . . . .B162<br />

Dual-tasks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D89<br />

Duloxetine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C36<br />

Duodenum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D146<br />

Dynapenia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B2<br />

Dysphagia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B18, C25<br />

E-learning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C80<br />

Early intervention . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C131<br />

Early Onset Dementia . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A24<br />

Early readmission . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D43<br />

Earthquiake . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C42<br />

Echocardiography . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D145<br />

Economic burden . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D42<br />

ECT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C18<br />

Education . . . .A67, A72, A73, A81, B67, B69, B70, C64, C71,<br />

C72, C74, C77, C98, C106, D57, D66, P34<br />

Education in nursing home care . . . . . . . . . . . . . . . . . . . .A115<br />

Education of med. students, residents and fellows . . . . .D110<br />

Educational assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . .D64<br />

Educational innovation . . . . . . . . . . . . . . . . . . . . . . . . . . . .D56<br />

S266<br />

AGS 2012 ANNUAL MEETING


K EYWORD<br />

I NDEX<br />

Educational intervention . . . . . . .B101, D56, D60, D85, D136<br />

Effectiveness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D50<br />

Elder abuse . . . . . . . . . . . . . . . . . . . . . . . . . . . .B125, C156, P42<br />

Elder mistreatment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C102<br />

Elder Self Neglect . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B75<br />

Elder Self-Neglect . . . . . . . . . . . . . . . . . . . . . . . . . . . .B93, D26<br />

Elderly . . . . . .A5, A27, A31, A34, A95, A147, B14, B73, C15,<br />

C40, C71, C98, C112, C160, D42, D90, D91, D121, D124<br />

ElderQuest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C65<br />

Elective joint replacement . . . . . . . . . . . . . . . . . . . . . . . .D143<br />

Electronic Medical Record . . . . . . . . . . . . . . .B23, B24, C123<br />

Electronic medical records . . . . . . . . . . . . . . . . . . . . . . . .B104<br />

Emergencies . . . . . . . . . . . . . . . . . . . . . . . . . . . .A54, A55, D34<br />

Emergency . . . . . . . . . . . . . . . . . . . . . . . . . . . .B170, C122, D33<br />

Emergency department . . . . . . . . .A40, A41, B29, B30, D115<br />

Emergency medicine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A42<br />

Emotion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D153<br />

Emotionalism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D84<br />

EMS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D34<br />

Encepalitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A17<br />

Encephalopathy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B11, D12<br />

End of life . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B98, C57<br />

End of life care . . . . . . . . . . . . . . . . . . . . . . . . .A151, B52, D97<br />

End of life decision making . . . . . . . . . . . . . . . . . . . . . . . . . .P2<br />

End of life pain control . . . . . . . . . . . . . . . . . . . . . . . . . . . .C28<br />

End stage renal disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A9<br />

End-of-life . . . . . . . . . . . . . . . . . . . . . . . . .A19, B31, C13, D46<br />

End-of-life care . . . . . . . . . . . . . . . . . . . . . . . .B154, C14, D134<br />

Endothelial senescence . . . . . . . . . . . . . . . . . . . . . . . . . . . .B60<br />

Enrollment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B150<br />

Epidemiology . . . . . . . . . . . . . . . . . .B46, B127, D37, D44, P32<br />

Epidural abscess . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C16<br />

Erythroid maturation . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B139<br />

Ethical conflicts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C14<br />

Ethics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A19, C60<br />

Ethnic/Racial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A46<br />

Ethnogeriatrics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A32<br />

Evacuation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B121<br />

Evaluation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D51<br />

Evaluation of fellowship programs . . . . . . . . . . . . . . . . . . .P38<br />

Evidence Based Medicine . . . . . . . . . . . . . . . . . . . . . . . . . .D69<br />

Evidence based practice . . . . . . . . . . . . . . . . . . . . . . . . . . .C79<br />

Excimer laser . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D144<br />

Executive Dysfunction . . . . . . . . . . . . . . . . . . . . . . . . . . .A123<br />

Executive Function . . . . . . . . . . . . . . . . . . . . . . . . . .B93, B163<br />

Exercise . . . . . . . . . . . . . . . . . . . . .A149, A160, C95, D28, P24<br />

Factitious disorder . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D20<br />

Factor Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C46<br />

Faculty Development . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D74<br />

Fail elderly . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C10<br />

Failure to thrive . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A8<br />

Fall . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P33<br />

Fall injury prevention . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B162<br />

Fall prevention . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D114<br />

Fall reduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D114<br />

Fall Risk Assessment . . . . . . . . . . . . . . . . . . . . .A72, C94, D89<br />

Falls . . . . . . .A138, A147, B28, B72, B82, B88, C36, C74, C77,<br />

D76, D78, D81, D88, D139, P15, P23, P31, P45<br />

Falls prevention . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C79, C127<br />

Falls risk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D36, P29<br />

Family . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A151, C21<br />

Family caregiver . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A61<br />

Family members . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D155<br />

Family members’ perceptions . . . . . . . . . . . . . . . . . . . . . .C155<br />

Family-centered . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C118<br />

Fear of falling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B166<br />

Feeding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B20<br />

Fellow education . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A85, D64<br />

Female urinary incontinence . . . . . . . . . . . . . . . . . . . . . . .D16<br />

Ferritin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B138<br />

Fever . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B5, B113<br />

Finger-stick burden . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B153<br />

Focus Groups . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D158<br />

Foley Catheter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A146<br />

Food access . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C111<br />

Foot . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C12<br />

Foreign-born elders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A32<br />

Fracture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A20, A51, D148<br />

Fractures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C129, P15, P31<br />

Fragility fractures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A156<br />

Frail . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C34<br />

Frail elderly . . . . . . . . . . . . . . . . . . . . . . . . . . . .A74, A106, D41<br />

Frail older adults . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D104<br />

Fraility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C122<br />

Frailty . . . . .A87, A93, A122, A164, B58, B61, B74, B78, B86,<br />

C82, C83, D59, D75, D77, D90, D93, D94<br />

Frontotemporal Dementia . . . . . . . . . . . . . . . . . . . . . . . .A128<br />

Functional ability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C155<br />

Functional Assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . .A37<br />

Functional assessment OSCE . . . . . . . . . . . . . . . . . . . . . . .A82<br />

Functional decline . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D39<br />

Functional disparities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B99<br />

Functional gastrointestinal disorder . . . . . . . . . . . . . . . . .B129<br />

Functional history taking . . . . . . . . . . . . . . . . . . . . . . . . . .A76<br />

Functional Impairment . . . . . . . . . . . . . . . . . . . . . . . . . . . .B31<br />

Functional Independence Measure . . . . . . . . . . . . . . . . .C138<br />

Functional Performance . . . . . . . . . . . . . . . . . . . . . . . . . . .A93<br />

Functional Reach Test . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D78<br />

Functional Recovery . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C164<br />

Functional status . . . . . . . . . . . . . . . . . . . . . . . . . . . .B39, B125<br />

Functional test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B156<br />

Gait . . . .A158, B82, B161, B163, C83, C136, C141, D80, D89,<br />

D157, P24<br />

Gait abnormality . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P30<br />

Gait analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C94<br />

Gait Imbalance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B16<br />

Gait speed . . . . . . . . . . . . . . . . . . . . . . . .B128, B156, C92, D44<br />

Game . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C65<br />

Gastrointestinal bleeding . . . . . . . . . . . . . . . . . . . . . . . . . . .A9<br />

Gender . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D39<br />

Gene polymorphism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C1<br />

Geriatric . . . . . . . . . . . . .A34, A35, A71, B73, B135, C88, D79<br />

Geriatric Emergency Medicine . . . . . . . . . . . . . . . . . . . . . .B28<br />

Geriatric Assesment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B171<br />

Geriatric assessment . . . . . . . . . .A165, C41, D162, D163, P14<br />

Geriatric assessment skills . . . . . . . . . . . . . . . . . . . . .A75, A79<br />

Geriatric competencies . . . . . . . . . . . . . . . . . . .A72, C73, D61<br />

Geriatric conditions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P8<br />

AGS 2012 ANNUAL MEETING<br />

S267


K EYWORD<br />

I NDEX<br />

Geriatric curriculum . . . . . . . . . . . . . . . . . . . . . . . . . .B64, D68<br />

Geriatric Education . . . . . . . . . . . . . .B62, B66, C69, D67, P35<br />

Geriatric Emergency Medicine . . . . . . . . . . . . . . . . . . . . .D35<br />

Geriatric Medicine Clerkship . . . . . . . . . . . . . . . . . . . . . . .D69<br />

Geriatric Oncology . . . . . . . . . . . . . . . . .A37, C38, C41, D163<br />

Geriatric opd . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A89<br />

Geriatric outpatient . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C86<br />

Geriatric outpatient clinic . . . . . . . . . . . . . . . . . . . . . . . . .C128<br />

Geriatric outpatients . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C85<br />

Geriatric population . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D144<br />

Geriatric service . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D134<br />

Geriatric syndromes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A90<br />

Geriatric Tool . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A66<br />

Geriatric training . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B71<br />

Geriatric trauma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A120<br />

<strong>Geriatrics</strong> . . . . . .A10, A39, A109, B102, C56, C67, C68, C115,<br />

C157, D51, D96, D104, P1, P27<br />

<strong>Geriatrics</strong> education . . . . . . . . . . . .A69, C124, D56, P37, P38<br />

<strong>Geriatrics</strong> focus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C123<br />

<strong>Geriatrics</strong> knowledge assessment . . . . . . . . . . . . . . . . . . . .P38<br />

<strong>Geriatrics</strong> Population . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D14<br />

<strong>Geriatrics</strong>/Frail Elders . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D46<br />

Geropsychiatric . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D120<br />

GI Bleed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C26<br />

GI Bleeding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A6<br />

Glucocorticoids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A51<br />

Goal-setting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A106<br />

Goals of care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A2, B18<br />

Goals-of-care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A19<br />

Graduate medical education . . . . . . . . . . . . . . . . . . . . . . . .D60<br />

Gray Matter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C133<br />

Group visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C91<br />

Guidelines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B148<br />

Hand off communications . . . . . . . . . . . . . . . . . . . . . . . . .B103<br />

HBPC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P10<br />

Health Care Expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P7<br />

Health care utilization . . . . . . . . . . . . . . . . . . . . . .A125, D101<br />

Health disparities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D98<br />

Health economics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B115<br />

Health Information Exchange . . . . . . . . . . . . . . . . . . . . .A126<br />

Health Information Technology . . . . . . . . . . . . . . . . . . . . . .P9<br />

Health literacy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C96<br />

Health related outcomes . . . . . . . . . . . . . . . . . . . . . . . . . .D123<br />

Health service use . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A42<br />

Health services research . . . . . . . . . . . . . . . . . . . . . . .B115, P7<br />

Health services use . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A96<br />

Health status . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C96, C156<br />

Health-related quality of life . . . . . . . . . . . . . . . . . . . . . . .C159<br />

Healthcare cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A104<br />

Healthcare costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P43<br />

Healthy aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D63<br />

Hearing impairment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D70<br />

Heart block . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C10<br />

Heart failure . . . .A33, A161, B46, B47, B85, C15, D21, D151,<br />

P2, P22<br />

Heart rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C44<br />

HELP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D127<br />

Hemodialysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D41<br />

Hemorrhage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C3<br />

Herpes Zoster . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A53<br />

High dose statins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C125<br />

Hip Fracture . . . . . . . . .B23, B24, B168, C40, C47, C50, D161<br />

Hip prosthesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D3<br />

Hippocampal sclerosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C19<br />

Hispanics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C96<br />

HIV . . . . . . . . . . . . . . . . . . . . . . . .A105, B87, B141, D15, D90<br />

HIV-Aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A63<br />

HIV/AIDS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A94<br />

Hodgkin Lymphoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A15<br />

Home and Community based care . . . . . . . . . . . . . . . . . . .B81<br />

Home care . . . . . . . . . . . . . . . . . . . . . . .A61, C55, D106, D113<br />

Home visit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C132<br />

Home Visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C124, D133<br />

Homebound . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D101<br />

Homecare . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A121, D117<br />

Homeless persons . . . . . . . . . . . . . . . . . . . . . . . . . . . .A90, A96<br />

Homeostenosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A68<br />

Hospice . . . . . . .A60, A97, A99, B102, B110, B148, C57, C63,<br />

D47, D97<br />

Hospice Care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B117<br />

Hospice quality . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D138<br />

Hospice/Palliative Care . . . . . . . . . . . . . . . . . . . . . . . . . . . .P12<br />

Hospital . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A112, B88<br />

Hospital care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A105<br />

Hospital discharge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C108<br />

Hospital Elder Life Program . . . . . . . . . . . . . . . . . . . . . . .B119<br />

Hospital falls . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D105, P32<br />

Hospital readmission . . . . . . . . . . . . . . . . . . . . . . . . . .D32, P44<br />

Hospital Readmissions . . . . . . . . . . . . . . . . . . . . . . . . . . . .C115<br />

Hospital transfer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D103<br />

Hospitalization . . . . . .A101, B116, C87, C92, D106, P13, P40<br />

Hospitalized elderly . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D129<br />

House call . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B116<br />

House calls program . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C126<br />

Housecalls . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P10<br />

Huddle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A112<br />

Hygroma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D2<br />

Hyperammonemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A3<br />

Hypercalcemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A15, B6<br />

Hypercoagulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A142<br />

Hyperferritinemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B17<br />

Hypernatremia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A12<br />

Hypersensitivity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A30<br />

Hypertension . . . . . . . . . . . . . . . . . . . . . . .A50, A95, B8, B134<br />

Hypoactive Delirium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A4<br />

Hypoglycemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C112<br />

Hypomagnesemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A29<br />

Hyponatremia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A147, D7<br />

ICU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C150<br />

IEED . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D84<br />

IgG2 deficiency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A23<br />

IL-6 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A63<br />

Imipenem . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A4<br />

Immigrant elders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A32<br />

Immune activation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B141<br />

Immune response . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B141<br />

Immunosenescence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B57<br />

Implantable cardioverter defibrillator . . . . . . . . . . . . . . . . .P2<br />

S268<br />

AGS 2012 ANNUAL MEETING


K EYWORD<br />

I NDEX<br />

Implantable Loop Recorders . . . . . . . . . . . . . . . . . . . . . . .A86<br />

Improving Quality of Care . . . . . . . . . . . . . . . . . . . . . . . . .A38<br />

In-hospital Mortality . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C148<br />

Inappropriate medication . . . . . . . . . . . . . . . . . . . . . . . . . .B77<br />

Inappropriate Medications . . . . . . . . . . . . . . . . . . . .B34, C110<br />

Inappropriate prescribing . . . . . . . . . . . . . . . . . . . .B113, B114<br />

Incidence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C54<br />

Incontinence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B132<br />

Infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D3<br />

Infection, antibiotic use, hospitalization . . . . . . . . . . . . . .C59<br />

Infections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C56<br />

Inflammation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A87, B131<br />

Inflammatory arthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A89<br />

Information exchange . . . . . . . . . . . . . . . . . . . . . . . . . . . .D108<br />

Information systems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C131<br />

Injurious Falls . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C45<br />

Injury . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A57, D105<br />

Injury prevention . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D65<br />

Innovation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C69<br />

Inpatient . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C118, D118<br />

Inpatient managment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B35<br />

Inpatient palliative care . . . . . . . . . . . . . . . . . . . . . . . . . . .C157<br />

Inpatient Stay . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D112<br />

Insidious . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D18<br />

Insomnia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A45, B89, B94<br />

Integrated care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D77<br />

Integrative Medicine . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A154<br />

Intensive Care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146, D21<br />

Interactive teaching . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D54<br />

Interdisciplinary care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D59<br />

Interdisciplinary team . . . . . . . . . . . . . . . . . . . . . . . . .A71, D71<br />

Interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A69<br />

Interleukin-6 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B139<br />

Internal medicine residency . . . . . . . . . . . . . . . . . . . . . . . .A66<br />

Internal Medicine Residents . . . . . . . . . . . . . . . . . . .D61, D72<br />

Interprofessional . . . . . . . . . . . . . . .A78, A84, C81, C118, D67<br />

Interprofessional communication . . . . . . . . . . . . . . . . . .D110<br />

Interprofessional education . . . . . .A74, C73, C76, C79, C81,<br />

D62, P39<br />

Interprofessional teams . . . . . . . . . . . . . . . . . . . . . . . . . . .D110<br />

Interprofessional Teamwork . . . . . . . . . . . . . . . . . . . . . . . .D55<br />

Intervention . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D116<br />

Intracranial hemorrhage in Elder Fallers . . . . . . . . . . . . .C45<br />

Intractable hallucinations . . . . . . . . . . . . . . . . . . . . . . . . . .D10<br />

Irritable bowel syndrome . . . . . . . . . . . . . . . . . . . . . . . . .B129<br />

ITP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A11<br />

Japanese-<strong>American</strong> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B124<br />

JCAHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D127<br />

Journals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C56<br />

Karnofsky Performance Status . . . . . . . . . . . . . . . . . . . . . .A37<br />

Kidney tranplant . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D162<br />

Kidney transplant . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A141<br />

Knee Osteoarthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B82<br />

Knee pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C95<br />

Knowledge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C106<br />

Knowledge assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . .D60<br />

Knowledge Translation . . . . . . . . . . . . . . . . . . . . . . . . . . .B119<br />

Laboratory test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D113<br />

Lactobacillus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B15<br />

Late onset rheumatoid arthritis . . . . . . . . . . . . . . . . . . . . .A89<br />

Leadership . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P37<br />

Learning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C144<br />

Length of Stay . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A36, P12<br />

Lens transparency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B36<br />

Leukemia cutis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B7<br />

Lichen Planus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C7<br />

Life sustaining interventions . . . . . . . . . . . . . . . . . . . . . . .B154<br />

Life-space . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B92<br />

Life-sustaining treatment . . . . . . . . . . . . . . . . . . . . . . . . . . .D6<br />

Lipedema . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A31<br />

Lithium toxicity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A12, A14<br />

Long Term Care . . . . . . . . . . . .A38, A102, B115, D122, D123<br />

Long term care facility . . . . . . . . . . . . . . . . . . . . . .C101, D102<br />

Long-term care . . . . . . . . . . . . . . . . . . . . .B153, C54, C78, C93<br />

Long-term care financing . . . . . . . . . . . . . . . . . . . . .C114, D98<br />

Long-term care insurance . . . . . . . . . . . . . . . . . . . . . . . . .A107<br />

Longitudinal analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B44<br />

Longitudinal cohort study . . . . . . . . . . . . . . . . . . . . .B134, C53<br />

Longitudinal curriculum . . . . . . . . . . . . . . . . . .A75, A76, A79<br />

Longitudinal study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C137<br />

Longterm-care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A118<br />

Loss of consciousness . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D20<br />

Low bed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D105<br />

Low income seniors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P44<br />

Low-density lipoprotein receptor-related protein-1 . . .A131<br />

Lower extremity function . . . . . . . . . . . . . . . . . . . . . . . . . .D94<br />

Lung cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C4<br />

Lung Transplantation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B40<br />

Lupus anticoagulant . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A91<br />

Lymphoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C147, D8<br />

Macrophage Activation Syndrome . . . . . . . . . . . . . . . . . . .B17<br />

Malaise . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D18<br />

Male osteoporosis . . . . . . . . . . . . . . . . . . . . . . . . . .A148, B143<br />

Malignancy . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B6, B138, D146<br />

Malnutrition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C39<br />

Mammography . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B107<br />

Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D132<br />

Mandated reporting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D65<br />

Mania . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C48<br />

Matrix Metalloproteinase . . . . . . . . . . . . . . . . . . . . . . . . .B142<br />

May-Thurner syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . .A18<br />

Measurement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B156<br />

Mechanical ventilation . . . . . . . . . . . . . . . . . . . . . .A117, A118<br />

Medical decision making . . . . . . . . . . . . . . . . . . . . . . . . . .B111<br />

Medical decision-making . . . . . . . . . . . . . . . . . . . . . . . . . . .B51<br />

Medical education . . . . . . . . . .A71, A83, C66, C67, C73, D59<br />

Medical intensive care unit . . . . . . . . . . . . . . . . . . . . . . . .D130<br />

Medical Interns . . . . . . . . . . . . . . . . . . . . . . . . .D51, D52, D68<br />

Medical student education . . . . . . . . . . . . . . . . . . . . . . . . .D63<br />

Medical Students . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D69<br />

Medicare . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D99<br />

Medicare Part D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B109<br />

Medication . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B109, C90, D87<br />

Medication adherence . . . . . . . . . . . . . . . . . . . .A88, B49, B75<br />

Medication compliance . . . . . . . . . . . . . . . . . . . . . . . . . . . .B75<br />

Medication discontinuation . . . . . . . . . . . . . . . . . . . . . . . . .C85<br />

AGS 2012 ANNUAL MEETING<br />

S269


K EYWORD<br />

I NDEX<br />

Medication discrepancy . . . . . . . . . . . . . . . . . .B97, D86, D121<br />

Medication Errors . . . . . . . . . . . . . . . . . . . . . . . . . . . .A41, B34<br />

Medication mismanagment . . . . . . . . . . . . . . . . . . . . . . . .D119<br />

Medication reconciliation . . . . . . . . . . . . . . .C116, D86, D121<br />

Medication Review . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B97<br />

Medication safety . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B38<br />

Medication titration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C10<br />

Medications . . . . . . . . . . . . . . . . . . . . . . . . . . .B83, C108, D126<br />

Memantine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D31<br />

Memory . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C35, C144<br />

Memory loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A136, C89<br />

Mentorship . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A83<br />

Metabolic syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D79<br />

Metformin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A29, A58<br />

Mexican-<strong>American</strong> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C47<br />

Microglia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A137<br />

MicroRNA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P21<br />

Mild Cognitive Impairment . . . . . . . . . . . . . . . . . .A136, C142<br />

Mild cognitive impairment (MCI . . . . . . . . . . . . . . . . . . .C139<br />

Mini-mental state exam . . . . . . . . . . . . . . . . . . . . . . . . . . .B108<br />

Mitochondria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B55, B61<br />

MMP-9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A87<br />

MMSE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C134<br />

MNA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C39<br />

Mobile phones . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D100<br />

Mobility . . . . . . . . . . . . . . . . . . . . . . . .B92, B127, C92, P3, P13<br />

Mobility Assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B79<br />

Mobility disability . . . . . . . . . . . . . . . . . . . . . . . . . .B128, C111<br />

MOCA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C134<br />

Model of care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B118, D109<br />

Mortality . . . . . .A95, A122, A162, B37, B42, B47, B78, B120,<br />

B134, B149, B157, B170, C44, C47, C48, C50, C51, D32,<br />

D40, D161<br />

Motor learning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D159<br />

Motor skill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B161, D157<br />

Multi-disciplinary team model . . . . . . . . . . . . . . . . . . . . .C132<br />

Multimodal Education . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D55<br />

Multimorbidity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C52, C104<br />

Multiple Myeloma ( MM . . . . . . . . . . . . . . . . . . . . . . . . . . . .A5<br />

Muscle biopsy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D30<br />

Musculoskeletal pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C27<br />

Myeloproliferative . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A142<br />

Myeloproliferative syndrome . . . . . . . . . . . . . . . . . . . . . .A143<br />

Myocardial infarction . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />

NAMCS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A100<br />

National survey . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B71<br />

Natural Disasters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C23<br />

Navigator . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C81<br />

Neighborhood socioeconomic status . . . . . . . . . . . . . . . . .A98<br />

Neuropsychiatric symptoms . . . . . . . . . . . . . . . . . . . . . . . .A25<br />

Neuropsychological Testing . . . . . . . . . . . . . . . . . . . . . . .A136<br />

Nicastrin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A129<br />

Nocturia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B76, B94<br />

Non cancer pain . . . . . . . . . . . . . . . . . . . . . . . . . . . .B150, D150<br />

Non-malignant pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A100<br />

Non-prescribing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B85<br />

Nonagenarians . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A55<br />

Noncancer pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B149<br />

Nonlinear . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C15<br />

Nontuberculous mycobacterial infection . . . . . . . . . . . .A145<br />

Nonverbal physician-patient communication . . . . . . . . .A103<br />

Normal aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A68<br />

Normal Pressure Hydrocephalus . . . . . . . . . . . . . . . . . . . .D25<br />

NOSOCOMIAL INFECTIONS . . . . . . . . . . . . . . . . . . .B137<br />

NSAIDs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A100, C27<br />

Number needed to treat . . . . . . . . . . . . . . . . . . . . . . . . . . .D50<br />

Nurse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C129<br />

Nurse Practitioner . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P11<br />

Nursing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D120<br />

Nursing education . . . . . . . . . . . . . . . . . . . . . . . . . . . .C80, D70<br />

Nursing home . . . . . . .A99, B34, B39, B50, B68, B110, B121,<br />

C49, C110, C120, D53, D58, D103, P33, P42<br />

Nursing home admission . . . . . . . . . . . . . . . . . . . . . . . . . . .D98<br />

Nursing home care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A115<br />

Nursing home residents . . . . . . . . . . . . . . . . . . . . . . .C59, D43<br />

Nursing homes . . . . . . . . . . . . . . . . . .B113, B114, C102, C135<br />

Nutrition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B164<br />

Nutritional deficiency . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C157<br />

Obesity . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B32, B37, C1, C161<br />

Observational study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B44<br />

Obstructive sleep apnea . . . . . . . . . . . . . . . . . . . . . . . . . . .B158<br />

Occupational Therapy . . . . . . . . . . . . . . . . . . . . . . . . . . . .A157<br />

Octogenarians . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D155<br />

Octreotide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A6<br />

Older Adult . . . . . . . . . . . . . . . . . . . . . . . . .A57, B145, D87, P6<br />

Older adult, lower urinary tract symptoms . . . . . . . . . . . .D87<br />

Older adults . . . . . . . .B29, B96, B99, B130, B165, B169, D30,<br />

D45, D137, D160<br />

Older women . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B25<br />

Oldest old octagenarians nonagenarians . . . . . . . . . . . . .B147<br />

Omeprazole . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C9<br />

On-call . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B68<br />

Opioids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A35<br />

Oral chemotherapy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B130<br />

Oral Health . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A38, C159<br />

Orthostatic Hyoptension . . . . . . . . . . . . . . . . . . . . . . . . . . .D76<br />

Orthostatic hypotension . . . . . . . . . . . . . . . . . . . . . . .B90, P29<br />

OSCE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A81<br />

Osteoarthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . .B21, B133, C2<br />

Osteochondritis dissecans . . . . . . . . . . . . . . . . . . . . . . . . . . .D5<br />

Osteopontin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B59<br />

Osteoporosis . . . . . . .A46, B1, B84, B132, C129, D148, D149<br />

Osteoporosis related fractures . . . . . . . . . . . . . . . . . . . . .A156<br />

Osteoporosis screening . . . . . . . . . . . . . . . . . . . . . . . . . . .A148<br />

Osteosarcopenia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B1<br />

Outcomes . . . . . . . . . . . . . . . . . . . . . . . . .A48, A118, B35, D91<br />

Outcomes assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B22<br />

Outdoor . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B155<br />

Outpatient . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C90<br />

Overuse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B107<br />

Oxidative stress . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A131<br />

PACE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D142, P40<br />

Paced respiration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C33<br />

Pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A155<br />

Pain Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B30<br />

Palliative care . . . . . .A60, A97, B83, C120, C132, C155, D41,<br />

D47, D104, D107, D116, D130, D134<br />

S270<br />

AGS 2012 ANNUAL MEETING


K EYWORD<br />

I NDEX<br />

Palliative care consult . . . . . . . . . . . . . . . . . . . . . . . . . . . .B147<br />

Palliative care education . . . . . . . . . . . . . . . . . . . . . . .B71, D64<br />

Palliative consult . . . . . . . . . . . . . . . . . . . . . . . . . . .A117, D129<br />

Palliative surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C13<br />

Pancreas cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B171<br />

Pancreatic mass . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C4<br />

Parasitic Infections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A8<br />

Parasthesia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C6<br />

Parkinson’s disease . . . . . . . . . . . . . . . .B76, B123, C84, D139<br />

Parkinson’s Disease . . . . . . . . . . . . . . . . . . . . . . . . . . .B124<br />

Patient adherence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B158<br />

Patient engagement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D111<br />

Patient preferences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C107<br />

Patient Safety . . . . . . . . . . . . . . . . . . . . . .A41, B77, B88, B103<br />

Patient Satisfaction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B30<br />

Patient-centered . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C121<br />

Patient-centered care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C76<br />

PC-MRI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D25<br />

Pelvic floor symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . .B132<br />

Peripheral nerve . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P30<br />

Peripheral Neuropathy . . . . . . . . . . . . . . . . . . . . . . . . . . . .B16<br />

Personal Competency Rating Scale . . . . . . . . . . . . . . . . .A128<br />

Perturbation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D80<br />

Pharmacoepidemiology . . . . . . . . . . . . . . . . . . . . . .A45, A114<br />

Pharmacokinetics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A35<br />

Pharmacology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B69<br />

Pharmacy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D82<br />

Phenotypes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A150<br />

Phone call . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C108<br />

Physical activity . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A98, B155<br />

Physical activity/Exercise . . . . . . . . . . . . . . . . . . . . . . .C98, P9<br />

Physical function . . . . . .A158, B120, B146, B166, D15, D159<br />

Physical Performance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P22<br />

Physical restraint . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A61<br />

Physical Therapy . . . . . . . . . . . . . . . . . . . . . . . . . . .C138, C163<br />

Physician assisted suicide . . . . . . . . . . . . . . . . . . . . . . . . . .B154<br />

Pillbox skills . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D119<br />

Pilot trial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C33<br />

Platelet Monocyte Aggregates . . . . . . . . . . . . . . . . . . . . . . .P20<br />

Platelets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P20<br />

Pneumonia . . . . . . . . . . . . . . . . . . . . . . . . .A48, B35, C43, D37<br />

Pneumonitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A30<br />

POEMS Syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B16<br />

POGOe . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D54<br />

Policy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C105<br />

Polycythemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A143<br />

Polyneuropathy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A16<br />

Polypharmacy . . . . . . . . . . . . . . . . . . . . .B87, B97, C116, C133<br />

Polyuria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B12<br />

Popliteal Vein Aneurysm . . . . . . . . . . . . . . . . . . . . . . . . . . . .B9<br />

Positive aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A150, B44<br />

Post Acute care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B64<br />

Post-acute care . . . . . . . . . . . . . . . . . . . . . . . .A52, A159, C164<br />

Post-treatment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A155<br />

Postmenopausal women . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C1<br />

Postoperative . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A163<br />

Postoperative mortality . . . . . . . . . . . . . . . . . . . . . . . . . . .A165<br />

Posttraumatic stress disorder . . . . . . . . . . . . . . . . . . . . . . .C11<br />

Postural complexity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B86<br />

Potentially Inappropriate . . . . . . . . . . . . . . . . . . . . . . . . . .A45<br />

PPA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A22<br />

Practice . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D120<br />

Practice effects . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C139<br />

Practice redesign . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B106<br />

Prediction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B33<br />

Prediction of mortality . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B95<br />

Prehypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A132<br />

Pressure ulcers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C50<br />

Prevelance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D150<br />

Preventing Delirium . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D136<br />

Prevention . . . . . . . . . . . . . . . . . . . . . . . .C153, D131, D141, P1<br />

Preventive . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C120<br />

Preventive care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B144<br />

Primary care . . . . . . . . . . . . . . .A113, A127, C109, C123, D77<br />

Prisoner . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C105<br />

Problem awareness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D70<br />

Prognosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A122, D46<br />

Program of All-inclusive Care for the Elderly . . . . . . . .C119<br />

Propofol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P27<br />

Prospective cohort . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P28<br />

Prospective cohort study . . . . . . . . . . . . . . . . . . . . . . . . . .B131<br />

Prostate cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A103, B126<br />

Prostatic acid phosphatase . . . . . . . . . . . . . . . . . . . . . . . .B126<br />

Prosthetic Joint Infection . . . . . . . . . . . . . . . . . . . . . . . . . . .B15<br />

Protective factors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C62<br />

Proteinuria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B122<br />

Proteomics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D93<br />

Proton pump inhibitor . . . . . . . . . . . . . . . . . . . . . . . . . .C9, C85<br />

Provider factors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A124<br />

Proxy decision making . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B50<br />

Pruritus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B7<br />

PSA screening . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A110<br />

Pseudoachalasia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B18<br />

Psoas sign . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A92<br />

Psoriasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D144<br />

Psychiatric . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D34<br />

Psychiatric illness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D19<br />

Psychological health . . . . . . . . . . . . . . . . . . . . . . . .A110, A130<br />

Psychosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D4<br />

Psychosocial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D125<br />

Psychotropic drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P33<br />

PTSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D82<br />

Public policy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C113<br />

Pulmonary embolus . . . . . . . . . . . . . . . . . . . . . . . . . .A142, C30<br />

Pulse wave velocity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C149<br />

QoL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C158<br />

Qualitative Research . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C127<br />

Qualitative study . . . . . . . . . . . . . . . . . . . . . . . . . . . .D52, D112<br />

Quality Improvement . . . . . . .A85, A104, A126, B104, B114,<br />

D103, D113, D136, P34<br />

Quality indicator . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C110<br />

Quality Indicators . . . . . . . . . . . . . . . . . . . . . . .A109, B112, P8<br />

Quality measure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B38<br />

Quality of care . . . . . . . . . . . . . . . . . . . . . . . .B106, C104, D140<br />

Quality of Life . . . . . . .A152, A153, A154, A157, B152, B155,<br />

C22, C46, C156, C161, C162, D38, D109, D152<br />

Quality-of-Life . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C13<br />

Question Bank . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B66<br />

AGS 2012 ANNUAL MEETING<br />

S271


K EYWORD<br />

I NDEX<br />

Race . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A47, B99<br />

Racial disparities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D97<br />

Radial neuropathy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C135<br />

Radiotherapy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D23<br />

Randomized Clinical Trial . . . . . . . . . . . . . . . . . . . . . . . . . .D26<br />

Randomized controlled trial . . . . . . . . . . . . . . . . . .B150, D50<br />

Rapamycin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B123, P19<br />

Rash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C8<br />

RCT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P24<br />

Re-hospitalization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C130<br />

Reaction Time . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B124<br />

Reactive Oxygen Species . . . . . . . . . . . . . . . . . . . . . . . . . .D49<br />

Readmission . . . . . . . . . .A123, A161, B116, C165, D124, P14<br />

Readmissions . . . . . . . . . . . . . . . . . . . . . . . . . .C99, C121, D125<br />

Recognition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C12<br />

Reconciliation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C90<br />

Reconstructive surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . .D24<br />

Recruitment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D95<br />

Recurrence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D122<br />

REDD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B4<br />

Referral . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P12<br />

Reflective journaling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A83<br />

Regional . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D99<br />

Regional Variation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P11<br />

Registry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D141<br />

Regulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P11<br />

Rehabilitation . . . . . . . . . .A146, A160, A161, C84, C130, P13<br />

Rehabilitation center . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A156<br />

Reimbursement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C109<br />

Relocation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C82<br />

Remaining life expectancy . . . . . . . . . . . . . . . . . . . . . . . . .B111<br />

Renal function . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D145<br />

Renin-angiotensin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B55<br />

Renin-angiotensin system . . . . . . . . . . . . . . . . . . . . . . . . . .B61<br />

Reproductive hormone . . . . . . . . . . . . . . . . . . . . . . . . . . . .C22<br />

Research . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D58<br />

Research Participation . . . . . . . . . . . . . . . . . . . . . . . . . . . .A94<br />

Residency training . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A80<br />

Resident Education . . . . . . . . . . . .A65, B66, D71, D133, P36<br />

Responsiveness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />

Resting metabolic rate . . . . . . . . . . . . . . . . . . . . . . . . . . . .B159<br />

Restorative sleep . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C62<br />

Restricting fatigue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B43<br />

Resuscitation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C63<br />

Resveratrol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P16<br />

Retroperitoneal bleed . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A92<br />

Review . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A88<br />

Revisit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D33<br />

Rhabdomyolysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D1<br />

Rheumatoid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C25<br />

Rheumatological diseases . . . . . . . . . . . . . . . . . . . . . . . . .A145<br />

Risk factor assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D88<br />

Risk Factors . . . . . . . . . . . . . . . . . . . . . . . . .D76, D81, P28, P44<br />

Risk Stratification . . . . . . . . . . . . . . . . . . . . . . . . . . . .B24, B41<br />

Risks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A163<br />

RITUXIMAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A11<br />

Rivaroxaban complications . . . . . . . . . . . . . . . . . . . . . . . .D164<br />

Rivastigmine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D27<br />

Roles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A84<br />

Rotation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D53<br />

Rural Health . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D55<br />

Rural older adults . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C151<br />

Safety awareness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A138<br />

Safety net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A60<br />

Sandwich Generation . . . . . . . . . . . . . . . . . . . . . . . . . . . .D154<br />

Sarcodynapenia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B2<br />

Sarcoidosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B6<br />

Sarcopenia . . . . . . . . . . . . . . . . . . . . . . . . . . . .B1, B2, B37, B58<br />

Score . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C51<br />

Screening . . . . . . . . . . . .B54, B105, B107, B143, D149, P1, P6<br />

Screening tools . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D32<br />

Seeking help . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D151<br />

Self care capacity competencies . . . . . . . . . . . . . . . . . . . . .A76<br />

Self neglect . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A111<br />

Self-assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C131<br />

Self-rated health . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B105, P3<br />

Self-Report . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B79<br />

Seniors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C75<br />

Sensitivity and specificity . . . . . . . . . . . . . . . . . . . . . . . . .A158<br />

Sepsis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C16, P20<br />

Septic arthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A1<br />

Septuagenarian . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C22<br />

Seriously ill inpatient . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B147<br />

Serum anticholinergic activity . . . . . . . . . . . . . . . . . . . . . .C137<br />

Service learning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D72<br />

Shared decision making . . . . . . . . . . . . . . . . . . . . . . . . . . . .B27<br />

Shingles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A53<br />

Short Physical Performance Battery . . . . . . . . . . . . . . . . . .B3<br />

Side effects . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C29<br />

Simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D67<br />

Simulation OSCE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D73<br />

Sirtuin 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P17<br />

Skilled Nursing Facilities . . . . . . . . . . . . . . . . . . . . . . . . . .C103<br />

Skilled nursing facility . . . . . . . . . . . . . . . . . . . . . . . . . . . .C165<br />

Skin cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C153<br />

Sleep . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A149, B76<br />

Sleep apnea . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A143, B89<br />

Sleep-disordered breathing (SDB . . . . . . . . . . . . . . . . . . .B59<br />

Sliding-scale insulin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B153<br />

SLUMS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C140<br />

SLUMS exam . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C142<br />

Small bowel obstruction . . . . . . . . . . . . . . . . . . . . . . . . . . .D12<br />

Small cell cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C4<br />

Smoothness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B161<br />

Social Isolation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D96<br />

Social services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C126<br />

Social support . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A105<br />

Social Work . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D58<br />

Socioeconomic status . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B32<br />

SPIKES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A70<br />

Spironolactone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B8<br />

Spontaneous tumor lysis . . . . . . . . . . . . . . . . . . . . . . . . . . . .A5<br />

Standardized Patients . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D66<br />

Statins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C43<br />

Sternoclavicular joint . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A1<br />

Stroke . . . . . . . . . . . . . . . . . . . . .A36, B120, C136, C143, C163<br />

Student Attitudes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A73<br />

Students . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P39<br />

Sub-acute . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C87<br />

S272<br />

AGS 2012 ANNUAL MEETING


K EYWORD<br />

I NDEX<br />

Sub-acute care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C130<br />

Subclavian stenosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A26<br />

Subcortical hyperintensities . . . . . . . . . . . . . . . . . . . . . . .B163<br />

Subdural hematoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D84<br />

Successful Aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A153<br />

Suicidal ideation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D6<br />

Suicide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D131<br />

Sunblock . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C153<br />

Superior opthalmic vein thrombosis . . . . . . . . . . . . . . . . .A91<br />

Surgery . . . . . . . . . . . . . . . . . . .A109, B167, B170, B171, D126<br />

Surgical complications . . . . . . . . . . . . . . . . . . . . . . . . . . . .B169<br />

Surgical inpatients . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A116<br />

Survey . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C63, D156<br />

Survival . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C17<br />

Sustained attention . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B72<br />

Syncope . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D13, D22<br />

Systematic review . . . . . . . . . . . . . . . . . . . . . .B22, C127, D116<br />

Systems based practice . . . . . . . . . . . . . . . . . . . . . . . . . . . .A77<br />

Systems-based practice . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P36<br />

T cell . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B57<br />

Tachycardia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C20<br />

Tai chi . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B86<br />

Taiwanese . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D137<br />

Tamsulosin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D16<br />

TB Meningitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D18<br />

TBI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A162<br />

Team care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B106<br />

Team-based care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C76<br />

Technology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D96<br />

Telehealth . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D100<br />

Telemedicine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D45<br />

Terminal illness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C28<br />

Terry’s nails . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A28<br />

Tertiary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D118<br />

Thai traditional music . . . . . . . . . . . . . . . . . . . . . . . . . . . .A130<br />

Thermal therapy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C95<br />

Timed Up & Go Test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D78<br />

TMP/SMX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D7<br />

TNF-R1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A63<br />

Topical clindamycin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D9<br />

Total actual costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D135<br />

Total hip arthroplasty . . . . . . . . . . . . . . . . . . . . . . . . . . . .D160<br />

Total knee arthroplasty . . . . . . . . . . . . . . . . . . . . . . . . . . .D160<br />

Total mortality . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C53<br />

Transcatheter aortic valve . . . . . . . . . . . . . . . . . . . . . . . . .B152<br />

Transcriptome, mouse . . . . . . . . . . . . . . . . . . . . . . . . . . . .A137<br />

Transfer of care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A116<br />

Transition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A121<br />

Transition of care . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B19, D86<br />

Transitional Care . . . . . . . . . . . . . . . .C117, D108, D117, D133<br />

Transitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A112, C121<br />

Transitions of care . . . . . . . . .A119, A124, B157, C122, C124,<br />

D47, D71<br />

Traumatic brain injury . . . . . . . . . . . . . . . . . . . . . . .A27, B131<br />

Treatment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D14<br />

Treatment refusal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C60<br />

Triple Antithrombotic Therapy . . . . . . . . . . . . . . . . . . . . . .C26<br />

TSS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B4<br />

Tube feeding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B157<br />

Ulcer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D146<br />

Unbefriended . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C11<br />

Undergraduate medical education . . . . . . . . . . . . . . . . . . .P35<br />

Underweight . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C161<br />

Unexplained Falls . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A86<br />

Unintentional weight loss . . . . . . . . . . . . . . . . . . . . . . . . . .D19<br />

Unplanned . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D124<br />

Unresponsiveness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C24<br />

Unsteadiness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A52<br />

Urinary Catheters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P34<br />

Urinary incontinence . . . . . . .B80, B81, C33, C84, D151, P25<br />

Urinary tract infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C49<br />

Urinary tract infections . . . . . . . . . . . . . . . . . . . . . . . . . . .A146<br />

Utilization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A121, B112<br />

Vaccination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A53<br />

Variability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C83<br />

Venous thromboembolism . . . . . . . . . . . . . . . .B167, C54, C93<br />

Vertebral fracture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D149<br />

VES-13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B91, P4<br />

Veterans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B101<br />

Veterans Health Administration . . . . . . . . . . . . . . . . . . . .C117<br />

Video . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C69, D54<br />

Visual hallucinations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D92<br />

Visual impairment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D92<br />

Vitamin D . . . . . . . . . .A104, B48, B140, C55, C148, P22, P45<br />

Vitamin D deficiency . . . . . . . . . . . . . .A46, A144, C151, D36<br />

Vitamin D Replacement . . . . . . . . . . . . . . . . . . . . . . . . . . .D26<br />

Vitamin D supplement . . . . . . . . . . . . . . . . . . . . . . . . . . . .C151<br />

Vitamin D supplementation . . . . . . . . . . . . . . . . . . .A144, P23<br />

Volunteering . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C160<br />

VTE prophylaxis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D143<br />

Vulnerability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B91<br />

Vulnerable elderly . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C34<br />

Waldenstrom’s macroglobulinemia . . . . . . . . . . . . . . . . . . .D8<br />

Walking ability . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B146, D159<br />

Warfarin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A92, C93, D99<br />

Wear time . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B165<br />

Weekend . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A162<br />

Weight loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B73, C32<br />

Wheelchair wrist drop . . . . . . . . . . . . . . . . . . . . . . . . . . . .C135<br />

Wii Fit technology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B3<br />

Wish to die . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D48<br />

Withdrawal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A117<br />

Wood . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B14<br />

Work force . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D53<br />

Wound dehiscence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D24<br />

Zarit Burden Inventory . . . . . . . . . . . . . . . . . . . . . . . . . . . .C86<br />

Zoledronic Acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B5<br />

Zolpidem . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B11<br />

Zoonoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A21<br />

AGS 2012 ANNUAL MEETING<br />

S273


This page intentionally left blank

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!